Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7260475500138626,-2.8014880720924027,0.0,0.0,0.0,58/87,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;SRP19;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL21;SEC61A1;RPL34;RPL10A;RPL12;RPL35;RPL14;SRP14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.694900713157909,-2.719448863372228,0.0,0.0,0.0,58/91,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;SRP19;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL21;SEC61A1;RPL34;RPL10A;RPL12;RPL35;RPL14;SRP14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,protein targeting to ER (GO:0045047),-0.6787645840257068,-2.6977489344082777,0.0,0.0,0.0,60/99,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;CHMP4B;CHMP4A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;SRP19;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL21;SEC61A1;RPL34;RPL10A;RPL12;RPL35;RPL14;SRP14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,cytoplasmic translation (GO:0002181),-0.6721462306723704,-2.6411484593831696,0.0,0.0,0.0,59/91,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;EIF3M;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;FTSJ1;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL22L1;TMA7;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5993248275308043,-2.4090503034331108,0.0,0.0,0.0,59/110,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;EIF3E;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;PABPC1;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;NCBP2;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;NCBP1;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.711957895343948,-2.31907997719481,0.0,0.0,0.0,19/32,14.47%,RHOJ;RHOA;MEOX2;THBS1;NOTCH1;JCAD;AKT3;KDR;STARD13;PTGS2;PIK3C2A;ANXA1;HDAC7;HDAC9;GATA2;FGF2;KLF4;VEGFA;SRPX2
prerank,peptide biosynthetic process (GO:0043043),-0.5308950181864157,-2.2632083452188883,0.0,0.0003616095570118559,0.002,74/153,20.60%,RPLP1;PCSK5;RPS15;RPL38;RPL18A;RPL41;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;MRPL52;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;GGTA1;RPL6;RPL18;RPS25;AGO2;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;MRPL23;YARS2;RPS9;RPS27;ASMT;RPL21;MRPL10;RPL34;RPL10A;RPL12;RPL35;RPL14;RPL19;RPL37;RPS18;RPS13;RPS15A;RRBP1;MRPS12;MRPL55;MRPL43;MRPL36;DMD;MRPL35;GGT7;RPL3
prerank,epithelial tube morphogenesis (GO:0060562),-0.6788044807240396,-2.2117196687613614,0.0,0.0006328167247707478,0.004,14/32,7.55%,MEF2C;PODXL;COL4A1;SLIT2;ACVR1;ACVRL1;PKD1;BMP4;MTSS1;RASIP1;SOX17;MET;HES1;PRKX
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.6559106555427783,-2.1952345020313553,0.0,0.0007031296941897197,0.005,19/39,13.82%,NRP1;COL4A1;SLIT2;LRP6;TIE1;ENG;LRP5;PKD1;BMP4;RASIP1;SIX1;TGFBR2;KDR;MET;FGF2;NOTCH4;SEMA3E;BMP2;VEGFA
prerank,regulation of ossification (GO:0030278),-0.6454342525943555,-2.143653715648125,0.0,0.0015187601394497947,0.012,18/36,13.74%,MEF2C;BMPR2;ZBTB16;PTN;SGMS2;LRP6;ACVR1;TGFB2;NOTCH1;BMP4;S1PR1;WNT5A;MDK;NBR1;TWIST1;BMP2;ECM1;ENPP1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.5389626779084896,-2.141423036759988,0.0,0.0013806910358634497,0.012,29/88,12.62%,PTPRM;NRP1;TEK;CAV1;SPARC;NRP2;BMPR2;ACVRL1;TIE1;VEGFC;THBS1;CDH13;F3;BMP4;AKT3;KDR;XDH;PRKD1;WNT5A;PPP1R16B;FLT4;FGF2;APOE;AGGF1;CAV2;PIK3CD;NRAS;BMP2;ECM1
prerank,extracellular matrix organization (GO:0030198),-0.45796190456595287,-2.117429913693283,0.0,0.002425797444954533,0.021,97/276,14.58%,COL8A1;SH3PXD2A;ELN;COL12A1;ADAMTSL3;VWF;FLRT2;PECAM1;SPARC;LAMA2;TLL1;SPOCK2;LAMA1;DCN;COL6A3;COL4A1;BSG;ITGA6;COL25A1;MFAP5;ADAMTSL1;COL15A1;COL6A2;COL8A2;VIT;DST;GSN;COL6A1;TGFB2;LAMC3;COL4A2;NDNF;THBS1;GAS6;ITGA5;CYP1B1;VCAM1;PLOD2;COL23A1;CDH1;CD44;ADAMTS5;KDR;APP;ITGA1;FN1;COL5A2;ITGB4;ITGA8;F11R;LAMA3;FBN1;ADAMTS17;SLC39A8;COL4A6;ITGB1;CREB3L1;ICAM1;P4HA1;CAPN2;ADAMTS6;RECK;SH3PXD2B;ADAM10;LOX;LUM;ITGB5;ADAMTS1;PLOD3;ADAM19;ADAMTS14;TGFBI;LAMB2;COL27A1;ECM2;VCAN;FGF2;SERPINE1;COL14A1;CRTAP;MMP11;CAPG;POSTN;JAM3;ITGA7;COL1A1;COMP;ITGA4;ADAMTS20;BGN;ITGB8;P4HA2;ICAM2;TNC;HAS1;ADAM15;AGRN
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.5369399721273678,-2.0681034096374056,0.0,0.006522880086098477,0.056,28/75,13.82%,NRP1;TEK;NRP2;BMPR2;VEGFC;CDH13;F3;PLCG1;JCAD;BMP4;AKT3;KDR;PRKD1;WNT5A;AGTR1;PPP1R16B;MDK;GATA2;FLT4;IGF2;FGF2;AGGF1;PIK3CD;NRAS;BMP2;ITGA4;ECM1;VEGFA
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.4761750023431607,-2.059609459897888,0.0,0.006960983972478225,0.064,68/168,16.39%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;AGO1;RPL32;RPL5;TENT2;RPS10;RPL10;RPS23;RPS24;EIF3E;RPL7;RPL37A;CNOT6L;DCP1B;RPS17;RPS16;RPL39;RPS27A;PABPC1;RPL13;CNOT11;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;TENT4B;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;NCBP2;PAN3;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;NCBP1;RPL19;RPL37;RPS18;NBAS;RPS13;RPS15A;TNKS1BP1
prerank,endothelial cell migration (GO:0043542),-0.603857907325234,-2.0585020440546278,0.0,0.0066656695009185436,0.066,18/37,13.82%,NRP1;NOS3;RHOA;FAP;MYH9;CDH13;CYP1B1;ID1;STARD13;CCN3;ADGRA2;PXN;PRKX;EMP2;PIK3CA;PTP4A3;SOX18;VEGFA
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.8310113114725529,2.057469733372572,0.0,0.14585611596151754,0.145,5/14,4.28%,ACTN2;ATP1B3;ANK2;LRRC38;ATP1B2
prerank,external encapsulating structure organization (GO:0045229),-0.4626725631263645,-2.0558361386327673,0.0,0.006644575610092852,0.071,78/205,14.58%,COL8A1;SH3PXD2A;ELN;ADAMTSL3;VWF;PECAM1;SPARC;LAMA2;SPOCK2;LAMA1;DCN;COL6A3;COL4A1;BSG;ITGA6;MFAP5;ADAMTSL1;COL15A1;COL6A2;COL8A2;VIT;COL6A1;LAMC3;COL4A2;NDNF;THBS1;ITGA5;VCAM1;COL23A1;CDH1;CD44;ADAMTS5;KDR;APP;ITGA1;FN1;COL5A2;ITGB4;ITGA8;F11R;LAMA3;FBN1;ADAMTS17;SLC39A8;COL4A6;ITGB1;ICAM1;ADAMTS6;RECK;LOX;LUM;ITGB5;ADAMTS1;ADAM19;ADAMTS14;TGFBI;LAMB2;COL27A1;ECM2;VCAN;FGF2;SERPINE1;COL14A1;MMP11;HRNR;POSTN;JAM3;ITGA7;COL1A1;COMP;ITGA4;ADAMTS20;BGN;ITGB8;ICAM2;TNC;ADAM15;AGRN
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.7352612341799314,-2.049552957677886,0.0,0.007296004591474503,0.084,13/18,14.47%,RHOJ;JCAD;AKT3;KDR;PTGS2;PIK3C2A;ANXA1;HDAC7;HDAC9;GATA2;FGF2;VEGFA;SRPX2
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.7010657770320298,-2.048863135546504,0.0,0.007101609911316168,0.086,11/22,13.07%,SLIT2;TMSB4X;GSN;KANK1;SSH2;KANK3;KANK4;PRKCD;TMSB10;HIP1R;PFN1
prerank,extracellular structure organization (GO:0043062),-0.45914591877658484,-2.045007256245211,0.0,0.007393963836795053,0.093,77/204,14.58%,COL8A1;SH3PXD2A;ELN;ADAMTSL3;VWF;PECAM1;SPARC;LAMA2;SPOCK2;LAMA1;DCN;COL6A3;COL4A1;BSG;ITGA6;MFAP5;ADAMTSL1;COL15A1;COL6A2;COL8A2;VIT;COL6A1;LAMC3;COL4A2;NDNF;THBS1;ITGA5;VCAM1;COL23A1;CDH1;CD44;ADAMTS5;KDR;APP;ITGA1;FN1;COL5A2;ITGB4;ITGA8;F11R;LAMA3;FBN1;ADAMTS17;SLC39A8;COL4A6;ITGB1;ICAM1;ADAMTS6;RECK;LOX;LUM;ITGB5;ADAMTS1;ADAM19;ADAMTS14;TGFBI;LAMB2;COL27A1;ECM2;VCAN;FGF2;SERPINE1;COL14A1;MMP11;POSTN;JAM3;ITGA7;COL1A1;COMP;ITGA4;ADAMTS20;BGN;ITGB8;ICAM2;TNC;ADAM15;AGRN
prerank,negative regulation of vascular permeability (GO:0043116),-0.822226528147742,-2.040902276232048,0.0,0.007340674007340675,0.096,11/12,15.34%,PDE3A;CLDN5;SLIT2;RAMP2;PTPRJ;PDE2A;CEACAM1;DDAH1;SH3GL2;VEGFA;FERMT2
prerank,positive regulation of chemotaxis (GO:0050921),-0.6009586103601823,-2.0382053544851573,0.0,0.007171922880735141,0.099,18/43,13.91%,NRP1;NTRK3;PTN;TMSB4X;THBS1;CDH13;F3;KDR;STX3;PRKD1;MET;IL6R;MDK;FGF2;HSPB1;EDN3;VEGFA;RARRES2
prerank,regulation of focal adhesion assembly (GO:0051893),-0.5671426619812232,-2.0334808893967,0.0,0.00724862793828311,0.105,22/54,10.48%,NRP1;TEK;LIMS1;VCL;RHOA;ACVRL1;THBS1;ACTG1;PEAK1;LIMCH1;CORO1C;MACF1;PTPRJ;KDR;PHLDB2;APOD;MYOC;EFNA5;SRC;MAP4K4;DUSP3;FAM107A
prerank,regulation of endothelial cell migration (GO:0010594),-0.5185076098481032,-2.0316513732545007,0.0,0.007263635449542496,0.11,30/85,10.62%,PTPRM;NRP1;FOXP1;TEK;RHOJ;SPARC;NRP2;DCN;BMPR2;DAB2IP;PTN;SLIT2;ETS1;ACVRL1;SCARB1;BMPER;THBS1;BMP4;KDR;PRKD1;WNT5A;PRCP;EMP2;CEACAM1;FLT4;FGF2;BCAR1;APOE;EDN1;PIK3CD
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5806818332304413,-2.0270492132593176,0.0,0.007962943786698576,0.125,22/48,14.47%,RHOJ;NOS3;TMSB4X;ETS1;THBS1;PLCG1;JCAD;AKT3;KDR;PTGS2;PIK3C2A;PRKD1;ANXA1;HDAC7;HDAC9;GATA2;ATP5F1B;FGF2;HSPB1;CD40;VEGFA;SRPX2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.6204232423236596,-2.022288988507883,0.0,0.00815067941504723,0.134,18/34,11.50%,NRP1;SEMA6A;DAB2IP;GAB1;VEGFC;RAMP2;NOTCH1;KDR;PRKD1;ERN1;ANXA1;FLT1;SPRY2;PIK3CA;FLT4;MT1G;MAPKAPK2;HSPB1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6422336147406416,-2.0178814835863705,0.0,0.00812926100282422,0.14,17/30,12.49%,ACTB;PECAM1;LAMA2;SLC12A2;CLDN5;VCL;TJP1;ESAM;ACTG1;LSR;F11R;ITGB1;TJP2;OCLN;JAM3;MFSD2A;SLC1A1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.625486238394958,-2.012671147522098,0.0,0.008765683520898506,0.152,8/33,2.97%,PTPRM;PTPRG;DCN;DAB2IP;SLIT2;ACVRL1;THBS1;CORO1C
prerank,retinoic acid metabolic process (GO:0042573),0.7800079065002044,2.0094994271514497,0.0,0.1639916647715475,0.291,4/14,2.49%,ALDH1A2;ALDH8A1;ADH7;CYP26B1
prerank,blood vessel morphogenesis (GO:0048514),-0.5562632166844977,-2.0008610651853984,0.0,0.010577079542596783,0.185,28/54,14.37%,NRP1;CAV1;LAMA1;COL4A1;ENG;RAMP2;LRP5;CYP1B1;ID1;RASIP1;TGFBR2;KDR;TBX1;SOX17;HES1;LOX;FLT1;STRA6;CCBE1;HEY2;FLT4;AGGF1;ADM;SOX18;SLC1A1;ITGB8;VEGFA;CDH2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.5730047689989005,-1.995958816146059,0.0,0.010823348120216927,0.196,17/46,12.40%,NRP1;TMEFF2;TEK;RHOA;PARVB;LAMC3;PIK3R1;PEAK1;FN1;ITGA8;VAMP3;NTN4;PXN;LAMB2;PARVA;MICALL2;ITGA4
prerank,circulatory system development (GO:0072359),-0.4833427037383785,-1.987057359438285,0.0,0.01219226889724974,0.222,36/118,13.73%,TEK;MEF2C;NTRK3;HEG1;PDLIM5;PLCE1;ECE1;MICAL2;ACVR1;PCSK5;ACVRL1;TGFB2;RAMP2;NOTCH1;PKD1;TGFBR2;FN1;TBX1;FBN1;SOX17;CRIP1;SH3PXD2B;STRA6;HDAC9;CXADR;PIK3CA;HEY2;ZFPM2;FLT4;NOTCH4;WDR11;LDB3;SOX18;BMP2;FBXW7;NCOA6
prerank,regulation of angiogenesis (GO:0045765),-0.4456367871171131,-1.985726421455164,0.0,0.012329719411662311,0.233,62/192,13.82%,PTPRM;TEK;RHOJ;SPARC;SEMA6A;DCN;CLDN5;DAB2IP;GAB1;NOS3;HIPK1;ETS1;TIE1;TGFB2;COL4A2;VEGFC;BMPER;RAMP2;THBS1;F3;CYP1B1;PTGIS;CD34;PLCG1;RUNX1;BTG1;AGO1;KDR;SERPINF1;ITGB1;PIK3R6;ADGRA2;PRKD1;WNT5A;ISM1;PPP1R16B;ADAMTS1;FLT1;SPRY2;ECSCR;EMP2;CEACAM1;GATA2;FGF2;SERPINE1;AGO2;AGGF1;KLF4;PIK3CD;SEMA3E;HGS;HSPB1;TWIST1;HHEX;THBS2;ECM1;TSPAN12;ITGB8;STAB1;CD40;AMOT;VEGFA
prerank,translation (GO:0006412),-0.44730265488626053,-1.9784123573678296,0.0,0.01324960017488753,0.257,82/208,17.86%,RPLP1;GATB;RPS15;RPL38;WARS2;RPL18A;RPL41;EEF2K;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;EEF2;MRPL52;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;LARS2;AGO2;RPL36;RPL28;FTSJ1;RPL27;RPL24;RPS29;RPL23;RPL17;MRPL23;YARS2;NDUFA7;RPS9;RPS27;ASMT;ABCE1;RPL22L1;TMA7;RPL21;MRPL10;EEF1E1;RPL34;GARS1;RPL10A;RPL12;RPL35;RPL14;GFM2;RPL19;RPL37;RPS18;RPS13;RPS15A;RRBP1;PTCD3;EEF1G;MRPS12;MRPL55;MRPL43
prerank,regulation of vasculogenesis (GO:2001212),-0.7546459877052858,-1.9748522489152176,0.002004008016032064,0.013423385070894649,0.269,9/14,8.50%,RAPGEF2;RAP1A;CD34;KDR;TMEM100;XDH;EMP2;CEACAM1;HEY2
prerank,sodium ion export across plasma membrane (GO:0036376),0.8013434151810139,1.9701493594691921,0.0,0.21068105638885867,0.485,3/13,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,smooth muscle cell differentiation (GO:0051145),-0.7810838757315202,-1.9683513411704463,0.0,0.014256988563952728,0.29,9/12,17.19%,MEF2C;MRTFB;TMEM204;BMP4;TBX18;HEY2;MYOCD;APLNR;HEY1
prerank,regulation of epithelial cell migration (GO:0010632),-0.5528391222872655,-1.9630440811260825,0.0,0.014934474704589648,0.307,15/51,8.77%,PTPRG;RHOJ;DOCK1;BMPR2;DAB2IP;PTN;TGFB2;BMPER;CORO1C;PLCG1;MACF1;PLCG2;EMP2;CEACAM1;SRC
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.6100681343246226,-1.9622191413884431,0.0,0.014660254123855654,0.311,13/35,9.64%,PDE3A;PDE4D;PDE7B;RAPGEF2;ADGRG6;GUCY1B1;PDE9A;CAP2;PDE2A;ADCY2;CAP1;AHR;APOE
prerank,regulation of cell junction assembly (GO:1901888),-0.630662695734414,-1.961968499252182,0.0,0.014366649967768326,0.313,11/27,7.71%,PRKCH;MEF2C;PDLIM5;RAPGEF2;CLDN5;TJP1;RAP1A;RUNX1;F11R;CBFB;OCLN
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.7459635344256531,-1.958337289112074,0.0,0.014603462879324947,0.327,3/14,3.06%,ABCG2;ABCC1;SLCO2B1
prerank,heme catabolic process (GO:0042167),-0.7459635344256531,-1.958337289112074,0.0,0.014603462879324947,0.327,3/14,3.06%,ABCG2;ABCC1;SLCO2B1
prerank,positive regulation of cell migration (GO:0030335),-0.4273464756858271,-1.9462115727645144,0.0,0.018035276655966312,0.387,82/253,13.82%,NRP1;LEF1;ACTN4;NTRK3;PODXL;CAV1;GCNT2;PECAM1;SEMA6A;DOCK1;RAPGEF2;BMPR2;DAB2IP;GAB1;SEMA3C;ITGA6;TJP1;SEMA7A;ACVR1;TGFB2;INSR;THBS1;NOTCH1;ACTG1;CDH13;F3;EGFR;PLCG1;STAT3;KDR;FN1;MGAT5;PLCG2;CPNE3;ITGB1;ARHGEF2;NIPBL;NUMB;RACK1;ADAM10;TWIST2;CXCL12;FLT1;CCN1;PPP3CA;MDK;MYOC;APC;SPRY2;SRC;PDGFC;TIAM1;SEMA5B;MAP4K4;AGO2;BCAR1;NEDD9;S100A11;EPHB2;RIPOR1;EDN1;FAM107A;NSMF;PIK3CD;SEMA3E;FBXO5;CCN4;CEMIP;COL1A1;RET;BMP2;SEMA3G;PTK2B;PDGFD;SMO;ROR2;HDAC6;PFN1;SHTN1;AKT2;PTPRC;VEGFA
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7890572846109741,-1.9432999853288735,0.0,0.018336250464088984,0.394,5/12,7.11%,PDE4D;CAV1;GJD3;CAMK2D;CALM3
prerank,sodium ion transport (GO:0006814),0.5334156302258786,1.9414110743609203,0.0,0.2492673304527522,0.652,11/85,2.74%,ATP1A2;SLC6A13;SLC6A1;SLC6A12;SLC8A3;SLC5A5;SLC24A3;ATP1B3;SLC6A9;SLC5A10;SLC23A1
prerank,artery morphogenesis (GO:0048844),-0.6166660196136097,-1.9359234409061268,0.0,0.019948793895154047,0.424,14/30,13.83%,NRP1;BMPR2;JAG1;TGFB2;ENG;NOTCH1;BMP4;TBX1;HES1;STRA6;HEY2;TBX2;VEGFA;LRP1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.7059810002237334,-1.9228575017516125,0.0,0.023517235492643136,0.489,8/18,12.51%,MTUS1;PTN;SLIT2;LYN;IL6R;MDK;EDN3;PTK2B
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.7389339096563162,-1.9220365283062515,0.00392156862745098,0.023299161230195712,0.492,8/13,13.82%,NRP1;COL4A1;ENG;TGFBR2;KDR;NOTCH4;SEMA3E;VEGFA
prerank,positive regulation of angiogenesis (GO:0045766),-0.47311763491093634,-1.921584567648413,0.0,0.0228376524672821,0.492,41/108,13.82%,TEK;GAB1;TJP1;NOS3;HIPK1;ETS1;TIE1;VEGFC;BMPER;RAMP2;THBS1;F3;ITGA5;CYP1B1;PTGIS;CD34;PLCG1;RUNX1;BTG1;KDR;ITGB1;PIK3R6;SMAD1;PRKD1;WNT5A;FLT1;MDK;GATA2;FGF2;SERPINE1;AGO2;AGGF1;KLF4;JAK1;PIK3CD;HSPB1;TWIST1;ECM1;ITGB8;CD40;VEGFA
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6556377218450665,-1.9200526486507279,0.002188183807439825,0.022836429633031334,0.501,12/24,15.34%,NRP1;TEK;LIMS1;PIK3R1;PTPRJ;KDR;MYOC;MAP4K4;DUSP3;VEGFA;S100A10;FERMT2
prerank,endothelial cell development (GO:0001885),-0.6292316677192581,-1.9149680919311756,0.0,0.02367003834355265,0.521,10/25,6.89%,PDE4D;PECAM1;RAPGEF2;COL15A1;RAP1A;ICAM1;MET;PDE2A;PPP1R16B;ROBO4
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.6500272063847738,-1.9134877322367179,0.002127659574468085,0.023756994542435152,0.528,7/21,13.72%,CAV1;LRP6;CSNK1A1;APC;PPP1CA;AMER1;FZD1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4887505062041733,-1.9095380161557265,0.0,0.024692766893095297,0.541,25/79,15.07%,BMPR2;DAB2IP;SLIT2;HTRA3;BMPER;THBS1;NOTCH1;CRIM1;SMURF1;CASK;CREB3L1;SMAD5;SMAD1;UBE2D3;EPN2;SPRY2;PTPN1;FGF2;HGS;LEMD3;HHEX;BMP2;SPRY1;GPC1;SKIL
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.6368411569948431,-1.9020729832173533,0.0,0.026983305144224683,0.572,9/25,13.79%,SPTBN1;PDE4D;RUNX1;PLCG2;ANXA1;RPS3;MALT1;PTPRC;CD86
prerank,positive regulation of neuron migration (GO:2001224),-0.7972145024113897,-1.9018948851896378,0.002,0.026454220729632043,0.572,8/11,13.41%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL;MDK;NSMF;SHTN1
prerank,cAMP-mediated signaling (GO:0019933),-0.6416969990923942,-1.8918933775810967,0.0,0.030350863684197017,0.643,10/24,9.63%,PDE3A;PDE4D;PDE7B;RAPGEF2;ADGRG6;CAP2;PDE2A;ADCY2;CAP1;AHR
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7195324514276376,-1.8904009232245267,0.0,0.030446842418215225,0.652,6/14,9.91%,RHOA;MEOX2;THBS1;NOTCH1;STARD13;KLF4
prerank,regulation of potassium ion transport (GO:0043266),0.6343813090861752,1.8856847653015272,0.0,0.44281608115724214,0.878,11/31,11.94%,CACNA1D;KCNIP3;ACTN2;ANK2;ADRA2A;DLG1;KCNH2;DRD3;VIP;DPP10;KCNIP4
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.49854817509616633,-1.8808055728805992,0.0,0.03377366297757954,0.689,22/70,12.40%,NRP1;TMEFF2;TEK;MEF2C;RHOA;PARVB;LAMC3;PIK3R1;PEAK1;FN1;ITGA8;ACTN1;TBCD;VAMP3;SIPA1L3;NTN4;PXN;ARL13B;LAMB2;PARVA;MICALL2;ITGA4
prerank,cation transmembrane transport (GO:0098655),0.5735930848554737,1.880082535876214,0.0,0.3980817274258349,0.901,4/44,2.09%,TRPM3;ATP1A2;TRPM6;SLC6A9
prerank,regulation of mononuclear cell migration (GO:0071675),-0.6312667678234455,-1.8796346626648484,0.0,0.03384994189591891,0.696,14/23,25.81%,BMP5;SLIT2;THBS1;LYN;IL34;MAPK1;MDK;STK10;RARRES2;CSF1R;MAPK3;MSN;CMKLR1;AIF1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.5727894009749185,-1.873579588255441,0.0,0.03616095570118558,0.723,11/36,9.64%,PTPRM;MEF2C;DCN;DAB2IP;SLIT2;ACVRL1;THBS1;NOTCH1;ANGPT2;FGF2;APOE
prerank,cell-cell junction assembly (GO:0007043),-0.505838197261379,-1.8710421383989797,0.0,0.03685879870594531,0.739,15/63,5.72%,CDH11;ACTB;CLDN5;VCL;TJP1;RHOA;GJC1;GJD3;RAMP2;CD9;ACTG1;WDR1;CTNNA1;TBCD;PAK2
prerank,epiboly involved in wound healing (GO:0090505),-0.6842226685939451,-1.8698840617149377,0.0020408163265306124,0.03674701256944618,0.743,7/16,8.02%,TMEFF2;RHOA;CD44;FLNA;ARHGAP35;CCN1;CEACAM1
prerank,sodium ion transmembrane transport (GO:0035725),0.515936037491854,1.8693886368519623,0.001697792869269949,0.38817791708276894,0.926,10/84,5.43%,ATP1A2;SLC6A13;SLC6A1;SLC6A12;SLC8A3;SLC24A3;ATP1B3;SLC6A9;ATP1B2;NALCN
prerank,negative regulation of angiogenesis (GO:0016525),-0.47606759113941594,-1.861282967397716,0.0,0.04024285341253976,0.778,28/84,13.94%,PTPRM;TEK;SPARC;SEMA6A;SLC12A2;DCN;CLDN5;DAB2IP;TGFB2;COL4A2;THBS1;AGO1;SERPINF1;CREB3L1;ISM1;ADAMTS1;EPN2;SPRY2;ECSCR;SERPINE1;KLF4;SEMA3E;HGS;HHEX;THBS2;STAB1;AMOT;KLF2
prerank,endoderm formation (GO:0001706),-0.5638207276623229,-1.8590197645698372,0.0,0.040964335983493076,0.786,12/35,12.40%,COL8A1;COL12A1;COL6A1;COL4A2;ITGA5;FN1;LAMA3;SOX17;ITGB5;SOX7;ITGA7;ITGA4
prerank,carboxylic acid transport (GO:0046942),0.5492077821619761,1.8559446894044713,0.0,0.4007184561535343,0.94,11/55,3.99%,SLC16A6;SLC6A13;SLC13A3;SLC6A12;SLC16A11;SLC38A3;SLC6A9;SLC23A2;SLC23A1;SLC16A12;SLC38A1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.6131501772439207,-1.8549169139159687,0.00425531914893617,0.0422431098896145,0.808,14/25,23.22%,NRP1;ITGA6;THBS1;EGFR;APP;AR;PTGES3;SRC;NCKAP1L;PTH1R;KCTD20;GLMN;EGF;BCL10
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.5456611915155245,-1.8480714905590676,0.0,0.04558321762622838,0.838,19/39,14.55%,ACTN4;GCNT2;JAG1;RHOA;ACER2;THBS1;NOTCH1;CORO1C;KANK1;TBCD;CASK;AJAP1;MYOC;EFNA5;MAP4K4;SEMA3E;FZD4;AP1AR;ADAM15
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.5710287687834219,-1.8461191216621002,0.0,0.045783787801667745,0.844,11/33,9.91%,MEF2C;RHOA;ACVRL1;MEOX2;THBS1;NOTCH1;STARD13;ANGPT2;FGF2;APOE;KLF4
prerank,endocardial cushion morphogenesis (GO:0003203),-0.6566000521883002,-1.8457302494999457,0.0021008403361344537,0.04532549791170481,0.844,11/18,12.91%,NOS3;ACVR1;ACVRL1;TGFB2;ENG;NOTCH1;BMP4;TGFBR2;HEYL;BMP2;TBX2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.7070150006553669,-1.8429770109848258,0.004273504273504274,0.046516897091609735,0.852,7/14,12.75%,ECE1;NOS3;ENPEP;AGTR1;EDN1;EDN3;ACE2
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.6633903451206441,-1.8425625130169603,0.002053388090349076,0.04613809211510361,0.855,10/19,15.34%,NRP1;TEK;LIMS1;PTPRJ;KDR;MYOC;MAP4K4;VEGFA;S100A10;FERMT2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.6669876109584909,-1.8418603296371672,0.00205761316872428,0.04573281464686509,0.857,8/18,7.50%,HEG1;KANK1;RASIP1;STMN1;MET;KCTD10;ARHGAP35;MYOC
prerank,cardiac myofibril assembly (GO:0055003),0.7302899153581792,1.8406868171810702,0.005905511811023622,0.43036557672595915,0.959,4/15,3.95%,NEBL;PDGFRA;OBSL1;CSRP3
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6109567595489019,-1.8379553625382994,0.0,0.04747986661441698,0.865,15/26,14.78%,SLC39A10;SLC30A1;SLC39A8;SLC30A9;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;SLC39A7;SLC30A5;MT3
prerank,cellular response to copper ion (GO:0071280),-0.6895937369985248,-1.837063845273566,0.0040650406504065045,0.04747042561468682,0.867,10/16,19.01%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MT3;MT2A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.4959183344828124,-1.8362262259690507,0.0,0.04724428862359897,0.869,16/67,9.72%,UTRN;NRP1;LIMS1;LIMS2;DOCK1;VIT;NDNF;CDH13;FN1;FLNA;MDK;MYOC;FBLN2;EMP2;ECM2;NEDD9
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.6868926794206731,-1.8329687821754372,0.004056795131845842,0.04855754248663428,0.88,8/14,13.82%,NRP1;GAB1;VEGFC;KDR;PIK3CA;FLT4;PIK3CD;VEGFA
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.5666488558098823,-1.8326592388874137,0.002178649237472767,0.04802375811315786,0.881,15/32,10.64%,JAG1;ACER2;ACVRL1;THBS1;CORO1C;PHLDB2;CASK;AJAP1;APOD;MYOC;SRC;MAP4K4;SERPINE1;FAM107A;SEMA3E
prerank,regulation of T cell migration (GO:2000404),-0.6671838998845213,-1.831502389480558,0.0021231422505307855,0.04802472130451976,0.885,7/18,9.84%,LRCH1;RHOA;CD200;APP;CXCL12;APOD;DOCK8
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4917946538528612,-1.8246974113151595,0.0,0.051719939883965976,0.907,25/67,12.51%,NRP1;ABI1;NRP2;DOCK1;DAB2IP;RHOA;WASF2;VEGFC;PIK3R1;KDR;CLEC14A;PAK2;PRKD1;NCK1;PXN;FLT1;PIK3CA;SRC;FLT4;VAV2;MAPKAPK2;BCAR1;NCF2;HSPB1;PTK2B
prerank,lipid translocation (GO:0034204),-0.6381274635991419,-1.8243335565803147,0.0,0.05123284203743974,0.907,8/21,7.48%,ATP10A;ATP8B1;ATP8A1;ABCC1;ABCA1;TMEM30A;ATP11B;ATP11C
prerank,gliogenesis (GO:0042063),-0.6826591878907265,-1.8233272361586557,0.004166666666666667,0.05124150163472607,0.91,8/15,26.61%,TGFB2;CD9;ANXA1;CDH2;CDK6;METTL3;METRN;METTL14
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.6965329046547101,-1.8226798011129142,0.0,0.05106913152890164,0.914,6/15,6.52%,NTRK3;VEGFC;CDH13;F3;KDR;CXCL12
prerank,regulation of cation transmembrane transport (GO:1904062),0.628853388771798,1.8204107963279343,0.0,0.4847979473387583,0.981,10/29,11.94%,CACNA1D;KCNIP3;WNK3;SNTA1;DLG1;FGF12;KCNH2;PDZK1;DPP10;KCNIP4
prerank,epithelial cell migration (GO:0010631),-0.542478000014996,-1.8184660932140468,0.004357298474945534,0.053124152741010976,0.925,15/37,14.76%,NRP1;NOS3;RHOA;FAP;CDH13;CYP1B1;KANK1;STARD13;ADGRA2;PXN;PRKX;PIK3CA;PTP4A3;FAT2;PKN3
prerank,zinc ion homeostasis (GO:0055069),-0.5918431671106923,-1.8171371346892577,0.0,0.05318864623389576,0.93,15/28,14.78%,SLC39A10;SLC30A1;SLC39A8;SLC30A9;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;SLC39A7;SLC30A5;MT3
prerank,regulation of interleukin-1 production (GO:0032652),-0.6775946081024431,-1.8116987492853005,0.003952569169960474,0.05611502306904607,0.938,5/15,8.02%,FOXP1;GAS6;TMED10;ANXA1;CEACAM1
prerank,cardiac ventricle development (GO:0003231),-0.6275479014166395,-1.8102250635553927,0.0041841004184100415,0.056281625743808225,0.941,12/20,25.43%,ENG;NOTCH1;HES1;PDE2A;HEYL;STRA6;HEY2;HEY1;DLL4;SALL1;GJA5;MATR3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.5018973895898755,-1.8039811441537368,0.0,0.06019476162453455,0.946,19/54,13.82%,MEF2C;NOS3;TMSB4X;ETS1;ACVRL1;THBS1;PLCG1;AKT3;KDR;ANGPT2;PRKD1;PRCP;GATA2;ATP5F1B;FGF2;APOE;HSPB1;CD40;VEGFA
prerank,endothelial cell proliferation (GO:0001935),-0.656165770987119,-1.8009227396693315,0.002074688796680498,0.06171106711198111,0.951,8/17,7.55%,TEK;BMPR2;ACVRL1;BMPER;CD34;BMP4;ERN1;PRKX
prerank,regulation of dopamine secretion (GO:0014059),0.6129579709149869,1.7996817048384552,0.003795066413662239,0.5524151308710866,0.994,9/25,11.44%,SYT11;SYT12;SYT9;SYT1;SYT13;CHRNB2;DRD3;SYT10;DTNBP1
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6384046756059566,-1.7993489560878986,0.010482180293501049,0.06218177674116371,0.952,9/19,14.75%,LIFR;RUNX1;WNT5A;CBFB;KLF4;TLE5;CD24;IFIH1;IRAK2
prerank,cell-matrix adhesion (GO:0007160),-0.4476588287421842,-1.798698867852907,0.0,0.06191181039051222,0.953,31/95,15.60%,ITGBL1;THSD1;VCL;PKD1;PEAK1;CD34;VCAM1;BCR;CD44;ITGA1;FN1;ITGB4;ITGA8;MKLN1;PTPRK;ACTN1;MSLN;ITGB1;ITGB5;EMP2;SRC;ECM2;TIAM1;WHAMM;BCAM;ITGA7;ITGA4;ITGB8;ADAM15;FERMT2;VTN
prerank,histone lysine demethylation (GO:0070076),0.6237011506135746,1.795321297827679,0.007736943907156673,0.5319117879707723,0.994,10/25,19.45%,KDM7A;PHF8;KDM5B;KDM6B;PHF2;KDM2A;KDM5C;KDM4A;KDM1A;KDM3B
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.6655919589106496,-1.794706281180476,0.006122448979591836,0.06426768923427571,0.96,9/17,15.78%,PTN;NOTCH1;TNFRSF1B;HES1;IL34;MDK;PTPRZ1;BMP2;ID2
prerank,motor neuron axon guidance (GO:0008045),-0.6634319612850537,-1.7913409859911622,0.0020920502092050207,0.06597296199621473,0.967,4/15,2.63%,SLIT2;NTN1;TMEFF1;CHN1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5406552839487696,-1.7896725574169676,0.0,0.06644575610092851,0.969,14/38,16.35%,BMP5;NOS3;TNFSF10;THBS1;BCL2L1;FAS;ICAM1;ARHGEF2;FEM1B;SERPINE1;GPX1;MADD;TMBIM1;SP100
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.5415850331823087,-1.7892303658287267,0.0,0.06599780718339417,0.97,16/39,17.68%,TEK;RAMP2;NDNF;THBS1;GAS6;PLCG1;KDR;ICAM1;ECSCR;GATA2;SERPINE1;PDCD4;ITGA4;CD40;SEMA5A;GPER1
prerank,regulation of vasoconstriction (GO:0019229),-0.5749526840513619,-1.7862416617807562,0.0,0.06768326436270242,0.976,9/27,12.75%,CAV1;BMPR2;ECE1;ADRA1B;ATP2B1;AGTR1;KCNMB2;ADM;ACE2
prerank,actin cytoskeleton reorganization (GO:0031532),-0.4805543221085117,-1.7779441653576296,0.0024752475247524753,0.07310076275593516,0.983,23/63,13.24%,NRP1;GAB1;RHOA;GSN;PARVB;MYH9;THSD7A;MKLN1;TNIK;FLNA;RAP2A;S1PR1;CDC42BPA;ANXA1;CXADR;PTPN1;BCAR1;NEDD9;FGF7;WHAMM;PARVA;MICALL2;TRPV4
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7287146847963515,-1.7777714187364198,0.004073319755600814,0.07243000121560841,0.983,4/10,8.02%,PRKG1;CD9;PRKCD;CEACAM1
prerank,membrane repolarization (GO:0086009),0.6907287444300851,1.7755637588447057,0.0056179775280898875,0.6032518723650556,0.999,5/15,8.02%,ATP1A2;KCND3;ATP1B3;ATP1B2;KCNH2
prerank,collagen fibril organization (GO:0030199),-0.45360884062579565,-1.7751966816044056,0.0,0.07386944477538965,0.983,29/88,9.91%,COL8A1;COL12A1;TLL1;COL6A3;COL4A1;ITGA6;COL25A1;COL15A1;COL6A2;COL8A2;DST;COL6A1;TGFB2;COL4A2;CYP1B1;PLOD2;COL23A1;COL5A2;ITGB4;LAMA3;COL4A6;P4HA1;LOX;LUM;PLOD3;ADAMTS14;COL27A1;COL14A1;CRTAP
prerank,endothelial cell differentiation (GO:0045446),-0.7218034547441113,-1.774572942239382,0.00398406374501992,0.07354138192974095,0.984,5/12,3.61%,BMPR2;JAG1;ACVRL1;TIE1;KDR
prerank,positive regulation of vasculature development (GO:1904018),-0.44294248372531647,-1.7732085891603646,0.0,0.07396628328267771,0.986,34/94,13.82%,TEK;GAB1;NOS3;HIPK1;ETS1;TIE1;VEGFC;RAMP2;THBS1;F3;CYP1B1;PTGIS;CD34;PLCG1;RUNX1;BTG1;KDR;ITGB1;PIK3R6;PRKD1;WNT5A;FLT1;GATA2;FGF2;SERPINE1;AGO2;AGGF1;PIK3CD;HSPB1;TWIST1;ECM1;ITGB8;CD40;VEGFA
prerank,positive regulation of cell motility (GO:2000147),-0.39944209906388406,-1.7731937723991047,0.0,0.07322216852868194,0.986,64/205,13.82%,LEF1;ACTN4;NTRK3;PODXL;CAV1;GCNT2;PECAM1;SEMA6A;SPOCK2;SEMA3C;ITGA6;TJP1;NTN1;SEMA7A;ACVR1;INSR;THBS1;NOTCH1;ACTG1;CDH13;F3;EGFR;STAT3;KDR;MGAT5;CPNE3;ITGB1;NUMB;RACK1;ADAM10;TWIST2;CXCL12;FLT1;CCN1;PPP3CA;MDK;MYOC;APC;SPRY2;PDGFC;TIAM1;SEMA5B;MAP4K4;BCAR1;NEDD9;EPHB2;RIPOR1;EDN1;FAM107A;PIK3CD;SEMA3E;TWIST1;CCDC25;CEMIP;COL1A1;RET;BMP2;SEMA3G;PTK2B;PDGFD;SMO;ROR2;AKT2;VEGFA
prerank,sodium-independent organic anion transport (GO:0043252),-0.7393926835741933,-1.772625852040381,0.005847953216374269,0.07293702044264908,0.986,5/10,8.49%,SLCO3A1;SLCO1C1;SLCO2A1;SLCO2B1;SLC16A2
prerank,endocardial cushion development (GO:0003197),-0.6077058203913182,-1.77094417691744,0.004228329809725159,0.07367794724116562,0.989,11/21,12.91%,BMPR2;NOS3;ACVR1;ACVRL1;TGFB2;ENG;NOTCH1;BMP4;HEYL;BMP2;TBX2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5264225484230238,-1.7707955166313183,0.0022026431718061676,0.07304878313818289,0.989,18/42,21.29%,UTRN;NRP1;TEK;LIMS1;CDH13;PTPRJ;KDR;MYOC;EMP2;MAP4K4;PTK2B;VEGFA;S100A10;FERMT2;CCL25;CDK6;JUP;ROCK1
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.4690876404940723,-1.7698058339187952,0.0,0.07326752039395718,0.991,24/72,11.03%,NRP1;HEG1;ARHGEF28;NET1;ARHGEF3;STARD8;BCR;ABCA1;KANK1;RASIP1;STMN1;STARD13;F11R;ARHGEF2;EPS8;MET;ARHGDIB;KCTD10;ARHGAP35;MYOC;EPS8L2;APOE;LPAR6;ADGRG1
prerank,cellular response to drug (GO:0035690),-0.5846681321688699,-1.7660840085191092,0.0022222222222222222,0.07576257263294933,0.993,7/25,7.09%,MEF2C;ACER2;GAS6;RAP2A;TFRC;AIM2;KCNQ1
prerank,aggrephagy (GO:0035973),-0.5778470365437443,-1.7657711417502353,0.008064516129032258,0.07530519024771899,0.993,13/27,17.93%,UBC;DYNC1I2;RPS27A;UBB;ARL13B;DYNC1I1;SQSTM1;HDAC6;DYNLL1;CFTR;ATG5;ACBD5;DYNC1H1
prerank,monosaccharide transmembrane transport (GO:0015749),0.6907929197831255,1.7643968834770942,0.007936507936507936,0.6269167070409445,1.0,6/16,8.55%,SLC2A12;SLC5A3;SLC5A10;SLC23A2;SLC23A1;SLC45A3
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5562823123811216,-1.7631128096832112,0.010121457489878543,0.07689644783719105,0.994,9/30,9.75%,BMP5;NOS3;TNFSF10;BCL2L1;FAS;ICAM1;ARHGEF2;SERPINE1;GPX1
prerank,positive regulation of transporter activity (GO:0032411),0.7109593727788165,1.762399059467422,0.014198782961460446,0.5962351068352828,1.0,7/13,9.59%,WNK3;PON1;STK39;KMT2A;NR1H3;RXRA;PDZK1
prerank,regulation of fatty acid oxidation (GO:0046320),0.6948139607982954,1.7618629072484002,0.005905511811023622,0.5620090817406093,1.0,7/16,11.96%,PRKAG2;APPL2;PPARA;LONP2;PPARGC1A;ABCD1;SOX9
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7192055520058553,-1.7614512687105064,0.006085192697768763,0.07766608341320985,0.995,6/11,10.14%,MECOM;CD34;RUNX1;WNT5A;ARIH2;ETV6
prerank,heart development (GO:0007507),-0.40733748250358837,-1.760451863836725,0.0,0.07773400110564861,0.995,41/150,13.82%,TEK;MEF2C;FLRT2;NTRK3;BMP5;HEG1;PDLIM5;PLCE1;BMPR2;ECE1;MICAL2;ACVR1;PCSK5;ACVRL1;TGFB2;INSR;RAMP2;NOTCH1;PKD1;BMP4;TGFBR2;FN1;TBX1;FBN1;SGCD;SOX17;CRIP1;NIPBL;SH3PXD2B;STRA6;HDAC9;CXADR;ZFPM2;WDR11;MYOCD;LDB3;SOX18;BMP2;TBX2;NCOA6;VEGFA
prerank,positive regulation of vasculogenesis (GO:2001214),-0.7631338025904326,-1.759728436445455,0.007984031936127744,0.07764541813555043,0.995,6/10,8.02%,RAPGEF2;RAP1A;CD34;KDR;TMEM100;CEACAM1
prerank,regulation of neuron migration (GO:2001222),-0.5785542355926026,-1.7544336296217131,0.004032258064516129,0.08121345107057858,0.996,10/26,13.45%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL;MDK;NSMF;ADGRG1;SHTN1;IGSF10
prerank,morphogenesis of an epithelium (GO:0002009),-0.5755435870860061,-1.7504255730174196,0.004434589800443459,0.08396540431448904,0.998,14/25,24.50%,ACTB;VCL;LRP6;ACTG1;TBX18;LAMA3;PRKX;LIN7C;TIMELESS;TRAF3IP1;SOX8;KDM2B;ARHGAP12;LHX1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.617527376120119,-1.748151247129166,0.00398406374501992,0.08502966744029698,0.998,13/20,29.14%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA5A;SEMA6D;SEMA3F;SEMA4C;SEMA4D;SEMA4F;SEMA6B
prerank,phospholipid translocation (GO:0045332),-0.5731851612530223,-1.7480886176643364,0.0022172949002217295,0.08437172804988896,0.998,10/28,7.48%,ATP10A;ATP8B1;ATP8A1;ABCC1;ABCA1;PLSCR1;PLSCR4;TMEM30A;ATP11B;ATP11C
prerank,lamellipodium assembly (GO:0030032),-0.561581824114962,-1.7467647981207728,0.0020242914979757085,0.0850482873885587,0.998,11/26,13.00%,ABLIM1;VCL;PARVB;CDH13;SPATA13;ITGB1;S1PR1;ABLIM3;GOLPH3;WHAMM;ABLIM2
prerank,protein localization to cell-cell junction (GO:0150105),-0.6590737143026166,-1.7466367538998508,0.0039603960396039604,0.08442453126361173,0.998,8/15,10.02%,ACTB;TJP1;ACTG1;LSR;F11R;TJP2;PAK2;JAK1
prerank,amide transport (GO:0042886),-0.5720970957449123,-1.7466284357323687,0.0064516129032258064,0.08369981210994333,0.998,9/26,6.72%,ABCG2;DISP1;CERT1;SLC5A6;PLTP;PLEKHA8;AQP11;SLC38A5;TAP2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.6200532793002949,-1.7453661015861393,0.014675052410901468,0.08414242029890347,0.999,7/17,17.68%,PRKG1;MEF2C;TAFA5;TGFB3;PDCD4;PTEN;GPER1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.5370369873980946,-1.7449033615159002,0.0022026431718061676,0.08382895639267453,0.999,12/35,10.33%,HEG1;DAB2IP;TGFB2;KANK1;RASIP1;STMN1;MET;KCTD10;ARHGAP35;MYOC;SPRY2;EPHB2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6937322222489902,-1.743743656865392,0.0038095238095238095,0.08426282009318077,0.999,8/13,18.96%,LTBP1;GREM2;FBN1;BMP2;NRROS;CD46;CHRDL1;GREM1
prerank,limb morphogenesis (GO:0035108),-0.5985477537477624,-1.7433918952380147,0.01050420168067227,0.08385632906705703,0.999,7/20,5.55%,MBNL1;LRP6;PCSK5;TGFB2;TBX3;GLI3;NIPBL
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.669664833811412,-1.7409822505886818,0.008064516129032258,0.08536590360085393,0.999,7/14,8.95%,GHR;PIK3R1;SOCS2;STAT3;LYN;PXN;PTPN1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.4925553360404415,-1.7406621966284168,0.0,0.08490379687134252,0.999,16/50,13.79%,LIMS1;ACTN4;RHOA;EGFR;APP;NOD1;NR3C2;RPS3;NFAT5;IFI35;TERF2IP;PTP4A3;PDCD4;PHB2;TCIM;CD86
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.6820956494718701,-1.7400550979302005,0.006396588486140725,0.08462868999267467,0.999,4/13,7.11%,PDE4D;CAV1;CAMK2D;CALM3
prerank,presynapse assembly (GO:0099054),0.6785952654852785,1.7389498510108998,0.007858546168958742,0.6643648481471551,1.0,8/16,10.84%,CEL;IL1RAPL1;NLGN2;WNT7A;NLGN3;LRP4;PTPRD;BSN
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.43214177247541097,-1.7388846179630084,0.0,0.08509031497537245,0.999,32/100,12.90%,ROR1;TEK;NTRK3;DCN;DAB2IP;GAB1;PIP5K1B;TGFB2;PIP4K2A;INSR;PIK3R1;EGFR;KDR;FN1;PIK3IP1;LYN;PPP1R16B;MAPK1;FLT1;MYOC;PPP2R5C;CEACAM1;PIK3CA;SRC;PDGFC;IER3;FGF2;PIK3CD;UNC5B;TWIST1;PDGFD;ROR2
prerank,phospholipid transport (GO:0015914),-0.48680029595965923,-1.7360651336477222,0.0,0.08689299814229152,1.0,16/52,7.63%,ATP10A;ATP8B1;PITPNC1;ATP8A1;SCARB1;ABCC1;ABCA1;SCARB2;PLTP;TMEM30A;ATP11B;TNFAIP8L3;NPC2;MTTP;ATP11C;ABCA3
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.6525550695474722,-1.7349680051382157,0.006185567010309278,0.08716407277289437,1.0,5/16,7.92%,ST3GAL4;RHOA;ETS1;MDK;NFAT5
prerank,regulation of regulated secretory pathway (GO:1903305),0.5552429005004018,1.72980384674166,0.008787346221441126,0.6855923428396905,1.0,11/34,11.44%,SYT11;SYT12;UNC13D;SYT9;SYT1;SNAPIN;SYT13;RIMS1;LRRK2;SYT10;DTNBP1
prerank,xenobiotic transport (GO:0042908),-0.631170262448211,-1.7289346822823586,0.016494845360824743,0.09222793427465284,1.0,6/17,9.11%,ABCG2;SLC47A1;ABCC1;SLC7A5;ABCA3;SLC22A18
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.4712084463656423,-1.7283672137625323,0.004796163069544364,0.09202673938306122,1.0,20/64,10.64%,UTRN;JAG1;VCL;RHOA;ACER2;THBS1;ACTG1;CDH13;PEAK1;LIMCH1;CORO1C;MACF1;CASK;AJAP1;MYOC;EMP2;EFNA5;MAP4K4;DUSP3;SEMA3E
prerank,secretion (GO:0046903),0.6819122018963532,1.7255536062395433,0.0019157088122605363,0.6754628817711047,1.0,6/14,12.82%,SLC22A6;RIMS1;PRKCI;DRD3;VIP;SLC22A2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.595655475670237,-1.7252778167176053,0.010615711252653927,0.0943399155404264,1.0,6/21,7.25%,FOXP1;PRKCH;SLC39A10;RUNX1;LYN;CBFB
prerank,lamellipodium organization (GO:0097581),-0.5390588380392889,-1.7251088441798406,0.006122448979591836,0.09371666897234822,1.0,13/29,14.74%,ABLIM1;VCL;PARVB;CDH13;SPATA13;ITGB1;S1PR1;ABLIM3;SNX1;GOLPH3;WHAMM;ABLIM2;SNX2
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.4429590392393262,-1.721717325027727,0.0,0.09580251947349648,1.0,29/84,13.82%,NRP1;FOXP1;TEK;SPARC;NRP2;BMPR2;NOS3;TMSB4X;ETS1;SCARB1;THBS1;PLCG1;BMP4;AKT3;KDR;PRKD1;WNT5A;MET;GATA2;FLT4;ATP5F1B;FGF2;BCAR1;EDN1;PIK3CD;HSPB1;PTK2B;CD40;VEGFA
prerank,microvillus organization (GO:0032528),-0.6848424039961478,-1.7211786907405064,0.006,0.09556023099638888,1.0,9/13,18.43%,RAPGEF2;FXYD5;RAP1A;TNIK;RAP2A;RAPGEF6;MAP4K4;RAP2B;STK26
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7243413207122683,-1.7205875549917313,0.009823182711198428,0.09558453236614156,1.0,8/11,16.60%,NDNF;CD34;KDR;ADIPOR2;PRCP;GATA2;VEGFA;MCAM
prerank,carnitine shuttle (GO:0006853),0.7378661341980861,1.719310107510658,0.01443298969072165,0.6803917705686346,1.0,2/11,1.77%,PRKAG2;PRKAA2
prerank,response to copper ion (GO:0046688),-0.6104698118074285,-1.7189286384381062,0.010351966873706004,0.09621712613728055,1.0,11/20,19.01%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MT3;ATP5F1D;MT2A
prerank,heart morphogenesis (GO:0003007),-0.47881770590437356,-1.7175334640048372,0.0,0.09695519274063336,1.0,18/50,13.82%,FLRT2;NOS3;ACVR1;ACVRL1;TGFB2;ENG;INSR;TBX3;NOTCH1;TBX1;SOX17;NIPBL;HES1;HEYL;HEY2;BMP2;TBX2;VEGFA
prerank,regulation of striated muscle contraction (GO:0006942),0.5868424170193061,1.7163396466844318,0.007194244604316547,0.6655213555210588,1.0,3/27,1.72%,ATP1A2;SLC8A3;ANK2
prerank,cellular protein metabolic process (GO:0044267),-0.35851798365487725,-1.7153960783708557,0.0,0.09813893056482287,1.0,127/396,17.45%,MSRB3;DAB2IP;ST8SIA4;LTBP1;RPLP1;PCSK5;ST3GAL6;GAS6;RPS15;RPL38;PLOD2;RPL18A;ATG3;RPL41;BMP4;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;APP;FN1;RPS10;RPL10;RPS23;RPS24;FBN1;RPL7;RPL37A;PDIA6;MSLN;IGFBP6;RPS17;RPS16;RPL39;RPS27A;ST3GAL1;UBE2D3;CST3;MSRB2;RPL13;ADAM10;MRPL52;LOX;RPLP0;RPL30;RPS5;RPL35A;PAPPA;RPS8;CCN1;RPS7;RPL22;CSNK1G3;ABCA3;RPS3;SPPL3;LAMB2;RPS28;KTN1;MFGE8;RPL29;RPL7A;RPS26;MGAT4A;RPL6;VCAN;RPL18;IGF2;RPS25;AGO2;RPL36;APOE;RPL28;YES1;RPL27;CPE;RPL24;RPS29;SFTPA2;SFTPA1;RPL23;RPL17;MRPL23;YARS2;RPS9;RPS27;ASMT;PNPLA2;UBE2L3;RPL21;MRPL10;FBXW2;STK38;EVA1A;RPL34;AKT2;RPL10A;UBL5;RPL12;LMCD1;HM13;TNC;RPL35;CDH2;RPL14;D2HGDH;PPP4R2;ST8SIA2;GOLM1;ICMT;PHKA2;RPL19;RPL37;RPS18;RPS13;ZDHHC2;RPS15A;PHEX;CHRDL1;RRBP1;MRPS12;IGFBP4;UBE2G1;MMP2;MRPL55
prerank,establishment of endothelial barrier (GO:0061028),-0.5535220872396076,-1.7138936876403044,0.002105263157894737,0.09885163942463651,1.0,12/29,7.33%,PDE4D;PECAM1;RAPGEF2;TJP1;RAP1A;F11R;ICAM1;TJP2;PDE2A;PPP1R16B;ROBO4;RAPGEF6
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5774285142974324,-1.7138929821969795,0.008350730688935281,0.09811940505852809,1.0,8/24,9.35%,TEK;RAMP2;NDNF;GAS6;KDR;ICAM1;GATA2;SERPINE1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5900883986294586,-1.7133418551748623,0.006355932203389831,0.09783532687521869,1.0,12/21,28.79%,MTUS1;THBS1;IL34;MAPK1;MDK;PTK2B;RARRES2;CSF1R;MAPK3;CMKLR1;DDT;MIF
prerank,embryonic eye morphogenesis (GO:0048048),-0.7067345324466012,-1.7103507442823085,0.00998003992015968,0.10014209191992562,1.0,8/11,22.99%,MFAP5;LRP6;FBN1;RARG;TBX2;ALDH1A3;EFEMP1;KDM2B
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.7182402438561613,-1.7100661905895778,0.006,0.09972824732111756,1.0,4/10,6.52%,RAPGEF2;GAS6;LYN;CXCL12
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5730292711092198,1.709821692224279,0.012867647058823529,0.6742776000510559,1.0,8/27,10.21%,SYT11;SYT12;SYT9;VAMP7;SYT1;SYT13;RIMS1;SYT10
prerank,positive regulation of heart rate (GO:0010460),-0.6269106371320255,-1.7091435596878475,0.008264462809917356,0.10004877945008597,1.0,6/17,11.67%,PDE4D;ADRA1B;KCNQ1;EDN1;ADM;EDN3
prerank,rRNA metabolic process (GO:0016072),-0.3930268370261479,-1.7081985808375535,0.0,0.10031049111508883,1.0,74/160,24.47%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;RPL6;RPL18;RPS25;PELP1;RPL36;DDX54;RPL28;RPL27;RPL24;RPL23;RPL17;RPS9;RPS27;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;DDX27;ESF1;TRIR;RPL19;DDX49;RPL37;RRP12;PWP2;RCL1;MRTO4;NOP58;EBNA1BP2;RPL3;RPL15;EXOSC4;DKC1;EXOSC5;IMP4;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46
prerank,regulation of platelet aggregation (GO:0090330),-0.6119553677066755,-1.7065248879281594,0.008368200836820083,0.10137634169589824,1.0,6/17,8.02%,PRKG1;CD9;F11R;LYN;PRKCD;CEACAM1
prerank,receptor metabolic process (GO:0043112),-0.47528709315670503,-1.7063234298679433,0.0,0.1008674207638106,1.0,30/53,31.60%,CAV1;CALCRL;DNM3;RAMP2;CD9;SMURF1;RAB31;ITGB1;TFRC;SNX1;ACKR3;ADM;LRP1;RAB11B;PIK3R4;LDLRAP1;ARRB2;NEDD4;SYK;AP2M1;PHETA1;GRB2;PHETA2;DNM1;NSG1;DNM2;CD36;LMTK2;SH3GLB1;GRK2
prerank,cellular response to fluid shear stress (GO:0071498),-0.6838740940845445,-1.704079817107146,0.005964214711729622,0.10244550474435532,1.0,7/12,22.49%,MEF2C;MTSS1;KLF4;SREBF2;KLF2;ASS1;HAS2
prerank,positive regulation of cellular component movement (GO:0051272),-0.5757187926312767,-1.7007289277283437,0.004329004329004329,0.10528488258373316,1.0,11/24,15.76%,ACTN4;SPOCK2;NTN1;ETS1;LYN;TWIST1;CCDC25;AKT2;VEGFA;CAVIN1;CSF1R
prerank,sulfation (GO:0051923),0.7052747968739258,1.7005348299907828,0.024714828897338403,0.7003576509005649,1.0,2/11,1.22%,UST;CHST4
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.5776819409222763,-1.6990456571850792,0.006036217303822937,0.10638303781387413,1.0,12/24,22.00%,NRP1;SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;VEGFA;SEMA5A;SEMA6D;SEMA3F;SEMA4C
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.526116459167671,-1.6990172500974359,0.0021008403361344537,0.10569773048122914,1.0,17/35,22.00%,NRP1;SEMA6A;NRP2;SEMA3C;SEMA7A;FLNA;MET;SEMA5B;SEMA3E;SEMA3G;ARHGDIA;SEMA5A;SEMA6D;PLXNA4;PLXND1;SEMA3F;SEMA4C
prerank,neurotransmitter biosynthetic process (GO:0042136),0.6768823352042895,1.6985868836578224,0.014314928425357873,0.6827519643322094,1.0,6/14,19.63%,MOXD1;DAGLA;SLC6A4;SLC22A2;ALDH9A1;ACHE
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.7378313410812328,-1.6977554729290136,0.010080645161290322,0.10634764876691533,1.0,4/10,5.88%,FAP;NOTCH1;TNFRSF1B;CST3
prerank,sprouting angiogenesis (GO:0002040),-0.4815284199095795,-1.6968992431849754,0.0,0.10652699919552978,1.0,21/51,10.80%,NRP1;TEK;RSPO3;SLIT2;ACVRL1;ENG;VEGFC;BMPER;RAMP2;THBS1;CDH13;BMP4;KDR;ADGRA2;RECK;CCBE1;FLT4;FGF2;PARVA;SEMA3E;ESM1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.584724663288509,1.6947830932203691,0.011450381679389313,0.6782232219662438,1.0,7/26,11.59%,ATP1A2;CRHR1;ADRA2A;GNB5;GSTM2;DRD3;GSTO1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.6428391868755451,1.6905599518712737,0.014893617021276596,0.6774562455648508,1.0,3/17,1.31%,ATP1A2;BMP7;TFPI
prerank,regulation of protein localization to membrane (GO:1905475),-0.5477855902090342,-1.6891877871683008,0.008791208791208791,0.1138475511691588,1.0,14/28,19.96%,SPTBN1;GPC6;ACTB;GSN;AR;CDK5;STX7;ZDHHC7;STX8;GPC1;ZDHHC2;LDLRAP1;CRIPT;GPC4
prerank,myelination in peripheral nervous system (GO:0022011),-0.6559367045932984,-1.6859002571274282,0.0057251908396946565,0.11658171581543231,1.0,6/13,10.76%,ADGRG6;PARD3;LGI4;MYOC;SOD1;PRX
prerank,response to progesterone (GO:0032570),-0.6026849707701321,-1.6858635245397582,0.010080645161290322,0.11588508657854779,1.0,6/18,9.46%,CAV1;ABHD2;TGFB2;THBS1;SRC;TGFB3
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.42414296600253315,-1.6849029582802015,0.0,0.11628839971247715,1.0,29/92,13.82%,NRP1;FOXP1;TEK;SPARC;NRP2;DOCK1;BMPR2;ETS1;SCARB1;TGFB2;THBS1;PLCG1;BMP4;KDR;PLCG2;PRKD1;WNT5A;SRC;FLT4;MAP4K4;FGF2;BCAR1;FGF7;EDN1;PIK3CD;PTK2B;HDAC6;PFN1;VEGFA
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5978118470885563,1.6846922923110932,0.013157894736842105,0.6864355243840496,1.0,5/23,5.38%,PRKAG2;BMP7;SPHK1;WNK3;PLK1
prerank,regulation of interleukin-2 production (GO:0032663),-0.495366616790169,-1.6838130105909375,0.00228310502283105,0.11690978785862716,1.0,11/43,13.79%,SPTBN1;PDE4D;CD34;RUNX1;PLCG2;ANXA1;RPS3;HDAC7;MALT1;PTPRC;CD86
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.4114345970347656,-1.6825033309121926,0.0025575447570332483,0.11765460041322108,1.0,29/118,10.57%,FMNL2;MEF2C;SHANK3;SPARC;PDLIM5;PID1;NEDD4L;ETS1;BMPER;PHLDB1;CHN1;HECW2;TBX1;PHLDB2;TNIK;RAP2A;PAK2;ADGRA2;ARHGAP35;EMP2;CEACAM1;EFNA5;CDK5;FLT4;MYO19;FGF2;ABI3;CFL1;NSMF
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4403066760561781,-1.680973434055031,0.002331002331002331,0.11863476379605413,1.0,32/70,22.73%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;NCK1;MAPK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;CDC42;ARPC3;SYK;FCGR1A;FYN;FCGR2B;MYO1C
prerank,positive regulation of response to wounding (GO:1903036),-0.5528011978958316,-1.680210860430616,0.01050420168067227,0.11864502285958226,1.0,8/24,7.71%,PTN;ACTG1;KANK1;SCARF1;ITGB1;ANXA1;MDK;OCLN
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.35946833291846475,-1.6777050024424534,0.0,0.1206221229649006,1.0,125/306,25.44%,ST3GAL4;RPLP1;PTMA;EXT1;RPA1;KAT7;RPS15;RPL38;RPL18A;RPL41;EEF2K;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;EEF2;MRPL52;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;TIPIN;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;AGO2;RPL36;APOE;RPL28;GOLPH3;RPL27;B4GALT5;RPL24;RPS29;GCNT1;RPL23;RPL17;MRPL23;YARS2;RPS9;RPS27;ASMT;BLM;KIN;RPL21;MRPL10;ORC1;RPL34;RPL10A;RPL12;RPL35;RPL14;NR4A2;TIMELESS;RPL19;RPL37;RPS18;RPS13;RPS15A;ING4;RRBP1;EEF1G;MRPS12;MRPL55;ORC2;ST3GAL2;RHNO1;MRPL43;NBN;BARD1;RPA2;EPC1;RMI1;CDC45;MRPL36;ORC5;PCLAF;POLA1;POLR3A;MRPL35;DUT;SET;RPL3;POLR2I;RFC4;CHEK1;POLA2;THAP1;TOP1;BCL3;MCM3;RPL15;RPS21;POLR2F;RPS19;RPL8;RPL13A;EXT2;RPL23A;RBMS1;SRBD1;MRPL11;POLE3;TYMS
prerank,microvillus assembly (GO:0030033),-0.6549502977587702,-1.676919576942516,0.01,0.12097212882895989,1.0,9/14,18.43%,RAPGEF2;FXYD5;RAP1A;TNIK;RAP2A;RAPGEF6;MAP4K4;RAP2B;STK26
prerank,positive regulation of locomotion (GO:0040017),-0.5469294871625315,-1.6769062367045282,0.008350730688935281,0.12024313766524423,1.0,10/27,15.76%,SPOCK2;NTN1;THBS1;STX3;TWIST1;CCDC25;AKT2;RARRES2;CAVIN1;CSF1R
prerank,intraciliary retrograde transport (GO:0035721),0.6731857809700664,1.676540179541272,0.032989690721649485,0.7073415268398312,1.0,7/12,10.31%,TTC21B;DYNLT2B;WDR19;WDR35;DYNC2LI1;DYNC2I2;IFT122
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5854628873060038,-1.6742158706888381,0.006396588486140725,0.12223646059852956,1.0,9/20,13.32%,GSN;THBS1;PLCG1;SFRP4;PLA2R1;ECSCR;PDCD4;ITGA4;CD40
prerank,regulation of catecholamine secretion (GO:0050433),0.5493642766846104,1.6685250964337472,0.01303538175046555,0.7304514736412507,1.0,10/29,11.44%,SYT11;SYT12;SYT9;SYT1;SYT13;CHRNB2;DRD3;SYT10;CHGA;DTNBP1
prerank,regulation of cell migration (GO:0030334),-0.352715800041216,-1.668025350088212,0.0,0.12876444660552605,1.0,106/382,13.82%,LEF1;TMEFF2;FRMD5;ACTN4;NTRK3;PODXL;CAV1;GCNT2;PECAM1;SEMA6A;DOCK10;CLDN5;JAG1;SEMA3C;ITGA6;VCL;SLIT2;TJP1;SRGAP1;RHOA;TMSB4X;CLIC4;SEMA7A;ACVR1;ACVRL1;ENG;INSR;THBS1;NOTCH1;ACTG1;CDH13;F3;LIMCH1;EGFR;CYP1B1;FOXO3;PRR5L;CORO1C;CDH1;MACF1;STAT3;SPATA13;PTPRJ;KANK1;KDR;ADARB1;MGAT5;PTPRK;DACH1;FLNA;CPNE3;RAP2A;ITGB1;NUMB;RECK;RACK1;ADAM10;TWIST2;CXCL12;ANXA1;ROBO4;FLT1;CCN1;PPP3CA;MDK;MYOC;PRKX;APC;SPRY2;CEACAM1;STK24;SRC;PDGFC;TIAM1;SEMA5B;MAP4K4;FGF2;SERPINE1;ABI3;BCAR1;NEDD9;FGF7;DUSP3;TMSB10;EPHB2;RIPOR1;EDN1;FAM107A;PIK3CD;SEMA3E;PLXNC1;CD74;CEMIP;COL1A1;RET;BMP2;SEMA3G;PTK2B;PDGFD;SST;SMO;ROR2;IGSF10;AKT2;AMOT;VEGFA
prerank,vasoconstriction (GO:0042310),-0.6984798409921088,-1.6671194024042133,0.012345679012345678,0.1292977382093318,1.0,5/11,11.67%,EDNRA;PIK3C2A;ACTA2;EDN1;EDN3
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.5086841164685149,-1.6669940901693825,0.013761467889908258,0.12867532224418196,1.0,17/33,15.20%,RHOJ;SEMA6A;TJP1;BMPER;THBS1;ITGA5;CREB3L1;SMAD1;PPP1R16B;EPN2;CEACAM1;FGF2;KLF4;JAK1;VEGFA;KLF2;CEMIP2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6844131885025375,-1.6652800194739457,0.02286902286902287,0.12999753327760058,1.0,8/11,20.85%,LIMD1;STAT3;PUM2;PUM1;FMR1;FXR1;XPO5;AJUBA
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.4369692123085586,-1.6638015293729014,0.0023752969121140144,0.1310275793034414,1.0,32/71,22.73%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;NCK1;MAPK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;CDC42;ARPC3;SYK;FCGR1A;FYN;FCGR2B;MYO1C
prerank,histone H3-K9 demethylation (GO:0033169),0.6977834251215721,1.6617298919989636,0.027450980392156862,0.7457183325588064,1.0,5/11,19.45%,KDM7A;PHF8;KDM4A;KDM1A;KDM3B
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4665540461945261,-1.6602833882538603,0.004338394793926247,0.1348280838656133,1.0,11/51,5.76%,BMPR2;HTRA3;GREM2;BMPER;NOTCH1;CRIM1;SMURF1;FBN1;SMAD5;SMAD1;UBE2D3
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6305982752754495,1.6600769694849697,0.025193798449612403,0.731894488695787,1.0,6/18,7.82%,UNC13C;NAPB;GRID2;GRIK5;GRIK2;NAPA
prerank,mesenchyme morphogenesis (GO:0072132),-0.6047473197491399,-1.659281654386327,0.00816326530612245,0.13502868964359777,1.0,9/17,12.91%,NOS3;ACVR1;ACVRL1;TGFB2;ENG;NOTCH1;HEYL;BMP2;TBX2
prerank,cellular glucan metabolic process (GO:0006073),0.7221139993635277,1.658688782016859,0.026465028355387523,0.7170776706348815,1.0,5/11,13.55%,PRKAG2;PHKG2;PHKB;PYGL;PYGM
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.4590939884672917,-1.6579433995511754,0.0021598272138228943,0.13591999224183132,1.0,21/51,25.81%,PTN;VEGFC;THBS1;GAS6;CXCL12;IL6R;IL34;MAPK1;MDK;SERPINE1;EDN3;VEGFA;RARRES2;CSF1R;MAPK3;HMGB1;PLA2G7;CCR2;ANO6;CMKLR1;AIF1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.4329516707654017,-1.6575827726498766,0.0,0.13543026805626276,1.0,23/75,13.69%,PTPRM;TEK;SPARC;SEMA6A;DCN;CLDN5;DAB2IP;TGFB2;COL4A2;THBS1;AGO1;SERPINF1;ISM1;ADAMTS1;SPRY2;ECSCR;KLF4;SEMA3E;HGS;HHEX;THBS2;STAB1;AMOT
prerank,intestinal lipid absorption (GO:0098856),0.7004767377512243,1.6572625178257627,0.023032629558541268,0.7032523840299432,1.0,3/11,2.07%,CEL;ABCG5;SOAT2
prerank,potassium ion transport (GO:0006813),0.4339084366547742,1.6560259528293522,0.0016207455429497568,0.689990673687235,1.0,21/120,12.63%,ATP1A2;KCNK2;SLC24A3;KCND3;ATP1B3;KCNA3;KCNJ13;LRRC38;KCNJ5;TMEM175;KCNJ10;NALCN;KCNC3;KCND2;KCNH2;KCNC2;KCNN4;KCNJ16;KCNH7;KCNK4;SLC9A9
prerank,cGMP-mediated signaling (GO:0019934),-0.6544052027683582,-1.655447652701439,0.01996007984031936,0.13743290281491768,1.0,5/13,9.64%,PDE3A;GUCY1B1;PDE9A;PDE2A;APOE
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.6454657154664548,-1.6551280147444636,0.023668639053254437,0.13697706579335941,1.0,3/14,3.88%,IL6ST;OSMR;PTGS2
prerank,monocyte differentiation (GO:0030224),-0.6932393885239487,-1.6538696433857958,0.012024048096192385,0.13783631265587962,1.0,5/10,15.76%,MYH9;BMP4;MT1G;VEGFA;CSF1R
prerank,heterocycle biosynthetic process (GO:0018130),-0.634613364536219,-1.653100306428499,0.015748031496062992,0.13799794080174121,1.0,7/14,21.80%,GPHN;GCH1;LIAS;NFS1;MOCS1;NOXRED1;PYCR3
prerank,protein localization to synapse (GO:0035418),0.6870303616064016,1.6520415853387735,0.02335456475583864,0.6920834116099944,1.0,5/12,10.84%,NLGN2;ZDHHC12;SHANK1;DLG4;BSN
prerank,regulation of microtubule-based movement (GO:0060632),0.7000995483903841,1.6516082031414518,0.03067484662576687,0.6754527274884562,1.0,4/11,8.39%,MAP2;TTC21B;DYNLT2B;DRC1
prerank,modified amino acid transport (GO:0072337),0.6557454343631982,1.650584470203805,0.01775147928994083,0.6632876224356098,1.0,4/15,7.83%,SLC6A13;SLC16A12;PDPN;SLC19A1
prerank,regulation of glucose import (GO:0046324),0.5503836635988767,1.6496929108970713,0.005484460694698354,0.6508692091966968,1.0,8/30,9.68%,PRKAG2;OSBPL8;IGF1;APPL2;PRKCI;SORBS1;RHOQ;CREBL2
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.5389102067791229,-1.6490603792929168,0.012448132780082987,0.1422892042524755,1.0,13/25,27.92%,NCKAP5;STMN1;MAP7D3;TPPP3;FGF13;TRPV4;NCKAP5L;KATNB1;KIF24;STMN4;KIF14;CENPJ;MAPT
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.5894792320505058,-1.646168863552298,0.025,0.14515730837569918,1.0,9/18,16.64%,SPTBN1;ACTB;AR;CDK5;STX7;ZDHHC7;STX8;ZDHHC2;LDLRAP1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.44053633314506474,-1.6457624470554404,0.007194244604316547,0.14487907447677562,1.0,28/67,22.09%,TEK;GHR;ABI1;INSR;EGFR;KDR;BMX;TEC;LYN;FLT1;SRC;FLT4;ABI3;IL15;EPHB2;DYRK1A;PIBF1;PTK2B;CSF1R;FGFR3;PTPN6;EFEMP1;MAPK3;BTK;JAK3;HCK;SYK;FYN
prerank,negative regulation of calcium ion transport (GO:0051926),0.6488276436578642,1.6451205909278315,0.030534351145038167,0.658103745034344,1.0,2/15,4.37%,ATP1A2;ADRA2A
prerank,metal ion export (GO:0070839),0.5340820938807243,1.643307284832898,0.02,0.6518958071724493,1.0,4/31,4.28%,ATP1A2;KCND3;ATP1B3;ATP1B2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4289877795117553,-1.642982551471715,0.0,0.14754997870784609,1.0,32/73,22.73%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;NCK1;MAPK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;CDC42;ARPC3;SYK;FCGR1A;FYN;FCGR2B;MYO1C
prerank,membrane lipid biosynthetic process (GO:0046467),-0.4472079709725414,-1.6422786388272927,0.0045662100456621,0.14760983377798567,1.0,26/58,20.23%,SGMS1;ST3GAL4;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;PRKD3;PRKD1;SPNS2;ELOVL5;CERS5;CERS6;ST8SIA6;PLPP1;SAMD8;ELOVL6;ELOVL1;PLPP3;VAPB;ELOVL4;ST3GAL2;SGPP1;SPTSSA;PPM1L;ACER3
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.5262457486335472,-1.641626537159785,0.004415011037527594,0.14764780834260063,1.0,12/29,13.07%,SHANK3;SLIT2;TJP1;KANK1;SSH2;KANK3;KANK4;PRKCD;PIK3CA;LIMA1;HIP1R;PFN1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.5440556043336395,-1.64044116246174,0.010080645161290322,0.14857833567922968,1.0,9/24,15.60%,DAB2IP;ITGA5;TMEM204;EPN2;PTPN1;HGS;HHEX;MT3;VTN
prerank,regulation of wound healing (GO:0061041),-0.4846721923605706,-1.6400030033245734,0.01932367149758454,0.14837279649624857,1.0,12/42,10.33%,CAV1;ACTG1;KANK1;CD109;CASK;ITGB1;AJAP1;ANXA1;OCLN;FGF2;SERPINE1;EPHB2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.5335498360854797,-1.6375970599582959,0.00823045267489712,0.15060342646549543,1.0,12/27,7.50%,TMEFF2;SHANK3;TJP1;WASF2;PIK3R1;STMN1;F11R;PHLDB2;ARAP1;PAK2;MET;MYOC
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6845660944521685,-1.6373510161785918,0.014953271028037384,0.15014009047047175,1.0,3/11,9.62%,NRP1;STMN1;BCAR1
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5788827012152725,-1.6359503567721827,0.016194331983805668,0.15140827984406197,1.0,13/19,24.99%,BMPR2;ACVR1;TGFB2;NOTCH1;TGFBR2;HEYL;HEY2;BMP2;HEY1;SLIT3;ZFPM1;SMAD6;OLFM1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.6151844937110454,-1.634998404361116,0.02004008016032064,0.15186233142120065,1.0,7/14,19.05%,THBS1;IL34;MAPK1;MDK;RARRES2;CSF1R;MAPK3
prerank,negative regulation of anoikis (GO:2000811),-0.6358041544272196,-1.6331851875943122,0.014553014553014554,0.1535703296919463,1.0,6/14,8.77%,CAV1;NOTCH1;ITGA5;ITGB1;PIK3CA;SRC
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.6351242969236659,-1.6328273830540077,0.020491803278688523,0.1534123711270432,1.0,8/13,21.00%,ARID1B;ARID1A;SERTAD1;ZMIZ2;SPI1;CDCA4;ZMIZ1;CHEK1
prerank,clathrin coat assembly (GO:0048268),-0.623766474340526,-1.6323736309338293,0.015717092337917484,0.15326955715803847,1.0,5/15,5.93%,HIP1;PIK3C2A;FCHO2;SGIP1;CLTB
prerank,vasculogenesis (GO:0001570),-0.49765767643766184,-1.6307871482726624,0.015283842794759825,0.1545746926760124,1.0,14/32,13.82%,CAV1;ENG;RAMP2;NOTCH1;RASIP1;TGFBR2;KDR;SOX17;HEY2;AGGF1;ADM;SOX18;ITGB8;VEGFA
prerank,negative regulation of signaling receptor activity (GO:2000272),0.569602636007977,1.6299326465658455,0.01768172888015717,0.7061288153692515,1.0,6/25,2.89%,ERRFI1;SNX6;SLC6A9;CHMP6;GPRC5A;PPARA
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.3766471138870155,-1.6267248698510146,0.0,0.1595364269290464,1.0,42/151,15.76%,NRP1;ROR1;TEK;NTRK3;GCNT2;RAPGEF2;PDE8A;SEMA7A;BMPER;NOTCH1;GAS6;RAP1A;EGFR;CD44;KDR;APP;MFHAS1;TNFRSF11A;ICAM1;TNFAIP8L3;GAREM1;SPRY2;CCL13;PDGFC;FLT4;FGF2;APOE;ACKR3;CD74;PHB2;BMP2;PTK2B;PDGFD;ROR2;HTR2A;PTPRC;FBXW7;P2RY6;MTURN;MT3;FERMT2;CSF1R
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.491886686044264,-1.6260902643293542,0.0066518847006651885,0.15947644099536737,1.0,9/35,10.48%,PTPRM;MEF2C;CAV1;SPARC;THBS1;XDH;FLT1;APOE;CAV2
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5405030691380484,-1.624746087459253,0.015810276679841896,0.16056406022881117,1.0,12/24,27.26%,PECAM1;VCAM1;F11R;ITGB1;ICAM1;ITGA4;NT5E;SYK;MSN;ROCK1;SEMA4D;SELP
prerank,neurotransmitter uptake (GO:0001504),0.6941044321574036,1.6235782088609931,0.018480492813141684,0.7250544640767803,1.0,6/12,15.95%,ATP1A2;SLC29A2;SLC38A1;SNAP25;SLC22A2;GLUL
prerank,B cell receptor signaling pathway (GO:0050853),-0.4974422387781795,-1.6233497998608517,0.004329004329004329,0.1620338699726467,1.0,15/32,21.23%,MEF2C;RFTN1;PLCG2;BMX;TEC;CD38;BCAR1;PIK3CD;NFATC2;SH2B2;PTPRC;NCKAP1L;LAT2;BTK;SYK
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.7057862378482206,1.6230311786893177,0.028747433264887063,0.7109565864032923,1.0,2/10,4.37%,ATP1A2;ADRA2A
prerank,aspartate family amino acid catabolic process (GO:0009068),0.6098072784842077,1.6227919847343208,0.01937984496124031,0.6960613056816721,1.0,6/19,15.79%,DDO;ALDH7A1;ASPA;GCDH;GOT1;GOT2
prerank,supramolecular fiber organization (GO:0097435),-0.3463593568484799,-1.6226658484387504,0.0,0.16225551300797184,1.0,83/334,13.75%,HIP1;COL8A1;COL12A1;MYO1D;PGM5;TLL1;COL6A3;MYO1B;COL4A1;RHOBTB1;ITGA6;COL25A1;SHROOM4;RHOA;COL15A1;COL6A2;COL8A2;B2M;DST;GSN;COL6A1;TGFB2;COL4A2;CYP1B1;PLOD2;NCKAP5;CORO1C;COL23A1;H3-3A;APP;COL5A2;STMN1;ITGB4;UBC;LAMA3;ACTN1;COL4A6;ARHGEF2;P4HA1;RPS27A;UBB;CST3;TPM4;TNXB;ADAM10;LOX;LUM;IAPP;PLOD3;CLIP4;MAP7D3;ALDOA;MFAP4;ADAMTS14;EMP2;TGFBI;MFGE8;TPM2;MYH11;COL27A1;TMOD3;MYO19;TPPP3;TPM3;BCAR1;COL14A1;MYO1F;CRTAP;CD2AP;WHAMM;FGF13;CDC42EP2;GFAP;CLIP2;COL1A1;HIP1R;ITM2B;RND3;TRPV4;P4HA2;MARCKS;NCKAP5L;AVIL
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5787070633684768,1.622357032636083,0.020676691729323307,0.6830627982066131,1.0,9/25,9.59%,ACTN2;ATP1B3;ANK2;SLC6A9;WNK3;STK39;ATP1B2;WNK4;PDZK1
prerank,triglyceride homeostasis (GO:0070328),0.5566193688424452,1.6219793996909024,0.018726591760299626,0.6699416009536785,1.0,7/26,9.10%,RORA;IL18;FITM2;ACSM2A;PNPLA8;C1QTNF3;NR1H3
prerank,cell-substrate junction assembly (GO:0007044),-0.4986152743713429,-1.6218589995430843,0.008421052631578947,0.16277344246692904,1.0,12/33,10.16%,THSD1;ITGA6;DST;PEAK1;BCR;FN1;ITGB4;PTPRK;LAMA3;ACTN1;SRC;WHAMM
prerank,endodermal cell differentiation (GO:0035987),-0.5104795286085714,-1.619981176768836,0.013856812933025405,0.16433217172133427,1.0,12/31,12.40%,COL8A1;COL12A1;COL6A1;COL4A2;ITGA5;FN1;LAMA3;ITGB5;RTF1;PAF1;ITGA7;ITGA4
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.668729572142155,-1.6199807761509653,0.02736842105263158,0.1634979982608199,1.0,6/10,19.05%,FAS;LYN;MAPK1;NBR1;GREM1;MAPK3
prerank,regulation of anoikis (GO:2000209),-0.5762774640585101,-1.6196283195362287,0.00847457627118644,0.16311330487575698,1.0,8/19,11.20%,CAV1;NOTCH1;ITGA5;ITGB1;MYBBP1A;PIK3CA;SRC;TLE5
prerank,activation of protein kinase B activity (GO:0032148),0.5423551482839336,1.6196088532519262,0.02734375,0.667427603467721,1.0,8/29,6.83%,FGF1;OSBPL8;IGF1;IL18;RICTOR;ADRA2A;PDPK1;NRG1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.6410937783076118,1.6185078833252673,0.018832391713747645,0.6588767072551752,1.0,4/15,5.08%,OSBPL8;FITM2;PPARA;ABHD5
prerank,regulation of oxidative phosphorylation (GO:0002082),0.6062232754811179,1.6184920810825123,0.02131782945736434,0.6455089913398939,1.0,7/16,18.41%,NUPR1;PPIF;COX7A1;COX7A2L;ABCD1;ATP7A;MLXIPL
prerank,cilium-dependent cell motility (GO:0060285),0.5834626864635447,1.6184084313356721,0.022900763358778626,0.6329692397441096,1.0,6/22,13.59%,CFAP44;DNAH1;TEKT2;TEKT5;DRC1;DNAAF2
prerank,regulation of blood coagulation (GO:0030193),-0.5242822061140087,-1.6171362673588203,0.016632016632016633,0.16592518123159838,1.0,10/27,11.56%,ST3GAL4;CAV1;FAP;THBS1;CD34;SERPINE1;APOE;EPHB2;EDN1;ENPP4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5222655133890584,-1.6164413519436218,0.014861995753715499,0.16617767192479835,1.0,9/26,10.10%,PDE8A;DAB2IP;PTPN12;IQGAP1;EGFR;PLCG1;EEF1A1;GAREM1;DUSP3
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.650682709374901,-1.6162301687533052,0.031683168316831684,0.16574760841930739,1.0,5/12,17.64%,TMEFF2;AR;EDN1;AP2A1;HDAC2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5800537152664111,1.6160268762905574,0.01744186046511628,0.6312411799409343,1.0,3/23,1.72%,ATP1A2;CACNB1;ANK2
prerank,ribosomal small subunit assembly (GO:0000028),-0.6128495934793149,-1.6152983507391652,0.020202020202020204,0.1663618779813158,1.0,8/16,23.34%,RPS15;XRCC5;RPS5;RPS28;RPS27;RRP7A;PWP2;RPS19
prerank,substantia nigra development (GO:0021762),-0.49393115844746815,-1.615273458710969,0.0125,0.16557353457868718,1.0,11/37,15.36%,ACTB;RHOA;YWHAE;GNB4;CALM3;MAOB;YWHAQ;NDRG2;CNP;DYNLL1;GLUD1
prerank,cellular potassium ion homeostasis (GO:0030007),0.6549375171674406,1.615028073516539,0.026717557251908396,0.6236135523710793,1.0,3/13,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5426835244137307,-1.6148708388626056,0.01276595744680851,0.1653326754746633,1.0,10/24,4.34%,NRP1;NRP2;BMPR2;SEMA3C;ACVR1;TGFB2;ENG;BMP4;TGFBR2;TBX1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6107105100197807,1.6148102501160688,0.029239766081871343,0.6128082755671785,1.0,3/17,1.72%,ATP1A2;CACNA1D;ANK2
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.573986478874575,-1.6147084310657147,0.012738853503184714,0.16467434633961126,1.0,9/19,19.05%,THBS1;IL34;MPP1;MAPK1;MDK;JAM3;RARRES2;CSF1R;MAPK3
prerank,platelet degranulation (GO:0002576),-0.3909233563195459,-1.6141605606571,0.002652519893899204,0.16459993080905924,1.0,34/118,13.91%,ABCC4;VWF;ACTN4;PECAM1;SPARC;PCDH7;VCL;TMSB4X;TGFB2;VEGFC;CD9;THBS1;GAS6;LHFPL2;TAGLN2;APP;WDR1;FN1;CD109;ACTN1;FLNA;LYN;ALDOA;CHID1;SOD1;IGF2;SERPINE1;TGFB3;ISLR;PSAP;ECM1;VEGFA;TMX3;RARRES2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6705815786165504,1.6138771787936717,0.028056112224448898,0.6054758049129545,1.0,3/12,3.76%,IL18;NUPR1;TAFA3
prerank,mesonephros development (GO:0001823),0.7012322602252008,1.613197689414016,0.028409090909090908,0.597301491136685,1.0,3/11,1.12%,BMP7;FGF1;OSR1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.638795566218286,-1.6126496671851307,0.014141414141414142,0.16577352520492064,1.0,6/12,14.93%,CBLB;F3;PTPRJ;APOD;HGS;CBL
prerank,platelet aggregation (GO:0070527),-0.49726868789591916,-1.6117180134204288,0.010570824524312896,0.1662482553287151,1.0,12/33,11.50%,ACTB;VCL;ACTG1;MYH9;FN1;ACTN1;FLNA;UBASH3B;PPIA;CLIC1;MYL9;HSPB1
prerank,positive regulation of hemostasis (GO:1900048),-0.6858581684161204,-1.6112386547440076,0.02443609022556391,0.1652796748582189,1.0,7/10,25.73%,ST3GAL4;THBS1;SERPINE1;ENPP4;HPSE;F2R;DMTN
prerank,positive regulation of coagulation (GO:0050820),-0.6858581684161204,-1.6112386547440076,0.02443609022556391,0.1652796748582189,1.0,7/10,25.73%,ST3GAL4;THBS1;SERPINE1;ENPP4;HPSE;F2R;DMTN
prerank,histone H3-K36 demethylation (GO:0070544),0.7053888664619647,1.6107866785366425,0.027083333333333334,0.5976876044375451,1.0,4/10,11.87%,KDM7A;PHF8;KDM2A;KDM4A
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4729850148498614,-1.6100832501377076,0.015250544662309368,0.16632582901581106,1.0,16/47,16.71%,NRP1;LIMS1;ACTN4;LIMS2;DOCK1;CORO1C;KANK1;FLNA;MDK;MYOC;EFNA5;NEDD9;AP1AR;S100A10;FERMT2;RREB1
prerank,neuron cell-cell adhesion (GO:0007158),0.6442214718737213,1.6056839112137995,0.03353057199211045,0.6105837851696388,1.0,4/14,7.03%,CEL;NLGN2;NRXN3;NLGN3
prerank,receptor internalization (GO:0031623),-0.46880453698911034,-1.6051126888872351,0.017582417582417582,0.1730514943483931,1.0,14/44,13.83%,CAV1;CALCRL;DNM3;RAMP2;CD9;RAB31;ITGB1;TFRC;LMBRD1;SNX1;CEACAM1;ACKR3;ADM;LRP1
prerank,cellular response to cadmium ion (GO:0071276),-0.5433463490886801,-1.6045242570665066,0.03292181069958848,0.17304120806360296,1.0,14/24,19.05%,EGFR;JUN;MAPK1;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MT3;MT2A;MAPK3
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.591380271283085,-1.6039552135018815,0.015904572564612324,0.17314338723727488,1.0,9/16,20.36%,THBS1;JCAD;AGTR1;PPP1R16B;GATA2;FGF2;VEGFA;APLNR;DLL4
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6838019690941508,-1.6035913597917115,0.018404907975460124,0.1728619825385396,1.0,5/10,16.62%,PDE3A;PDE4D;PDE2A;RNF157;APLNR
prerank,regulation of neuroinflammatory response (GO:0150077),0.5882265000446788,1.602312769029247,0.03747534516765286,0.6151051254137014,1.0,5/19,3.39%,IGF1;IL18;NUPR1;SPHK1;DAGLA
prerank,cellular sodium ion homeostasis (GO:0006883),0.6272432635852555,1.6014408430364613,0.025590551181102362,0.6086298028701795,1.0,3/15,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,regulation of osteoblast differentiation (GO:0045667),0.44260363380861606,1.6010600264037522,0.0051813471502590676,0.6001837688811545,1.0,15/82,6.95%,RANBP3L;SMOC1;BMP7;BMP6;WNT4;TMEM64;IGF1;DDX5;SUFU;BMPR1A;LRP3;WWTR1;NPNT;CITED1;FGFR2
prerank,integrin-mediated signaling pathway (GO:0007229),-0.41894142431337966,-1.6005783267578142,0.011655011655011656,0.17647383441338318,1.0,28/73,15.34%,NRP1;ITGBL1;DOCK1;PTN;SEMA7A;DST;MYH9;ITGA5;FN1;ITGB4;LAMA3;ITGB1;TEC;PRKD1;ADAM10;ITGB5;ADAMTS1;CEACAM1;SRC;BCAR1;NEDD9;ISG15;PTK2B;ITGB8;NME2;ADAM15;PLPP3;FERMT2
prerank,sterol biosynthetic process (GO:0016126),0.5187003187761187,1.5976558258106042,0.017921146953405017,0.6061207837380783,1.0,11/33,20.27%,PRKAG2;ACAT2;INSIG2;DHCR24;SC5D;SQLE;CYP51A1;MSMO1;GGPS1;HMGCR;LBR
prerank,histone H3-K4 trimethylation (GO:0080182),0.675195793394749,1.597199259845547,0.049079754601226995,0.598423321990261,1.0,5/11,19.43%,CTR9;KMT2A;BEND3;TET2;SETD1B
prerank,inorganic cation transmembrane transport (GO:0098662),0.3773049207110736,1.5971180413710444,0.0,0.589255278593503,1.0,25/268,6.47%,TRPM3;ATP1A2;KCNK2;SLC6A13;SLC6A1;CACNA1D;SLC6A12;SLC8A3;SLC41A1;SLC24A3;TRPM6;KCND3;ATP1B3;TRPV1;KCNA3;SLC30A6;LRRC38;SLC6A9;TMEM175;KCNJ10;SLC30A10;ATP6V1H;NALCN;SLC39A13;KCNC3
prerank,regulation of spindle organization (GO:0090224),-0.5663761026734574,-1.5962098602568595,0.029787234042553193,0.1822803787950247,1.0,9/18,23.88%,SENP6;MAP9;DYNC1H1;DCTN1;GPSM2;TPX2;FSD1;PARP3;NUP62
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6121631336550397,-1.5950997369078674,0.022222222222222223,0.18320334465014418,1.0,9/14,24.62%,THBS1;PLCG1;ECSCR;PDCD4;ITGA4;CD40;GPER1;RGCC;ANO6
prerank,ncRNA processing (GO:0034470),-0.3580921069275328,-1.5918590023584847,0.0,0.18749868327362684,1.0,86/200,24.47%,RPLP1;RPS15;RPL38;RPL18A;RPL41;AGO1;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;SMAD1;RPL39;HELQ;INTS11;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;RPL6;RPL18;RPS25;PELP1;AGO2;RPL36;DDX54;RPL28;RPL27;DROSHA;RPL24;RPL23;RPL17;RPS9;RPS27;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;DDX27;ESF1;RPL19;INTS10;DDX49;RPL37;RRP12;RPP21;ADAT1;PWP2;AGO4;RCL1;MRPL44;INTS9;MRTO4;NOP58;EBNA1BP2;METTL3;RPL3;RPL15;EXOSC4;DKC1;EXOSC5;IMP4;TARBP2;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.4683193934813366,-1.5907874297037927,0.011467889908256881,0.18841255048151598,1.0,14/44,16.62%,MEF2C;MICAL2;ACVR1;ENG;TBX3;NOTCH1;TGFBR2;SOX17;HES1;SOX18;SMO;TBX2;STIL;APLNR
prerank,hemopoiesis (GO:0030097),-0.40373403623577486,-1.5900941387187932,0.005076142131979695,0.18864237931175054,1.0,24/87,10.14%,MECOM;KITLG;TEK;SNRK;ZBTB16;JAG1;MFAP5;HIPK1;TGFB2;RUNX2;CD34;RUNX1;BMP4;TGFBR2;KDR;KAT6A;WNT5A;FLT1;PRKX;ARIH2;FLT4;NOTCH4;TAL1;ETV6
prerank,positive regulation of protein modification process (GO:0031401),-0.35727635337926883,-1.5876501754818562,0.0,0.1917548697086856,1.0,66/203,18.58%,TEK;NTRK3;PECAM1;SLCO3A1;PDE8A;NIBAN1;ENG;INSR;VEGFC;GAS6;LIMCH1;EGFR;LIMK2;BMP4;KDR;APP;NOS1AP;CARD14;TBX1;RALB;FAM161A;FAS;TNIK;RAP2A;TFRC;AXIN2;RACK1;NPTN;PPIA;LYN;PPP1R16B;IL34;PRKCD;NNMT;CALM3;CCN1;RB1CC1;SPPL3;EFNA5;TMEM119;FLT4;IGF2;FGF2;FGF7;NSMF;TERF2IP;DYRK1A;CD74;KRAS;BMP2;CD40;AKT2;VEGFA;RARRES2;MT3;PLAUR;FMR1;CSF1R;RAB3GAP2;ALG10B;FXR1;CEP295;GPER1;TAOK1;C3;CCND1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5667766918083118,-1.5874035790924903,0.027833001988071572,0.19134334581991919,1.0,6/18,3.88%,LTBP1;CD200;TGFB2;CD34;FN1;PTGS2
prerank,positive regulation of wound healing (GO:0090303),-0.4765659570431692,-1.587101102715334,0.023305084745762712,0.19089594520629005,1.0,18/36,25.73%,ST3GAL4;THBS1;ACTG1;KANK1;ITGB1;ANXA1;OCLN;SERPINE1;ENPP4;PLPP3;FERMT2;VTN;RREB1;MYLK;HPSE;PRKCE;F2R;DMTN
prerank,maturation of 5.8S rRNA (GO:0000460),0.6073532159812616,1.5870174827372967,0.03512396694214876,0.6243862054070222,1.0,2/17,0.34%,NSA2;MPHOSPH6
prerank,organic anion transport (GO:0015711),-0.41828990415090234,-1.586561611743014,0.006864988558352402,0.19089127441617862,1.0,14/76,8.49%,ABCG2;ABCC4;SLC4A10;SLC26A7;SLCO3A1;LRRC8D;SLCO1C1;SLCO2A1;LRRC8C;SLCO2B1;SLC39A8;CA4;LRRC8A;SLC16A2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.6257519716236771,-1.5862887479892627,0.027777777777777776,0.19042183267592688,1.0,5/13,12.09%,DAB2IP;EPN2;PTPN1;HGS;HHEX
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6207010177982795,-1.5827419406941747,0.020876826722338204,0.1951863251169545,1.0,7/13,11.83%,SEMA7A;TGFB2;IRAK3;PLCG2;WNT5A;TGFB3;CD74
prerank,filopodium assembly (GO:0046847),-0.5894780105951415,-1.5821275019841488,0.02610441767068273,0.19536828621321464,1.0,4/16,3.19%,FGD5;DNM3;FGD6;SPATA13
prerank,response to hydroxyurea (GO:0072710),-0.6532763982032244,-1.580863480346911,0.023622047244094488,0.19660980058510552,1.0,7/11,21.67%,KAT7;DDI2;BLM;TIMELESS;FMR1;SPIDR;NSMCE3
prerank,triglyceride biosynthetic process (GO:0019432),0.5975855763471075,1.5806246550374106,0.040697674418604654,0.6430610344992816,1.0,5/18,12.75%,LPGAT1;GK;LPIN1;MOGAT1;DGAT2
prerank,regulation of muscle contraction (GO:0006937),0.5492672677223882,1.5800580797416828,0.023131672597864767,0.6360888815381236,1.0,5/26,7.44%,ATP1A2;ANXA6;ENO1;CHRM2;TNNI1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6480849272864809,1.5800027033022577,0.042105263157894736,0.6268599383221725,1.0,4/13,2.43%,ERRFI1;SNX6;CHMP6;GPRC5A
prerank,acylglycerol homeostasis (GO:0055090),0.582727763108907,1.579817691342053,0.02766798418972332,0.6183563907780303,1.0,5/20,9.10%,RORA;IL18;ACSM2A;PNPLA8;NR1H3
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6611654508654132,1.5793305618993647,0.046242774566473986,0.6115756672718151,1.0,4/12,6.71%,ATP1B3;WNK3;ATP1B2;WNK4
prerank,mesenchymal cell differentiation (GO:0048762),0.4736833835706799,1.578479363566555,0.019891500904159132,0.6062013901935,1.0,11/51,7.14%,RANBP3L;BMP7;TGFBR3;WNT4;ROCK2;DDX5;S100A4;LOXL3;RBPJ;FGFR2;DDX17
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5604102313844957,-1.577859612805641,0.02663934426229508,0.20033326680003344,1.0,7/19,7.71%,PRKCH;CLDN5;TJP1;RUNX1;F11R;CBFB;OCLN
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.52564800620619,-1.57619667651765,0.018218623481781375,0.20217809489840144,1.0,11/24,7.50%,TMEFF2;TJP1;WASF2;PIK3R1;STMN1;F11R;PHLDB2;ARAP1;PAK2;MET;MYOC
prerank,positive regulation of vasoconstriction (GO:0045907),-0.6324967586648514,-1.5760595763488308,0.02178217821782178,0.20159031405563313,1.0,2/13,1.51%,CAV1;ADRA1B
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.4580405138384988,-1.5754154936802636,0.01327433628318584,0.20173545357305409,1.0,11/42,8.79%,LIMS1;GCNT2;RHOA;VIT;NDNF;NOTCH1;CORO1C;TBCD;FBLN2;EMP2;ECM2
prerank,sodium ion homeostasis (GO:0055078),0.562693209539424,1.5753247418168743,0.032818532818532815,0.6113152749018309,1.0,3/21,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,positive regulation of GTPase activity (GO:0043547),-0.3599290495951978,-1.5751055703906,0.0,0.2013438922762039,1.0,54/188,15.77%,DOCK9;LIMS1;TBC1D4;NTRK3;RABGAP1L;DOCK10;RAPGEF2;ARHGAP42;ITGA6;NET1;BCAR3;SIPA1L2;RAP1A;TBC1D8;CORO1C;BCR;F11R;TBC1D12;SNX18;SNX13;TIAM2;USP6NL;TBC1D5;ARAP1;ITGB1;TBC1D2B;SIPA1L3;ARHGEF15;RACK1;TBC1D1;RAPGEF6;RGS6;TGM2;EVI5L;CCL13;ABR;TIAM1;MAP4K4;TBC1D13;DOCK8;CAV2;RGS10;SIPA1;RALGAPA1;TAX1BP3;CD40;TBC1D7;TBC1D10A;AGRN;ARHGAP27;S100A10;FERMT2;RAP1GAP;TBC1D25
prerank,cellular response to growth factor stimulus (GO:0071363),-0.36843151753069525,-1.574611074880197,0.0,0.20125726117411125,1.0,44/151,10.10%,NRP1;PDE3A;LIMS1;MEF2C;NTRK3;SEMA6A;RAPGEF2;PDE8A;BMPR2;DAB2IP;PTPN12;ACVR1;ACVRL1;RAMP2;NDNF;NOTCH1;RAP1A;IQGAP1;EGFR;RUNX2;PLCG1;CD44;BMP4;EEF1A1;TGFBR2;KDR;TBX1;CPNE3;TMEM100;PRKD1;WNT5A;ERN1;RACK1;PDE2A;ANXA1;FLT1;GAREM1;SPRY2;FLT4;MT1G;MAPKAPK2;BCAR1;KLF4;DUSP3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5495862488082298,1.574568109792639,0.028409090909090908,0.6060831814491454,1.0,6/26,11.40%,PRKAG2;LPGAT1;PRKAA2;SLC45A3;NR1H3;WDTC1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4612666347499168,-1.5739320612903043,0.01873536299765808,0.20153067542508418,1.0,16/44,14.78%,YWHAE;THBS1;GAS6;NGF;CD44;CAST;RPS6KA3;CARD16;SRC;XIAP;GPX1;KLF4;USP47;CSNK2A1;VEGFA;MT3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.66387095146422,-1.5731934313313456,0.016194331983805668,0.20179644215727438,1.0,6/10,23.95%,RUNX1;CBFB;NCKAP1L;SH3RF1;HMGB1;SOCS1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6713186271222509,-1.5731336675247918,0.034,0.20104427812338563,1.0,5/10,7.77%,SEMA6A;DCN;DAB2IP;XDH;SPRY2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.42393979403700816,-1.5709120919313153,0.0022727272727272726,0.2035710504906869,1.0,22/65,17.80%,HIP1;DAB2IP;PTPN12;BCAR3;CDH13;EGFR;AFAP1L2;PTPRJ;ITGA1;ARAP1;SPRY2;CEACAM1;MVB12B;DUSP3;HGS;SH3GL2;HIP1R;SPRY1;CBL;PLAUR;GPER1;PDE6H
prerank,regulation of membrane repolarization (GO:0060306),-0.6109784330859794,-1.5694119936951183,0.02826086956521739,0.2050800800800801,1.0,6/13,7.09%,CAV1;NEDD4L;YWHAE;KCNJ2;CACNA2D1;KCNQ1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5816093752861842,-1.5676980099668498,0.037815126050420166,0.20699671388849622,1.0,6/17,9.74%,MAML2;PBX1;NOTCH3;NOTCH1;HEYL;NOTCH4
prerank,mesoderm formation (GO:0001707),-0.5626838671893587,-1.5676030363321407,0.0437375745526839,0.20628779249468904,1.0,4/17,5.13%,BMPR2;ITGB4;ITGA8;ITGB1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.6063705774568908,1.5668520022193093,0.027881040892193308,0.6301931423278962,1.0,5/16,11.59%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,amino sugar metabolic process (GO:0006040),-0.6569329162372927,-1.565504657419444,0.029940119760479042,0.20913681289254818,1.0,3/10,10.72%,CSGALNACT1;ST3GAL1;GFPT2
prerank,regulation of glycolytic process (GO:0006110),0.44527307249955456,1.5653457233232846,0.008605851979345954,0.6281323981465868,1.0,8/68,3.98%,PRKAG2;IGF1;NUPR1;GCK;PRKAA2;PPARA;POM121;NUP155
prerank,positive regulation of hydrolase activity (GO:0051345),-0.37067349606476213,-1.5647861612245435,0.0,0.20962832061381148,1.0,37/137,15.39%,DOCK9;LIMS1;DOCK10;RAPGEF2;ITGA6;RHOA;CD200;NET1;BCAR3;RAP1A;F11R;SNX18;SNX13;USP6NL;ARAP1;ITGB1;RACK1;CALM3;RAPGEF6;RGS6;TGM2;EVI5L;RPS3;CCL13;MAP4K4;DOCK8;CAV2;RGS10;PSAP;BMP2;CD40;TBC1D7;AGRN;ARHGAP27;S100A10;FERMT2;RAP1GAP
prerank,heart looping (GO:0001947),-0.4697022032052628,-1.5647338973392773,0.0200445434298441,0.20887601183167687,1.0,12/40,16.62%,MEF2C;MICAL2;ENG;TBX3;NOTCH1;TGFBR2;SOX17;SOX18;SMO;TBX2;STIL;APLNR
prerank,regulation of integrin activation (GO:0033623),-0.5972100843741377,-1.5631294438926817,0.031683168316831684,0.2109234737026532,1.0,12/15,32.06%,PIEZO1;RASIP1;SRC;JAM3;FERMT2;KIF14;SELP;FARP2;PTGER4;FBLIM1;RAP1B;SKAP1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.5767280322364393,-1.5614682004036704,0.023809523809523808,0.21286724855992853,1.0,9/18,11.68%,PTN;DAAM2;NOTCH1;TNFRSF1B;HES1;IL34;TNFRSF21;MDK;PTPRZ1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6303563379773081,-1.5604677680253312,0.027559055118110236,0.2136828151844837,1.0,5/11,8.96%,CD200;THBS1;CD34;PTGS2;ATP6AP2
prerank,ceramide biosynthetic process (GO:0046513),-0.4626076468924817,-1.559094311044473,0.010869565217391304,0.2150458633863518,1.0,11/40,9.26%,SGMS1;ST6GALNAC3;ST8SIA4;SGMS2;DEGS2;AGK;ST6GALNAC5;CERS5;CERS6;ST8SIA6;SAMD8
prerank,cyclooxygenase pathway (GO:0019371),0.6802757177373078,1.5588811769689703,0.038461538461538464,0.6472307266381245,1.0,2/10,0.31%,PTGDS;PTGS1
prerank,negative regulation of cell adhesion (GO:0007162),-0.4112826721848609,-1.558154555294542,0.009501187648456057,0.21572469020744883,1.0,24/72,13.79%,PODXL;GCNT2;SEMA6A;JAG1;RHOA;ACER2;ACVRL1;NOTCH1;CDH13;CYP1B1;CDH1;TBCD;ARHGDIB;ADAM10;MDK;TGFBI;SERPINE1;EPHB2;PLXNC1;JAM3;FZD4;SIPA1;PTPRC;ARHGDIA
prerank,cell junction assembly (GO:0034329),-0.38726236931672625,-1.558140432577523,0.005037783375314861,0.2148904411119917,1.0,17/100,4.67%,CDH11;ACTB;LIMS1;SHANK3;FARP1;LIMS2;DNM3;SPOCK2;CLDN5;ITGA6;TJP1;RHOA;GJC1;ACTG1;CDH1;FN1;FLNA
prerank,autophagy of peroxisome (GO:0030242),-0.6235764597865561,-1.5580206766673457,0.0408997955010225,0.2142385954646491,1.0,7/12,17.13%,MAP1LC3B;RB1CC1;NBR1;PIK3C3;SQSTM1;PIK3R4;ACBD5
prerank,cardiac muscle cell action potential (GO:0086001),0.520422031495694,1.5578902512386383,0.02877697841726619,0.6431316458186211,1.0,6/30,8.02%,ATP1A2;CACNA1D;KCND3;ANK2;FGF12;KCNH2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6750988916829745,1.5574422152475293,0.05588822355289421,0.6369040374577418,1.0,5/10,15.22%,USH1C;WHRN;ADGRV1;PDZD7;TSKU
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5440727200721182,1.5566443138903896,0.03544776119402985,0.6322113657458288,1.0,10/26,18.36%,EYA1;HSPA1A;EYA4;EYA2;HTRA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.579288671501007,-1.554432533128343,0.021739130434782608,0.21839152936989845,1.0,7/16,10.48%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.579288671501007,-1.554432533128343,0.021739130434782608,0.21839152936989845,1.0,7/16,10.48%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,peptidyl-tyrosine modification (GO:0018212),-0.4286722383320956,-1.5541486459730807,0.0023752969121140144,0.21809097806393277,1.0,24/56,22.09%,TEK;ABI1;INSR;EGFR;KDR;TEC;LYN;FLT1;SRC;FLT4;ABI3;EPHB2;DYRK1A;TPST2;PTK2B;CSF1R;FGFR3;PTPN6;EFEMP1;BTK;JAK3;HCK;SYK;FYN
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.3704752205583366,-1.5539115002506076,0.0,0.21770378496312406,1.0,31/140,10.13%,ARHGAP31;ARHGAP10;RHOJ;CHN2;PLCE1;ARAP2;SLIT2;SRGAP1;RHOA;NET1;ARHGEF3;MCF2L;STARD8;CHN1;BCR;RASGRF2;ARAP3;STARD13;TIAM2;ARAP1;ARHGEF2;ARHGAP32;ARHGDIB;ARHGAP35;TGM2;ABR;SRC;TIAM1;VAV2;ARHGEF12;CD2AP
prerank,atrioventricular valve development (GO:0003171),-0.5956453319884122,-1.5524716314743299,0.04384133611691023,0.21926483932834842,1.0,11/14,25.01%,BMPR2;ACVR1;TGFB2;NOTCH1;TGFBR2;HEYL;BMP2;APLNR;SLIT3;ZFPM1;GJA5
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6026018346398971,-1.5524349258345451,0.038910505836575876,0.2184542200580693,1.0,5/13,11.49%,CD9;CDH13;ABCA1;ITGB1;SREBF2
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.32866352590630965,-1.5523471240214135,0.0,0.2177427060931255,1.0,75/348,9.88%,NRP1;TEK;GHR;NTRK3;CAV1;BMP5;PECAM1;SLCO3A1;RAPGEF2;PDE8A;BMPR2;NIBAN1;BCAR3;ACVR1;ACVRL1;TGFB2;ENG;INSR;VEGFC;RPS6KA5;RBPMS;GAS6;RASSF2;RAP1A;LIMCH1;IQGAP1;EGFR;ITGA5;LIMK2;NGF;CD44;BMP4;PTPRJ;CSPG4;KDR;APP;CARD14;CACUL1;FNIP2;TBX1;PLCG2;RALB;FAS;TNIK;CAB39;RAP2A;TFRC;ARHGEF2;PAK2;TEC;PRKD1;AXIN2;RACK1;XRCC5;NPTN;PPIA;LYN;IL6R;IL34;MAPK1;CALM3;CCN1;RB1CC1;SPRY2;EFNA5;TMEM119;SRC;PDGFC;FLT4;IGF2;FGF2;TGFB3;IL15;RPTOR;FGF7
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.5095339777158476,-1.5507446192170686,0.03497942386831276,0.21971396684040362,1.0,10/25,17.80%,HIP1;BCAR3;AFAP1L2;ARAP1;HIP1R;CBL;PLAUR;RTN4;GPER1;PDE6H
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.6627073269589496,1.5492240753586575,0.06369426751592357,0.655771285546626,1.0,5/10,12.39%,KMT2A;CAMK1;PIH1D1;SPHK2;RAPGEF3
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6275153683628367,1.5486824281520428,0.050682261208576995,0.6499857866062866,1.0,7/13,15.95%,DDO;ASPA;MTHFS;GAD1;GOT1;GOT2;GLUL
prerank,substrate-dependent cell migration (GO:0006929),-0.5939196778194025,-1.5481943393898925,0.03861003861003861,0.22298909646423629,1.0,7/14,13.63%,NRP1;NTN1;VEGFC;ANKS1A;CD2AP;SHTN1;PTPRC
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.637984950012165,-1.5481411346865914,0.024742268041237112,0.22222977562101892,1.0,7/11,21.00%,ARID1B;ARID1A;SERTAD1;ZMIZ2;CDCA4;ZMIZ1;CHEK1
prerank,regulation of MAPK cascade (GO:0043408),-0.35856159025162665,-1.5478838132038293,0.0,0.22180827740025327,1.0,45/157,13.67%,ROR1;TEK;NTRK3;CAV1;DAB2IP;ADRA1B;BCAR3;INSR;STK3;IQGAP1;EGFR;JCAD;PTPRJ;KDR;FN1;TBX1;PLCG2;FAS;TNIK;DHX33;PAK2;LYN;IAPP;MAPK1;FLT1;CCN1;MYOC;NBR1;CEACAM1;FLT4;ATP6AP2;MAP4K4;IGF2;FGF2;DUSP3;YWHAZ;CAV2;PHLPP1;CD74;RET;BMP2;ROR2;PEBP1;PTPRC;CD24
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.32183075946271983,-1.546843397419157,0.0,0.22285216250733492,1.0,104/390,16.25%,NRP1;PTPRG;ACTB;ROR1;TEK;GHR;FLRT2;ABI1;NTRK3;NRP2;ARHGEF28;DOCK1;RAPGEF2;GAB1;RHOA;BCAR3;TIE1;WASF2;COL4A2;INSR;MERTK;VEGFC;FOXO1;RAB14;ACTG1;ANKS1A;PIK3R1;CHN1;EGFR;NGF;GRB14;SOCS2;STAT3;ATP6V0A4;PTPRJ;MTSS1;KDR;STMN1;AP2B1;PIK3C2A;COL4A6;ANGPT2;SPRED2;UBASH3B;PAK2;PRKD1;MET;LYN;NCK1;PXN;MAPK1;FLT1;SHOC2;APC;GRIN2B;ATP6V0D1;EFNA5;PIK3CA;SRC;PDGFC;FLT4;ATP6V0A1;TIAM1;EIF2AK3;VAV2;IGF2;FGF2;MAPKAPK2;BCAR1;NEDD9;SORT1;FGF7;GTF2F1;NCF2;YES1;EPHB2;CAV2;MPZL1;NCBP2;COL1A1;RET;SH2B2;PTK2B;PDGFD;ROR2;ATP6V1D;FGFRL1;AKT2;IRS1;VEGFA;RARRES2;AP2A1;RBFOX2;POLR1G;ALK;CBL;ARPC2;NCBP1;GIT1;FOXO4;CSF1R;NCKAP1L;DDIT4;SHC4
prerank,entry into host (GO:0044409),-0.606861042949664,-1.5444822058615337,0.04048582995951417,0.2260469100633924,1.0,10/13,32.81%,CDH1;MET;PPIA;SRC;CBL;CXCR4;GRB2;CBLL1;ITGAV;CTNNB1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.533453713178029,-1.5436791468668651,0.043209876543209874,0.22662927381620668,1.0,9/21,10.10%,VCL;RHOA;ACTG1;PEAK1;LIMCH1;CORO1C;MACF1;EFNA5;DUSP3
prerank,cardiac cell development (GO:0055006),-0.6297258044126172,-1.5426588533799537,0.02912621359223301,0.22748694710466633,1.0,5/11,13.82%,JAG1;NOTCH1;MYH11;CXADR;VEGFA
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6384276258160259,1.5419207004103825,0.039337474120082816,0.6711248719344998,1.0,5/11,17.36%,DAB2;RAB21;MTMR2;EIPR1;PTPN23
prerank,SNARE complex assembly (GO:0035493),-0.6396649294808728,-1.5399092895780238,0.04106776180698152,0.23132284798093686,1.0,2/10,5.49%,STXBP6;VAMP3
prerank,positive regulation of leukocyte migration (GO:0002687),-0.5036492497111541,-1.5395900561584008,0.025477707006369428,0.23107926111814503,1.0,8/27,16.03%,PTN;ICAM1;IL6R;MDK;JAM3;EDN3;VEGFA;NCKAP1L
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5884995537329859,-1.5388421047540726,0.028688524590163935,0.23145154520207734,1.0,8/15,23.54%,EGFR;KDR;BMX;TEC;DYRK1A;PTK2B;MAPK3;IGF1R
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.606630398610026,1.5372190511682127,0.04801670146137787,0.6843699213117586,1.0,2/15,4.00%,MOXD1;SAT1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.48500245478711645,-1.5358583138299708,0.024742268041237112,0.2360149520517676,1.0,11/34,16.71%,NRP1;LIMS1;LIMS2;DOCK1;FLNA;MDK;MYOC;NEDD9;S100A10;FERMT2;RREB1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3549024194200465,-1.535549758418954,0.0,0.23571027078464535,1.0,32/149,8.37%,PRKCH;ROR1;CAV1;SLCO3A1;TRAF5;RPS6KA5;NFKBIA;STAT3;IRAK3;APP;UBC;NOD1;CARD14;MID2;DHX33;TNFRSF11A;CARD16;TFRC;ARHGEF2;RPS27A;TRIM37;UBB;PRKD1;WNT5A;AIM2;PPIA;TRIM14;PSMA6;AR;TRIM25;RPS3;IL1RAP
prerank,regulation of BMP signaling pathway (GO:0030510),-0.404152075870635,-1.5334045564352772,0.002325581395348837,0.23844441468962543,1.0,15/73,8.78%,BMPR2;HTRA3;ACVRL1;ENG;BMPER;NOTCH1;CRIM1;SMURF1;BMP4;SFRP4;SMAD5;SMAD1;UBE2D3;CCN1;XIAP
prerank,positive regulation of cell junction assembly (GO:1901890),-0.4204687002669614,-1.5327569392010003,0.011013215859030838,0.23879362204725071,1.0,18/56,15.90%,NRP1;TEK;LIMS1;CAV1;CLDN5;PTPRJ;KDR;CLSTN2;MYOC;IL1RAP;MAP4K4;EPHB2;ACE2;VEGFA;SRPX2;S100A10;FERMT2;NPHP1
prerank,sterol metabolic process (GO:0016125),0.4537261895925542,1.5321538124204501,0.015228426395939087,0.6989880301930902,1.0,22/60,18.61%,PRKAG2;LIPA;SOAT2;CYP26B1;CYP11B1;INSIG2;APOF;SOAT1;CLN8;SC5D;OSBPL5;CYP27A1;RXRA;FDX1;SQLE;CYP51A1;TSKU;GBA2;FDX2;MSMO1;ABCA5;HMGCR
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.39709810116063327,-1.53177495279881,0.008492569002123142,0.2397846121984053,1.0,21/72,12.90%,ROR1;TEK;NTRK3;DCN;GAB1;TGFB2;INSR;PIK3R1;KDR;FN1;LYN;FLT1;MYOC;PIK3CA;SRC;PDGFC;FGF2;PIK3CD;UNC5B;PDGFD;ROR2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.38922963914724307,-1.5313783619374508,0.007407407407407408,0.23967245606426016,1.0,25/86,13.82%,NRP1;GHR;PECAM1;ACVR1;EGFR;ITGA5;CD44;PTPRJ;CSPG4;APP;PLCG2;ARHGEF2;PAK2;TEC;IL6R;PRKCD;EFNA5;SRC;IGF2;IL15;FGF7;CD74;PTK2B;PTPRC;VEGFA
prerank,regulation of protein phosphorylation (GO:0001932),-0.33806626710438925,-1.5303988323016917,0.0,0.24056630596321038,1.0,72/256,15.94%,TEK;NTRK3;PECAM1;SLCO3A1;PLCE1;PID1;PDE8A;DAB2IP;SLIT2;NIBAN1;LRP6;ENG;INSR;VEGFC;BMPER;GAS6;LIMCH1;EGFR;PRR5L;LIMK2;CORO1C;BMP4;KDR;APP;FN1;CARD14;FNIP2;TBX1;RALB;FAS;TNIK;BRD4;RAP2A;TFRC;XDH;AXIN2;RACK1;NPTN;PPIA;LYN;IL34;CCN1;RB1CC1;OCLN;PPP2R5C;EFNA5;TMEM119;SOD1;FLT4;EIF2AK3;IGF2;FGF2;FGF7;EPHB2;TERF2IP;HSPB1;CD74;KRAS;SH3GL2;BMP2;CD40;AKT2;VEGFA;RARRES2;MT3;PAQR3;PLPP3;PLAUR;FMR1;CSF1R;ATF4;FKBP8
prerank,hippo signaling (GO:0035329),-0.49459253534490927,-1.5296033138254508,0.036170212765957444,0.2411304879675011,1.0,11/26,20.14%,TJP1;YWHAE;STK3;TEAD4;YWHAB;TJP2;TEAD1;AMOT;LATS1;AMOTL1;TEAD3
prerank,transepithelial transport (GO:0070633),-0.5688854213174074,-1.5295698949408463,0.02976190476190476,0.24032065683283083,1.0,7/15,12.77%,ABCG2;SLC12A2;ABCC1;SLC1A3;CXADR;SLC1A1;SLC26A6
prerank,bile acid and bile salt transport (GO:0015721),-0.5096684907823626,-1.5287397378498855,0.04487179487179487,0.24094948807592487,1.0,5/24,8.02%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.5064805727212458,-1.5280666458445602,0.02869757174392936,0.2412855854995995,1.0,12/24,25.81%,SLIT2;CCN3;LYN;CXCL12;SERPINE1;GREM1;HMGB1;DUSP1;PLA2G7;CCR2;ANO6;AIF1
prerank,regulation of cardiac conduction (GO:1903779),0.45969791261671183,1.5280063134632471,0.01916376306620209,0.7096567032836647,1.0,11/54,11.04%,ATP1A2;SLC8A3;ATP1B3;ANK2;DMPK;ITPR1;ATP1B2;CORIN;FXYD4;ITPR2;RYR2
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.4200371423365659,-1.5272771088760182,0.011363636363636364,0.24181677397622617,1.0,28/56,34.79%,ALPK1;UBC;RPS6KA3;NOD1;PLCG2;RPS27A;UBB;MAPKAPK2;CTSB;SFTPA2;SFTPA1;IRAK2;TAB1;CTSS;NOD2;HMGB1;MYD88;BCL10;TLR4;CD36;TLR6;MAPKAPK3;TLR1;CD14;TLR3;S100A9;IRAK4;TLR2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.36708791228447063,-1.5272750630177583,0.002688172043010753,0.24096676994609656,1.0,33/121,13.82%,NRP1;GHR;PECAM1;IL6ST;ACVR1;GAS6;ITGA5;STAT3;CD44;PTPRJ;CSPG4;PLCG2;ARHGEF2;PAK2;TEC;HES1;LYN;IL6R;IL34;EFNA5;SRC;PTPN1;IGF2;IL15;NEDD9;FGF7;PIBF1;CD74;ARL2BP;PTK2B;CD40;PTPRC;VEGFA
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.5164989010284529,-1.5271850350523775,0.04791666666666667,0.24026981490151314,1.0,16/22,44.28%,RUNX1;CBFB;MDK;NFATC2;SOX12;CD46;LAG3;SOCS1;IL2RA;IL4I1;VSIR;FANCA;BCL6;CTLA4;TNFRSF18;FOXP3
prerank,negative regulation of platelet activation (GO:0010544),-0.5609202330310846,-1.5267763254913362,0.022964509394572025,0.24019058380824865,1.0,6/16,9.64%,PRKG1;NOS3;CD9;PRKCD;CEACAM1;APOE
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6158578133717992,-1.526581596193541,0.052104208416833664,0.23972690639357305,1.0,5/12,7.77%,SEMA6A;DCN;DAB2IP;XDH;SPRY2
prerank,protein depolymerization (GO:0051261),-0.49763915113328566,-1.5258220408799779,0.022964509394572025,0.240196943308802,1.0,10/27,18.44%,MICAL2;GSN;NCKAP5;WDR1;STMN1;CFL1;NCKAP5L;KATNB1;KIF24;STMN4
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3630125513357473,-1.5250492023458495,0.0,0.24060219223054471,1.0,29/138,12.90%,PTPRG;ROR1;TEK;ABI1;NTRK3;BMPR2;IL6ST;PTN;LIFR;TIE1;INSR;MERTK;EGFR;NGF;MTSS1;KDR;MET;LYN;FLT1;SRC;FLT4;BCAR1;NEDD9;YES1;EPHB2;MPZL1;RET;PTK2B;ROR2
prerank,genitalia development (GO:0048806),-0.6112188516792908,-1.5249915464822879,0.04789272030651341,0.23985286642885176,1.0,5/12,12.25%,TBX3;PKD1;WNT5A;STRA6;FOXF2
prerank,establishment of skin barrier (GO:0061436),-0.585359745110836,-1.524964665404961,0.04086021505376344,0.23824788567846591,1.0,5/15,12.12%,LSR;STMN1;MET;HRNR;UGCG
prerank,regulation of water loss via skin (GO:0033561),-0.585359745110836,-1.524964665404961,0.04086021505376344,0.23824788567846591,1.0,5/15,12.12%,LSR;STMN1;MET;HRNR;UGCG
prerank,response to lipid (GO:0033993),-0.37589205243235424,-1.5248887350529166,0.005025125628140704,0.2375533303733587,1.0,19/105,9.38%,FOXP1;NOS3;ACER2;PPARD;FOXO1;FOXO3;SOCS2;STAT3;ALPL;IRAK3;RPS6KA3;ESR1;TNFRSF11A;GCH1;STRN3;ANXA1;SRR;TRIM16;MAPKAPK2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5291023157860082,1.5238761260121678,0.03278688524590164,0.7209187072398592,1.0,7/26,4.79%,CACNA1D;ACTN2;ATP1B3;ANK2;STK39;ATP1B2;DLG1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.562073569024041,1.5223034083348541,0.03773584905660377,0.7200916624491163,1.0,5/20,11.59%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,macrophage activation involved in immune response (GO:0002281),-0.5872249241825642,-1.5221890828461868,0.04271844660194175,0.24134722773458012,1.0,9/13,33.08%,PLCG2;IFI35;DYSF;SYK;NMI;SBNO2;TREM2;GRN;TYROBP
prerank,energy reserve metabolic process (GO:0006112),0.581492788302602,1.5213010372952798,0.05471698113207547,0.7166047670174029,1.0,7/19,13.55%,PRKAG2;LEPR;PHKG2;MRAP2;PHKB;PYGL;PYGM
prerank,anion transmembrane transport (GO:0098656),0.4331161536594267,1.521028059737068,0.015544041450777202,0.7097418937588708,1.0,11/67,6.01%,SLC6A13;SLC13A4;SLC13A3;SLC6A9;SLC23A2;SLC23A1;SLC25A42;SLC16A12;SLC25A5;SFXN2;SLC25A11
prerank,regulation of cellular component organization (GO:0051128),-0.3622905429099015,-1.52102267136649,0.0,0.2425711347440959,1.0,31/135,12.45%,HIP1;LTBP4;PLCE1;RAPGEF2;DAB2IP;TJP1;MLLT3;NET1;STON2;HJURP;STK38L;RAP1A;CDH13;SOCS2;IRAK3;TFRC;CAMK2D;WNT5A;AGTR1;ANKRA2;CEACAM1;PTPN1;ZFYVE16;BCAR1;APOE;RPTOR;FAM107A;BAG5;GFAP;DCUN1D5;HIP1R
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5015859854710387,-1.520720861079441,0.037037037037037035,0.24228943535392009,1.0,6/25,7.36%,BMPR2;ACVRL1;ENG;NOTCH1;BMP4;CCN1
prerank,organic hydroxy compound transport (GO:0015850),-0.4641410387551563,-1.5206591638547728,0.034482758620689655,0.2416077152019991,1.0,9/36,8.02%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;SLC16A1;NPC2;OSBP;STRA6;CEACAM1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.5058902366885465,-1.5205140248798292,0.03680981595092025,0.24105842752075188,1.0,9/24,8.02%,TMEFF2;RHOA;ACVRL1;ITGA5;CD44;FLNA;ARHGAP35;CCN1;CEACAM1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.5882599538511584,1.520362779457076,0.04789272030651341,0.7047847990816329,1.0,7/16,15.98%,UPB1;DPYD;CRMP1;NT5C3A;UPP2;DPYSL2;TET2
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5389778604419126,-1.520251437515934,0.040152963671128104,0.2407803931371007,1.0,6/19,10.11%,CYTH3;PARD3;RHOA;RAP2A;SIPA1L3;GOLPH3
prerank,membrane depolarization during action potential (GO:0086010),0.5256292668374666,1.5201446568558883,0.04701627486437613,0.6978799274471481,1.0,2/26,0.44%,ATP1A2;CACNA1D
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5585050888619103,1.519388543625293,0.06390977443609022,0.6859800696515402,1.0,9/21,18.36%,EYA1;HSPA1A;EYA4;EYA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5585050888619103,1.519388543625293,0.06390977443609022,0.6859800696515402,1.0,9/21,18.36%,EYA1;HSPA1A;EYA4;EYA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6838364912161409,1.519181604609626,0.04480651731160896,0.6795001372034378,1.0,5/10,16.54%,KMT5A;SETD4;SETD7;SMYD2;METTL18
prerank,regulation of macrophage migration (GO:1905521),-0.6449559505950462,-1.518816305410221,0.043137254901960784,0.2426375939619318,1.0,3/10,12.51%,MTUS1;CD200;PTK2B
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.5442455910902183,1.5186671181619709,0.06382978723404255,0.674537329710132,1.0,6/23,4.22%,ERRFI1;SNX6;SH3BP5L;CHMP6;GPRC5A;SH3BP5
prerank,potassium ion transmembrane transport (GO:0071805),0.38795661608624044,1.5172826668734078,0.011146496815286623,0.6733101738496453,1.0,24/135,12.63%,ATP1A2;KCNK2;SLC24A3;KCND3;ATP1B3;KCNA3;KCNJ13;LRRC38;KCNJ5;ATP1B2;TMEM175;KCNJ10;NALCN;KCNC3;KCND2;KCNH2;KCNC2;KCNN4;KCNJ16;SLC12A5;KCNH7;SLC12A1;KCNK4;SLC9A9
prerank,negative regulation of leukocyte migration (GO:0002686),-0.646602715956849,-1.5172729387551152,0.05835010060362173,0.2447608528068298,1.0,3/10,1.54%,BMP5;SLIT2;CD200
prerank,regulation of biomineral tissue development (GO:0070167),-0.5005715962734723,-1.5170591882405584,0.028282828282828285,0.24428407481067196,1.0,11/26,13.74%,SGMS2;NOS3;NOTCH1;GAS6;S1PR1;NBR1;HEY2;FBXO5;TWIST1;ECM1;ENPP1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5981943477256607,-1.5168374191036778,0.0411522633744856,0.24393617946179416,1.0,4/13,7.92%,RHOA;ETS1;MDK;NFAT5
prerank,ganglion development (GO:0061548),-0.6271838143520695,-1.5165402134221053,0.04693877551020408,0.243678297621623,1.0,2/11,0.78%,NRP1;NRP2
prerank,regulation of acrosome reaction (GO:0060046),0.6447808001050033,1.5162019445541548,0.056,0.671208237341428,1.0,3/10,10.18%,SERPINA10;GLRA1;PLCB1
prerank,protein export from nucleus (GO:0006611),0.512176582527878,1.5150593087693764,0.04684317718940937,0.6692530668566441,1.0,1/27,0.01%,RANBP3L
prerank,thyroid hormone generation (GO:0006590),0.6449679801621702,1.5149340985315407,0.080078125,0.6629594369165447,1.0,2/10,2.36%,SLC5A5;CPQ
prerank,response to laminar fluid shear stress (GO:0034616),-0.6404851181975488,-1.5143427699350749,0.045364891518737675,0.24686513494740958,1.0,7/10,29.21%,ABCA1;KLF4;SREBF2;KLF2;ASS1;SMAD6;SMAD7
prerank,positive regulation of cell development (GO:0010720),-0.48037864211535775,-1.5140687918400033,0.0367170626349892,0.24657029367788744,1.0,12/31,22.65%,PDE3A;BMP4;SERPINF1;NUMB;TGM2;SPEN;GPER1;NKX6-1;LIG4;NUMBL;SNW1;SOX11
prerank,positive chemotaxis (GO:0050918),-0.5411167647600901,-1.5136330363767765,0.03333333333333333,0.24662894432258117,1.0,6/17,16.30%,NRP1;PTPRJ;MET;FGF7;VEGFA;SEMA5A
prerank,cellular response to zinc ion (GO:0071294),-0.5773176332641212,-1.5126735756755494,0.04230769230769231,0.24766014282656615,1.0,11/15,19.01%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MT3;GLRA2;MT2A
prerank,regulation of monooxygenase activity (GO:0032768),-0.5194675886073762,-1.5117283196643037,0.05240174672489083,0.24856547845053592,1.0,8/23,15.53%,CAV1;NOS3;NOSTRIN;EGFR;NOS1AP;DDAH1;CYGB;POR
prerank,vascular transport (GO:0010232),0.42049681654481874,1.5107272078001912,0.02464788732394366,0.6742386240166478,1.0,16/81,4.55%,ATP1A2;SLC6A13;SLC6A1;SLC13A3;SLC22A8;LEPR;SLC5A5;SLC24A3;SLC38A3;SLC6A9;SLC5A3;SLC16A12;SLC29A2;SLC38A1;ATP1B2;LRP3
prerank,cellular response to decreased oxygen levels (GO:0036294),0.438768666585896,1.5094432216236484,0.014760147601476014,0.6729446196743032,1.0,10/65,7.57%,BMP7;RORA;EPAS1;CPEB2;SLC8A3;OPRD1;LMNA;PGK1;KCND2;CPEB4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.43337026833920395,-1.509425975795929,0.018561484918793503,0.25210271462549855,1.0,17/50,15.24%,YWHAE;THBS1;GAS6;NGF;CD44;RPS6KA3;CARD16;PAK2;SRC;XIAP;GPX1;KLF4;USP47;CSNK2A1;VEGFA;MT3;PLAUR
prerank,rRNA processing (GO:0006364),-0.3440178844802457,-1.5080250925191243,0.005780346820809248,0.2538289123383673,1.0,86/172,27.88%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;THUMPD1;RPL6;RPL18;RPS25;PELP1;RPL36;DDX54;RPL28;RPL27;RPL24;RPL23;RPL17;RPS9;RPS27;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;RRP15;DDX27;ESF1;RPL19;DDX49;RPL37;RRP12;MRPL1;PWP2;RCL1;MRTO4;NOP58;EBNA1BP2;RPL3;NHP2;RPL15;EXOSC4;DKC1;EXOSC5;IMP4;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46;RIOK1;MDN1;WDR55;WDR18;EXOSC3;TEX10;XRN2;ERI1;LYAR
prerank,endothelial tube morphogenesis (GO:0061154),-0.6224313519908655,-1.5079812362267462,0.051587301587301584,0.25308192473805813,1.0,4/10,3.79%,RHOA;ACVRL1;BMP4;STARD13
prerank,negative regulation of ion transport (GO:0043271),0.5366154020062593,1.5077287943707194,0.05172413793103448,0.6737316268482795,1.0,6/24,10.46%,SYT11;ACTN2;WNK3;ADRA2A;WNK4;VIP
prerank,response to cadmium ion (GO:0046686),-0.4993895261783837,-1.5063761196452017,0.03278688524590164,0.25525230506073415,1.0,14/26,19.05%,EGFR;JUN;MAPK1;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MT3;MT2A;MAPK3
prerank,regulation of lipid biosynthetic process (GO:0046890),0.489083178717284,1.5062342871562,0.04371584699453552,0.6735044989450342,1.0,11/32,18.41%,PRKAG2;PRKAA2;FITM2;PPARA;SORBS1;CREBL2;STAR;CREB1;AKT1;MID1IP1;MLXIPL
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5406903024387298,1.5056104039423006,0.05849056603773585,0.6696179583763675,1.0,7/21,10.07%,BMP6;DAB2;OVOL2;BMPR1A;WWTR1;VEPH1;TGFBR1
prerank,regulation of multicellular organismal development (GO:2000026),-0.48815707546608444,-1.5048400195697098,0.0397196261682243,0.2574330784826176,1.0,9/25,17.73%,PTN;INSR;RAB14;SOX17;NIPBL;SPAAR;CD24;TDG;DUSP6
prerank,regulation of defense response (GO:0031347),-0.39018522906286185,-1.5044318423107756,0.020930232558139535,0.2573629343524651,1.0,37/76,27.07%,FOXP1;IL1R1;TMSB4X;SEMA7A;PTGS2;BRD4;MGLL;WNT5A;AGTR1;ANXA1;PSMA6;XIAP;APOE;SPATA2;IL1RL2;BIRC3;ACE2;ADAMTS12;BCL6B;N4BP1;NOD2;HCK;MYD88;ZBP1;CASP4;SBNO2;CASP1;FCGR2B;GGT1;CYLD;ERAP1;CCR2;AREL1;CASP8;LRP8;AKNA;TREM2
prerank,transport across blood-brain barrier (GO:0150104),0.41694617229646613,1.5037315679157313,0.020869565217391306,0.6712082373414281,1.0,16/83,4.55%,ATP1A2;SLC6A13;SLC6A1;SLC13A3;SLC22A8;LEPR;SLC5A5;SLC24A3;SLC38A3;SLC6A9;SLC5A3;SLC16A12;SLC29A2;SLC38A1;ATP1B2;LRP3
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5527316998676516,1.5036220892229075,0.05805243445692884,0.6589079524299283,1.0,8/20,10.76%,IVD;SLC25A44;DBT;ACAT1;ACADSB;ECHS1;BCAT2;BCKDHB
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5527316998676516,1.5036220892229075,0.05805243445692884,0.6589079524299283,1.0,8/20,10.76%,IVD;SLC25A44;DBT;ACAT1;ACADSB;ECHS1;BCAT2;BCKDHB
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6085278765638875,1.5029833274690318,0.057494866529774126,0.655396880459826,1.0,5/13,13.27%,IGF1;SOAT1;GOLGA2;PLCB1;ABCA2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5754868617027957,-1.5013840168037076,0.04408817635270541,0.26197808828715596,1.0,8/15,16.30%,TMSB4X;KDR;PRKD1;MET;FGF2;HSPB1;VEGFA;SEMA5A
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.5344407343599288,-1.5011253686891033,0.029787234042553193,0.26162165366297474,1.0,8/18,12.40%,MEF2C;PLCG1;AKT3;FLT1;MDK;IGF2;FGF2;ITGA4
prerank,positive regulation of developmental growth (GO:0048639),-0.42332780167688694,-1.50106894946241,0.02197802197802198,0.2608921695908171,1.0,9/49,3.36%,GHR;NEDD4L;NTN1;SEMA7A;INSR;NGF;SMURF1;MACF1;ITSN2
prerank,determination of heart left/right asymmetry (GO:0061371),-0.4424557092950242,-1.4993900875923154,0.022321428571428572,0.26318409785481284,1.0,12/43,16.62%,MEF2C;MICAL2;ENG;TBX3;NOTCH1;TGFBR2;SOX17;SOX18;SMO;TBX2;STIL;APLNR
prerank,sensory perception (GO:0007600),0.45901085469196523,1.4992342011263475,0.03225806451612903,0.6649129581839668,1.0,15/45,20.11%,USH1C;RETREG1;WHRN;PCDH15;PTGES;NTSR2;CHRNB2;ADGRV1;TTC8;KCNK4;OPRM1;PENK;P2RX4;SCN9A;OPRL1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.453266738514029,1.4992305323509894,0.03423423423423423,0.6588199193518322,1.0,5/48,3.98%,PRKAG2;GCGR;GCK;POM121;NUP155
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.5472518121810769,-1.4991195175756482,0.0486815415821501,0.2620177648913281,1.0,12/17,34.14%,SOCS2;STAT3;BRWD1;JAK1;IRS1;CISH;SMARCA4;JAK3;SOCS1;IL2RG;TSLP;IL7R
prerank,cellular response to interleukin-7 (GO:0098761),-0.5472518121810769,-1.4991195175756482,0.0486815415821501,0.2620177648913281,1.0,12/17,34.14%,SOCS2;STAT3;BRWD1;JAK1;IRS1;CISH;SMARCA4;JAK3;SOCS1;IL2RG;TSLP;IL7R
prerank,positive regulation by host of viral transcription (GO:0043923),-0.5723711393757129,-1.4990676336591382,0.05919661733615222,0.2612921941886743,1.0,7/15,26.95%,LEF1;JUN;CHD1;SMARCA4;SNW1;NUCKS1;CCNT1
prerank,carbohydrate homeostasis (GO:0033500),0.42819951264132006,1.4987461170644794,0.025951557093425604,0.6548020551780798,1.0,18/67,15.93%,LEPR;GCGR;APPL2;GCK;PRKAA2;CYP11B1;ACSM2A;ADRA2A;PAX6;ADCY8;CEBPA;PDK2;USF1;PYGL;HECTD4;IL6;BACE2;RBP4
prerank,apical junction assembly (GO:0043297),-0.4215112534801587,-1.4984430249092622,0.020316027088036117,0.2615419731861511,1.0,15/53,7.76%,PECAM1;CLDN5;VCL;ESAM;PARD3;RHOA;RAMP2;WDR1;F11R;CTNNA1;TBCD;PAK2;CLDN14;OCLN;APC
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.6212753980144121,-1.4967102278897382,0.05091649694501019,0.263980574289816,1.0,5/11,8.58%,JAG1;TGFB2;BMP4;HEY2;ZFPM2
prerank,negative regulation of wound healing (GO:0061045),-0.4902507812337621,-1.496362937501378,0.04157549234135667,0.2638064487078252,1.0,10/28,10.45%,SLC12A2;CD34;CD109;PHLDB2;CASK;AJAP1;FGF2;SERPINE1;APOE;EDN1
prerank,ribosome biogenesis (GO:0042254),-0.33762882742216976,-1.4959718901569066,0.002967359050445104,0.2637151740600016,1.0,87/187,26.25%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;SURF6;RPL6;RPL18;RPS25;PELP1;RPL36;DDX54;RPL28;RPL27;RPL24;RPL23;RPL17;RPS9;RPS27;ABCE1;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;DDX27;ESF1;RPL19;DDX49;RPL37;RRP12;GTF3A;PWP2;URB2;RCL1;MRPL36;LTV1;MRTO4;NOP58;EBNA1BP2;RPL3;SDAD1;RRS1;RPL15;NOP16;EXOSC4;DKC1;EXOSC5;IMP4;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46;CUL4A;RIOK1;MDN1;WDR55;WDR18
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.6139943530783627,-1.4957848545539993,0.06868686868686869,0.26323234594865647,1.0,8/11,32.81%,LRP6;WNT5A;FZD1;NR4A2;RYK;LMX1A;WNT2;CTNNB1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6171529276383799,-1.4955510972733623,0.04831932773109244,0.2628105274946992,1.0,7/11,18.85%,MAP3K5;CYP1B1;PRKCD;STK24;GSKIP;DIABLO;PRODH
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.420134334832684,-1.4946600697965824,0.0175054704595186,0.2636376213611986,1.0,20/49,24.31%,MEF2C;THBS1;KMT2E;RUNX1;H3-3A;AGO1;CBFB;DPY30;MYL9;PITHD1;KMT2C;MTURN;PRMT6;AGO4;L3MBTL1;ZFPM1;TESC;KMT2B;PRMT1;ASH2L
prerank,aortic valve development (GO:0003176),-0.4630622855199474,-1.4945623202725846,0.041758241758241756,0.26301709598359146,1.0,14/34,12.38%,ELN;BMPR2;JAG1;SLIT2;NOS3;TIE1;NOTCH1;BMP4;NFATC1;TNFRSF1B;HEYL;HEY2;TWIST1;BMP2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5531658147050224,-1.4903817537096322,0.05567010309278351,0.2699174270055496,1.0,7/16,22.36%,ATP5MF;ATP5F1E;ATP5F1B;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5456974817045613,1.489722009375717,0.05113636363636364,0.6860083330015205,1.0,4/20,6.84%,ATP1A2;ATP1B3;ATP1B2;LACC1
prerank,regulation of microglial cell activation (GO:1903978),0.588744473084348,1.489274060480842,0.0783132530120482,0.6818676955515786,1.0,3/15,3.76%,SYT11;SPHK1;TAFA3
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.634562262330588,-1.4879837331658856,0.05432595573440644,0.2736941893798511,1.0,5/10,13.83%,PTPN12;PTPRJ;APOD;HGS;LRP1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.44882507260307253,-1.4862677492159637,0.035555555555555556,0.27613682093671016,1.0,10/33,11.66%,ETS1;TGFB2;FOXO3;STAT3;JUN;GNL3;GATA2;FGF2;KLF4;TEAD1
prerank,macrophage activation (GO:0042116),-0.4590861386856448,-1.4861796409932144,0.034623217922606926,0.27547481208038316,1.0,15/34,29.40%,FOXP1;CD93;APP;PLCG2;IFI35;DYSF;CRTC3;SYK;NMI;SBNO2;TLR4;AIF1;TREM2;MAPT;TMEM106A
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6473750479541992,1.4845821560733956,0.07251908396946564,0.6954134412088535,1.0,3/10,4.13%,ATP1A2;OSR1;STK39
prerank,regulation of glycogen metabolic process (GO:0070873),0.6155624918357416,1.482684521086575,0.06349206349206349,0.6973690542045713,1.0,6/12,20.59%,GCGR;PPP1R3F;RUBCNL;AKT1;KHK;INPP5K
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5646249117880631,-1.4826051075808702,0.052845528455284556,0.28125861424780824,1.0,6/15,9.04%,RSPO3;DAAM2;SFRP4;CSNK1E;ZNRF3;TIAM1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6491416105382581,1.4822869008835475,0.08183632734530938,0.6930094821875278,1.0,4/10,16.37%,IL18;PRKCZ;SPHK2;RARA
prerank,striated muscle tissue development (GO:0014706),-0.47866251986868225,-1.481242875155699,0.03669724770642202,0.2830145293689641,1.0,9/29,5.91%,MEF2C;PGM5;CAV1;BMP5;BMPR2;SVIL;SIX1;SGCD;MYL6
prerank,sympathetic nervous system development (GO:0048485),-0.5567252105162818,-1.4798541452413825,0.06212424849699399,0.28474115878330436,1.0,2/15,0.78%,NRP1;NRP2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5374138195753297,-1.4797969779240696,0.043568464730290454,0.284020163961499,1.0,7/17,21.23%,PODXL;TGFB2;PIEZO1;RET;NCKAP1L;RAC3;SYK
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.6061399710516651,-1.4790860553251093,0.0658682634730539,0.28449043479989544,1.0,7/10,32.81%,LRP6;WNT5A;FZD1;RYK;WNT2;WNT3;CTNNB1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.507954133261076,1.4787243875536848,0.046966731898238745,0.7020373397573043,1.0,10/26,12.52%,SLC8A3;PRKCZ;NLGN2;WNT7A;NLGN3;SHANK1;RIMS1;LRRK2;DLG4;MTMR2
prerank,positive regulation of neuron projection development (GO:0010976),-0.38319337347716403,-1.4769780049206025,0.014598540145985401,0.2877878726385152,1.0,25/85,13.75%,ROR1;NTRK3;BMP5;RAPGEF2;DAB2IP;PTN;ITGA6;NDNF;RAP1A;SCARF1;SCARB2;PRKD1;WNT5A;NPTN;LYN;ARHGAP35;MDK;RETREG3;APOE;VLDLR;RET;PTK2B;ROR2;FZD1;AVIL
prerank,endochondral bone morphogenesis (GO:0060350),-0.5992810890286858,-1.4769240065934377,0.052845528455284556,0.287041943904689,1.0,6/11,17.35%,MEF2C;BMPR2;BMP4;TMEM119;TRPV4;FGFR3
prerank,neutrophil migration (GO:1990266),-0.4082224281006305,-1.4765432644140675,0.024213075060532687,0.28696104335703887,1.0,29/58,40.70%,PECAM1;BSG;TGFB2;PPIA;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB;PIK3CG;PRTN3;S100A9;IRAK4;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;FCER1G;PPBP;CCL8;CCL19;CCL14
prerank,nuclear migration (GO:0007097),0.6080812464742665,1.476469063489873,0.06521739130434782,0.7056341195479197,1.0,5/13,11.14%,SYNE3;SYNE2;CLMN;PCM1;DOCK7
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.4820971326567317,-1.4754316615346026,0.05603448275862069,0.2882794739351841,1.0,13/25,21.00%,CD200;ITGA5;VCAM1;ITGB1;CXADR;CTNNA3;PARVA;JAM3;ITGA7;ITGA4;DSG2;DSP;JUP
prerank,skeletal muscle organ development (GO:0060538),-0.48878637039792405,-1.4742461402913658,0.035955056179775284,0.2897857812237357,1.0,7/26,7.63%,MEF2C;CAV1;DISP1;SVIL;SIX1;MYL6;STRA6
prerank,regulation of GTPase activity (GO:0043087),-0.3389793034712243,-1.4733665216172607,0.002638522427440633,0.29061004334995244,1.0,37/177,11.07%,PRKG1;DOCK9;LIMS1;LRCH1;CHN2;FGD5;DOCK10;RAPGEF2;DAB2IP;ITGA6;FGD6;NET1;BCAR3;RAP1A;SH3BP4;CHN1;RASIP1;F11R;SNX18;SNX13;USP6NL;ARAP1;ITGB1;RACK1;RAPGEF6;RGS6;TGM2;EVI5L;CCL13;EFNA5;SOD1;MAP4K4;VAV2;DOCK8;CAV2;RGS10;PLXNC1
prerank,cytoskeleton organization (GO:0007010),-0.36157604704785945,-1.473334570125389,0.014492753623188406,0.2898520709615162,1.0,28/114,12.96%,FMNL2;ARHGAP10;FGD5;SEMA6A;PLCE1;RHOBTB1;MICAL2;MARK1;RHOA;FGD6;DST;LIMD1;ARAP3;PALLD;TNIK;SIPA1L3;MAST4;MDK;CCL13;CNN2;BRWD1;APOE;NEDD9;CFL1;RANBP9;NECTIN2;SIPA1;RND3
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5408337343035037,-1.4729230737870256,0.06196581196581197,0.2897751914428547,1.0,3/17,0.51%,NRP1;TEK;NTRK3
prerank,purine nucleotide catabolic process (GO:0006195),-0.5809910818474706,-1.4726280422275322,0.054279749478079335,0.289494502949735,1.0,7/13,21.88%,XDH;GPX1;NT5C1A;NT5E;NT5C;HINT1;GDA
prerank,skeletal system morphogenesis (GO:0048705),0.4592702279690247,1.472138818468365,0.033271719038817,0.7184044825587309,1.0,11/42,10.07%,WWOX;PDGFRA;RFLNA;CYP26B1;HOXB9;HOXB3;FGFR2;HOXA3;HOXB4;MEGF8;TGFBR1
prerank,ethanol metabolic process (GO:0006067),0.6121315802197705,1.4708559279111086,0.08284023668639054,0.7179641011115383,1.0,5/12,10.60%,ADH7;ADH4;ALDH1A1;ACSS2;ALDH2
prerank,glycerolipid catabolic process (GO:0046503),-0.5316001649446033,-1.4702045288837429,0.07186858316221766,0.2932305406212131,1.0,6/19,12.54%,PLA2G4A;ABHD2;GPCPD1;MGLL;PRDX6;ABHD6
prerank,meiosis I (GO:0007127),0.5252772720873041,1.4700516358112798,0.054820415879017016,0.7152609002310397,1.0,4/23,6.97%,MEI1;DNMT3L;TDRD9;MEIOB
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.5366999018789664,-1.4698007432049418,0.07081545064377683,0.2931446415291885,1.0,5/17,9.34%,BTG1;BMP4;SFRP4;TMEM100;FGF2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4811653481240088,1.469721392442624,0.07509157509157509,0.7106060987399712,1.0,9/31,11.29%,SYT11;SYT12;SYT9;RAB3GAP1;ADRA2A;SYT1;SYT13;SYT10;SCAMP5
prerank,prostanoid biosynthetic process (GO:0046457),0.5666625028364591,1.4695074051799673,0.07858546168958742,0.7057492782473117,1.0,4/15,7.75%,PTGDS;PTGS1;PNPLA8;PTGES
prerank,ERBB signaling pathway (GO:0038127),-0.40013908002554077,-1.469502768968575,0.02511415525114155,0.2929507504220148,1.0,15/64,9.62%,PLCE1;GAB1;PTPN12;RPS6KA5;PIK3R1;IQGAP1;EGFR;PLCG1;PIK3C2A;CPNE3;MAPK1;GAREM1;PIK3CA;SRC;BCAR1
prerank,protein localization to vacuole (GO:0072665),-0.5763779585416571,-1.4683280637921223,0.05439330543933055,0.2943986000605839,1.0,6/13,17.84%,SH3BP4;LMBRD1;KPTN;MFSD1;RTN4;RNF128
prerank,positive regulation of dephosphorylation (GO:0035306),-0.47398696030842413,-1.4681787530761246,0.04194260485651214,0.2938570754662709,1.0,8/27,12.38%,PPIA;PPP1R16B;PRKCD;CALM3;SPPL3;SRC;NSMF;BMP2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6248356836724,1.4676560911649592,0.08076923076923077,0.7078102985317107,1.0,4/10,11.30%,UPB1;DPYD;NT5C3A;UPP2
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.38163025169668124,-1.4673266268679201,0.019704433497536946,0.2947384230963404,1.0,26/76,25.56%,NRP1;TEK;NTRK3;WDR1;CDC42EP5;CDC42EP3;NCK1;SYNPO2;CDK5;EDN1;CDC42EP2;PTK2B;PFN1;LIMK1;NCKAP1L;SEMA5A;DYNC1H1;FCHSD1;HCK;CDC42;GPSM2;HCLS1;NUP62;FES;PRKCE;CARMIL1
prerank,glycogen metabolic process (GO:0005977),0.5119619394672238,1.4656575096923206,0.06702898550724638,0.7106098020347361,1.0,8/27,15.02%,PRKAG2;PHKG2;PGM1;PHKB;GYG1;PYGL;PYGM;PER2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.4149938874378661,-1.465346679700998,0.019522776572668113,0.29765625096490733,1.0,19/47,19.05%,DAB2IP;TGFB2;FOXO1;EGFR;MID1;FAS;RAP2A;PPIA;MAPK1;NBR1;MAP4K4;PER1;PHLPP1;TAOK3;KLHDC10;NOD2;TAOK1;GREM1;MAPK3
prerank,ERBB2 signaling pathway (GO:0038128),-0.46073416408685497,-1.464878136255886,0.044967880085653104,0.2976948131553927,1.0,8/31,8.77%,GAB1;PTPN12;PIK3R1;EGFR;CPNE3;MYOC;PIK3CA;SRC
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.3797063289564031,-1.464576347338555,0.012254901960784314,0.29744519154308646,1.0,24/78,14.30%,SPTBN1;PRKCH;ACTB;PID1;PIK3R1;EGFR;BCL2L1;NKD2;ITGB1;STX3;NUMB;TMEM59;ZDHHC8;AR;CDK5;ABI3;STAC;EPHB2;SQSTM1;STX7;ZDHHC7;LRP1;TMBIM1;STX8
prerank,ceramide metabolic process (GO:0006672),-0.4114524162238835,-1.4641519157165224,0.026200873362445413,0.29742386064225146,1.0,11/49,9.26%,SGMS1;ST6GALNAC3;SGMS2;ACER2;DEGS2;AGK;CERS5;CERS6;ORMDL3;PLPP1;SAMD8
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.5989974121264466,-1.464112826829903,0.06832298136645963,0.29666730880369874,1.0,4/12,13.15%,WAPL;CTCF;AXIN2;RAD21
prerank,positive regulation of protein binding (GO:0032092),-0.39582113638136274,-1.4630319659559923,0.013953488372093023,0.29797735493634064,1.0,22/56,21.74%,CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;BMP4;APP;RALB;SPPL3;TIAM1;APOE;NMD3;BMP2;HIP1R;LRP1;VTN;EPB41;MARK3;PPP2CA;RIPK2;DTX3L
prerank,regulation of stress fiber assembly (GO:0051492),-0.3854958235458528,-1.4627365685758995,0.018140589569160998,0.2977051125199273,1.0,17/74,7.50%,NRP1;TMEFF2;TJP1;RHOA;WASF2;ACTG1;PIK3R1;LIMCH1;STMN1;F11R;PHLDB2;ARAP1;PAK2;ARHGEF15;MET;PXN;MYOC
prerank,long-chain fatty acid transport (GO:0015909),0.49699950147427824,1.46244996452995,0.056074766355140186,0.7186431157736535,1.0,3/30,1.77%,PRKAG2;ACSL1;PRKAA2
prerank,regulation of inclusion body assembly (GO:0090083),0.6177295659041787,1.461902455681771,0.06809338521400778,0.7154568940040628,1.0,3/11,2.94%,HSPA1A;SNCAIP;DNAJB8
prerank,intracellular cholesterol transport (GO:0032367),-0.5467702266852327,-1.461332216001058,0.08333333333333333,0.299544936090929,1.0,6/15,16.64%,LRP6;ABCA1;NPC2;OSBP;STARD4;LDLRAP1
prerank,regulation of axon guidance (GO:1902667),-0.6256884840101498,-1.460934086575555,0.06438631790744467,0.29952159564149144,1.0,1/10,0.06%,NRP1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.567142877088315,-1.4600400769977855,0.05979381443298969,0.30041884448014716,1.0,5/14,7.96%,LIMS1;LIMS2;FLNA;PRKD1;EMP2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5835591642174807,-1.4598492510620014,0.05835010060362173,0.2999933747060184,1.0,3/12,6.90%,PRKG1;MEF2C;ADAMTS1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.60633193137345,1.4594989855812848,0.08267716535433071,0.7203662390120394,1.0,2/12,3.69%,IL18;IL17D
prerank,positive regulation of developmental process (GO:0051094),-0.33444827314049436,-1.4587071583464153,0.008021390374331552,0.30140800539163,1.0,41/164,16.71%,SLC6A6;SHANK3;BMP5;DCN;BMPR2;DAB2IP;ZBTB16;PTN;ACVR1;INSR;PHLDB1;CORO1C;BMP4;KDR;RPS6KA3;MFF;PHLDB2;TFRC;WNT5A;AR;MDK;SHLD1;TMEM119;SRC;VHL;AGO2;APOE;B4GALT5;CFL1;FBXO5;EDN3;VLDLR;FZD4;BMP2;VEGFA;ALK;MAD2L2;FMR1;PA2G4;RTN4;RREB1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.5730234569077839,1.4584711005250985,0.08,0.7192722649722654,1.0,5/15,14.83%,DAB2;PIK3CB;TNK2;WASL;DGKD
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.3653369043205306,-1.4577336872196507,0.012953367875647668,0.3025451806935382,1.0,33/98,20.04%,PID1;ECE1;SLCO1C1;PPARD;INSR;THBS1;NFKBIA;SFRP4;TGFBR2;TBC1D5;VAMP3;XDH;AGTR1;ACACB;APOE;KLF4;FASN;GHITM;STARD4;ACE2;AGPAT1;VEGFA;ROMO1;MT3;RAB1B;FMR1;IFNAR1;DHRS4;GREM1;ZC3H12A;CBR1;RIPK1;ARRB2
prerank,negative regulation of cell motility (GO:2000146),-0.3583206513791901,-1.457228542808768,0.01015228426395939,0.3027967677659181,1.0,21/108,5.90%,TMEFF2;FRMD5;CLDN5;JAG1;VCL;SLIT2;SRGAP1;CLIC4;ACVRL1;ENG;LIMCH1;CYP1B1;FOXO3;CDH1;PTPRJ;KANK1;ADARB1;PTPRK;DACH1;RAP2A;RECK
prerank,potassium ion import across plasma membrane (GO:1990573),0.45157729760564813,1.4564270542380433,0.051470588235294115,0.7223230857399431,1.0,10/41,11.41%,ATP1A2;ATP1B3;KCNJ13;KCNJ5;ATP1B2;KCNJ10;KCNH2;KCNJ16;SLC12A5;SLC12A1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.4531683597255027,1.4562885864433175,0.04585537918871252,0.7173722619964845,1.0,5/41,6.84%,PRKAG2;GCK;POM121;NUP155;LACC1
prerank,plasma membrane invagination (GO:0099024),-0.46699982216149244,-1.4558463313554175,0.05,0.3047356451904178,1.0,17/29,30.48%,DOCK1;RHOA;GSN;MYH9;SNX18;GULP1;CDC42;FCGR1A;ALKBH4;FCGR2B;ARHGAP12;AIF1;BIN2;MSR1;CD36;SPIRE2;ARHGAP25
prerank,UV protection (GO:0009650),-0.6178109731993147,-1.455318826841913,0.07010309278350516,0.3050005118347641,1.0,6/10,20.32%,MFAP4;CAT;GPX1;ERCC2;SCARA3;XPA
prerank,selective autophagy (GO:0061912),-0.4053733566485454,-1.4551058653073525,0.02558139534883721,0.3046242887808591,1.0,29/56,30.21%,UBC;DYNC1I2;RPS27A;UBB;ARL13B;MAP1LC3B;RB1CC1;UFC1;NBR1;DYNC1I1;SQSTM1;PHB2;HDAC6;DYNLL1;AUP1;KLHL3;CFTR;ATG5;ACBD5;DYNC1H1;ULK2;ULK1;UBQLN1;TEX264;WDFY3;ATG14;STBD1;PARK7;USP30
prerank,negative regulation of blood pressure (GO:0045776),-0.5752182439595979,-1.4539031198877383,0.08582834331337326,0.30616048399609447,1.0,3/13,6.88%,BMPR2;NOS3;PRCP
prerank,arachidonic acid metabolic process (GO:0019369),0.4729251199141366,1.4528099232385467,0.05222437137330754,0.7262408061561421,1.0,6/35,7.75%,PTGDS;PTGS1;DAGLA;PLA2G4C;PNPLA8;PTGES
prerank,axon guidance (GO:0007411),-0.32834828023237184,-1.4526535927665838,0.0111731843575419,0.3078789455627918,1.0,47/201,12.67%,PTPRM;NRP1;SPTBN1;SHANK3;LAMA2;SEMA6A;NRP2;LAMA1;GAB1;SEMA3C;BSG;SLIT2;NTN1;SEMA7A;NOTCH3;TMEFF1;RPS6KA5;NOTCH1;PIK3R1;CHN1;PLCG1;PALLD;LAMA3;KLF7;WNT5A;NTN4;NPTN;CXCL12;ROBO4;ARHGAP35;MAPK1;SPTAN1;EFNA5;PIK3CA;SRC;SEMA5B;EPHB2;PIK3CD;SEMA3E;DSCAML1;PLXNC1;UNC5B;VLDLR;RANBP9;RET;SEMA3G;SMO
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.36993807738973694,-1.4524380742977763,0.009732360097323601,0.3074776727360623,1.0,26/93,17.70%,PDE4D;NTRK3;CAV1;BCAR3;GAS6;RASSF2;EGFR;NGF;CD44;APP;FNIP2;TFRC;PRKD1;RACK1;NCK1;SPRY2;RPTOR;TERF2IP;HDAC6;VEGFA;PAQR3;MAD2L2;DDIT4;TNKS1BP1;PTEN;LATS1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.5431607433999418,-1.4524338214530266,0.0697211155378486,0.30666569206122957,1.0,5/15,13.61%,PRKCH;BMP4;SFRP4;TRIM16;NME2
prerank,regulation of transport (GO:0051049),-0.4362936741786417,-1.4518537286923163,0.05321507760532151,0.3069785494306567,1.0,15/36,24.52%,NRP1;ACTB;ACTG1;ICA1;DNAJA1;CDK5;GAPVD1;REEP5;EPB41;RAB11A;CLDN10;DISP3;POFUT2;MUL1;FES
prerank,lymphocyte chemotaxis (GO:0048247),-0.45089488449189075,-1.4508691730223824,0.044967880085653104,0.3081783789169458,1.0,19/34,42.06%,CYP7B1;SLC12A2;GAS6;CCL13;PIK3CD;CCL25;HSD3B7;PIK3CG;CXCL16;CCL5;GPR183;CCL11;CCL4;CH25H;CCL7;CCL8;CCL19;CCL14;MSMP
prerank,inorganic cation import across plasma membrane (GO:0098659),0.4054029594834475,1.4496632824682,0.03389830508474576,0.734121403281058,1.0,14/75,11.47%,ATP1A2;SLC6A1;SLC8A3;ATP1B3;TRPV1;KCNJ13;KCNJ5;ATP1B2;KCNJ10;KCNH2;KCNJ16;SLC12A5;SLC12A1;TRPM2
prerank,cation transport (GO:0006812),0.3632661968575927,1.4488140148855753,0.0189873417721519,0.7322804450242845,1.0,14/167,3.16%,TRPM3;ATP1A2;SLC8A3;SLC5A5;SLC41A1;TRPM6;KCND3;KCNA3;KCNJ13;NDFIP1;SLC6A9;SLC5A10;SLC23A1;KCNJ5
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4838947151966785,-1.4486527722626394,0.055674518201284794,0.3117453256176998,1.0,11/24,21.47%,PKD1;UBB;APOE;GPX1;TMF1;PTK2B;PRKACA;LATS1;PSMD14;UCHL5;PSME1
prerank,regulation of hydrolase activity (GO:0051336),-0.37963826896949354,-1.4484230066863029,0.022123893805309734,0.3113659180070419,1.0,20/71,17.63%,PRKG1;CAV1;CHN2;FGD5;DAB2IP;FGD6;CHN1;RASIP1;SCARB2;RAPGEF6;EFNA5;SOD1;VAV2;PLXNC1;ARHGAP27;RAP1GAP;PAFAH1B1;RAB3GAP2;PLXNA4;TDG
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.36749256168603284,-1.448347935664725,0.012195121951219513,0.31072803917252406,1.0,22/87,6.74%,GCNT2;CLDN5;PARD3;RHOA;ACVR1;ACVRL1;TGFB2;ENG;SMURF1;ID1;TGFBR2;UBC;F11R;PTPRK;JUN;ITGB1;SMAD5;SMAD1;RPS27A;UBB;ITGB5;PXN
prerank,response to molecule of bacterial origin (GO:0002237),-0.38233157725987005,-1.4477566839190321,0.0182648401826484,0.3110760488255951,1.0,30/69,33.32%,FOXP1;NOS3;IRAK3;RPS6KA3;TNFRSF11A;GCH1;C4B;SRR;MAPKAPK2;LIAS;CD24;IFNAR1;ERBIN;IRF5;GGT7;FCGR2B;GGT1;SMAD6;TLR4;F2R;PELI1;SELP;TRIB1;LGALS9;NOCT;MAPKAPK3;NOS2;NOS1;CD14;S100A9
prerank,embryonic organ development (GO:0048568),-0.3875675611880313,-1.447744598174119,0.02650602409638554,0.31028282936449586,1.0,24/61,17.72%,KITLG;PBX1;RARB;PCSK5;TGFB2;TEAD4;PBX3;TGFBR2;KDR;RPL10;GLI3;SOX17;STRA6;HEY2;TAL1;TEAD1;MFSD2A;SOX18;TBX2;RARRES2;ATF4;STIL;HEY1;ALDH1A3
prerank,purine ribonucleotide transport (GO:0015868),-0.5491509018910488,-1.4472869523065464,0.06485355648535565,0.3104347050306008,1.0,4/16,6.88%,ABCC4;LRRC8D;LRRC8C;LRRC8A
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.38043709667383707,-1.4469190826649119,0.023148148148148147,0.3104139522614358,1.0,24/71,18.30%,FAP;UBC;CAPN2;RPS27A;UBB;ZYG11B;PSMA6;CHMP4B;OTUD7B;DDI2;CTSO;MALT1;CTSB;ISG15;FBXO44;HDAC6;RNF123;HM13;RHBDD1;CTSF;ADAMTS12;CTSS;RSPRY1;ATE1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5662482023224357,1.4462493021086296,0.07561436672967864,0.7379941667715684,1.0,4/17,6.99%,PRKAG2;PRKAA2;PPARA;PANK2
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.5480515659771775,-1.445565925539326,0.07676348547717843,0.31249610482129636,1.0,5/15,9.83%,PTPN12;CDH13;EGFR;CEACAM1;MVB12B
prerank,metanephric mesenchyme development (GO:0072075),0.6206270400172336,1.4454393971199686,0.1,0.7361689442886236,1.0,2/10,1.12%,WNT4;OSR1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.5761673419500839,-1.4449936457842552,0.07862903225806452,0.3127067954654162,1.0,5/12,16.62%,NIPBL;PRKD1;SAP30BP;VEGFA;APLNR
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5703116061466326,-1.4439975034430812,0.05450733752620545,0.3139229992901603,1.0,8/13,23.64%,PLCG1;AKT3;MDK;IGF2;FGF2;ITGA4;HMGB1;SIRT6
prerank,striated muscle contraction (GO:0006941),0.4363285032865185,1.443912342750564,0.04436860068259386,0.7371340214700037,1.0,8/53,11.04%,ATP1A2;DTNA;CSRP3;TNNI1;ARHGEF11;KCNH2;MYH14;RYR2
prerank,positive regulation of immune system process (GO:0002684),-0.5280748465745502,-1.4437896559900505,0.07157894736842105,0.3135794917552618,1.0,7/16,16.03%,TGFB2;ANXA1;IL15;PIK3CD;RSAD2;VEGFA;NCKAP1L
prerank,positive regulation of phosphorylation (GO:0042327),-0.31854819916197274,-1.4433066853564738,0.0,0.31378902305552386,1.0,63/240,16.03%,NRP1;ROR1;TEK;NTRK3;PECAM1;SLCO3A1;PDE8A;ITGA6;NIBAN1;TIE1;ENG;INSR;MERTK;VEGFC;THBS1;GAS6;LIMCH1;EGFR;LIMK2;BMP4;KDR;APP;CARD14;TBX1;RALB;FAS;TNIK;RAP2A;TFRC;AXIN2;RACK1;MET;NPTN;PPIA;LYN;IL34;AR;FLT1;CCN1;RB1CC1;PTGES3;EFNA5;TMEM119;FLT4;IGF2;FGF2;FGF7;EPHB2;CD74;KRAS;RET;BMP2;ROR2;CD40;AKT2;VEGFA;RARRES2;MT3;ALK;PLAUR;FMR1;CSF1R;NCKAP1L
prerank,hepaticobiliary system development (GO:0061008),0.5178276471712312,1.4431676091139,0.1087866108786611,0.7349023464522251,1.0,4/20,8.14%,TGFBR3;WNT4;CEBPA;PHF2
prerank,cellular response to inorganic substance (GO:0071241),-0.488762427142034,-1.4421779660292573,0.07302231237322515,0.31526311052357797,1.0,13/21,31.94%,FOXO1;GUCY1B1;DDI2;BLM;TIMELESS;MT3;FMR1;SPIDR;NSMCE3;ADCY10;CDK2;MMP3;AQP1
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.2943286562423008,-1.4419331699560005,0.0,0.31497073259525366,1.0,111/509,13.82%,HIP1;ROR1;KITLG;VWF;TEK;LIMS1;ACTN4;NTRK3;CAV1;GCNT2;DCN;RAPGEF2;DAB2IP;GAB1;RHOA;ADRA1B;TRAF5;BCAR3;TNFSF10;TGFB2;ENG;INSR;THBS1;GAS6;RPS15;PIK3R1;CDH13;F3;IQGAP1;EGFR;BCL2L1;JCAD;PTPRJ;RPS20;ALPK1;KDR;APP;MIER1;FN1;NOS1AP;MFHAS1;REL;NOD1;ESR1;MID2;TBX1;PLCG2;FLNA;DHX33;BRD4;CARD16;ITGB1;TFRC;TNFAIP8L3;PRKD1;WNT5A;S100A13;RACK1;MET;SLC44A2;NR3C2;LYN;TRIM14;PLK2;IAPP;TRIM25;FLT1;PUM2;MYOC;TGM2;SPRY2;RPS3;BCAP31;NFAT5;IFI35;SCHIP1;PIK3CA;SRC;PDGFC;FLT4;IGF2;FGF2;RPTOR;FGF7;GOLPH3;CAV2;MALT1;PIK3CD;TERF2IP;RPL23;PTP4A3;EDA2R;UNC5B;PDCD4;CD74;PHB2;RET;BMP2;BIRC3;TNFRSF19;PDGFD;ECM1;RRAGA;ROR2;TCIM;CD40;AKT2;PTPRC;IRS1;CD86;VEGFA
prerank,positive regulation of telomerase activity (GO:0051973),-0.45057454519445783,-1.4414282286238738,0.05543237250554324,0.31513301819325273,1.0,14/33,22.80%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;HMBOX1;KLF4;CCT2;PARM1;GREM1;MAPK3;MAP2K7;MAP3K4;DKC1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.37914059245522785,-1.4397579945999075,0.019704433497536946,0.31775471225389124,1.0,23/74,15.55%,LEF1;GCNT2;BMP5;DAB2IP;TGFB2;PHLDB1;SDHAF2;TGFBR2;IL17RD;PHLDB2;SPRED2;AXIN2;MDK;SPRY2;VASN;TIAM1;TGFB3;TWIST1;COL1A1;BMP2;SPRY1;FERMT2;MAD2L2
prerank,positive regulation of cell adhesion (GO:0045785),-0.3686201416491592,-1.4393550119773812,0.02926829268292683,0.31776738863399095,1.0,14/74,8.79%,LIMS1;FRMD5;ZFHX3;VIT;TGFB2;NDNF;PTPRJ;STX3;CXCL12;PPP3CA;MDK;FBLN2;TGM2;ECM2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.3196533111706362,-1.4392188245966648,0.0,0.3172050047597046,1.0,61/214,18.34%,NRP1;ROR1;TEK;NTRK3;GCNT2;SEMA6A;RAPGEF2;PDE8A;DAB2IP;SEMA7A;BMPER;NOTCH1;GAS6;RAP1A;EGFR;CD44;KDR;APP;FN1;MFHAS1;SPRED2;ICAM1;TNFAIP8L3;LYN;CCN1;GAREM1;SPRY2;CEACAM1;CCL13;PDGFC;PTPN1;FLT4;FGF2;APOE;DUSP3;YWHAZ;EPHB2;ACKR3;CD74;PHB2;RANBP9;BMP2;PTK2B;PDGFD;ROR2;HTR2A;PTPRC;FBXW7;SPRY1;P2RY6;MTURN;MT3;FERMT2;CSF1R;FGFR3;PTEN;GPER1;DUSP6;NOD2;PTPN6;CCL25
prerank,lipid transport (GO:0006869),-0.36754322536425066,-1.4388044498464576,0.027918781725888325,0.31732794922086355,1.0,22/97,8.27%,ABCC4;ATP8B1;PITPNC1;SLCO3A1;SLCO1C1;ATP8A1;SCARB1;PPARD;SLCO2A1;CERT1;SLCO2B1;ABCA1;PLTP;PLEKHA8;TNFAIP8L3;NPC2;SPNS2;OSBP;MTTP;ABCA3;CEACAM1;ABCD2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.6219481712310118,-1.4370854883825281,0.06286836935166994,0.3201029893239344,1.0,5/10,17.31%,IRAK3;KLF4;TLE5;PTPRC;SIGIRR
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.4162484078523895,-1.436665466717314,0.03361344537815126,0.32009687095242556,1.0,12/45,9.62%,PLCE1;GAB1;RPS6KA5;PIK3R1;IQGAP1;EGFR;PLCG1;PIK3C2A;GAREM1;PIK3CA;SRC;BCAR1
prerank,regulation of ATP metabolic process (GO:1903578),0.4333128956744812,1.4362589141765094,0.04275092936802974,0.7593219514411002,1.0,17/54,21.55%,PRKAG2;GCK;POM121;NUP155;COX7A1;COX7A2L;ABCD1;NUP98;BEND3;SPHK2;NUP37;ATP7A;NUP88;NDC1;EIF6;ATP5IF1;JMJD8
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.4746299537041532,-1.4355499804386413,0.05165289256198347,0.3215535757556205,1.0,5/23,6.07%,GHR;NOTCH1;CYP1B1;MGAT5;HES1
prerank,thymus development (GO:0048538),-0.5615459890065653,-1.4354736475660006,0.0642570281124498,0.3209031057387581,1.0,5/13,8.86%,SIX1;TBX1;HES1;ZBTB1;SOD1
prerank,negative regulation of heart contraction (GO:0045822),0.6187101642160192,1.4342575383148712,0.09003831417624521,0.7626035750495285,1.0,1/11,0.03%,ATP1A2
prerank,response to zinc ion (GO:0010043),-0.4839180652064636,-1.4338725827053997,0.05555555555555555,0.32324594709652177,1.0,13/25,14.92%,CRIP1;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;SLC30A5;D2HGDH;MT3;GLRA2
prerank,muscle tissue development (GO:0060537),-0.5706722448825489,-1.43380724384908,0.09053497942386832,0.3225376894651983,1.0,7/13,12.67%,PGM5;ENG;BMP4;STRA6;CSRP2;PTCH1;SMO
prerank,smooth muscle tissue development (GO:0048745),-0.6122978978977927,-1.4328427494620637,0.0847457627118644,0.3236936255750232,1.0,5/10,12.67%,ENG;BMP4;STRA6;PTCH1;SMO
prerank,hexose biosynthetic process (GO:0019319),0.45098131199257924,1.4324639306475269,0.055357142857142855,0.7647579026469048,1.0,19/42,21.46%,CHST15;SORD;ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;G6PC3;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;SLC25A13
prerank,lipid catabolic process (GO:0016042),0.5307295041592488,1.4300595332544106,0.09494949494949495,0.7703517004565887,1.0,6/18,23.27%,CEL;PLA1A;PLAAT3;HSD11B1;LIPC;LIPH
prerank,regulation of cell killing (GO:0031341),-0.5410230037720806,-1.4298142222168149,0.09663865546218488,0.3290050268174109,1.0,6/16,8.48%,TGFB2;CR1L;ICAM1;WNT5A;CD55;CFH
prerank,positive regulation of myoblast differentiation (GO:0045663),0.545080847903345,1.4295172336516189,0.07341269841269842,0.7673940361470363,1.0,2/16,1.88%,RANBP3L;IGFBP3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.444326679510901,-1.4291543231257058,0.06140350877192982,0.32950014997357663,1.0,10/33,9.35%,TEK;RAMP2;NDNF;GAS6;KDR;CAST;ICAM1;MDK;GATA2;SERPINE1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.5040522480328605,-1.4287844443006228,0.07385229540918163,0.3294709495929874,1.0,8/20,15.85%,NOTCH1;RUNX2;SMAD5;SMAD1;BMP2;VEGFA;MT3;ATF4
prerank,regulation of cellular component biogenesis (GO:0044087),-0.4261876500453202,-1.4287706157469664,0.049484536082474224,0.32867503140987087,1.0,11/39,11.21%,RAPGEF2;DAB2IP;TJP1;HJURP;TIE1;NOTCH1;RAP1A;ANKRA2;APOE;BAG5;GFAP
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.45830332192777723,1.4280718485360164,0.055855855855855854,0.7683309684965854,1.0,6/37,6.60%,PRKAG2;BMP7;SPHK1;WNK3;PLK1;PPEF2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5871229265757351,-1.4272648751003851,0.09270216962524655,0.33098025020982463,1.0,3/11,6.52%,MERTK;GAS6;CXCL12
prerank,negative regulation of ATPase activity (GO:0032780),0.557603324254215,1.4272464340081723,0.0973630831643002,0.766634236783329,1.0,9/16,22.87%,PPIF;IFIT1;PAM16;TSC1;SIRT1;OXA1L;ATP5IF1;VCPKMT;TNNI3
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5565002529292338,1.4270677003438814,0.09387755102040816,0.7621773742888188,1.0,4/15,7.09%,CHST4;RENBP;LARGE1;GNPDA1
prerank,positive regulation of MAPK cascade (GO:0043410),-0.30855735705515946,-1.4266834851201866,0.0,0.3313912289571519,1.0,63/245,14.78%,NRP1;ROR1;TEK;NTRK3;GCNT2;RAPGEF2;PDE8A;DAB2IP;ADRA1B;SEMA7A;BCAR3;TGFB2;INSR;BMPER;NOTCH1;GAS6;RAP1A;IQGAP1;EGFR;JCAD;CD44;PTPRJ;MID1;KDR;APP;MFHAS1;TBX1;PLCG2;DHX33;ICAM1;TNFAIP8L3;PIK3R6;IL34;IAPP;FLT1;GAREM1;SPRY2;CCL13;PDGFC;FLT4;IGF2;FGF2;APOE;EDN1;CAV2;ACKR3;EDN3;CD74;PHB2;RET;BMP2;PTK2B;PDGFD;ROR2;HTR2A;CD40;PTPRC;FBXW7;CD24;VEGFA;P2RY6;MTURN;MT3
prerank,prostaglandin biosynthetic process (GO:0001516),0.535539368044104,1.4266448253009774,0.08811475409836066,0.758865151853562,1.0,4/18,7.75%,PTGDS;PTGS1;PNPLA8;PTGES
prerank,pulmonary valve development (GO:0003177),-0.5112270578466346,-1.4261361749503243,0.06680584551148225,0.33173211994559265,1.0,12/18,8.50%,BMPR2;JAG1;SLIT2;NOS3;TGFB2;NOTCH1;BMP4;NFATC1;TNFRSF1B;HEYL;STRA6;HEY2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5183356434996962,-1.4260125306955458,0.07933194154488518,0.33113910097369587,1.0,7/16,12.60%,NRP1;PTPRJ;PIK3C2A;PDGFC;PTPN1;BCAR1;PDGFD
prerank,blood vessel diameter maintenance (GO:0097746),-0.43877434300903295,-1.4259726419718266,0.05714285714285714,0.3304073153333438,1.0,11/34,13.94%,EDNRA;ECE1;NOS3;AGTR1;KCNMB2;GCLC;EDN1;EDN3;ACE2;GCLM;KLF2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4592614354975954,-1.4249309336527771,0.06553911205073996,0.3316389707417494,1.0,9/27,13.74%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;PTPN1;IRS1;ENPP1
prerank,muscle organ development (GO:0007517),-0.4033524534215394,-1.424864638139669,0.03811659192825112,0.33098919520115705,1.0,10/54,4.50%,UTRN;MEF2C;LAMA2;COL6A3;TCF12;SMTN;TEAD4;FHL1;TBX1;SGCD
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4956117394088755,1.424711879663646,0.07169811320754717,0.7620027901804107,1.0,12/26,24.97%,CTR9;EEF2KMT;KMT2A;ANTKMT;SETD4;KMT5C;BEND3;TET2;SETD1B;VCPKMT;SETD2;SETD5
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6157187408044854,-1.4244526521267054,0.09053497942386832,0.3311129442508198,1.0,4/10,15.99%,ABCA1;ZDHHC8;APOE;PRKACA
prerank,positive regulation of T cell activation (GO:0050870),-0.38876898557831696,-1.423861365482393,0.026607538802660754,0.33155631743085,1.0,17/62,20.27%,IL6ST;VCAM1;TFRC;ANXA1;NCK1;SLC7A1;MDK;ZBTB1;IL15;DOCK8;PTPRC;CD86;NCKAP1L;CD46;NOD2;JAK3;ZMIZ1
prerank,cellular response to mechanical stimulus (GO:0071260),-0.4063405877594003,-1.422427493709859,0.06278026905829596,0.3336282790305779,1.0,25/46,33.02%,PIEZO2;PIEZO1;F11R;FAS;CRADD;PDE2A;CASP8AP2;CNN2;CD40;BAK1;MAPK3;MYD88;CHEK1;CASP1;BCL10;CASP8;TLR4;MAP3K14;PTGER4;FADD;HABP4;AQP1;TMEM150C;TLR3;MAPK8
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4905367595865532,-1.4221015712277998,0.08225108225108226,0.33358698426644073,1.0,3/20,1.51%,PDE4D;RAPGEF2;ADRA1B
prerank,hemidesmosome assembly (GO:0031581),-0.5854837624649463,-1.4219771480728312,0.06860706860706861,0.33301298879036323,1.0,4/11,4.22%,ITGA6;DST;ITGB4;LAMA3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.5320404422019542,1.421573441462067,0.09090909090909091,0.7699421696927555,1.0,4/18,10.65%,MCM3AP;PABPN1;PCID2;DDX19B
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.37400795676750576,-1.4215186915843505,0.034013605442176874,0.33309116320116783,1.0,19/73,17.70%,NTRK3;CAV1;BCAR3;GAS6;EGFR;NGF;CD44;APP;FNIP2;TFRC;PRKD1;SPRY2;RPTOR;TERF2IP;HDAC6;VEGFA;MAD2L2;TNKS1BP1;LATS1
prerank,vesicle organization (GO:0016050),-0.40619386114507955,-1.4200342564465618,0.037914691943127965,0.3356188701016287,1.0,14/46,16.55%,CAV1;CD34;WASHC4;CHMP2B;ALS2CL;ZFYVE16;RAB22A;SORT1;CAV2;SQSTM1;SNX10;FNBP1L;SAR1A;USP50
prerank,cellular response to misfolded protein (GO:0071218),0.5219285932074987,1.4194367037669446,0.0900735294117647,0.7738334830958578,1.0,7/20,14.15%,DERL1;DNAJC18;DNAJB14;RNF126;UBE2W;BAG6;RNF5
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5486458726901262,-1.4185859988553176,0.08453608247422681,0.3379842561320706,1.0,6/14,14.97%,THBS1;CREB3L1;SPRY2;FGF2;SPRY1;GPC1
prerank,cellular response to hydroxyurea (GO:0072711),-0.6102214376066122,-1.4183044521154486,0.07228915662650602,0.33780716490309565,1.0,6/10,21.67%,DDI2;BLM;TIMELESS;FMR1;SPIDR;NSMCE3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.48255194388926853,1.4181253394939097,0.08422939068100359,0.7740972509236645,1.0,3/28,2.62%,PRKAG2;PRKAA2;FITM2
prerank,extracellular matrix disassembly (GO:0022617),-0.39041315449027186,-1.4178105041797062,0.03773584905660377,0.3379510593988461,1.0,23/53,31.98%,TLL1;BSG;GSN;CD44;ADAMTS5;CAPN2;SH3PXD2B;ADAM10;MMP11;CAPG;ADAM15;CTSS;MMP2;NOXO1;HTRA1;SCUBE1;TIMP1;SCUBE3;KLKB1;MMP3;TLL2;TIMP2;HPN
prerank,prostaglandin metabolic process (GO:0006693),0.49585508542717305,1.4176468115599086,0.06547619047619048,0.7710661926216796,1.0,5/26,7.80%,PTGDS;PTGS1;PNPLA8;PTGES;PTGR1
prerank,alpha-amino acid catabolic process (GO:1901606),0.47447759700402553,1.4170690842813554,0.0779467680608365,0.7685218051023026,1.0,6/29,9.06%,DDO;IDO1;ACAT1;HAAO;ACADSB;KMO
prerank,limb development (GO:0060173),0.4771459731402328,1.4166715502399094,0.08118081180811808,0.7651733806230997,1.0,7/28,10.31%,SMOC1;RSPO2;INTU;LRP4;IQCE;MEGF8;IFT122
prerank,mesoderm development (GO:0007498),-0.49881518632118743,-1.415388763084938,0.06860706860706861,0.3422045988734343,1.0,8/18,20.01%,TIE1;TBX3;TBX1;BMX;VEGFA;BTK;MEST;HCK
prerank,regulation of ruffle assembly (GO:1900027),-0.4803229098071792,-1.4143933405692537,0.06903765690376569,0.3434095352959451,1.0,6/23,13.07%,CAV1;KANK1;EPS8;ABI3;EPS8L2;PFN1
prerank,histone H2A acetylation (GO:0043968),0.5460577649727854,1.414181474931286,0.11516314779270634,0.7707082067798225,1.0,7/16,13.06%,BRD8;RUVBL2;MEAF6;DMAP1;EP400;SPHK2;YEATS4
prerank,fatty acid transmembrane transport (GO:1902001),0.5202044088794162,1.4138577641079624,0.09981167608286252,0.7670503185235485,1.0,2/19,1.77%,PRKAG2;PRKAA2
prerank,regulated exocytosis (GO:0045055),-0.32693636246992513,-1.413741553156725,0.014326647564469915,0.34404730130810757,1.0,45/173,14.34%,ABCC4;VWF;ACTN4;PECAM1;SPARC;PCDH7;VCL;TMSB4X;TGFB2;VEGFC;CD9;THBS1;GAS6;LHFPL2;MYH9;TAGLN2;APP;WDR1;FN1;STX1A;RAB31;CD109;TMED10;ACTN1;RAB11FIP5;FLNA;LYN;RAB11FIP1;ALDOA;CHID1;CDK5;SYT4;SOD1;IGF2;SERPINE1;TGFB3;ISLR;PSAP;STEAP2;RAB3A;ECM1;VEGFA;TMX3;RARRES2;RAB11B
prerank,wound healing (GO:0042060),0.40797704183911854,1.4135595719522576,0.04498269896193772,0.763360174939147,1.0,13/62,10.07%,FGF1;SYT11;ANXA6;IGF1;SMAD3;PDGFRA;WNT7A;MYOF;CORO1B;NRG1;FZD7;TGFBR1;CFLAR
prerank,regulation of neuron projection development (GO:0010975),-0.32871500716139235,-1.4135008091627035,0.005115089514066497,0.3437869482715912,1.0,41/163,14.84%,ROR1;NTRK3;SHANK3;PDLIM5;RAPGEF2;DAB2IP;PTN;ITGA6;MARK1;NDNF;MBOAT1;DISC1;RAP1A;CHN1;KANK1;SCARF1;SCARB2;PAK2;PRKD1;WNT5A;NPTN;LYN;ARHGAP35;MDK;NCS1;RETREG3;CDK5;ABI3;APOE;CFL1;BAG5;MFSD2A;RET;PTK2B;ROR2;TRPV4;FZD1;AVIL;CDH2;MT3;PAQR3
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5808371560835985,-1.4129626186872755,0.07128309572301425,0.3441901994378093,1.0,6/11,28.79%,SLIT2;CCN3;GREM1;DUSP1;DDT;MIF
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.43403944299144137,-1.412850976721822,0.06625258799171843,0.3436150562587344,1.0,16/33,28.96%,HIP1;BCAR3;AFAP1L2;ARAP1;HIP1R;FBXW7;CBL;PLAUR;GPER1;PDE6H;EGF;NUP62;SHKBP1;AGT;BTC;NEU3
prerank,lipid droplet formation (GO:0140042),0.6134367674068989,1.4113269200309038,0.10961538461538461,0.7679700782989133,1.0,4/10,14.04%,FITM2;PLA2G4C;CDS1;SQLE
prerank,regulation of T cell differentiation (GO:0045580),-0.44215499125295116,-1.4106212474983626,0.07029478458049887,0.34738106189589746,1.0,23/33,44.28%,RUNX1;CBFB;MDK;ZBTB1;SOD1;NFATC2;PRDM1;METTL3;ZMIZ1;CCR2;TCF7;IL2RA;ZAP70;CLPTM1;PRELID1;FANCA;GATA3;CRTAM;IL4;CTLA4;XBP1;TNFRSF18;FOXP3
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4845003657179122,-1.4102845987524386,0.08064516129032258,0.3472827709433305,1.0,6/21,13.63%,FOXP1;PRKCH;SLC39A10;RPS3;NECTIN2;PTPRC
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5278364749664044,1.4102018496802817,0.10734463276836158,0.7677838201171665,1.0,2/17,4.28%,ATP1A2;ATP1B2
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5279230391627583,-1.4101618069569397,0.09333333333333334,0.34670739279083257,1.0,4/16,11.61%,BMPR2;PRCP;DDAH1;ADM
prerank,negative regulation of cell migration (GO:0030336),-0.33591394418930687,-1.4101538881724072,0.02610966057441253,0.3459300664047021,1.0,25/137,6.09%,PTPRG;TMEFF2;CLDN5;DAB2IP;JAG1;VCL;SLIT2;SRGAP1;CLIC4;ACVRL1;ENG;LIMCH1;CYP1B1;FOXO3;CORO1C;CDH1;PTPRJ;KANK1;ADARB1;PTPRK;DACH1;PHLDB2;RAP2A;RECK;ARHGDIB
prerank,T cell mediated immunity (GO:0002456),-0.5601884212494566,-1.4098705503145088,0.08712871287128712,0.3457483120071181,1.0,6/13,20.91%,JAG1;EMP2;CD55;CD46;GNL1;CADM1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3460064738004598,-1.4097889202836882,0.028037383177570093,0.3451076919170459,1.0,21/104,5.76%,CAV1;BMPR2;HTRA3;ACVR1;BMPER;NOTCH1;CRIM1;SMURF1;PRDM16;TGFBR2;IL17RD;UBC;CD109;CCN3;ASPN;SPRED2;SMAD5;SMAD1;RPS27A;UBB;UBE2D3
prerank,T cell migration (GO:0072678),-0.5646951435117258,-1.4093799509305234,0.09292929292929293,0.3452682884297352,1.0,9/13,35.90%,SLC12A2;S1PR1;PIK3CD;MSN;PIK3CG;CXCL16;MYO1G;GPR183;ZAP70
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.4412222532086317,1.4090352785295275,0.06060606060606061,0.7679202436846515,1.0,4/41,3.98%,PRKAG2;GCK;POM121;NUP155
prerank,basement membrane organization (GO:0071711),-0.5460401587228307,-1.4087839469783996,0.07335907335907337,0.3457988618040171,1.0,5/14,8.04%,FLRT2;COL4A1;RAMP2;NTN4;LAMB2
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5564986322341655,-1.4084501342423144,0.09939148073022312,0.3456710791513709,1.0,3/12,1.96%,MBNL1;LRP6;TGFB2
prerank,positive regulation of behavior (GO:0048520),-0.597416347052784,-1.4074689889220433,0.09580838323353294,0.34712087522812,1.0,3/10,7.63%,MEF2C;SGIP1;STRA6
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.6049015387919265,-1.4073321910316634,0.08614232209737828,0.3465994730362546,1.0,6/10,34.79%,KDR;NOD2;IL33;TLR4;NAMPT;TLR2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.42016871822688234,-1.407069220538061,0.048034934497816595,0.34640760603176224,1.0,15/37,17.68%,PRKG1;MEF2C;JUN;ERN1;ADAMTS1;TAFA5;FGF2;TGFB3;PDCD4;P2RY6;HTR1B;LDLRAP1;MMP2;PTEN;GPER1
prerank,regulation of cell population proliferation (GO:0042127),-0.28129797717006433,-1.4070148000895741,0.0,0.34573268853187716,1.0,144/691,14.08%,LEF1;ELN;KITLG;LIMS1;ABI1;NTRK3;GCNT2;BMP5;ZBTB7C;RAPGEF2;BMPR2;IL6ST;CLDN5;DAB2IP;OSMR;PTN;JAG1;TJP1;LIFR;NOS3;RHOA;CD200;ACER2;ETS1;ACVRL1;TGFB2;ENG;INSR;VEGFC;TBX3;THBS1;NOTCH1;LRP5;CDH13;SH3BP4;TBC1D8;EGFR;CYP1B1;CTCF;NGF;RUNX1;BTG1;STAT3;BMP4;PTPRJ;SFRP4;SIX1;TGFBR2;KDR;APP;ITGA1;ADARB1;FN1;PTPRK;JUN;CACUL1;TBX1;CBFA2T3;GNL3;NUAK1;TNFRSF11A;IGFBP6;STX3;TFRC;CNOT6L;ARHGEF2;JAG2;AQP11;DNAJA2;AGTR1;S100A13;AXIN2;HES1;ADAM10;XRCC5;LYN;IL6R;IL34;AR;ADAMTS1;FLT1;KLF11;NACC2;GAREM1;APC;PPP2R5C;RPS6KA2;EMP2;IFI35;CDC123;TIPIN;RBBP4;PLPP1;XIAP;PDGFC;FLT4;TIAM1;VHL;IGF2;FGF2;TGFB3;TSPAN31;IL15;FGF7;KLF4;S100A11;S1PR3;EDN1;BTG3;HGS;ESM1;SERTAD1;RPL23;TES;ADGRG1;PBRM1;MYOCD;SOX7;FBXO5;DDAH1;GRK5;EDN3;RPS9;KRAS;WNT9A;HHEX;BMP2;PTK2B;PDGFD;SST;RARG;ACE2;ROR2;TBX2;NACC1;EEF1E1;CSNK2A1;RERG;AKT2;IRS1;CD86;VEGFA;RBFOX2;COPS9
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5095576919124168,1.4069051065049416,0.08670520231213873,0.7722174562721852,1.0,7/22,16.04%,AEBP1;MAP2;PRUNE1;ARL2;EFEMP2;ABL1;GBA2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5381069972754634,-1.406660281392422,0.09876543209876543,0.34572077591200084,1.0,4/13,7.25%,RUNX1;TGFBR2;GLI3;CBFB
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.3923777119018407,-1.4066234230914068,0.03508771929824561,0.3450105381346968,1.0,21/53,22.11%,DAB2IP;PKD1;GABARAPL2;UBB;ECSCR;PRKCG;APOE;GPX1;TMF1;RAD23B;FOXF2;FBXW7;GNA12;FMR1;PRKACA;PSMD14;PSME3IP1;UCHL5;PSME1;TMTC3;GLMN
prerank,neurotransmitter transport (GO:0006836),0.3991730694954663,1.4066000446334677,0.05317324185248713,0.7688063457617326,1.0,17/73,15.95%,ATP1A2;SLC29A2;SLC38A1;SYT1;SYN2;SNAPIN;RIMS1;SNAP25;SLC6A4;GLS2;GAD1;SYN3;SLC22A2;CPLX1;NAAA;SYN1;GLUL
prerank,cellular component disassembly (GO:0022411),-0.3865435050832726,-1.4060630220890034,0.04028436018957346,0.34539279043992976,1.0,22/53,31.23%,TLL1;BSG;GSN;CD44;ADAMTS5;CAPN2;SH3PXD2B;ADAM10;MMP11;CAPG;ADAM15;CTSS;MMP2;NOXO1;HTRA1;SCUBE1;TIMP1;SCUBE3;KLKB1;MMP3;TLL2;TIMP2
prerank,positive regulation of DNA replication (GO:0045740),-0.5243493133348949,-1.4056124570907131,0.0947136563876652,0.345571848844876,1.0,7/16,24.66%,BCAR3;KAT7;EGFR;BRPF3;FAF1;EGF;CTC1
prerank,activation of GTPase activity (GO:0090630),-0.35697325535075136,-1.4054787006541116,0.014925373134328358,0.34508472832934767,1.0,27/89,15.77%,TBC1D4;NTRK3;RABGAP1L;ARHGAP42;SIPA1L2;TBC1D8;CORO1C;BCR;TBC1D12;TIAM2;USP6NL;TBC1D5;TBC1D2B;SIPA1L3;ARHGEF15;TBC1D1;EVI5L;ABR;TIAM1;TBC1D13;SIPA1;RALGAPA1;TAX1BP3;TBC1D7;TBC1D10A;RAP1GAP;TBC1D25
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3407455019401531,-1.405368960811045,0.0136986301369863,0.3445093800697249,1.0,38/113,22.14%,DAB2IP;RPA1;PIEZO1;ABCA1;ICE1;RASIP1;UNC13B;ESR1;FNIP2;DHX33;TFRC;GBP5;RACK1;RPS3;CHD1L;SRC;TPPP3;GTF2H5;TAL1;CAPG;CDC42EP2;GTF2H1;ISG15;ERCC2;VEGFA;PSMC4;FERMT2;BAK1;USP50;SLF2;RPA2;XPA;SPIDR;MYD88;AJUBA;SYK;FAF1;BIK
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5304186657440956,1.4050193104496356,0.09803921568627451,0.7708108436704302,1.0,7/18,9.52%,PRKCZ;NLGN2;WNT7A;NLGN3;SHANK1;RIMS1;DLG4
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.560773625642103,-1.4047795068255653,0.088659793814433,0.34499363813548595,1.0,5/12,17.95%,KAT7;TIPIN;BLM;WRNIP1;NBN
prerank,negative regulation of viral life cycle (GO:1903901),-0.5356683463873355,-1.404475748295293,0.1016597510373444,0.34493574033803914,1.0,5/15,6.36%,GSN;LY6E;MID2;IFITM3;PPIA
prerank,cellular response to oxygen levels (GO:0071453),0.6091628457312719,1.403565822818801,0.10566037735849057,0.7720900387138117,1.0,4/10,7.57%,ATP6V0A2;CCDC115;TMEM199;CPEB4
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5974433373423412,1.4028465210730565,0.1232876712328767,0.7703561391129202,1.0,1/11,0.51%,TAS1R2
prerank,neuron migration (GO:0001764),-0.3996291046833341,-1.402480332484117,0.06451612903225806,0.3483522771439789,1.0,14/48,16.20%,NRP1;MEF2C;RAPGEF2;MARK1;NDNF;DISC1;CEP85L;CDK5;FGF13;VEGFA;NR4A2;MAP1B;PAFAH1B1;DDIT4
prerank,negative regulation of response to stimulus (GO:0048585),-0.3792385856640397,-1.4020014958934353,0.032418952618453865,0.3486736151266718,1.0,18/60,11.58%,SLIT2;ACVR1;CD34;VPS13C;AKT3;KLF7;CASK;UBASH3B;AQP11;HHIP;LYN;PTPN1;SOCS5;KLF4;TLE5;FBXO5;DDAH1;TWIST1
prerank,regulation of activated T cell proliferation (GO:0046006),0.47013179582106535,1.4008839331518406,0.07747747747747748,0.7739845322321568,1.0,3/30,1.23%,IGF1;IL18;IDO1
prerank,positive regulation of binding (GO:0051099),-0.35305364377093296,-1.3999687941327572,0.018912529550827423,0.3521646027545396,1.0,33/84,23.31%,CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;NGF;BMP4;APP;STMN1;RALB;MET;HES1;SPPL3;TIAM1;HMBOX1;APOE;NMD3;BMP2;HIP1R;LRP1;NCBP1;PLAUR;VTN;EPB41;DPH3;MARK3;HMGB1;RIPK2;DTX3L;SKI;EGF;TRIB3
prerank,adherens junction organization (GO:0034332),-0.3976802225157239,-1.399857684987211,0.05227272727272727,0.3516788346399973,1.0,11/48,6.00%,CDH11;ACTB;VCL;TJP1;RAMP2;CDH13;CDH1;CTNNA1;TBCD;PAK2;NECTIN3
prerank,ATP transport (GO:0015867),0.6153591242170577,1.3986934274756762,0.1364522417153996,0.7788755643513969,1.0,2/10,4.92%,SLC25A42;SLC25A5
prerank,monocarboxylic acid metabolic process (GO:0032787),0.36209722713933534,1.3979982228282242,0.034653465346534656,0.7771229385361494,1.0,32/117,17.36%,ALDH1A2;IGF1;ALDH8A1;ADH7;CYP26B1;PPARA;ME2;PCCA;AASDH;PNPLA8;GLYAT;PANK2;ACADSB;ECHDC3;PTGR1;CPT1C;FA2H;AMACR;MTHFS;CROT;SLC27A4;VDAC1;LDHB;NAAA;PER2;GGT5;GOT2;GBA2;ACOT1;MSMO1;AASDHPPT;ACOT6
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.3783773710403824,-1.3978579642610574,0.04367816091954023,0.3552841713761254,1.0,17/63,16.58%,MEF2C;IL6ST;VCAM1;TFRC;ANXA1;NCK1;SLC7A1;CD38;IL15;EPHB2;NFATC2;CD74;CD40;PTPRC;CD86;NCKAP1L;CD46
prerank,actin filament organization (GO:0007015),-0.3276975287258418,-1.3977423061541243,0.01837270341207349,0.35473263140131456,1.0,37/151,14.25%,HIP1;MYO1D;ABI1;MYO1B;RHOBTB1;SHROOM4;RHOA;SVIL;GSN;CORO1C;PLS3;ACTN1;FLNA;ARHGEF2;EPS8;TPM4;ALDOA;EMP2;TPM2;TMOD3;MYO19;TPM3;BCAR1;NEDD9;MYO1F;CD2AP;WHAMM;CAPG;CDC42EP2;HIP1R;RND3;TRPV4;VILL;GAS2L1;MARCKS;AVIL;SHROOM1
prerank,response to interleukin-6 (GO:0070741),-0.6014872344717093,-1.3976094187223032,0.1026694045174538,0.354247202256458,1.0,3/10,2.73%,PID1;ST3GAL6;PTGIS
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5691869023040688,-1.3976055623928763,0.08300395256916997,0.35348479031659275,1.0,4/11,5.60%,CACNB2;CACNA2D1;NOS1AP;CAMK2D
prerank,protein trimerization (GO:0070206),-0.542284711318669,-1.3974528903878434,0.07835051546391752,0.35225605415510464,1.0,3/14,2.82%,SCARA5;DISP1;SLC1A5
prerank,protein homotrimerization (GO:0070207),-0.542284711318669,-1.3974528903878434,0.07835051546391752,0.35225605415510464,1.0,3/14,2.82%,SCARA5;DISP1;SLC1A5
prerank,cellular response to glucose starvation (GO:0042149),0.4412424668895415,1.3971221943395076,0.07513416815742398,0.7761674963992735,1.0,7/41,8.36%,PRKAG2;PRKAA2;PRKAG3;NIM1K;CPEB4;IMPACT;SESN1
prerank,positive regulation of heart contraction (GO:0045823),0.5153434708830527,1.396897137450516,0.09423076923076923,0.772478941067284,1.0,1/19,0.03%,ATP1A2
prerank,dicarboxylic acid transport (GO:0006835),0.4811633879999812,1.3968643484223344,0.09262759924385633,0.7681074506391737,1.0,6/28,9.70%,SLC22A6;SLC13A3;SLC26A1;PDPN;SLC19A1;SLC25A12
prerank,positive regulation of B cell proliferation (GO:0030890),-0.4357674502236361,-1.3957627322883157,0.05785123966942149,0.354918211402117,1.0,9/29,16.03%,MEF2C;TFRC;CD38;EPHB2;NFATC2;CD74;CD40;PTPRC;NCKAP1L
prerank,microtubule depolymerization (GO:0007019),-0.5194381856192626,-1.3948247200057817,0.07246376811594203,0.35606213767133305,1.0,8/17,26.55%,NCKAP5;STMN1;NCKAP5L;KATNB1;KIF24;STMN4;KIF14;CCSAP
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5571169384761553,-1.394500038898737,0.11642411642411643,0.3559710252692056,1.0,3/12,8.27%,FOXP1;LYN;ORMDL3
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3676179229591805,-1.3942136556539382,0.058823529411764705,0.3557657439444994,1.0,32/76,23.12%,MAML2;IL6ST;JAG1;NOS3;NOTCH3;TGFB2;NOTCH1;EGFR;STAT3;CCN3;JAG2;EPN2;SRC;GATA2;NOTCH4;MFNG;SREBF2;TCIM;FBXW7;LFNG;CD46;HEY1;NOD2;PRAG1;YJEFN3;METTL3;ZMIZ1;DLL4;MAML3;SNW1;DLL1;EGF
prerank,stabilization of membrane potential (GO:0030322),0.5329017217399338,1.3942037624642365,0.1102514506769826,0.7749567996673148,1.0,4/16,16.88%,KCNK2;KCNN4;KCNK4;KCNK10
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5251725169929093,1.3939194786134683,0.11070110701107011,0.7716088251004681,1.0,7/18,17.40%,ROCK2;PICALM;CASP3;CLU;EPHA4;ABCA2;RELA
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.46362619400493144,1.3936803993241875,0.08925318761384335,0.7680988175999578,1.0,3/31,1.84%,RANBP3L;TMEM64;SUFU
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5643429276517542,1.3934781164072771,0.0992063492063492,0.7644960988957848,1.0,2/14,3.69%,IL18;IL17D
prerank,sensory perception of sound (GO:0007605),0.3800221183633197,1.3927298199115172,0.04433497536945813,0.7631924023848837,1.0,16/88,9.17%,EYA1;CACNA1D;USH1C;DCDC2;COL4A3;KIT;ALDH7A1;WHRN;GSDME;EML2;PCDH15;CCDC50;MYO3A;CHRNB2;ADGRV1;MYH14
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.34174838937493207,-1.39169384519353,0.025510204081632654,0.3605150076538039,1.0,27/112,6.74%,PDE3A;LIMS1;MEF2C;GCNT2;CLDN5;PARD3;RHOA;ACVR1;ACVRL1;TGFB2;ENG;SMURF1;ID1;TGFBR2;UBC;F11R;PTPRK;JUN;ITGB1;SMAD5;SMAD1;RPS27A;UBB;WNT5A;PDE2A;ITGB5;PXN
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.456904423901833,-1.3915582788764191,0.07337526205450734,0.36003197712042856,1.0,6/27,9.67%,UTRN;NEDD4L;FXYD5;CAMK2D;SLMAP;FXYD6
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4591682756712784,1.3909668962278496,0.07992565055762081,0.7661260867347353,1.0,9/31,10.07%,PDGFRA;OSR1;HOXB9;HOXB3;FGFR2;HOXA3;HOXB4;MEGF8;TGFBR1
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.43900785959416233,-1.3907240163597385,0.054466230936819175,0.3609846771135506,1.0,15/30,30.12%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;POLR1A;UBTF;CCNH;POLR1H;POLR2F;POLR1E;POLR2H;POLR1C;POLR2E
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.49329282319328444,1.3907038315757185,0.10384615384615385,0.7628658983515619,1.0,7/23,10.39%,BMP7;UACA;CPNE1;C1QTNF3;NLRC3;NLRP3;ADGRG3
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5973206881861945,-1.3901909957444425,0.10578842315369262,0.36132482811920874,1.0,3/10,6.29%,SHANK3;APP;NPTN
prerank,positive regulation of protein deacetylation (GO:0090312),-0.5345550211921625,-1.3890893509296072,0.09795918367346938,0.3629237648795034,1.0,5/14,16.62%,NIPBL;NNMT;SAP30BP;DYRK1A;APLNR
prerank,negative regulation of inclusion body assembly (GO:0090084),0.6105927711775837,1.3885822624982291,0.11462450592885376,0.7668566738875614,1.0,4/10,15.61%,HSPA1A;DNAJB8;HSPA1B;DNAJB2
prerank,nitrogen compound transport (GO:0071705),-0.32551683046207575,-1.3884621884031692,0.01038961038961039,0.3634845410340642,1.0,27/141,9.19%,ABCG2;SLC6A6;CALCRL;SLC12A2;LRRC8D;RAMP2;SEC14L1;CERT1;MYH9;SLC1A5;ABCC1;SLC7A5;LMAN2L;SCARB2;TMEM30A;ATP11B;CHMP2B;SLC38A5;SLC43A2;SLC44A2;SLC7A7;SLC7A1;CMTM6;CUBN;SLC7A14;SLC43A1;TXNIP
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.49090284741037316,1.387641589727038,0.08086785009861933,0.7663449594866147,1.0,2/23,1.35%,METAP2;NMT2
prerank,response to metal ion (GO:0010038),-0.3722938640978646,-1.3872830687713549,0.03189066059225513,0.36515540359159954,1.0,19/67,15.61%,CAV1;NEDD4L;TRPC3;THBS1;PLSCR1;GPHN;CRIP1;CALM3;PPP3CA;PPP1CA;MT1A;MT1X;TRPC1;SEC31A;SLC30A5;ITPR3;D2HGDH;MT3;ATP5F1D
prerank,cellular response to superoxide (GO:0071451),-0.578125804762295,-1.3862937572337952,0.12890625,0.36640356506906285,1.0,3/10,14.78%,NOS3;SOD1;MT3
prerank,calcium ion transmembrane transport (GO:0070588),0.38305619228065174,1.3858983809221785,0.04297520661157025,0.7688100739041541,1.0,10/86,5.43%,TRPM3;CACNA1D;SLC8A3;SLC24A3;TRPM6;TRPV1;CACNB3;AFG3L2;GRIN2D;NALCN
prerank,positive regulation of cellular process (GO:0048522),-0.2805005261019696,-1.3853076268906008,0.0,0.36777756104139425,1.0,165/565,22.77%,LEF1;SLC6A6;KITLG;FRMD5;ACTN4;NTRK3;CAV1;GCNT2;BMP5;IL6ST;CLDN5;OSMR;ZFHX3;PTN;TJP1;LIFR;PARD3;LRP6;ACER2;ETS1;TGFB2;TRPC3;INSR;MERTK;VEGFC;TBX3;THBS1;NOTCH1;LRP5;GAS6;TBC1D8;EGFR;BMP4;PTPRJ;H3-3A;TGFBR2;KDR;TNFRSF1B;FN1;RPS6KA3;CACUL1;TBX1;TNFRSF11A;STX3;CNOT6L;AQP11;DNAJA2;WNT5A;S100A13;AXIN2;HES1;ADAM10;LYN;CXCL12;IL6R;IL34;PRKCD;AR;FLT1;PPP3CA;MDK;TGM2;GAREM1;DOCK2;APC;EMP2;CDC123;TIPIN;SMC5;PDGFC;GATA2;FLT4;TIAM1;VHL;IGF2;FGF2;TGFB3;TSPAN31;IL15;ACACB;CDKN2AIP;RPTOR;FGF7;TAL1;FASN;S1PR3;EDN1;ESM1;SERTAD1;RPL23;ADGRG1;PABIR1;FBXO5;GRK5;EDN3;RPS9;KRAS;MFSD2A;PTK2B;PDGFD;RAB27A;USP47;TBX2;AGPAT1;NACC1;CSNK2A1;AKT2;IRS1;CD86;VEGFA;LRP1;COPS9;ROMO1;MT3;NCBP1;PTGFR;KLHL22;DDX49;FMR1;CSF1R;PA2G4;RPS15A;UBE2A;TBRG4;TCIRG1;FXR1;FGFR3;PTEN;HDAC2;GPER1;GRIN1;DYNC1H1;PTPN6;CCND1;KIF20B;PRODH;GREM1;ZC3H12A;CRLF1;PRC1;HCK;CDC42;CCPG1;ACER3;PSMD10;PTHLH;POU3F3;NOXO1;CHEK1;NSMCE4A;POFUT2;CCND2;RIPK2;FAF1;MYRF;RPRD1B;FXN;HAS2;CDKN1B;FCGR2B;CEP131;DLL1;SOX11;CTF1;EXOSC4
prerank,negative regulation of protein polymerization (GO:0032272),-0.4561019946874992,-1.3849874275792602,0.08666666666666667,0.3676985584449574,1.0,11/27,13.07%,SLIT2;KANK1;STMN1;SSH2;KANK3;TBCD;KANK4;PRKCD;DYRK1A;HIP1R;PFN1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.5902803732045705,-1.3836827489138768,0.11405295315682282,0.36980477149866137,1.0,2/10,2.85%,PODXL;PIEZO1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5901038602625153,-1.3831943022488342,0.11023622047244094,0.3693022886256458,1.0,5/10,20.11%,CDC42EP5;CDC42EP3;APC;CDC42EP2;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5901038602625153,-1.3831943022488342,0.11023622047244094,0.3693022886256458,1.0,5/10,20.11%,CDC42EP5;CDC42EP3;APC;CDC42EP2;CDC42
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4380977972539034,1.3824038944345716,0.08736059479553904,0.7787051200229086,1.0,10/40,9.21%,SLC13A3;SLC38A3;SLC7A11;SLC23A2;SLC23A1;SLC38A1;SLC7A13;SLC25A11;SLC19A1;SLC38A9
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5883032468487123,-1.3820529524190532,0.12144212523719165,0.37089414716500757,1.0,3/10,6.94%,LRCH1;CD200;APOD
prerank,actin filament depolymerization (GO:0030042),-0.5648767273260795,-1.3817963121067238,0.11545988258317025,0.37075133348499795,1.0,4/11,10.52%,MICAL2;GSN;WDR1;CFL1
prerank,protein maturation (GO:0051604),0.3693000980094183,1.3815024528552917,0.02707275803722504,0.7782342648699669,1.0,10/95,4.65%,AEBP1;NNAT;METAP2;TSPAN5;ADAMTS13;PCSK4;CPN1;FURIN;PITRM1;AFG3L2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.48289534294966907,1.380833719777197,0.09456740442655935,0.7769799618771724,1.0,2/22,2.46%,ALDH1A2;RBP1
prerank,cell projection assembly (GO:0030031),-0.4614921527013651,-1.3799982270275215,0.06638115631691649,0.37364663514088803,1.0,8/22,21.07%,RHOJ;GSN;PARVB;PARVA;CAPG;NCKAP1L;CDC42;RAC3
prerank,cardiac conduction system development (GO:0003161),0.487782348128318,1.3796794054484978,0.10408921933085502,0.777505034067006,1.0,4/24,3.48%,NOTCH2;GJB6;MSX2;BMPR1A
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.4788028692463323,1.3796209563563542,0.11900191938579655,0.7735400790311456,1.0,8/26,15.17%,LGR4;APPL2;NLRP2B;OTUD4;FLOT2;CACTIN;TYRO3;TLR5
prerank,T-helper cell differentiation (GO:0042093),-0.5404610881490223,-1.379319236377606,0.12524461839530332,0.37431701302468623,1.0,2/14,0.18%,LEF1;FOXP1
prerank,mitochondrion disassembly (GO:0061726),-0.4216854203461782,-1.3792219630036955,0.06578947368421052,0.3737636143321268,1.0,14/34,25.57%,ATG3;WIPI1;GABARAPL2;CISD2;MAP1LC3B;RB1CC1;SQSTM1;GABARAP;ATG12;ATG5;WDR45B;ULK2;ULK1;FUNDC2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.4696583238376977,-1.3789648759929558,0.10931174089068826,0.3735243298794856,1.0,7/21,13.85%,DAB2IP;SLIT2;TGFB2;SPRY2;CD2AP;EPHB2;SPRY1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5858871135670756,-1.378726574097762,0.10843373493975904,0.37329649398614917,1.0,4/10,8.95%,GHR;STAT3;LYN;PTPN1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.48503084008976927,1.3780159261311662,0.09633911368015415,0.7762604057458099,1.0,5/26,4.37%,ERRFI1;SNX6;CHMP6;GPRC5A;ADRA2A
prerank,positive regulation of tissue remodeling (GO:0034105),0.6043043767795115,1.3776229231129653,0.12446351931330472,0.7737187615316524,1.0,2/10,0.87%,ROCK2;IL18
prerank,acute inflammatory response (GO:0002526),-0.46364051740268136,-1.3774842054939251,0.08943089430894309,0.3752355270307634,1.0,11/23,36.33%,F3;PLSCR1;IL6R;SIGIRR;ANO6;CEBPB;AHSG;VNN1;HPR;HP;CRP
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.41647147705285736,-1.3769722630795944,0.08222222222222222,0.3756275077404636,1.0,10/36,12.82%,CAV1;NOS3;NOSTRIN;SCARB1;EGFR;NOS1AP;GCH1;APOE;DDAH1;CYGB
prerank,neutrophil chemotaxis (GO:0030593),-0.385089967906422,-1.3766027745955427,0.0639269406392694,0.37572940780474584,1.0,26/53,40.70%,BSG;TGFB2;PPIA;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB;PIK3CG;S100A9;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;FCER1G;PPBP;CCL8;CCL19;CCL14
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.32259334515691435,-1.3758090407989567,0.020618556701030927,0.3767126840426256,1.0,48/151,20.23%,SGMS1;ST3GAL4;PLA2G4A;SGMS2;ELOVL7;ACER2;PCSK5;CERT1;CEPT1;DEGS2;PRKD3;GPHN;GCH1;PRKD1;SPNS2;SLC44A2;ELOVL5;AKR1A1;CERS5;CERS6;PLPP1;SAMD8;APOE;GOLPH3;B4GALT5;ELOVL6;GCNT1;MFSD2A;SLC44A1;LPIN3;CSNK2A1;NFS1;ESD;ELOVL1;GSTT1;PLPP3;VAPB;MOCS1;ELOVL4;ST3GAL2;STARD10;SGPP1;ASS1;SPTSSA;LCMT2;DMD;PPM1L;ACER3
prerank,positive regulation of cell population proliferation (GO:0008284),-0.2847102487363324,-1.3757543070273117,0.0035714285714285713,0.37607948545118003,1.0,89/423,13.82%,LEF1;FOXP1;PRKCH;KITLG;MEF2C;NTRK3;GCNT2;BMP5;PID1;IL6ST;CLDN5;OSMR;PTN;TJP1;LIFR;ACER2;TGFB2;INSR;VEGFC;TBX3;THBS1;NOTCH1;LRP5;GAS6;CDH13;TBC1D8;EGFR;BMP4;TGFBR2;KDR;FN1;CACUL1;TBX1;TNFRSF11A;STX3;CNOT6L;AQP11;DNAJA2;WNT5A;S100A13;HES1;ADAM10;LYN;IL6R;IL34;AR;FLT1;CCN1;MDK;GAREM1;EMP2;CDC123;TIPIN;ZFPM2;TMEM119;PDGFC;FLT4;TIAM1;IGF2;FGF2;TGFB3;TSPAN31;IL15;S100A6;FGF7;S1PR3;EDN1;ESM1;SERTAD1;RPL23;FBXO5;GRK5;EDN3;RPS9;CD74;CCN4;KRAS;BMP2;PTK2B;PDGFD;TBX2;NACC1;CSNK2A1;AKT2;NME2;PTPRC;IRS1;CD86;VEGFA
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.54334269033696,-1.375229075273372,0.10772357723577236,0.3764381317747492,1.0,7/13,20.93%,DCN;CSPG4;VCAN;HEXA;BGN;NCAN;BCAN
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.51368108434487,1.3750986174764088,0.11991869918699187,0.7798450185223792,1.0,6/19,11.47%,IGF1;PICALM;RTN1;FLOT2;NTRK2;CLU
prerank,neutrophil mediated immunity (GO:0002446),-0.2854799009298179,-1.3750412597586057,0.0036496350364963502,0.37608130404909207,1.0,115/432,19.05%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;APAF1;KMT2E;RAP1A;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;RAB6A;STOM;RAB31;TMEM30A;PLEKHO2;ATP11B;CAB39;CPNE3;UBR4;ADGRE5;NPC2;CST3;SLC44A2;ADAM10;VAT1;XRCC5;EEF2;SLC2A3;PPIA;PRKCD;PRCP;PSMB7;MAPK1;SPTAN1;OSTF1;ALDOA;DOCK2;CMTM6;CTSD;CEACAM1;CNN2;CD55;ORMDL3;CAP1;ATP6AP2;ATP6V0A1;AGA;PYGB;CAT;CAND1;PFKL;S100A11;FTL;GAA;CTSB;PRDX6;PSAP;CRACR2A;HRNR;ENPP4;STK10;PGM2;RAB3A;NRAS;SCAMP1;CYSTM1;RAB27A;ATP6V1D;ARSA;IST1;CYB5R3;NME2;PTPRC;LRG1;DYNLL1;PGAM1;DERA;CCT2;TMBIM1;SURF4;SRP14;RAB5C;PLAUR;PSMD11;PA2G4;PPIE;RAP2B;NCKAP1L;PDAP1;SNAP23;CDA;TCIRG1;IMPDH1;CTSS;SYNGR1;CD53;CREG1;PDXK;DYNC1H1;PSMD14;PTPN6;C3;DSP;TMEM179B;CKAP4;RAB3D
prerank,neutrophil activation (GO:0042119),-0.5540645854824375,-1.3747805484471434,0.1028225806451613,0.3759291484737705,1.0,5/12,21.23%,KMT2E;PRKCD;IL15;PREX1;SYK
prerank,cardiac muscle cell differentiation (GO:0055007),-0.46806600947630217,-1.3746260632893152,0.08519269776876268,0.3756004728236665,1.0,7/21,13.82%,MEF2C;ACVR1;MYH11;CXADR;MYOCD;BMP2;VEGFA
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5542283978001566,1.374417272383028,0.12966601178781925,0.7784423512075113,1.0,3/13,3.48%,BMP6;DAB2;BMPR1A
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.4600964445063795,-1.3738604645646788,0.08917197452229299,0.3765695054261297,1.0,9/22,12.95%,UBC;RPS27A;XPC;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.41249464544399406,1.3737857083432305,0.07801418439716312,0.7768432397326608,1.0,11/50,10.53%,RORA;DCDC2;SUFU;INTU;TULP3;FGFR2;EVC;ARMC9;MEGF8;IFT122;TEDC2
prerank,actin polymerization or depolymerization (GO:0008154),-0.3910464093821358,-1.373476957396819,0.06802721088435375,0.37663205990153625,1.0,14/50,13.75%,ABI1;MICAL2;SVIL;GSN;WDR1;MSRB2;WASHC3;FAM107A;CFL1;CAPG;MICALL2;PSTPIP2;VILL;AVIL
prerank,positive regulation of protein kinase activity (GO:0045860),-0.31975035158672543,-1.3732131991118317,0.005763688760806916,0.37645705586936584,1.0,28/148,9.78%,RAPGEF2;DAB2IP;RHOA;TGFB2;INSR;GAS6;RASSF2;STK3;RAP1A;IQGAP1;TGFBR2;CACUL1;RALB;TNIK;CAB39;PAK2;XRCC5;IL6R;IL34;PRKCD;CALM3;CCN1;EMP2;SRC;PTPN1;MAP4K4;NEDD9;RPTOR
prerank,ribosome assembly (GO:0042255),-0.39117704543567955,-1.3730134973394201,0.07158351409978309,0.3761299633082052,1.0,19/47,26.01%,RPS15;RPL5;RPL10;MRPL20;RPLP0;RPS5;RPS28;RPL6;RPL24;RPS27;RRP7A;MTERF3;PWP2;RPL3;RRS1;RPS19;RPL23A;PPAN;MDN1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4351488344271824,1.372926953634994,0.08566433566433566,0.7762265398440672,1.0,13/44,10.67%,ACTN2;ATP1B3;ANK2;WNK3;KCNJ5;ATP1B2;KCNJ10;WNK4;KCNH2;GABBR1;KCNN4;KCNJ16;GABBR2
prerank,response to X-ray (GO:0010165),-0.5271155610113588,-1.372509603083471,0.11368015414258188,0.3764268353660405,1.0,10/14,35.29%,NIPBL;XRCC5;ANXA1;BLM;LIG4;NUCKS1;IKBIP;BRCC3;XRRA1;XRCC4
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.45447719353342475,-1.3724965012035526,0.09307359307359307,0.3757054453850345,1.0,7/24,14.95%,PLCE1;WASF2;PIK3R1;OCLN;PIK3CA;AVIL;ARPC2
prerank,regulation of establishment of protein localization (GO:0070201),-0.5264749385072643,-1.3724173918997036,0.08560311284046693,0.37512362937650295,1.0,9/14,27.41%,DNAJA1;CTSD;GAPVD1;PTP4A3;CEP295;SPIDR;TREM2;SCFD1;CENPJ
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.4063150336108033,-1.3715381485340654,0.0759493670886076,0.3763377482605693,1.0,13/40,12.38%,LEF1;GCNT2;JAG1;TGFB2;NOTCH1;TGFBR2;AXIN2;MDK;TIAM1;TGFB3;TWIST1;COL1A1;BMP2
prerank,nucleoside catabolic process (GO:0009164),0.5796640978687779,1.3712577520882956,0.11290322580645161,0.7792819599487164,1.0,4/11,11.30%,UPB1;DPYD;NT5C3A;UPP2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.44778106867818496,-1.3704520407885628,0.09894736842105263,0.37788991079278206,1.0,5/27,7.92%,RHOA;ETS1;CD44;MDK;NFAT5
prerank,nucleotide catabolic process (GO:0009166),-0.5031735581063204,-1.3703692747228455,0.09611451942740286,0.3773273513453126,1.0,7/16,21.88%,XDH;GPX1;NT5C1A;DERA;NT5E;NT5C;GDA
prerank,innate immune response in mucosa (GO:0002227),-0.5811923803203995,-1.3697920928968161,0.11976047904191617,0.37783427470528363,1.0,2/10,5.46%,DEFA6;RPL39
prerank,potassium ion homeostasis (GO:0055075),0.48098000654339934,1.3692398273272723,0.12380952380952381,0.7836172511292716,1.0,6/23,11.41%,ATP1A2;ATP1B3;ATP1B2;KCNH2;SLC12A5;SLC12A1
prerank,cellular amide metabolic process (GO:0043603),0.3659141201573824,1.3690802372530464,0.046822742474916385,0.7802741310679022,1.0,28/102,17.36%,AEBP1;ALDH1L1;CPN1;ACSM2A;ACSM2B;PLAAT5;PM20D1;PCCA;SMPD3;GLYAT;PANK2;SLC19A1;ORMDL2;CLN8;SMPD2;MTHFS;PLA2G15;ABCA2;NAAA;MTHFD1;MTHFR;CERK;PLAAT3;ACOT1;FPGS;AASDHPPT;MTHFD2;ACOT6
prerank,linoleic acid metabolic process (GO:0043651),0.5274654106124823,1.3685181875850454,0.09233791748526522,0.7784731322808387,1.0,4/17,9.07%,ACSL1;PNPLA8;GSTM2;ABCD1
prerank,cellular metal ion homeostasis (GO:0006875),0.3637517227347289,1.3681192867459098,0.05317324185248713,0.7760290320484661,1.0,11/102,4.28%,ATP1A2;SLC8A3;SLC41A1;SLC24A3;ATP1B3;ATP13A5;ANK2;DMPK;CSRP3;ATP13A3;ATP1B2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.41537156618657517,-1.3677964856551883,0.0734341252699784,0.38156216988582986,1.0,10/37,8.86%,CAV1;BCL2L1;UBB;RACK1;NCK1;RPS7;NACC2;RPS3;BCAP31;SOD1
prerank,neutrophil degranulation (GO:0043312),-0.28495036208198876,-1.3677822369547892,0.0,0.3808381094737916,1.0,114/425,19.05%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;APAF1;RAP1A;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;RAB6A;STOM;RAB31;TMEM30A;PLEKHO2;ATP11B;CAB39;CPNE3;UBR4;ADGRE5;NPC2;CST3;SLC44A2;ADAM10;VAT1;XRCC5;EEF2;SLC2A3;PPIA;PRKCD;PRCP;PSMB7;MAPK1;SPTAN1;OSTF1;ALDOA;DOCK2;CMTM6;CTSD;CEACAM1;CNN2;CD55;ORMDL3;CAP1;ATP6AP2;ATP6V0A1;AGA;PYGB;CAT;CAND1;PFKL;S100A11;FTL;GAA;CTSB;PRDX6;PSAP;CRACR2A;HRNR;ENPP4;STK10;PGM2;RAB3A;NRAS;SCAMP1;CYSTM1;RAB27A;ATP6V1D;ARSA;IST1;CYB5R3;NME2;PTPRC;LRG1;DYNLL1;PGAM1;DERA;CCT2;TMBIM1;SURF4;SRP14;RAB5C;PLAUR;PSMD11;PA2G4;PPIE;RAP2B;NCKAP1L;PDAP1;SNAP23;CDA;TCIRG1;IMPDH1;CTSS;SYNGR1;CD53;CREG1;PDXK;DYNC1H1;PSMD14;PTPN6;C3;DSP;TMEM179B;CKAP4;RAB3D
prerank,negative regulation of hydrolase activity (GO:0051346),0.4067183835610074,1.3677045423328809,0.07747747747747748,0.7737703579338454,1.0,9/49,8.07%,CPEB2;MAP2;GCHFR;SH3RF2;SH2D4A;GMIP;ARL2;GPSM1;LRRK2
prerank,neural crest cell migration (GO:0001755),-0.4148054750361283,-1.3676018588020704,0.07142857142857142,0.38046888621601266,1.0,10/36,12.43%,NRP1;SEMA6A;SEMA3C;SEMA7A;CORO1C;FN1;TBX1;SEMA5B;SEMA3E;SEMA3G
prerank,mucosal immune response (GO:0002385),-0.5170133159959075,-1.36655284132531,0.10330578512396695,0.3820543776648402,1.0,3/15,7.57%,DEFA6;RPL39;OTUD7B
prerank,carboxylic acid catabolic process (GO:0046395),0.563897364694677,1.3664027617573766,0.14583333333333334,0.7749254137027651,1.0,4/12,11.76%,PON1;RENBP;GNPDA1;NPL
prerank,regulation of B cell proliferation (GO:0030888),-0.39086148696296885,-1.3662277590867202,0.056768558951965066,0.3819825968280229,1.0,12/44,16.03%,MEF2C;TFRC;LYN;TNFRSF21;CD38;AHR;EPHB2;NFATC2;CD74;CD40;PTPRC;NCKAP1L
prerank,mononuclear cell differentiation (GO:1903131),-0.4497751244390063,-1.3660251123413252,0.09650924024640657,0.3816356360868419,1.0,8/24,15.76%,GAS6;MYH9;BMP4;LYN;RELB;MT1G;VEGFA;CSF1R
prerank,regulation of macroautophagy (GO:0016241),0.3623018489137461,1.3657708090294316,0.052805280528052806,0.7737265383047017,1.0,26/105,15.49%,PRKAG2;SNX6;PRKAA2;RRAGC;PRKAG3;ATP6V0A2;ATP6V0B;QSOX1;ATP6V1H;CASP3;IKBKG;GPSM1;LRRK2;SESN1;ATP6V1B2;SLC38A9;ATP6V1E1;PAFAH1B2;ATG13;LAMTOR2;ATP6V0E2;TSC1;ATP6V1C1;ATP6V0D2;LAMTOR3;SIRT1
prerank,response to ketone (GO:1901654),-0.4445934208044906,-1.3656655440644074,0.08713692946058091,0.3816764106482261,1.0,5/24,2.26%,CAV1;SLIT2;ABHD2;TGFB2;THBS1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.32656891157067397,-1.365442350166718,0.028277634961439587,0.3813734262279521,1.0,28/128,6.74%,GCNT2;BMP5;BMPR2;CLDN5;PARD3;RHOA;ACVR1;ACVRL1;TGFB2;ENG;RUNX2;SMURF1;ID1;BMP4;TGFBR2;RNF111;UBC;F11R;PTPRK;JUN;ITGB1;SMAD5;TMEM100;SMAD1;RPS27A;UBB;ITGB5;PXN
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.47791635749389827,-1.364146955662894,0.07805907172995781,0.3835412118892211,1.0,11/20,13.85%,ACVRL1;TGFB2;ENG;TBX3;NOTCH1;BMP4;HEYL;HEY2;PDCD4;BMP2;SPRY1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5030104376473089,-1.3634435918532621,0.10953346855983773,0.38428226518033753,1.0,6/16,13.24%,NOS3;NDNF;GUCY1B1;APOE;DDAH1;GUCY1A1
prerank,regulation of peptide hormone secretion (GO:0090276),0.39522391757304176,1.3634368206490797,0.07665505226480836,0.7788755178619101,1.0,22/67,18.39%,CACNA1D;GCK;ITPR1;PASK;CACNA2D2;ADRA2A;SNAP25;KCNC2;CLOCK;ITPR2;GRP;RAPGEF3;ENSA;KCNS3;PER2;EIPR1;IL6;GIPR;PRKCA;HFE;PICK1;DPP4
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5305800918724347,-1.3630958985813248,0.10526315789473684,0.3842561454435129,1.0,7/14,13.85%,CAV1;ZEB1;SPRED2;XDH;SPRY2;NOTCH4;SPRY1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5478639114141353,-1.363056069660174,0.11764705882352941,0.38361447966722845,1.0,5/11,18.04%,WIPI1;APOE;PIK3C3;UGCG;WDR45B
prerank,Golgi to endosome transport (GO:0006895),-0.5077903112964042,-1.3628791327316336,0.09090909090909091,0.3832347877346655,1.0,8/16,13.98%,RAB14;VPS13C;WIPI1;SORT1;VPS13A;AP1AR;SYS1;AP2A1
prerank,regulation of developmental growth (GO:0048638),-0.4361815087858486,-1.362864757952762,0.08369098712446352,0.382516942007467,1.0,12/29,17.70%,GHR;INSR;SIX1;APP;NIPBL;SPAAR;SOD1;APOE;MFSD2A;SIX4;FGFR3;LATS1
prerank,regulation of exocytosis (GO:0017157),0.41656720148118803,1.3627303719851314,0.08394160583941605,0.7776957953245724,1.0,16/46,16.47%,IL1RAPL1;UNC13D;CHMP6;RAB21;SYT1;CLASP1;RAB3C;STXBP5L;NSF;CPLANE2;RAB2B;RAB13;CPLX1;CADPS2;STX4;CPLX2
prerank,carbohydrate derivative transport (GO:1901264),-0.4843806769582582,-1.3622274338909959,0.10495049504950495,0.3832357594012412,1.0,6/18,12.19%,SCARB1;SLC10A7;PLTP;NPC2;VLDLR;MFSD2A
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.578378658367515,1.3621099429933479,0.13404255319148936,0.7764131405131574,1.0,3/11,3.73%,LEPROT;ACTN2;PICALM
prerank,neutrophil activation involved in immune response (GO:0002283),-0.28361597407363026,-1.361784346777673,0.0036363636363636364,0.3834625961062743,1.0,114/428,19.05%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;APAF1;RAP1A;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;RAB6A;STOM;RAB31;TMEM30A;PLEKHO2;ATP11B;CAB39;CPNE3;UBR4;ADGRE5;NPC2;CST3;SLC44A2;ADAM10;VAT1;XRCC5;EEF2;SLC2A3;PPIA;PRKCD;PRCP;PSMB7;MAPK1;SPTAN1;OSTF1;ALDOA;DOCK2;CMTM6;CTSD;CEACAM1;CNN2;CD55;ORMDL3;CAP1;ATP6AP2;ATP6V0A1;AGA;PYGB;CAT;CAND1;PFKL;S100A11;FTL;GAA;CTSB;PRDX6;PSAP;CRACR2A;HRNR;ENPP4;STK10;PGM2;RAB3A;NRAS;SCAMP1;CYSTM1;RAB27A;ATP6V1D;ARSA;IST1;CYB5R3;NME2;PTPRC;LRG1;DYNLL1;PGAM1;DERA;CCT2;TMBIM1;SURF4;SRP14;RAB5C;PLAUR;PSMD11;PA2G4;PPIE;RAP2B;NCKAP1L;PDAP1;SNAP23;CDA;TCIRG1;IMPDH1;CTSS;SYNGR1;CD53;CREG1;PDXK;DYNC1H1;PSMD14;PTPN6;C3;DSP;TMEM179B;CKAP4;RAB3D
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3530145878017633,-1.3615568988323346,0.041666666666666664,0.38329259610173855,1.0,22/80,15.68%,NRP1;PLCE1;WASF2;PIK3R1;CDC42EP5;CDC42EP3;ARAP1;EPS8;ARHGAP35;OCLN;APC;PIK3CA;TGFB3;EPS8L2;CDC42EP2;FNBP1L;PFN1;AVIL;CCP110;AGRN;ARPC2;FMR1
prerank,retina homeostasis (GO:0001895),-0.4643259936398739,-1.3613972735475484,0.10251046025104603,0.38288563809328335,1.0,6/23,11.50%,ACTB;POTEF;B2M;ACTG1;SOD1;HSPB1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4826191079237977,-1.3610476312816788,0.11479028697571744,0.3829497064810574,1.0,9/19,33.02%,SLCO1C1;APP;KLF4;KLF2;EGF;WFS1;TMEM106A;HPN;MAPK8
prerank,regulation of glucose transmembrane transport (GO:0010827),0.5085246119074732,1.3606530478101178,0.11657559198542805,0.7784733272348571,1.0,2/18,4.22%,PRKAG2;CLIP3
prerank,regulation of centriole replication (GO:0046599),-0.49034956639695304,-1.3605978075812117,0.11637931034482758,0.3831681115176772,1.0,9/18,31.50%,TRIM37;PLK2;CEP76;STIL;CEP295;CDK5RAP2;NUP62;CENPJ;CEP295NL
prerank,regulation of leukocyte activation (GO:0002694),-0.5249319492362713,-1.3591472286066066,0.11267605633802817,0.3856228423278232,1.0,6/14,17.68%,CD200;PLSCR1;MFHAS1;LYN;CD74;GPER1
prerank,heart contraction (GO:0060047),0.42981743000193123,1.359056224840979,0.1059245960502693,0.781205599199843,1.0,7/41,11.04%,ATP1A2;CSRP3;SGCZ;TNNI1;KCNH2;SGCG;RYR2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.4174148107261277,-1.3584132764424806,0.08552631578947369,0.38653071147280316,1.0,13/35,13.79%,NRP1;TEK;NTRK3;TJP1;ESAM;F11R;ARHGDIB;MDK;CDK5;ABI3;SEMA3E;PTK2B;ARHGDIA
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.4303626729872034,-1.3581245408150284,0.08520179372197309,0.3864600931058215,1.0,10/32,16.71%,PLCE1;WASF2;PIK3R1;CORO1C;OCLN;PIK3CA;SRC;AVIL;ARPC2;RREB1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.5417949749960999,-1.3578781597309495,0.10687022900763359,0.38627947871242896,1.0,7/13,34.79%,KDR;EDN1;NOD2;IL33;TLR4;NAMPT;TLR2
prerank,regulation of myelination (GO:0031641),-0.4537522876721452,-1.3576624654765392,0.11158798283261803,0.386027772117336,1.0,7/25,11.68%,PTN;PARD3;TNFRSF1B;LGI4;TNFRSF21;EIF2AK3;PTPRZ1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4191818284215647,1.3575989027546729,0.10427350427350428,0.7830340829644986,1.0,9/46,10.26%,ATP1A2;CACNG7;NLGN2;SYT1;NLGN3;ATAD1;LRRK2;DRD3;DGKI
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.42258953187614245,-1.3572558724337314,0.10065645514223195,0.3861017816775787,1.0,10/29,17.39%,BMP5;DAB2IP;SDHAF2;IL17RD;SPRED2;SPRY2;VASN;SPRY1;MAD2L2;PTEN
prerank,L-serine metabolic process (GO:0006563),-0.5783142151491635,-1.3570317790059239,0.09670781893004116,0.38583944032349776,1.0,6/10,28.59%,SERINC5;SRR;SERINC3;SHMT2;CBS;SHMT1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5289012744749343,1.3567373810927474,0.12673267326732673,0.782750666187583,1.0,5/16,7.85%,LEPROT;CHMP6;STAM;VTA1;SNF8
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5443665281772097,-1.3557433148972164,0.11293634496919917,0.3879285473356858,1.0,4/12,9.84%,RHOA;APP;CXCL12;DOCK8
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5497101280993877,-1.355724770007823,0.1144578313253012,0.3872387191703143,1.0,4/12,2.65%,PODXL;JAG1;PROM1;IQGAP1
prerank,glucose homeostasis (GO:0042593),0.3739305645018175,1.3556430799379757,0.06217616580310881,0.783368470060628,1.0,22/83,15.93%,LEPR;GCGR;APPL2;GCK;PRKAA2;CYP11B1;ACSM2A;ADRA2A;PAX6;ADCY8;CEBPA;PDK2;HKDC1;PPARGC1A;USF1;PYGL;HECTD4;SIRT1;IL6;BACE2;HK1;RBP4
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5116272777271029,-1.3547867486886667,0.10816326530612246,0.3885897607108163,1.0,9/15,32.10%,BMP4;SIX1;SMO;VEGFA;SIX4;SOX8;LHX1;AGT;NOG
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.42641206607182114,1.3546957726507893,0.10114503816793893,0.7832791021850788,1.0,11/37,11.69%,TTC21B;WDR19;IFT74;WDR35;DYNC2LI1;KIF3C;DYNC2I2;IFT122;PCM1;KIF3A;IFT80
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5538289686058903,1.3538806761005806,0.13900414937759337,0.7826477969411239,1.0,3/13,5.71%,CHST4;RENBP;LARGE1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.33819063882214334,-1.3538766167659444,0.05172413793103448,0.38979617709878744,1.0,33/93,22.51%,DAB2IP;SH3RF3;TRAF5;TGFB2;MAP3K5;RASSF2;MID1;APP;MFHAS1;XDH;FLT4;EDA2R;BMP2;PTK2B;TNFRSF19;ANKRD6;VEGFA;MTURN;TAOK3;KLHDC10;EDAR;RELL1;NOD2;TAOK1;ZC3H12A;SH3RF1;RIPK1;SPI1;HMGB1;TRAF4;MAP3K4;SEMA4C;FCGR2B
prerank,positive regulation of cell projection organization (GO:0031346),-0.3319264934239922,-1.3536483998718165,0.04113110539845758,0.3895766155587737,1.0,32/115,13.79%,ROR1;NTRK3;RAPGEF2;DAB2IP;PTN;ITGA6;SLIT2;RHOA;NDNF;RAP1A;NGF;SCARF1;TIAM2;SCARB2;PRKD1;WNT5A;NPTN;LYN;FBXW8;ARHGAP35;MDK;RETREG3;TIAM1;APOE;PLXNC1;FZD4;RET;PTK2B;ROR2;FZD1;AVIL;ARHGDIA
prerank,protein homotetramerization (GO:0051289),0.41057958612782486,1.352863689847266,0.09847198641765705,0.7830257472537252,1.0,4/49,1.13%,ALDH1A2;UPB1;APPL2;TRPV1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5807237621894842,-1.351436611518266,0.11717171717171718,0.3938194064266968,1.0,3/10,2.86%,RAPGEF2;RAP1A;NGF
prerank,regulation of kinase activity (GO:0043549),-0.33961023860567213,-1.3507106990948239,0.028423772609819122,0.3946941429315484,1.0,21/89,12.90%,ROR1;TEK;NTRK3;PLCE1;TIE1;INSR;MERTK;EGFR;EEF1A1;KDR;MET;NLRC5;FLT1;EMP2;CDKN1C;SOD1;FLT4;EPHB2;CD74;RET;ROR2
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.27349171270663897,-1.349593896863201,0.0,0.3964109547032372,1.0,153/532,21.87%,LIMS1;GHR;ACTN4;IL6ST;IL1R1;OSMR;ZEB1;LIFR;TMSB4X;TRAF5;B2M;GREM2;FOXO1;RPS6KA5;PIK3R1;F3;FOXO3;VCAM1;BCL2L1;NFKBIA;SOCS2;STAT3;CD44;PTPRJ;MID1;IRAK3;TNFRSF1B;FN1;UBC;PTGS2;STX1A;NOD1;ADIPOR2;CARD14;IFITM3;MTAP;TNFRSF11A;ITGB1;STX3;ICAM1;RPS27A;IRF9;S1PR1;CAMK2D;UBB;PAK2;TEC;AIM2;PPIA;RPLP0;CXCL12;IL6R;ANXA1;IL34;PRKCD;PSMA6;TNFRSF11B;INPP5D;PSMB7;IL20RB;TRIM25;XAF1;IFI35;CEACAM1;CCL13;CNN2;IL1RAP;PIK3CA;BRWD1;SRC;CNTFR;SOD1;FGF2;SOCS5;IL15;IRF2;PSMB6;JAK1;YWHAZ;IL4R;CFL1;ACKR3;MAOA;PIK3CD;PSMB5;IL1RL2;CEBPD;EDA2R;SQSTM1;TWIST1;ISG15;PTPRZ1;PDCD4;UGCG;BIRC3;PTK2B;POU2F1;CD40;RSAD2;IRS1;CD86;VEGFA;PSMB8;IL17RE;IRAK2;MT3;CBL;TAB1;PSMC4;PSMD11;CSF1R;PRKACA;SP100;IFITM1;BOLA2;CISH;IFNAR1;SOCS3;MMP2;MAP3K8;PSMB4;JUNB;EDAR;PSMD14;NOD2;IL33;PTPN6;CCL25;CCND1;MT2A;MAPK3;MCL1;CRLF1;IRF5;RIPK1;SPI1;SMARCA4;JAK3;HCK;CDC42;PSMD10;CAPZA1;MYD88;TNFSF8;SYK;MSN;PSME1;RIPK2;IFITM2;NUMBL;F13A1;HNRNPF;FCGR1A
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.46683675205202074,-1.348731760832816,0.10697674418604651,0.3974604660002702,1.0,9/22,18.96%,RASSF2;RAP2A;CALM3;PDGFC;PDGFD;VEGFA;TNKS1BP1;NBN;GREM1
prerank,regulation of cartilage development (GO:0061035),-0.488062078694781,-1.3486512415821015,0.09448818897637795,0.39689890668283173,1.0,5/18,7.43%,BMPR2;ZBTB16;TRPS1;BMP4;MDK
prerank,negative regulation of cell cycle (GO:0045786),0.37908238274170425,1.3484686919508955,0.06260869565217392,0.797159504959417,1.0,14/73,7.55%,BMP7;NUPR1;SMAD3;CDKN2A;GMNC;ANGEL2;TSPYL2;PLK1;NLRP2B;CEBPA;HTRA2;NR2F2;TRIM35;INHA
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5755626560125899,-1.3480244748337284,0.11740890688259109,0.39678657510625504,1.0,5/10,23.19%,AP2B1;VLDLR;AP2A1;MYLIP;AP2M1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5755626560125899,-1.3480244748337284,0.11740890688259109,0.39678657510625504,1.0,5/10,23.19%,AP2B1;VLDLR;AP2A1;MYLIP;AP2M1
prerank,regulation of embryonic development (GO:0045995),-0.40954007992821995,-1.3479395543597772,0.06428571428571428,0.39622935139331356,1.0,8/34,10.52%,INSR;RAB14;PHLDB1;PHLDB2;SOX17;NIPBL;B4GALT5;CFL1
prerank,artery development (GO:0060840),-0.4577429554546236,-1.3475061455190458,0.11373390557939914,0.3965055427672743,1.0,8/23,7.63%,NRP1;BMPR2;ACVRL1;ENG;TBX1;HES1;PDE2A;STRA6
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.530940064713785,-1.3473816468738948,0.14342629482071714,0.39605286731723516,1.0,8/13,35.75%,RACK1;NCK1;PTPN1;ATF6B;WFS1;HSPA5;ABCA7;DDRGK1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5014569535138236,-1.3473673014959695,0.09533898305084745,0.3953635284405,1.0,3/15,9.64%,SCARB1;PLTP;APOE
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.38078122855076485,-1.3471164164137155,0.07311827956989247,0.3952402356211401,1.0,22/48,30.26%,ACTB;ARID1B;MYBBP1A;ARID1A;SERTAD1;ATAD2;POLR1F;POLR1G;POLR1A;ZMIZ2;CDCA4;ZMIZ1;CHEK1;POLR1H;MYO1C;POLR2F;POLR1E;POLR2H;DDX21;POLR1C;POLR2E;SMARCA5
prerank,manganese ion transport (GO:0006828),-0.5217312176795754,-1.3466078605363225,0.12673267326732673,0.3955922926674345,1.0,5/14,9.94%,TRPC3;SLC39A8;TRPC6;TRPC4;TRPC1
prerank,natural killer cell activation (GO:0030101),-0.4520110541057639,-1.3465838043651923,0.09247311827956989,0.3949328638983811,1.0,7/23,16.52%,PBX1;KAT7;ELF4;PIK3CD;NFIL3;PTPRC;ULBP1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.5064799634469671,-1.3460491458416413,0.10103092783505155,0.39541742547771297,1.0,11/14,47.19%,TYROBP;POU4F1;ATP6AP1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;CSF1;IL12B
prerank,positive regulation of synapse assembly (GO:0051965),0.4588575648054025,1.345632155112531,0.09737827715355805,0.8051026083431384,1.0,10/27,17.49%,IL1RAPL1;NLGN2;WNT7A;VSTM5;GRID2;NLGN3;PTPRD;BDNF;EPHB1;SYNDIG1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.42801625412172095,-1.3454736923580546,0.08577878103837472,0.3959690158257541,1.0,10/29,12.95%,RPA1;UBC;RPS27A;XPC;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,protein phosphorylation (GO:0006468),-0.27448193324746234,-1.3453612446193313,0.0,0.39555508200932327,1.0,153/479,23.22%,PRKG1;PRKCH;TEK;ABI1;ERG;SNRK;BMPR2;DAB2IP;MARK1;NEK7;ACVR1;CDK17;HIPK1;ACVRL1;TGFB2;MAP3K5;INSR;MERTK;RPS6KA5;STK38L;PKD1;GAS6;STK3;PEAK1;EGFR;LIMK2;EEF2K;BCR;BMP4;AKT3;TGFBR2;IRAK3;KDR;APP;CRY1;CDK14;RPS6KA3;FNIP2;BMX;TNIK;CAB39;NUAK1;MAP3K20;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;TEC;PRKD1;CIT;TNKS;ERN1;ADAM10;LYN;CDC42BPA;DCLK1;PRKCD;PLK2;CDKL2;CSNK1A1;MAPK1;FLT1;CSNK1G3;PRKX;PRKCG;RPS6KA2;STK24;CDK5;SRC;FLT4;MAP4K4;EIF2AK3;STK33;MAPKAPK2;ABI3;GTF2H5;JAK1;YWHAZ;NEK3;BCKDK;EPHB2;PIK3CD;GTF2H1;VRK3;GRK5;STK10;DYRK1A;MORC3;PRKG2;RET;INCENP;BMP2;PTK2B;STK32A;STK16;CSNK2A1;STK38;AKT2;PIK3R4;ACVR1C;PKN3;ALK;LIMK1;CSF1R;PRKACA;MKNK2;TAOK3;CAD;MAST2;FGFR3;COQ8A;LATS1;MASTL;STRADA;TAOK1;HUNK;PTPN6;PRAG1;STK26;MAPK12;CDK16;EFEMP1;CDK6;MAPK3;BTK;CAMK1G;MARK3;STK17B;RIPK1;JAK3;HCK;TRIB2;CSNK1D;MAP3K6;DYRK2;CHEK1;ULK2;SYK;ROCK1;TOP1;CDKL4;CCNH;SLK;FYN;SIK3;MAP4K3;RYK;CDK11B;PRKAR1B;STK32C;USP15;CDK18
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5043581268165404,-1.3451729205014347,0.1292929292929293,0.39531169827032725,1.0,5/15,20.12%,TGFB2;IRAK3;TGFB3;JAK3;CUEDC2
prerank,retinoid metabolic process (GO:0001523),0.38224937669835635,1.3451078014477638,0.07380073800738007,0.803507527858948,1.0,7/71,2.49%,ALDH1A2;ALDH8A1;ADH7;ADH4;ABCA4;RBP1;CYP26B1
prerank,ribosomal large subunit assembly (GO:0000027),-0.4666824044717718,-1.3445310254077734,0.09734513274336283,0.39595855563547394,1.0,12/24,28.85%,RPL5;RPL10;MRPL20;RPLP0;RPL6;RPL24;RPL3;RRS1;RPL23A;PPAN;MDN1;RSL24D1
prerank,aortic valve morphogenesis (GO:0003180),-0.4287466690618413,-1.3440533356531617,0.07991360691144708,0.39631626996218083,1.0,10/30,8.50%,ELN;JAG1;SLIT2;NOS3;TIE1;NOTCH1;BMP4;NFATC1;HEYL;HEY2
prerank,positive regulation of axon extension (GO:0045773),-0.46357940944006604,-1.343586688214029,0.09745762711864407,0.3965454548421593,1.0,8/22,16.30%,NRP1;NTN1;SEMA7A;MACF1;SHTN1;VEGFA;LIMK1;SEMA5A
prerank,axonogenesis (GO:0007409),-0.2970772985097593,-1.3431972160493038,0.020833333333333332,0.39665360577485154,1.0,48/237,12.43%,NRP1;SPTBN1;ACTB;SHANK3;LAMA2;SEMA6A;NRP2;LAMA1;GAB1;SEMA3C;BSG;SLIT2;PARD3;SEMA7A;NOTCH3;RPS6KA5;NOTCH1;PIK3R1;PLCG1;PALLD;APP;LAMA3;KLF7;WNT5A;NTN4;NPTN;CXCL12;ROBO4;ARHGAP35;MAPK1;SPTAN1;EFNA5;PIK3CA;CDK5;SRC;SEMA5B;S100A6;B4GALT5;EPHB2;PIK3CD;SEMA3E;DSCAML1;UNC5B;VLDLR;RAB3A;RANBP9;RET;SEMA3G
prerank,regulation of histone methylation (GO:0031060),0.5452653979669413,1.342912175226378,0.13771186440677965,0.8085411141674304,1.0,6/13,15.32%,CTR9;TET1;JARID2;NSD1;PIH1D1;MTHFR
prerank,positive regulation of macrophage migration (GO:1905523),-0.4724004038448992,-1.3427740465796116,0.11836734693877551,0.39689268772401626,1.0,9/19,27.07%,THBS1;IL34;MAPK1;MDK;RARRES2;CSF1R;MAPK3;CMKLR1;TREM2
prerank,catecholamine metabolic process (GO:0006584),0.5323498489190885,1.3427323493027836,0.15132924335378323,0.805498341991096,1.0,5/14,18.63%,SNCAIP;DRD3;COMT;ATP7A;RNF180
prerank,tight junction assembly (GO:0120192),-0.38051608215404137,-1.3423836983584352,0.057649667405764965,0.3970518137184805,1.0,13/49,7.76%,PECAM1;CLDN5;ESAM;PARD3;RAMP2;ACTG1;LSR;F11R;TBCD;PAK2;CLDN14;OCLN;APC
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.48810996352376723,1.3407000147730164,0.13851992409867173,0.8101045327588284,1.0,3/20,6.77%,WNT4;GCK;C1QTNF3
prerank,regulation of stem cell proliferation (GO:0072091),0.5047402042193151,1.339989964776829,0.13345864661654136,0.8092341847388738,1.0,6/17,17.55%,FBLN1;HNRNPU;EIF2AK2;AGO3;TERT;KDM1A
prerank,myoblast differentiation (GO:0045445),0.536151644667196,1.3391310382180357,0.12966601178781925,0.8091435470444169,1.0,6/14,8.75%,EPAS1;IGF1;DDX5;NRG1;DDX17;HINFP
prerank,bone morphogenesis (GO:0060349),-0.5195397014698635,-1.3381156597698067,0.12655601659751037,0.4057043295267321,1.0,4/14,3.34%,BMPR2;LRP6;LRP5;SFRP4
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.35694033222524335,-1.337889991723268,0.06422018348623854,0.40548238343468845,1.0,12/67,6.61%,MYO10;PODXL;CAV1;ATP8B1;TBC1D8;ATG3;USP6NL;TBC1D5;IFT140;TBC1D2B;TBC1D1;PPP1R16B
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.3884804113887798,1.3371629135622982,0.08941605839416059,0.8136382797907428,1.0,18/57,19.03%,CACNG7;ACTN2;NLGN2;NPTX1;DLG1;SHISA7;SHANK1;GSG1L;DLG4;NPTXR;CNIH3;OPRM1;SHISA8;LRRC7;GRIA2;NEFL;MINK1;MAPK8IP2
prerank,erythrocyte differentiation (GO:0030218),0.4105409455093942,1.337157209427876,0.10321489001692047,0.8099644788751891,1.0,9/44,8.34%,TGFBR3;KIT;FLVCR1;SLC25A5;IKZF1;ABCB10;CASP3;INHA;MED1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.4565345154235576,1.3368417479747734,0.12361623616236163,0.8075845263785152,1.0,7/26,9.68%,OSBPL8;IGF1;CLIP3;PRKCI;SORBS1;RHOQ;CREBL2
prerank,organic cation transport (GO:0015695),-0.46944870735257826,-1.3365752393817754,0.12215320910973085,0.4076036592726738,1.0,5/20,12.51%,SLC47A1;SEC14L1;SLC44A2;SLC22A18;SLC44A1
prerank,in utero embryonic development (GO:0001701),-0.4459241515815446,-1.3364676325204763,0.11336032388663968,0.40713453324523674,1.0,12/25,20.39%,MBNL1;PKD1;FUT8;ADAM10;IGF2;TGFB3;BMP2;VEGFA;STIL;LIG4;SOX8;LMX1B
prerank,ncRNA transcription (GO:0098781),-0.5362606209715298,-1.3363127384440072,0.12749003984063745,0.40675219009060937,1.0,6/13,19.88%,SPIN1;USPL1;POLR1G;CAVIN1;GTF3A;SIRT7
prerank,ganglioside biosynthetic process (GO:0001574),-0.497560357287286,-1.3341325424432662,0.12836438923395446,0.4108434009737775,1.0,8/15,17.75%,ST6GALNAC3;ST8SIA4;ST3GAL1;ST6GALNAC5;ST8SIA6;B4GALT5;ST8SIA2;ST3GAL2
prerank,sphingolipid biosynthetic process (GO:0030148),-0.35132789269823217,-1.333699923300451,0.04830917874396135,0.4110719408009035,1.0,26/71,20.23%,SGMS1;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;AGK;PRKD3;PRKD1;SPNS2;ELOVL5;ST6GALNAC5;CERS5;CERS6;PLPP1;SAMD8;ELOVL6;ELOVL1;PLPP3;VAPB;ELOVL4;SGPP1;SPTSSA;ASAH2;PPM1L;ACER3
prerank,granulocyte chemotaxis (GO:0071621),-0.36996225144738604,-1.3327748594578301,0.0896551724137931,0.4124316156856225,1.0,27/55,40.70%,BSG;TGFB2;PPIA;ANXA1;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB;PIK3CG;S100A9;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;FCER1G;PPBP;CCL8;CCL19;CCL14
prerank,indolalkylamine catabolic process (GO:0046218),0.5875353810066304,1.3327084457408296,0.14989733059548255,0.8207891454344287,1.0,3/10,9.06%,IDO1;HAAO;KMO
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.4104780531929754,-1.3323595623653348,0.0835214446952596,0.4127655522520481,1.0,10/36,11.84%,LEF1;FZD6;NFATC1;AGO1;WNT5A;GNB1;GNG2;PPP3CA;AGO2;FZD4
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5391969820275923,-1.331695758406347,0.1282051282051282,0.4135890276241153,1.0,5/11,13.94%,SEMA6A;THBS1;CREB3L1;EPN2;KLF2
prerank,positive regulation of apoptotic process (GO:0043065),-0.2868640494666536,-1.330675908824712,0.003134796238244514,0.41519870011928717,1.0,85/293,20.44%,DAB2IP;ITGA6;SLIT2;NET1;FAP;TNFSF10;ARHGEF3;TGFB2;MAP3K5;FOXO1;DCUN1D3;MCF2L;APAF1;RASSF2;STK3;CYP1B1;FOXO3;PTGIS;NGF;BTG1;BMP4;SFRP4;RASGRF2;UNC13B;UBC;JUN;DNAJA1;TIAM2;FAS;ITGB1;MAP3K20;ARHGEF2;CRADD;RPS27A;UBB;RACK1;IAPP;KLF11;TGM2;APC;MYBBP1A;RPS3;RPS6KA2;CTSD;CDK5;ABR;SOD1;TIAM1;VAV2;ARHGEF12;TGFB3;TCTN3;TLE5;TNFAIP8;SQSTM1;BMP2;HIP1R;PLEKHG2;SAP18;RARG;EEF1E1;JMY;ACVR1C;BAK1;ATF4;PREX1;ING4;DIABLO;TOP2A;GPER1;LATS1;DUSP6;BARD1;PSEN2;ZC3H12A;IRF5;RYBP;ARHGEF5;STK17B;RIPK1;FOXL2;TRIO;PSENEN;HMGB1;RHOB
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3941896789426226,-1.3295162041236828,0.07209302325581396,0.41692443991294564,1.0,10/41,10.46%,MEF2C;JAG1;TGFB2;ENG;NOTCH1;BMP4;TGFBR2;HEYL;HEY2;CPE
prerank,T cell activation involved in immune response (GO:0002286),-0.5438008652745462,-1.3294647311507546,0.13051823416506717,0.41631388866148455,1.0,3/12,11.83%,ICAM1;MDK;CD74
prerank,myofibril assembly (GO:0030239),0.409827153943599,1.329270079691267,0.09717314487632508,0.831058366374324,1.0,8/42,10.07%,ACTN2;PDGFRA;OBSL1;CAPN3;CSRP3;CSRP1;TMOD2;CFLAR
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5266223498283439,-1.3292510915746703,0.147117296222664,0.41462459426220594,1.0,8/12,33.66%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5266223498283439,-1.3292510915746703,0.147117296222664,0.41462459426220594,1.0,8/12,33.66%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5266223498283439,-1.3292510915746703,0.147117296222664,0.41462459426220594,1.0,8/12,33.66%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,regulation of cell growth (GO:0001558),-0.294824802443577,-1.3291942305371434,0.019444444444444445,0.414092452579275,1.0,51/204,17.55%,APBB2;LTBP4;PLCE1;BMPR2;SLIT2;NET1;ACVRL1;TGFB2;DCUN1D3;SH3BP4;EGFR;SOCS2;BTG1;PTPRJ;H3-3A;FHL1;RPS6KA3;CCN3;SOX17;CCDC85B;TFRC;CAMK2D;AGTR1;RACK1;ADAM10;CEACAM1;BCAR1;CDKN2AIP;RPTOR;FAM107A;PABIR1;NME6;DCUN1D5;MFSD2A;SIPA1;USP47;CSNK2A1;RERG;ENPP1;PTCH2;ADAM15;MT3;NCBP1;KLHL22;MAD2L2;DDX49;RTN4;CDA;CISH;NUBP1;OSGIN1
prerank,dendrite self-avoidance (GO:0070593),-0.49791630010606214,-1.3290019213703066,0.13496932515337423,0.4138052063916121,1.0,6/16,13.17%,BSG;PALLD;NPTN;ROBO4;DSCAML1;EMB
prerank,negative regulation of response to wounding (GO:1903035),-0.4741478464401925,-1.3288961944467332,0.12323232323232323,0.41330254877194705,1.0,8/19,16.66%,CD109;CASK;AJAP1;MDK;FGF2;SERPINE1;GIT1;RTN4RL1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.4090396693200328,-1.3286432189961621,0.10256410256410256,0.4131049400569813,1.0,9/34,14.95%,PLCE1;SLIT2;WASF2;PIK3R1;OCLN;PIK3CA;ABI3;AVIL;ARPC2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4861150571862548,1.3280559459063292,0.12797074954296161,0.8323713904159704,1.0,5/21,11.59%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.37736591393789526,-1.3277563352118875,0.08071748878923767,0.4142673149735883,1.0,24/47,30.39%,PID1;THBS1;TGFBR2;PLCG2;XDH;AGTR1;PRKCD;SOD1;ACE2;RAB27A;ROMO1;GRIN1;DHRS4;ZC3H12A;CBR1;RIPK1;SYK;TLR4;GRB2;DCXR;AGT;MAPT;CD36;TLR6
prerank,carbohydrate catabolic process (GO:0016052),0.4124503022225152,1.3271496539196457,0.10758377425044091,0.8323865339973392,1.0,9/38,7.77%,GCK;ENO1;PGM1;ALDOB;ENO4;PGK1;NAGA;HKDC1;MAN2C1
prerank,positive regulation of histone methylation (GO:0031062),0.46659787637642314,1.3270317689402822,0.13916500994035785,0.8292224443475908,1.0,6/24,8.14%,CTR9;KMT2A;TET1;AUTS2;JARID2;PHF1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.38344757033019095,-1.326621849014545,0.08705357142857142,0.41614549731625217,1.0,15/44,14.84%,DAB2IP;BMP4;PTPRJ;IRAK3;DNAJA1;LYN;PRKCD;SPRY2;PTPN1;APOE;AIDA;PDCD4;STK38;SPRY1;PAQR3
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4916086978338095,1.3263869264661234,0.14728682170542637,0.8283606125228401,1.0,4/18,8.02%,ATP1A2;STK39;PPIF;KCNH2
prerank,metal ion homeostasis (GO:0055065),-0.39800439497828743,-1.3260778360079413,0.08296943231441048,0.41659746929753433,1.0,17/40,28.40%,TMTC2;CAV1;SLC12A7;SLC12A2;SLC12A6;JPH2;CNNM2;MT3;SLC7A8;GRIN1;SLC12A8;SLC8A1;LETM1;WFS1;SELENON;SLC12A4;TESMIN
prerank,positive regulation of synaptic transmission (GO:0050806),0.37181488563888204,1.3254105171029,0.09705372616984402,0.8289550182842138,1.0,14/72,9.52%,SLC8A3;CACNG7;PRKCZ;NLGN2;ZDHHC12;ADCY1;GRIN2D;SYT1;ADCY8;NLGN3;GRIK2;SHISA7;RIMS1;DLG4
prerank,calcium ion transport (GO:0006816),0.3515382974561302,1.325250576932378,0.06995230524642289,0.8260900029546157,1.0,11/113,3.93%,TRPM3;CACNA1D;SLC8A3;SLC24A3;TRPM6;CACNG7;TRPV1;ANK2;CACNB3;GRIN3A;ITPR1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5214673950532916,1.3251180486475314,0.14619883040935672,0.823045225782849,1.0,4/15,11.59%,CPEB2;PPIF;GSTO2;GSTO1
prerank,tryptophan metabolic process (GO:0006568),0.5714041894841118,1.32493785018665,0.162217659137577,0.8201704648450152,1.0,5/11,19.53%,IDO1;HAAO;KMO;ATP7A;KYAT1
prerank,aorta morphogenesis (GO:0035909),-0.48822295602197163,-1.3239077860594506,0.12704918032786885,0.42083829223649727,1.0,10/17,21.06%,JAG1;ACVRL1;ENG;TBX1;HEY2;TBX2;LRP1;HEY1;DLL4;MYLK
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.43593129200005004,-1.3237064091100605,0.11382113821138211,0.420588384828487,1.0,12/23,24.50%,BMP4;SIX1;MDK;FGF2;PIK3CD;SMO;VEGFA;SIX4;SOX8;EGF;SIRT6;LHX1
prerank,superoxide metabolic process (GO:0006801),-0.43275766485079253,-1.3233133549849345,0.09523809523809523,0.4207259316905859,1.0,8/29,16.67%,SH3PXD2A;NOS3;SH3PXD2B;SOD1;NCF2;MT3;NRROS;PREX1
prerank,cellular amino acid catabolic process (GO:0009063),0.36237400537318726,1.3232775361557407,0.08762886597938144,0.8230685106034049,1.0,18/87,11.66%,DDO;IDO1;ALDH7A1;IVD;SLC25A44;DBT;ACAT1;GLDC;HAAO;ACADSB;ECHS1;BCAT2;ASPA;KMO;GLS2;BCKDHB;GAD1;GCDH
prerank,primary alcohol metabolic process (GO:0034308),0.4638605506937855,1.3230360264560308,0.12595419847328243,0.8205694112023546,1.0,4/25,2.64%,IGF1;ADH7;ADH4;CYP11B1
prerank,lung development (GO:0030324),0.43665473066471794,1.3228597922154361,0.11328125,0.817751980494597,1.0,7/33,6.95%,FGF1;ERRFI1;FGF9;LOXL3;CEBPA;PDPN;FGFR2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5490463598426122,-1.3228296091185023,0.15592515592515593,0.42108077648229203,1.0,4/11,5.85%,LRP5;TGFBR2;TBX1;WNT5A
prerank,regulation of JUN kinase activity (GO:0043506),-0.40744729406861685,-1.3223821388205241,0.1111111111111111,0.4213440119296715,1.0,8/33,11.79%,DAB2IP;MAP3K5;DNAJA1;TNFRSF11A;RPS3;AIDA;EDN1;PDCD4
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5453770410564072,1.3216206581424847,0.16666666666666666,0.8193819927004428,1.0,3/11,7.09%,RENBP;GNPNAT1;GNPDA1
prerank,histone H2B ubiquitination (GO:0033523),0.5823796843464025,1.3212227979036806,0.15918367346938775,0.8174992663919707,1.0,4/10,11.83%,CTR9;LEO1;RNF20;CDC73
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2891532674018504,-1.320818255173368,0.006006006006006006,0.42417629853962624,1.0,61/260,15.14%,NRP1;ABCC4;FGD5;DNM3;RAPGEF2;ABLIM1;VCL;FGD6;NTN1;FXYD5;GSN;PARVB;NOTCH1;PKD1;DISC1;RAP1A;CDH13;EMP1;SPATA13;MTSS1;EXOC6;EXOC4;FAM161A;TNIK;FLNA;IFT140;RAP2A;ITGB1;S1PR1;ABLIM3;ARL13B;RAPGEF6;BBS9;EMP2;ATP6V0D1;PDE6D;MAP4K4;RP2;GOLPH3;CD2AP;WHAMM;PARVA;EHD2;EXOC1;WDR11;TCTN3;PIBF1;SNX10;FNBP1L;EHD4;ATP6V1D;ABLIM2;HDAC6;SHTN1;DYNLL1;AVIL;CYS1;DZIP1L;BBIP1;TMEM216;CFAP43
prerank,mismatch repair (GO:0006298),0.45283484712052635,1.3206885248315299,0.13992537313432835,0.8161143494668155,1.0,10/27,15.25%,RNASEH2A;ERCC1;PMS2;POLD2;MSH4;MSH6;MLH3;MSH3;RPA3;ABL1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.43725473120662783,-1.320667338504419,0.10412147505422993,0.42383275541272813,1.0,15/27,22.98%,VPS13C;RAB6A;TMED10;GBP5;GOLPH3;RIPOR1;VPS13D;VPS13A;ARL5A;SYS1;PAQR3;BICD2;COG7;CSNK1D;GAK
prerank,adenine nucleotide transport (GO:0051503),-0.49061277426555305,-1.319703848657018,0.10191082802547771,0.4253192259104701,1.0,4/17,6.88%,ABCC4;LRRC8D;LRRC8C;LRRC8A
prerank,cellular response to calcium ion (GO:0071277),0.37942626621702985,1.3196743431513727,0.07452339688041594,0.8169557280776396,1.0,16/67,12.06%,SYT11;SYT12;PRKAA2;CPNE1;CAPN3;SYT9;ADCY1;CPNE4;PPIF;SYT1;ADCY8;SYT13;ADGRV1;SYT10;TRPM2;CPNE6
prerank,regulation of acute inflammatory response (GO:0002673),-0.4778575218584294,-1.319602990881878,0.125,0.4248530528042799,1.0,2/18,1.02%,IL6ST;OSMR
prerank,positive regulation of chromatin organization (GO:1905269),-0.5410944822260211,-1.3195074194905003,0.13535353535353536,0.4243073489647505,1.0,4/12,10.66%,H3-3A;MIER1;TAL1;TERF2IP
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.4512289513191744,-1.3190375295679462,0.12987012987012986,0.4246477213697307,1.0,7/21,18.14%,YWHAE;MFHAS1;YWHAB;PPP1R16B;BOD1L1;PPP1R11;MASTL
prerank,tryptophan catabolic process (GO:0006569),0.5760471414810677,1.318761382229476,0.16561844863731656,0.8171216676430823,1.0,3/11,9.06%,IDO1;HAAO;KMO
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3374622758671371,-1.3187288235389067,0.03271028037383177,0.4246274672238161,1.0,24/91,10.04%,ABCG2;SLC39A10;SCARA5;SLC40A1;APP;SLC30A1;SLC39A8;TFRC;SLC30A9;SLC31A1;ATOX1;ATP6V0D1;SOD1;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;CAND1;SLC39A7;FTL
prerank,cGMP metabolic process (GO:0046068),-0.5377696892066283,-1.3184923473955215,0.13414634146341464,0.4244904860117388,1.0,5/12,18.89%,GUCY1B1;PDE9A;PDE2A;GUCY1A1;NPPC
prerank,cellular response to interleukin-6 (GO:0071354),-0.4375986375667255,-1.3180808104076616,0.1391304347826087,0.42475464162443116,1.0,8/26,10.02%,PID1;IL6ST;ST3GAL6;PTGIS;STAT3;IL6R;SRC;JAK1
prerank,prostanoid metabolic process (GO:0006692),0.5357919424758326,1.3178363325420859,0.15918367346938775,0.8174148452923593,1.0,3/13,7.80%,PTGS1;PTGES;PTGR1
prerank,negative regulation of axon extension (GO:0030517),-0.4232288460423268,-1.317805865857982,0.11578947368421053,0.4246813991941429,1.0,13/30,22.00%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;MT3;SEMA5A;RTN4;SEMA6D;SEMA3F;RTN4R;SEMA4C
prerank,embryonic limb morphogenesis (GO:0030326),-0.40323592960233245,-1.3175386835763772,0.09977827050997783,0.4245471269054636,1.0,12/34,12.91%,MBNL1;ECE1;LRP6;TGFB2;TBX3;GLI3;MAP3K20;NIPBL;TWIST1;PTCH1;RARG;TBX2
prerank,melanocyte differentiation (GO:0030318),0.5569823131933592,1.3174944543898301,0.17657992565055763,0.8154224352924674,1.0,3/11,6.63%,LRMDA;KIT;CITED1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.522214080598515,-1.3167641089846167,0.13016528925619836,0.4255144032921811,1.0,5/12,19.05%,LYN;IL34;MAPK1;CSF1R;MAPK3
prerank,focal adhesion assembly (GO:0048041),-0.4504563283061002,-1.3163462951778178,0.10412573673870335,0.4257624618326131,1.0,7/21,10.16%,THSD1;PEAK1;BCR;PTPRK;ACTN1;SRC;WHAMM
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5270511320688638,-1.3163189492177017,0.1497005988023952,0.42511197950919954,1.0,3/12,4.28%,BMP5;SLIT2;CCN3
prerank,amyloid fibril formation (GO:1990000),-0.36657237861824327,-1.3162783906011368,0.08843537414965986,0.42450773145956233,1.0,12/51,8.14%,B2M;GSN;H3-3A;APP;UBC;RPS27A;UBB;CST3;ADAM10;IAPP;TGFBI;MFGE8
prerank,regulation of ion transport (GO:0043269),0.3664168512876031,1.3160122833826104,0.08376963350785341,0.8178153506204701,1.0,16/76,11.44%,SYT11;SYT12;SNX6;KCNJ13;KCNJ5;SYT9;KCNJ10;SYT1;SYT13;CHRNB2;DRD3;PDZK1;KCNJ16;SYT10;CHRM1;DTNBP1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.321522922489324,-1.3151141773110295,0.049479166666666664,0.4264577053265491,1.0,29/114,21.47%,LIMS1;ACTN4;TMSB4X;TRAF5;FOXO3;NFKBIA;TNFRSF1B;CARD14;TNFRSF11A;AIM2;PSMA6;TNFRSF11B;PSMB7;PSMB6;PSMB5;EDA2R;BIRC3;PTK2B;CD40;PSMB8;PSMC4;PSMD11;PSMB4;EDAR;PSMD14;RIPK1;PSMD10;TNFSF8;PSME1
prerank,response to alcohol (GO:0097305),0.4534128275127438,1.3150905104692368,0.1347248576850095,0.8182036805309638,1.0,9/27,15.79%,TGFBR3;ADH7;GRIN3A;GLRA1;CHRNB2;DRD3;TGFBR1;ABCA2;GOT2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5557682472406276,1.3150257888047354,0.1510204081632653,0.8151192255530033,1.0,2/12,0.41%,NOTCH2;DOCK11
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.4885191367261518,-1.3146713296577501,0.13373253493013973,0.4266481737746105,1.0,6/16,16.12%,INSR;IRAK3;MTRF1;HDAC6;TBC1D25;CLEC16A
prerank,proton transmembrane transport (GO:1902600),0.41966835227125887,1.3140854433151825,0.12021857923497267,0.8154712914165934,1.0,2/36,5.32%,ATP1A2;ATP6V1H
prerank,DNA damage checkpoint signaling (GO:0000077),0.44020251762249096,1.3135114250427569,0.12408759124087591,0.8143648826661992,1.0,10/28,17.82%,DOT1L;E2F1;HINFP;CLOCK;FBXO6;PRPF19;CHEK2;ATM;CLSPN;RAD17
prerank,regulation of cell size (GO:0008361),-0.4453119509725997,-1.3132191520687309,0.11088709677419355,0.42927947483920326,1.0,9/23,21.28%,RHOA;VAV2;RPTOR;EDN1;RARG;PRR16;PTEN;AKT1S1;MSN
prerank,response to histamine (GO:0034776),0.5596841013033181,1.3130282834498754,0.16666666666666666,0.8129737395929737,1.0,4/10,18.56%,DRD3;GABRB2;HRH1;GABRB3
prerank,cholesterol metabolic process (GO:0008203),0.37429199383284717,1.312691762180126,0.09532062391681109,0.8110430274712008,1.0,21/68,18.61%,CEL;ACAT2;SOAT2;CYP11B1;INSIG2;DHCR24;APOF;SOAT1;CLN8;OSBPL5;CYP27A1;RXRA;FDX1;SQLE;CYP51A1;TSKU;GBA2;MSMO1;GGPS1;ABCA5;HMGCR
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5585650497108985,-1.3117931161914744,0.15336134453781514,0.43184163921159513,1.0,6/10,22.57%,ACTN4;RARB;TBX1;RARG;SNW1;RXRG
prerank,aspartate family amino acid metabolic process (GO:0009066),0.485576828353423,1.311722621139619,0.166,0.8117002413482399,1.0,10/18,22.48%,ASPG;ADI1;ASPA;SLC25A12;GOT1;MTHFD1;MTHFR;GOT2;SLC25A13;MSRA
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3330243779111687,-1.3116979014759307,0.054373522458628844,0.4313291285841195,1.0,25/86,14.01%,ARHGEF28;PLCE1;DAB2IP;TGFB2;NOTCH1;STARD8;NGF;BCR;KANK1;STARD13;ARHGEF2;EPS8;ARHGDIB;LYN;SHOC2;SPRY2;EPS8L2;EPHB2;LRRC59;SQSTM1;GABARAP;ARHGDIA;DENND4B;SPRY1;MADD
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.39888849028738815,-1.3110139799876193,0.11914893617021277,0.4321504374351514,1.0,12/39,9.74%,MAML2;IL6ST;JAG1;NOS3;TGFB2;NOTCH1;STAT3;CCN3;JAG2;EPN2;SRC;NOTCH4
prerank,macrophage differentiation (GO:0030225),-0.5190748165154357,-1.310192572433328,0.15157894736842106,0.4332491526763243,1.0,7/13,28.72%,BMP4;IL15;VEGFA;CSF1R;CDC42;CASP8;PARP1
prerank,negative chemotaxis (GO:0050919),-0.40262023193200697,-1.3094285201028775,0.11546840958605664,0.4343090574442984,1.0,6/33,1.72%,SEMA6A;SEMA3C;SLIT2;RHOA;NTN1;SEMA7A
prerank,vasodilation (GO:0042311),-0.5147474218468474,-1.3093402765144309,0.16334661354581673,0.4338227492010078,1.0,4/13,17.68%,NOS3;SOD1;KLF2;GPER1
prerank,homeostasis of number of cells (GO:0048872),-0.5235374500196415,-1.3089518686620307,0.13827655310621242,0.4339326482170232,1.0,3/12,4.28%,NOS3;NOTCH1;CCN3
prerank,glucose import (GO:0046323),-0.5196587891813316,-1.3087371373262042,0.16598360655737704,0.4337907115996898,1.0,4/13,13.54%,SLC2A1;SLC2A3;SORT1;ZDHHC7
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5533423566508158,-1.3078641876039108,0.15289256198347106,0.4351268378929345,1.0,4/10,11.47%,ACER2;CYP1B1;SERPINE1;JAM3
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.47528967239697895,-1.3077000292614285,0.12761506276150628,0.43474098071799216,1.0,8/17,22.00%,TGFB2;MID1;LYN;TAOK3;KLHDC10;NOD2;TAOK1;SEMA4C
prerank,peptidyl-lysine methylation (GO:0018022),0.4482016323306243,1.3076069007191606,0.1316270566727605,0.8246010243531052,1.0,8/26,13.15%,KMT5A;EEF2KMT;ANTKMT;N6AMT1;SETD4;SETD7;SMYD3;SMYD2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5443593035959853,-1.3071259228301164,0.16089613034623218,0.4352650868047951,1.0,5/10,30.42%,TGFBR2;CD55;NCKAP1L;SOCS1;LGALS9
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.46113585176358485,-1.3069721925568043,0.12527964205816555,0.43492121366614545,1.0,9/21,26.39%,MYH9;ADAM10;ADAM19;SPPL3;HM13;PSEN2;PSENEN;ERAP1;PRTN3
prerank,liver development (GO:0001889),0.4263843690902736,1.3068820377117227,0.13636363636363635,0.8241689933661441,1.0,5/32,9.22%,TGFBR3;WNT4;CEBPA;PHF2;E2F8
prerank,regulation of T cell proliferation (GO:0042129),-0.35736310862721155,-1.3064401586730978,0.08571428571428572,0.4354167548418565,1.0,17/61,22.73%,IL6ST;VCAM1;TNFRSF1B;TFRC;ANXA1;NCK1;SLC7A1;TNFRSF21;IL15;PTPRC;CD86;NCKAP1L;CD46;JAK3;TNFSF8;GLMN;CD276
prerank,negative regulation of cell development (GO:0010721),0.4634298422038602,1.3062985799882711,0.1378026070763501,0.823210595528837,1.0,5/25,5.27%,IGF1;APPL2;RFLNA;WNT7A;PAX6
prerank,regulation of actin filament polymerization (GO:0030833),-0.3484338521435774,-1.305882778958121,0.06521739130434782,0.43593927631747437,1.0,25/69,26.41%,SLIT2;ESAM;KANK1;SSH2;KANK3;CDC42EP5;CDC42EP3;KANK4;PRKCD;NCK1;CDC42EP2;HIP1R;PLEKHG2;PTK2B;PFN1;NCKAP1L;LATS1;FCHSD1;HCK;RASA1;HCLS1;SSH1;PRKCE;CARMIL1;TWF2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.4254153821921375,-1.3058518509719477,0.12366737739872068,0.4353024985301439,1.0,10/26,12.95%,RNF111;UBC;RPS27A;XPC;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.30177140183545337,-1.305214830892077,0.01818181818181818,0.43613891453637177,1.0,44/161,18.06%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;STK3;LIMD1;SDHAF2;SFRP4;TBX18;GLI3;TLE4;NKD2;SOX17;IGFBP6;WNT5A;AXIN2;PSMA6;TLE3;CSNK1A1;ZNRF3;PSMB7;MDK;INVS;APC;APOE;PSMB6;AMER1;PSMB5;TLE5;FZD4;DKK2;BMP2;ANKRD6;PSMB8;RBMS3;AMER2;PSMC4;MAD2L2;PSMD11;IGFBP4;LATS1;PSMB4;PSMD14
prerank,oogenesis (GO:0048477),-0.4992045673048256,-1.3034274642025745,0.15863453815261044,0.4394876602031451,1.0,12/15,46.82%,PTN;MDK;METTL3;PIWIL2;NANOS3;TRIP13;NANOS1;IHO1;MARF1;NANOS2;FMN2;HORMAD1
prerank,mitochondrial fission (GO:0000266),-0.48606975965967836,-1.302828426424233,0.14038876889848811,0.4402173319797841,1.0,9/16,33.24%,DNM3;MFF;MTFR2;GDAP1;MIEF1;MUL1;DNM1;DNM2;MTFR1L
prerank,protein localization to lysosome (GO:0061462),-0.41350286383798096,-1.302404123197399,0.13695652173913042,0.44046879062971017,1.0,11/28,20.84%,SH3BP4;SCARB2;LMBRD1;ZFYVE16;KPTN;MFSD1;HGS;RTN4;RNF128;NEDD4;GGA3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.40015006434967454,-1.3024039571825536,0.10845986984815618,0.4397651663635286,1.0,10/33,24.80%,LEF1;RUNX1;IL34;CD74;ID2;RIPK1;TESC;HCLS1;FES;CASP8
prerank,regulation of mast cell activation (GO:0033003),-0.5482302855865997,-1.3023959642250373,0.16796875,0.43908397205432903,1.0,7/10,33.12%,PLSCR1;LYN;NECTIN2;MILR1;CD300LF;TSLP;CD84
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5341939385729404,-1.3023682234991685,0.16666666666666666,0.4377482026733713,1.0,5/12,13.34%,ACTN4;CORO1C;KANK1;EFNA5;AP1AR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5341939385729404,-1.3023682234991685,0.16666666666666666,0.4377482026733713,1.0,5/12,13.34%,ACTN4;CORO1C;KANK1;EFNA5;AP1AR
prerank,protein K63-linked ubiquitination (GO:0070534),0.4036055371338997,1.3023679891701705,0.13454545454545455,0.8352753969970135,1.0,7/41,11.03%,RNF152;UBE2E2;RNF126;TRIM5;PELI3;RNF135;PRPF19
prerank,positive regulation of JNK cascade (GO:0046330),-0.34367356089528633,-1.3022056312939696,0.06937799043062201,0.4374551526531092,1.0,21/70,20.49%,DAB2IP;SH3RF3;TRAF5;MAP3K5;RASSF2;APP;MFHAS1;FLT4;EDA2R;PTK2B;TNFRSF19;ANKRD6;MTURN;TAOK3;EDAR;NOD2;TAOK1;SH3RF1;RIPK1;HMGB1;TRAF4
prerank,inorganic anion transport (GO:0015698),0.38872372895248886,1.3016811314115098,0.10469314079422383,0.8346636440521662,1.0,11/53,9.87%,SLC13A4;SLC5A5;ENPP3;SLC26A1;GLRA1;CLCN6;SLC25A11;CLCN2;NMUR1;SLC34A3;CLCN4
prerank,receptor-mediated endocytosis (GO:0006898),-0.30633386149096087,-1.3015667987146304,0.04433497536945813,0.43825215820042496,1.0,33/132,14.61%,CAV1;CALCRL;SPARC;DNM3;LRP6;SCARB1;INSR;RAMP2;CD9;SCARF1;AP2B1;RAB31;SCARB2;FCHO2;ITGB1;TFRC;SGIP1;LMBRD1;CLTB;SNX1;CUBN;APOE;GPR107;CAV2;ACKR3;ADM;VLDLR;FNBP1L;HIP1R;STAB1;LRP1;AP2A1;ARHGAP27
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.41695404400813607,-1.3012986804252535,0.12761506276150628,0.4382476103340355,1.0,12/26,24.80%,ALPK1;UBC;NOD1;RPS27A;UBB;IFIH1;IRAK2;TAB1;NOD2;RIPK2;CYLD;CASP8
prerank,protein tetramerization (GO:0051262),0.37023203829063045,1.30080983740926,0.10570469798657718,0.8348072300298546,1.0,18/67,19.12%,ALDH1A2;UPB1;APPL2;TRPV1;CPSF6;KCNC3;CPSF7;GOLGA2;SSBP1;CUTC;TRPM2;ACACA;CTH;FARSA;OXA1L;ALDH9A1;ACOT13;USP16
prerank,response to muramyl dipeptide (GO:0032495),-0.5325674772296367,-1.3007125980143828,0.14979757085020243,0.4389008863233047,1.0,6/12,21.51%,NOD1;ARHGEF2;NOD2;ERBIN;IRF5;RIPK2
prerank,gluconeogenesis (GO:0006094),0.4171037177476564,1.300698637969387,0.12834224598930483,0.8319622725548019,1.0,17/39,21.46%,ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;G6PC3;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;SLC25A13
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.466948508285918,-1.3004655890699668,0.12981744421906694,0.4387476057949969,1.0,10/18,29.68%,AGTR1;RFK;EDN1;EDN3;POR;NOD2;FXN;PDP1;AGT;PARK7
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5146871845401296,1.3000637909314108,0.15247524752475247,0.8311903828566476,1.0,8/15,22.55%,FANCD2;EME2;MDC1;MRE11;CHEK2;RAD17;RAD9B;ATF2
prerank,sphingolipid metabolic process (GO:0006665),-0.32320530078323817,-1.2997874722938234,0.05426356589147287,0.4396272460350658,1.0,38/108,22.64%,SGMS1;ST6GALNAC3;ESYT2;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;AGK;PRKD3;PRKD1;SPNS2;ELOVL5;CERS5;CERS6;ORMDL3;PLPP1;SAMD8;ESYT3;HEXA;ELOVL6;PSAP;UGCG;ARSA;ELOVL1;PLPP3;VAPB;ELOVL4;SGPP1;SPTSSA;ASAH2;PPM1L;ACER3;ARV1;PPP2CA;GLTP;CERS4;PLPP2
prerank,steroid hormone biosynthetic process (GO:0120178),0.43864272239783747,1.2993735068860008,0.14495412844036698,0.8306936833628005,1.0,9/29,23.22%,HSD17B2;CYP11B1;MED1;FDX1;STAR;FDX2;HSD17B11;FDXR;TSPOAP1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5322351305395498,-1.2993609662625438,0.16565656565656567,0.43986135343758426,1.0,4/12,4.62%,GSN;LY6E;MID2;IFITM3
prerank,regulation of viral entry into host cell (GO:0046596),-0.4186112728987962,-1.2991037340461822,0.13507109004739337,0.43973112938630177,1.0,8/30,12.21%,GSN;LY6E;MID2;IFITM3;TRIM14;TRIM25;CD74;NECTIN2
prerank,negative regulation of chemotaxis (GO:0050922),-0.41100204570169535,-1.2989224589991553,0.13972055888223553,0.43947435346563374,1.0,13/31,16.65%,SEMA6A;SEMA3C;SLIT2;SEMA7A;THBS1;NOTCH1;ANGPT2;SEMA5B;DUSP3;SEMA3E;SEMA3G;SEMA5A;SEMA6D
prerank,negative regulation of protein transport (GO:0051224),0.45249633166926856,1.2989039190912095,0.14671814671814673,0.8293218270427403,1.0,10/25,18.74%,NDFIP1;PKDCC;SERGEF;DRD3;CYP51A1;SNX3;NDFIP2;IL12A;HMGCR;RHBDF1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.4032255493446499,-1.2983914259265938,0.12446351931330472,0.439941317389917,1.0,17/32,26.64%,CDK17;CDK14;BRD4;KLF11;CDK5;FBXO5;ORC1;DHFR;ID2;CDK16;CDC45;POLA1;CDK18;E2F7;TYMS;NPAT;TFDP1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.4519343145913619,-1.2981761087308945,0.11300639658848614,0.43974631959545757,1.0,9/21,19.95%,PDE4D;CAV1;RASSF2;RACK1;NCK1;PAQR3;DDIT4;PTEN;DMD
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.45699848315882063,-1.2979535311316377,0.14166666666666666,0.4395479812841335,1.0,6/19,13.74%,SLC26A2;BPNT2;PAPSS2;SLC35B3;TPST2;ENPP1
prerank,intracellular lipid transport (GO:0032365),0.4718313603815286,1.2974669392784366,0.14555765595463138,0.8317894691207127,1.0,2/21,1.77%,PRKAG2;PRKAA2
prerank,negative regulation of growth (GO:0045926),-0.31153515725916964,-1.2970819553328958,0.04336734693877551,0.440876117998616,1.0,35/121,17.55%,APBB2;BMPR2;SLIT2;ACVRL1;TGFB2;NOTCH1;DCUN1D3;SH3BP4;BTG1;PTPRJ;FHL1;CCN3;SOX17;CCDC85B;RACK1;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;CDKN2AIP;NME6;SIPA1;RERG;ENPP1;ADAM15;MT3;RTN4;CDA;ING4;FGFR3;OSGIN1
prerank,chloride transport (GO:0006821),-0.33242822613102385,-1.2967084415482075,0.07142857142857142,0.4409994449500357,1.0,20/74,16.14%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;CLIC4;ANO1;CLIC5;SLC1A3;SLC12A6;LRRC8A;CLIC1;GABRA3;GLRB;SLC1A1;SLC26A6;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5571163516791873,-1.296484746728229,0.16270566727605118,0.44080401526678387,1.0,4/10,16.86%,ETFBKMT;HDAC6;MT3;AOC3
prerank,positive regulation of cartilage development (GO:0061036),-0.469140497087663,-1.2964606131180116,0.1437246963562753,0.44018142708332497,1.0,5/17,7.43%,BMPR2;ZBTB16;ACVRL1;BMP4;MDK
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4792186092268663,1.2961492886022188,0.1708253358925144,0.8337030207915314,1.0,7/20,19.10%,EPAS1;HSPA1A;TGFBR1;HSPA1B;DNAJB2;HSP90AA1;WASHC1
prerank,steroid biosynthetic process (GO:0006694),0.38435971029400434,1.2960909465494244,0.11359724612736662,0.8307772081811482,1.0,18/56,21.56%,PRKAG2;CYP11B1;INSIG2;PRLR;SC5D;DHRS11;CYP27A1;AMACR;OSBPL9;SQLE;CYP51A1;STAR;MSMO1;HMGCR;HSD17B4;LBR;FDXR;HSD11B1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.544819758886874,-1.2959557584410442,0.16317991631799164,0.4407068895877123,1.0,3/10,20.69%,CAV1;KCNE4;KCNAB1
prerank,keratinocyte differentiation (GO:0030216),-0.4216003305156438,-1.2959433380999594,0.15498938428874734,0.4400570337076582,1.0,8/29,12.12%,JAG1;CLIC4;BCR;WNT5A;ANXA1;TXNIP;SCEL;UGCG
prerank,lymphocyte migration (GO:0072676),-0.4028562721263121,-1.2955182634687945,0.14135021097046413,0.44043262788828275,1.0,22/32,48.38%,S1PR1;CCL13;RET;CCL25;MSN;MYO1G;CCL5;CCL11;ZAP70;CCL4;GATA3;CRTAM;CCL7;CCL8;CCL19;CCL14;MSMP;CCR6;CCL1;CCL3;TBX21;XCL1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.510914327948966,1.2951645633425826,0.1527777777777778,0.8311894237801369,1.0,4/14,11.30%,UPB1;DPYD;NT5C3A;UPP2
prerank,neuromuscular process controlling balance (GO:0050885),0.5336638770751436,1.2950675389744304,0.17479674796747968,0.8285028450008254,1.0,3/12,7.70%,USH1C;PCDH15;SHANK1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.39009540252588687,-1.2950181503653333,0.12582781456953643,0.44092602245729073,1.0,5/36,2.53%,DOCK1;RHOBTB1;GSN;THBS1;MYH9
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.4786187528000968,-1.294978743194704,0.15195071868583163,0.44036255530508406,1.0,12/16,47.19%,TNFRSF21;JAK3;TRIB2;FCGR2B;DLL1;VSIR;TYROBP;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5259692961172124,-1.2946249655925066,0.158,0.4403529542572924,1.0,4/13,14.32%,TMEM30A;SEC16B;INSIG1;SAR1A
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.4145558887175645,-1.2937007232486664,0.13071895424836602,0.4419196010057021,1.0,8/28,19.85%,DAB2IP;NGF;CRADD;CASP8AP2;SORT1;GABARAP;DIABLO;SPI1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.4213156033762276,-1.2936830803201829,0.13432835820895522,0.4412738590978721,1.0,15/27,34.79%,IRAK3;UBC;RPS27A;UBB;IRAK2;TAB1;BTK;MYD88;TLR4;CD36;TLR6;TLR1;CD14;IRAK4;TLR2
prerank,reverse cholesterol transport (GO:0043691),-0.5036222808480041,-1.2933319113235182,0.18,0.4413383822150386,1.0,3/13,9.64%,SCARB1;ABCA1;APOE
prerank,skeletal system development (GO:0001501),-0.30282594069905217,-1.293176135342064,0.041884816753926704,0.44101239082374466,1.0,35/148,12.38%,CDH11;BMP5;TLL1;ZBTB16;TRPS1;EXT1;PCSK5;TGFB2;TBX3;SLC10A7;PKD1;TEAD4;PLS3;BPNT2;CD44;ALPL;RPS6KA3;KIAA1217;PAPSS2;FBN1;WNT5A;SH3PXD2B;HHIP;RPL13;TNFRSF11B;MYOC;TGM2;VCAN;EIF2AK3;IGF2;XYLT1;ETS2;COL1A1;COMP;BMP2
prerank,heterochromatin organization (GO:0070828),-0.4949179157643681,-1.2930302780144842,0.15885947046843177,0.4406623121579668,1.0,3/14,6.30%,MECOM;PRDM16;EZH1
prerank,neuromuscular junction development (GO:0007528),0.45989953440927284,1.2925652016431237,0.15145985401459855,0.8353156609351672,1.0,6/24,8.27%,UNC13C;CACNB1;CACNB3;PDZRN3;LRRK2;LRP4
prerank,regulation of vasculature development (GO:1901342),-0.4161928959899189,-1.2924777301882677,0.15350877192982457,0.4412225518263062,1.0,14/26,35.46%,ETS1;BMPER;ADGRA2;EMP2;FGF2;TSPAN12;SP100;PLXND1;HMOX1;GPNMB;VASH2;CTNNB1;PROK2;HTATIP2
prerank,negative regulation of apoptotic process (GO:0043066),-0.26533933009516397,-1.2922533576966635,0.0034602076124567475,0.44109249171611603,1.0,150/444,24.15%,LEF1;ARHGAP10;PRKCH;TEK;MEF2C;CAV1;IL6ST;TJP1;PTMA;MERTK;YWHAE;FOXO1;TBX3;NDNF;THBS1;NOTCH1;GAS6;PIK3R1;EGFR;ITGA5;BCL2L1;NGF;NFKBIA;SOCS2;CD44;BMP4;SIX1;KDR;UBC;RPS6KA3;RPL10;CARD14;NAA16;DNAJA1;TBX1;FAS;FLNA;CARD16;ITGB1;TFRC;RNF144B;RPS27A;UBB;PAK2;WNT5A;ADAM10;ANXA1;PRKCD;TPT1;PLK2;MAPK1;MDK;SPRY2;CD38;PRKCG;FOXQ1;PIK3CA;SRC;XIAP;SOD1;FLT4;VHL;MAP4K4;CAT;TGFB3;APOE;GPX1;KLF4;GCLC;GOLPH3;YWHAZ;BABAM2;CFL1;MALT1;TNFAIP8;HSPB1;SQSTM1;UNC5B;GRK5;PTPRZ1;CD74;PHB2;SERPINB9;COMP;BIRC3;PTK2B;USP47;TCIM;CSNK2A1;AKT2;NME2;ARHGDIA;VEGFA;HIGD2A;NR4A2;MT3;CBL;RHBDD1;PLAUR;NR1H4;PA2G4;BAG1;NCKAP1L;STIL;SIX4;RNF157;HDAC2;BARD1;PSEN2;GREM1;MAPK3;ZC3H12A;SH3RF1;MCL1;CRLF1;LIG4;ASAH2;SOX8;RIPK1;HCK;PSMD10;HYPK;AGAP2;MYD88;SET;POU3F3;BEX3;CCND2;RIPK2;BCL3;UBE2Z;FXN;RASA1;DDAH2;DLL1;KDM2B;SMAD6;NFATC4;HCLS1;IGF1R;TAF9;TAX1BP1;PTRH2;NUP62;EGR3;FANK1;NAA15;AATF;TMBIM6;TRIAP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.33553609844482574,-1.2916732049117816,0.07819905213270142,0.4417809748073296,1.0,37/80,26.85%,TNFSF10;MAP3K5;YWHAE;THBS1;GAS6;NGF;CD44;RPS6KA3;NOD1;CARD16;BCAP31;CTSD;SRC;XIAP;GPX1;KLF4;MALT1;SOX7;USP47;CSNK2A1;VEGFA;ACVR1C;MT3;GPER1;SH3RF1;FOXL2;HMGB1;BEX3;SYK;CASP1;BCL10;TRIAP1;DAPK1;EPHA7;F2R;ARL6IP1;RPS6KA1
prerank,protein catabolic process (GO:0030163),0.3744197317564567,1.2913356732631736,0.09908256880733946,0.8372060982419365,1.0,18/59,15.07%,MAGEA2;SIAH2;CAPN3;RNF41;SOCS6;HTRA2;CTRL;CLN8;FBXO6;LAMP2;PRPF19;CHEK2;FBXO17;BAG6;CLN5;RNF5;UCHL3;ADAMTS9
prerank,sensory perception of taste (GO:0050909),0.562819875648761,1.290720295556695,0.17634854771784234,0.836507066341095,1.0,1/10,0.51%,TAS1R2
prerank,anterograde axonal transport (GO:0008089),0.41326891763750084,1.2905318935880872,0.140597539543058,0.834157496798712,1.0,16/37,23.72%,TRAK1;KIF5C;RAB21;AP3S2;SNAPIN;KIF3A;DTNBP1;AP3B2;NEFL;KIF1B;KIF3B;KIF1A;AP3S1;MAP1A;DLG2;SPAST
prerank,presynapse organization (GO:0099172),0.5635921070573789,1.2904574543108163,0.17330677290836655,0.8313462952255163,1.0,3/10,7.03%,NLGN2;WNT7A;NLGN3
prerank,modulation of chemical synaptic transmission (GO:0050804),0.34696070773930543,1.2899813291472242,0.09317803660565724,0.8300622111774312,1.0,22/107,12.83%,ATP1A2;SLC8A3;CEL;SNCAIP;NLGN2;NPTX1;GRID2;IQSEC2;SYT1;NLGN3;GRIK5;GRIK2;RIMS1;LRRK2;CHRNB2;DLG4;DGKI;LRRC4C;NPTXR;SYN3;BDNF;CPLX1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3907169900678097,1.2898400456653287,0.11754385964912281,0.8275203792656098,1.0,10/45,10.07%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;BMP8A;INHA;GDF9;TGFBR1
prerank,blood circulation (GO:0008015),-0.3682692410588402,-1.2897228473791387,0.09195402298850575,0.44592485205512034,1.0,17/49,13.59%,ELN;NOS3;ACVRL1;MEOX2;GUCY1B1;TBC1D8;SGCD;AGTR1;CXCL12;SOD1;GPX1;GCLC;EDN3;ACE2;GCLM;GUCY1A1;CYB5R3
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.5215521239733506,-1.2893875439387288,0.156,0.44597399667217247,1.0,4/11,14.73%,TIPIN;FBXO5;BLM;TIMELESS
prerank,acidic amino acid transport (GO:0015800),0.49763826409411027,1.289365228173397,0.18395303326810175,0.8262881751398365,1.0,2/17,0.21%,SLC6A13;SLC6A1
prerank,magnesium ion transport (GO:0015693),0.5320975264371983,1.2892113911280834,0.18426103646833014,0.8239059965119665,1.0,5/12,19.10%,SLC41A1;TUSC3;MAGT1;MMGT1;MRS2
prerank,positive regulation of glucose import (GO:0046326),0.4616083921595452,1.2887870316218901,0.14048059149722736,0.8225861336169793,1.0,6/21,9.68%,OSBPL8;IGF1;PRKCI;SORBS1;RHOQ;CREBL2
prerank,myelination (GO:0042552),-0.36688005670092255,-1.2881187744967766,0.09375,0.44820439427516556,1.0,20/46,24.61%,ADGRG6;PARD3;CMTM8;LGI4;TNFRSF21;MYOC;EIF2B2;ABCD2;B4GALT5;GPC1;ARHGEF10;PMP22;NFASC;ACER3;MYRF;SKI;MPZ;PLLP;MARVELD1;CXCR4
prerank,regulation of JNK cascade (GO:0046328),-0.32299195130010666,-1.287959831702599,0.07213930348258707,0.4478872520341981,1.0,29/101,20.49%,MECOM;DAB2IP;SH3RF3;TRAF5;MAP3K5;RASSF2;EGFR;APP;MFHAS1;RAP2A;FLT4;MAP4K4;AIDA;DUSP3;PER1;EDA2R;PHLPP1;PTK2B;TNFRSF19;ANKRD6;MTURN;TAOK3;EDAR;NOD2;TAOK1;SH3RF1;RIPK1;HMGB1;TRAF4
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3301307571750919,-1.2875707604655364,0.07300884955752213,0.44743473055632765,1.0,33/78,27.25%,AP2B1;DYNC1I2;SEC24D;CTSD;SEC23A;CAPZA2;DYNC1I1;SEC31A;KIF23;CD74;DCTN3;SH3GL2;DYNLL1;SEC24B;AP2A1;DCTN5;CTSF;DCTN6;SEC13;CTSS;DYNC1H1;CAPZA1;AP1S2;LAG3;DCTN1;SEC24A;FCGR2B;AP2M1;KIF22;KIFAP3;KIF4A;ACTR1A;CTSE
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3301307571750919,-1.2875707604655364,0.07300884955752213,0.44743473055632765,1.0,33/78,27.25%,AP2B1;DYNC1I2;SEC24D;CTSD;SEC23A;CAPZA2;DYNC1I1;SEC31A;KIF23;CD74;DCTN3;SH3GL2;DYNLL1;SEC24B;AP2A1;DCTN5;CTSF;DCTN6;SEC13;CTSS;DYNC1H1;CAPZA1;AP1S2;LAG3;DCTN1;SEC24A;FCGR2B;AP2M1;KIF22;KIFAP3;KIF4A;ACTR1A;CTSE
prerank,anterograde trans-synaptic signaling (GO:0098916),0.31021501297955345,1.2871224647213433,0.0514018691588785,0.826206493981611,1.0,50/224,17.62%,SLC6A1;UNC13C;DTNA;CEL;APBA3;CACNB1;CACNB3;NOVA1;NLGN2;PCDHB11;GABRG1;NPTX1;GLRA1;CHRM2;CAMK1;DLG1;SYT1;SYN2;HTR7;NLGN3;HRH2;GRIK2;KCND2;CHRNB2;SNAP25;DLG4;SLC12A5;SYT10;HTR1F;GABBR2;BSN;CHRM1;GAD1;PCDHB3;CPNE6;CPLX1;SPG11;GABRG3;GABRB2;RIT2;SYN1;AMPH;GRIA2;SCN2B;HTR1A;KCNQ3;HRH1;PENK;PTCHD1;MINK1
prerank,response to cytokine (GO:0034097),-0.3017320377478494,-1.2869265524956344,0.04177545691906005,0.4481691660249528,1.0,56/141,25.19%,LEF1;PID1;IL6ST;IL1R1;OSMR;LIFR;RHOA;PTPN12;BCL2L1;STAT3;PLSCR1;IRAK3;APP;REL;IFITM3;TNFRSF11A;GCH1;ADAM10;TRIM56;IL6R;ANXA1;RELB;XAF1;NFAT5;SRC;MAPKAPK2;IL1RL2;TLE5;ISG15;CD74;CD40;IRAK2;CSF1R;SP100;IFITM1;LDLRAP1;SIGIRR;PTPN6;MCL1;ASAH2;KYNU;RIPK1;JAK3;GGT7;MYD88;MAP2K7;IFITM2;CASP1;GGT1;MAP4K3;HCLS1;TAF9;CXCR4;CASP8;SHMT2;PTPN11
prerank,monoacylglycerol metabolic process (GO:0046462),-0.5091285233609724,-1.2866916898487157,0.1721311475409836,0.44801716362487704,1.0,5/13,23.99%,PLA2G4A;MGLL;ABHD6;AWAT2;MOGAT3
prerank,regulation of amyloid-beta formation (GO:1902003),0.42241577856404533,1.285765187058671,0.14678899082568808,0.8284277314040807,1.0,9/34,13.27%,IGF1;ROCK2;PICALM;RTN1;CASP3;NTRK2;CLU;EPHA4;ABCA2
prerank,positive regulation of cell differentiation (GO:0045597),-0.28183213550771585,-1.2853481016870034,0.014492753623188406,0.4503779366123643,1.0,46/237,9.46%,LEF1;PRKCH;SLC6A6;KITLG;MEF2C;GCNT2;RAPGEF2;BMPR2;IL6ST;ZBTB16;PTN;ZEB1;RHOA;ACVR1;ACVRL1;TGFB2;PPARD;BOC;LRP5;RAP1A;RUNX2;CD34;NGF;ZHX3;BTG1;BMP4;TGFBR2;KDR;RPS6KA3;CTNNA1;ARHGEF2;TMEM100;PRKD1;AGTR1;AXIN2;IL6R;AR;LRRC8A;CCN1;MDK;HEYL;CEACAM1;TMEM119;TIAM1;VHL;TGFB3
prerank,regulation of T cell cytokine production (GO:0002724),-0.4956404298136292,-1.2848628058968874,0.17078189300411523,0.4508152294348882,1.0,4/15,10.53%,B2M;TNFRSF1B;CD55;MALT1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4210921257221102,1.284226532186599,0.13382899628252787,0.8317445500257737,1.0,10/33,14.03%,CEL;NLGN2;GRID2;IQSEC2;NLGN3;GRIK5;GRIK2;LRRC4C;BDNF;PSMC5
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3905409442893821,1.2840622566220294,0.12387791741472172,0.8294355569263802,1.0,11/45,13.63%,BMP7;SMAD3;ZWINT;ANGEL2;FZD3;TOM1L2;TRIM35;MAD2L1;GAS1;PRCC;FOXC1
prerank,chemical synaptic transmission (GO:0007268),0.3023699585505887,1.2834507037009348,0.04122137404580153,0.82882763481013,1.0,60/284,17.26%,SLC6A1;UNC13C;DTNA;CEL;APBA3;NQO1;CACNB1;CACNB3;NOVA1;NLGN2;PCDHB11;NAPB;GABRG1;NPTX1;GLRA1;CHRM2;CAMK1;GRID2;DLG1;GRIN2D;SYT1;SYN2;SNAPIN;HTR7;NLGN3;HRH2;GRIK5;GRIK2;KCND2;NAPA;RIMS1;CHRNB2;SNAP25;DLG4;SLC12A5;SYT10;HTR1F;GABBR2;BSN;CHRM1;GAD1;PCDHB3;CPNE6;SYN3;CPLX1;SPG11;GABRG3;GABRB2;RIT2;NAAA;SYN1;AMPH;GRIA2;SCN2B;HTR1A;KCNQ3;HRH1;PENK;KIF1B;PTCHD1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4336105333290592,1.2833903711656198,0.15430861723446893,0.8231317359346649,1.0,8/29,19.11%,ACSM2A;ACSM2B;ACAT1;GLYAT;CROT;ACOT1;ACOT6;ACOT13
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4336105333290592,1.2833903711656198,0.15430861723446893,0.8231317359346649,1.0,8/29,19.11%,ACSM2A;ACSM2B;ACAT1;GLYAT;CROT;ACOT1;ACOT6;ACOT13
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.4347921130895972,-1.283186250546685,0.14285714285714285,0.45394871625786015,1.0,11/22,36.31%,PSMA6;PSMB7;PSMB6;PSMB5;PSMB8;PSMB4;PSMB3;PSMB9;PSMA5;ENC1;PSMA3
prerank,histone monoubiquitination (GO:0010390),0.45584178804750775,1.2825506418878005,0.17077798861480076,0.8232395254607594,1.0,6/24,12.26%,DDB2;CTR9;LEO1;RNF20;CDC73;RING1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.45488862783244,-1.282231952802155,0.1375968992248062,0.45548657758946054,1.0,6/18,12.40%,VCAM1;SLC39A8;ITGB1;GOLPH3;GCNT1;ITGA4
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.4811755879640912,-1.282088969280019,0.15010141987829614,0.45511387824606214,1.0,7/15,15.55%,RPL5;RPS7;RPL23;BAG5;FBXO5;LIMK1;MAD2L2
prerank,negative regulation of viral release from host cell (GO:1902187),0.5151523429343973,1.282085974014897,0.18234165067178504,0.8222094170902282,1.0,9/13,28.72%,TRIM5;TRIM35;PML;TRIM13;TRIM32;CHMP3;TRIM28;TRIM8;TRIM11
prerank,regulation of establishment of planar polarity (GO:0090175),-0.32493918952686,-1.2820155309024044,0.09113924050632911,0.454578675616745,1.0,29/88,23.25%,RHOA;FZD6;PRICKLE2;SMURF1;AP2B1;WNT5A;PSMA6;PSMB7;TIAM1;PSMB6;PSMB5;FZD4;DAAM1;ROR2;PFN1;FZD1;AP2A1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;CELSR2;ARRB2;CDC42;PSMD10;PSME1;AP2M1;PSMB3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.4366230340669141,-1.2817645419213624,0.16149068322981366,0.4544619314904796,1.0,4/22,2.86%,NTRK3;RAPGEF2;RAP1A;NGF
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.518943064146428,-1.2812294326152895,0.18235294117647058,0.45496428740362327,1.0,4/12,10.72%,CSGALNACT1;FUT8;PARG;GFPT2
prerank,Notch signaling pathway (GO:0007219),-0.3524589969135061,-1.281047570748045,0.09263657957244656,0.45470128361375045,1.0,24/59,22.60%,SORBS2;MAML2;PBX1;JAG1;NOTCH3;NOTCH1;JAG2;HES1;ADAM10;MDK;HEYL;HEY2;NOTCH4;BMP2;HEY1;PSEN2;PSENEN;DLL4;PLXND1;MAML3;DTX3L;SNW1;SUSD5;DLL1
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.35289936753281953,-1.2805764026145334,0.10262008733624454,0.4551644124472186,1.0,17/55,15.32%,GPC6;DCN;GNS;CD44;CSPG4;LUM;VCAN;FGF2;SDC3;HEXA;CEMIP;BGN;NAGLU;AGRN;GPC1;CEMIP2;SGSH
prerank,iron ion transmembrane transport (GO:0034755),-0.5438573080862691,-1.280357440564759,0.174573055028463,0.45498402481415406,1.0,3/10,4.90%,SCARA5;SLC40A1;SLC39A8
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.46986326357084673,-1.280064440569616,0.1710794297352342,0.4550241165953928,1.0,5/17,8.78%,SLIT2;TMEM204;SFRP4;CASK;XIAP
prerank,regulation of inflammatory response (GO:0050727),-0.29091055630555723,-1.2799848117018082,0.03888888888888889,0.45452247379225064,1.0,38/190,12.75%,FOXP1;TEK;IL1R1;TMSB4X;CD200;SEMA7A;ETS1;PPARD;PTGIS;NFKBIA;ABCC1;APP;TNFRSF1B;MFHAS1;PTGS2;CCN3;BRD4;MGLL;VAMP3;WNT5A;AGTR1;PDE2A;ANXA1;PRKCD;PSMA6;MDK;IFI35;XIAP;SERPINE1;IL15;APOE;KLF4;SPATA2;IL1RL2;PDCD4;CCN4;BIRC3;ACE2
prerank,lipid homeostasis (GO:0055088),0.38214882173263415,1.2798956786601219,0.11657559198542805,0.8277897070867615,1.0,22/57,21.69%,PRKAA2;RBP1;FITM2;ABHD5;PNPLA8;CEBPA;ADCK1;ORMDL2;CLN8;ABCD1;NR1H3;USF1;DGAT2;ABCA2;ABCB4;SIRT1;TM6SF2;TLCD3A;MLXIPL;DDX3X;ATP13A2;RCN3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3277122426148702,-1.2798362729459225,0.08277404921700224,0.45417098364926944,1.0,33/79,27.25%,AP2B1;DYNC1I2;SEC24D;CTSD;SEC23A;CAPZA2;DYNC1I1;SEC31A;KIF23;CD74;DCTN3;SH3GL2;DYNLL1;SEC24B;AP2A1;DCTN5;CTSF;DCTN6;SEC13;CTSS;DYNC1H1;CAPZA1;AP1S2;LAG3;DCTN1;SEC24A;FCGR2B;AP2M1;KIF22;KIFAP3;KIF4A;ACTR1A;CTSE
prerank,cellular response to organonitrogen compound (GO:0071417),-0.3199303065345214,-1.2797039940393247,0.0825242718446602,0.45379268775635107,1.0,25/99,16.14%,PDE3A;ACTB;MEF2C;RAPGEF2;SLIT2;RAP1A;SH3BP4;CDH1;CTNNA1;CAPN2;PDE2A;KCNQ1;SPAAR;AHR;RPTOR;GOLPH3;NSMF;IPO5;SLC26A6;RRAGA;P2RY6;HTR1B;GLRA2;NR1H4;CFTR
prerank,transition metal ion transport (GO:0000041),-0.3970244920823806,-1.2796412731860074,0.12421052631578948,0.4532691086266422,1.0,12/35,14.78%,TRPC3;SLC30A1;SLC39A8;TFRC;SLC30A9;TRPC6;SLC31A1;TRPC4;ATOX1;TRPC1;SLC30A5;MT3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.5118983832370054,-1.279143288755077,0.16594827586206898,0.45375179575623215,1.0,5/13,14.72%,GAS6;WNT5A;CD74;AGPAT1;IFIH1
prerank,regulation of heart contraction (GO:0008016),0.34879407603777823,1.279098492009764,0.11019736842105263,0.8278258620537124,1.0,8/90,4.28%,ATP1A2;CELF2;SLC8A3;ATP1B3;ANK2;DMPK;ITPR1;ATP1B2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.49664776984165027,-1.2784252790906996,0.17391304347826086,0.45477258448145275,1.0,3/14,1.27%,PRKG1;MEF2C;SLIT2
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.4819944839850342,-1.27842000745814,0.18590998043052837,0.454124410258588,1.0,4/15,11.38%,STOX2;TGFB2;RAI2;SCEL
prerank,anion transport (GO:0006820),0.42134152430753286,1.2780241043590799,0.16257088846880907,0.8290058607064252,1.0,3/33,0.32%,SLC13A4;SLC22A6;SLC13A3
prerank,vesicle transport along actin filament (GO:0030050),-0.4492624832056314,-1.2780185334031942,0.1544885177453027,0.4543974113483391,1.0,6/19,12.00%,MYO1D;ACTN4;MYO1B;MYO19;MYO1F;FNBP1L
prerank,organic substance transport (GO:0071702),-0.3095115512250808,-1.277424186049404,0.0654911838790932,0.4551497501243558,1.0,22/121,9.19%,ABCG2;SLC47A1;CALCRL;ATP8A1;DISP1;SLCO2A1;RAMP2;MYH9;SLCO2B1;ABCA1;LMAN2L;PLTP;PLEKHA8;CHMP2B;SPNS2;TAP2;ABCA3;CMTM6;ABCD2;CUBN;SLC22A18;TXNIP
prerank,Wnt signaling pathway (GO:0016055),-0.32199299219191935,-1.2766792149547477,0.07459207459207459,0.45611115010377645,1.0,26/92,15.34%,LEF1;LRP6;FZD6;LRP5;SFRP4;UBC;PLCG2;CSNK1E;RPS27A;UBB;CSNK1G1;WNT5A;CSNK1A1;CSNK1G3;APC;VPS26A;CPE;AMER1;FZD4;WNT9A;RARG;CD24;FZD1;NR4A2;PLPP3;FERMT2
prerank,regulation of exosomal secretion (GO:1903541),0.4709086432124542,1.2765231165390023,0.16472868217054262,0.8317506656631176,1.0,4/19,7.85%,CHMP6;STAM;SMPD3;SNF8
prerank,myeloid leukocyte differentiation (GO:0002573),-0.35063151295399464,-1.2759223994012687,0.09732360097323602,0.45718532125328726,1.0,26/65,28.72%,LEF1;FOXP1;MYH9;RUNX1;BMP4;TGFBR2;CBFA2T3;TNFRSF11A;MT1G;IL15;PIK3CD;SNX10;VEGFA;CSF1R;SPI1;CDC42;SBNO2;OSTM1;CASP8;PRTN3;EFNA2;TREM2;CDK2;BATF2;FARP2;PARP1
prerank,gene expression (GO:0010467),-0.2710871918779342,-1.275476585905494,0.013157894736842105,0.4575713661330043,1.0,119/348,23.88%,RPLP1;PTMA;RBPMS;RPS15;RPL38;RPL18A;RPL41;RBM3;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;ADARB1;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;ANGPT2;RPS17;RPS16;RPL39;RPS27A;RPL13;MRPL52;RPLP0;CDC40;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;NUP107;RPL6;RPL18;RPS25;EIF4E;AGO2;RPL36;DDX54;RPL28;GOLPH3;RPL27;DROSHA;CPSF4;RPL24;RPS29;WDR33;RPL23;RPL17;MRPL23;YARS2;ATXN1;RPS9;RPS27;ASMT;NCBP2;HHEX;SYNCRIP;TPR;RPL21;MRPL10;THOC3;RPL34;CLP1;RPL10A;RBM6;RPL12;RPL35;RPL14;NR4A2;NCBP1;SRSF3;DHX38;RPL19;RPL37;RPS18;SEC13;RPS13;RPS15A;DDX25;RRBP1;MRPS12;MRPL55;MRPL43;EPC1;MRPL44;MRPL36;NUP50;NUFIP1;POLR3A;MRPL35;NUP85;RPL3;POLR2I;THAP1;BCL3;HNRNPF;EIF4A3;AAAS;RPL15;DKC1;TESC;RPS21;POLR2F;RPS19;RPL8;SLU7;RPL13A;NUP62
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.4157143523692477,-1.2750955287773857,0.1517094017094017,0.4578172950706337,1.0,7/27,7.04%,MAP3K5;KAT7;UBC;MAP3K20;RPS27A;UBB;MAPK1
prerank,cellular response to cytokine stimulus (GO:0071345),-0.26361859182142694,-1.2748360987207945,0.0,0.4577447361610836,1.0,106/416,20.01%,LEF1;GHR;LRCH1;SLC12A2;PID1;IL6ST;DAB2IP;IL1R1;OSMR;ZEB1;LIFR;RHOA;PTPN12;GREM2;ST3GAL6;FOXO1;GAS6;PIK3R1;F3;FOXO3;PTGIS;VCAM1;BCL2L1;SOCS2;STAT3;PTPRJ;IRAK3;TNFRSF1B;FN1;UBC;PTGS2;STX1A;GBP4;ITGB1;STX3;ICAM1;ARHGEF2;RPS27A;S1PR1;UBB;GBP5;TEC;WNT5A;AIM2;YBX3;PDE2A;CXCL12;IL6R;ANXA1;IL34;INPP5D;TNFRSF21;IL20RB;RPS3;NFAT5;CCL13;IL1RAP;PIK3CA;CNTFR;MT1X;FGF2;SOCS5;DOCK8;JAK1;YWHAZ;IL4R;MAOA;PIK3CD;IL1RL2;CEBPD;TWIST1;PTPRZ1;SYNCRIP;TPR;POU2F1;SLC26A6;CD40;CD86;VEGFA;IRAK2;CBL;CSF1R;PRKACA;LDLRAP1;IFNAR1;ADAMTS12;SOCS3;SIGIRR;MMP2;GPER1;GAPDH;JUNB;ERBIN;PTPN6;CCL25;CCND1;USP10;MT2A;ZC3H12A;MCL1;CRLF1;IRF5;ASAH2;RIPK1;JAK3;HCK
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.36036966113004293,-1.2736877922894385,0.11286681715575621,0.4597641465374746,1.0,13/52,11.52%,SPTBN1;PRKCH;PIK3R1;EGFR;NKD2;ITGB1;STX3;RACK1;ZDHHC8;STAC;EPHB2;ACSL3;SQSTM1
prerank,positive regulation of programmed cell death (GO:0043068),-0.277887924634685,-1.2731156408717996,0.02147239263803681,0.4604174173346422,1.0,77/272,20.44%,DAB2IP;ITGA6;SLIT2;NET1;TNFSF10;ARHGEF3;MAP3K5;FOXO1;DCUN1D3;MCF2L;APAF1;RASSF2;STK3;CYP1B1;FOXO3;NGF;BMP4;SFRP4;RASGRF2;UNC13B;UBC;JUN;DNAJA1;TIAM2;FAS;ITGB1;MAP3K20;ARHGEF2;CRADD;RPS27A;UBB;RACK1;IAPP;KLF11;TGM2;APC;RPS6KA2;CTSD;ABR;SOD1;TIAM1;VAV2;ARHGEF12;TGFB3;TCTN3;TNFAIP8;SQSTM1;BMP2;HIP1R;PLEKHG2;SAP18;RARG;HDAC6;EEF1E1;JMY;ACVR1C;BAK1;ATF4;PREX1;ING4;DIABLO;TOP2A;GPER1;LATS1;DUSP6;BARD1;PSEN2;IRF5;RYBP;ARHGEF5;STK17B;RIPK1;FOXL2;TRIO;PSENEN;HMGB1;RHOB
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5367990904127038,1.2730590906750492,0.18395303326810175,0.8425768474253295,1.0,2/12,1.72%,ANXA6;ANK2
prerank,sensory perception of pain (GO:0019233),0.45912392181458594,1.2725818315930189,0.17928286852589642,0.8415492801860152,1.0,8/21,20.11%,RETREG1;PTGES;CHRNB2;KCNK4;OPRM1;P2RX4;SCN9A;OPRL1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.36516879229743937,-1.2718255485302001,0.10690423162583519,0.46279269096021647,1.0,12/43,11.66%,ETS1;TGFB2;PPARD;FOXO3;STAT3;BMP4;JUN;GNL3;GATA2;FGF2;KLF4;TEAD1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.5286749931570154,-1.2715853996435007,0.16966067864271456,0.46270977849664835,1.0,6/11,29.57%,AGK;TIMM22;ROMO1;TIMM29;TIMM10;TIMM8B
prerank,organic acid transport (GO:0015849),0.3420107452854374,1.2714080702013517,0.09385113268608414,0.8432378221688368,1.0,15/94,7.83%,SLC6A13;SLC22A6;SLC13A3;SLC6A12;ACSL1;SLC38A3;SLC7A11;SLC23A2;SLC23A1;SLC26A1;SLC38A1;SLC25A11;STARD5;PDPN;SLC19A1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5412360119623938,-1.2709841727842204,0.17973231357552583,0.4634557490006556,1.0,4/10,8.59%,PARD3;DGKH;PRKD3;PLPP1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5541361142823403,1.2708376062625002,0.20512820512820512,0.8426234504066769,1.0,6/10,18.41%,LPGAT1;SLC45A3;ABCD1;NR1H3;MID1IP1;MLXIPL
prerank,positive regulation of signal transduction (GO:0009967),-0.28340366465478845,-1.2706193972259276,0.040983606557377046,0.463694418112059,1.0,57/238,14.23%,NRP1;VWF;TEK;LIMS1;NTRK3;MAML2;SHANK3;LIMS2;IL6ST;DAB2IP;JAG1;RSPO3;NOS3;TGFB2;NOTCH1;GAS6;DISC1;PIK3R1;F3;ITGA5;PTGIS;JCAD;MACF1;STAT3;KANK1;MGAT5;CCN3;FAS;FLNA;CRADD;JAG2;ERN1;NPTN;EPN2;RPS3;EMP2;CCBE1;SPIN1;SRC;ATP6AP2;IGF2;TRIM16;CDKN2AIP;NOTCH4;CAV2;ESM1;CD74;HHEX;BMP2;PTK2B;SMO;AGPAT1;CSNK2A1;PTPRC;IRS1;KLF2;P2RY6
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5105868736030363,1.2699199847504326,0.20040080160320642,0.8433056625618769,1.0,3/14,3.76%,SYT11;IGF1;TAFA3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5078649007724392,-1.2698703323738874,0.17227722772277226,0.46485089358652576,1.0,5/12,15.38%,DAB2IP;PIK3R1;ERN1;PTPN1;BAK1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5140873425709832,1.269197145852846,0.19305856832971802,0.8432035908714502,1.0,3/13,7.09%,RENBP;GNPNAT1;GNPDA1
prerank,histone H3-K4 methylation (GO:0051568),0.4365196452321882,1.2690850456320628,0.16539923954372623,0.8407056646877386,1.0,8/26,19.43%,CTR9;KMT2A;DYDC2;SETD4;BEND3;MEN1;TET2;SETD1B
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3464694286483154,1.2683970696350397,0.11129568106312292,0.8404247452230847,1.0,15/85,9.17%,EYA1;CACNA1D;USH1C;DCDC2;COL4A3;ALDH7A1;WHRN;GSDME;EML2;PCDH15;CCDC50;MYO3A;CHRNB2;ADGRV1;MYH14
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.44354809862400507,1.2680644612097174,0.16485507246376813,0.8388603837876853,1.0,2/23,6.95%,TGFBR3;FGFR2
prerank,positive regulation of innate immune response (GO:0045089),-0.4023058473462604,-1.2679117278243395,0.17333333333333334,0.4687393544035123,1.0,12/30,23.34%,POLR3F;PLSCR1;GBP5;WNT5A;NLRC5;IFI35;POLR3B;SPI1;ZBP1;POLR3D;NMI;RPS19
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.3345265544320894,-1.267598092173756,0.09927360774818401,0.4687639468397237,1.0,20/72,13.07%,SHANK3;SLIT2;KANK1;STMN1;SSH2;KANK3;TBCD;KANK4;ARHGEF2;ATXN7;PRKCD;IAPP;APC;PIK3CA;APOE;FGF13;LIMA1;DYRK1A;HIP1R;PFN1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.3434713271423296,-1.2674917445785956,0.09927360774818401,0.46832938463225743,1.0,16/65,8.91%,CAV1;LTBP1;HTRA3;SMURF1;PRDM16;TGFBR2;IL17RD;UBC;CD109;FBN1;ASPN;SPRED2;RPS27A;UBB;SPRY2;VASN
prerank,B cell activation (GO:0042113),-0.33593790255757283,-1.2669583417116117,0.0971563981042654,0.4688740464602534,1.0,17/68,13.79%,MEF2C;VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;HDAC9;EPHB2;MALT1;PIK3CD;PHB2;HHEX;ITGA4;CTPS1;CD40;PTPRC;CD86
prerank,regulation of interleukin-12 production (GO:0032655),-0.3610812105651686,-1.2666272889315304,0.10722610722610723,0.46892886201600636,1.0,16/47,25.71%,FOXP1;THBS1;IRAK3;PLCG2;MDK;PIBF1;CD40;MAST2;IRF5;JAK3;HMGB1;SYK;RIPK2;MAPK11;CMKLR1;TLR4
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4421950871140451,-1.2663911248753204,0.17002237136465326,0.46885624186916885,1.0,8/21,13.83%,CAV1;NFKBIA;PLTP;ZDHHC8;ABCA3;APOE;PTCH1;LRP1
prerank,electron transport chain (GO:0022900),-0.479437882486884,-1.2661060782888571,0.16808510638297872,0.46882321037322744,1.0,6/15,15.53%,ENOX2;PDIA5;NDUFA5;ETFA;UQCRFS1;POR
prerank,regulation of intracellular transport (GO:0032386),0.40702093472500805,1.2660727270664176,0.15985130111524162,0.8438285465303274,1.0,18/38,26.60%,MAP2;TTC21B;DYNLT2B;ANTKMT;LRRK2;GRIPAP1;RINT1;GAS1;SPAG5;RNF139;CAPN10;ATP13A2;WWC1;LAMP1;MLC1;ATP9A;HAP1;RBM4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.32952119765854876,-1.2655774399145887,0.10526315789473684,0.469394487025502,1.0,29/72,25.19%,LIFR;HIPK1;GAS6;RUNX1;IRAK3;RACK1;CBFB;PTPN1;JAK1;SPATA2;CD74;ABCE1;BIRC3;AGPAT1;PTPRC;CD24;MADD;IRAK2;SOCS3;SIGIRR;PTPN6;RIPK1;ZBP1;SYK;CYLD;TAX1BP1;SOCS1;CASP8;PTPN11
prerank,amino sugar biosynthetic process (GO:0046349),0.5133706541941634,1.2651490987032208,0.1794871794871795,0.8445007479720675,1.0,3/12,7.09%,RENBP;GNPNAT1;GNPDA1
prerank,intestinal absorption (GO:0050892),-0.5049446691270258,-1.2642431234951044,0.1908548707753479,0.47175817420455324,1.0,5/13,12.77%,F11R;TJP2;KCNQ1;UGCG;SLC26A6
prerank,peptidyl-serine modification (GO:0018209),-0.29397048050237473,-1.263946452756997,0.055710306406685235,0.4718103241658365,1.0,56/166,21.40%,PRKCH;MARK1;HIPK1;RPS6KA5;NDNF;STK38L;PKD1;GAS6;AKT3;TGFBR2;RPS6KA3;CAB39;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;PRKD1;TNKS;PRKCD;PLK2;CSNK1A1;MAPK1;GALNT13;CSNK1G3;PRKX;PRKCG;RPS6KA2;HPF1;CDK5;EIF2AK3;MAPKAPK2;VRK3;DYRK1A;MORC3;POGLUT3;STK32A;CSNK2A1;STK38;AKT2;PKN3;PRKACA;MKNK2;NAA10;MAST2;LATS1;MASTL;MAPK12;CAMK1G;MARK3;GALNT4;CSNK1D;DYRK2;ULK2;ROCK1;TOP1
prerank,regulation of myoblast differentiation (GO:0045661),0.41525859441128404,1.26361890110234,0.17723880597014927,0.8477107594344611,1.0,8/32,11.98%,RANBP3L;IGFBP3;FLOT2;SOSTDC1;PLCB1;MAPK14;SOX9;SRA1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.45127231284136543,1.2631950986574354,0.18,0.8465314045964055,1.0,4/22,4.37%,TIMP3;SH3D19;FURIN;ADRA2A
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5353848238579111,1.2628943486641526,0.19959677419354838,0.8450111994069293,1.0,3/12,8.01%,UNC13C;SYT1;RIMS1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.34332914905531453,1.262543443603203,0.11714770797962648,0.8434780633599941,1.0,7/90,1.08%,EPAS1;PPARGC1B;LEPR;ACSL1;IL18;PTH2R;APPL2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.44765481330170737,-1.2623498145987642,0.16702819956616052,0.47488489507986087,1.0,9/18,27.04%,SEC14L1;RNF125;PUM2;BIRC3;PUM1;ZCCHC3;USP15;UFD1;OASL
prerank,cardiac muscle cell contraction (GO:0086003),-0.4391111582273566,-1.262301850573701,0.16701902748414377,0.4743387970173454,1.0,8/19,15.01%,GSN;KCNJ2;CACNA2D1;CACNA1G;CAMK2D;PIK3CA;SCN4B;ATP1A1
prerank,gas transport (GO:0015669),-0.5336294637103716,-1.2620474161468345,0.2082514734774067,0.4742539770187236,1.0,8/10,42.32%,IPCEF1;CYGB;CA2;MYC;AQP1;MB;NGB;RHAG
prerank,negative regulation of complement activation (GO:0045916),-0.5422953890613544,-1.261776439529199,0.20463320463320464,0.474250934021049,1.0,4/10,16.58%,CR1L;CD55;SUSD4;CD46
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.477717826217817,1.2616351137424398,0.20428015564202334,0.8440588267177767,1.0,4/16,7.89%,TOP2B;MEIOB;EME2;MSH4
prerank,gland development (GO:0048732),-0.3512805947835946,-1.2606088686146517,0.10572687224669604,0.47630831538877516,1.0,16/59,9.74%,CAV1;IGSF3;TBX3;LSR;SIX1;TBX1;MET;HES1;ANXA1;ARHGAP35;MDK;STRA6;ZBTB1;SOD1;TGFB3;NOTCH4
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4927191655862658,1.2600337292733008,0.21855670103092784,0.8476363597865949,1.0,5/15,9.10%,LPGAT1;PPARA;SLC45A3;PPARGC1A;NR1H3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4398556020296095,1.2597778026587467,0.17054263565891473,0.8458490811927402,1.0,4/23,6.34%,TGFBR3;SMAD3;DKK3;NREP
prerank,glycolytic process (GO:0006096),0.4282404714125618,1.2595239868257455,0.15947467166979362,0.8440280885417768,1.0,7/28,7.67%,GCK;ENO1;PGM1;ALDOB;ENO4;PGK1;HKDC1
prerank,regulation of adaptive immune response (GO:0002819),-0.4590191269459188,-1.2591305908654438,0.16875,0.47898923131697807,1.0,9/18,33.94%,IL6ST;ADCY7;AHR;FCGR2B;SAMSN1;FADD;IL4I1;SKAP1;SASH3
prerank,response to ethanol (GO:0045471),0.49954921952162135,1.2590685278568357,0.18951612903225806,0.8430535286109636,1.0,5/14,8.73%,ADH7;GRIN3A;GLRA1;CHRNB2;DRD3
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2935237547437225,-1.2589730059563384,0.05361930294906166,0.4786918725904602,1.0,52/153,21.40%,PRKCH;MARK1;HIPK1;RPS6KA5;STK38L;PKD1;GAS6;AKT3;TGFBR2;RPS6KA3;CAB39;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;PRKD1;TNKS;ERN1;PRKCD;PLK2;CSNK1A1;MAPK1;CSNK1G3;PRKX;PRKCG;RPS6KA2;CDK5;EIF2AK3;MAPKAPK2;VRK3;DYRK1A;MORC3;STK32A;CSNK2A1;STK38;AKT2;PKN3;PRKACA;MKNK2;MAST2;LATS1;MASTL;MAPK12;CAMK1G;MARK3;RIPK1;CSNK1D;DYRK2;ULK2;ROCK1;TOP1
prerank,cellular response to glucagon stimulus (GO:0071377),0.4807282397576679,1.2589135000187894,0.19123505976095617,0.8409427423827446,1.0,4/17,6.20%,ADCY5;GCGR;ADCY1;ADCY8
prerank,regulation of cytoplasmic translation (GO:2000765),0.5137812427016726,1.2588337971503454,0.20226843100189035,0.8385534114656805,1.0,3/14,7.57%,CPEB2;UNK;CPEB4
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3949980640893814,-1.2586544437629221,0.1341991341991342,0.4788025306387296,1.0,16/32,30.12%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;MAPK3;POLR1A;UBTF;CCNH;POLR1H;POLR2F;POLR1E;POLR2H;POLR1C;POLR2E
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.409948502594475,-1.2585699835613824,0.1655328798185941,0.4783513550479163,1.0,7/28,11.52%,SHANK3;PTN;APP;APOE;EPHB2;FAM107A;SQSTM1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.26266034996398957,-1.2583998574305721,0.025,0.47805084778264856,1.0,91/417,14.83%,MECOM;LEF1;FOXP1;LIMS1;ATP8B1;DAB2IP;ZBTB16;ELK3;ZEB1;FOXP2;MDFIC;PPARD;WWP1;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;GAS6;RUNX2;LIMD1;CTCF;ZHX3;ID1;BMP4;PRDM16;CRY1;L3MBTL3;PTPRK;DACH1;GLI3;JUN;KAT6A;CBFA2T3;BHLHE40;CREB3L1;CCDC85B;KCTD1;NIPBL;PSPC1;WNT5A;HES1;XRCC5;TWIST2;SP3;DAP;HEYL;FOXN3;NACC2;PRDM5;MYBBP1A;CD38;HDAC9;SPEN;YWHAQ;CDKN1C;HEY2;NAB1;ZFPM2;CDK5;HMBOX1;AHR;CIR1;KLF4;GCLC;PER1;TLE5;SOX7;TWIST1;ATXN1;PDCD4;PHB2;HHEX;SOX18;BMP2;POU2F1;SAP18;USP47;TBX2;NACC1;HDAC6;NFIL3;SUV39H1;RBFOX2;MTERF3;ZNF318;YAF2;TIMELESS;MT3;SPINDOC;ARID5A
prerank,autonomic nervous system development (GO:0048483),-0.4585441495751746,-1.2565106204717786,0.18144329896907216,0.48174818847734824,1.0,2/17,3.71%,NRP1;FN1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2724869901081602,-1.256280829087999,0.036923076923076927,0.481633128017692,1.0,54/234,15.25%,PRKCH;ROR1;CAV1;SLCO3A1;LRP6;CD200;TRAF5;RPS6KA5;STK3;NFKBIA;STAT3;IRAK3;APP;UBC;NOD1;CARD14;ESR1;MID2;PLCG2;DHX33;TNFRSF11A;CARD16;TFRC;ARHGEF2;RPS27A;TRIM37;UBB;PRKD1;WNT5A;AIM2;PPIA;TRIM14;PSMA6;AR;TRIM25;RPS3;IL1RAP;EDN1;MALT1;TERF2IP;MYOCD;EDA2R;FZD4;PHB2;SMO;CD40;FZD1;VEGFA;JMY;IRAK2;ALK;PLPP3;TAB1;CRTC3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3757177715772954,-1.2559639873273563,0.14153132250580047,0.48170219153192406,1.0,14/36,23.57%,EIF3H;GABARAPL2;AQP11;PRKCG;UBXN1;USP7;BAG5;N4BP1;RYBP;PSME3IP1;UCHL5;FHIT;GIPC1;TAF9
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3127463701752337,-1.255423052671013,0.08557457212713937,0.4823549338377559,1.0,28/94,21.51%,IL1R1;RPS6KA5;NFKBIA;IRAK3;UBC;NOD1;RPS27A;UBB;PSMA6;PSMB7;IL1RAP;PSMB6;PSMB5;SQSTM1;PSMB8;IRAK2;TAB1;PSMC4;PSMD11;MAP3K8;PSMB4;PSMD14;NOD2;MAPK3;PSMD10;MYD88;PSME1;RIPK2
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.28613887313430686,-1.2552559166590722,0.055865921787709494,0.48208763658624937,1.0,40/175,20.71%,LIMS1;ACTN4;PID1;DAB2IP;TMSB4X;TRAF5;FOXO3;NFKBIA;TNFRSF1B;CARD14;TNFRSF11A;ARHGEF2;AIM2;YBX3;PSMA6;TNFRSF11B;PSMB7;TNFRSF21;RPS3;CCL13;PSMB6;PSMB5;EDA2R;BIRC3;PTK2B;CD40;PSMB8;PSMC4;PSMD11;ADAMTS12;GPER1;PSMB4;EDAR;PSMD14;ERBIN;CCL25;ZC3H12A;RIPK1;PSMD10;TNFSF8
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.31809648848880173,-1.2551552429369255,0.10049019607843138,0.4816327996404624,1.0,30/85,23.25%,RHOA;FZD6;PRICKLE2;SMURF1;AP2B1;WNT5A;PSMA6;PSMB7;TIAM1;PSMB6;PSMB5;FZD4;DAAM1;ROR2;PFN1;FZD1;AP2A1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;CELSR2;ARRB2;CDC42;PSMD10;PSME1;RYK;AP2M1;PSMB3
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.45161442097208004,-1.2549326353422403,0.17813765182186234,0.4814664622724829,1.0,11/21,21.29%,NOS3;NOTCH1;GAS6;ASPN;HEY2;PTK2B;ECM1;ENPP1;HEY1;GREM1;ROCK1
prerank,rRNA methylation (GO:0031167),0.4453169497580475,1.2545254366634366,0.19343065693430658,0.8522562799677347,1.0,5/22,15.06%,FDXACB1;MRM3;NSUN3;MTERF4;METTL5
prerank,positive regulation of embryonic development (GO:0040019),0.4725677271998732,1.2544716829159623,0.1744421906693712,0.8497317906973276,1.0,2/19,1.12%,WNT4;OSR1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.44314469922768146,-1.2534033397871636,0.1900990099009901,0.484422941319493,1.0,3/18,4.16%,DCN;KDR;MFF
prerank,phosphorylation (GO:0016310),-0.2603534339232851,-1.2525517229585146,0.01048951048951049,0.48581053500404525,1.0,74/385,12.51%,PRKG1;PRKCH;ERG;SNRK;BMPR2;MARK1;NEK7;ACVR1;CDK17;HIPK1;ACVRL1;TGFB2;MAP3K5;INSR;MERTK;RPS6KA5;DGKH;STK38L;GAS6;STK3;PEAK1;LIMD1;LIMK2;BCR;STAT3;AKT3;DGKZ;TGFBR2;IRAK3;APP;CDK14;AGK;FNIP2;BMX;TNIK;NUAK1;PANK3;MAP3K20;CSNK1E;CAMK2D;PAK2;TEC;PRKD1;ERN1;ADAM10;LYN;CDC42BPA;DCLK1;PRKCD;PLK2;CDKL2;CSNK1A1;MAPK1;PRKCG;STK24;PIK3CA;CDK5;MAP4K4;EIF2AK3;MAPKAPK2;JAK1;YWHAZ;NEK3;BCKDK;EPHB2;PIK3CD;GRK5;STK10;DYRK1A;MORC3;PRKG2;RET;BMP2;PTK2B
prerank,aminoglycan catabolic process (GO:0006026),-0.40919393842049556,-1.2525057230918983,0.14224137931034483,0.4852594682542722,1.0,9/28,22.25%,GPC6;GNS;SDC3;NAGLU;AGRN;GPC1;SGSH;GPC4;HPSE
prerank,Rho protein signal transduction (GO:0007266),-0.34932799086918176,-1.252452615897023,0.1352549889135255,0.48472722293814485,1.0,21/53,14.86%,RHOJ;RHOA;NTN1;ARHGEF3;CDH13;CDC42EP5;CDC42EP3;EPS8;AGTR1;ARHGDIB;EPS8L2;RIPOR1;CFL1;ADGRG1;CDC42EP2;ARHGAP1;TAX1BP3;SHTN1;ARHGDIA;GNA12;LIMK1
prerank,DNA methylation (GO:0006306),0.442662974007343,1.2523946958835117,0.19172932330827067,0.8550223636737474,1.0,13/23,24.15%,DNMT3L;DNMT3A;N6AMT1;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3;PICK1;BAZ2A;HELLS;ATRX;METTL4
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.42714160909023396,-1.2519676206388146,0.16427104722792607,0.4852182752440274,1.0,8/23,21.79%,DAB2IP;MAP3K5;TNFRSF11A;RPS3;EDN1;TAOK3;ARHGEF5;MAP3K4
prerank,mitotic spindle assembly (GO:0090307),-0.3611704824337616,-1.25193871089736,0.15151515151515152,0.4846288323103803,1.0,16/42,23.01%,RHOA;FLNA;SMC1A;STAG1;MAP9;PIBF1;KIF23;MZT1;STAG2;TOGARAM1;ARHGEF10;RAB11A;PRC1;TPX2;AAAS;KIFC1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.3339349292353266,-1.251814995106992,0.11380145278450363,0.48425308392736127,1.0,24/62,24.52%,MEF2C;ZBTB16;THBS1;KMT2E;RUNX1;H3-3A;AGO1;LYN;CBFB;DPY30;MYL9;PAF1;PTK2B;KMT2C;PRMT6;AGO4;CDK6;SPI1;L3MBTL1;ZFPM1;KMT2B;PRMT1;ASH2L;FES
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.3820721857685441,-1.2517912067494306,0.15268817204301074,0.48363211910009934,1.0,16/33,27.78%,ACER2;TGFB2;CYP1B1;LYN;SERPINE1;JAM3;RET;NCKAP1L;RAC3;SYK;TESC;ADA;PTPN11;PIK3CG;SNAI2;CIB1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.4455890994375632,1.2508210798748922,0.19360902255639098,0.8584521387984748,1.0,6/22,10.67%,CACNA1D;CRHR1;DRD3;ADGRV1;LTB4R2;GABBR2
prerank,positive regulation of transferase activity (GO:0051347),-0.2920861520259735,-1.2500118426717106,0.06578947368421052,0.4872981114547831,1.0,48/142,23.60%,ROR1;TEK;NTRK3;NEK7;CD200;TIE1;INSR;MERTK;DCUN1D3;EGFR;EPM2AIP1;KDR;SERINC5;TNKS;MET;XRCC5;MAPK1;FLT1;PTGES3;FLT4;IGF2;HMBOX1;KLF4;EPHB2;DCUN1D5;CD74;RET;UBE2L3;ROR2;FBXW7;CCT2;ALK;CSF1R;PARM1;FGFR3;NBN;GREM1;MAPK3;MAP2K7;RFC4;EPHB6;DTX3L;MAP3K4;RYK;DKC1;TRIB3;IGF1R;POLG2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.4030216813147891,-1.2499726958318587,0.1836283185840708,0.48674682574150746,1.0,11/27,20.85%,EGFR;LIMD1;STAT3;BMP4;PUM2;AGO2;PUM1;FMR1;FXR1;RIPK1;AJUBA
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5115409722805312,-1.2495036923012923,0.20588235294117646,0.48725344351921307,1.0,5/11,10.62%,MEF2C;RAPGEF2;LYN;ANXA1;PIK3CD
prerank,response to estradiol (GO:0032355),-0.38711114119431167,-1.2493034080166014,0.15732758620689655,0.48707706353173197,1.0,7/31,7.72%,EGFR;SOCS2;STAT3;ESR1;STRN3;ANXA1;NRIP1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.439865366122084,1.2492390947918939,0.18065693430656934,0.8619436308535015,1.0,3/25,2.79%,IGF1;MSX2;DOT1L
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4554528539303805,1.2490007929400448,0.1836734693877551,0.8601064233004077,1.0,8/19,22.39%,OBSL1;IL1RAPL1;PTPRD;CDKL3;CDKL5;CAPRIN2;CUL7;DBNL
prerank,regulation of cellular localization (GO:0060341),0.3872765226815186,1.2481784161127614,0.15807560137457044,0.8604836803018039,1.0,4/46,2.25%,PARD6G;ADCY5;MAP2;UNC13D
prerank,positive regulation of kinase activity (GO:0033674),-0.3070438396408205,-1.2480317523052293,0.0748663101604278,0.489336649479551,1.0,25/107,13.63%,ROR1;TEK;NTRK3;RAPGEF2;TIE1;INSR;MERTK;GAS6;RASSF2;RAP1A;IQGAP1;EGFR;KDR;CACUL1;MET;XRCC5;FLT1;CCN1;FLT4;EPHB2;CD74;RET;PTK2B;ROR2;PTPRC
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.3449143783120006,-1.247530766189527,0.1261061946902655,0.48983601312699926,1.0,22/51,30.42%,STAT3;APP;TMED10;GBP5;WNT5A;S100A13;AIM2;TRIM16;MALT1;HSPB1;USP50;NOD2;HMGB1;MYD88;RIPK2;CASP1;CASP8;TLR4;TMEM106A;CD36;TLR6;LGALS9
prerank,mRNA splice site selection (GO:0006376),0.4328465400633575,1.2474362388038598,0.19148936170212766,0.8606248484697443,1.0,12/30,23.83%,CELF2;SRSF5;SRSF10;PSIP1;YTHDC1;NOL3;SRSF6;CELF6;PUF60;LUC7L;CELF1;SNRPC
prerank,negative regulation of protein modification process (GO:0031400),-0.31682969250508475,-1.2471643572211004,0.10218978102189781,0.4900935263112665,1.0,18/79,10.66%,NTRK3;PID1;DAB2IP;SLIT2;NIBAN1;LRP6;PRR5L;CORO1C;MFHAS1;YWHAB;XDH;PPIA;LYN;PPP1R16B;OCLN;CRTAP;EPHB2;TERF2IP
prerank,positive regulation of protein secretion (GO:0050714),0.351240748235229,1.246975327988961,0.13636363636363635,0.8597046129532374,1.0,7/69,2.86%,BMP6;IGF1;NNAT;FRMD4A;WLS;GCK;NLGN2
prerank,Rap protein signal transduction (GO:0032486),-0.5426808093696522,-1.2468412013735721,0.2055888223552894,0.4902174803630536,1.0,4/10,6.89%,RAPGEF2;RAP1A;RAP2A;PLK2
prerank,response to estrogen (GO:0043627),-0.39869700923353396,-1.2468321651167933,0.17420814479638008,0.4895789993429346,1.0,8/31,14.83%,CAV1;ESR1;AR;TRIM25;PELP1;SERPINB9;CD24;ARID5A
prerank,regulation of histone deacetylation (GO:0031063),-0.47444343939307204,-1.2465705968815683,0.20786516853932585,0.48953172875104534,1.0,5/13,17.53%,NIPBL;CAMK2D;SAP30BP;APLNR;PRMT6
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3533673739218265,1.2458545137937422,0.1399662731871838,0.8612698291274603,1.0,18/69,15.61%,DERL1;DNAJC18;JKAMP;DNAJB14;UBE4B;TMUB1;ECPAS;DNAJC10;USP19;FBXO6;SGTB;TMEM67;RNF121;FBXO17;BAG6;RNF5;UBXN4;DNAJB2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.25500900992876,-1.2451228352155954,0.003703703703703704,0.4921804180686803,1.0,111/476,17.36%,MECOM;LEF1;MEF2C;ZBTB16;ZFHX3;MLLT3;LRP6;ACVR1;MDFIC;ETS1;ACVRL1;PPARD;FLI1;MAP3K5;FOXO1;NOTCH1;LRP5;KMT2E;EGFR;RUNX2;FOXO3;CTCF;AFAP1L2;RUNX1;CDH1;STAT3;BMP4;NFATC1;PRDM16;SIX1;RNF111;GLI3;JUN;NAA16;ESR1;TBX1;KAT6A;ARID1B;TFEB;BRD4;SOX17;SMARCC1;ZXDC;SMAD5;XPC;NFYA;WNT5A;HES1;TRIM56;SP3;AR;ELF4;CD38;ACTA2;CDKN1C;HEY2;SPIN1;ARID1A;VHL;TRIM16;FGF2;ELK1;TGFB3;AHR;APOE;NOTCH4;FGF7;KLF4;TAL1;ETS2;PITHD1;MYOCD;GTF2H1;NFATC2;DYRK1A;TEAD1;ATAD2;CD74;FZD4;HHEX;SOX18;FOXF2;COL1A1;RET;BLM;BMP2;NFIL3;HNRNPAB;NME2;FZD1;NCOA6;CD86;KLF2;ZNF318;YAF2;MRPL12;MT3;MAD2L2;NR1H4;ENY2;BRCA2;ID2;ATF4;SIX4;SP100;RREB1;DNAJC2;HEY1;ZBTB48;ZNF496;MED14
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.32813363252173966,-1.2449534628526708,0.10501193317422435,0.4919315598045845,1.0,17/73,10.46%,HIP1;ACER2;TNFSF10;APAF1;F3;NGF;NOD1;FAS;CRADD;XDH;RACK1;HSPE1;DAP;CASP8AP2;ATP2A3;EIF2AK3;IFT57
prerank,osteoclast differentiation (GO:0030316),-0.42751129614466876,-1.2448355988156812,0.1828793774319066,0.4915598492339533,1.0,10/22,28.52%,FOXP1;TNFRSF11A;SRC;SNX10;CSF1R;SBNO2;OSTM1;EFNA2;TREM2;FARP2
prerank,detection of mechanical stimulus (GO:0050982),-0.44059011620924726,-1.2443315817506702,0.1952191235059761,0.49214046850742527,1.0,3/19,2.85%,PIEZO2;PKD1;PIEZO1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.46629103859444626,1.2442128923074025,0.18627450980392157,0.8649185680685605,1.0,6/18,15.60%,SMAD3;CLASP1;PDPN;IER3IP1;EFEMP2;IL6
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.453208761584036,-1.2438863429366311,0.21181262729124237,0.49256260091509135,1.0,7/17,22.36%,ATP5MF;ATP5F1E;ATP5F1B;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4933967325905655,-1.243838109178942,0.20920502092050208,0.4920196379859358,1.0,4/13,4.67%,PKD1;NFKBIA;YWHAB;FLNA
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3667203874644776,1.2433684897631028,0.14049586776859505,0.8653663145980358,1.0,19/52,19.84%,CELF2;DDX5;NOVA1;RBM11;HNRNPU;DDX17;HNRNPL;PTBP1;SRRM4;YTHDC1;FXR2;RBM5;MBNL3;RNPS1;SRSF6;CELF6;RBFOX1;PUF60;REST
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.4137250511797885,-1.2432310795626982,0.1704781704781705,0.4928733453433869,1.0,9/25,26.05%,TMTC2;CAV1;JPH2;CNNM2;MT3;GRIN1;SLC8A1;WFS1;SELENON
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4987473686364734,-1.242797808258205,0.21868787276341947,0.4933012266131895,1.0,4/12,13.63%,RUNX1;LYN;CBFB;PTPRC
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.4293575419922826,-1.2424501834107364,0.19527896995708155,0.49348458187142297,1.0,5/22,12.97%,B2M;ZBTB1;CD55;MALT1;STX7
prerank,neutral amino acid transport (GO:0015804),-0.3957167367777011,-1.242371832472342,0.17419354838709677,0.4930203858421868,1.0,9/28,14.08%,SLC6A6;SLC1A5;SLC7A5;SLC38A5;SLC43A2;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,apoptotic cell clearance (GO:0043277),-0.3867403811498297,-1.2421646170420109,0.164079822616408,0.4928470403140475,1.0,6/30,7.67%,RHOBTB1;SCARB1;THBS1;GAS6;ANXA1;TGM2
prerank,regulation of receptor binding (GO:1900120),-0.5295530191861763,-1.2420871920504144,0.19842829076620824,0.4923464590328648,1.0,4/10,14.55%,B2M;GREM2;ATP2A3;ADAM15
prerank,secondary alcohol metabolic process (GO:1902652),0.38720900205519665,1.2420104115070072,0.16757741347905283,0.867795717045024,1.0,13/42,16.04%,SOAT2;CYP11B1;APOF;SOAT1;CLN8;OSBPL5;CYP27A1;RXRA;FDX1;SQLE;TSKU;IDH2;GBA2
prerank,signal release from synapse (GO:0099643),0.3875565809889789,1.241992738689102,0.17266187050359713,0.8651854987736801,1.0,22/43,28.87%,SYT1;SYN2;SNAPIN;RIMS1;SNAP25;SYT10;GAD1;SYN3;CPLX1;NAAA;SYN1;CPLX2;STXBP3;SLC32A1;GAD2;SNPH;STXBP2;PPFIA3;NRXN2;DNAJC5;NRXN1;BRSK1
prerank,cilium movement (GO:0003341),0.37662971699209374,1.2417585276809573,0.15653775322283608,0.8633988464736196,1.0,15/48,22.29%,DNAH1;TEKT2;RSPH4A;TEKT5;CFAP61;ROPN1L;CFAP251;DNHD1;DNAH9;DNAAF2;DNAAF5;SPA17;CFAP54;CFAP91;DNAH5
prerank,regulation of glucose metabolic process (GO:0010906),0.4057046272847788,1.241272977160514,0.21195652173913043,0.8627890880686594,1.0,9/34,19.03%,RORA;GCGR;PDK2;SLC45A3;PDK1;SIRT1;RUBCNL;AKT1;KHK
prerank,lipid biosynthetic process (GO:0008610),0.35362465537257076,1.2408874311461389,0.1456140350877193,0.8615628494204939,1.0,23/77,23.27%,ACSL1;PRKAA2;FITM2;ACSM2A;ACSM2B;AGPAT4;PCYT2;PRLR;CLN8;DHRS11;ACSS2;CYP51A1;STAR;ACACA;GGPS1;HMGCR;FDXR;PAM;ALOX5;DOLPP1;CBR4;LIPC;LIPH
prerank,DNA alkylation (GO:0006305),0.46297687735059867,1.240348460607179,0.20743639921722112,0.8583563721944901,1.0,7/19,12.07%,DNMT3L;DNMT3A;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3
prerank,DNA methylation or demethylation (GO:0044728),0.46297687735059867,1.240348460607179,0.20743639921722112,0.8583563721944901,1.0,7/19,12.07%,DNMT3L;DNMT3A;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3
prerank,epithelial to mesenchymal transition (GO:0001837),0.38642238428835873,1.2402603490455528,0.17537313432835822,0.8560875084333679,1.0,9/47,7.14%,BMP7;TGFBR3;WNT4;ROCK2;DDX5;S100A4;LOXL3;RBPJ;DDX17
prerank,ketone body metabolic process (GO:1902224),0.5340869169660384,1.2399166751715602,0.2210953346855984,0.854800560056401,1.0,3/10,10.55%,OXCT1;ACAT1;BDH1
prerank,regulation of fibroblast migration (GO:0010762),-0.4453975860794796,-1.2398568119345232,0.20491803278688525,0.49693978696495905,1.0,7/20,14.60%,THBS1;PRR5L;CORO1C;ITGB1;FGF2;HAS1;GNA12
prerank,skin development (GO:0043588),-0.3381449930794336,-1.2395052578154597,0.12028301886792453,0.4971038004521263,1.0,17/65,12.26%,JAG1;ITGA6;CLIC4;PKD1;BCR;LSR;COL5A2;STMN1;ITGB4;WNT5A;MET;ANXA1;TXNIP;HRNR;SCEL;UGCG;COL1A1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.4846503918605058,-1.2392554807372231,0.22332015810276679,0.4970275780923089,1.0,8/13,42.29%,CBLB;IPO5;KPNA2;KPNA1;NUP35;NUP54;KPNB1;KPNA7
prerank,bicarbonate transport (GO:0015701),-0.4244052171923595,-1.2387651445092644,0.19959677419354838,0.49760349864568454,1.0,7/25,16.14%,SLC4A10;SLC26A7;SLC39A8;CA4;SLC26A6;CA2;CFTR
prerank,regulation of cholesterol storage (GO:0010885),-0.4700668718239928,-1.2380950271644966,0.20634920634920634,0.49855992294221996,1.0,5/15,11.49%,SCARB1;PPARD;ABCA1;TTC39B;SREBF2
prerank,cardiac muscle tissue development (GO:0048738),0.37245172288062256,1.2380850600409077,0.16376306620209058,0.8590936654468302,1.0,9/50,7.98%,NOTCH2;BMP7;GJB6;MSX2;BMPR1A;CSRP3;SGCZ;NRG1;KDM6B
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4487863658580268,-1.2380556139771415,0.22151898734177214,0.4979894403072722,1.0,10/17,8.50%,JAG1;SLIT2;NOS3;TGFB2;NOTCH1;BMP4;NFATC1;HEYL;STRA6;HEY2
prerank,positive regulation of defense response (GO:0031349),-0.32015752220568655,-1.2375719931509572,0.1079136690647482,0.4984773544080278,1.0,17/89,11.84%,MEF2C;ETS1;NFKBIA;POLR3F;ABCC1;PLSCR1;APP;GBP5;WNT5A;AGTR1;PDE2A;MDK;IFI35;SERPINE1;IL15;PDCD4;CCN4
prerank,insulin receptor signaling pathway (GO:0008286),-0.33074747013453465,-1.2375640206236864,0.12259615384615384,0.4978505663653286,1.0,20/69,13.91%,GAB1;BCAR3;INSR;FOXO1;PIK3R1;GRB14;ATP6V0A4;PIK3C2A;APC;ATP6V0D1;PIK3CA;ATP6V0A1;IGF2;BCAR1;CAV2;SH2B2;ATP6V1D;AKT2;IRS1;RARRES2
prerank,organonitrogen compound catabolic process (GO:1901565),0.3625686895494887,1.237456825124054,0.14590747330960854,0.8588584019576929,1.0,15/57,16.79%,ADAMTS13;CPQ;RENBP;CAPN3;PNPLA8;GNPDA1;CTRL;CLN8;SMPD2;PLA2G15;NPL;CLN5;UCHL3;TRHDE;CTH
prerank,activation of adenylate cyclase activity (GO:0007190),0.3920023654691407,1.2366665853724823,0.17553191489361702,0.8592201474044914,1.0,5/35,6.20%,ADCY5;LGR4;ADCY1;CRHR1;ADCY8
prerank,modulation by symbiont of host process (GO:0044003),-0.5253130933655905,-1.236383214332079,0.18774703557312253,0.5000160870332834,1.0,5/10,10.78%,B2M;UBC;RPS27A;UBB;HGS
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.35892855825448244,-1.2362549023300216,0.1517094017094017,0.4996364435289041,1.0,12/45,16.54%,GCNT2;FOXO3;RBM3;APP;ZC3H7A;RPL10;PUM2;EIF4E;PER1;TDRD7;PUM1;DDX25
prerank,positive regulation of vascular permeability (GO:0043117),-0.49755149346981276,-1.2362174447205934,0.21348314606741572,0.4990864008165253,1.0,7/12,13.82%,PDE3A;TJP1;TJP2;PDE2A;OCLN;TRPV4;VEGFA
prerank,intracellular sterol transport (GO:0032366),-0.487793651428552,-1.2361178266277506,0.20486815415821502,0.49871553690515474,1.0,4/13,11.36%,ABCA1;NPC2;OSBP;STARD4
prerank,cellular response to interleukin-4 (GO:0071353),-0.5198200774769046,-1.2354558962141025,0.2032854209445585,0.4997098905144882,1.0,1/10,0.18%,LEF1
prerank,bone development (GO:0060348),0.3805671107233181,1.234958544331314,0.17204301075268819,0.8630917708173043,1.0,3/39,2.49%,RANBP3L;DYM;CYP26B1
prerank,male meiosis I (GO:0007141),0.4754264299058,1.2341852749248434,0.20934579439252338,0.8632452123829668,1.0,3/16,14.13%,DNMT3L;TDRD9;MYBL1
prerank,pharyngeal system development (GO:0060037),-0.45334785241561004,-1.2339263558724853,0.20404040404040405,0.5026173511645432,1.0,6/15,6.07%,BMP5;BMPR2;TGFB2;BMP4;TBX1;HES1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4938503139817696,-1.2333622560778752,0.21338912133891214,0.5033614401728272,1.0,8/12,32.10%,SIX1;SMO;VEGFA;SIX4;SOX8;LHX1;AGT;NOG
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.3846892262993385,-1.2332908721781886,0.17745302713987474,0.502883814953524,1.0,14/32,23.40%,FOXO3;RBM3;APP;RPL10;TMED10;PRKCD;SAMD8;EIF4E;PGAM1;NR1H4;DDX25;TIGAR;ROCK1;NANOS3
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5141000532455281,-1.2329184435967748,0.2331288343558282,0.5031547036061574,1.0,4/10,11.60%,UBC;RPS27A;UBB;ISG15
prerank,glucose transmembrane transport (GO:1904659),-0.44153128815233866,-1.23285764078855,0.1961206896551724,0.5026606138953191,1.0,5/18,13.11%,SLC2A1;PPARD;SLC2A3;SORT1;SLC2A9
prerank,negative regulation of cell population proliferation (GO:0008285),-0.2583408904025941,-1.232614600529044,0.016286644951140065,0.5026277314166875,1.0,72/351,13.33%,ABI1;BMP5;ZBTB7C;RAPGEF2;BMPR2;DAB2IP;NOS3;CD200;B2M;FAP;ETS1;ACVRL1;TGFB2;TBX3;NOTCH1;CDH13;SH3BP4;CYP1B1;CTCF;NGF;BTG1;BMP4;PTPRJ;SFRP4;MTSS1;APP;ITGA1;ADARB1;PTPRK;CCN3;CBFA2T3;IGFBP6;AQP11;WNT5A;AXIN2;HES1;LYN;AR;ADAMTS1;APOD;KLF11;NACC2;APC;PPP2R5C;RPS6KA2;IFI35;RBBP4;CDKN1C;SLC16A2;PLPP1;GATA2;VHL;TGFB3;KLF4;S100A11;BTG3;HGS;TES;ADGRG1;PBRM1;MYOCD;SOX7;DDAH1;MORC3;WNT9A;BMP2;PTK2B;SST;RARG;ROR2;EEF1E1;RERG
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5114109628980551,-1.2323792965328302,0.19607843137254902,0.5025346653181384,1.0,8/11,34.03%,CREB3L1;ATF6B;ATF4;ATF3;MBTPS2;CEBPB;HSPA5;TP53
prerank,regulation of lipid metabolic process (GO:0019216),0.33708292403058626,1.2322907804091914,0.13398692810457516,0.867844349331435,1.0,24/88,19.41%,PRKAG2;RORA;PPARA;NFYB;SMARCD3;NFYC;PANK2;CHD9;MED1;SC5D;RXRA;SQLE;CYP51A1;TBL1XR1;RUBCNL;ACACA;TM6SF2;NCOR2;GGPS1;MID1IP1;HMGCR;NCOR1;SIN3A;OPA3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.3039895022017661,-1.2321347226397101,0.09592326139088729,0.5024776275847399,1.0,31/107,15.04%,CAV1;SLC39A10;STIM2;ATP2B1;SLC10A7;SLC30A1;SLC39A8;SLC30A9;NPTN;CXCL12;TPT1;CCL13;ATP2A3;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;SLC39A7;TMCO1;EDN1;EDN3;HTR2A;SLC30A5;TRPV4;CD40;MT3;VAPB
prerank,ureteric bud development (GO:0001657),0.45649977107002293,1.2308681267939372,0.23828125,0.8705040528948468,1.0,4/17,6.95%,BMP7;OSR1;NPNT;FGFR2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4132382802974645,-1.2296818340908697,0.16527196652719664,0.5077253488862832,1.0,6/22,17.68%,ASXL3;APOD;CEACAM1;CCDC3;ALK;GPER1
prerank,positive regulation of blood coagulation (GO:0030194),-0.44708422313037954,-1.2295031913999193,0.1953125,0.5075660688687509,1.0,5/17,11.56%,ST3GAL4;THBS1;F3;SERPINE1;ENPP4
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.4509206038192144,1.2292475830058327,0.22093023255813954,0.8739859571816377,1.0,6/18,17.36%,DAB2;RAB21;DENND10;MTMR2;SNX3;PTPN23
prerank,bile acid biosynthetic process (GO:0006699),-0.41404511927828297,-1.2291274185050574,0.19444444444444445,0.5078009853790978,1.0,4/24,6.51%,CYP7B1;OSBPL3;CYP39A1;OSBP
prerank,neurotransmitter secretion (GO:0007269),0.3822897853358587,1.228879119167196,0.1735985533453888,0.8728283487543096,1.0,22/44,28.87%,SYT1;SYN2;SNAPIN;RIMS1;SNAP25;SYT10;GAD1;SYN3;CPLX1;NAAA;SYN1;CPLX2;STXBP3;SLC32A1;GAD2;SNPH;STXBP2;PPFIA3;NRXN2;DNAJC5;NRXN1;BRSK1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4978348825624399,-1.2283704858054252,0.2391304347826087,0.5089092679121194,1.0,3/12,6.07%,JAG1;NOTCH1;HES1
prerank,cardiac muscle contraction (GO:0060048),0.4046502666391743,1.2282557965506176,0.2202486678507993,0.8726490159823979,1.0,5/34,11.04%,ATP1A2;CSRP3;TNNI1;KCNH2;RYR2
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.4530195450479122,-1.2275746665248506,0.22153209109730848,0.510177974983248,1.0,6/17,13.82%,CLDN5;VCL;PPP1R12A;F11R;S1PR3;VEGFA
prerank,calcium ion import across plasma membrane (GO:0098703),0.49285422976384907,1.2271900626870962,0.22664015904572565,0.8741793940723881,1.0,2/14,1.13%,SLC8A3;TRPV1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5106692903778216,-1.2268161523337653,0.2413793103448276,0.511346585853975,1.0,3/11,2.83%,FAP;PTGIS;BCL2L1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.38678857583311876,1.2267835097745505,0.18703703703703703,0.8730923001958956,1.0,9/40,8.79%,BMP7;BMP6;WNT4;OSR1;BMPR1A;FZD9;WNT6;PKDCC;ADGRV1
prerank,response to fatty acid (GO:0070542),-0.4526674339753348,-1.2267778729222285,0.2217741935483871,0.5107951497877554,1.0,6/17,15.58%,PID1;FOXO1;FOXO3;IRS1;SCD;NR1H4
prerank,antibacterial humoral response (GO:0019731),-0.45456625913979737,-1.2267729700090795,0.21544715447154472,0.5101629956123829,1.0,3/16,14.39%,DEFA6;RPL39;PLA2G6
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4546282908875553,-1.226441956244205,0.23076923076923078,0.5103188453317709,1.0,6/16,10.56%,BCL2L1;CXCL12;TPT1;NACC2;RPS3;ACKR3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5062236644255617,-1.2261885457623527,0.23391812865497075,0.5102895941042858,1.0,7/11,38.76%,ANXA1;SOCS5;ZC3H12A;JAK3;SMAD7;RC3H2;IL4
prerank,positive regulation of secretion (GO:0051047),-0.507641018845766,-1.2261785285081488,0.20078740157480315,0.5096717129990734,1.0,7/11,48.13%,ACSL3;AQP1;SCIN;GPLD1;XBP1;TRH;ABCB11
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.43804857426173927,-1.2258831394708383,0.2,0.5097554997162156,1.0,10/20,24.79%,TTC39B;APOE;SREBF2;ACADVL;NR1H4;LDLRAP1;ARV1;SREBF1;LPCAT3;MBTPS2
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.4701612164048633,1.224961017192716,0.22709923664122136,0.8775283697825116,1.0,2/18,0.87%,IGF1;IL18
prerank,regulation of protein binding (GO:0043393),-0.29269593319776815,-1.2240493160972488,0.08845208845208845,0.5135687731557937,1.0,38/114,21.74%,ACTB;CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;DISC1;BMP4;APP;BTBD1;RALB;CARD16;CSNK1E;RACK1;PRKCD;SPPL3;TIAM1;PPP1CA;GTF2F1;PRMT7;TLE5;NMD3;BMP2;HIP1R;LRP1;VTN;PRKACA;EPB41;LDLRAP1;PEX14;MARK3;PSME3IP1;PPP2CA;EFHB;ROCK1;RIPK2;DTX3L
prerank,positive regulation of protein processing (GO:0010954),-0.4371490968673098,-1.22403325531832,0.17197452229299362,0.5129506901537553,1.0,4/19,7.99%,GSN;MYH9;NKD2;CCBE1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4863707912392336,1.2238618572290154,0.21881390593047034,0.8790334607719531,1.0,3/13,5.83%,BMP7;METRNL;HNRNPU
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3921271720730363,-1.2230047314152652,0.21141649048625794,0.5147281763072228,1.0,8/30,12.65%,DCN;CSGALNACT1;NDNF;CSPG4;VCAN;HEXA;CHSY3;BGN
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3232107144990317,-1.2227384069390608,0.12910798122065728,0.5147398187150352,1.0,21/76,13.79%,LIMS1;ACTN4;RHOA;TMSB4X;RASSF2;EGFR;NFKBIA;APP;NOD1;CCN3;NR3C2;RPS3;NFAT5;IFI35;HDAC7;TERF2IP;PTP4A3;PDCD4;PHB2;TCIM;CD86
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.36815086044205536,-1.222350408720867,0.16335540838852097,0.5149965985648773,1.0,14/34,26.87%,PTPRB;PTPN12;PTPRJ;UBASH3B;PTPN1;DUSP3;PTPRZ1;DUSP6;PTPN6;PTPRF;DUSP1;PTPN11;DUSP7;DUSP18
prerank,regulation of microtubule nucleation (GO:0010968),0.5249470381972674,1.2219491413225183,0.23529411764705882,0.8837554154194346,1.0,2/10,5.19%,HSPA1A;EML2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.33591777846852244,1.2217403365236954,0.14028776978417265,0.8820420775322159,1.0,29/77,19.03%,IGF1;HSPA1A;SIAH2;SLC25A5;PPIF;FZD9;PELI3;HTT;PHIP;TGFBR1;CFLAR;BCL2;CSNK2A2;CAAP1;PIH1D1;CLU;QARS1;BDNF;TMEM14A;NOC2L;SCG2;NDUFA13;HGF;NOL3;RELA;TCF7L2;AKT1;CX3CL1;MAPK8IP2
prerank,amino acid import across plasma membrane (GO:0089718),-0.41156034761286625,-1.2216297585305735,0.20217391304347826,0.5161447186226253,1.0,7/24,8.49%,SLC47A1;SLC6A6;SLC1A5;SLC7A5;SLC1A3;SLC7A1;SLC16A2
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.37352240823338945,-1.2214045312962194,0.18568232662192394,0.5160417920913458,1.0,13/36,25.74%,NRP1;SHANK3;ITGB1;EPHB2;EDN1;HDAC6;FBXW7;HDAC2;GREM1;NCOA3;EGF;CCR2;BUD31
prerank,copper ion transport (GO:0006825),-0.5113258249855419,-1.2209490569959158,0.23265306122448978,0.5164434736929191,1.0,9/11,31.12%,STEAP3;SLC31A1;ATOX1;STEAP2;SLC31A2;ATP7B;STEAP4;SLC11A2;COX17
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4745401588330642,1.2208050287241843,0.2328767123287671,0.8830096300737845,1.0,3/16,7.14%,DDX5;PQBP1;DDX17
prerank,negative regulation of cellular process (GO:0048523),-0.24802192234967618,-1.220111678833059,0.01509433962264151,0.5177597144567352,1.0,106/521,13.79%,APBB2;ABI1;PODXL;BMP5;ZBTB7C;RAPGEF2;PDE8A;BMPR2;DAB2IP;SLIT2;NOS3;CD200;ETS1;ACVRL1;TGFB2;CD9;NOTCH1;DCUN1D3;MYH9;CDH13;SH3BP4;CYP1B1;CD34;CTCF;VPS13C;NGF;BTG1;BMP4;PTPRJ;SFRP4;PLSCR1;APP;TNFRSF1B;ITGA1;ADARB1;FHL1;PTPRK;CCN3;TBX1;ACTN1;CBFA2T3;CASK;SOX17;IGFBP6;CCDC85B;VAMP3;AQP11;PRKD1;AXIN2;RACK1;ARHGDIB;ADAM10;LYN;NCK1;AR;ADAMTS1;CHMP4B;TNFRSF21;KLF11;CCN1;MDK;NACC2;APC;PPP2R5C;RPS6KA2;TGFBI;IFI35;RBBP4;PLPP1;VHL;EIF2AK3;TXNIP;FGF2;TGFB3;CDKN2AIP;NOTCH4;KLF4;S100A11;EPHB2;BTG3;HGS;TES;ADGRG1;PBRM1;PLXNC1;DYSF;MYOCD;SOX7;FBXO5;DDAH1;NME6;PDCD4;CCN4;WNT9A;BLM;BMP2;PTK2B;SST;RARG;SIPA1;ROR2;EEF1E1;RERG;SUZ12;ENPP1;ARHGDIA
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.40311211564864985,-1.2197384821027482,0.19916142557651992,0.5180917986952469,1.0,7/24,16.62%,PDE3A;PDE4D;RAPGEF2;PDE2A;PRKAR2B;RNF157;APLNR
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5132122079361774,-1.219560669693348,0.2222222222222222,0.5178731905381065,1.0,3/10,7.43%,BMP4;GLI3;MDK
prerank,muscle contraction (GO:0006936),-0.29111810780363206,-1.219307429561576,0.096,0.5178697486720532,1.0,21/126,9.93%,UTRN;EDNRA;CALD1;VCL;GJC1;SMTN;SNTB1;MYL12B;ITGA1;MYL6;TPM4;ITGB5;PXN;ALDOA;ACTA2;TPM2;MYH11;MYL9;TMOD3;TPM3;CHRNB1
prerank,positive regulation of catabolic process (GO:0009896),-0.3252543310193599,-1.2190919167940228,0.13793103448275862,0.5177323442163625,1.0,9/65,7.76%,DAB2IP;NEDD4L;WWP1;FOXO1;SMURF1;HECW2;WNT5A;PLK2;APC
prerank,regulation of dendrite development (GO:0050773),-0.37220101319832155,-1.2179696619085671,0.19271948608137046,0.5197692116546122,1.0,8/37,5.07%,BMP5;DAB2IP;PTN;NEDD4L;MARK1;HECW2;TNIK;RAP2A
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3885973843931232,-1.2174520270504345,0.1759656652360515,0.5203577247555259,1.0,9/28,13.74%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;PTPN1;IRS1;ENPP1
prerank,regulation of apoptotic process (GO:0042981),-0.24423698751376602,-1.2173983559693176,0.0,0.5198361705591961,1.0,182/676,20.51%,HIP1;LEF1;ARHGAP10;TEK;MEF2C;ACTN4;IL6ST;DAB2IP;ITGA6;SLIT2;TJP1;PTMA;STEAP3;NET1;ACER2;TNFSF10;ARHGEF3;MAP3K5;FOXO1;TBX3;THBS1;DCUN1D3;MCF2L;GAS6;APAF1;RASSF2;STK3;PIK3R1;EGFR;CYP1B1;FOXO3;BCL2L1;NGF;NFKBIA;SOCS2;CD44;BMP4;SFRP4;RASGRF2;KDR;UNC13B;UBC;RPS6KA3;RPL10;JUN;CARD14;NAA16;DNAJA1;TIAM2;ACTN1;FAS;FLNA;ITGB1;TFRC;MAP3K20;ARHGEF2;RNF144B;CRADD;RPS27A;UBB;PAK2;WNT5A;RACK1;ADAM10;PERP;PPIA;ANXA1;TPT1;PLK2;IAPP;KLF11;TGM2;APC;SPRY2;CD38;RPS3;RPS6KA2;CTSD;CDK5;ABR;SRC;XIAP;SOD1;FLT4;TIAM1;VHL;MAP4K4;VAV2;ARHGEF12;CAT;TGFB3;BCAR1;GCLC;GOLPH3;YWHAZ;BABAM2;IFT57;CFL1;MALT1;NSMF;CTSB;TCTN3;TNFAIP8;HSPB1;PHLPP1;SQSTM1;GRK5;CD74;PHB2;SERPINB9;COMP;BMP2;HIP1R;PLEKHG2;BIRC3;PTK2B;SAP18;RARG;USP47;TCIM;EEF1E1;AKT2;NME2;ARHGDIA;VEGFA;MADD;HIGD2A;LANCL1;JMY;ACVR1C;MT3;ALK;CBL;RHBDD1;PLAUR;BAK1;NR1H4;PA2G4;ATF4;BAG1;NCKAP1L;STIL;SIX4;RNF157;RTN4;PREX1;RBM25;ING4;DIABLO;TMEM219;OSGIN1;TOP2A;HDAC2;GPER1;LATS1;DUSP6;BARD1;PTPN6;STK26;PSEN2;GREM1;SH3RF1;MCL1;IRF5;RYBP;SOX8;ARHGEF5;STK17B;RIPK1;JAK3;HCK;AKT1S1;FOXL2;TRIO;PSMD10;PSENEN;HYPK;LCMT1;HMGB1;RHOB;MYD88;POU3F3
prerank,neuron apoptotic process (GO:0051402),-0.43382956907994596,-1.2173913269182601,0.18220338983050846,0.5192014216498257,1.0,8/19,19.47%,APP;FAS;CIT;TNFRSF21;CDK5;DIABLO;GAPDH;LIG4
prerank,cellular response to alcohol (GO:0097306),-0.3535790129424266,-1.217261411577954,0.188470066518847,0.5188924841536655,1.0,17/42,16.14%,LRP6;CDH1;CTNNA1;GNB1;ADCY7;GNG2;ADCY2;AHR;GOLPH3;GRAMD1A;PTCH1;BLM;SMO;ADAM15;GLRA2;PTGFR;CFTR
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4987761404776082,-1.2172045871681922,0.21413721413721415,0.5183887551788892,1.0,5/11,18.96%,MEF2C;TGFB2;MYOCD;GPER1;GREM1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3597894406290146,-1.217173807027313,0.15521064301552107,0.5178159570099403,1.0,10/38,13.94%,CAV1;INSR;PTGIS;CD34;NOS1AP;PTGS2;KLF4;EDN1;DDAH1;KLF2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.52870346340989,1.217094715980943,0.238,0.8946094585596254,1.0,7/10,29.88%,E2F8;SSBP1;DBF4;CDC7;ATRX;WIZ;STOML2
prerank,regulation of lipid kinase activity (GO:0043550),0.5089785232991704,1.2168057581002143,0.21956087824351297,0.8931450978307871,1.0,2/11,3.14%,PIK3R3;WDR91
prerank,calcium ion import into cytosol (GO:1902656),0.47870205858501225,1.2163785242608491,0.24951267056530213,0.892156550026202,1.0,2/15,1.13%,SLC8A3;TRPV1
prerank,negative regulation of cellular component organization (GO:0051129),0.3410924001719173,1.216289789189217,0.1736111111111111,0.8899643785204956,1.0,15/74,12.52%,BMP6;SYT11;HSPA1A;PRKCZ;PON1;DNAJB8;OPRD1;TFIP11;IMPACT;SCAMP5;CLU;WASL;RTEL1;RAPGEF3;MTMR2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4802267463999672,-1.2162867190148348,0.22692307692307692,0.5193560412744901,1.0,3/13,1.43%,PID1;NOS3;TMSB4X
prerank,cellular protein modification process (GO:0006464),-0.23724513989499366,-1.215791972703764,0.0,0.5199228445363998,1.0,272/983,22.21%,PRKG1;PTPRM;PTPRB;PTPRG;PRKCH;ST3GAL4;FBXL7;ERG;GCNT2;SNRK;BMPR2;ZBTB16;ST8SIA4;LTBP1;MARK1;NEK7;PTPN12;ACVR1;CDK17;HIPK1;ACVRL1;TGFB2;PTP4A2;ST3GAL6;MAP3K5;INSR;MERTK;RPS6KA5;THBS1;DCUN1D3;STK38L;B3GNT2;GAS6;STK3;PEAK1;PLOD2;SDHAF2;LIMK2;ATG3;SOCS2;BCR;BMP4;PTPRJ;WIPI1;AKT3;PPP1R12A;TGFBR2;IRAK3;APP;FN1;BTBD1;CDK14;SSH2;PTPRK;DCAF6;LMO7;FNIP2;FBN1;BMX;TNIK;NUAK1;PDIA6;MSLN;COP1;MAP3K20;CSNK1E;CAMK2D;ST3GAL1;PAK2;TEC;UBE2D3;PRKD1;CST3;TNKS;ERN1;ART3;ADAM10;LYN;DCAF10;LOX;FBXW8;CDC42BPA;KLHL2;DCLK1;ANXA1;PRKCD;PSMA6;PLK2;CDKL2;CSNK1A1;COG3;PSMB7;MAPK1;CCN1;PPP3CA;CSNK1G3;FBXO31;TGM2;FEM1B;PPP2R5C;FBXO30;PRKCG;LAMB2;PPM1H;KTN1;MFGE8;STK24;ST8SIA6;STT3B;MGAT4A;CDK5;PTPN1;VCAN;PTAR1;VHL;MAP4K4;AGA;EIF2AK3;FBXO4;PPP1CA;MAPKAPK2;CAND1;SOCS5;APOE;PSMB6;FBXO32;JAK1;YWHAZ;YES1;NEK3;BCKDK;B4GALT5;CPE;UBE2F;PIK3CD;MTMR7;PSMB5;SIRT5;OARD1;METAP1D;PIK3C3;GRK5;STK10;ISG15;DYRK1A;MORC3;ILKAP;PTPRZ1;RAB3A;PNPLA2;UGCG;PRKG2;RET;BMP2;DCAF13;PTK2B;DCAF5;UBE2L3;FBXW2;FBXO44;PPP2R3A;CSNK2A1;STK38;EVA1A;AKT2;PTPRC;FBXW7;UBL5;FBXL18;PPP1CC;TNC;RAB11B;CDH2;PSMB8;PIK3R4;ACVR1C;PPP4R2;ST8SIA2;PKN3;MT3;LIMK1;RAB1B;RHBDD1;GOLM1;TAB1;PSMC4;ICMT;KLHL22;KBTBD7;PHKA2;PSMD11;KLHL3;PRKACA;CTTNBP2NL;ALG10B;ASB13;MKNK2;PHEX;TAOK3;GPS1;ST6GALNAC2;PIGK;ATG5;CISH;CHRDL1;MAST2;SOCS3;IGFBP4;PTEN;COQ8A;LATS1;DUSP6;ST3GAL2;PSMB4;WDR45B;PSMD14;KCTD6;STRADA;TAOK1;HUNK;PTPN6;ATE1;CCNF;C3;PRAG1;STK26;CTDNEP1;CDK16;FBXL4;RAB11A;DSP;CDK6;CKAP4;MAPK3;MATN3;BTK;FBXW5;MARK3;STK17B;SIRT7;JAK3;HCK;PPM1L;PSMD10;LCMT1;TRIB2;PPP2R5B;PARP8;ENGASE;COPS6;CALU;COG7;CSNK1D;MAP3K6;DYRK2;PPP2CA;CHEK1;KLHL11;SYK;RCE1;ROCK1;PSME1;CDKL4;PTPRF;F13A1;DUSP1;KLHL25;FYN;CHM;ASB1;JMJD4;CCDC22
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.2809313875452017,-1.2153673206723186,0.07627118644067797,0.5203279087431721,1.0,40/150,16.20%,PDE4D;NTRK3;CAV1;PID1;DAB2IP;SLIT2;PARD3;NIBAN1;LRP6;ENG;RASSF2;PRR5L;CORO1C;SPRED2;UBASH3B;XDH;PAK2;RACK1;PPIA;LYN;PRKCD;NCK1;CALM3;OCLN;SPRY2;CEACAM1;EPHB2;TERF2IP;HSPB1;TWIST1;SH3GL2;GSKIP;DBNDD2;PTPRC;ENPP1;PAQR3;PLPP3;TAB1;FKBP8;DDIT4
prerank,organelle fission (GO:0048285),-0.4076811633909955,-1.2151566609770104,0.21041666666666667,0.5201644639358215,1.0,10/24,29.78%,DNM3;CORO1C;MFF;SEC16B;MTFR2;GDAP1;MIEF1;MUL1;DNM1;DNM2
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.29452757928857337,-1.2144955210414239,0.11645569620253164,0.5210667264119065,1.0,51/110,31.13%,DAB2IP;HJURP;GSN;ABCA1;ICE1;FNIP2;RALB;TFRC;RACK1;IAPP;ANKRA2;RPS3;SRC;APOE;TAL1;AIDA;CDC42EP2;GFAP;HDAC6;VEGFA;SAR1A;BAK1;NCLN;TRAF3IP1;SLF2;LATS1;ATF7IP;HCK;CDC42;LCMT1;SPIDR;AJUBA;SYK;FAF1;BIK;SVIP;PTPN11;ULK1;BBS10;SELP;MPP7;VCP;FARP2;HRK;PARK7;CD36;MMP3;FBLIM1;SH3GLB1;HSPA5;BMF
prerank,mitochondrial transport (GO:0006839),0.3594508822444874,1.2141049099712047,0.18029739776951673,0.8956510006790969,1.0,13/53,13.05%,PITRM1;FLVCR1;COX18;SLC25A5;PPIF;ABCB10;TOMM40;TIMM17A;MTX2;TOMM22;BCL2;MFN2;TMEM14A
prerank,response to iron ion (GO:0010039),0.5001071550019751,1.2133988582139812,0.23839662447257384,0.895767781794089,1.0,3/12,10.41%,BMP6;ACO1;BCL2
prerank,regulation of keratinocyte migration (GO:0051547),-0.4952300169869399,-1.2122758173599542,0.23151750972762647,0.5258071064077374,1.0,5/12,24.54%,MAP4K4;FGF7;PTEN;MAPRE2;EPB41L4B
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3709778137386242,-1.2121432798455085,0.15401785714285715,0.5254485622808194,1.0,11/39,12.41%,RPS15;RPS24;RPS17;RPS16;RPS5;RPS7;RPS28;SURF6;RPS25;RPS27;RRP7A
prerank,actomyosin structure organization (GO:0031032),-0.3109991685207118,-1.2117684222332838,0.13513513513513514,0.5257237115146791,1.0,14/75,8.89%,FRMD5;PGM5;TJP1;RHOA;MYH9;WDR1;F11R;ITGB1;CIT;CDC42BPA;ITGB5;CSRP2;SRC;TMOD3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.41267758156006673,-1.2116839832849595,0.22478991596638656,0.5252780603993886,1.0,8/24,16.07%,B2M;SEC24D;TAP2;BCAP31;SEC23A;SEC31A;SEC24B;SEC13
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3767597561917826,-1.2113500354820863,0.19313304721030042,0.5254987255267602,1.0,10/30,11.83%,BCL2L1;CD44;CXCL12;TPT1;RPS3;ACKR3;FBXO5;TWIST1;DYRK1A;CD74
prerank,protein localization to cell surface (GO:0034394),-0.3979791165895361,-1.211203829266014,0.18625277161862527,0.5252517557388264,1.0,9/26,16.42%,VCL;SMURF1;PTPRK;FLNA;EMP2;FGF7;JAM3;UNC50;PIGK
prerank,postreplication repair (GO:0006301),-0.35077155630837265,-1.210858902908256,0.16560509554140126,0.5255057893702074,1.0,17/45,22.58%,RPA1;UBC;UBE2V2;RPS27A;UBB;TRIM25;ZBTB1;WDR33;ISG15;USP43;UBE2A;RPA2;PRIMPOL;USP10;PCLAF;RFC4;POLD4
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4492386224800924,-1.21071370885255,0.21651785714285715,0.5252471085350514,1.0,8/17,13.74%,CAV1;KLF7;AJAP1;PRKX;CEACAM1;APOLD1;CD24;MAFF
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.45437339971700175,1.2106620364517198,0.25,0.9039870206821882,1.0,7/17,19.71%,BMP6;TRIM5;CACTIN;SASH1;PRKCA;CX3CL1;NFKBIL1
prerank,synapse assembly (GO:0007416),0.34163094036919395,1.2105096484688351,0.16460176991150444,0.9020253506365024,1.0,14/67,12.49%,SDK1;OBSL1;SDK2;NLGN2;PCDHB11;FLRT3;WNT7A;CBLN4;GRID2;NLGN3;GPM6A;FZD5;PCDHB3;BDNF
prerank,epithelial cell development (GO:0002064),0.45399813158720964,1.2104249230242439,0.22709923664122136,0.8998600921566731,1.0,6/20,12.70%,WNT5B;WNT7A;RILPL2;RILPL1;DACT2;PDZD7
prerank,canonical glycolysis (GO:0061621),0.4218626000774959,1.210264956754341,0.18681318681318682,0.8953826335349202,1.0,9/24,20.39%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4218626000774959,1.210264956754341,0.18681318681318682,0.8953826335349202,1.0,9/24,20.39%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,cellular response to hormone stimulus (GO:0032870),0.34465513621991617,1.2100017339331082,0.1875,0.8938773719411957,1.0,8/69,4.37%,ATP1A2;SLC5A5;TFPI;GCK;THRB;CYP11B1;BRD8;ADRA2A
prerank,pore complex assembly (GO:0046931),0.45755454248441274,1.2099168532695392,0.22862453531598512,0.8916966383881928,1.0,3/19,5.72%,AFDN;PLEKHA7;GSDMD
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3689168111911361,-1.2097041922431488,0.16596638655462184,0.5270441739585808,1.0,10/36,14.54%,SGMS1;DAB2IP;FAS;CRADD;PPIA;RPS3;PTPMT1;CSNK2A1;MADD;NR4A2
prerank,positive regulation of bone mineralization (GO:0030501),0.3902375106582782,1.2095727334291302,0.20848708487084872,0.8905220372892073,1.0,8/35,8.79%,BMP7;BMP6;WNT4;OSR1;BMPR1A;FZD9;PKDCC;ADGRV1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.45264508779952245,1.2095405222976583,0.21414913957934992,0.8881771509320244,1.0,3/19,8.03%,IGF1;NLRP2B;NLRP3
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5011401613035128,-1.209380522775346,0.2605210420841683,0.5271539738972689,1.0,3/11,6.22%,PID1;TFRC;VAT1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.2959015856621924,-1.2092329787907132,0.11471321695760599,0.52689117271233,1.0,28/113,13.82%,NRP1;TEK;BMP5;NRP2;BMPR2;PTN;VEGFC;CDH13;F3;EGFR;BMP4;AKT3;KDR;TBX1;PRKD1;WNT5A;PPP1R16B;MDK;FLT4;FGF2;AGGF1;FGF7;PIK3CD;NRAS;BMP2;ECM1;NME2;VEGFA
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3794334180418443,1.2085688239641372,0.1895910780669145,0.8894019243624235,1.0,8/41,9.07%,PTGS1;ACSL1;DAGLA;PLA2G4C;PNPLA8;GSTM2;PTGR1;ABCD1
prerank,regulation of transmembrane transport (GO:0034762),-0.37440152520544573,-1.2084958772742738,0.1912442396313364,0.5279711600855745,1.0,10/31,16.03%,ACTB;SLC2A1;NEDD4L;KCNJ2;OCLN;KCNJ12;ACE2;KCNJ8;KCNJ15;CTTNBP2NL
prerank,protein autoubiquitination (GO:0051865),0.35278084338718463,1.208431533165886,0.18297101449275363,0.8874843034695512,1.0,15/61,20.65%,RNF220;DDB2;SH3RF2;RNF41;TRIM71;RNF10;RNFT1;OBI1;RNF213;MDM2;RNF13;TRIM13;BFAR;NFX1;RNF146
prerank,positive regulation of myelination (GO:0031643),-0.49318226628320994,-1.2084297060097235,0.25748502994011974,0.5274833109526874,1.0,2/11,3.66%,PARD3;TNFRSF1B
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2949575979492059,-1.2083652372780023,0.13736263736263737,0.5270073256707201,1.0,31/119,18.23%,PIP5K1B;PIP4K2A;RAB14;INPP4A;PIK3R1;TTC7A;SOCS2;PIK3C2A;PLCG2;BMX;PLEKHA8;PIK3R6;EFR3B;PLEKHA4;INPP5D;PIK3CA;FGF2;SOCS5;PIGC;PIK3CD;MTMR7;FIG4;PIK3C3;MTMR12;PIK3R4;PI4KB;MTMR1;CISH;SOCS3;PTEN;PIGL
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.4054709663284013,-1.2081763500849907,0.18840579710144928,0.5268344095376363,1.0,10/21,24.73%,NGF;AIM2;GRIN2B;BIRC3;MT3;USP50;GRIN1;BEX3;FYN;EPHA7
prerank,UV-damage excision repair (GO:0070914),0.49480668485258095,1.20802112055883,0.23974082073434125,0.8866660630277579,1.0,2/12,3.27%,DDB2;ERCC1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3837254810804976,1.207943251230476,0.20357142857142857,0.8845365651558177,1.0,13/41,21.27%,SYT11;IGF1;C5AR2;ARG2;NLRC3;CACTIN;DICER1;HAVCR2;RARA;CX3CL1;SIRPA;NFKBIL1;ILRUN
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.37924846515242333,1.2078050289258697,0.20034843205574912,0.8826625963072346,1.0,13/43,21.27%,SYT11;IGF1;C5AR2;ARG2;NLRC3;CACTIN;DICER1;HAVCR2;RARA;CX3CL1;SIRPA;NFKBIL1;ILRUN
prerank,ephrin receptor signaling pathway (GO:0048013),-0.31162459515084956,-1.2074049518686922,0.1330049261083744,0.5281011678234245,1.0,36/82,27.46%,ACTB;ARHGEF28;RHOA;ACTG1;ANKS1A;CHN1;AP2B1;LYN;GRIN2B;EFNA5;SRC;TIAM1;VAV2;YES1;EPHB2;AP2A1;ARPC2;GIT1;MMP2;GRIN1;PSEN2;CDC42;PSENEN;EPHB6;ARPC3;ROCK1;FYN;RASA1;AP2M1;EPHA7;PTPN11;ACTR3;VAV3;EFNA2;ARPC1B;DNM1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.36231556732878695,-1.2072287167794737,0.18021978021978022,0.5279136618935469,1.0,7/39,8.77%,PTPRG;PODXL;JAG1;CDH1;CEACAM1;EFNA5;SRC
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4594078937568765,1.2072260515394926,0.22666666666666666,0.8824827674020301,1.0,8/17,19.13%,EMC2;EMC4;BAG6;MMGT1;GET1;UBL4A;EMC10;EMC1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.382617930603661,-1.2071153613896464,0.19956616052060738,0.5275488401152459,1.0,6/27,9.60%,BMPR2;ACVRL1;DACH1;TNKS;FGF2;HMBOX1
prerank,synapse organization (GO:0050808),0.31014257451201616,1.2069791535918624,0.14098360655737704,0.8809675105165381,1.0,12/125,3.51%,SDK1;SLC6A1;UNC13C;SLC8A3;CACNB1;CACNB3;OBSL1;PDZRN3;SDK2;NLGN2;PCDHB11;FLRT3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.48102400740799184,-1.2068506049116259,0.24949698189134809,0.5275491042739313,1.0,7/13,31.48%,TMEM30A;SEC16B;BCAP31;SAR1A;EDEM2;EDEM1;TMEM30B
prerank,mRNA metabolic process (GO:0016071),0.3353460115311006,1.2067873498804729,0.13752122241086587,0.8793603284706937,1.0,18/90,14.28%,HSPA1A;DDX5;CPSF3;SRSF5;CPSF6;HNRNPA2B1;PRMT9;SON;PTBP1;LSM5;PPARGC1A;SRRM4;SLBP;LSM11;AGO3;USP39;SRSF11;HSPA1B
prerank,cellular response to increased oxygen levels (GO:0036295),-0.49228839099428223,-1.2065843353809462,0.23578947368421052,0.5275311790557162,1.0,4/11,8.36%,CAV1;FOXO1;FAS;ATP6V0D1
prerank,regulation of intracellular signal transduction (GO:1902531),-0.2508428184404116,-1.2064491842620302,0.023026315789473683,0.5272105135988984,1.0,63/420,9.37%,ARHGAP31;SGMS1;ARHGAP10;VWF;TEK;NTRK3;RHOJ;CHN2;DAB2IP;PIP5K1B;ARAP2;SRGAP1;RHOA;TMSB4X;TRAF5;NET1;HIPK1;ARHGEF3;RPA1;PIP4K2A;MCF2L;RASSF2;STK3;STARD8;CHN1;EGFR;NFKBIA;BCR;MOB3B;RASGRF2;ARAP3;RPL5;STARD13;TIAM2;PLCG2;KAT6A;TNIK;NUAK1;ARAP1;ARHGEF2;PAK2;WNT5A;ARHGAP32;ARHGDIB;PDE2A;LYN;PPP1R16B;ARHGAP35;MAPK1;MYOC;PPP2R5C;CEACAM1;USP7;RBBP4;CDK5;ABR;XIAP;ATP6AP2;TIAM1;MAP4K4;VAV2;IER3;ARHGEF12
prerank,regulation of interleukin-10 production (GO:0032653),-0.3511522520947893,-1.2062057818629337,0.18202247191011237,0.5271688420317212,1.0,20/44,33.08%,CD34;STAT3;PLCG2;TNFRSF21;ISG15;PIBF1;CD46;NOD2;JAK3;HMGB1;TRIB2;SYK;FCGR2B;DLL1;TLR4;LGALS9;VSIR;TSLP;CD47;TYROBP
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.38215058141362673,1.2056685740692425,0.19148936170212766,0.8810359234373103,1.0,8/36,9.08%,AFDN;VAMP5;OPTN;RILPL2;RILPL1;GGA2;NSF;AMN
prerank,dopamine metabolic process (GO:0042417),0.44654652701853154,1.2056395714519015,0.23346303501945526,0.8787754229039477,1.0,4/18,11.40%,MOXD1;SNCAIP;DRD3;COMT
prerank,arachidonic acid secretion (GO:0050482),0.5194866192174254,1.204780830870926,0.25,0.8774023497221617,1.0,3/10,8.73%,BDKRB2;PNPLA8;DRD3
prerank,arachidonate transport (GO:1903963),0.5194866192174254,1.204780830870926,0.25,0.8774023497221617,1.0,3/10,8.73%,BDKRB2;PNPLA8;DRD3
prerank,regulation of cholesterol efflux (GO:0010874),-0.39188282650972683,-1.2047754831811186,0.19015659955257272,0.5298896130926417,1.0,13/30,21.58%,CAV1;NFKBIA;PLTP;ZDHHC8;TTC39B;ABCA3;APOE;SREBF2;PTCH1;LRP1;NAXE;YJEFN3;EEPD1
prerank,translesion synthesis (GO:0019985),-0.35567656177403045,-1.2046079356008148,0.16702819956616052,0.5296683528842777,1.0,22/42,29.64%,RPA1;UBC;RPS27A;UBB;REV3L;TRIM25;ZBTB1;ISG15;MAD2L2;USP43;RPA2;PRIMPOL;USP10;PCLAF;RFC4;POLD4;DTL;UFD1;RFC2;VCP;RCHY1;FAAP20
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.40147417126647456,-1.204410950464389,0.20930232558139536,0.5295139145713857,1.0,6/24,12.51%,GHR;NOTCH1;CYP1B1;HES1;PIBF1;PTK2B
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.45975673937329786,-1.2033648824285728,0.22727272727272727,0.5315163866149967,1.0,6/13,28.87%,UBE2J1;BCAP31;OS9;SVIP;EDEM2;EDEM1
prerank,positive regulation of ion transport (GO:0043270),0.3647554488843712,1.2022535454539864,0.19584055459272098,0.8845990791368804,1.0,7/48,5.33%,CACNA1D;ACTN2;ANK2;WNK3;ADRA2A;DLG1;VAMP7
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4922662740085478,1.2021803891135034,0.263671875,0.8825296616828364,1.0,5/13,18.26%,GTPBP1;LRRK2;RHOQ;RAB23;AK3
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.35317012764327715,1.2019461303631336,0.1996527777777778,0.8810689515907054,1.0,14/57,16.59%,ADCY5;ADCY1;ADRA2A;CHRM2;ADCY8;LPAR1;DRD3;GABBR1;GPR37;HTR1F;CHRM1;OPRM1;HTR1A;GRM8
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.42679846567517254,1.2017503947293575,0.21641791044776118,0.8795281812459007,1.0,5/24,8.19%,IGF1;PPP1R3F;GCK;PASK;SORBS1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4463621097926858,1.201747304267681,0.2361904761904762,0.8772177074890682,1.0,7/19,17.34%,ALDH1L1;SLC19A1;MTHFS;MTHFD1;MTHFR;FPGS;MTHFD2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.467757408016899,1.2011879412005664,0.265748031496063,0.8770457009070032,1.0,5/16,6.95%,TGFBR3;IGF1;BMPR1A;RBPJ;FGFR2
prerank,negative regulation of cation channel activity (GO:2001258),0.408739796018472,1.2011060833181235,0.20930232558139536,0.875013138671053,1.0,6/26,11.59%,SLC6A9;CRHR1;GNB5;GSTM2;DRD3;GSTO1
prerank,response to prostaglandin E (GO:0034695),0.5227986848009962,1.2005338604992617,0.256198347107438,0.8747467925809204,1.0,1/10,0.29%,TGFBR3
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.358542076499037,-1.2005118190634854,0.20776255707762556,0.537736387655846,1.0,13/39,17.11%,PIP4K2A;PIK3R1;TTC7A;SOCS2;PIK3C2A;EFR3B;PIK3CA;SOCS5;PIK3CD;PIK3C3;PI4KB;CISH;SOCS3
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3424736669088516,-1.2003442004380518,0.18306636155606407,0.5374828476504211,1.0,15/50,16.53%,PLCB4;PLCE1;RHOA;PLCL1;PIK3R1;NGF;PIK3C2A;TNFAIP8L3;PIK3CA;PIK3CD;EXOC1;PIK3C3;IRS1;CSF1R;PI4KB
prerank,nucleic acid-templated transcription (GO:0097659),0.37439138721108783,1.2002715426949218,0.20186915887850468,0.8734703329152754,1.0,16/42,23.54%,THRB;RRAGC;DTX1;E2F1;CREBL2;DRG1;TOPORS;XAB2;TERT;POLR2D;RNPS1;MEF2A;POLR2A;BAZ2A;MMS19;POLR2B
prerank,2-oxoglutarate metabolic process (GO:0006103),0.48438981780678253,1.1999058564745086,0.2254335260115607,0.8726044715336622,1.0,4/13,15.79%,ADHFE1;GOT1;IDH2;GOT2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.47451127062017795,1.1994685705097756,0.2509505703422053,0.8719114846018947,1.0,6/15,18.79%,SH3D19;FURIN;ADRA2A;NRDC;SNX33;SNX9
prerank,cell projection organization (GO:0030030),-0.3821674300174218,-1.1990806754475372,0.19777777777777777,0.5399441223649973,1.0,10/30,21.07%,RHOJ;GSN;PARVB;ITGB1;PARVA;CAPG;NPHP1;NCKAP1L;CDC42;RAC3
prerank,glycerol metabolic process (GO:0006071),0.5369305708367018,1.198768317481842,0.26043737574552683,0.872183746194371,1.0,5/10,20.39%,GK;TKFC;GOT1;COQ3;TPI1
prerank,ventricular septum development (GO:0003281),-0.3599053552209569,-1.1980892134872982,0.2108843537414966,0.5417480324642129,1.0,12/37,8.58%,BMPR2;SLIT2;ACVR1;TGFB2;NOTCH1;TGFBR2;HES1;PDE2A;HEYL;STRA6;HEY2;ZFPM2
prerank,skeletal muscle tissue development (GO:0007519),-0.37557675454350614,-1.1980028895384354,0.21226415094339623,0.5413395515566652,1.0,5/32,5.91%,MEF2C;CAV1;SVIL;SIX1;MYL6
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4941108730181425,-1.1977851859666238,0.23711340206185566,0.5412443343477826,1.0,2/11,4.44%,CDH13;PLCG2
prerank,modulation by host of symbiont process (GO:0051851),-0.3790716964512499,-1.1975884342999332,0.23094170403587444,0.541094119493599,1.0,15/31,37.11%,LEF1;JUN;SAP30BP;CHD1;SMARCA4;SNW1;NUCKS1;CCNT1;POU2F3;AQP1;HPN;CCL5;HDAC1;SAP30;CCL4
prerank,regulation of cell differentiation (GO:0045595),-0.27969390589659077,-1.1975139029529158,0.08256880733944955,0.540659528244652,1.0,42/148,21.29%,SLC6A6;LTBP4;SPOCK2;ZFHX3;TRPS1;PHLDB1;RUNX2;NGF;RUNX1;SIX1;RPS6KA3;TBX1;PHLDB2;AR;CBFB;MDK;APC;EMP2;HEY2;TIAM1;VHL;IGF2;NOTCH4;KLF4;CEBPD;EDN3;SUZ12;CD24;ALK;ID2;PA2G4;ATF4;PRKACA;BCL6B;HEY1;GREM1;CDK6;PTHLH;MOSMO;MCRIP1;PPP2CA;ROCK1
prerank,regulation of plasminogen activation (GO:0010755),-0.490145562814902,-1.1973279980860514,0.23481781376518218,0.5404463286816228,1.0,3/12,9.35%,THBS1;RUNX1;SERPINE1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.35378083273456823,-1.1969725219493803,0.1733615221987315,0.5407021078914861,1.0,6/40,7.43%,MEF2C;ZEB1;RHOA;NGF;ARHGEF2;HEYL
prerank,spindle assembly (GO:0051225),-0.3172924002163354,-1.1966038612777385,0.13963963963963963,0.5409661995922856,1.0,20/67,23.01%,RHOA;NEK7;STARD9;FLNA;SMC1A;TNKS;STAG1;RPS3;MAP9;PIBF1;MZT1;STAG2;TOGARAM1;ARHGEF10;RAB11A;MAPRE2;CSNK1D;TPX2;AAAS;KIFC1
prerank,alcohol catabolic process (GO:0046164),0.5266568191440388,1.1962420773111753,0.26204238921001927,0.8793183710513783,1.0,3/10,9.35%,CEL;ADH4;CYP27A1
prerank,error-prone translesion synthesis (GO:0042276),-0.4189240485173781,-1.1962005005857923,0.2157676348547718,0.5412534119868612,1.0,9/21,20.96%,RPA1;UBC;RPS27A;UBB;REV3L;MAD2L2;RPA2;PRIMPOL;RFC4
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3215612340630815,-1.1961968661334719,0.15476190476190477,0.5406255538156801,1.0,16/66,10.48%,PTPRM;CAV1;SPARC;DAB2IP;B2M;TGFB2;THBS1;MTSS1;PTPRK;CASK;XDH;AQP11;CEACAM1;CDKN1C;APOE;CAV2
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.4676423398099572,-1.1958090342334264,0.232,0.5409850261634896,1.0,3/13,3.22%,TBX3;NOTCH1;BMP4
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.47661752151338677,-1.1957587494032034,0.2289156626506024,0.5404861032479465,1.0,6/13,29.59%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.48237115291588506,-1.1957565393843737,0.22700587084148727,0.5398583846524404,1.0,6/12,29.59%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,dopaminergic neuron differentiation (GO:0071542),-0.42145133636153886,-1.195658739684982,0.236,0.5394799456102138,1.0,9/19,32.81%,LRP6;VEGFA;NR4A2;MANF;LMX1B;RYK;LMX1A;WNT2;CTNNB1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4172832513095266,1.195523780869726,0.23062381852551986,0.8796138969504365,1.0,4/23,6.77%,NUPR1;GCK;PPARA;C1QTNF3
prerank,negative regulation of cell differentiation (GO:0045596),0.29477225564839715,1.195433431447492,0.12371134020618557,0.8777018398495481,1.0,27/181,10.07%,RANBP3L;BMP7;RORA;COL5A1;TMEM64;SMAD3;OSR1;OVOL2;CTR9;SUFU;DTX1;PPARA;LRP3;MEIS1;LEO1;HNRNPU;WWTR1;E2F1;CITED1;USF3;PTBP1;MED1;ADGRV1;NR1H3;SPRED3;SOSTDC1;TGFBR1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.34453474950811086,1.1951349755264296,0.17272727272727273,0.8764802896198429,1.0,10/61,12.11%,EYA1;DNMT3L;EYA4;EYA2;SMOC2;OTUD4;ABRAXAS1;MRE11;RTEL1;PML
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.4655266179306673,-1.195087663325662,0.23636363636363636,0.5403945419734965,1.0,5/14,18.05%,ENTPD1;ENTPD6;ENTPD2;ADPRM;NUDT16
prerank,toll-like receptor signaling pathway (GO:0002224),-0.3052696105968966,-1.1945696647158106,0.12590799031476999,0.5409817730052962,1.0,28/84,21.51%,RFTN1;IRAK3;UBC;RPS6KA3;PLCG2;RPS27A;UBB;UBE2D3;MAPKAPK2;CTSB;SFTPA2;SFTPA1;TRIL;PIK3C3;BIRC3;PIK3R4;IRAK2;SCARA3;TAB1;NR1H4;CTSS;BTK;RIPK1;HMGB1;MYD88;TICAM1;NMI;RIPK2
prerank,canonical Wnt signaling pathway (GO:0060070),-0.3137944109435381,-1.1942515028928733,0.15765765765765766,0.5411457621531446,1.0,18/68,14.92%,LEF1;CAV1;LRP6;FZD6;LRP5;SFRP4;CSNK1E;WNT5A;CSNK1A1;APC;PPP1CA;AMER1;FZD4;WNT9A;RARG;FZD1;NR4A2;PLPP3
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.40163900625918136,-1.1939766646693526,0.21568627450980393,0.5411816328689678,1.0,4/23,5.66%,SLC12A7;SLC12A2;ATP6V0A4;SLC12A6
prerank,regulation of synapse maturation (GO:0090128),-0.4980536918287012,-1.1938220798605834,0.24615384615384617,0.5409182440655117,1.0,3/10,10.16%,DAB2IP;ARHGEF15;YWHAZ
prerank,respiratory tube development (GO:0030323),0.39920149961893014,1.1937827969304318,0.2184557438794727,0.8790190078449966,1.0,6/28,6.95%,FGF1;FGF9;LOXL3;CEBPA;PDPN;FGFR2
prerank,regulation of histone modification (GO:0031056),-0.46821487927714733,-1.1934858919008695,0.2540983606557377,0.5411535151584109,1.0,5/13,11.27%,NNMT;HPF1;IGF2;PARG;MYOCD
prerank,positive regulation of calcium ion transport (GO:0051928),-0.36212278823185823,-1.1932210553421025,0.2236842105263158,0.5411599893029698,1.0,7/36,6.52%,CAV1;STIM2;ATP2B1;TRPC3;CACNB2;TRPC6;CXCL12
prerank,cellular response to organic cyclic compound (GO:0071407),0.30055271418227464,1.192834433447808,0.14814814814814814,0.8803655296422532,1.0,16/141,8.34%,ATP1A2;RORA;ADCY5;SLC5A5;ROCK2;IL18;TRPV1;TFPI;ADCY1;RUVBL2;ADCY8;CASP3;KAT5;LRRK2;IMPACT;MED1
prerank,protein oxidation (GO:0018158),0.4872061827822519,1.192779005944669,0.2564102564102564,0.8783237452757567,1.0,3/11,7.13%,LOXL3;SUMF1;LOXL1
prerank,neural tube development (GO:0021915),0.469750755623492,1.1926117273897172,0.2725409836065574,0.8766625184846267,1.0,2/15,5.66%,ALDH1A2;TRIM71
prerank,melanosome organization (GO:0032438),0.4189829261745912,1.1922873584532927,0.22752293577981653,0.875584101174707,1.0,8/26,18.93%,GPR143;SNAPIN;DTNBP1;AP1M1;SHROOM2;HPS1;HPS4;RAB38
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.39338872944233094,1.1921899963476914,0.20226843100189035,0.8737608417545037,1.0,5/30,6.34%,TGFBR3;SMAD3;TWSG1;DKK3;NREP
prerank,homotypic cell-cell adhesion (GO:0034109),-0.35650240904629693,-1.1921238557175557,0.1965065502183406,0.5431964310146467,1.0,12/39,8.66%,ACTB;VCL;ACTG1;MYH9;FN1;ACTN1;FLNA;TJP2;UBASH3B;PPIA;CLIC1;MYL9
prerank,digestive tract development (GO:0048565),-0.3663762072093097,-1.1916538604327398,0.19775280898876405,0.5436764237755898,1.0,9/33,13.91%,RARB;PCSK5;TGFB2;PKD1;GLI3;NIPBL;STRA6;SMO;RARRES2
prerank,bicellular tight junction assembly (GO:0070830),-0.34303737924216066,-1.1909875760087796,0.18181818181818182,0.544668562836898,1.0,11/46,7.76%,PECAM1;CLDN5;ESAM;PARD3;RAMP2;F11R;TBCD;PAK2;CLDN14;OCLN;APC
prerank,regulation of DNA metabolic process (GO:0051052),-0.3452392826050672,-1.1904376381598747,0.1872146118721461,0.5454006312437856,1.0,23/44,34.14%,KAT7;UBE2V2;XRCC5;PARG;TERF2IP;YLPM1;WRNIP1;KPNA2;NBN;SIRT7;NUCKS1;TOM1L1;USP1;HNRNPD;TERF2;WDR18;KPNA1;STOX1;HELB;MYC;PIF1;TICRR;IL7R
prerank,acylglycerol metabolic process (GO:0006639),-0.3594798170197093,-1.19009440979825,0.20898876404494382,0.5456582226300816,1.0,8/37,12.54%,CAV1;ABHD2;DGKH;DGKZ;MGLL;APOE;PNPLA2;ABHD6
prerank,protein localization to chromosome (GO:0034502),-0.3651782584529854,-1.1897865313724065,0.20535714285714285,0.5457568367158349,1.0,10/34,18.16%,RPA1;WAPL;CTCF;ESR1;TNKS;XRCC5;TERF2IP;RAD21;SLF2;RPA2
prerank,autophagy of mitochondrion (GO:0000422),-0.3541265944748118,-1.1893995108465747,0.20824295010845986,0.5460119773891787,1.0,18/38,30.21%,ATG3;WIPI1;GABARAPL2;CISD2;MAP1LC3B;RB1CC1;SQSTM1;PHB2;GABARAP;ATG12;ATG5;WDR45B;ULK2;ULK1;FUNDC2;ATG14;WIPI2;USP30
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.24430882638784288,-1.189266865154761,0.050387596899224806,0.5456967810327213,1.0,100/497,14.83%,MECOM;LEF1;FOXP1;LIMS1;ATP8B1;BMPR2;DAB2IP;ZBTB16;ELK3;ZEB1;FOXP2;MDFIC;ACVRL1;PPARD;WWP1;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;WAPL;GAS6;RUNX2;LIMD1;CTCF;ZHX3;ID1;BMP4;PRDM16;CRY1;L3MBTL3;PTPRK;DACH1;GLI3;JUN;KAT6A;CBFA2T3;BHLHE40;CREB3L1;CCDC85B;KCTD1;NIPBL;PSPC1;WNT5A;RACK1;HES1;XRCC5;TWIST2;SP3;DAP;HEYL;FOXN3;NACC2;PRDM5;MYBBP1A;CD38;RPS3;HDAC9;SPEN;YWHAQ;CDKN1C;HEY2;NAB1;ZFPM2;CDK5;EIF2AK3;HMBOX1;AHR;CIR1;KLF4;S100A11;GCLC;PER1;TLE5;SOX7;TWIST1;ATXN1;PDCD4;PHB2;HHEX;SOX18;SYNCRIP;BMP2;POU2F1;SAP18;USP47;TBX2;NACC1;HDAC6;NFIL3;ENPP1;SUV39H1;RBFOX2;MTERF3;ZNF318;YAF2;TIMELESS;MT3;SPINDOC;ARID5A
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4100300211880253,1.1891979797377008,0.22180451127819548,0.8825215448959935,1.0,9/27,16.09%,PLAAT5;LPIN1;ETNK2;PNPLA8;PCYT2;CHKB;PLA2G15;NAAA;PLAAT3
prerank,plasma membrane repair (GO:0001778),0.485823116416229,1.1890055940936228,0.24206349206349206,0.8810487334384928,1.0,3/13,6.61%,SYT11;ANXA6;MYOF
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.44948915343235063,-1.188869835679557,0.25481798715203424,0.5459934012762861,1.0,8/15,13.82%,TJP1;BMPER;ITGA5;SMAD1;FGF2;KLF4;JAK1;VEGFA
prerank,embryonic digestive tract development (GO:0048566),-0.4250929364825404,-1.1888095611477267,0.2280334728033473,0.5455082668875773,1.0,6/18,7.63%,RARB;PCSK5;TGFB2;GLI3;NIPBL;STRA6
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4444149488459622,1.1887441205546991,0.24293785310734464,0.8797883242966071,1.0,2/20,5.27%,IGF1;PAX6
prerank,icosanoid biosynthetic process (GO:0046456),-0.4924146550584925,-1.1886082506631148,0.2504970178926441,0.5453695442148704,1.0,1/10,0.90%,PLA2G4A
prerank,transcription by RNA polymerase I (GO:0006360),-0.36773436766863793,-1.1875839010290972,0.2210065645514223,0.5472197843002179,1.0,16/34,30.12%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;MAPK3;POLR1A;UBTF;CCNH;POLR1H;POLR2F;POLR1E;POLR2H;POLR1C;POLR2E
prerank,positive regulation of cytokine production (GO:0001819),-0.2552565448523653,-1.1873476510739482,0.06687898089171974,0.5471356466303183,1.0,80/292,23.27%,SPTBN1;FOXP1;PDE4D;IL6ST;IL1R1;RFTN1;LRRFIP1;CD200;F3;CYP1B1;CD34;POLR3F;AFAP1L2;RUNX1;STAT3;SLC7A5;APP;PTGS2;NOD1;PLA2R1;TMED10;PLCG2;DHX33;ARHGEF2;GBP5;WNT5A;S100A13;XRCC5;IL6R;ANXA1;MDK;RPS3;CCBE1;G3BP1;SOD1;FLT4;EIF2AK3;SERPINE1;IL15;MALT1;PIK3CD;TWIST1;ISG15;POLR3H;PIBF1;CD74;AGPAT1;CD40;PTPRC;CD86;IFIH1;NR1H4;CSF1R;ATF4;NFKB2;CD46;POLR3B;GAPDH;NOD2;IL33;C3;IRF5;RIPK1;POLR3A;HMGB1;MYD88;ZBP1;POLR3D;CADM1;TICAM1;SYK;RIPK2;PAEP;GLMN;HPSE;MAPK11;CD276;ZFPM1;BCL10;POLR2F
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.34362201932777237,-1.1872267490290773,0.20652173913043478,0.5468386017076404,1.0,9/48,9.72%,NRP1;LIMS1;LIMS2;DOCK1;FLNA;FBXW8;MDK;MYOC;NEDD9
prerank,regulation of small molecule metabolic process (GO:0062012),0.4057791892025073,1.186750862407802,0.2244165170556553,0.8850070646746493,1.0,8/28,16.53%,RORA;PPARA;PDK2;PANK2;PDK1;EPHX2;SIRT1;NCOR2
prerank,regulation of proteolysis (GO:0030162),-0.3397856926046189,-1.186728501298458,0.19907407407407407,0.5474900187543865,1.0,13/48,15.38%,CAV1;LTBP4;DNAJC1;SPOPL;CST3;PERP;CDK5;GSAP;HDAC6;IST1;TBC1D10A;PLAUR;BAK1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4298677443513814,-1.1866851375319993,0.22950819672131148,0.5469648285414069,1.0,8/18,19.30%,MDFIC;MFHAS1;CTNNA1;APOD;OTUD7B;LATS1;POLR1A;CABP1
prerank,autophagosome assembly (GO:0000045),-0.3313490611270783,-1.1865145651501952,0.17671517671517672,0.5467522152433665,1.0,15/52,18.91%,ATG3;SMURF1;WIPI1;GABARAPL2;MAP1LC3B;RB1CC1;ATG16L1;PIK3C3;UBXN2A;GABARAP;RAB1B;ATG12;ATG5;WDR45B;EMC6
prerank,response to lipopolysaccharide (GO:0032496),-0.2772299001273041,-1.1864759393195274,0.13150684931506848,0.5462290501537582,1.0,35/138,23.22%,FOXP1;MEF2C;DAB2IP;NOS3;RHOA;SCARB1;IRAK3;TNFRSF1B;RPS6KA3;DEFA6;TNFRSF11A;GCH1;CARD16;WNT5A;SRR;SERPINE1;MAPKAPK2;PAF1;PDCD4;LIAS;CD86;GIT1;IFNAR1;NOD2;ERBIN;ZC3H12A;HMGB1;GGT7;MYD88;TICAM1;SBNO2;CASP1;GGT1;SMAD6;BCL10
prerank,negative regulation of hormone secretion (GO:0046888),-0.5017132883229654,-1.1857820915453345,0.25763358778625955,0.5472876787954544,1.0,3/10,17.52%,RAB11FIP5;RAB11FIP1;RAB11FIP3
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.26650631024809124,-1.1857393846433992,0.10086455331412104,0.5467708113334452,1.0,49/199,17.52%,PTPRG;MEF2C;BMP5;BMPR2;DAB2IP;NOS3;ATP2B1;PLCL1;RPS6KA5;NOTCH1;GAS6;EGFR;SDHAF2;CORO1C;ID1;BMP4;ADAMTS5;TBX18;IL17RD;KLF7;RAB11FIP5;SPRED2;ARHGDIB;NPTN;TLE3;NOVA2;RAB11FIP1;MDK;SPRY2;HDAC9;HEY2;VASN;IL15;MYOCD;ADM;PTCH1;BMP2;ABHD6;LNPEP;SPRY1;ACVR1C;MAD2L2;NR1H4;BRCA2;ATF4;HEY1;N4BP1;PTEN;RAB11FIP3
prerank,stem cell differentiation (GO:0048863),0.36782245327809177,1.185624852939498,0.2158273381294964,0.8870166493749115,1.0,10/39,10.98%,OSR1;DNMT3L;KIT;LMBR1L;WNT7A;FGFR2;JARID2;HOXB4;GPM6A;BATF
prerank,catecholamine biosynthetic process (GO:0042423),0.5044098292154243,1.1853872533481005,0.2842323651452282,0.8857028078311784,1.0,1/11,0.23%,MOXD1
prerank,peptide metabolic process (GO:0006518),0.33480274144696365,1.1853308698604132,0.1879310344827586,0.8837329133508829,1.0,6/75,3.24%,AEBP1;ADAMTS13;CPQ;CPN1;ETHE1;FURIN
prerank,carbohydrate biosynthetic process (GO:0016051),-0.41560906521606356,-1.1852901525190542,0.25413223140495866,0.5472207632244995,1.0,5/21,8.21%,ST3GAL4;ST3GAL6;FUT8;ST6GALNAC5;ST8SIA6
prerank,regulation of nervous system process (GO:0031644),0.4484184606015577,1.1849343291162373,0.2565130260521042,0.8830373308942668,1.0,3/18,4.08%,SLC8A3;ROCK2;NPTX1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.30097461190942626,1.1848572694083976,0.15609756097560976,0.8811370995729176,1.0,18/142,9.59%,ATP1A2;ADCY5;CCR9;ACKR2;SMAD3;PDGFRA;TAC1;C5AR2;BDKRB1;LPAR2;BDKRB2;ADCY8;FZD9;LPAR1;DRD3;PTGER1;DLG4;C3AR1
prerank,mitochondrial membrane organization (GO:0007006),0.394301960897031,1.1846171813221287,0.23314065510597304,0.879879195955776,1.0,11/32,17.15%,SLC25A5;PPIF;CHCHD3;MTX2;APOO;BCL2;MICOS10;MFN2;TMEM11;APOOL;HSPA9
prerank,organophosphate ester transport (GO:0015748),-0.38977927476497215,-1.1844231330516604,0.2222222222222222,0.5487141692094457,1.0,7/24,7.63%,PITPNC1;SCARB1;PLTP;TNFAIP8L3;NPC2;MTTP;ABCA3
prerank,regulation of smooth muscle contraction (GO:0006940),-0.418211733569031,-1.1843351318980329,0.2531914893617021,0.5483043362301931,1.0,3/20,1.53%,CAV1;PLCE1;ATP2B1
prerank,positive regulation of protein maturation (GO:1903319),-0.4963543065899537,-1.18424587200612,0.27346938775510204,0.5479153564953184,1.0,3/11,15.00%,NKD2;CCBE1;RHBDD1
prerank,cobalamin metabolic process (GO:0009235),-0.42766502508057447,-1.1840587711263535,0.2402464065708419,0.5477576246012252,1.0,4/17,8.59%,ABCC1;LMBRD1;MMADHC;CUBN
prerank,sulfate transport (GO:0008272),0.47425322696625816,1.1836279338641287,0.27099236641221375,0.8811531207128268,1.0,3/14,6.01%,SLC13A4;SLC26A1;SLC25A11
prerank,polarized epithelial cell differentiation (GO:0030859),-0.47409322965161027,-1.1834547871448142,0.252,0.54859173065502,1.0,5/13,21.28%,RHOA;RAP2A;ZDHHC7;CDC42;MSN
prerank,mitochondrion organization (GO:0007005),0.2968682138234262,1.183144977333157,0.14896988906497624,0.8808527604858252,1.0,37/165,14.67%,IFIT2;TRAK1;MIGA2;SPATA18;ESRRA;PITRM1;NIPSNAP2;POLRMT;AFG3L2;AIFM1;COX7A1;TOMM40;SUPV3L1;CHCHD3;MIEF2;FMC1;TIMM17A;NDUFS1;ADCK1;LRRK2;MTX2;COX7A2L;WASF1;PPARGC1A;TOMM22;MYH14;AFG1L;MPV17;CYCS;SSBP1;MFN2;GABPA;ATAD3A;TERT;TMEM11;AIFM2;GABPB1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.38199251011001206,-1.1825172118580558,0.24032586558044808,0.5501972515270799,1.0,10/27,17.41%,DCN;CSGALNACT1;CSPG4;VCAN;XYLT1;CHSY3;BGN;B3GAT1;B3GAT3;NCAN
prerank,organelle fusion (GO:0048284),0.42016720454554285,1.1821990260902369,0.24803149606299213,0.8821652469127729,1.0,8/22,20.76%,MIGA2;AFG3L2;CHCHD3;MIEF2;MFN2;STX4;MIGA1;BAX
prerank,import into cell (GO:0098657),0.3695267918238831,1.1817574125576176,0.225177304964539,0.8815175479191832,1.0,5/41,3.99%,ATP1A2;SLC6A13;SLC5A3;SLC29A2;SLC38A1
prerank,ventricular septum morphogenesis (GO:0060412),-0.38432147848066245,-1.1798460842231477,0.21784232365145229,0.5560651975294598,1.0,11/27,8.58%,BMPR2;SLIT2;ACVR1;TGFB2;NOTCH1;BMP4;TGFBR2;HES1;HEYL;HEY2;ZFPM2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.38667785196986315,1.1792153672013672,0.2335216572504708,0.8887123046003438,1.0,5/32,4.10%,IGF1;NUPR1;PRKAA2;PPARA;ENO1
prerank,visual system development (GO:0150063),0.3827511548793402,1.1792023101457607,0.2332730560578662,0.8866207951033641,1.0,16/37,19.53%,SMOC1;PBX2;MEIS1;PAX6;MAB21L2;PBX4;ZDHHC16;CPAMD8;FOXC1;ADAMTS18;ITGAM;RBP4;HIPK2;C1QA;SOX2;MEIS3
prerank,cellular response to lipid (GO:0071396),0.2863760200609587,1.179142665268384,0.15431164901664146,0.8847300096211165,1.0,28/191,12.34%,ATP1A2;RORA;ADCY5;ROCK2;TFPI;PABPN1;CTR9;WNT5B;PTK7;ADCY1;RUVBL2;TNIP3;ADCY8;WNT6;HTRA2;KAT5;NLRP3;MED1;TNIP2;CACTIN;NR1H3;FZD7;LCOR;MAPK14;CDC73;SOX9;KCNK4;SPHK2
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.4502931759270147,-1.1791354521883306,0.24116424116424118,0.5571604415750575,1.0,5/14,20.25%,ADAM10;ADAM19;DYRK1A;PSEN2;PSENEN
prerank,mesonephric tubule development (GO:0072164),0.4545516550736168,1.1791296926353152,0.26346153846153847,0.882650766819905,1.0,4/15,6.95%,BMP7;OSR1;NPNT;FGFR2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.4017726500305081,-1.179116981997947,0.24444444444444444,0.556576097062837,1.0,9/22,15.73%,RPS15;RPS20;PLA2R1;SPRED2;UBB;RPS7;RPL23;EEF1E1;RPL37
prerank,positive regulation of response to stimulus (GO:0048584),-0.35719247998563425,-1.178910426397204,0.18414918414918416,0.556439418687982,1.0,18/40,26.05%,B2M;TGFB2;WNT5A;PRKCD;ABI3;IL15;CDKN2AIP;EEF1E1;RSAD2;IFIH1;FMR1;FXR1;YPEL3;NSMCE4A;FCGR2B;TAF9;IER5;SELENON
prerank,pentose-phosphate shunt (GO:0006098),-0.483086039746338,-1.178655574727967,0.2647058823529412,0.556411689178639,1.0,5/11,25.90%,PGM2;RPE;DERA;RBKS;H6PD
prerank,organelle organization (GO:0006996),-0.2460097853995754,-1.1783404896568421,0.06191950464396285,0.5565489202178652,1.0,70/388,12.97%,FMNL2;ARHGAP10;SYNE1;CAV1;ATP8B1;FGD5;SEMA6A;PLCE1;MICAL2;MARK1;NOS3;FGD6;DST;RAB14;ATL3;TMEM135;LIMD1;VPS13C;ARAP3;PALLD;FAF2;LMAN2L;RAB31;TMED10;USP6NL;FAM161A;TNIK;CHMP2B;SIPA1L3;MAST4;ATXN7;PRKD1;PPIA;NRF1;FBXW8;CHMP4B;CHMP4A;CSNK1A1;COG3;SEC16B;MDK;ABCA3;CCL13;CNN2;ABCD2;CXADR;PEX7;BRWD1;ZFYVE16;ATP5F1B;EIF2AK3;APOE;NEDD9;SORT1;GOLPH3;CAV2;CFL1;SIRT5;BAG5;SEC31A;PHB2;FNBP1L;RANBP9;NECTIN2;UBXN2A;VPS13D;SIPA1;SEC61A1;STX7;ODF2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.29393712880683653,-1.1778309198231538,0.14742014742014742,0.557191254645642,1.0,30/86,26.29%,APP;WDR1;CDC42EP5;CDC42EP3;MET;NCK1;OCLN;RPS3;SYNPO2;APOE;GPX1;EDN1;CDC42EP2;PTK2B;PFN1;TRPV4;CLIP1;LIMK1;KATNB1;NCKAP1L;SEMA5A;TOGARAM1;FCHSD1;HCK;DCTN1;CDK5RAP2;FES;PRKCE;CARMIL1;AKAP9
prerank,cellular response to interleukin-1 (GO:0071347),-0.27803524780963995,-1.1774979228579645,0.11911357340720222,0.5574145026252305,1.0,39/143,23.25%,DAB2IP;IL1R1;RPS6KA5;PTGIS;NFKBIA;IRAK3;UBC;NOD1;RPS27A;UBB;PSMA6;PSMB7;CCL13;IL1RAP;PSMB6;PSMB5;SQSTM1;CD40;PSMB8;IRAK2;TAB1;PSMC4;PSMD11;ADAMTS12;MAP3K8;PSMB4;PSMD14;NOD2;CCL25;USP10;MAPK3;ZC3H12A;PSMD10;MYD88;PSME1;RIPK2;HAS2;MAPK11;PSMB3
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4605520017034339,-1.1772898845706223,0.27692307692307694,0.5572467488346398,1.0,5/13,14.67%,ENTPD1;ENTPD6;ENTPD2;ENPP1;SMPDL3A
prerank,cellular glucose homeostasis (GO:0001678),-0.3466224887786905,-1.1770321388056375,0.21052631578947367,0.5572519533831561,1.0,8/41,6.88%,LRRC8D;FOXO1;GAS6;PIK3R1;UNC13B;ERN1;RACK1;LRRC8A
prerank,rRNA transcription (GO:0009303),-0.43402952466789846,-1.1769633487037185,0.2552742616033755,0.5567960241398716,1.0,8/17,24.16%,GTF3C5;SPIN1;POLR1G;CAVIN1;GTF3A;SIRT7;GTF3C3;POLR1E
prerank,B cell proliferation (GO:0042100),-0.43371330409790354,-1.1759627470181822,0.2286282306163022,0.5585713625333196,1.0,4/17,13.63%,MEF2C;CTPS1;CD40;PTPRC
prerank,cellular copper ion homeostasis (GO:0006878),-0.45158177904858887,-1.1759005630777208,0.2727272727272727,0.5581401557778011,1.0,8/14,29.00%,APP;SLC31A1;ATOX1;MT2A;CCDC22;SLC31A2;ABCB6;ATP7B
prerank,relaxation of muscle (GO:0090075),0.4878714044093866,1.1758031991102678,0.28105906313645623,0.8924661168776076,1.0,1/13,0.03%,ATP1A2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.328121714490458,-1.174873008415305,0.1895424836601307,0.5601042670642529,1.0,15/55,20.95%,PID1;THBS1;CYP1B1;TGFBR2;XDH;AGTR1;SIRT5;ACE2;ROMO1;MT3;DHRS4;ZC3H12A;CBR1;RIPK1;NOXO1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3777083759630622,-1.174428457790183,0.22839506172839505,0.5605639856485767,1.0,8/29,25.41%,RUNX1;ESR1;STRN3;CBFB;LATS1;KCTD6;SRARP;YAP1
prerank,RNA processing (GO:0006396),0.2908425732058952,1.1740896167003074,0.14174454828660435,0.8968192136180856,1.0,55/176,23.03%,CELF2;PABPN1;RRAGC;NOVA1;SRSF5;TFIP11;CCAR2;CPSF6;HNRNPH3;ELAVL4;HNRNPA2B1;DUSP11;HNRNPU;TENT4A;DDX17;PRMT9;SON;HNRNPL;PTBP1;LSM5;PPARGC1A;ZMAT5;SRRM4;BICD1;LSM4;TUT4;MPHOSPH10;USP39;SRSF11;DICER1;RBM5;USB1;RNPS1;AKAP8L;DHX8;PRPF6;NOL3;PRPF3;DDX39B;THOC1;DDX47;ADAR;FASTKD5;SF3B2;SF3B1;SUPT4H1;SNRPB;HNRNPH1;CDK12;SCNM1;SF3B3;TSEN34;SRPK1;SNRPN;CELF1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.45130015215538216,1.1739065281393857,0.2665330661322645,0.8953477604718285,1.0,5/17,13.31%,CTR9;CPSF6;CPSF7;RNF20;ZC3H3
prerank,regulation of AMPA receptor activity (GO:2000311),0.4036578146983069,1.173254643788665,0.25806451612903225,0.8956428080192329,1.0,13/25,23.77%,CACNG7;NLGN2;NLGN3;SHISA7;SHANK1;GSG1L;CNIH3;SHISA8;MINK1;MAPK8IP2;CACNG4;CACNG5;CACNG8
prerank,ERAD pathway (GO:0036503),0.3238065769824291,1.1730400452207081,0.20973154362416108,0.8942438082816986,1.0,20/83,15.61%,DERL1;DNAJC18;JKAMP;DNAJB14;UBE4B;TMUB1;ECPAS;DNAJC10;USP19;FBXO6;SGTB;TMEM67;RNF121;CCDC47;UBXN6;FBXO17;BAG6;RNF5;UBXN4;DNAJB2
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3444055901532293,-1.1727285277039445,0.1934065934065934,0.5640181170587774,1.0,9/41,10.02%,PODXL;GCNT2;TJP1;PIEZO1;CD44;DENND6A;MDK;ADAM19;JAK1
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.2821276381233692,-1.1724920198227577,0.14397905759162305,0.5639726698614196,1.0,35/124,20.24%,LEF1;RHOA;FZD6;PRICKLE2;SMURF1;NFATC1;SFRP4;AGO1;AP2B1;WNT5A;GNB1;PSMA6;GNG2;PSMB7;PPP3CA;TIAM1;AGO2;PSMB6;PSMB5;FZD4;DAAM1;ROR2;PFN1;FZD1;AP2A1;PSMB8;PSMC4;PSMD11;PSMB4;AGO4;PSMD14;CELSR2;ARRB2;CDC42;PSMD10
prerank,dephosphorylation (GO:0016311),-0.27172278277074235,-1.1724357165348227,0.11428571428571428,0.5634780922137245,1.0,50/147,25.75%,PTPRM;PTPRB;PTPRG;PTPN12;SDHAF2;PTPRJ;ALPL;PPP1R12A;SSH2;PTPRK;PPP3CA;PPP2R5C;PPM1H;PLPP1;PTPN1;PPP1CA;DUSP3;MTMR7;ILKAP;PTPRZ1;DUSP23;PPP2R3A;PTPRC;PPP1CC;PPP4R2;PLPP3;THNSL2;TAB1;NT5C;CTTNBP2NL;PTEN;DUSP6;PTPN6;SGPP1;CTDNEP1;PPM1L;PPP2R5B;PPP2CA;PTPRF;DUSP1;ACP3;PLPP2;TIMM50;CTDSP1;SSH1;PDP1;PLPP6;DUSP7;PLPP5;PPP2R2A
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.3405666284865355,-1.1721401033563654,0.2,0.5635569834315687,1.0,10/43,13.74%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;PTPN1;IGF2;IRS1;ENPP1
prerank,positive regulation of cell growth (GO:0030307),-0.29323572760329775,-1.1721126564892936,0.1748768472906404,0.562997333893684,1.0,26/96,16.34%,NEDD4L;NTN1;SEMA7A;TGFB2;EGFR;NGF;SMURF1;MACF1;H3-3A;ITSN2;RPS6KA3;ADAM10;SYT4;CDKN2AIP;RPTOR;EDN1;PABIR1;MFSD2A;USP47;CSNK2A1;SHTN1;LIMK1;NCBP1;KLHL22;DDX49;RNF157
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.4869802066105082,-1.1720980366445717,0.2559055118110236,0.5624125718295501,1.0,3/10,11.79%,DNAJA1;AIDA;PDCD4
prerank,eye morphogenesis (GO:0048592),-0.4147526563079926,-1.1714141675127199,0.26,0.5635406023997286,1.0,10/19,18.80%,MFAP5;STAT3;COL5A2;FBN1;NIPBL;RARG;VEGFA;AGTPBP1;ALDH1A3;EFEMP1
prerank,cAMP biosynthetic process (GO:0006171),0.5135240821413355,1.1712176538320822,0.27104722792607805,0.8988433675773126,1.0,3/10,6.20%,ADCY5;ADCY1;ADCY8
prerank,sarcomere organization (GO:0045214),0.39629241104569346,1.1710210926155455,0.2375886524822695,0.8974360793314458,1.0,4/27,8.50%,ACTN2;CAPN3;CSRP3;CSRP1
prerank,regulation of cytokine production (GO:0001817),-0.27835581192017395,-1.1707944922057063,0.15669515669515668,0.5645596604707214,1.0,55/126,30.42%,FOXP1;ATP2B1;RPS6KA5;AFAP1L2;TNFRSF1B;PLA2R1;S100A13;NPTN;LYN;TRIM56;ANXA1;HDAC9;SOD1;MAPKAPK2;IL15;PER1;PIK3CD;TRIL;ISG15;CCN4;ACE2;AGPAT1;PTPRC;IFIH1;BCL6B;MAST2;N4BP1;GAPDH;PPP1R11;IL33;POLA1;PLD3;ZBP1;CADM1;GLMN;ASB1;FCGR2B;CD276;ACKR1;CCR2;RGCC;CASP8;PIK3CG;PLD4;SNAI2;HILPDA;TREM2;NFAM1;AGT;MIF;IGF2BP2;PTGER4;IGF2BP1;IRF3;LGALS9
prerank,mitochondrion distribution (GO:0048311),0.4896144964187864,1.1706080817293352,0.27634194831013914,0.8968730205806427,1.0,7/12,26.43%,TRAK1;LRRK2;ARMC1;MEF2A;DNM1L;MTM1;HAP1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.27977140682004603,1.1705376675713113,0.14887218045112782,0.8950300637309349,1.0,81/241,24.68%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;SRSF5;TFIP11;SF3B5;HNRNPH3;HNRNPA2B1;CCAR1;PQBP1;HNRNPU;HNRNPA3;SRSF10;CPSF7;HNRNPL;PTBP1;LSM5;ZMAT5;ELAVL1;CACTIN;IK;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;ZMAT2;USP39;PRCC;SRSF11;RBM5;LSM8;POLR2D;SNIP1;ELAVL2;RNPS1;ALYREF;DHX8;SNU13;PRPF6;PRPF3;HNRNPH2;SRRT;DDX39B;MTREX;SNRPB2;SRSF6;SUGP1;CWF19L1;PUF60;POLR2A;SF3B2;SF3B1;PRPF40A;GCFC2;SNRPB;PPIL1;HNRNPH1;DDX39A;SART3;PRPF38A;PPIL3;SF3B3;SNRPN;EFTUD2;POLR2B;HNRNPC;SNRPC;DDX41;WDR83;RBM15B;CSTF2;SRSF2;U2SURP
prerank,negative regulation of signal transduction (GO:0009968),-0.2556966593080135,-1.170493637012792,0.07352941176470588,0.5647447125889128,1.0,63/249,17.39%,BMP5;SEMA6A;PID1;DCN;DAB2IP;NTN1;PTPN12;ACVR1;NOTCH3;PIP4K2A;THBS1;EGFR;GRB14;PTPRJ;NFATC1;KANK1;SFRP4;IRAK3;CRY1;GLI3;YWHAB;NKD2;CARD16;CREB3L1;UBASH3B;XDH;RACK1;HHIP;LYN;PRKCD;NCK1;APOD;EPN2;SPRY2;GATA2;PTPN1;FGF2;SOCS5;HGS;HERC4;PTCH1;HHEX;BMP2;TCIM;TAX1BP3;CSNK2A1;PTPRC;FBXW7;IRS1;ENPP1;LRP1;SPRY1;PTCH2;TMBIM1;NR4A2;GPC1;DDIT4;CILP;RNF157;ADAMTS12;HEY1;SIGIRR;PTEN
prerank,negative regulation of programmed cell death (GO:0043069),-0.2457837956772209,-1.1704310476755229,0.07467532467532467,0.564279292014661,1.0,81/355,16.34%,MECOM;LEF1;ARHGAP10;TEK;IL6ST;TJP1;PTMA;FOXO1;TBX3;THBS1;GAS6;PIK3R1;EGFR;BCL2L1;NGF;NFKBIA;SOCS2;CD44;BMP4;KDR;UBC;RPS6KA3;RPL10;CARD14;NAA16;DNAJA1;FAS;FLNA;TFRC;RNF144B;RPS27A;UBB;PAK2;WNT5A;MET;ADAM10;ANXA1;TPT1;PLK2;SPRY2;CD38;SRC;XIAP;FLT4;VHL;MAP4K4;CAT;GCLC;GOLPH3;YWHAZ;BABAM2;CFL1;MALT1;TNFAIP8;HSPB1;SQSTM1;GRK5;CD74;PHB2;SERPINB9;COMP;BIRC3;PTK2B;USP47;TCIM;AKT2;NME2;ARHGDIA;VEGFA;HIGD2A;MT3;CBL;RHBDD1;PLAUR;NR1H4;PA2G4;BAG1;NCKAP1L;STIL;SIX4;RNF157
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.33001607021571777,-1.1702759924363022,0.2219626168224299,0.5640713209641164,1.0,11/52,11.52%,SPTBN1;PRKCH;PIK3R1;EGFR;NKD2;ITGB1;STX3;ZDHHC8;STAC;EPHB2;SQSTM1
prerank,regulation of autophagy (GO:0010506),0.28499838188747306,1.1701087030624238,0.16417910447761194,0.8945481397734177,1.0,45/216,16.00%,PRKAG2;RNF152;SNX6;LEPR;NUPR1;CTSA;PRKAA2;RRAGC;PRKAG3;ATP6V0A2;PLEKHF1;ITPR1;OPTN;PIK3CB;TRIM5;ATP6V0B;ATP6V1H;CASP3;ZKSCAN3;HTRA2;KAT5;MTMR4;RMC1;LRRK2;GOLGA2;ATP6V1B2;SLC38A9;ATP6V1E1;BCL2;CSNK2A2;FZD5;IL10RA;ATG13;KDM4A;LAMTOR2;TBC1D14;ATP6V0E2;ATP6V1C1;VDAC1;ATP6V0D2;NPRL2;LAMTOR3;ABL1;HGF;ATM
prerank,myotube differentiation (GO:0014902),0.4483037557479226,1.1696772819982368,0.26429980276134124,0.8940267197261257,1.0,4/17,5.03%,IGF1;ADAM12;ADAMTS15;ADGRB3
prerank,regulation of T cell mediated immunity (GO:0002709),-0.49549474458968173,-1.1694553240216403,0.2887189292543021,0.565411758987985,1.0,4/10,24.13%,TNFRSF1B;ZBTB1;HMGB1;CCR2
prerank,regulation of protein secretion (GO:0050708),0.3077318119043406,1.1691969246551275,0.1797752808988764,0.8937033963738399,1.0,35/119,18.74%,BMP6;CACNA1D;IGF1;FRMD4A;GCK;ITPR1;CACNA2D2;ADRA2A;LLGL2;STXBP5L;SERGEF;DRD3;SNAP25;KCNC2;LLGL1;CLOCK;MYO18A;ITPR2;IER3IP1;RAPGEF3;ENSA;CYP51A1;KCNS3;PER2;EIPR1;IL6;GIPR;PRKCA;IL1A;PICK1;APBB1;IL12A;DPP4;HMGCR;RHBDF1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.36502999383348805,-1.1687938520144858,0.22388059701492538,0.5664755209982597,1.0,9/32,20.14%,CAV1;TRPC3;PLCG1;TRPC1;CEMIP;APLNR;GPER1;GRIN1;NPSR1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.38374556397145193,-1.1683669262456078,0.24,0.5669103401453296,1.0,7/25,10.48%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,regulation of keratinocyte proliferation (GO:0010837),0.42446443739169715,1.167963754014164,0.25555555555555554,0.8962714915022749,1.0,6/22,11.06%,NOTCH2;CDH3;FGFR2;MED1;CRNN;STXBP4
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.28809456527961663,-1.167902506933273,0.16923076923076924,0.5674320691649338,1.0,40/109,27.53%,PIK3R1;PLCG1;NFATC1;JUN;PLCG2;PAK2;TEC;LYN;PSMA6;PSMB7;MAPK1;PPP3CA;PIK3CA;VAV2;PSMB6;MALT1;PSMB5;NFATC2;PSMB8;TAB1;PSMC4;PSMD11;LAT2;PSMB4;PSMD14;MAPK3;BTK;NFATC3;PSMD10;MAP2K7;SYK;PSME1;BCL10;PSMB3;GRAP2;VAV3;GRB2;CUL1;FBXW11;CALM1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3880612816058472,1.1675399582297783,0.24489795918367346,0.8957406842610731,1.0,7/31,11.04%,TGFBR3;BMPR1A;RBPJ;NRG1;FGFR2;TGFBR1;RYR2
prerank,folic acid metabolic process (GO:0046655),0.43684991448203697,1.1674171034417302,0.28294573643410853,0.8940718529157972,1.0,7/18,17.34%,ALDH1L1;SLC19A1;MTHFS;MTHFD1;MTHFR;FPGS;MTHFD2
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.32472757731657736,-1.167170770364514,0.20224719101123595,0.5685532607986873,1.0,22/52,31.10%,PDIA5;WIPI1;PDIA6;ERN1;TATDN2;ATP6V0D1;SEC31A;KDELR3;ACADVL;VAPB;SRPRA;EXTL3;PPP2R5B;DCTN1;YIF1A;DNAJB11;WFS1;GOSR2;EDEM1;PLA2G4B;ADD1;HSPA5
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.2974042356882642,-1.1670299031438474,0.19002375296912113,0.568298183240712,1.0,26/84,24.17%,CDC27;UBC;ANAPC5;RPS27A;UBB;PSMA6;PSMB7;CDC16;FBXO31;PSMB6;PSMB5;FBXO5;FZR1;PSMB8;PTTG1;PSMC4;PSMD11;ECRG4;PSMB4;PSMD14;CDC26;PSMD10;PSME1;PSMB3;CDC23;CUL3
prerank,cellular protein localization (GO:0034613),-0.25162038859724184,-1.166904344682519,0.08978328173374613,0.5680286064256241,1.0,73/285,16.84%,TBC1D4;RABGAP1L;VCL;ESAM;RAB14;TBC1D8;EGFR;SMURF1;ID1;SCFD2;WIPI1;PTPRK;TBC1D12;RAB6A;STX1A;HERC2;SNX13;RAB31;TMED10;USP6NL;TBC1D5;FLNA;RAP2A;STX3;TBC1D2B;ARHGEF2;NIPBL;WNT5A;SH3PXD2B;AXIN2;SNX1;TBC1D1;COG3;OCLN;EVI5L;EMP2;HEY2;VPS26A;RAB22A;TBC1D13;FGF7;DNAJC27;CPE;HGS;WDR11;SEC31A;JAM3;CD74;HHEX;RRAGA;STX7;HDAC6;ARL5A;AMOT;TBC1D10A;CNTLN;AP2A1;STX8;SAR1A;RAB5C;RAB1B;FERMT2;TBC1D25;BICD2;NPHP1;RAB3GAP2;SEC13;UNC50;ARF5;PIGK;COPA;COPB2;IFT27
prerank,cellular component assembly (GO:0022607),-0.25795152719333164,-1.166903474779901,0.09968847352024922,0.5674179181539972,1.0,48/253,14.65%,SPTBN1;ACTB;LIMS1;SLC2A1;RHOJ;LIMS2;MYO1B;CALD1;PARD3;RHOA;GSN;PARVB;ACTG1;GAS6;PLS3;DARS1;FAS;FLNA;WIPF1;VAMP3;WNT5A;EPS8;HES1;CLDN14;ABCA3;OCLN;APC;IL1RAP;RBBP4;CAPZA2;NEDD9;CD2AP;YWHAZ;PARVA;FAM107A;CAPG;LIMA1;TEAD1;CD74;RANBP9;PTK2B;STX7;RAD21;CD40;FZD1;SHROOM1;HAS1;ZW10
prerank,cellular response to organic substance (GO:0071310),-0.2852111903531719,-1.1666239036668788,0.16666666666666666,0.5674447774163828,1.0,16/116,6.03%,LEF1;GHR;PID1;BMPR2;SLIT2;RHOA;PTPN12;ACVR1;ACVRL1;RAMP2;CYP1B1;SOCS2;STAT3;TGFBR2;CPNE3;RACK1
prerank,synaptic vesicle exocytosis (GO:0016079),0.3720300519552009,1.1662300876704994,0.24954128440366974,0.8962389009060011,1.0,11/40,16.47%,UNC13C;SYT1;SNAP29;SNAPIN;SNAP47;RIMS1;SNAP25;SYT10;CPLX1;STX4;CPLX2
prerank,positive regulation of potassium ion transport (GO:0043268),0.38047980378172036,1.1660130060014644,0.2530329289428076,0.894913280318326,1.0,11/38,10.67%,ACTN2;ANK2;KCNJ5;ADRA2A;DLG1;KCNJ10;KCNH2;GABBR1;KCNN4;KCNJ16;GABBR2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.2849958410017797,-1.1659012513424267,0.16129032258064516,0.5686021931562955,1.0,28/101,15.76%,RAPGEF2;DAB2IP;RHOA;PKD1;EGFR;RALB;CAB39;PIK3R6;WNT5A;CCNY;IL34;CALM3;FLT1;SRC;PDGFC;FGF2;RPTOR;EDN1;EDN3;CEMIP;INCENP;PDGFD;TCIM;CD40;CD24;VEGFA;FERMT2;CSF1R
prerank,glial cell development (GO:0021782),-0.3850307864967262,-1.165812035711319,0.23564356435643563,0.5682013007897966,1.0,15/25,34.79%,APP;MDK;EIF2B2;MT3;NRROS;EIF2B1;CDK6;MYRF;DLL1;SOX11;MXRA8;NSUN5;PRDM8;S100A9;TLR2
prerank,positive regulation of phospholipid transport (GO:2001140),-0.49212655707562025,-1.1654960254087916,0.2632612966601179,0.5684177565280025,1.0,3/10,9.64%,TMEM30A;ABCA3;APOE
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.44289882849496154,1.1642640893490124,0.2819047619047619,0.8991477193659938,1.0,4/17,16.09%,LPGAT1;PLA2G4C;LCLAT1;PLAAT3
prerank,cartilage development (GO:0051216),-0.3306752770555007,-1.164186896794011,0.19456066945606695,0.5710277112921656,1.0,13/49,13.24%,MEF2C;ZBTB16;PKD1;RUNX2;RUNX1;CD44;BMP4;CCN3;SNX19;FGF2;BMP2;ITGB8;TRPV4
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3021583804531591,-1.1635205658467596,0.18052256532066507,0.5720989106120575,1.0,26/75,18.34%,HEG1;DAB2IP;LRP6;LRP5;BMP4;PTPRJ;RASIP1;IRAK3;LYN;PRKCD;APC;SPRY2;CDKN1C;IPO7;PTPN1;APOE;MYOCD;IPO5;HHEX;STK38;SPRY1;PAQR3;PRKAR2B;PTEN;LATS1;UCHL1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.4505401807733677,1.163330693347596,0.29568788501026694,0.9003986749183721,1.0,5/16,11.46%,IGF1;IGFBP3;CDH3;PHIP;MYORG
prerank,positive regulation of T cell differentiation (GO:0045582),-0.3491062931950205,-1.1632817799377,0.24541284403669725,0.5721341452082727,1.0,21/36,42.93%,LEF1;GLI3;MDK;ZBTB1;SOX12;NCKAP1L;CD46;ZMIZ1;SOCS1;IL4I1;VNN1;VSIR;ZAP70;GATA3;TESPA1;BCL6;IL4;TNFSF9;XBP1;IL23A;SOX4
prerank,regulation of protein dephosphorylation (GO:0035304),-0.3475658674227417,-1.1629719007016146,0.2119815668202765,0.5722777097903239,1.0,9/37,11.71%,MFHAS1;YWHAB;PPIA;PPP1R16B;PRKCD;CALM3;SPPL3;NSMF;PPP1R2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.379821785442507,-1.1626042991804453,0.23628691983122363,0.5725251959193812,1.0,9/25,15.39%,SLIT2;LIMK2;KANK1;PRKCD;EVI5L;ABI3;TBC1D7;CCP110;RAP1GAP
prerank,regulation of hemopoiesis (GO:1903706),-0.48510019606196975,-1.1623141650502056,0.2765957446808511,0.572586905600954,1.0,3/10,7.25%,PTN;RUNX1;CBFB
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.33408012134525084,-1.1621998501721655,0.2459016393442623,0.5722689286030348,1.0,11/45,10.02%,B2M;VCAM1;CD44;MID1;ICAM1;IRF9;CAMK2D;PRKCD;TRIM25;IRF2;JAK1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3416907071061209,-1.1612370093756281,0.23863636363636365,0.5739526257625417,1.0,8/39,10.60%,UTRN;NEDD4L;FXYD5;HECW2;CAMK2D;SLMAP;FXYD6;FGF13
prerank,relaxation of cardiac muscle (GO:0055119),0.480857593539471,1.1612062418346243,0.2828282828282828,0.9058919121842711,1.0,1/13,0.03%,ATP1A2
prerank,sulfur compound transport (GO:0072348),0.4009624993995363,1.1611958677256211,0.26691042047531993,0.9038537540804727,1.0,4/27,6.01%,SLC6A13;SLC13A4;SLC26A1;SLC25A11
prerank,negative regulation of secretion by cell (GO:1903531),-0.353616004974454,-1.1607149645580916,0.24307036247334754,0.5746083689114304,1.0,11/38,14.79%,STXBP6;NOTCH1;TNFRSF1B;SLC30A1;VAMP3;GRM7;ANXA1;SYT4;APOE;RSAD2;HTR1B
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.27423826559760084,1.1606853469463443,0.15844544095665172,0.9036462882620931,1.0,87/264,24.43%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;STRAP;SRSF5;TFIP11;SF3B5;HNRNPH3;HNRNPA2B1;CCAR1;PQBP1;HNRNPU;HNRNPA3;DDX17;SRSF10;CPSF7;HNRNPL;PTBP1;LSM5;ZMAT5;ELAVL1;CACTIN;IK;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;ZMAT2;USP39;SNUPN;PRCC;SRSF11;RBM5;LSM8;POLR2D;SNIP1;ELAVL2;RNPS1;ALYREF;DHX8;SNU13;PRPF6;PRPF3;HNRNPH2;SRRT;DDX39B;MTREX;SNRPB2;SRSF6;SUGP1;CWF19L1;PUF60;POLR2A;SF3B2;SF3B1;PRPF40A;GCFC2;SNRPB;DCPS;PPIL1;HNRNPH1;DDX39A;PRMT5;SCNM1;SART3;PRPF38A;PPIL3;SF3B3;SRPK1;SNRPN;EFTUD2;POLR2B;HNRNPC;SNRPC;DDX41;WDR83;RBM15B;CSTF2;SRSF2
prerank,negative regulation of cellular protein localization (GO:1903828),0.37928218115551127,1.1598711131275545,0.26306306306306304,0.9045929452604435,1.0,5/34,4.82%,LEPROT;ROCK2;ACTN2;PICALM;TTBK2
prerank,muscle cell differentiation (GO:0042692),0.3866986945034267,1.1590298373609262,0.25493716337522443,0.9055705182305497,1.0,6/32,4.75%,RORA;NEBL;DUSP29;SPEG;WNT5B;SGCZ
prerank,acyl-CoA metabolic process (GO:0006637),0.36750193503392303,1.1579615749059182,0.26145038167938933,0.9074278697226205,1.0,10/35,22.41%,ACSM2A;ACSM2B;SUCLA2;GLYAT;ACACA;ACOT1;ACOT6;ACOT13;SUCLG2;ACOT9
prerank,neural crest cell differentiation (GO:0014033),-0.4134044498381931,-1.157939950205715,0.26380368098159507,0.5809917278491502,1.0,7/18,26.12%,MEF2C;LRP6;CDH2;SOX8;SOX11;TAPT1;SNAI2
prerank,negative regulation of neuron differentiation (GO:0045665),0.4224696493243789,1.1579201591024293,0.2706766917293233,0.9055111091435828,1.0,4/22,11.96%,BMP7;DTX1;MED1;SOX9
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.267516506271782,-1.156503499644561,0.14066496163682865,0.5837811622804355,1.0,27/150,10.62%,HIP1;KITLG;TEK;GCNT2;GAB1;ENG;INSR;THBS1;GAS6;PIK3R1;F3;EGFR;PTPRJ;MFHAS1;ESR1;ITGB1;TNFAIP8L3;MET;IAPP;MYOC;SPRY2;PIK3CA;SRC;IGF2;FGF2;FGF7;PIK3CD
prerank,response to chemokine (GO:1990868),-0.4548026625534564,-1.1562166478223483,0.2883817427385892,0.5838802416150686,1.0,5/13,9.84%,LRCH1;SLC12A2;RHOA;CXCL12;DOCK8
prerank,mitotic chromosome condensation (GO:0007076),0.40134550972353417,1.1558785371549476,0.27703984819734345,0.9109615575666576,1.0,6/26,10.44%,KMT5A;NCAPD2;PHF8;PLK1;TENT4A;CSNK2A2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4170085885595394,1.1557495009872982,0.266553480475382,0.9093457848068367,1.0,4/21,8.02%,CACNA1D;ANK2;SNTA1;KCNH2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.41492309208853245,1.1555185213818622,0.28205128205128205,0.9081675915941837,1.0,6/22,13.27%,ROCK2;PICALM;CASP3;CLU;EPHA4;ABCA2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.41504884344235743,-1.1554340101142115,0.2766393442622951,0.5852179015597306,1.0,2/17,1.51%,RAPGEF2;ADRA1B
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.4477169391494108,1.155433137707887,0.26746506986027946,0.9064419832540057,1.0,3/18,6.37%,HSPA1A;SLC25A5;FZD9
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.337280290699886,1.155353865772562,0.2345890410958904,0.90466863559086,1.0,10/56,10.07%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;BMP8A;INHA;GDF9;TGFBR1
prerank,epidermis development (GO:0008544),0.3399739006212543,1.1553423133822711,0.24592833876221498,0.9026782977545309,1.0,7/56,6.95%,OVOL2;LAMB3;CRABP2;CCN2;SPRR1A;FLOT2;FGFR2
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3560227636031894,-1.154853062603055,0.2460136674259681,0.5859909685645123,1.0,7/32,10.57%,ITGA1;PPIA;PPP1R16B;PRKCD;CALM3;SPPL3;NSMF
prerank,positive regulation of type 2 immune response (GO:0002830),0.46691699272008547,1.1548321022862644,0.2931726907630522,0.9025286342164311,1.0,5/14,16.37%,IL18;PRKCZ;NLRP3;IL6;RARA
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4670832391580206,-1.1546964448076247,0.278118609406953,0.5857713214035053,1.0,3/12,4.22%,ACTB;ACTG1;LAMA3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3431356985079514,1.1544645088315137,0.2376425855513308,0.901861135761393,1.0,15/47,19.50%,BMP7;TMEM64;LMO3;METRNL;HNRNPU;CREBL2;AAMDC;ADIG;CDS1;TFE3;CREB1;AKT1;FNDC5;PIM1;ASXL2
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.37176900945652747,-1.1542955294353137,0.24782608695652175,0.5861448189702667,1.0,8/31,15.55%,TFRC;VAMP3;SHLD1;EPHB2;PHB2;PTPRC;CD86;MAD2L2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2852700084883379,1.1542796167361993,0.19218241042345277,0.9005451986415569,1.0,17/159,5.82%,SDK1;ROBO1;ALCAM;CLDN20;OBSL1;IL1RAPL1;SDK2;TENM1;CDH15;CDH3;PCDHB11;CDH17;FLRT3;MPZL2;GRID2;CDH10;IGSF9
prerank,regulation of hippo signaling (GO:0035330),-0.4250493518527295,-1.154006201563965,0.2839248434237996,0.5862128134518866,1.0,7/17,22.65%,LIMD1;MOB3B;CIT;SCHIP1;MARK3;AJUBA;SOX11
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.40884457926289874,-1.1534467954439716,0.2606924643584521,0.5869949196492676,1.0,5/19,9.75%,ACOX1;MAOB;SOD1;CAT;GPX1
prerank,establishment of vesicle localization (GO:0051650),0.43124711912606706,1.153167983237099,0.2851782363977486,0.9026084079570835,1.0,4/18,6.54%,SYT11;KIF5C;IKBKG;SNAPIN
prerank,protein complex oligomerization (GO:0051259),0.3153528825187097,1.1529321796377885,0.23183391003460208,0.9014198518498773,1.0,30/85,23.72%,UPB1;WDCP;TMEM120B;VSTM5;ATL1;CPSF6;GSDMD;ADCY8;KCNC3;CPSF7;ELAVL1;RNF135;KCNC2;CUTC;BEND3;MICU1;RNF213;NOL3;ALAD;TRMT61B;OXA1L;NLRC4;HGSNAT;PYCARD;DNM1L;MAT2A;IKZF4;ALS2;MPP2;SPAST
prerank,autophagy of nucleus (GO:0044804),-0.4344472691055748,-1.15263595243386,0.26789366053169733,0.5883941909764615,1.0,9/16,28.64%,ATG3;WIPI1;RB1CC1;ATG12;ATG5;WDR45B;ULK2;ULK1;WIPI2
prerank,ameboidal-type cell migration (GO:0001667),-0.3296905567883986,-1.1522973401766228,0.23515439429928742,0.5886394561530678,1.0,19/51,22.00%,SEMA6A;SEMA3C;SEMA7A;CORO1C;CCN3;TBX1;SEMA5B;SEMA3E;ITGA4;SEMA3G;FAT2;AMOT;PKN3;SEMA5A;SEMA6D;AMOTL1;SOX8;SEMA3F;SEMA4C
prerank,extracellular matrix assembly (GO:0085029),-0.39479128144185444,-1.1519686135010638,0.2698744769874477,0.588877551300651,1.0,7/23,8.19%,RAMP2;GAS6;TNXB;NTN4;MFAP4;LAMB2;MYH11
prerank,negative regulation of TOR signaling (GO:0032007),0.3722529476195267,1.151796699434776,0.24508050089445438,0.9035607794246671,1.0,14/36,22.75%,RNF152;PRKAA2;NPRL3;DEPTOR;SESN1;TSC1;NPRL2;SIRT1;ATM;FNIP1;CASTOR2;PDCD6;TMEM127;EPM2A
prerank,neuron projection morphogenesis (GO:0048812),0.29591400984205735,1.1517939404317348,0.1825525040387722,0.9015729783705844,1.0,28/137,12.64%,ALCAM;BMP7;MAP2;DCDC2;BAIAP2;CPNE1;FLRT3;WNT7A;ATL1;GAS7;AFG3L2;FGFR2;SHANK1;CNTNAP2;FLRT1;LRRK2;IMPACT;LRP4;KLK8;GPM6A;LLGL1;DLG4;SLITRK4;DOCK7;DTNBP1;WASL;BDNF;NYAP2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4485401560822133,1.1512992093088348,0.2718253968253968,0.9013991598346187,1.0,8/16,22.08%,HNRNPA2B1;TNKS2;SMG5;RTEL1;SMG6;ATM;PINX1;SLX4
prerank,negative regulation of developmental process (GO:0051093),-0.3038032834617125,-1.1510387607318733,0.2261904761904762,0.5905549372418879,1.0,21/69,19.85%,NOS3;NOTCH1;GAS6;BMP4;KANK1;TBX1;KLF7;TFRC;ARHGEF15;CST3;VAT1;HEY2;NOTCH4;BMP2;TBX2;SUZ12;HEY1;FGFR3;GREM1;CDK6;SPI1
prerank,response to glucagon (GO:0033762),0.42615277579135824,1.1505022764575232,0.30115830115830117,0.9022641185109914,1.0,4/19,6.20%,ADCY5;GCGR;ADCY1;ADCY8
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.39400158863381773,1.150496211682108,0.26272912423625255,0.9003007005522647,1.0,5/26,4.43%,GCHFR;SPHK1;NQO1;PM20D1;ARG2
prerank,kinetochore organization (GO:0051383),0.46983478961334885,1.1503930957403745,0.3280943025540275,0.8986785446410851,1.0,6/13,21.79%,NDC80;CENPC;POGZ;NUF2;CENPA;CENPH
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.31867875813455204,-1.1501483894797813,0.22823529411764706,0.5922048980268035,1.0,12/54,7.09%,CAV1;NEDD4L;YWHAE;KCNJ2;NOS1AP;FHL1;FLNA;CAB39;GNB1;KCNMB2;GNG2;KCNQ1
prerank,regulation of chromatin organization (GO:1902275),-0.4356745440389562,-1.1496736396849625,0.28270042194092826,0.5927330255627322,1.0,4/14,10.36%,MLLT3;HPF1;IGF2;PARG
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.33682400554147895,1.1496616363305594,0.23979591836734693,0.899382018804274,1.0,6/61,6.99%,PRKAG2;NQO1;PPARA;PSMD3;PDK2;PANK2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.48476914524553005,-1.1494528936472572,0.3165322580645161,0.5926610247486459,1.0,3/10,4.34%,LRP5;TGFBR2;TBX1
prerank,nuclear export (GO:0051168),0.3199356534248746,1.1494408230026458,0.21891418563922943,0.8982060755700065,1.0,16/80,18.54%,RANBP3L;SRSF5;POM121;NUP155;NUP62CL;STRADB;NEMF;RITA1;UPF3B;SRSF11;DESI1;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.4710291819128693,1.1491159771784272,0.2966601178781925,0.8973238033558439,1.0,4/11,12.05%,ENPP3;NT5C3A;DCK;THTPA
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.48652370081885,-1.1486958468442001,0.3186372745490982,0.5939329171907443,1.0,5/10,8.77%,DCN;KDR;RACK1;MYOC;SRC
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.35942640140253923,1.1484862018887727,0.24901960784313726,0.8976422865940504,1.0,8/43,6.46%,BMP7;BMP6;WNT4;IGF1;BMPR1A;LRP3;WWTR1;NPNT
prerank,bile acid metabolic process (GO:0008206),-0.3745179564715389,-1.1484381505747598,0.27350427350427353,0.5939470981088104,1.0,4/27,6.51%,CYP7B1;OSBPL3;CYP39A1;OSBP
prerank,central nervous system development (GO:0007417),-0.2520357414400369,-1.148264993772541,0.10303030303030303,0.593788182634678,1.0,63/250,20.93%,ADGRL2;SLC2A1;ZBTB16;PBX1;ZFHX3;COL4A1;SHROOM4;VIT;GSN;WWP1;TBX3;PKD1;PBX3;STAT3;LSR;TGFBR2;EML1;RPS6KA3;BPTF;CHST8;NIPBL;ADGRA2;DCLK1;APOD;UFC1;EIF2B2;GRIN2B;CDK5;PDGFC;ATP6AP2;VCAN;CAPG;BTD;DSCAML1;ADGRG1;PTPRZ1;ATXN1;PTCH1;MFSD2A;SH3GL2;SMO;SNTG2;MARCKS;NCOA6;SOX12;CDH2;NR4A2;ALDH5A1;DDIT4;PTEN;NCAN;ECRG4;GRIN1;UGP2;C3;HAPLN3;LIG4;SOX8;CHD8;POU3F3;ADGRL3;NKX2-2;BCAN
prerank,negative regulation of receptor binding (GO:1900121),-0.4870345743765268,-1.147905670783562,0.3073770491803279,0.5940822703973975,1.0,4/10,21.70%,B2M;ATP2A3;ADAM15;PTPRF
prerank,positive regulation of phagocytosis (GO:0050766),-0.3253520159196209,-1.1475190732002956,0.2324561403508772,0.5944232067316358,1.0,20/47,30.30%,MERTK;GAS6;PTPRJ;RAB31;C4B;DOCK2;GATA2;IL15;RAB27A;PTPRC;NCKAP1L;C3;FCGR2B;ANO6;CD300LF;TREM2;LYAR;IL2RG;AHSG;PLA2G5
prerank,regulation of insulin secretion (GO:0050796),0.30838631345800804,1.1472996537525442,0.20840336134453782,0.8998319111699972,1.0,27/101,18.39%,CACNA1D;ADCY5;NNAT;GCK;NLGN2;ITPR1;CACNA2D2;ADRA2A;BMP8A;SNAP25;KCNC2;CLOCK;ITPR2;STXBP4;CHGA;RAPGEF3;ENSA;KCNS3;PER2;EIPR1;IL6;GIPR;RBP4;PRKCA;PICK1;TCF7L2;DPP4
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3622518545577945,-1.146116678668627,0.25957446808510637,0.5972736284791496,1.0,5/30,9.41%,BMPR2;ACVRL1;DACH1;SRC;TENT4B
prerank,negative regulation of neurogenesis (GO:0050768),-0.3596342827917526,-1.1458048143274135,0.2577777777777778,0.5974105632384601,1.0,5/34,2.27%,RAPGEF2;PTN;RHOA;B2M;NOTCH1
prerank,regulation of protein import into nucleus (GO:0042306),-0.3429114319628011,-1.145523603219143,0.22811059907834103,0.5975209283835344,1.0,9/36,12.57%,MDFIC;PIK3R1;CDH1;BMP4;FLNA;PRKCD;APOD;IPO5;TPR
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4678005348656408,1.1455000679331522,0.33064516129032256,0.9044022594846061,1.0,4/13,8.19%,PRKCZ;ECHDC3;GKAP1;SORBS1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.28105918141308206,-1.1454632428392566,0.18829516539440203,0.5970770216966621,1.0,22/109,12.35%,PLA2G4A;PIP5K1B;PIP4K2A;RAB14;INPP4A;PIK3R1;PLCG1;PIK3C2A;PLCG2;BMX;PLEKHA8;PIK3R6;PLEKHA4;INPP5D;PIK3CA;FGF2;MTMR11;PIK3CD;MTMR7;FIG4;PIK3C3;MTMR12
prerank,peptidyl-amino acid modification (GO:0018193),0.4955031907159295,1.1449358129185498,0.30218687872763417,0.9045903305707214,1.0,4/10,23.24%,METAP2;ATP7A;TTLL4;METAP1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.30410489116440687,-1.144902844222893,0.19036144578313252,0.5978498300575603,1.0,20/73,21.47%,KITLG;TCF12;LMO2;RUNX1;PSMA6;PSMB7;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;SPI1;METTL3;PSMD10;PSME1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4194464304237548,1.144638285263265,0.2905027932960894,0.9037154329467503,1.0,7/20,12.77%,ROCK2;DLG1;LLGL2;RHOQ;LLGL1;FHOD1;RAB13
prerank,amide biosynthetic process (GO:0043604),-0.3275574843484724,-1.1445967746653796,0.25162689804772237,0.5980406288585531,1.0,23/47,32.14%,SGMS1;SGMS2;PCSK5;DEGS2;AGK;CERS5;CERS6;SAMD8;ASMT;ASS1;SPTSSA;ASAH2;DMD;CERS4;SMPD1;TLCD3B;NANP;CERS3;SPTLC3;SPTSSB;NMRAL1;ALOXE3;AANAT
prerank,C21-steroid hormone metabolic process (GO:0008207),0.41573052789648146,1.143898071801912,0.27325581395348836,0.904463920120929,1.0,6/20,23.22%,CYP11B1;FDX1;STAR;FDX2;FDXR;TSPOAP1
prerank,regulation of protein localization to nucleus (GO:1900180),-0.33216224151690743,-1.1434484576426556,0.22388059701492538,0.6004193878767451,1.0,9/43,9.16%,KAT7;LIMK2;BMP4;MFHAS1;CTNNA1;TFRC;OTUD7B;ORMDL3;EIF2AK3
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.278694095834309,-1.1431612551386667,0.18581907090464547,0.6005352269720087,1.0,21/110,11.61%,ADGRL4;ADGRL2;CALCRL;RAPGEF2;ADGRG6;ADRA1B;RAMP2;ABCA1;ADCY4;ADGRE5;S1PR1;GNB1;ADCY7;GNG2;IAPP;ADGRD1;ADCY2;S1PR3;ADGRG1;ADGRG2;ADM
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4808053607240518,-1.142920133155869,0.28857715430861725,0.6005385003759913,1.0,4/10,24.43%,UBE2J1;INSIG1;OS9;SVIP
prerank,glycoprotein biosynthetic process (GO:0009101),-0.2976955634872853,-1.1429137449599502,0.20673076923076922,0.5999428745014714,1.0,14/79,10.87%,ST3GAL4;GCNT2;BMPR2;ST8SIA4;CSGALNACT1;ST3GAL6;B3GNT2;CHST8;COG3;ST8SIA6;XYLT1;GOLPH3;B4GALT5;GCNT1
prerank,renal filtration (GO:0097205),-0.4781016251138617,-1.1422611181873823,0.3004201680672269,0.6010012285093076,1.0,7/10,41.01%,CD34;MCAM;MYO1E;JCHAIN;SULF1;SULF2;ITGA3
prerank,nervous system development (GO:0007399),0.25612071309569995,1.1422408733583924,0.14148351648351648,0.9084547453483865,1.0,88/429,16.70%,SDK1;ROBO1;ALDH1A2;NOTCH2;TRAK1;NR2E1;ESS2;OBSL1;INTU;SDK2;RAPGEF5;VXN;ARNT2;TENM1;NLGN2;ADAM22;LRCH4;CELSR1;PCDHB11;DAGLA;FLRT3;NPTX1;IL1RAPL2;GFRAL;CHRM2;CRMP1;NRTN;ADGRB2;PAX6;MAB21L2;MARCKSL1;TRIM71;WWTR1;FGF12;FZD9;IGSF8;DPF1;ATN1;NRG1;NLGN3;JARID2;SCRG1;WDR62;LSAMP;LPAR1;CLN8;ADGRV1;TMOD2;WDPCP;ZIC2;GPM6A;DLG4;SRRM4;APC2;TGFBR1;LDB2;LDB1;NES;RITA1;CHRM1;FZD5;FKTN;PCDHB3;CHERP;CPNE6;DPYSL2;ARHGAP26;BDNF;ZIC5;HDAC4;L1CAM;CLN5;TYRO3;FUT10;CYP51A1;GFRA4;CSPG5;SCN8A;DPF3;NRSN2;EPHB1;GBA2;KALRN;HPCAL4;AXL;TRIM3;NAV3;NRSN1
prerank,neuron projection extension (GO:1990138),0.37390028137741,1.1421306475639312,0.2653061224489796,0.9069027634429021,1.0,8/32,8.15%,ALCAM;CPNE1;FLRT3;AUTS2;NLGN3;LLPH;FLRT1;IMPACT
prerank,tetrapyrrole metabolic process (GO:0033013),-0.4052118546536295,-1.1418803866830152,0.2865979381443299,0.6013516709557578,1.0,4/18,8.59%,ABCC1;LMBRD1;MMADHC;CUBN
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4162732106682547,1.1418631822494818,0.29672447013487474,0.9059217960446441,1.0,9/19,16.66%,HS3ST3B1;HS6ST1;HS6ST3;NDST1;NDST4;HS3ST5;HS6ST2;NDST2;HS2ST1
prerank,actin filament-based transport (GO:0099515),-0.3920561017105295,-1.1417358740824597,0.28043478260869564,0.6011147531035069,1.0,6/21,12.00%,MYO1D;ACTN4;MYO1B;MYO19;MYO1F;FNBP1L
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3018013645237221,-1.1416575465347136,0.21818181818181817,0.6006795107316715,1.0,17/65,23.25%,FBXL7;FHL1;PSMA6;PSMB7;PSMB6;PSMB5;PABIR1;USP47;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;CHEK1;PSME1;PSMB3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3588572865778972,-1.141410591005064,0.25925925925925924,0.6007176643191969,1.0,9/29,17.48%,SLC4A10;APP;APOE;EPHB2;NSMF;RAB3A;ZDHHC2;MCTP1;SYNGR1
prerank,cellular response to glucose stimulus (GO:0071333),-0.3610684405188246,-1.1413183957836686,0.2735229759299781,0.6003083590468177,1.0,15/30,29.41%,GAS6;UNC13B;RAB11FIP5;ERN1;RACK1;RAB11B;KCNB1;PRKACA;GPER1;RAB11FIP2;IGF1R;TRA2B;SELENOT;SLC39A14;PDK3
prerank,regulation of bone mineralization (GO:0030500),-0.31803181425436244,-1.1410026701189118,0.22482435597189696,0.6005061521008768,1.0,18/55,13.74%,MEF2C;BMPR2;PTN;SGMS2;ATP2B1;ACVR1;BMP4;S1PR1;CCN1;NBR1;TMEM119;TGFB3;TWIST1;ISG15;BMP2;PTK2B;ECM1;ENPP1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.4378801875979643,1.140953272608442,0.2816326530612245,0.9071846488405552,1.0,6/16,20.52%,CTR9;KMT2A;AUTS2;PIH1D1;KDM1A;SMAD4
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.4914108414254147,-1.1404199752147768,0.29615384615384616,0.6013855333367357,1.0,4/10,24.54%,MAP4K4;FGF7;MAPRE2;EPB41L4B
prerank,negative regulation of nuclear division (GO:0051784),0.4805738099325275,1.1403305915386863,0.3177966101694915,0.9074737957659207,1.0,2/11,6.64%,BMP7;TOM1L2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.286101758698586,1.1403281060096222,0.22660098522167488,0.9055609918615175,1.0,32/148,18.36%,PRKAG2;KMT5A;PRKAA2;PRKAG3;RICTOR;CHD4;TTC5;MEAF6;MAP2K6;PDPK1;KAT5;CHD3;TAF10;RFC5;MRE11;BRD7;CSNK2A2;MAPK14;TAF1;PML;CHEK2;SMYD2;NOC2L;RPA3;BANP;ATM;CHD5;MDM2;CDK5R1;RAD17;HIPK2;AKT1
prerank,regulation of phosphatase activity (GO:0010921),0.39504591619398044,1.1402334202719497,0.26011560693641617,0.9040119548973415,1.0,4/24,13.71%,SH3RF2;SH2D4A;HTT;TSC1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.4281299769146292,-1.1402311658356348,0.2723809523809524,0.6012250142432242,1.0,7/16,25.86%,RBM3;PRDX6;NCBP1;NCL;SNW1;TRA2B;DAZAP1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.48715209288670086,1.139545424957529,0.3090551181102362,0.9045860006327217,1.0,4/11,13.38%,ARR3;ARRB1;DRD3;GRK3
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.33673847352152647,-1.1395234222115431,0.23870967741935484,0.602407943951458,1.0,14/40,22.21%,SMURF1;RPL5;RPS7;RPL23;RAD23B;FOXF2;PTK2B;CSNK2A1;FBXW7;GNA12;PTEN;LATS1;GLMN;CCDC22
prerank,mRNA export from nucleus (GO:0006406),0.30772754356399834,1.1394569188041839,0.23208191126279865,0.902998422671072,1.0,27/102,19.97%,MCM3AP;PABPN1;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;PCID2;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;POLR2D;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP
prerank,regulation of chromosome organization (GO:0033044),-0.3919876765834799,-1.1393618067930409,0.2973568281938326,0.6021963941984563,1.0,12/22,34.31%,WAPL;XRCC5;TERF2IP;YLPM1;SHCBP1L;LIG4;HNRNPD;TERF2;MAPT;MYC;PIF1;BUB1
prerank,regulation of organelle organization (GO:0033043),-0.29491016033582734,-1.1388352905407622,0.2191142191142191,0.6029712321118552,1.0,35/80,30.91%,TJP1;CLIC4;F11R;MFF;USP6NL;SCARB2;CAPN2;PAK2;PDE2A;ARMH3;MAPK1;GOLPH3;SQSTM1;SAR1A;SURF4;TBC1D25;CLEC16A;PRMT6;TAOK1;MAPK3;ARHGEF5;SIRT7;MSN;STX5;RHOT2;MUL1;AKAP9;ARL6IP1;CAMSAP2;MAPT;STOX1;LMAN1;CAMSAP3;VPS35;CLN3
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.41927554018736357,1.1388311986188375,0.3067961165048544,0.9033030545637281,1.0,2/19,0.40%,AFDN;BMP6
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.43949964167442557,1.1387894388435922,0.3022774327122153,0.9015468566839479,1.0,3/17,2.36%,ROBO1;EFNB2;PIK3R3
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.40068521061522466,-1.138786369469148,0.2865853658536585,0.6024865852276664,1.0,4/20,6.54%,ST3GAL4;ST3GAL6;FUT8;ST6GALNAC5
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.41000265610076336,1.1387050602173319,0.2774566473988439,0.8999384674079978,1.0,5/20,10.40%,PRKAA2;RUVBL2;ARRB1;PPARGC1A;BRD7
prerank,positive regulation of ossification (GO:0045778),-0.339365468488182,-1.1385320932984093,0.2494331065759637,0.6024891118573952,1.0,14/39,12.38%,MEF2C;BMPR2;ZBTB16;PTN;ATP2B1;ACVR1;TGFB2;BMP4;WNT5A;CCN1;TMEM119;TGFB3;ISG15;BMP2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4007446415352734,1.1384545118037037,0.28489483747609945,0.8989635186138202,1.0,6/22,10.28%,APPL2;TAFA3;TRIM71;FZD9;LRRK2;NES
prerank,Ras protein signal transduction (GO:0007265),-0.27157995790639,-1.1375942826235759,0.17994858611825193,0.6042853636062108,1.0,42/137,16.71%,PLCE1;RAPGEF2;RHOA;NTN1;ARHGEF3;RASGRP3;RAP1A;CDH13;CDC42EP5;JUN;CDC42EP3;RALB;RAP2A;PRKD1;EPS8;AGTR1;GNB1;ARHGDIB;PLK2;RAPGEF6;SHOC2;G3BP1;TIAM1;FGF2;EPS8L2;RIPOR1;CFL1;GRAP;ADGRG1;CDC42EP2;KRAS;NRAS;ARHGAP1;TAX1BP3;RERG;SHTN1;ARHGDIA;GNA12;LIMK1;RAP2B;USP50;RREB1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4018430386013273,1.1375331758380764,0.2641165755919854,0.9002820843674091,1.0,6/22,15.46%,KRI1;EXOSC8;NOP9;PES1;EXOSC2;WDR12
prerank,autophagosome organization (GO:1905037),-0.3203712585059409,-1.1374740994067551,0.2167689161554192,0.6039484729652831,1.0,15/50,21.01%,ATG3;WIPI1;GABARAPL2;MAP1LC3B;RB1CC1;ATG16L1;PIK3C3;UBXN2A;GABARAP;RAB1B;ATG12;ATG5;WDR45B;EMC6;ULK2
prerank,mitochondrial fusion (GO:0008053),0.4264824446237446,1.136302625566145,0.29518072289156627,0.9027118430595892,1.0,5/18,11.63%,MIGA2;AFG3L2;CHCHD3;MIEF2;MFN2
prerank,negative regulation of phosphatase activity (GO:0010923),0.398352858375689,1.1362307895142931,0.30115830115830117,0.9010807615338907,1.0,3/25,5.02%,SH3RF2;SH2D4A;PPP4R4
prerank,histone H2A monoubiquitination (GO:0035518),0.4372806961149304,1.1360433756922241,0.31643002028397565,0.8998383022712915,1.0,5/17,12.26%,DDB2;PCGF2;PCGF5;PCGF6;RING1
prerank,cell-cell junction organization (GO:0045216),0.31165015319840744,1.1359289203614371,0.23920265780730898,0.8983362944314875,1.0,12/79,8.04%,SDK1;AFDN;SMAD3;SDK2;NLGN2;CDH15;CDH3;CDH17;PKP4;CDH10;CDH18;PRKCI
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.40573724584586907,-1.1358973398141905,0.2727272727272727,0.6073809546541267,1.0,7/19,21.23%,GAS6;MDK;ZBTB1;NCKAP1L;BTK;ZMIZ1;SYK
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.41421010160795224,-1.1356684706573936,0.2860169491525424,0.6073234340021998,1.0,10/17,21.83%,CACNA1G;STX1A;SYT4;RAB3A;RAB27A;CACNA1I;KCNB1;CACNA1H;RAB3D;SLC4A8
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.44060694376716636,1.1347840577917279,0.3067961165048544,0.9005638569872916,1.0,3/16,6.63%,FGF1;NPNT;CITED1
prerank,mRNA processing (GO:0006397),0.26568756121856163,1.1344688215702832,0.17851959361393324,0.89987160898282,1.0,92/287,24.43%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;SRSF5;TFIP11;CPSF6;SF3B5;HNRNPH3;HNRNPA2B1;CCAR1;PQBP1;HNRNPU;HNRNPA3;SRSF10;PRMT9;SON;CPSF7;HNRNPL;PTBP1;LSM5;PPARGC1A;ZMAT5;ELAVL1;CACTIN;IK;SRRM4;RNMT;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;ZMAT2;RPRD2;USP39;PRCC;SRSF11;RBM5;LSM8;POLR2D;SNIP1;ELAVL2;RNPS1;AKAP8L;ALYREF;DHX8;SNU13;PRPF6;PRPF3;HNRNPH2;SRRT;DDX39B;MTREX;THOC1;SNRPB2;SRSF6;SUGP1;CWF19L1;PUF60;POLR2A;SF3B2;SF3B1;SARNP;SUPT4H1;PRPF40A;GCFC2;SNRPB;PPIL1;HNRNPH1;DDX39A;SART3;PRPF38A;PPIL3;SF3B3;SNRPN;CELF1;EFTUD2;POLR2B;HNRNPC;SNRPC;DDX41;WDR83;RBM15B;CSTF2;SRSF2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4753227912520358,-1.1344356252191312,0.32,0.6098036951215013,1.0,4/10,7.11%,CACNB2;CACNA2D1;NOS1AP;CALM3
prerank,long-term synaptic potentiation (GO:0060291),0.40370534995308915,1.13435608266986,0.2948453608247423,0.8984184016642479,1.0,3/21,5.02%,SLC8A3;PRKCZ;GRIN2D
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.471643028298953,1.1342872116009914,0.3220675944333996,0.8968304050973221,1.0,4/11,13.14%,PPARA;SLC30A10;ABCD1;TRAP1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.360114170451333,-1.1342757336979472,0.2928870292887029,0.609600660686229,1.0,17/29,32.90%,UBC;RPS27A;UBB;UBE2D3;BIRC3;CD40;RIPK1;TICAM1;CASP8;TLR4;CD300LF;FADD;IRF3;TLR6;CD14;IKBKB;TLR3
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.4186872142191417,-1.1342550859955363,0.3060796645702306,0.6090481030458065,1.0,8/16,29.65%,SMC1A;NIPBL;RAD21;MAU2;REC8;SGO1;DSCC1;NAA50
prerank,protein transport (GO:0015031),-0.23932211088430458,-1.1338911575979589,0.08108108108108109,0.6093029904208992,1.0,76/332,16.89%,SPTBN1;TBC1D4;CALCRL;RABGAP1L;STEAP3;RAB14;RAMP2;SLC10A7;MYH9;TBC1D8;MACF1;SCFD2;ABCA1;ATP6V0A4;TBC1D12;LMAN2L;RAB6A;STX1A;HERC2;SNX13;RAB31;MIA2;TMED10;USP6NL;TBC1D5;CHMP2B;STX3;TBC1D2B;TFRC;MON1A;ARHGEF2;SNX1;TBC1D1;MTTP;CMTM6;EVI5L;ATP6V0D1;ATP6V0A1;VPS26A;RAB22A;TXNIP;TBC1D13;APOE;GOLPH3;DNAJC27;WDR11;SEC31A;VLDLR;CD74;RAB3A;SCAMP1;PDIA4;ARHGAP1;ATP6V1D;STX7;HDAC6;ARL5A;SYS1;TBC1D10A;LRP1;AP2A1;STX8;SAR1A;RAB11B;RAB5C;RAB1B;HIKESHI;TBC1D25;RAB3GAP2;SEC13;ARF5;COPA;COPB2;TCIRG1;IFT27;LRP1B
prerank,small GTPase mediated signal transduction (GO:0007264),-0.2815592146814166,-1.1338146493213908,0.1935483870967742,0.6088716536564114,1.0,25/103,13.41%,ARHGAP31;PLCE1;RAPGEF2;NTN1;RASGRP3;BCR;JUN;TIAM2;RALB;PRKD1;ARHGAP32;GNB1;PLK2;RAPGEF6;SHOC2;G3BP1;ABR;TIAM1;FGF2;GRAP;KRAS;NRAS;ARHGAP1;RERG;SHTN1
prerank,protein modification process (GO:0036211),-0.2998268068642892,-1.1335566517859808,0.22985781990521326,0.6088779174419453,1.0,20/76,16.26%,ST8SIA4;ST3GAL6;PLOD2;ATG3;ST3GAL1;UBE2D3;LOX;CSNK1G3;YES1;CPE;UBE2L3;FBXW2;STK38;AKT2;UBL5;PPP4R2;ST8SIA2;ICMT;PHKA2;PHEX
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.35834476047579594,1.1334885343201477,0.27288428324697755,0.8978591977720475,1.0,5/38,3.16%,CACNA1D;DSC2;KCND3;ANK2;KCNJ5
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.2819977407812752,-1.1333689498927164,0.20052083333333334,0.6087735052097093,1.0,24/108,11.29%,HIP1;ACER2;GSN;TNFSF10;MAP3K5;APAF1;F3;NGF;NOD1;FAS;CRADD;XDH;RACK1;HSPE1;DAP;CASP8AP2;RPS3;BCAP31;CTSD;ATP2A3;EIF2AK3;IFT57;MALT1;SOX7
prerank,regulation of astrocyte differentiation (GO:0048710),-0.45302105216033,-1.1331213097377788,0.3113207547169811,0.6087518992010522,1.0,4/12,15.78%,NOTCH1;HES1;BMP2;ID2
prerank,amino acid transport (GO:0006865),-0.3211258387698489,-1.132999502331882,0.2557603686635945,0.6084713704123659,1.0,11/49,9.02%,SLC6A6;SLC38A11;SH3BP4;SLC1A5;SLC7A5;SLC38A5;SLC43A2;SLC7A7;SLC7A1;SLC7A14;SLC43A1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3387835469285433,-1.1328098325913192,0.270042194092827,0.6083600703875737,1.0,10/39,15.55%,PODXL;JAG1;FXYD5;NOTCH1;CDH1;NOTCH4;KLF4;BMP2;VEGFA;MAD2L2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.26347033683219995,-1.1327875853628335,0.17708333333333334,0.6077954428603928,1.0,51/146,28.00%,FBXL7;YWHAE;RAD51B;FHL1;DYNC1I2;BRD4;CSNK1E;PSMA6;PSMB7;TUBA1A;PSMB6;CEP76;PSMB5;FBXO5;DCTN3;USP47;ODF2;DYNLL1;PSMB8;CCP110;PSMC4;PRKAR2B;PSMD11;PAFAH1B1;PRKACA;PSMB4;DYNC1H1;PSMD14;CCND1;RAB11A;PSMD10;CSNK1D;DCTN1;PSME1;CEP41;TPX2;TUBA4A;CEP131;PSMB3;CDK5RAP2;CEP152;DTL;HMMR;KIF14;AKAP9;ACTR1A;CUL1;CDK2;CENPJ;CNTRL;AVEN
prerank,negative regulation of endocytosis (GO:0045806),0.4002137783125117,1.1326421644290254,0.2958801498127341,0.8990381363892541,1.0,6/24,12.52%,SYT11;PICALM;NR1H3;SCAMP5;CD300A;MTMR2
prerank,synaptic vesicle endocytosis (GO:0048488),0.37195761526605103,1.1318617766006964,0.2691588785046729,0.9000802464572515,1.0,8/33,11.76%,DNAJC6;CEL;NLGN2;PICALM;SYT1;NLGN3;SYNJ2;CANX
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3972653280722716,-1.1317915975768247,0.2883817427385892,0.6097087892490192,1.0,6/21,12.65%,DCN;CSGALNACT1;CSPG4;VCAN;CHSY3;BGN
prerank,fatty acid metabolic process (GO:0006631),0.2970892340953187,1.1317077775842075,0.2512315270935961,0.8987841212889126,1.0,25/115,17.36%,ACSL1;CEL;PON1;ACSM2A;ACSM2B;PPARA;LPIN1;AASDH;PNPLA8;ACADSB;ECHDC3;PPARGC1A;CPT1C;SLC27A6;FA2H;PLA2G15;CROT;SLC27A4;NAAA;PER2;GGT5;ACACA;ACOT1;MSMO1;ACOT6
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.45900655270900736,1.1314402022031294,0.3226452905811623,0.8979378182037776,1.0,6/12,22.71%,PLK1;GOLGA2;CDC14B;RAB1A;UBE2S;BTRC
prerank,receptor signaling pathway via STAT (GO:0097696),-0.37195852922709416,-1.1312920801765287,0.28830645161290325,0.6103855529142885,1.0,4/25,3.15%,GHR;PKD1;SOCS2;STAT3
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.4382520402206883,1.1311507156488594,0.3125,0.8972042952600592,1.0,4/16,15.49%,RORA;PDK2;PDK1;SIRT1
prerank,response to organonitrogen compound (GO:0010243),0.3581067938626491,1.131034258469397,0.28136200716845877,0.8958220567501048,1.0,10/38,15.60%,TRPV1;RRAGC;DERL1;GLRA1;DRD3;TRPM2;CCDC47;UBXN6;RNF5;IL6
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4692301530781069,-1.1304338454879828,0.3089108910891089,0.6120209272525331,1.0,3/10,13.61%,PRKCH;TRIM16;NME2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.39123668437187126,1.1301598268125634,0.2760511882998172,0.8970204032170352,1.0,9/25,20.39%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,positive regulation of metabolic process (GO:0009893),0.3015326877736219,1.1300754852702244,0.22885572139303484,0.8955121117959227,1.0,7/103,1.08%,EPAS1;PPARGC1B;LEPR;ACSL1;IL18;PTH2R;APPL2
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.42993373463635887,-1.1300278659121363,0.30434782608695654,0.612543876315779,1.0,5/15,18.32%,ENTPD1;ENTPD6;ENTPD2;NME2;AK4
prerank,ganglioside metabolic process (GO:0001573),-0.3853583866107712,-1.1297800016453208,0.3117408906882591,0.612580456080021,1.0,6/20,14.69%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA6;HEXA;ST8SIA2
prerank,response to steroid hormone (GO:0048545),0.3802699534011938,1.1295738653267309,0.2884990253411306,0.8954804952032737,1.0,7/31,14.78%,ATP1A2;TFPI;MED1;NR1H3;PAQR7;ABCA2;WBP2
prerank,lipid oxidation (GO:0034440),-0.46247700143286385,-1.1294041470117695,0.3045267489711934,0.6128688304018549,1.0,2/12,5.09%,ADIPOR2;ACOX1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3350976960344131,-1.129242736995684,0.2630480167014614,0.6126596878636366,1.0,11/39,14.93%,DAB2IP;PTPN12;EGFR;PTPRJ;ITGA1;SPRY2;DUSP3;HGS;SH3GL2;SPRY1;CBL
prerank,atrial septum development (GO:0003283),0.46433809108317864,1.1291626541080955,0.30386740331491713,0.8950793813023281,1.0,2/13,1.72%,NOTCH2;ANK2
prerank,negative regulation of microtubule polymerization (GO:0031115),0.46762601793698416,1.1289627185852893,0.30416666666666664,0.8939559933555473,1.0,5/12,15.52%,MAP2;CLIP3;EML2;TUBB4A;MAPRE1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.38079401962669096,-1.128934666866209,0.2957446808510638,0.6127915631505446,1.0,11/20,32.10%,ACVR1;ACVRL1;AIDA;DSCAML1;PTCH1;GREM1;LMX1B;LHX1;BMPR1B;TBX20;NOG
prerank,regulation of MAP kinase activity (GO:0043405),0.3010569053569466,1.1289128684961778,0.2553542009884679,0.892330308188314,1.0,11/92,8.22%,ROBO1;BMP7;FGF1;TENM1;KIT;ADRA2A;PIK3CB;PPEF2;SNF8;LRRK2;KSR1
prerank,regulation of cell adhesion (GO:0030155),-0.26923634418119036,-1.128670773533297,0.19086021505376344,0.6128553749881974,1.0,50/129,25.85%,FRMD5;PODXL;ZFHX3;ACVRL1;CDH13;PTPRJ;PPP1R12A;NUAK1;STX3;ARHGDIB;ADAM10;LYN;CXCL12;PPP3CA;MDK;PRKX;TGM2;TGFBI;EFNA5;SRC;EPHB2;ADGRG1;PLXNC1;RET;PTK2B;SIPA1;ARHGDIA;VEGFA;ZDHHC2;SEMA5A;PLXNA4;CELSR2;GPR4;PLXND1;PPP2CA;ROCK1;DUSP1;RASA1;DLL1;TESC;LPXN;ATXN3;FES;EPB41L4B;CXCR4;EPHA7;PTPN11;PIK3CG;RND1;KIF14
prerank,epidermal cell differentiation (GO:0009913),-0.33418779704935386,-1.1286230447687398,0.2822222222222222,0.6123658944820217,1.0,9/41,12.95%,JAG1;CLIC4;BCR;WNT5A;ANXA1;TXNIP;SCEL;UGCG;ERCC2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.34210558676734537,1.128247139629044,0.266173752310536,0.8928494865963635,1.0,10/48,11.49%,ROBO1;NLRP2B;OTUD4;USP18;PELI3;CACTIN;NR1H3;OAS3;PARP14;STAT2
prerank,response to peptide (GO:1901652),-0.35783981025532435,-1.1277619524746767,0.28958333333333336,0.6138522726664298,1.0,12/33,22.09%,KAT7;STAT3;ANXA1;EIF2B2;CACNA1B;IRS1;MMP2;EIF2B1;NOD2;ERBIN;IRF5;FYN
prerank,Golgi ribbon formation (GO:0090161),0.4630002901484241,1.1268029727419748,0.3366733466933868,0.8960745439659226,1.0,4/13,10.19%,OPTN;STX16;GOLGA2;MYO18A
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.401124224318268,-1.1266676148872476,0.2948717948717949,0.615986679176647,1.0,7/20,14.97%,THBS1;CREB3L1;NPTN;SPRY2;FGF2;SPRY1;GPC1
prerank,regulation of protein localization (GO:0032880),0.32824778639723134,1.1266299916004587,0.26017699115044246,0.8948769435957606,1.0,9/58,10.46%,AFDN;MAP2;PICALM;TRIM5;CAMK1;DLG1;CEP290;WDPCP;VIP
prerank,negative regulation of autophagy (GO:0010507),0.3342997986446097,1.1265598236097023,0.2665441176470588,0.8933555298043424,1.0,12/54,13.71%,LEPR;NUPR1;CTSA;QSOX1;ZKSCAN3;LRRK2;GOLGA2;BCL2;IL10RA;KDM4A;TBC1D14;TSC1
prerank,protein processing (GO:0016485),0.29813471422903465,1.1260932157087584,0.22135007849293564,0.8932691942807902,1.0,11/102,8.52%,AEBP1;METAP2;ADAMTS13;PCSK4;CPN1;FURIN;PITRM1;AFG3L2;HTRA2;SPRTN;LONP2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4135558477244861,-1.1258846692005458,0.3064516129032258,0.6173502337920128,1.0,6/15,27.62%,APP;IAPP;APOE;PFDN6;TREM2;LDLR
prerank,chordate embryonic development (GO:0043009),-0.3144463211447108,-1.1258705595806775,0.24782608695652175,0.6167732902933911,1.0,18/55,16.19%,MBNL1;BMP5;PCSK5;PKD1;FUT8;KIAA1217;TBX1;WNT5A;ADAM10;IGF2;TGFB3;XYLT1;PTCH1;COL1A1;BMP2;VEGFA;STIL;SIX4
prerank,cholesterol biosynthetic process (GO:0006695),0.37304411495677603,1.1257450099320332,0.29684601113172543,0.8927250348936928,1.0,10/31,20.27%,ACAT2;INSIG2;DHCR24;SC5D;SQLE;CYP51A1;MSMO1;GGPS1;HMGCR;LBR
prerank,regulation of neuron projection arborization (GO:0150011),-0.42628954162615884,-1.1252493861793786,0.3305785123966942,0.6177739098458226,1.0,4/15,12.19%,MACF1;WNT5A;FZD4;MFSD2A
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.4398141230643043,-1.1249458881191632,0.32238193018480493,0.6179770167086853,1.0,3/14,2.88%,TMSB4X;PKD1;NFKBIA
prerank,chondrocyte differentiation (GO:0002062),-0.3527632721345692,-1.1247830234928728,0.27672955974842767,0.6177549392998755,1.0,8/32,9.16%,MEF2C;BMPR2;RUNX2;RUNX1;BMP4;CCN3;SNX19;EIF2AK3
prerank,response to interleukin-1 (GO:0070555),-0.29694504629361956,-1.1247665253303634,0.23923444976076555,0.6171860894450435,1.0,20/73,23.57%,DAB2IP;IL1R1;PTGIS;IRAK3;APP;TNFRSF11A;ANXA1;CCL13;SRC;TLE5;CD40;IRAK2;ADAMTS12;CCL25;USP10;ZC3H12A;MYD88;HAS2;MAPK11;TAF9
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4744997398625655,-1.124692228884009,0.3285123966942149,0.6161511019778647,1.0,6/10,23.05%,NFATC1;PPP3CA;NFAT5;NFATC2;NFATC3;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),-0.4744997398625655,-1.124692228884009,0.3285123966942149,0.6161511019778647,1.0,6/10,23.05%,NFATC1;PPP3CA;NFAT5;NFATC2;NFATC3;NFATC4
prerank,eye development (GO:0001654),0.3398268297842696,1.1242896656485475,0.26654740608228983,0.895918594556273,1.0,16/54,15.93%,SMOC1;COL5A1;PBX2;RAB3GAP1;MEIS1;PAX6;MAB21L2;PBX4;CEP290;ZDHHC16;CPAMD8;SHROOM2;FOXC1;TSKU;ADAMTS18;RBP4
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.3321612655988419,-1.1238019706274212,0.2831858407079646,0.6177730581607075,1.0,15/40,21.10%,CRY1;UBE2V2;PRKCD;FEM1B;IER3;WDR76;PARG;FBXO5;WRNIP1;FMR1;FXR1;RPA2;MCL1;SIRT7;NSMCE4A
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.2806197863836102,-1.123801178104031,0.2152777777777778,0.6171692311041832,1.0,28/108,13.83%,RSPO3;MDFIC;DAAM2;DISC1;RUNX1;MACF1;NFATC1;KANK1;SFRP4;APP;CDK14;ESR1;NKD2;RACK1;CCNY;CBFB;SPIN1;ATP6AP2;TIAM1;PPP1CA;AMER1;SOX7;HHEX;BMP2;GSKIP;TAX1BP3;CSNK2A1;LRP1
prerank,regulation of signal transduction (GO:0009966),-0.2567876219219332,-1.123593148687671,0.2056338028169014,0.6171077616519279,1.0,49/190,16.63%,PLCE1;RSPO3;RGS3;LIFR;RGS12;ACVR1;MDFIC;RGS5;TMEM204;SOCS2;RUNX1;PLSCR1;APP;ESR1;IGFBP6;MGLL;UBASH3B;PRKD1;HHIP;PPIA;NCK1;PXN;CBFB;RGS6;CD55;SRC;PTPN1;SOCS5;CDKN2AIP;WDR11;MFNG;SREBF2;GRK5;PTCH1;UGCG;CDC42SE2;GSKIP;TSPAN12;ZDHHC7;CD24;RGS4;IRAK2;GIT1;GIT2;LFNG;SEMA5A;SP100;CD46;NCLN
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.43724584961280305,-1.1235285866211577,0.32475247524752476,0.6166876306537659,1.0,3/13,6.06%,PDE8A;RACK1;MET
prerank,regulation of telomerase activity (GO:0051972),-0.32800982179167015,-1.123250107635995,0.2669683257918552,0.6167355169465442,1.0,15/45,22.80%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;SRC;HMBOX1;KLF4;CCT2;PARM1;GREM1;MAPK3;MAP2K7;MAP3K4;DKC1
prerank,regulation of phospholipase C activity (GO:1900274),-0.42648423134415037,-1.1231125809594522,0.31006160164271046,0.6164956097111971,1.0,5/15,9.34%,NTRK3;PLCG1;ESR1;FLT1;FGF2
prerank,regulation of cell morphogenesis (GO:0022604),-0.3633290861899296,-1.1229261140316023,0.2791666666666667,0.6163696577310434,1.0,7/30,12.19%,FMNL2;SPARC;MACF1;CD44;EFNA5;CFL1;MFSD2A
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4257790281351116,1.122865690923192,0.31274900398406374,0.8991617684141527,1.0,10/17,26.15%,CORO1B;WASF1;CYFIP1;WASF3;PICK1;CTNNA2;BRK1;ARF1;GMFB;ARFIP1
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.33492659736911556,-1.1227750365158768,0.28725701943844495,0.6161342710156911,1.0,11/40,14.23%,NTRK3;EDNRA;EGFR;PLCG1;ESR1;FLT1;FGF2;PHB2;HTR2A;CD86;P2RY6
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3067614931282349,-1.1226015826127624,0.25565610859728505,0.6159818300343368,1.0,22/59,18.12%,PTPRM;HMCN1;PECAM1;BSG;PKD1;CDH13;CDH1;PALLD;ITGB1;NECTIN3;NPTN;ROBO4;CEACAM1;DSCAML1;NECTIN2;FAT2;EMB;CDH2;KIRREL3;PVR;DSG2;CELSR2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3659193923783606,-1.1221929994950208,0.29606625258799174,0.6163598000332694,1.0,8/27,17.44%,SLC47A1;SLC7A5;SLC1A3;SLC38A5;SLC7A1;SLC1A1;SLC36A4;SLC7A8
prerank,regulation of type I interferon production (GO:0032479),-0.28683543575586723,-1.1221915944784866,0.25485436893203883,0.615766307541779,1.0,26/84,23.79%,LRRFIP1;POLR3F;DHX33;RNF125;XRCC5;NLRC5;TRIM56;TRIM25;G3BP1;ISG15;POLR3H;IFIH1;NFKB2;POLR3B;TRAF3IP1;PCBP2;GAPDH;IRF5;POLA1;POLR3A;MYD88;ZBP1;POLR3D;POLR2F;CYLD;TAX1BP1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.4750748800370874,1.1220438287703798,0.3235867446393762,0.9001981024767995,1.0,3/10,15.49%,KLF15;NOC2L;SIRT1
prerank,regulation of RNA metabolic process (GO:0051252),0.32978453623641973,1.1220084518642934,0.26362038664323373,0.8985572804337965,1.0,24/59,19.62%,OAS2;NOVA1;HNRNPH3;PQBP1;FASTK;PTBP2;SON;HNRNPL;PTBP1;MED1;OAS3;SRRM4;CLK3;AFF2;GRSF1;PCBP4;MBNL3;CLK2;FAM50A;METTL18;HNRNPH2;PTBP3;MITF;CLK1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.24585777117706348,-1.121868903648977,0.14984709480122324,0.6159792578513383,1.0,53/248,13.10%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;DAAM2;STK3;EGFR;LIMD1;SDHAF2;KANK1;SFRP4;CDK14;GLI3;TLE4;NKD2;SOX17;IGFBP6;CSNK1E;CSNK1G1;ADGRA2;WNT5A;TNKS;AXIN2;CCNY;PLEKHA4;PSMA6;TLE3;CSNK1A1;ZNRF3;PSMB7;MDK;CSNK1G3;INVS;APC;XIAP;ATP6AP2;PPP1CA;APOE;PSMB6;AMER1;PSMB5;TLE5;SOX7;SCEL;FZD4;DKK2;HHEX;COL1A1;BMP2;GSKIP;USP47;ANKRD6
prerank,regulation of lipase activity (GO:0060191),-0.4464517112239147,-1.1218333230842967,0.3111111111111111,0.6154682259556179,1.0,2/13,1.78%,RHOA;PCSK5
prerank,regulation of monocyte differentiation (GO:0045655),-0.43373976704186334,-1.12179164672803,0.3139784946236559,0.6149839127106543,1.0,3/14,11.83%,FOXP1;IL34;CD74
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.4928346822829911,1.1214839256225115,0.3271604938271605,0.8986984393693703,1.0,3/10,6.35%,DNMT3L;DNMT3A;PCGF5
prerank,mesenchyme development (GO:0060485),0.44271325968940933,1.1214820960045973,0.30392156862745096,0.8969511035741937,1.0,4/15,10.07%,BMP7;FGFR2;CRELD1;TGFBR1
prerank,cellular response to virus (GO:0098586),0.37156235209334587,1.121220805936616,0.2786259541984733,0.8961159178506144,1.0,11/30,20.76%,CHUK;GSDME;VWCE;MAPK14;IL6;GBF1;IL12A;HSP90AA1;POU2F2;DDX3X;BAX
prerank,amino acid transmembrane transport (GO:0003333),-0.3267425335061462,-1.1207450711685767,0.267260579064588,0.6169730503308395,1.0,10/45,8.49%,SLC47A1;SLC6A6;LRRC8D;SLC38A11;SLC7A5;SFXN1;SLC38A5;SLC7A7;SLC7A1;SLC16A2
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3841714705828413,-1.1205785260181425,0.31027253668763105,0.6167878134117236,1.0,6/22,9.34%,NTRK3;PLCG1;ESR1;AGTR1;FLT1;FGF2
prerank,glycoprotein metabolic process (GO:0009100),-0.30788455668659065,-1.1203265273683025,0.24423963133640553,0.616850929836329,1.0,14/53,14.69%,ST3GAL4;ST6GALNAC3;ST8SIA4;FUT8;ST8SIA6;STT3B;MGAT4A;AGA;GOLPH3;B4GALT5;GCNT1;FBXO44;MGAT4B;ST8SIA2
prerank,negative regulation of ossification (GO:0030279),-0.38687375587560946,-1.1201914806833981,0.3044397463002114,0.6166161284262793,1.0,6/23,13.74%,MEF2C;NOTCH1;MDK;PTK2B;ECM1;ENPP1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.2660336766327288,-1.1200298157970823,0.195822454308094,0.6164317707293812,1.0,39/136,20.24%,DAB2IP;TMSB4X;CD200;FZD6;PKD1;GAS6;CYP1B1;PTGIS;NFKBIA;ID1;SFRP4;IRAK3;ESR1;FLNA;BHLHE40;TRIM37;AIM2;HES1;NLRC5;DAP;HEYL;USP7;KLF4;PHB2;PTCH1;MTURN;IRAK2;MAD2L2;ID2;SP100;SIGIRR;PEX14;HDAC2;ERBIN;LRRC14;ZC3H12A;SPI1;ARRB2;PSMD10
prerank,L-amino acid transport (GO:0015807),-0.36175834312947014,-1.1200050223147293,0.2925764192139738,0.6158896387122024,1.0,8/28,17.44%,SLC7A5;SFXN1;SLC1A3;SLC38A5;SLC7A1;SLC1A1;SLC36A4;SLC7A8
prerank,cell junction organization (GO:0034330),0.31333103927705525,1.1189882864783323,0.2633390705679862,0.9022265079060787,1.0,7/71,2.86%,SDK1;SLC6A1;SLC8A3;SMAD3;SDK2;FLNC;NLGN2
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.391721114307337,-1.1188658583353885,0.3,0.6182680248772203,1.0,7/19,11.67%,PLCE1;NFATC1;PPP3CA;NFAT5;EDN1;NFATC2;EDN3
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.32371428207352415,-1.1185525968166137,0.2648305084745763,0.6184546422160564,1.0,16/43,17.35%,FOXP1;THBS1;CDH13;BMP4;JUN;ERN1;IL6R;ADAMTS1;FGF2;EDN1;CCN4;P2RY6;HTR1B;ID2;LDLRAP1;MMP2
prerank,cellular response to metal ion (GO:0071248),0.2934045894071319,1.118466911909939,0.2348993288590604,0.9022143892546399,1.0,24/123,12.42%,BMP6;SYT11;SYT12;SLC41A1;PRKAA2;CPNE1;CYP11B1;CAPN3;SYT9;ADCY1;CHUK;GLRA1;CPNE4;PPIF;SYT1;ADCY8;SYT13;LRRK2;ADGRV1;DLG4;SYT10;TRPM2;CPNE6;MAPK9
prerank,cardiac atrium morphogenesis (GO:0003209),-0.4230658456792846,-1.1183823095757581,0.31958762886597936,0.618312954117221,1.0,6/16,12.38%,BMPR2;TGFB2;ENG;NOTCH1;HEY2;BMP2
prerank,leukocyte tethering or rolling (GO:0050901),-0.4033579523532792,-1.1183550441004482,0.313373253493014,0.6177771648727446,1.0,5/17,12.40%,VCAM1;ITGB1;GOLPH3;GCNT1;ITGA4
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.44589066387959025,-1.1180909501639775,0.34063745019920316,0.61787400647664,1.0,6/12,32.25%,CHMP4B;CHMP4A;SEC61A1;SEC62;HSPA5;GET3
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.39933899525957395,1.11781367878348,0.29791271347248577,0.9026740104279334,1.0,4/25,4.40%,HSPA1A;DNAJC18;DNAJB4;DNAJB14
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2818711732351879,1.1175516055521217,0.2369281045751634,0.9018088990341975,1.0,24/152,10.46%,CACNA1D;ADCY5;LGR4;GCGR;PTH2R;ADGRG4;ADCY1;CRHR1;ADRA2A;LPAR2;CHRM2;ADGRB2;ADGRB3;ADCY8;GPR12;GPR26;LPAR1;PTGER1;GABBR1;ADGRL1;GPR37;HTR1F;ADGRG3;VIP
prerank,regulation of multicellular organism growth (GO:0040014),-0.43164254081793435,-1.1173890363958847,0.3424657534246575,0.6190873268913197,1.0,5/15,12.19%,GHR;APP;SOD1;PTCH1;MFSD2A
prerank,positive regulation of cellular respiration (GO:1901857),0.4679679476808315,1.117270301023883,0.3130081300813008,0.9010229556989057,1.0,1/11,0.90%,NUPR1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.44350811551290703,-1.1172626957931455,0.3320388349514563,0.6187931189579504,1.0,4/13,12.38%,BMP5;SOD1;APOE;BMP2
prerank,positive regulation of inflammatory response (GO:0050729),-0.28998745413409605,-1.1168915266135386,0.25240384615384615,0.6191691587293692,1.0,15/86,11.84%,IL6ST;OSMR;ETS1;NFKBIA;ABCC1;APP;WNT5A;AGTR1;PDE2A;MDK;IFI35;SERPINE1;IL15;PDCD4;CCN4
prerank,cellular response to sterol (GO:0036315),0.4558904676772014,1.116335758402297,0.31746031746031744,0.9025641161912135,1.0,3/13,5.58%,RORA;INSIG2;GRAMD1B
prerank,regulation of steroid metabolic process (GO:0019218),0.39474693562807334,1.116085124673941,0.3031423290203327,0.9016375414227374,1.0,5/23,15.67%,RORA;PANK2;ABCA2;EPHX2;STAR
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.3577515183410012,-1.1159939846609492,0.30648769574944074,0.6208825742474948,1.0,12/28,24.89%,NOTCH3;EGFR;GATA2;TCIM;FBXW7;LFNG;HEY1;METTL3;DLL4;DLL1;EGF;ZBTB7A
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.43983667652413794,-1.1159912829013214,0.3210412147505423,0.6203015524427268,1.0,4/13,10.46%,NOTCH1;TGFBR2;HEY2;CPE
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.43305669337176966,1.1154703052583104,0.3163064833005894,0.9019253274180613,1.0,4/15,12.98%,NLGN2;ZDHHC12;SYN3;ZDHHC3
prerank,negative regulation of JNK cascade (GO:0046329),-0.3448289090633656,-1.1152754809148016,0.29508196721311475,0.6215272744008375,1.0,6/31,11.79%,MECOM;DNAJA1;AIDA;DUSP3;PER1;PDCD4
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.2848400979575039,-1.1148509954899157,0.24937027707808565,0.6219823725866138,1.0,34/83,27.24%,ACVR1;CDK17;CDK14;CACUL1;BRD4;PLK2;KLF11;CDK5;EIF4E;FBXO5;NASP;ORC1;DHFR;LATS1;CCND1;CDK16;CDC45;CDK6;POLA1;CCNH;CDKN1B;CDK18;CUL3;LATS2;PLK3;CDC34;PIM2;CDKN3;TYMS;CUL4A;NPAT;TFDP1;CUL1;CDK2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.45228120996631715,-1.1146980530963673,0.32987551867219916,0.6218025857683215,1.0,3/11,4.88%,CAV1;NEDD4L;CAB39
prerank,positive regulation of immune response (GO:0050778),-0.2989731233954491,-1.114679955903597,0.2686230248306998,0.6212673688195187,1.0,16/64,22.51%,IL6ST;TGFB2;POLR3F;PLSCR1;GBP5;IFI35;IL15;CD74;RSAD2;PTPRC;CD46;POLR3B;NOD2;POLR3D;NMI;FCGR2B
prerank,action potential (GO:0001508),-0.3224456932647357,-1.1143943253443183,0.25,0.6214332284693689,1.0,14/44,21.60%,KCNJ2;CACNA1G;GNA11;KCNMB2;KCNQ1;CACNA1I;KCNB1;KCNE4;SCN3A;GPER1;CACNA1H;GNA14;DMD;SCN7A
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.32506594499321384,1.114347511178658,0.28546409807355516,0.9040550054862826,1.0,12/54,14.94%,HSPA1A;SPHK1;CPNE1;CHUK;CLIP3;NLRP2B;IKBKG;PELI3;CFLAR;RNF31;HSPA1B;RBCK1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.40260525594699753,1.1142912032002001,0.29615384615384616,0.9025182227689491,1.0,4/21,10.53%,DCDC2;EVC;ARMC9;TEDC2
prerank,heart trabecula morphogenesis (GO:0061384),-0.4034197587700634,-1.1138519534509388,0.3252747252747253,0.6222333898969514,1.0,7/18,5.58%,TEK;BMP5;ADGRG6;TGFB2;ENG;NOTCH1;S1PR1
prerank,regulation of cell cycle (GO:0051726),-0.24292888807338128,-1.1132149482013471,0.19230769230769232,0.6231914385650018,1.0,84/271,23.40%,APBB2;MECOM;TTC28;DAB2IP;NEK7;LRP6;FAP;PLAGL1;TGFB2;TBX3;THBS1;NOTCH1;DCUN1D3;PKD1;IQGAP1;AFAP1L2;STAT3;BMP4;ADARB1;PTPRK;JUN;MAP3K20;ERN1;RACK1;ADAM10;APC;MYBBP1A;RPS6KA2;CDC123;RBBP4;CDK5;XIAP;WHAMM;RPL23;FBXO5;GRK5;PDCD4;BMP2;BIRC3;LIN54;SIPA1;CSNK2A1;AKT2;GAS2L1;PTPRC;MADD;PUM1;JMY;FOXO4;ID2;PRKACA;RPS15A;TBRG4;ING4;GPER1;JUNB;NBN;BARD1;MASTL;CCND1;MAPK12;KIF20B;CDC26;CDK6;ASAH2;PCLAF;CCPG1;METTL3;RHOB;L3MBTL1;CHEK1;JUND;THAP1;TTLL12;DUSP1;RPRD1B;FBXL6;CCNB2;CDKN1B;RNF40;CDK11B;CYLD;PRDM11;NANOS3
prerank,response to organophosphorus (GO:0046683),-0.40462194201138135,-1.1128100899104558,0.32007952286282304,0.6235884967711107,1.0,3/16,9.27%,TRPC3;ABCC9;TRIM16
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.42038802257397495,-1.1124010018042714,0.30284552845528456,0.6240505981939614,1.0,8/17,26.33%,PKD1;EGFR;CCNY;CCND1;PSMD10;CCND2;RGCC;MAPRE3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.25556469231403245,-1.1123862848404227,0.2132564841498559,0.6234995591686463,1.0,46/163,23.25%,PDE4D;MEF2C;RFTN1;PIK3R1;PLCG1;PTPRJ;PLCG2;BMX;PAK2;TEC;NCK1;PSMA6;INPP5D;PSMB7;TNFRSF21;CD38;SPPL3;EIF2B2;PIK3CA;BCAR1;PSMB6;MALT1;PIK3CD;PSMB5;NFATC2;SH2B2;PTPRC;PSMB8;PSMC4;PSMD11;NCKAP1L;DENND1B;LAT2;EIF2B1;PSMB4;PSMD14;ZC3H12A;BTK;PSMD10;SYK;PSME1;RIPK2;FYN;CD276;BCL10;PSMB3
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.44654750833241297,1.1121241779274538,0.33858267716535434,0.9081694862743933,1.0,3/14,8.03%,IL18;PRKCZ;NLRP3
prerank,cellular response to light stimulus (GO:0071482),-0.30142392760038345,-1.1119488900093135,0.2543859649122807,0.624052810129583,1.0,28/66,34.03%,PTPRK;GNB1;PRKCD;ZBTB1;USP47;COPS9;RHBDD1;BAK1;FMR1;ATF4;N4BP1;RHNO1;GPR88;METTL3;NEDD4;NSMCE3;TRIAP1;SMPD1;GPR52;PARP1;SDE2;BMF;MYC;AQP1;RRH;OPN1MW3;OPN1MW;TP53
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.42720506584559415,1.1119151395079774,0.33539094650205764,0.9071295585918148,1.0,4/17,11.47%,IGF1;RTN1;NTRK2;CLU
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3822028827446273,1.1117799556906465,0.30798479087452474,0.9058680637958556,1.0,7/26,13.78%,SLC5A3;PPARA;SLC30A10;ABCD1;SPHK2;TRAP1;CYBA
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.2901324475963235,-1.1117548877211296,0.27380952380952384,0.6239417833338121,1.0,33/73,33.08%,THBS1;STAT3;PTPRJ;APP;PLCG2;ARHGEF2;WNT5A;EPHB2;HSPB1;TWIST1;PTPRC;CD86;IFIH1;NOD2;IL33;RIPK1;HMGB1;SYK;FRMD8;BCL10;CCR2;PTPN11;TLR4;DDT;MIF;RASGRP1;TMEM106A;FADD;LGALS9;TLR1;CD14;TLR3;TYROBP
prerank,DNA modification (GO:0006304),-0.38593946532593715,-1.1115214226166328,0.33076923076923076,0.6239894677455557,1.0,17/22,41.10%,TERF2IP;TDG;NEIL3;MUTYH;EXOSC4;SMUG1;EXOSC5;PARP3;TINF2;TERF2;EXOSC3;PARP1;OGG1;UNG;PARP2;NTHL1;TERF1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3551072718128263,-1.1114767708032531,0.2857142857142857,0.623495328461754,1.0,11/29,18.19%,TEK;DGKZ;TNFAIP8L3;PRKD1;FLT1;FGF2;PTK2B;IRS1;PIK3R4;FGFR3;NOD2
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.27175779498894703,-1.1112578675947633,0.23869346733668342,0.6234660250086747,1.0,23/107,16.14%,DAB2IP;NIBAN1;MAP3K5;THBS1;PIK3R1;RASGRF2;JUN;CREB3L1;ERN1;NCK1;UFC1;BCAP31;ATP2A3;EIF2AK3;TMCO1;PDIA4;BBC3;RHBDD1;ATF6B;BAK1;ATF4;OS9;CFTR
prerank,regulation of metal ion transport (GO:0010959),0.4312650024788275,1.1106488926332756,0.3125,0.9079627991479303,1.0,5/16,15.47%,ANK2;DLG1;SLC30A10;BCL2;ORAI1
prerank,positive regulation of T cell migration (GO:2000406),-0.3916942423908224,-1.1102564543660811,0.30837004405286345,0.6254950649748556,1.0,6/20,9.84%,RHOA;APP;WNT5A;ADAM10;CXCL12;DOCK8
prerank,mitotic nuclear division (GO:0140014),-0.2885370009638417,-1.1101545054553656,0.2577565632458234,0.6251968040585927,1.0,31/71,27.78%,RHOA;SMC4;FLNA;SMC1A;PPP2R2D;EPS8;CHMP4B;STAG1;NCAPG2;MAP9;PIBF1;MZT1;ZW10;KLHL22;STAG2;TOGARAM1;NUSAP1;ARHGEF10;RAB11A;TPX2;KNSTRN;AAAS;KIFC1;NUP62;NSL1;NDEL1;CENPK;MIS12;CDCA8;SGO1;TUBG2
prerank,secondary palate development (GO:0062009),-0.4309421543268618,-1.1101194545548665,0.34591194968553457,0.6246927102478709,1.0,5/14,9.46%,LEF1;TGFB2;TGFBR2;WNT5A;TGFB3
prerank,negative regulation of interleukin-6 production (GO:0032715),0.38024963738615136,1.1100976844751431,0.29724770642201837,0.9082348200020586,1.0,5/27,7.55%,SYT11;C5AR2;C1QTNF3;NLRC3;ARRB1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.44342830328234384,1.1099224822481908,0.29365079365079366,0.9070890428656366,1.0,6/14,18.54%,SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;SRSF6
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.4561841002832655,1.109530280429313,0.35192307692307695,0.9066989599440798,1.0,4/12,16.23%,LPIN1;PLK1;PRKCB;PRKCA
prerank,negative regulation of myotube differentiation (GO:0010832),-0.44932786331418606,-1.1093148736618554,0.3426294820717131,0.6261259322088458,1.0,3/12,8.65%,NOTCH1;CCN3;TMEM119
prerank,Fc receptor signaling pathway (GO:0038093),-0.27385325594013693,-1.109299019638278,0.2552083333333333,0.6255804744025554,1.0,40/110,27.53%,PIK3R1;PLCG1;NFATC1;JUN;PLCG2;PAK2;TEC;LYN;PSMA6;PSMB7;MAPK1;PPP3CA;PIK3CA;VAV2;PSMB6;MALT1;PSMB5;NFATC2;PSMB8;TAB1;PSMC4;PSMD11;LAT2;PSMB4;PSMD14;MAPK3;BTK;NFATC3;PSMD10;MAP2K7;SYK;PSME1;BCL10;PSMB3;GRAP2;VAV3;GRB2;CUL1;FBXW11;CALM1
prerank,regulation of cellular respiration (GO:0043457),-0.4123162997898351,-1.109165560989974,0.34791252485089463,0.6253554015934507,1.0,9/17,38.76%,PRDM16;CBFA2T3;IFNAR1;SHMT2;VCP;IFNLR1;NOS2;PRELID1;IL4
prerank,BMP signaling pathway (GO:0030509),0.319029622969348,1.1084625446527783,0.2793594306049822,0.9086559827914508,1.0,7/62,5.24%,BMP7;TGFBR3;BMP6;DDX5;SMAD3;BMPR1A;BMP8A
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3693414996737902,1.1078073884708466,0.30833333333333335,0.9091722509068142,1.0,10/29,18.41%,LPGAT1;PPARA;SORBS1;SLC45A3;NR1H3;CREBL2;CREB1;AKT1;MID1IP1;MLXIPL
prerank,postsynaptic membrane organization (GO:0001941),0.42286202769217207,1.1077534042553148,0.3300589390962672,0.9076691158234987,1.0,6/17,9.52%,CEL;NLGN2;NLGN3;SHISA7;LRP4;DLG4
prerank,neuron development (GO:0048666),-0.26250872211803644,-1.1073485126538396,0.21823204419889503,0.6292159916981493,1.0,25/141,12.27%,PTPRM;FRY;MEF2C;RAPGEF2;PBX1;TGFB2;PBX3;RUNX1;APP;STMN1;TBCD;STX3;VSX1;MAP4;ETV1;LYN;LGI4;MYOC;CDK5;APOE;B4GALT5;FRYL;MICALL2;UGCG;SH3GL2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3451316141243072,1.1072007065146137,0.3044982698961938,0.9077208208094526,1.0,12/44,20.27%,PRKAG2;INSIG2;SC5D;CYP27A1;AMACR;OSBPL9;SQLE;PER2;MSMO1;HMGCR;HSD17B4;LBR
prerank,monocyte chemotaxis (GO:0002548),-0.3460542207826232,-1.1070128728864672,0.3037974683544304,0.629464921260255,1.0,5/32,8.06%,TNFRSF11A;IL6R;ANXA1;FLT1;CCL13
prerank,regulation of neurotransmitter secretion (GO:0046928),0.36558481731464637,1.1068440473236063,0.3129496402877698,0.9072439312774943,1.0,9/32,16.47%,SYT11;SNCAIP;SNAPIN;RIMS1;LRRK2;DTNBP1;CPLX1;SYN1;CPLX2
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.25338202124033354,-1.1067917486734709,0.22408963585434175,0.6294491725820796,1.0,37/172,14.60%,PLA2G4A;PIP5K1B;PIP4K2A;RAB14;INPP4A;DGKH;PIK3R1;CEPT1;DGKZ;PLSCR1;AGK;PIK3C2A;PLCG2;BMX;PLEKHA8;CPNE3;PIK3R6;SLC44A2;PLEKHA4;INPP5D;PIK3CA;FGF2;PIK3CD;MTMR7;FIG4;PIK3C3;MFSD2A;MTMR12;SLC44A1;AGPAT1;LPIN3;CSNK2A1;ABHD4;ABHD8;ETNK1;PIK3R4;AGPAT5
prerank,lymphocyte mediated immunity (GO:0002449),-0.43957495238391975,-1.1062335721823537,0.3359683794466403,0.6302100383737406,1.0,4/12,17.01%,JAG1;CD55;CD46;GNL1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4380178723090426,1.105842396926436,0.34502923976608185,0.9090092648449328,1.0,1/14,0.12%,PPP2R2B
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3354402247810056,-1.1046779764945085,0.29912663755458513,0.6335301888362567,1.0,10/35,18.38%,HIP1;B2M;MKLN1;SGIP1;SERPINE1;HIP1R;CBL;VTN;LDLRAP1;C3
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.45425863280123235,1.1040105207710034,0.33,0.9136168217184735,1.0,1/12,0.26%,BMP7
prerank,oligosaccharide metabolic process (GO:0009311),-0.31643894843416,-1.1037461071425911,0.2735229759299781,0.6353032945777466,1.0,7/46,8.21%,ST3GAL4;ST6GALNAC3;ST8SIA4;ST3GAL6;FUT8;ST6GALNAC5;ST8SIA6
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.29591545743739217,-1.1036545419561683,0.26108374384236455,0.6349742948852864,1.0,10/70,7.47%,DAB2IP;HIPK1;TGFB2;BCL2L1;NGF;TNFRSF1B;FAS;CRADD;IL6R;CASP8AP2
prerank,metal ion transport (GO:0030001),0.30469887721260386,1.103520233493498,0.2893401015228426,0.9136800166522226,1.0,15/86,11.47%,CACNA1D;SLC8A3;SLC41A1;CACNG7;CACNB3;NDFIP1;GRIN3A;ITPR1;TUSC3;NMUR1;CHRNB2;KCNN4;MAGT1;RYR2;TRPM2
prerank,regulation of postsynapse organization (GO:0099175),-0.3505087684578163,-1.1034644044893447,0.31422505307855625,0.6349030240655856,1.0,7/28,13.56%,SHANK3;PDLIM5;WNT5A;CDK5;ABI3;CFL1;ABHD17C
prerank,vasculature development (GO:0001944),-0.4180611721462033,-1.1033415102845348,0.31101511879049676,0.6346160590725055,1.0,9/16,16.62%,BMPR2;ACVRL1;STRA6;PIK3CA;FLT4;NOTCH4;SOX18;FBXW7;APLNR
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.37229454988870253,-1.1032192141773869,0.3078602620087336,0.6343366567930212,1.0,6/25,10.53%,B2M;SLC7A5;PLCG2;WNT5A;CD55;MALT1
prerank,organophosphate catabolic process (GO:0046434),0.4642027226363681,1.1030975362571884,0.3442622950819672,0.9133556856687611,1.0,4/11,26.58%,PON1;PLBD2;ABHD12;ANGPTL3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.38998592179160213,-1.1029581295365978,0.3037190082644628,0.6344066694742421,1.0,8/19,15.99%,VCAM1;PTPRJ;KDR;STIMATE;BCAP31;PTPRC;PTGFR;PRKACA
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.38035304425284533,1.1028915651148163,0.31496062992125984,0.9123492699467315,1.0,4/27,6.49%,IGF1;PDGFRA;SPHK1;E2F1
prerank,acylglycerol biosynthetic process (GO:0046463),0.39149561826446533,1.1028779003610645,0.3181818181818182,0.9107115318387135,1.0,6/23,12.75%,LPGAT1;GK;LPIN1;MOGAT1;PLA2G15;DGAT2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.33727415323616644,-1.1024172277512128,0.3060796645702306,0.635174873600947,1.0,13/34,18.19%,TEK;DAB2IP;PIK3R1;TNFAIP8L3;PIK3IP1;PRKD1;FLT1;FGF2;PTK2B;IRS1;PIK3R4;FGFR3;NOD2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4190694264372843,-1.1023596934110802,0.3299595141700405,0.6347087474437003,1.0,8/15,34.03%,WHAMM;JMY;ARPC2;ARPC3;ACTR3;ARPC1B;ARPC1A;ARPC5
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.2941940232755059,-1.1020447049893065,0.2548076923076923,0.634879800698183,1.0,34/73,30.26%,ACTB;CTCF;H3-3A;MYBBP1A;RBBP4;IGF2;GPX1;PRMT7;MTA1;DNMT3B;HDAC6;SUZ12;POLR1F;POLR1G;TASOR;ZFP57;TDG;EPC1;POLR1A;SPI1;AEBP2;DNMT1;GLMN;POLR1H;MYO1C;POLR2F;POLR1E;BMI1;POLR2H;PHF19;DDX21;POLR1C;POLR2E;SMARCA5
prerank,negative regulation of protein processing (GO:0010955),-0.4393500519910473,-1.102022636228772,0.336734693877551,0.6343506491819432,1.0,3/12,9.35%,THBS1;TMEM59;SERPINE1
prerank,positive regulation of macroautophagy (GO:0016239),0.3328532950938214,1.1019136179246185,0.2931937172774869,0.9125248766825065,1.0,10/48,10.33%,PRKAA2;OPTN;RAB3GAP1;FYCO1;SLC25A5;IKBKG;GPSM1;SESN1;HTT;PAFAH1B2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.30648348284848737,-1.101721202628931,0.26636568848758463,0.6345485215534538,1.0,12/56,11.93%,RAD51B;CDC27;KMT2E;EGFR;ANAPC5;BRD4;ANXA1;ADAMTS1;CDC16;RPTOR;FBXO5;PHB2
prerank,positive regulation of B cell activation (GO:0050871),-0.30825096468778246,-1.1014318042291633,0.2727272727272727,0.6346633619841542,1.0,14/50,21.23%,MEF2C;TFRC;CD38;SHLD1;EPHB2;NFATC2;CD74;CD40;PTPRC;MAD2L2;NCKAP1L;NOD2;BTK;SYK
prerank,regulation of translational initiation (GO:0006446),-0.29768871735251895,-1.1008599285750476,0.2751196172248804,0.6354829305302597,1.0,16/63,15.85%,EIF3E;ALKBH1;EIF3H;NCK1;CDC123;EIF2B2;EIF2AK3;AGO2;HSPB1;NCBP2;TPR;EIF1B;NCBP1;EIF4G3;FMR1;ATF4
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3130216874159191,-1.1008158483735344,0.25934065934065936,0.6350190896806478,1.0,15/51,20.11%,NRP1;RHOA;LIMCH1;ARHGEF15;PXN;MYOC;SYNPO2;TGFB3;PFN1;LIMK1;S100A10;FERMT2;ARHGEF10;ARHGEF5;CDC42
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.41742456499593633,1.1005633612682528,0.3333333333333333,0.9155728412072384,1.0,6/18,14.80%,RAB3GAP1;SNAPIN;RIMS1;LRRK2;DTNBP1;SYN1
prerank,response to interleukin-4 (GO:0070670),-0.4698160197654287,-1.1005520916337037,0.33814432989690724,0.6350832536638715,1.0,1/10,0.18%,LEF1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.4585826738997226,1.1004223218647697,0.3319755600814664,0.9144394709220385,1.0,4/12,13.27%,ROCK2;PICALM;FLOT2;ABCA2
prerank,protein monoubiquitination (GO:0006513),0.35657173214059756,1.1001381774034673,0.3083941605839416,0.9137554784155435,1.0,9/36,14.73%,CTR9;RNF126;LEO1;TOPORS;RNF20;UBE2W;OBI1;CDC73;UBE2R2
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.31283766952358255,-1.100099251046524,0.31363636363636366,0.6356588897124312,1.0,10/47,10.45%,FOXO3;NFKBIA;RBM3;APP;RPL10;AGTR1;EIF4E;APOE;KLF4;EDN1
prerank,regulation of microtubule-based process (GO:0032886),-0.33162906985614576,-1.0999095310715141,0.29157175398633256,0.6355658846080302,1.0,14/36,23.36%,PHLDB1;MACF1;PHLDB2;APC;EFNA5;FAM107A;HDAC6;BICD2;MEMO1;TRAF3IP1;TAOK1;ROCK1;CYLD;MAP6D1
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2709546509128368,-1.099822499746842,0.2755102040816326,0.6352206177636555,1.0,26/104,14.89%,ST3GAL4;DCN;CSGALNACT1;SLC26A2;ST3GAL6;SLC10A7;B3GNT2;CSPG4;B4GALT4;PAPSS2;GSS;ST3GAL1;LUM;AKR1A1;GGTA1;VCAN;GCLC;SLC35B3;B4GALT5;CHSY3;LIAS;BGN;GCLM;CHST1;ESD;GSTT1
prerank,negative regulation of cholesterol transport (GO:0032375),0.48138481370791325,1.0994004918508835,0.34210526315789475,0.9146527085755255,1.0,4/10,23.76%,ABCG5;ABCA2;NFKB1;SHH
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.37999404718037133,1.0992692539392925,0.31346153846153846,0.9134328686484308,1.0,6/25,8.07%,GLRA1;RAB3GAP1;GRID2;GRIN2D;NLGN3;LRRK2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.4593468191490424,-1.0992063126848255,0.3306613226452906,0.6361601257480557,1.0,9/11,41.45%,LYN;JAK1;PLAUR;SYK;CCL5;ANK3;RDX;TNFSF11;BLK
prerank,protein-containing complex disassembly (GO:0032984),-0.30596512241805734,-1.0989361894150287,0.3144208037825059,0.6362460712956698,1.0,11/54,13.72%,CAV1;LRP6;GABARAPL2;CSNK1A1;MAP1LC3B;APC;PPP1CA;AMER1;RPL23;GABARAP;FZD1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4196777771752971,1.0988569323065818,0.350597609561753,0.9131620983083543,1.0,6/18,23.59%,KMT2A;SETD4;SETD7;SMYD2;SETD1B;SETD2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.464341988929368,1.0983933074630041,0.35039370078740156,0.9130803329776802,1.0,6/11,20.96%,NECAB1;SOAT1;ABCA2;BACE2;NECAB3;ITM2C
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.4212727601882441,-1.0983691198867949,0.3438818565400844,0.6370074034097862,1.0,5/14,25.25%,THBS1;IRAK3;PIBF1;JAK3;CMKLR1
prerank,pre-replicative complex assembly (GO:0036388),-0.295998129935031,-1.0979775307021267,0.2577565632458234,0.6373946951698185,1.0,19/64,23.25%,UBC;RPS27A;UBB;PSMA6;PSMB7;PSMB6;PSMB5;ORC1;PSMB8;PSMC4;PSMD11;ORC2;PSMB4;PSMD14;ORC5;PSMD10;PSME1;MCM3;PSMB3
prerank,membrane organization (GO:0061024),-0.24393015965909842,-1.0979376828034586,0.20391061452513967,0.6369271518026831,1.0,51/227,16.64%,HIP1;SPTBN1;ACTB;DNM3;STON2;ACTG1;CERT1;EGFR;CORO1C;UBC;AP2B1;PIK3C2A;SCARB2;PLEKHA8;CHMP2B;FCHO2;TFRC;SGIP1;RPS27A;VAMP3;UBB;WNT5A;CLTB;FNBP1;CHMP4B;CHMP4A;EPN2;NEMP1;GAPVD1;CHRNB1;RABIF;HGS;DYSF;SUN1;LEMD3;FZD4;FNBP1L;SH3GL2;HIP1R;UBXN2A;AP2A1;REEP3;SAR1A;CBL;ARPC2;VAPB;TLCD1;CFTR;SYNGR2;SNAP23;LDLRAP1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.46154369939336815,-1.097495021245031,0.3503787878787879,0.6374612194950433,1.0,4/10,21.28%,RHOA;RAP2A;CDC42;MSN
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.23334006698051707,-1.0969153116862937,0.17080745341614906,0.6383256820038429,1.0,54/308,13.83%,LEF1;PRKCH;GHR;CAV1;GCNT2;BMPR2;ZBTB16;PTN;ADRA1B;ACVR1;TGFB2;GAS6;EBF2;ABCA1;BMP4;PRDM16;SIX1;TGFBR2;GATM;PLA2R1;ADIPOR2;TFRC;WNT5A;S100A13;AXIN2;MDK;APC;SHLD1;TMEM119;PDGFC;SOD1;TIAM1;TRIM16;FGF2;SERPINE1;TGFB3;AGO2;IL15;APOE;B4GALT5;ELOVL6;IL4R;CFL1;PIK3CD;FBXO5;HADH;TWIST1;COL1A1;BMP2;SMO;AGPAT1;NME2;VEGFA;LRP1
prerank,nuclear membrane disassembly (GO:0051081),0.4371570586513371,1.0958885986624167,0.353515625,0.9198407500548168,1.0,5/14,16.67%,LPIN1;PLK1;PRKCB;PRKCA;AKAP8L
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3001473066045459,1.0954842225503407,0.2915951972555746,0.91955005643801,1.0,26/84,20.57%,CELF2;DDX5;NOVA1;RBM11;HNRNPU;DDX17;SRSF10;SON;HNRNPL;PTBP1;TIA1;SRRM4;C1QBP;YTHDC1;NUP98;FXR2;RBM5;PCBP4;MBNL3;RNPS1;SRSF6;CELF6;RBFOX1;PUF60;REST;LARP7
prerank,phagolysosome assembly (GO:0001845),-0.43747792055274226,-1.0951975766451596,0.3638132295719844,0.6421152796965798,1.0,7/12,32.71%,RAB14;ARL8B;RAB20;RAB39A;PLA2G5;CLN3;RAB34
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.3842968287085029,1.0950042286917898,0.3300970873786408,0.9195841760199193,1.0,7/24,12.68%,LEPR;COQ10A;NDUFS1;PPARGC1A;CYCS;MRAP2;COX10
prerank,protein alkylation (GO:0008213),0.39009856113676683,1.0949685379777294,0.33214285714285713,0.9180398963067896,1.0,8/22,21.67%,EEF2KMT;PRMT2;FAM98B;PCMT1;PRMT3;ETF1;SNRPB;VCPKMT
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3567481407771106,-1.0949600478958106,0.33755274261603374,0.6421723056055618,1.0,10/24,24.80%,UBC;NOD1;RPS27A;UBB;IRAK2;TAB1;NOD2;RIPK2;CYLD;CASP8
prerank,respiratory system development (GO:0060541),0.3621833232506996,1.0947600381877156,0.33589251439539347,0.9171143904615335,1.0,6/32,6.95%,FGF1;FGF9;LOXL3;CEBPA;PDPN;FGFR2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.35727696623454,-1.0943432783447324,0.32926829268292684,0.6431827561244721,1.0,17/26,38.22%,CDC27;HECW2;ANAPC5;CDC16;FBXO5;LCMT1;DUSP1;CDC23;CDK5RAP2;CUL3;ANAPC11;NSMCE2;CDC6;ESPL1;UBE2C;CENPE;CCNB1
prerank,neuron projection organization (GO:0106027),-0.4084515308097888,-1.094180806383949,0.3452631578947368,0.6430186016434559,1.0,3/15,8.27%,INSR;APP;ABCD2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.4253303336185003,-1.0940832163334056,0.3630705394190871,0.6426909564164465,1.0,8/13,29.06%,CD44;TWIST1;DYRK1A;CD74;PSMD10;SNAI2;MIF;PTTG1IP
prerank,cellular response to hypoxia (GO:0071456),0.2820251441715336,1.093966404557591,0.2672,0.9179605200026775,1.0,21/126,16.71%,BMP7;RORA;EPAS1;CPEB2;SLC8A3;OPRD1;PSMD3;LMNA;PGK1;KCND2;HIF3A;NDRG1;ANGPT4;TERT;PSMD1;ARNT;PSMC5;PSMA1;SIRT1;PSMD12;MDM2
prerank,chloride transmembrane transport (GO:1902476),-0.3109442445424691,-1.093752591497943,0.2980132450331126,0.6429143283500915,1.0,14/48,16.14%,SLC12A7;SLC12A2;ANO1;SLC1A3;SLC12A6;LRRC8A;GABRA3;GLRB;SLC1A1;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,fat cell differentiation (GO:0045444),0.3194068629160326,1.0936700207620842,0.3100358422939068,0.9173197370671053,1.0,20/57,22.09%,OSBPL8;WNT5B;TMEM120B;METRNL;CLIP3;CEBPA;C1QTNF3;MED1;PPARGC1A;ADIG;CTBP2;FAM120B;PER2;SIRT1;TCF7L2;OSBPL11;INHBB;TRIM32;NR4A3;BBS2
prerank,response to hydrogen peroxide (GO:0042542),-0.3213807479124749,-1.0936339319055683,0.3235955056179775,0.6426308146811942,1.0,10/45,9.75%,NET1;MAP3K5;CYP1B1;ANXA1;PRKCD;RPS3;STK24;SOD1;CAT;GPX1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.43364366441002783,-1.0934432557271991,0.3367983367983368,0.6425351447966494,1.0,2/13,0.78%,NRP1;NRP2
prerank,positive regulation of exosomal secretion (GO:1903543),0.42371408918236414,1.093208496634412,0.34790874524714827,0.9173215893711439,1.0,3/15,7.85%,STAM;SMPD3;SNF8
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.45131745786808636,1.092976299688876,0.33131313131313134,0.9164385047554918,1.0,4/12,17.23%,UCKL1;DCK;UPP2;UMPS
prerank,acute-phase response (GO:0006953),-0.43377905356918345,-1.0929545209126472,0.34108527131782945,0.6431506390048308,1.0,5/12,29.30%,PLSCR1;IL6R;SIGIRR;CEBPB;AHSG
prerank,carnitine metabolic process (GO:0009437),0.45199553714049573,1.0927430106168816,0.33468559837728196,0.9156633081859261,1.0,5/12,19.15%,BBOX1;CPT1C;CROT;ALDH9A1;CPT2
prerank,positive regulation of growth (GO:0045927),-0.2930679602085316,-1.092642878632825,0.28672985781990523,0.6433180617709975,1.0,16/64,15.63%,RFTN1;TGFB2;INSR;EGFR;H3-3A;RPS6KA3;ADAM10;CDKN2AIP;RPTOR;PABIR1;MFSD2A;USP47;CSNK2A1;NCBP1;KLHL22;DDX49
prerank,negative regulation of cytokine production (GO:0001818),-0.24897025205001833,-1.092035775211234,0.24728260869565216,0.6443156482988052,1.0,51/163,24.19%,LEF1;TMSB4X;ATP2B1;CD200;RPS6KA5;THBS1;GAS6;CD34;IRAK3;FN1;RNF125;NPTN;NLRC5;ANXA1;ADCY7;APOD;TNFRSF21;TRIM25;OTUD7B;CEACAM1;HDAC7;HDAC9;ABCD2;CHID1;KLF4;ISG15;PIBF1;PDCD4;PTPRC;IFIH1;NR1H4;NCKAP1L;TRAF3IP1;PCBP2;SIGIRR;N4BP1;PPP1R11;PTPN6;ZC3H12A;JAK3;CUEDC2;HMGB1;TRIB2;BCL3;ASB1;FCGR2B;DLL1;ZFPM1;CYLD;TAX1BP1;RGCC
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3047502289112321,1.0919738518540674,0.30677966101694915,0.9166186599187205,1.0,11/85,7.28%,FGF1;TGFBR3;BMP6;IGF1;NUPR1;OSR1;FGF9;MCC;FUT2;FGFR2;NLRC3
prerank,cellular response to chemokine (GO:1990869),-0.31652463527800323,-1.0918866126141957,0.2863636363636364,0.6441209256887749,1.0,8/46,12.51%,LRCH1;SLC12A2;RHOA;CXCL12;CCL13;DOCK8;ACKR3;PTK2B
prerank,embryonic skeletal system development (GO:0048706),0.34742810987453027,1.091514540828911,0.31910946196660483,0.9165421022405851,1.0,8/35,11.22%,PDGFRA;OSR1;HOXB9;HOXB3;HOXA3;HOXB4;MEGF8;UCMA
prerank,macroautophagy (GO:0016236),0.289388744474878,1.091354952933899,0.29152542372881357,0.9154281678768881,1.0,21/118,12.89%,PRKAG2;PRKAA2;PRKAG3;CHMP6;STAM;SNX14;VAMP7;VTA1;TOMM40;SNAP29;SNF8;AMBRA1;VPS16;TOMM22;CSNK2A2;LAMP2;LIX1L;MFN2;ATG13;UBXN6;VPS39
prerank,negative regulation of MAPK cascade (GO:0043409),-0.2742155900780125,-1.0912187142227932,0.28292682926829266,0.645201283529918,1.0,26/87,18.34%,CAV1;SEMA6A;DAB2IP;FOXO1;BMP4;PTPRJ;IRAK3;SPRED2;PPIA;LYN;PRKCD;SPRY2;PTPN1;APOE;DUSP3;EPHB2;RANBP9;STK38;PEBP1;PTPRC;SPRY1;PAQR3;PTEN;GPER1;DUSP6;UCHL1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.26851878326597695,1.0911909085502047,0.2700617283950617,0.914407123628458,1.0,17/182,4.65%,ROBO1;NOTCH2;WNT4;IGF1;SLC24A3;ROCK2;OVOL2;PRKAA2;NDFIP1;CPNE1;OPRD1;BMPR1A;PICALM;OPTN;TNRC6A;LRP3;TET1
prerank,positive regulation of DNA repair (GO:0045739),0.3353263401538289,1.0907582605907464,0.3283582089552239,0.9142105910663019,1.0,5/46,6.74%,EYA1;EYA4;EYA2;XRCC1;ABRAXAS1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3514038391987726,-1.0904679783544977,0.33539094650205764,0.6465841809121695,1.0,4/27,7.53%,MARK1;MBOAT1;DISC1;NCS1
prerank,negative regulation of glycolytic process (GO:0045820),0.4698205891985666,1.0904300710470785,0.34824902723735407,0.9121114654770324,1.0,2/10,2.89%,NUPR1;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4698205891985666,1.0904300710470785,0.34824902723735407,0.9121114654770324,1.0,2/10,2.89%,NUPR1;PPARA
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.24645109395936532,-1.0903658972465888,0.20273972602739726,0.6462642220592841,1.0,43/186,15.65%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;STK3;LIMD1;SDHAF2;NFATC1;SFRP4;GLI3;TLE4;NKD2;SOX17;IGFBP6;WNT5A;AXIN2;RACK1;PSMA6;TLE3;CSNK1A1;ZNRF3;PSMB7;MDK;INVS;APC;APOE;PSMB6;AMER1;PSMB5;TLE5;FZD4;DKK2;BMP2;ANKRD6;TAX1BP3;LRP1;PSMB8;RBMS3;AMER2;PSMC4;MAD2L2;PSMD11
prerank,regulation of gene expression (GO:0010468),0.23350465260524483,1.0899834607070698,0.16908212560386474,0.9119431100082206,1.0,127/903,12.42%,PRDM6;ROBO1;DENND4A;NOTCH2;BMP7;AFDN;RORA;FGF1;BMP6;WNT4;PPARGC1B;IGF1;HSPA1A;SLC24A3;GCGR;ROCK2;SMAD3;OSR1;FGF4;PABPN1;OVOL2;CTR9;ANK2;PRKAA2;SUFU;NDFIP1;ZBTB38;SCRT1;MYBL2;PIK3R3;NOVA1;CRABP2;CPNE1;ARNT2;ZNF431;OPRD1;NFYB;CDH3;ESRRA;POU1F1;TULP3;BMPR1A;PICALM;FGF9;CCAR2;HNRNPH3;TNRC6A;PIK3CB;TRIM5;LRP3;ASCC2;PEG3;CCAR1;PQBP1;PAX6;RBPJ;ACTR8;MZF1;TRIM71;WWTR1;ZNF462;PDCD5;RNF14;NFYC;E2F1;CIAO3;WNT6;CEBPA;CITED1;FASTK;PTBP2;FLOT2;SRSF10;SON;CHD3;AFF3;NTRK2;FAM98B;SNF8;KDM6B;RIMS1;HNRNPL;PTBP1;PHF1;HES6;MED1;CRNN;MAFA;PPARGC1A;HINFP;CACTIN;ZNF711;FZD7;PARP14;NKAP;SSBP2;CLOCK;CREBL2;SRRM4;PRDM2;GON4L;MEGF8;NSD1;TGFBR1;LDB1;HRG;RNF20;RNF6;CLK3;MAPK14;YTHDC1;ZFPL1;FUBP1;MAGED1;TAF1;CTSH;DTNBP1;CLU;ATRAID;DMTF1;KDM4A;SOX9;RLIM;PML;CHEK2;RBAK;MAPK9
prerank,DNA replication initiation (GO:0006270),-0.3299222336179198,-1.0899737074054945,0.314410480349345,0.6466445640630949,1.0,16/37,27.24%,RPA1;ORC1;ORC2;RPA2;CDC45;ORC5;POLA1;POLA2;MCM3;PURA;CDC34;PRIM2;POLE3;MCM5;MCM6;CDK2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.4519783756261504,-1.0897145698624964,0.37344398340248963,0.6467386927157043,1.0,3/12,11.83%,FOXP1;KLF4;CD74
prerank,cellular response to dsRNA (GO:0071359),0.4244136645413191,1.0894859545544757,0.3172541743970315,0.9120221899498311,1.0,3/15,7.53%,COLEC12;PQBP1;IFIT1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.39449111644334334,1.0892089629182011,0.32827324478178366,0.9113184357018594,1.0,3/22,7.55%,BMP7;CDKN2A;INHA
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.31953664921682967,-1.087934897743021,0.32409381663113007,0.6506374776890682,1.0,16/42,22.58%,RPA1;UBC;RPS27A;UBB;TRIM25;ZBTB1;ISG15;WRNIP1;USP43;RPA2;PRIMPOL;USP10;PCLAF;POLA1;RFC4;POLD4
prerank,positive regulation of dendrite development (GO:1900006),-0.4661132337488382,-1.0878153280683847,0.35902255639097747,0.6503365300731586,1.0,3/10,1.04%,BMP5;DAB2IP;PTN
prerank,regulation of chromosome segregation (GO:0051983),-0.40643762706307035,-1.0877894420774745,0.3463114754098361,0.6497999436217827,1.0,10/16,37.61%,PUM2;SMC5;CSNK2A1;PUM1;MKI67;CDC6;BUB1;SMC6;IHO1;KIF2C
prerank,regulation of lysosomal lumen pH (GO:0035751),0.4524733223534091,1.0873499959895359,0.3360995850622407,0.9160205763446841,1.0,4/12,13.99%,CCDC115;TMEM199;LRRK2;CLN5
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.4528436906810306,-1.0870753651751643,0.3425531914893617,0.6510188143992116,1.0,4/11,15.85%,H3-3A;RBBP4;NASP;UBN1
prerank,embryonic heart tube development (GO:0035050),-0.4096862183485561,-1.0869157282945912,0.31896551724137934,0.6508536934500423,1.0,5/14,12.91%,ACVR1;SOX17;HES1;SOX18;TBX2
prerank,Golgi inheritance (GO:0048313),0.459664758320976,1.0867004200622818,0.3649193548387097,0.916529244310373,1.0,4/11,16.60%,PLK5;GOLGA2;STK25;GBF1
prerank,leukotriene biosynthetic process (GO:0019370),-0.41227123564546675,-1.0865872926977258,0.36875,0.6511374169842352,1.0,6/14,30.47%,PLA2G4A;GGTA1;GGT7;GGT1;PLA2G5;ALOX5AP
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3535202284905527,1.0863976438170218,0.32437619961612285,0.9159209732979996,1.0,11/33,18.36%,IGF1;HSPA1A;SLC25A5;PPIF;FZD9;ADCK1;CLU;TMEM14A;HGF;NOL3;AKT1
prerank,regulation of protein processing (GO:0070613),-0.3629344891072497,-1.0854230613027458,0.3237704918032787,0.6535071292505743,1.0,4/21,7.99%,RUNX1;NKD2;TMEM59;CCBE1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.37614861170864267,1.084941053042407,0.3187022900763359,0.9192003384928003,1.0,6/24,11.95%,ANXA6;ITPR1;ITPR2;RYR2;TRPM2;CHERP
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.32402424148106423,1.084936747254802,0.3415061295971979,0.91762051904627,1.0,11/53,16.00%,EYA1;DDX5;EYA4;EYA2;CCAR2;ABRAXAS1;SPRED3;FXR2;MSX1;SIRT1;ATM
prerank,keratan sulfate catabolic process (GO:0042340),0.4577656457729009,1.0846449413341854,0.341948310139165,0.9170577349769234,1.0,3/11,6.66%,OGN;OMD;GALNS
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2986741862517938,-1.0840675883496165,0.30851063829787234,0.6565105079536753,1.0,10/55,7.91%,CAV1;DAB2IP;TNFSF10;BCL2L1;FAS;CRADD;PAK2;RACK1;RPS3;BCAP31
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.3420747964084924,-1.0840049166962873,0.33747412008281574,0.6560747064207589,1.0,4/29,3.15%,GHR;PKD1;SOCS2;STAT3
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.21343173034445617,-1.0839847289997315,0.10695187165775401,0.6555408532991169,1.0,140/834,13.94%,LEF1;MEF2C;MAML2;ERG;BMP5;MRTFB;PID1;DCN;BMPR2;DAB2IP;PBX1;ZFHX3;ELK3;JAG1;ITGA6;MICAL2;RARB;LRP6;ACVR1;NOTCH3;ETS1;ACVRL1;PLAGL1;TCF12;TGFB2;MEOX2;PPARD;ENG;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;LRP5;PKD1;PIK3R1;CDH13;EGFR;RUNX2;FOXO3;NFKBIA;ASXL3;LMO2;RUNX1;STAT3;BMP4;NFATC1;AGO1;PLSCR1;PPP1R12A;SIX1;RNF111;APP;NFIA;UBC;REL;DCAF6;RPS6KA3;GLI3;JUN;GLYR1;ESR1;LMO7;TBX1;NFIX;KLF7;BPTF;KAT6A;GNL3;TFEB;BRD4;SOX17;ARHGEF2;SMAD5;SMAD1;RPS27A;UBB;PRKD1;SLC30A9;WNT5A;TNKS;MET;HES1;ETV1;NLRC5;NRF1;SP3;NCK1;ETV5;AR;ELF4;CCN1;PPP3CA;HEYL;NRIP1;NFAT5;HEY2;ZFPM2;GATA2;IGF2;FGF2;SERPINE1;ELK1;PELP1;TGFB3;AGO2;AHR;NOTCH4;IRF2;KLF4;TAL1;SS18;GTF2F1;RFXAP;EDN1;PER1;TCF20;TMF1;MYOCD;SREBF2;SQSTM1;TWIST1;TEAD1;ATAD2;HHEX;SOX18;FOXF2;FOSL2;BMP2;POU2F1;RARG;LPIN3;CD40;NME2;NCOA6;MAFF;SOX12;VEGFA;KMT2C;KLF2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3735756240655842,1.0831745183626424,0.34593572778827975,0.9203434917261105,1.0,8/28,16.04%,MAP2;PRUNE1;CLASP1;ARL2;SKA2;ABL1;MAPRE1;GBA2
prerank,regulation of TORC1 signaling (GO:1903432),0.35684883237097653,1.0831330913970065,0.35687732342007433,0.9188887239628676,1.0,9/33,18.67%,RNF152;RRAGC;GPR137C;SESN1;PIH1D1;ATM;TELO2;RRAGB;CASTOR2
prerank,chromosome condensation (GO:0030261),0.34470827780452135,1.0830877089686624,0.3266423357664234,0.9174589741922766,1.0,10/36,16.67%,KMT5A;NCAPD2;AIFM1;PHF8;PLK1;TENT4A;CSNK2A2;ACIN1;CHMP1A;AKAP8L
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.30133831956767465,-1.0829007439795175,0.3264367816091954,0.6576727334655109,1.0,15/55,23.25%,FBXL7;FHL1;PSMA6;PSMB7;PSMB6;PSMB5;USP47;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;PSMB3
prerank,retinol metabolic process (GO:0042572),0.4297654807927488,1.0827756471335674,0.3698630136986301,0.9169269611414766,1.0,2/14,1.22%,ADH7;ADH4
prerank,actin filament capping (GO:0051693),-0.3882986337420168,-1.082537898467355,0.35051546391752575,0.6574372154679347,1.0,7/18,13.75%,SVIL;GSN;EPS8;CAPZA2;CAPG;VILL;AVIL
prerank,barbed-end actin filament capping (GO:0051016),-0.3882986337420168,-1.082537898467355,0.35051546391752575,0.6574372154679347,1.0,7/18,13.75%,SVIL;GSN;EPS8;CAPZA2;CAPG;VILL;AVIL
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.43907832611606995,1.082166995169937,0.3623481781376518,0.9174222047131344,1.0,5/14,11.92%,ANGEL2;ELAVL4;ELAVL1;MAPK14;BOLL
prerank,regulation of platelet activation (GO:0010543),-0.377076586284258,-1.0821143237295878,0.33268101761252444,0.65793803804109,1.0,5/21,9.64%,PLA2G4A;NOS3;TEC;LYN;APOE
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.45006103463309494,1.0820154000849094,0.3849462365591398,0.9163537316111007,1.0,5/12,15.92%,BICD1;PCM1;KIF3A;CCDC120;NINL
prerank,axonal transport of mitochondrion (GO:0019896),0.468272012434331,1.081989830123439,0.3720472440944882,0.9148812199121038,1.0,5/11,26.43%,TRAK1;ACTR10;NEFL;SPAST;HAP1
prerank,negative regulation of synaptic transmission (GO:0050805),0.3802417544810527,1.081193672155578,0.3669724770642202,0.9158518221452224,1.0,5/23,12.52%,SYT11;ATAD1;LRRK2;DRD3;MTMR2
prerank,iron ion homeostasis (GO:0055072),0.3144437131310811,1.0808167456621611,0.3105924596050269,0.91556059991064,1.0,10/58,8.00%,BMP6;NDFIP1;HEPHL1;ATP6V0A2;PICALM;FLVCR1;ACO1;CCDC115;TMEM199;CP
prerank,anterograde synaptic vesicle transport (GO:0048490),0.42879247504652723,1.0803398011550975,0.3638132295719844,0.9140490139886324,1.0,4/15,13.56%,AP3S2;SNAPIN;DTNBP1;AP3B2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.42879247504652723,1.0803398011550975,0.3638132295719844,0.9140490139886324,1.0,4/15,13.56%,AP3S2;SNAPIN;DTNBP1;AP3B2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.3074537978737085,-1.0802846853888177,0.32894736842105265,0.662066050454012,1.0,19/45,30.42%,STAT3;APP;GBP5;WNT5A;AIM2;TRIM16;MALT1;HSPB1;USP50;NOD2;MYD88;RIPK2;CASP1;CASP8;TLR4;TMEM106A;CD36;TLR6;LGALS9
prerank,DNA dealkylation (GO:0035510),-0.45939508680597374,-1.0802248250436057,0.4024144869215292,0.6610669133728592,1.0,2/10,4.43%,FTO;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.45939508680597374,-1.0802248250436057,0.4024144869215292,0.6610669133728592,1.0,2/10,4.43%,FTO;ALKBH1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.381079871068614,-1.0802190849538476,0.35943775100401604,0.6605045472836247,1.0,7/19,7.99%,SEMA6A;DCN;DAB2IP;JCAD;XDH;SPRY2;CCBE1
prerank,protein localization to cell periphery (GO:1990778),-0.2596738208611211,-1.080155169351387,0.2759493670886076,0.6600802072916367,1.0,23/133,7.96%,SPTBN1;CAV1;RAPGEF2;BSG;LRP6;RAMP2;GAS6;RAP1A;TTC7A;PACS1;CACNB2;SMURF1;CDH1;F11R;TNIK;FLNA;NKD2;FCHO2;RAP2A;EFR3B;RAPGEF6;SLMAP;EMP2
prerank,monocarboxylic acid transport (GO:0015718),0.32817799221071947,1.080073270093972,0.32971014492753625,0.913406667382339,1.0,5/51,3.04%,SLC16A6;SLC6A13;SLC6A12;SLC16A11;SLC16A12
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3155205311716994,1.080018047269676,0.33086876155268025,0.9120406344884134,1.0,7/62,8.53%,ROBO1;NOTCH2;IGF1;PIK3CB;AUTS2;ARRB1;LPAR1
prerank,negative regulation of transposition (GO:0010529),0.4209749184809624,1.0798227886451495,0.36381709741550694,0.9111095672709765,1.0,4/16,14.13%,TDRD9;SPOCD1;TUT4;MYBL1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.332593470446985,-1.0797889903927085,0.3383947939262473,0.6605059350234695,1.0,14/34,24.19%,INSR;LRP5;CDC27;ANAPC5;CDC16;IGF2;EDN1;EDN3;NUSAP1;EGF;CDC23;NUP62;CUL3;RGCC
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.31109737128549686,-1.0796930301694185,0.3090507726269316,0.6601757606747204,1.0,14/49,17.35%,GHR;IL6ST;STAT3;HES1;LYN;IL6R;IL15;PIBF1;ARL2BP;CD40;VEGFA;CSF1R;SOCS3;FGFR3
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.4533343101484769,-1.079340119956736,0.3900414937759336,0.660445091837824,1.0,4/11,8.77%,CORO1C;CD44;KANK1;SRC
prerank,DNA-dependent DNA replication (GO:0006261),-0.2577405935204139,-1.0791894091046885,0.28608923884514437,0.6602376726393665,1.0,47/128,27.75%,RPA1;UBC;RPS27A;UBB;REV3L;PSMA6;PSMB7;RPAIN;PSMB6;PSMB5;BLM;WRNIP1;ORC1;PSMB8;DDX23;PSMC4;PSMD11;ORC2;PSMB4;PSMD14;RPA2;PRIMPOL;CDC45;ORC5;SIRT7;POLA1;PSMD10;RFC4;POLA2;MCMBP;PSME1;MCM3;WDHD1;PURA;POLD4;PSMB3;POLB;POLG2;CDC34;PRIM2;POLE3;GINS3;MCM5;MCM6;RFC2;CDK2;RECQL5
prerank,regulation of chemokine production (GO:0032642),-0.32575297425273675,-1.0791733957650307,0.32075471698113206,0.6597078305702521,1.0,14/36,27.07%,FOXP1;APP;WNT5A;IL6R;CD74;CSF1R;SIGIRR;IL33;ACKR1;TLR4;AIF1;SNAI2;HMOX1;TREM2
prerank,alpha-amino acid metabolic process (GO:1901605),0.3327837364779942,1.079141782987419,0.3339317773788151,0.9118556814434431,1.0,14/45,16.57%,ASPG;RIMKLA;MMUT;ASPA;KMO;SLC25A12;GLS2;GOT1;KYAT3;MTHFD1;MTHFR;GOT2;GLUL;ATP7A
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.343898711522795,1.0789404685901196,0.33810375670840787,0.9110010732030863,1.0,6/37,9.82%,ALCAM;IL1RAPL1;TENM1;GRID2;PTPRD;ADGRL1
prerank,cellular response to peptide (GO:1901653),-0.3008115393274695,-1.0787491219506307,0.319634703196347,0.6601586186706062,1.0,22/56,23.54%,CAV1;CACNA2D1;VCAM1;ABCC1;APP;NOD1;ICAM1;ARHGEF2;CDK5;SRC;RPL23;ITGA4;LRP1;TIMELESS;GPER1;GRIN1;NOD2;CASP4;RIPK2;FYN;FCGR2B;IGF1R
prerank,coenzyme A biosynthetic process (GO:0015937),0.454446093149663,1.0785287366961944,0.3520309477756286,0.9077852231888138,1.0,3/11,6.99%,PANK1;ACAT1;PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.454446093149663,1.0785287366961944,0.3520309477756286,0.9077852231888138,1.0,3/11,6.99%,PANK1;ACAT1;PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.454446093149663,1.0785287366961944,0.3520309477756286,0.9077852231888138,1.0,3/11,6.99%,PANK1;ACAT1;PANK2
prerank,lipid modification (GO:0030258),-0.32513013758961096,-1.0783623596814835,0.35909090909090907,0.6605565753201035,1.0,14/37,27.98%,DGKH;MBOAT1;DGKZ;PLPP1;PLPP3;SGPP1;DGKB;PLPP2;LPCAT3;PLA2G7;PLPP6;DGKG;PLPP5;DGKA
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3334026442742882,1.0778899266311666,0.34831460674157305,0.9083118275741728,1.0,6/43,4.47%,ERRFI1;SNX6;CHMP6;GPRC5A;STAM;RNF126
prerank,cellular response to BMP stimulus (GO:0071773),0.30664715547948007,1.0772103270095394,0.32972972972972975,0.909053836770393,1.0,7/66,5.24%,BMP7;TGFBR3;BMP6;DDX5;SMAD3;BMPR1A;BMP8A
prerank,cytosolic calcium ion transport (GO:0060401),-0.3467026246387706,-1.0763988446256807,0.35106382978723405,0.6649388114905356,1.0,10/28,14.31%,ATP2B1;MICU3;CACNA2D1;SLC35G1;ATP2A3;MCUB;JPH2;MICU2;ITPR3;SMDT1
prerank,cellular response to hexose stimulus (GO:0071331),-0.3650090691636382,-1.0762111453043017,0.348643006263048,0.6648444358628567,1.0,12/23,29.41%,GAS6;UNC13B;ERN1;RACK1;SLC26A6;KCNB1;PRKACA;GPER1;IGF1R;TRA2B;SLC39A14;PDK3
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.35575101837066925,-1.0761034575985968,0.355119825708061,0.6645713134048373,1.0,12/25,29.59%,CSGALNACT1;EXT1;B3GNT2;HAS1;HAS2;B3GNT3;B3GALT5;B3GNT8;EXT2;B3GALT1;CSGALNACT2;B3GNT6
prerank,regulation of immune response (GO:0050776),-0.25690093196658886,-1.07591174926036,0.2777777777777778,0.6644454232865781,1.0,28/135,17.43%,FOXP1;CLEC2D;CD200;B2M;TGFB2;CD34;VCAM1;PLSCR1;ITGB1;ICAM1;LYN;ADCY7;CXADR;XIAP;IL15;AHR;NECTIN2;COL1A1;ITGA4;BIRC3;CD40;RSAD2;ICAM2;IFITM1;ULBP1;PVR;N4BP1;DENND1B
prerank,pancreas development (GO:0031016),-0.4381673983225056,-1.0758230609188153,0.3699421965317919,0.6640871317069803,1.0,9/12,43.05%,MET;NKX6-1;FOXF1;ZIC3;SELENOT;NPHP3;CCDC40;ISL1;DNAAF1
prerank,protein localization to membrane (GO:0072657),-0.24697740791164816,-1.075809196381112,0.2724795640326976,0.6635521208913365,1.0,44/187,15.35%,SPTBN1;CAV1;SHANK3;RAPGEF2;PTN;BSG;RFTN1;LRP6;RAMP2;GAS6;RAP1A;TTC7A;PACS1;CACNB2;SMURF1;CDH1;F11R;TNIK;FLNA;NKD2;FCHO2;RAP2A;SH3PXD2B;EFR3B;RAPGEF6;SLMAP;EMP2;CPE;EHD2;FGF13;HGS;RAB3A;PTCH1;EHD4;ITGA4;LIN7C;ARL5A;KCNB2;RAB11B;PPIL2;AGRN;S100A10;FERMT2;KCNB1
prerank,plasma membrane organization (GO:0007009),0.3097707052449434,1.0757638400723721,0.3288135593220339,0.9123627714094756,1.0,10/61,10.09%,COL5A1;SYT11;ANXA6;ANK2;MICALL1;PLSCR2;MYOF;NSF;ABCD1;FA2H
prerank,protein localization to nucleus (GO:0034504),0.28704616632228985,1.07506225740965,0.317157712305026,0.9131767067210426,1.0,23/102,17.13%,BMP7;APPL2;IPO13;FAM53A;POM121;NUP155;LMNA;PLK1;NUP62CL;HNRNPU;ARL2;TNPO3;TOR1B;TOPORS;NXT1;PML;IPO8;MSX1;TNPO2;BANP;IPO4;MDM2;NUP88
prerank,camera-type eye morphogenesis (GO:0048593),-0.44763238899231644,-1.0748688170175362,0.37572254335260113,0.6653468060764414,1.0,5/10,22.99%,LRP6;TBX2;VEGFA;SKI;KDM2B
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.36121613858863755,-1.0747713914319332,0.3426724137931034,0.6650293502306245,1.0,4/22,7.99%,DAB2IP;MFHAS1;LYN;IFI35
prerank,regulation of nervous system development (GO:0051960),-0.33116919985368576,-1.0747108297720092,0.3561946902654867,0.6645806087057683,1.0,8/37,11.68%,PTN;TNFRSF1B;BHLHE40;HES1;LGI4;HEYL;HEY2;PTPRZ1
prerank,peptide cross-linking (GO:0018149),-0.3548301508124358,-1.0743076638455387,0.36327345309381237,0.6650470190859581,1.0,5/25,7.67%,NDNF;THBS1;FN1;ANXA1;TGM2
prerank,signal transduction in response to DNA damage (GO:0042770),0.3252538598904338,1.0737360866162056,0.3321616871704745,0.9159056667358797,1.0,19/49,22.83%,DOT1L;E2F1;HINFP;CLOCK;NDRG1;FBXO6;MAPK14;BATF;PRPF19;CHEK2;ABL1;GADD45A;ATM;CLSPN;RAD17;MYO6;CASP9;ATRX;MDM4
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4370234033133534,1.07307154650087,0.36619718309859156,0.9165658986442288,1.0,6/12,23.22%,CYP11B1;FDX1;STAR;FDX2;FDXR;TSPOAP1
prerank,microtubule anchoring at centrosome (GO:0034454),0.46236003643343465,1.0726724283065563,0.38876889848812096,0.9163099167120997,1.0,4/10,15.92%,PCM1;KIF3A;CCDC120;NINL
prerank,regulation of membrane depolarization (GO:0003254),-0.37992282326216387,-1.072423219930295,0.3787878787878788,0.6691164959257949,1.0,3/18,5.60%,NEDD4L;FHL1;CAMK2D
prerank,transcription by RNA polymerase II (GO:0006366),0.24880458775927686,1.072369000890212,0.296875,0.9158282574228862,1.0,39/305,11.83%,MAF;NOTCH2;RORA;DDX5;NR2E1;PABPN1;SOX5;CTR9;THRB;DTX1;NR6A1;CCN2;PPARA;CPSF3;ESRRA;GLIS3;GTF2I;CCNT2;TCEA1;PCID2;LEO1;RBPJ;WWTR1;INTS4;ZC3H8;CPSF7;MED1;PPARGC1A;TAF10;EAF2;NR1H3;RXRA;RNMT;MBD1;TSC22D1;TAF1;SLBP;MLLT1;CDC73
prerank,engulfment of apoptotic cell (GO:0043652),-0.3946643917743955,-1.072356155192479,0.3613963039014374,0.6686993506916878,1.0,2/15,2.26%,RHOBTB1;THBS1
prerank,regulation of protein kinase B signaling (GO:0051896),-0.24184003592912975,-1.0720078591290234,0.2776280323450135,0.6690000464609699,1.0,30/193,9.88%,HIP1;KITLG;TEK;NTRK3;GCNT2;GAB1;ENG;INSR;THBS1;GAS6;PIK3R1;F3;EGFR;PTPRJ;MFHAS1;ESR1;ITGB1;TNFAIP8L3;XDH;RACK1;MET;IAPP;MYOC;SPRY2;PPP2R5C;PIK3CA;SRC;IGF2;FGF2;FGF7
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.20860365729361383,-1.071669007306373,0.10967741935483871,0.6693089735838025,1.0,256/1082,20.68%,MECOM;LEF1;MEF2C;MAML2;ERG;BMP5;MRTFB;PID1;DCN;BMPR2;DAB2IP;ZBTB16;PBX1;ZFHX3;ELK3;JAG1;ITGA6;MLLT3;RARB;LRP6;ACVR1;MDFIC;ETS1;ACVRL1;PLAGL1;TCF12;MEOX2;PPARD;ENG;FLI1;MAP3K5;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;LRP5;PKD1;KMT2E;PIK3R1;CDH13;EGFR;RUNX2;FOXO3;CTCF;NFKBIA;AFAP1L2;ASXL3;LMO2;RUNX1;CDH1;STAT3;BMP4;ICE1;NFATC1;PRDM16;AGO1;PLSCR1;PPP1R12A;SIX1;RNF111;APP;NFIA;UBC;REL;DCAF6;RPS6KA3;GLI3;JUN;GLYR1;NAA16;ESR1;LMO7;TBX1;NFIX;KLF7;BPTF;KAT6A;DHX33;ARID1B;TFEB;BRD4;SOX17;SMARCC1;ZXDC;ARHGEF2;SMAD5;SMAD1;RPS27A;XPC;NFYA;UBB;PRKD1;SLC30A9;WNT5A;TNKS;MET;HES1;ETV1;NLRC5;NRF1;TRIM56;SP3;NCK1;ETV5;AR;ELF4;CCN1;PPP3CA;HEYL;NRIP1;CD38;NFAT5;ACTA2;CDKN1C;HEY2;SPIN1;ZFPM2;ARID1A;GATA2;VHL;EIF2AK3;IGF2;TRIM16;FGF2;SERPINE1;ELK1;PELP1;TGFB3;AGO2;AHR;APOE;NOTCH4;RPTOR;IRF2;FGF7;KLF4;TAL1;SS18;GTF2F1;RFXAP;ETS2;EDN1;PER1;TCF20;PITHD1;SERTAD1;TMF1;MYOCD;GTF2H1;NFATC2;SREBF2;SQSTM1;TWIST1;DYRK1A;TEAD1;ATAD2;CD74;FZD4;HHEX;SOX18;FOXF2;COL1A1;RET;BLM;FOSL2;BMP2;POU2F1;RARG;NFIL3;LPIN3;CD40;HNRNPAB;NME2;FZD1;NCOA6;MAFF;SOX12;CD86;VEGFA;KMT2C;KLF2;ZNF318;TFCP2;YAF2;NR4A2;AGRN;MRPL12;MT3;E2F5;ATF6B;CRTC3;FOXO4;MAD2L2;NR1H4;ENY2;BRCA2;ID2;RGMA;ATF4;SIX4;NFKB2;SP100;RREB1;DNAJC2;CSRNP2;FOXD2;HEY1;ZBTB48;IER2;ZNF496;ELL;SP7;MED14;HDAC2;GPER1;JUNB;GRIN1;NOD2;NR2F1;IL33;ATF7IP;EPC1;HIVEP1;PCBP1;NKX6-1;GREM1;FOXE1;MAPK3;ZC3H12A;ZMIZ2;NUFIP1;UBTF;IRF5;RYBP;SOX8;PAX3;SSBP4;RIPK1;TGFB1I1;SPI1;SIRT7;SMARCA4;FOXL2;CDCA4;NFATC3;ZMIZ1;HMGB1;LMX1B;CHD8;ATF3;POU3F3;NUP85;MAP2K7;MED13;MAML3
prerank,RNA interference (GO:0016246),-0.3969204674493099,-1.071607385179252,0.3668032786885246,0.6688839992395468,1.0,7/17,23.33%,AGO1;AGO2;DROSHA;CLP1;AGO4;MRPL44;TARBP2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3391112632799794,-1.0715219169526147,0.35526315789473684,0.6685252785239892,1.0,10/32,21.79%,NEK7;TNKS;XRCC5;MAPK1;FBXO4;HMBOX1;CCT2;MAPK3;MAP2K7;MAP3K4
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3566054348960034,-1.0714873542019865,0.34334763948497854,0.6680526146439743,1.0,8/23,19.05%,GNB1;GNG2;MAPK1;KCNQ1;TGM2;ATF4;PRKACA;MAPK3
prerank,phagosome acidification (GO:0090383),0.3719847841670038,1.0712946136079906,0.3487544483985765,0.9177566409329893,1.0,8/26,14.53%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.38240400210953734,1.0710393072519533,0.376425855513308,0.9170828457300004,1.0,5/21,13.20%,SLC8A3;ANXA6;AFG3L2;SLC25A23;MICU1
prerank,regulation of protein acetylation (GO:1901983),0.4448054484316152,1.0706031085478693,0.3824130879345603,0.9170136276607579,1.0,5/12,15.49%,MAGEA2;CAMK1;KAT5;RAPGEF3;SIRT1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.38616594023604406,-1.0704314025059949,0.36942675159235666,0.6702057825247307,1.0,4/17,7.77%,PARD3;SPRED2;CALM3;SPRY2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2753534140815026,1.0702073799174883,0.33540372670807456,0.9167933438647715,1.0,18/132,9.07%,RNF152;IGF1;PRKAA2;GTPBP1;SH3D19;PPARA;FURIN;PLEKHF1;PHKG2;OPTN;ADRA2A;PIK3CB;TRIM5;ABHD5;SUPV3L1;KAT5;LRRK2;ABCD1
prerank,positive regulation of dendrite extension (GO:1903861),-0.3931882754109212,-1.069972132081356,0.37267080745341613,0.6708042444090083,1.0,6/17,17.70%,NEDD4L;SMURF1;ITSN2;SYT4;RNF157;UNC13A
prerank,regulation of T cell chemotaxis (GO:0010819),0.45645168870345226,1.0699064984527213,0.40874524714828897,0.9162640790657591,1.0,2/11,4.13%,OXSR1;STK39
prerank,leukotriene metabolic process (GO:0006691),-0.37075873302886087,-1.0698888111112843,0.3737166324435318,0.6704168118860601,1.0,4/19,14.97%,PLA2G4A;ABCC1;MAPKAPK2;ABCC10
prerank,lymphocyte differentiation (GO:0030098),-0.2816364553029218,-1.0694601560312278,0.31592039800995025,0.6709238171299238,1.0,15/68,13.63%,PBX1;KAT7;VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;JAG2;RELB;HDAC9;PIK3CD;HHEX;ITGA4;NFIL3;PTPRC
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3452412254301284,1.0693241685397672,0.34306569343065696,0.9167199004786838,1.0,5/34,6.49%,RORA;SMAD3;LRP3;WWTR1;E2F1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.36316789092928464,1.0692459992030148,0.34,0.9154992035636776,1.0,4/30,4.40%,HSPA1A;DNAJC18;DNAJB4;DNAJB14
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.42261274266578225,1.069140671577995,0.3803088803088803,0.9143633377855485,1.0,3/14,5.75%,CTR9;KMT2A;AUTS2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.46728860366536773,1.0689338436207498,0.415506958250497,0.9135577802283462,1.0,2/10,4.13%,OXSR1;STK39
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3392324262182116,-1.0687688990571236,0.3497942386831276,0.6721284947322143,1.0,9/30,21.23%,CD34;STAT3;PLCG2;ISG15;PIBF1;CD46;NOD2;HMGB1;SYK
prerank,membrane assembly (GO:0071709),0.35576747315303336,1.068119279344588,0.35567970204841715,0.9146759815611022,1.0,8/34,8.56%,CEL;IL1RAPL1;NLGN2;PICALM;FLOT2;NLGN3;LRP4;PTPRD
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.44143650501460563,1.067552346770924,0.380859375,0.9149572278502868,1.0,4/13,8.19%,IGF1;GCK;PHKG2;SORBS1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.2980163481139744,-1.0674441901259077,0.33410672853828305,0.6750721660719492,1.0,19/55,24.13%,IL6ST;VCAM1;TFRC;ANXA1;NCK1;SLC7A1;RPS3;IGF2;IL15;PTPRC;CD24;CD86;NCKAP1L;CD46;JAK3;HMGB1;SYK;CD276;CCR2
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.33673999554364076,-1.066966319994597,0.3410526315789474,0.6757029365348172,1.0,11/29,24.36%,LEF1;TLE4;AXIN2;TLE3;RUVBL1;SMARCA4;BCL9;TRRAP;BCL9L;ASH2L;TCF7
prerank,cellular macromolecule catabolic process (GO:0044265),0.31302596337019734,1.0666024374567948,0.34234234234234234,0.9164961622128754,1.0,11/49,15.07%,MAGEA2;RNASEH2A;SIAH2;SUPV3L1;HTRA2;FBXO6;CHEK2;FBXO17;RNF5;SND1;ADAMTS9
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3138688481435462,-1.0664855191534222,0.3434125269978402,0.6763922243767937,1.0,15/40,20.04%,HIP1;B2M;INSR;SFRP4;TBC1D5;SGIP1;SERPINE1;VEGFA;CBL;VTN;FMR1;LDLRAP1;C3;GREM1;ARRB2
prerank,regulation of dendrite extension (GO:1903859),-0.38745119444597864,-1.0663809987910255,0.375,0.6760907786442922,1.0,6/18,17.70%,NEDD4L;SMURF1;ITSN2;SYT4;RNF157;UNC13A
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.37595260521336704,-1.065773937084948,0.3852813852813853,0.6771182224566643,1.0,6/20,12.86%,PLOD2;PLSCR1;GATM;GSS;GCLC;GCLM
prerank,myeloid cell differentiation (GO:0030099),-0.302753627384452,-1.0654094197081154,0.337995337995338,0.6774348973275129,1.0,9/47,9.95%,SNRK;ZBTB16;KMT2E;RUNX1;MFHAS1;KAT6A;LYN;PRKX;TAL1
prerank,regulation of axonogenesis (GO:0050770),0.32200363505391283,1.0651599671267538,0.34900542495479203,0.9197076007162203,1.0,11/51,11.82%,ROBO1;PLXNA2;RUFY3;PLXNA1;NTRK2;KIF13B;LRP4;PLXNA3;SIPA1L1;LRRC4C;EPHA4
prerank,regulation of epidermal cell differentiation (GO:0045604),0.38221919929048553,1.0648399998608067,0.3761814744801512,0.9192989053200924,1.0,3/21,4.58%,ERRFI1;ROCK2;MAFG
prerank,regulation of cellular component movement (GO:0051270),-0.3022704500727224,-1.064813758736146,0.32599118942731276,0.6783687300340238,1.0,19/49,24.52%,ACTN4;RHOA;ETS1;CD9;EGFR;ACTN1;ARAP1;LYN;HDAC6;VEGFA;MEMO1;SP100;PRAG1;CDK6;ROCK1;NRG2;EGF;RPS19;FES
prerank,intracellular pH reduction (GO:0051452),0.35127755596100396,1.0647377743905018,0.35688405797101447,0.9181772494312482,1.0,9/33,14.53%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;CLCN3;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,DNA integrity checkpoint signaling (GO:0031570),0.33999711444852576,1.0644450294401917,0.3456140350877193,0.9176189991205486,1.0,10/36,17.82%,DOT1L;E2F1;HINFP;CLOCK;FBXO6;PRPF19;CHEK2;ATM;CLSPN;RAD17
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4189482488379431,-1.064443026525058,0.3830227743271222,0.6787496161436641,1.0,5/13,16.11%,SHANK3;APP;EPHB2;SQSTM1;ZDHHC2
prerank,chemical homeostasis (GO:0048878),0.3090180988479764,1.0639749171988808,0.3583916083916084,0.917672461691216,1.0,17/61,17.29%,WNK3;RBP1;FITM2;SLC4A9;ABHD5;PNPLA8;CEBPA;WNK4;ADCK1;CLN8;NR1H3;USF1;SLC4A3;SLC66A1;ABCB4;TM6SF2;TLCD3A
prerank,copper ion homeostasis (GO:0055070),-0.3931531642804211,-1.063627669862542,0.38271604938271603,0.6802952279660263,1.0,9/17,29.00%,APP;SLC31A1;ATOX1;XIAP;MT2A;CCDC22;SLC31A2;ABCB6;ATP7B
prerank,regulation of protein localization to cell surface (GO:2000008),0.3544397954628781,1.0635801307755088,0.3378119001919386,0.9175182188182205,1.0,11/33,18.46%,LEPROT;ACTN2;PICALM;BDNF;ABCA2;STX4;GBF1;SNX33;HFE;GPM6B;GPD1L
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4142210307742382,-1.063575692028665,0.3938814531548757,0.6798595122390672,1.0,5/13,18.64%,PTGIS;PTGS2;NNMT;NUDT12;NAXE
prerank,aromatic amino acid family catabolic process (GO:0009074),0.4171948858455367,1.0628206011816708,0.3812375249500998,0.9184798757738659,1.0,5/15,19.53%,IDO1;HAAO;KMO;GSTZ1;KYAT1
prerank,neuron projection fasciculation (GO:0106030),-0.4422521910970477,-1.0627781842985737,0.3945720250521921,0.6814349144672078,1.0,4/10,16.45%,ARHGAP35;EPHB2;SEMA5A;RTN4
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3702840073463406,-1.0627563614141513,0.3755186721991701,0.6809032687215091,1.0,4/21,12.38%,MEF2C;ITGA1;CALM3;BMP2
prerank,protein glycosylation (GO:0006486),-0.2546746060350233,-1.0620424583157,0.3167082294264339,0.6821227097167226,1.0,32/125,19.41%,ST3GAL4;GCNT2;ST8SIA4;ST3GAL6;B3GNT2;FUT8;PLOD2;EOGT;MGAT5;SLC39A8;AQP11;ST3GAL1;COG3;PLOD3;ST8SIA6;STT3B;MGAT4A;B4GALT5;GFPT2;PMM1;MGAT4B;GALNT10;ST8SIA2;GALNT6;ALG10B;ST6GALNAC2;KRTCAP2;ST3GAL2;ALG6;TMEM258;POMT2;GALNT9
prerank,COPII-coated vesicle budding (GO:0090114),0.30330270625348277,1.061998294434592,0.352622061482821,0.919675041963882,1.0,21/68,17.94%,F5;BET1;SEC23B;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;MIA3;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC31B;SEC22B;TFG;F8
prerank,positive regulation of ATPase activity (GO:0032781),0.3410894611634218,1.0619063866646588,0.3774597495527728,0.9185153356021521,1.0,16/41,25.46%,ATP1B3;ATP1B2;ALDOB;HNRNPU;MSH6;DNAJC10;SSBP1;RYR2;MSH3;DNAJB2;ATP2A1;FGF10;DNAJB1;VMP1;TOR1AIP1;DNAJC9
prerank,regulation of cell projection organization (GO:0031344),-0.41825251138005104,-1.0616906962400916,0.39029126213592236,0.6825038408398552,1.0,3/13,12.19%,MACF1;SPRY2;MFSD2A
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3965990013191683,1.0615971941258175,0.39447731755424065,0.9180606844181655,1.0,7/19,16.50%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;CHMP1A
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2625518984408506,-1.0613950688482765,0.3215962441314554,0.6826783923998028,1.0,21/98,15.35%,SPTBN1;PRKCH;YWHAE;PIK3R1;EGFR;MFF;YWHAB;NKD2;ITGB1;STX3;ZDHHC8;YWHAQ;YWHAZ;STAC;EPHB2;SQSTM1;CEMIP;AKT2;LRP1;BBC3;KCNB1
prerank,histone ubiquitination (GO:0016574),0.38770951177164725,1.0613263370981687,0.374031007751938,0.9174176363943244,1.0,10/21,28.22%,CTR9;LEO1;RNF20;CDC73;PHC1;UBR2;RNF8;UBE2B;UBE2N;UHRF1
prerank,regulation of tissue remodeling (GO:0034103),0.39996073207088145,1.0612504234980495,0.3774703557312253,0.9162400011076611,1.0,2/18,0.87%,LEPR;IL18
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.280562749485297,-1.0610248611428164,0.34523809523809523,0.6830605508912417,1.0,31/69,33.08%,THBS1;STAT3;PTPRJ;APP;PLCG2;ARHGEF2;WNT5A;EPHB2;HSPB1;TWIST1;PTPRC;IFIH1;NOD2;IL33;RIPK1;HMGB1;SYK;FRMD8;CCR2;PTPN11;TLR4;DDT;MIF;RASGRP1;TMEM106A;FADD;LGALS9;TLR1;CD14;TLR3;TYROBP
prerank,O-glycan processing (GO:0016266),0.31686193095191806,1.0609223060088755,0.3718861209964413,0.9158280108352743,1.0,6/54,4.00%,GXYLT2;CHST4;MUC19;ST3GAL3;GALNT11;GALNT14
prerank,cellular response to exogenous dsRNA (GO:0071360),0.43957336750834997,1.0609212959852141,0.3641509433962264,0.9143756851844135,1.0,3/12,7.53%,COLEC12;PQBP1;IFIT1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.30878662362496073,-1.0604977048910738,0.35789473684210527,0.6839121245834978,1.0,13/44,20.11%,NRP1;RHOA;LIMCH1;ARHGEF15;PXN;MYOC;TGFB3;LIMK1;S100A10;FERMT2;ARHGEF10;ARHGEF5;CDC42
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.24890014854005557,-1.0604850610450218,0.3324022346368715,0.6833639636468991,1.0,35/144,16.87%,YWHAE;GAS6;PIK3R1;PRR5L;CDH1;ICE1;MFF;YWHAB;FLNA;TMEM30A;UBE2D3;SAE1;ABLIM3;PRKCD;SEC16B;ARIH2;YWHAQ;YWHAZ;RIPOR1;SREBF2;IPO5;MICALL2;CEMIP;TPR;UBE2L3;AKT2;FBXW7;UBL5;SAR1A;BBC3;ZFAND1;UBE2J2;KCNB1;ZDHHC2;B3GAT3
prerank,regulation of microtubule polymerization (GO:0031113),0.3355178880842668,1.0604664530409786,0.37050359712230213,0.9144763208980558,1.0,13/40,17.57%,MAP2;CLIP3;EML2;PRUNE1;CLASP1;ARL2;DRG1;TUBB4A;ABL1;MAPRE1;GBA2;NAV3;CDK5R1
prerank,cellular response to starvation (GO:0009267),0.26939983798242834,1.0604110080194706,0.3152,0.9131885101890711,1.0,19/147,9.50%,PRKAG2;RNF152;GCGR;PRKAA2;NPRL3;RRAGC;PRKAG3;PPARA;ATP6V0B;NIM1K;ATP6V1H;CPEB4;LRRK2;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1
prerank,positive regulation of cation channel activity (GO:2001259),0.33134351379273097,1.0601782002315465,0.35121107266435986,0.9125031062953459,1.0,8/40,11.59%,ACTN2;ANK2;LRRC38;ANTKMT;GSTM2;NLGN3;HTT;GSTO1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3462947448905326,-1.0601573094525671,0.3812375249500998,0.6836697484996646,1.0,9/26,13.98%,ITSN2;AP2B1;FCHO2;SGIP1;LMBRD1;CLTB;GPR107;FNBP1L;AP2A1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.38102191330397117,-1.060070176058282,0.3645621181262729,0.6832925364376938,1.0,7/18,22.15%,PLCG2;DOCK2;IFI35;DYSF;SYK;NMI;SBNO2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3662760742041438,1.0600201847192836,0.3841698841698842,0.9115540920586018,1.0,10/25,21.98%,CCAR2;CCNT2;EAF2;LDB1;ALYREF;DDX39B;THOC1;SUPT4H1;HTATSF1;WDR43
prerank,cardiac muscle cell development (GO:0055013),-0.37166277128560804,-1.0597536646459822,0.367032967032967,0.6835839929790425,1.0,5/20,8.50%,SORBS2;PDLIM5;MYH11;CXADR;HEY2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.45093441554159497,-1.0593295259463111,0.39223300970873787,0.6841127311936558,1.0,4/10,20.34%,ESR1;PSMC4;ATF7IP;HMGB1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.2810652550894229,1.059170370412122,0.33931484502446985,0.9128526485094756,1.0,32/102,21.44%,CPEB2;ADCY5;GCGR;GCK;CYP11B1;ADCY1;CRHR1;INSIG2;LPIN1;SLC30A10;ADCY8;PDPK1;PRKCI;SORBS1;RHOQ;USF1;EPRS1;RAB13;PRKDC;GOT1;RELA;AKT1;ADCY6;NFKB1;INHBB;RAB15;INPP5K;MYO5A;PRKAR1A;DENND4C;CAPN10;NR4A3
prerank,Notch signaling involved in heart development (GO:0061314),0.4494286396417847,1.0590777022469244,0.38922155688622756,0.9117407898960472,1.0,3/11,5.34%,NOTCH2;GALNT11;RBPJ
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.35516582807343844,1.0588687409868178,0.38727272727272727,0.9110110100049233,1.0,8/31,13.42%,MAGEA2;PLK1;ARRDC3;DCUN1D4;GOLGA2;TOPORS;CDC14B;RAB1A
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.349719626829162,1.0587247985508277,0.3638132295719844,0.9100157799229355,1.0,7/34,8.07%,GABRG1;GLRA1;RAB3GAP1;GRID2;GRIN2D;NLGN3;LRRK2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.38542540007650294,-1.0587186118652776,0.35700197238658776,0.6850826987055169,1.0,7/17,15.87%,NRP1;ADAMTS1;MDK;S100A11;CCN4;VTN;DOCK4
prerank,proteolysis (GO:0006508),0.24880978249230182,1.0579205727628656,0.3106508875739645,0.9112033708087014,1.0,48/252,17.78%,AEBP1;METAP2;ADAMTS13;PCSK4;CTSA;SUFU;CPQ;CPNE1;CPN1;PGPEP1;FURIN;PITRM1;CAPN3;AFG3L2;DPP8;CASP3;PLAT;HTRA2;SPRTN;NAPSA;PLG;CTRL;LONP2;ATG4D;ADGRV1;CPA2;FBXO6;CTSH;ENDOU;NEDD8;APH1A;DESI2;DESI1;ATG4C;CNDP2;VASH1;ADAMTS9;TRHDE;GGT5;HGF;BACE2;PAPPA2;MDM2;CAPN7;SRGN;ADAMTS7;TRABD2B;ST14
prerank,lipid droplet organization (GO:0034389),0.3807109394204736,1.0575448354993306,0.3886792452830189,0.911027365335014,1.0,5/22,14.04%,FITM2;RAB3GAP1;PLA2G4C;CDS1;SQLE
prerank,positive regulation of DNA recombination (GO:0045911),-0.3431695560955894,-1.0575055406703462,0.3798283261802575,0.6877360621934929,1.0,7/27,15.55%,TFRC;SHLD1;FUS;ERCC2;FANCB;TIMELESS;MAD2L2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.37145038787224904,-1.057056248458626,0.40301724137931033,0.6882801859137221,1.0,8/20,18.68%,AGO1;ZC3H7A;PUM2;AGO2;DROSHA;PUM1;AGO4;MRPL44
prerank,regulation of cellular component size (GO:0032535),-0.3391601300490991,-1.0568266926970835,0.3673036093418259,0.6882803743357513,1.0,12/30,27.40%,EPS8;RAB22A;VAV2;PPP1CA;RPTOR;RARG;PTEN;MSN;RAB3B;AP2M1;VAV3;NEB
prerank,microtubule nucleation (GO:0007020),0.3902905759164895,1.0564255418064068,0.376425855513308,0.9131682921433303,1.0,5/20,9.75%,CLASP1;TUBGCP5;GOLGA2;TUBGCP4;TUBG1
prerank,sulfur amino acid metabolic process (GO:0000096),0.37150940162051777,1.0559998622153162,0.38289205702647655,0.9131619338356891,1.0,7/24,16.79%,ADI1;MMUT;CDO1;MTHFD1;MTHFR;AHCY;CTH
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.22688910555882372,-1.0559739958207692,0.2829581993569132,0.6899061369477169,1.0,58/291,15.58%,PDE3A;ACTB;MEF2C;PID1;RAPGEF2;DAB2IP;SLIT2;RHOA;FOXO1;GUCY1B1;RAP1A;SH3BP4;EGFR;TNFRSF1B;PTPRK;JUN;ESR1;TBX1;DEFA6;CARD16;CAPN2;PRKD1;WNT5A;GNB1;PDE2A;LYN;PRKCD;PXN;GNG2;MAPK1;KCNQ1;TGM2;NRIP1;RPS3;SPAAR;SERPINE1;AHR;INSIG1;RPTOR;NSMF;IPO5;PAF1;PDCD4;FZD4;WNT9A;RET;PTK2B;SLC26A6;RRAGA;IRS1;CD86;P2RY6;ROMO1;MT3;GLRA2;ZFAND1;GIT1;NR1H4
prerank,regulation of response to external stimulus (GO:0032101),-0.25519290765149477,-1.0556872643292636,0.3176470588235294,0.6900163548620545,1.0,43/121,25.72%,FOXP1;CAV1;IL1R1;TMSB4X;SEMA7A;PTGS2;BRD4;MGLL;ADGRA2;WNT5A;AGTR1;ANXA1;PSMA6;STK24;CD55;SPAAR;XIAP;SPATA2;EPHB2;IL1RL2;BIRC3;ACE2;ADAMTS12;BCL6B;N4BP1;NOD2;HCK;MYD88;ZBP1;CASP4;SBNO2;CASP1;FCGR2B;GGT1;CYLD;ERAP1;GUCA1B;CCR2;CXCR4;AREL1;CASP8;LRP8;F2R
prerank,regulation of cell communication (GO:0010646),-0.3287018717869566,-1.0554686802676607,0.3811659192825112,0.6900426485901755,1.0,10/35,12.26%,SOCS2;TBX18;MGLL;CAMK2D;ANXA1;CXADR;PTPN1;GRK5;UGCG;CDC42SE2
prerank,positive regulation of glycolytic process (GO:0045821),0.38946099088522035,1.0550416315798734,0.37065637065637064,0.9132416915779561,1.0,2/20,1.77%,IGF1;PRKAA2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.38946099088522035,1.0550416315798734,0.37065637065637064,0.9132416915779561,1.0,2/20,1.77%,IGF1;PRKAA2
prerank,nucleoside salvage (GO:0043174),0.45593507920741094,1.0544062706700614,0.40159045725646125,0.9138859429160016,1.0,3/10,11.30%,UCKL1;DCK;UPP2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.43213202818690266,1.054288310275788,0.4130879345603272,0.9128543299889558,1.0,4/13,18.67%,RNF152;SESN1;ATM;CASTOR2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.2428469143388218,1.0542131995708004,0.30869565217391304,0.9116813617099278,1.0,39/348,9.01%,ROBO1;BMP7;AFDN;FGF1;BMP6;IGF1;HSPA1A;SLC24A3;GCGR;ROCK2;SMAD3;OSR1;FGF4;OVOL2;MAGI2;ANK2;PIK3R3;CDH3;FGF9;TNRC6A;PIK3CB;LRP3;PAX6;RBPJ;PDCD5;E2F1;WNT6;CITED1;ATAD1;ARRB1;NTRK2;FAM98B;SNF8;PPHLN1;RIMS1;MED1;PPARGC1A;HINFP;NSF
prerank,cellular response to leucine (GO:0071233),-0.45521396493719946,-1.0541083440649166,0.4174397031539889,0.692316312006467,1.0,5/10,20.24%,RPTOR;SESN3;KLHL22;UBR1;RRAGD
prerank,response to leucine (GO:0043201),-0.45521396493719946,-1.0541083440649166,0.4174397031539889,0.692316312006467,1.0,5/10,20.24%,RPTOR;SESN3;KLHL22;UBR1;RRAGD
prerank,lipoprotein catabolic process (GO:0042159),-0.43652617016389506,-1.0538997859087955,0.39711934156378603,0.6922116231788882,1.0,5/11,28.35%,CTSD;APOE;ABHD17C;ABHD17B;LYPLAL1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.45657449318189797,1.0538029759400847,0.39436619718309857,0.9115652397006468,1.0,3/10,8.73%,CRHR1;GNB5;DRD3
prerank,B cell homeostasis (GO:0001782),-0.4446455794218295,-1.0532378097755968,0.4074074074074074,0.6933072423449105,1.0,3/10,6.40%,MEF2C;DOCK10;LYN
prerank,response to sterol (GO:0036314),0.45792920704450624,1.053007382576923,0.3971486761710794,0.912653510755549,1.0,3/11,13.27%,RORA;TGFBR1;ABCA2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4307369707780968,-1.05255982031158,0.39801980198019804,0.6944485347944168,1.0,4/11,6.75%,RSPO3;MLLT3;CSNK1E;PLEKHA4
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.41652321751928156,-1.0524208192501954,0.4,0.6942389707715378,1.0,6/13,8.59%,ABHD2;BMP4;ESR1;NR3C2;AR;PLPP1
prerank,regulation of protein kinase activity (GO:0045859),-0.2561782302508116,-1.0523744644953974,0.3558897243107769,0.6937873779681851,1.0,32/106,23.67%,PLCE1;RAPGEF2;LRP6;GAS6;RASSF2;RAP1A;IQGAP1;CACUL1;UBASH3B;PAK2;XRCC5;PPIA;CCN1;CEACAM1;SOD1;HSPB1;GSKIP;PTK2B;DBNDD2;PTPRC;TAB1;RAP2B;AKT1S1;AGAP2;TRIB2;TRAF4;MMD2;MMD;PRKRIP1;TRIB3;TARBP2;CAMKK2
prerank,muscle cell development (GO:0055001),0.35423380710538005,1.0520702437684037,0.3965183752417795,0.9141795839852495,1.0,5/30,6.61%,IGF1;NEBL;ANK2;SGCZ;MYOF
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.28206042769497297,-1.0519209793819784,0.352112676056338,0.6944052703036772,1.0,17/69,17.39%,PLCB4;PLCE1;RHOA;PLCL1;PIK3R1;NGF;PIK3C2A;PIK3CA;EDN1;PIK3CD;EXOC1;PIK3C3;HTR2A;IRS1;CSF1R;PI4KB;PTEN
prerank,regulation of brown fat cell differentiation (GO:0090335),0.40241981660393455,1.051822824634092,0.39191919191919194,0.9135650629268296,1.0,8/16,21.77%,BMP7;METRNL;HNRNPU;TFE3;SIRT1;FNDC5;PIM1;NAPEPLD
prerank,vascular process in circulatory system (GO:0003018),-0.41446616288617844,-1.051811804875508,0.3838383838383838,0.6935261339164039,1.0,5/13,12.86%,NOS3;AGTR1;GCLC;ACE2;GCLM
prerank,regulation of tube diameter (GO:0035296),-0.41446616288617844,-1.051811804875508,0.3838383838383838,0.6935261339164039,1.0,5/13,12.86%,NOS3;AGTR1;GCLC;ACE2;GCLM
prerank,positive regulation of cell division (GO:0051781),0.33645021675993536,1.051558954067034,0.3788706739526412,0.912992734968994,1.0,5/38,8.73%,FGF1;TAS1R2;PKP4;FGFR2;DRD3
prerank,mammary gland epithelium development (GO:0061180),0.4228050125463136,1.0513480600539609,0.4247967479674797,0.9122576383210018,1.0,1/14,0.43%,WNT4
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.33525487921692454,-1.051240976142899,0.386892177589852,0.6938106021234439,1.0,12/29,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5
prerank,CENP-A containing chromatin organization (GO:0061641),-0.33525487921692454,-1.051240976142899,0.386892177589852,0.6938106021234439,1.0,12/29,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5
prerank,steroid metabolic process (GO:0008202),0.290909153023793,1.0510155161990151,0.3717277486910995,0.9118757923027733,1.0,19/72,21.56%,LIPA;CYP26B1;CYP11B1;DHCR24;PRLR;DHRS11;CYP27A1;AMACR;FDX1;PIAS4;CYP51A1;STAR;GBA2;FDX2;MSMO1;HSD17B4;NPC1;FDXR;HSD11B1
prerank,regulation of coagulation (GO:0050818),-0.43061892687458697,-1.0510058079970288,0.3948412698412698,0.6938460520534439,1.0,2/11,10.33%,CAV1;EPHB2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.37234601243081333,-1.0509906434593124,0.3932135728542914,0.6933135845749075,1.0,9/20,28.90%,PKD1;EGFR;CCNY;CCND1;PSMD10;CCND2;RGCC;MAPRE3;STOX1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.2839970736031757,-1.050910504266916,0.3870967741935484,0.6929400712616631,1.0,17/63,16.14%,SLC12A7;SLC12A2;ANO1;SLC26A2;SLC5A6;SLC1A3;SLC12A6;LRRC8A;GABRA3;GLRB;SLC37A3;SLC1A1;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.45321150679357947,1.0508198232164239,0.39553752535496955,0.9111210513525437,1.0,5/10,19.13%,EMC2;EMC4;MMGT1;EMC10;EMC1
prerank,positive regulation of cellular component organization (GO:0051130),-0.2566285445954951,-1.0508189041112586,0.34704370179948585,0.6925964627114052,1.0,18/107,9.95%,ATP10A;SHANK3;DAB2IP;NEDD4L;TGFB2;INSR;RUNX1;ICE1;FNIP2;TMEM30A;TFRC;RACK1;AR;RPS3;TGFB3;APOE;GPX1;TAL1
prerank,embryonic organ morphogenesis (GO:0048562),-0.3059583226121449,-1.0496842245633624,0.36784140969163,0.6949132376014312,1.0,15/42,19.87%,MFAP5;ACVR1;SIX1;TBX1;FBN1;SOX17;NIPBL;HES1;DSCAML1;RARG;ID2;ALDH1A3;EFEMP1;FOXE1;HOXA4
prerank,response to interferon-gamma (GO:0034341),-0.28265621924113266,-1.0492533799059913,0.3813953488372093,0.6954206776861457,1.0,21/67,25.81%,IFITM3;GBP4;GCH1;GBP5;WNT5A;CCL13;CD74;SYNCRIP;SLC26A6;CD40;SP100;IFITM1;GAPDH;CCL25;KYNU;IFITM2;CASP1;RPL13A;DAPK1;TLR4;AIF1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.4423846149879827,-1.0487283064550108,0.3898305084745763,0.6962267343577101,1.0,7/11,15.93%,RAPGEF2;TJP1;F11R;TJP2;RAPGEF6;RAB1B;RAP2B
prerank,myoblast fusion (GO:0007520),0.43113473727462637,1.0486677830152684,0.39183673469387753,0.9165718739760979,1.0,3/12,5.03%,ADAM12;ADAMTS15;ADGRB3
prerank,positive regulation of protein depolymerization (GO:1901881),-0.4297593991800768,-1.0481748186429214,0.4032258064516129,0.6970961000577165,1.0,4/11,16.30%,WDR1;TRPV4;KATNB1;SEMA5A
prerank,aorta development (GO:0035904),0.418785979108858,1.0480642111335154,0.37701612903225806,0.9170933867596163,1.0,1/14,0.08%,ROBO1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.31095787765357463,-1.0479214188430934,0.3581081081081081,0.697170279403854,1.0,17/37,27.92%,PHLDB1;STMN1;PHLDB2;EFNA5;FAM107A;GAS2L1;BICD2;TRAF3IP1;TAOK1;STMN4;MAPRE2;ROCK1;CYLD;MAP6D1;MAPRE3;SKA3;MAPT
prerank,early endosome to Golgi transport (GO:0034498),-0.42155040314023356,-1.0473767867935353,0.39738805970149255,0.6980124596768578,1.0,7/11,33.21%,RAB6A;SNX1;SURF4;SNX2;STX5;LMAN1;RBSN
prerank,regulation of Rac protein signal transduction (GO:0035020),0.40231257703131995,1.0473198204159266,0.3684210526315789,0.9180643661477674,1.0,3/16,8.77%,PIK3CB;AUTS2;ARHGAP24
prerank,DNA strand elongation (GO:0022616),0.39232304194169987,1.0472952010413987,0.4044265593561368,0.9167465386639021,1.0,6/18,16.77%,GINS1;POLD2;MRE11;TERT;MCM7;MCMDC2
prerank,AMP metabolic process (GO:0046033),-0.41844608169174186,-1.047285963480708,0.40325865580448067,0.6976645796430645,1.0,6/13,19.90%,XDH;NT5C1A;NT5E;ADSS1;AK4;AMPD2
prerank,positive regulation of reproductive process (GO:2000243),-0.3205528267074013,-1.046791624625304,0.37731958762886597,0.6983220882018609,1.0,5/31,13.82%,PDE3A;LHFPL2;AGO2;PGAM4;VEGFA
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3430119363326788,-1.0464641300831357,0.3796095444685466,0.6986286258914096,1.0,8/25,10.60%,CAV1;TBX18;NOS1AP;CAMK2D;CALM3;CXADR;CTNNA3;FGF13
prerank,protein-DNA complex assembly (GO:0065004),-0.2539889738949434,-1.0460472531095781,0.37066666666666664,0.6991566656160588,1.0,31/116,22.03%,RPA1;H3-3A;UBC;RPS27A;XPC;UBB;PSMA6;PSMB7;CHD1L;GTF2H5;PSMB6;PSMB5;GTF2H1;RAD23B;DMC1;ERCC2;ORC1;PSMB8;PSMC4;PSMD11;ORC2;PSMB4;PSMD14;RPA2;CHAF1A;ORC5;PSMD10;XPA;PSME1;CCNH;MCM3
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.34279868175545913,-1.0457660524996801,0.3683083511777302,0.6993231193293323,1.0,7/25,13.94%,INSR;NOS1AP;PTGS2;KLF4;EDN1;DDAH1;KLF2
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.3056115774116218,-1.045442209022787,0.37757437070938216,0.6995856213268784,1.0,12/42,20.48%,ACTB;ARID1B;SMARCC1;GATAD2B;RBBP4;ARID1A;PBRM1;NASP;ACTR6;HDAC2;SMARCA4;CHD8
prerank,GTP metabolic process (GO:0046039),0.41428232683323124,1.0454237192489713,0.4186046511627907,0.9213793297671334,1.0,5/15,18.26%,GTPBP1;LRRK2;RHOQ;RAB23;AK3
prerank,epithelial cell differentiation (GO:0030855),0.2840986677079914,1.0453085634239467,0.34563758389261745,0.9203679939392141,1.0,12/88,11.20%,MAF;DAB2;OVOL2;HNRNPH3;PGK1;CITED1;FGFR2;KDM6B;E2F8;FZD7;E2F4;PIH1D1
prerank,anterior/posterior pattern specification (GO:0009952),-0.2937774125975458,-1.0451863354996147,0.3752711496746204,0.6996345129445383,1.0,12/53,12.38%,BMPR2;PCSK5;LRP5;TBX1;BHLHE40;HES1;HEYL;HEY2;ATP6AP2;HOXA6;HHEX;BMP2
prerank,activation of protein kinase activity (GO:0032147),0.27998229701228783,1.0451520433989199,0.3781942078364566,0.919436773925849,1.0,13/106,7.86%,FGF1;OSBPL8;ADCY5;IGF1;IL18;RICTOR;ADCY1;ADRA2A;ADCY8;STRADB;PDPK1;NRG1;PRLR
prerank,hyaluronan catabolic process (GO:0030214),-0.36758857098016257,-1.0449480634254018,0.3736951983298539,0.6996988348877763,1.0,5/18,15.20%,CD44;FGF2;HEXA;CEMIP;CEMIP2
prerank,keratan sulfate metabolic process (GO:0042339),-0.3315999326402983,-1.0443335720867915,0.40301724137931033,0.7007290659179002,1.0,9/31,10.33%,ST3GAL4;ST3GAL6;B3GNT2;GNS;B4GALT4;ST3GAL1;LUM;B4GALT5;HEXA
prerank,spliceosomal complex assembly (GO:0000245),0.32145685186334394,1.0442198235546623,0.3763440860215054,0.9209156378382622,1.0,18/46,23.03%,CELF2;SRSF5;SRSF10;YTHDC1;PRPF19;USP39;RBM5;PRPF6;NOL3;DDX39B;SRSF6;CELF6;PUF60;SF3B1;GCFC2;LUC7L;SRPK1;CELF1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.426777068202273,1.0440488068417642,0.3944223107569721,0.9201062919134328,1.0,3/12,15.93%,STRAP;SOX9;RBP4
prerank,post-translational protein modification (GO:0043687),-0.22247287227058254,-1.04371153562767,0.2961783439490446,0.7017132262299239,1.0,91/332,22.21%,FBXL7;ZBTB16;LTBP1;PTP4A2;DCUN1D3;GAS6;SOCS2;BMP4;APP;FN1;BTBD1;DCAF6;LMO7;FBN1;PDIA6;MSLN;COP1;CST3;ADAM10;DCAF10;FBXW8;KLHL2;PSMA6;PSMB7;CCN1;FBXO31;FEM1B;FBXO30;LAMB2;KTN1;MFGE8;STT3B;MGAT4A;VCAN;VHL;FBXO4;CAND1;SOCS5;APOE;PSMB6;FBXO32;UBE2F;PSMB5;RAB3A;PNPLA2;DCAF13;DCAF5;FBXW2;FBXO44;EVA1A;FBXW7;FBXL18;TNC;RAB11B;CDH2;PSMB8;RAB1B;RHBDD1;GOLM1;PSMC4;ICMT;KLHL22;KBTBD7;PSMD11;KLHL3;ASB13;GPS1;ATG5;CISH;CHRDL1;SOCS3;IGFBP4;PSMB4;PSMD14;KCTD6;CCNF;C3;FBXL4;RAB11A;CKAP4;MATN3;FBXW5;PSMD10;COPS6;CALU;KLHL11;PSME1;KLHL25;CHM;ASB1;CCDC22
prerank,regulation of actomyosin structure organization (GO:0110020),0.4214517668829276,1.0433218382780285,0.39644970414201186,0.9210206570271913,1.0,4/13,15.08%,ROCK2;FHOD1;TSC1;WAS
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3772433440722368,-1.0430937744764612,0.3831578947368421,0.7027617974793124,1.0,8/17,29.06%,CD44;TWIST1;DYRK1A;CD74;PSMD10;SNAI2;MIF;PTTG1IP
prerank,regulation of filopodium assembly (GO:0051489),-0.31048574782200583,-1.0430760659191924,0.3676148796498906,0.7022400175457196,1.0,11/38,17.18%,NRP1;MYO10;PIK3R1;ARAP1;PPP1R16B;PRKCD;TGFB3;FNBP1L;AGRN;FMR1;FXR1
prerank,negative regulation of cell growth (GO:0030308),-0.24954073400061288,-1.042705114158324,0.3645833333333333,0.7026304663856922,1.0,23/121,14.78%,APBB2;BMPR2;SLIT2;ACVRL1;TGFB2;DCUN1D3;SH3BP4;BTG1;PTPRJ;FHL1;CCN3;SOX17;CCDC85B;RACK1;CDKN2AIP;FGF13;NME6;SEMA3G;SIPA1;RERG;ENPP1;ADAM15;MT3
prerank,apoptotic process (GO:0006915),-0.23625811405056243,-1.042622193383355,0.3323170731707317,0.7022629582203455,1.0,69/203,25.20%,HIP1;SEMA6A;MAGI3;ZBTB16;FAP;PLAGL1;PPARD;FOXO1;APAF1;STK3;BCL2L1;NFKBIA;PLSCR1;TGFBR2;APP;TBX1;FAS;CIT;PPIA;PRKCD;DAP;IAPP;TNFRSF21;CASP7;FEM1B;EFNA5;PIK3CA;RFK;CDK5;IER3;AHR;IFT57;PDCD4;PTK2B;TNFRSF19;ERCC2;ADAM15;BBC3;BAK1;DDIT4;RTN4;ING4;DIABLO;FXR1;ATCAY;GAPDH;LIG4;PAX3;RIPK1;RHOB;MYD88;PPP2CA;CHEK1;CASP4;PAEP;BIK;CASP1;CDK11B;EGLN3;TRAIP;BOK;DAPK1;PLK3;MRPS30;CXCR4;CASP8;BNIP2;JADE1;PRKCE
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.315790242569584,-1.0420760526704635,0.3955056179775281,0.7030999925292015,1.0,6/33,11.79%,PRKG1;MEF2C;APOD;TAFA5;TGFB3;PDCD4
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.39859825909551416,-1.041711737621576,0.43209876543209874,0.7034682465716948,1.0,6/13,18.76%,CACNA1G;STX1A;SYT4;CACNA1I;KCNB1;CACNA1H
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.29182955688849715,-1.041260957939703,0.378076062639821,0.7040802023602594,1.0,13/54,11.60%,CAV1;DCUN1D3;RPL5;CRY1;SPOPL;DNAJA1;SPRY2;RPS3;PRKCG;UBXN1;BAG5;SQSTM1;ISG15
prerank,mRNA polyadenylation (GO:0006378),-0.3459753459035094,-1.0412478283902298,0.4147368421052632,0.7029748348562626,1.0,8/26,13.42%,APP;TENT2;PABPC1;PAPOLA;TENT4B;WDR33;PAF1;CLP1
prerank,RNA polyadenylation (GO:0043631),-0.3459753459035094,-1.0412478283902298,0.4147368421052632,0.7029748348562626,1.0,8/26,13.42%,APP;TENT2;PABPC1;PAPOLA;TENT4B;WDR33;PAF1;CLP1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4432811027359964,-1.0411202359163614,0.4209486166007905,0.7027460447837639,1.0,8/10,47.66%,MALT1;ZC3H12A;SMAD7;NFKBID;RC3H2;IL4;FOXP3;TBX21
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3826363173504948,-1.040933656986129,0.4054621848739496,0.7026710967464924,1.0,4/16,8.21%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA6
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.4354422614374396,1.0408231301350732,0.4050880626223092,0.9274736092730912,1.0,2/11,8.49%,COLEC12;TNIP2
prerank,retinal metabolic process (GO:0042574),0.42743425508659194,1.0404961854403967,0.4188911704312115,0.9271655934190417,1.0,2/12,2.38%,ALDH8A1;ABCA4
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.36132664850002905,-1.0404324626988364,0.3898678414096916,0.7034100373375808,1.0,10/21,19.19%,PDE4D;PDE9A;XDH;PDE2A;HPRT1;NT5C1A;NT5E;HINT1;NUDT16;MLYCD
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.41190546396186856,1.0402548524579769,0.4164989939637827,0.9265912319061209,1.0,3/16,7.14%,PPARGC1B;DDX5;DDX17
prerank,mitochondrion morphogenesis (GO:0070584),-0.42998275007736547,-1.0395097892493919,0.41566265060240964,0.7052183128551723,1.0,3/11,8.00%,PID1;MFF;NUBPL
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3454638788513578,1.0391634740558164,0.4084249084249084,0.9286017909009294,1.0,9/30,20.27%,ACAT2;INSIG2;DHCR24;SQLE;CYP51A1;MSMO1;GGPS1;HMGCR;LBR
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.4388116903338966,1.039129891676608,0.41598360655737704,0.9273221801450838,1.0,3/10,11.76%,RENBP;GNPDA1;NPL
prerank,amino acid import (GO:0043090),0.3811069163746357,1.0389055004581935,0.3951310861423221,0.9266568585334006,1.0,2/21,0.21%,SLC6A13;SLC6A1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.31152267319149396,-1.0388718001450197,0.40186915887850466,0.7063694209597065,1.0,14/37,23.57%,RPL5;EIF3H;RPS7;UBXN1;USP7;RPL23;BAG5;CSNK2A1;N4BP1;RYBP;UCHL5;FHIT;GIPC1;TAF9
prerank,cellular iron ion homeostasis (GO:0006879),0.3060669592739743,1.0387286306424022,0.3702359346642468,0.9258509060477158,1.0,9/55,8.00%,BMP6;NDFIP1;HEPHL1;ATP6V0A2;FLVCR1;ACO1;CCDC115;TMEM199;CP
prerank,protein localization to mitochondrion (GO:0070585),0.4404740673623262,1.0384354485684983,0.4179431072210066,0.9253803885241471,1.0,6/11,20.60%,COX18;LRRK2;HK1;MTCH2;AKT1;MAIP1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.4434846446574718,1.0381111251425768,0.4334677419354839,0.9250167651749093,1.0,2/11,3.93%,STX18;ATL1
prerank,activation of protein kinase A activity (GO:0034199),0.396824097736815,1.0381042726742353,0.4280155642023346,0.9236660916125493,1.0,3/16,6.20%,ADCY5;ADCY1;ADCY8
prerank,hexose transmembrane transport (GO:0008645),0.37518816083283957,1.0378679150832602,0.4118773946360153,0.9230374105677704,1.0,3/21,2.69%,SLC2A12;SLC5A3;SLC5A10
prerank,negative regulation of cyclase activity (GO:0031280),0.4190094050082378,1.0373791246462976,0.41064638783269963,0.9232279792370219,1.0,4/14,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,pinocytosis (GO:0006907),-0.439523381412251,-1.0373015542893906,0.4268774703557312,0.7097949784140934,1.0,7/10,32.71%,DOCK2;MAPKAPK2;SNX5;CARMIL1;AHSG;MAPKAPK3;RAB34
prerank,glycine transport (GO:0015816),0.4510275143139975,1.0372094135702847,0.43907156673114117,0.92242853482638,1.0,1/10,2.09%,SLC6A9
prerank,protein localization to plasma membrane (GO:0072659),0.26840553418548496,1.036789844879024,0.3781942078364566,0.9224043123782883,1.0,16/129,6.93%,AFDN;ROCK2;ANK1;KCNIP3;ACTN2;ATP1B3;TSPAN5;FYB1;ANK2;CACNB3;WNK3;PLEKHF1;DLG1;FYB2;RAB3C;FLOT2
prerank,cellular response to interferon-gamma (GO:0071346),-0.26638526669120693,-1.0366713124366895,0.3688118811881188,0.7108264167697413,1.0,29/88,25.81%,B2M;VCAM1;CD44;MID1;GBP4;ICAM1;IRF9;CAMK2D;GBP5;WNT5A;PRKCD;TRIM25;CCL13;IRF2;JAK1;SYNCRIP;SLC26A6;SP100;GAPDH;CCL25;MT2A;IRF5;HCK;FCGR1A;CASP1;RPL13A;DAPK1;TLR4;AIF1
prerank,renal system development (GO:0072001),-0.289975279451291,-1.0364534859855248,0.4215686274509804,0.710770785025693,1.0,10/52,7.63%,PCSK5;TGFB2;PKD1;BMP4;TBX18;SIX1;ITGA8;SOX17;AGTR1;STRA6
prerank,positive regulation of response to external stimulus (GO:0032103),-0.25018974667616245,-1.0364243034295708,0.36633663366336633,0.7102635214584063,1.0,19/128,9.58%,PTN;ETS1;THBS1;NFKBIA;POLR3F;ABCC1;PLSCR1;SCARF1;APP;STX3;GBP5;WNT5A;AGTR1;PDE2A;PUM2;MDK;IFI35;SERPINE1;IL15
prerank,positive regulation of endocytosis (GO:0045807),-0.3023022681136092,-1.0362567861879781,0.3917748917748918,0.7101057573291335,1.0,15/45,18.38%,HIP1;NEDD4L;B2M;ANKFY1;RAB31;SGIP1;SERPINE1;APOE;LRP1;CBL;VTN;NCKAP1L;LDLRAP1;CD151;C3
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3892531373771818,-1.0361161803355912,0.40365111561866124,0.7093515180049299,1.0,4/15,8.77%,RHOA;ITGB1;ITGB5;SRC
prerank,stress fiber assembly (GO:0043149),-0.3892531373771818,-1.0361161803355912,0.40365111561866124,0.7093515180049299,1.0,4/15,8.77%,RHOA;ITGB1;ITGB5;SRC
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4303827549939438,1.036075688145831,0.4105691056910569,0.9233462388314962,1.0,4/13,6.95%,TGFBR3;BMPR1A;RBPJ;FGFR2
prerank,negative regulation of GTPase activity (GO:0034260),-0.34310588087701904,-1.0359746226580098,0.4305555555555556,0.7091553128430523,1.0,4/22,3.89%,LRCH1;DAB2IP;SH3BP4;F11R
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.325493411722703,1.035964663173713,0.40977443609022557,0.922347002086279,1.0,8/41,11.95%,SLC8A3;TRPV1;ITPR1;GRIN2D;ITPR2;RYR2;TRPM2;CHERP
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.40302062607144395,1.0357041329855763,0.3948919449901768,0.9218266539983704,1.0,2/15,0.78%,IGF1;ROCK2
prerank,negative regulation of phosphorylation (GO:0042326),-0.2635280933839643,-1.0356260205315138,0.3944020356234097,0.7094883735506579,1.0,25/85,17.39%,NTRK3;PID1;DAB2IP;SLIT2;NIBAN1;LRP6;PRR5L;CORO1C;BMP4;CBFA2T3;XDH;PPIA;LYN;OCLN;CDKN1C;EPHB2;TERF2IP;SH3GL2;DYNLL1;PAQR3;PLPP3;GIT1;FKBP8;TRAF3IP1;PTEN
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.2634582409108079,-1.0350257660404352,0.37320574162679426,0.7104871308089697,1.0,21/88,14.27%,STXBP6;MYO1B;CLINT1;RAB14;VPS13C;EXOC6;APP;EXOC4;SORT1;RABIF;FTL;RP2;EXOC1;HGS;STEAP2;SCAMP1;SH3GL2;VPS13A;SYS1;AP2A1;PUM1
prerank,regulation of protein sumoylation (GO:0033233),0.39905821970312017,1.0348744625906765,0.4093567251461988,0.9230877793389455,1.0,5/17,13.52%,MAGEA2;CAPN3;GNL3L;PIAS4;HDAC4
prerank,positive regulation of nervous system process (GO:0031646),-0.3689867313265465,-1.0345589229067336,0.41975308641975306,0.7110897293463884,1.0,3/18,3.68%,PARD3;TNFRSF1B;UNC13B
prerank,DNA geometric change (GO:0032392),0.3654183420699347,1.034406459384136,0.4110898661567878,0.9232503333148948,1.0,5/24,11.77%,RECQL4;HNRNPA2B1;SUPV3L1;MRE11;RTEL1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2677019249984576,-1.0343591344669796,0.3790523690773067,0.7110140694107496,1.0,28/76,26.03%,CAV1;DCUN1D3;CRY1;GNL3;UBB;SAE1;XIAP;FBXO4;FAM107A;AMER1;MALT1;DCUN1D5;BIRC3;UBE2L3;TBC1D7;FBXW7;PHF23;ZC3H12A;PSMD10;CENPX;RIPK2;NSMCE3;BCL10;CUL3;PIAS3;MUL1;UBQLN1;WFS1
prerank,glucose metabolic process (GO:0006006),0.30412045119716674,1.03426867340472,0.3833049403747871,0.9223450840551121,1.0,21/58,21.46%,SORD;ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;BRAT1;G6PC3;HECTD4;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;OMA1;SLC25A13
prerank,positive regulation of actin nucleation (GO:0051127),-0.4321506340238701,-1.034204200788091,0.4228456913827655,0.710852673223443,1.0,3/11,10.16%,GSN;WASF2;WHAMM
prerank,positive regulation of MAP kinase activity (GO:0043406),0.2956426386961843,1.033889748233171,0.3889845094664372,0.9222299758317276,1.0,8/66,10.29%,ROBO1;FGF1;TENM1;KIT;ADRA2A;LRRK2;MAP3K10;SASH1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3415680047972707,1.0336584472917756,0.39517625231910947,0.9216022194989905,1.0,2/30,0.69%,NOTCH2;IGF1
prerank,regulation of telomere capping (GO:1904353),-0.34886373713590624,-1.033542492210993,0.4112734864300626,0.7119561586187922,1.0,10/23,26.20%,NEK7;TNKS;MAPK1;USP7;NBN;MAPK3;MAP2K7;MAP3K4;HNRNPD;TERF2
prerank,protein palmitoylation (GO:0018345),0.3395629460557366,1.0334645128124609,0.4007561436672968,0.9208639580200197,1.0,10/30,17.45%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.2966246042743372,-1.0329938596579429,0.40217391304347827,0.7128672840995963,1.0,18/42,31.32%,SHLD1;TERF2IP;FUS;SMCHD1;FANCB;PPP4R2;TIMELESS;MAD2L2;RPA2;SPIDR;CHEK1;SIRT6;SHLD3;RAD51AP1;PARP1;CGAS;HELB;MRNIP
prerank,negative regulation of neuron death (GO:1901215),-0.25959269077754293,-1.032888699240135,0.3717948717948718,0.7125677548109645,1.0,23/93,16.19%,MEF2C;CD200;NDNF;CD34;NGF;SIX1;TNFRSF1B;CHMP4B;CHMP4A;MDK;PRKCG;FOXQ1;CDK5;SOD1;TGFB3;APOE;UNC5B;PTPRZ1;PTK2B;MT3;NENF;ATF4;SIX4
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.2929924130836048,-1.0327984868016207,0.3962703962703963,0.7122546059441971,1.0,12/50,11.60%,CAV1;CRY1;SPOPL;DNAJA1;SPRY2;RPS3;PRKCG;UBXN1;BAG5;FBXO5;SQSTM1;ISG15
prerank,DNA replication (GO:0006260),-0.2547661674422919,-1.0325456638528703,0.373134328358209,0.712364503457828,1.0,48/105,32.49%,RPA1;KAT7;REV3L;TIPIN;RPAIN;BLM;WRNIP1;KIN;ORC1;TIMELESS;ING4;ORC2;RHNO1;NBN;BARD1;RPA2;RMI1;CDC45;ORC5;PCLAF;POLA1;DUT;SET;RFC4;CHEK1;POLA2;MCMBP;TOP1;MCM3;WDHD1;POLD4;POLB;POLG2;RBMS1;POLE3;MCM5;MCM6;RFC2;CDK2;RECQL5;FAM111A;HELB;GRWD1;ORC3;CDK1;CDC6;PIF1;FEN1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3500300152037789,-1.032367402986812,0.42358078602620086,0.7122681462834659,1.0,12/24,26.60%,ZBTB16;TRPS1;ACVRL1;MDK;WNT9A;ADAMTS12;EFEMP1;GREM1;PTHLH;PTPN11;SNAI2;BMPR1B
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.24747863481352267,-1.0323561649582176,0.4,0.7117319837626351,1.0,47/122,29.48%,NIBAN1;BCAR3;TGFB2;INSR;KAT7;THBS1;EGFR;RBM3;EPM2AIP1;KDR;RPL5;EIF3E;EEF2;NLRC5;AR;IGF2;FGF2;KLF4;NMD3;AKT2;IRS1;FMR1;BRPF3;PRR16;FXR1;NOD2;IL33;METTL3;PIWIL2;DYRK2;FAF1;BCL3;EIF4A3;EGF;PRMT1;RGCC;CTC1;PPP1R3E;TLR4;HNRNPD;METTL14;RPS4X;SLC25A37;NSUN5;PCIF1;TMEM106A;GLI1
prerank,regulation of dephosphorylation (GO:0035303),0.4121053085321085,1.0319838052854131,0.4153225806451613,0.9242096871650726,1.0,5/15,15.53%,PPP1R16A;MTMR4;SMG5;MTMR2;SMG6
prerank,regulation of protein catabolic process (GO:0042176),-0.2591186500574022,-1.031959787312335,0.3702770780856423,0.7121802725547244,1.0,30/99,23.30%,DAB2IP;NEDD4L;WWP1;FOXO1;EGFR;SMURF1;EEF1A1;HECW2;IRAK3;FLNA;WNT5A;PLK2;APC;PRKCG;HGS;GFAP;CSNK2A1;FZR1;MAD2L2;ZDHHC2;BARD1;HACE1;NEDD4;AGAP2;FAF1;AZIN1;CDKN1B;ODC1;STX5;OAZ1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.42781952656984423,-1.03167609927469,0.4389763779527559,0.7123380188392848,1.0,2/11,2.27%,FOXO1;NOTCH1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.43138673597870913,-1.0316484885913835,0.4305555555555556,0.7118371454334905,1.0,6/11,30.21%,LANCL1;STK26;FYN;UBQLN1;PARK7;MMP3
prerank,cellular response to heat (GO:0034605),0.33794940603179924,1.031599136576494,0.41289198606271776,0.924089180760759,1.0,3/35,1.13%,FGF1;HSPA1A;TRPV1
prerank,exit from mitosis (GO:0010458),-0.4049619503271671,-1.0314042607205325,0.41386554621848737,0.711879764967936,1.0,3/12,6.91%,PPP2R2D;EPS8;CHMP4B
prerank,negative regulation of RNA splicing (GO:0033119),0.38039919441004233,1.0313764151923503,0.3931297709923664,0.9234467108970998,1.0,8/19,18.54%,PTBP2;SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;PTBP3;SRSF6
prerank,positive regulation of exocytosis (GO:0045921),0.3352140816727558,1.0313640330046978,0.41523809523809524,0.9221415902061864,1.0,7/35,13.80%,UNC13D;STAM;CLASP1;SMPD3;SNF8;RAB2B;CADPS2
prerank,histone lysine methylation (GO:0034968),0.3409262344710685,1.0312359495626526,0.41811175337186895,0.9212004544456694,1.0,7/33,13.73%,DOT1L;KMT2A;N6AMT1;DYDC2;SMYD3;SMYD2;MEN1
prerank,cellular protein catabolic process (GO:0044257),-0.28143930278408924,-1.0312053083763801,0.42152466367713004,0.7118222670446559,1.0,19/59,20.39%,DAB2IP;FAP;AP2B1;CAPN2;PSMA6;CTSO;MALT1;CTSB;VLDLR;RNF123;AP2A1;CTSF;TCIRG1;ADAMTS12;CTSS;UBE2G1;RSPRY1;RIPK1;MYLIP
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3269086992813344,1.0311141869357658,0.37174721189591076,0.9202386491850287,1.0,10/38,16.68%,RORA;TNIP3;NLRC3;NLRX1;CACTIN;STAT1;MAPKBP1;OTUD7A;SIRT1;PPM1B
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2589354656944044,1.0310598226453411,0.37574850299401197,0.9190750083652617,1.0,31/170,15.44%,PRDM6;IGF1;ROCK2;NOVA1;TRIM5;PEG3;ZNF462;CIAO3;KIF16B;MTMR4;AFF3;KDM6B;CRNN;HINFP;CACTIN;ZNF711;NKAP;RSPO1;PRDM2;MEGF8;HRG;FUBP1;ATRAID;MTMR2;AFF2;ZFP64;ZNF507;TSKU;PCBP4;TAPBP;TBC1D16
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.27936235993011793,1.0310085203758457,0.40066225165562913,0.9179280409086812,1.0,12/86,10.07%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;BMP8A;RBPJ;CITED1;INHA;GDF9;TGFBR1
prerank,DNA duplex unwinding (GO:0032508),-0.28746650543756574,-1.0307578209298187,0.3972911963882618,0.712398676390614,1.0,12/50,12.95%,RPA1;UBC;RPS27A;XPC;UBB;ANXA1;CHD1L;GTF2H5;GTF2H1;RAD23B;BLM;ERCC2
prerank,synaptic vesicle cycle (GO:0099504),0.35013326200214895,1.0303947430194722,0.4003623188405797,0.9185140988625989,1.0,10/30,22.60%,WNT7A;SNAPIN;RIMS1;SNAP25;SYT10;CPLX1;CPLX2;SYNDIG1;SLC32A1;SYT7
prerank,regulation of histone acetylation (GO:0035065),0.33330649812951596,1.030314399885257,0.40262172284644193,0.9174420887592719,1.0,8/33,13.56%,KMT2A;CAMK1;RUVBL2;ARRB1;PPARGC1A;BRD7;RAPGEF3;NOC2L
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4399991250595811,1.0297799465793762,0.43917525773195876,0.917716483355027,1.0,4/12,11.38%,THRB;BRD8;MED1;CTSH
prerank,pre-miRNA processing (GO:0031054),-0.3886164292120844,-1.029368727010857,0.4484848484848485,0.715450502076526,1.0,6/14,23.33%,AGO1;AGO2;DROSHA;AGO4;MRPL44;TARBP2
prerank,positive regulation of lipid transport (GO:0032370),-0.4104040323127825,-1.0293061376003434,0.4455852156057495,0.7150499605809805,1.0,3/12,13.83%,ABCA3;APOE;LRP1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3444767496261075,-1.0288105517892157,0.429769392033543,0.7158368933864165,1.0,10/23,25.52%,UBC;RPS27A;XPC;UBB;RAD23B;GPS1;XPA;COPS6;COPS4;CUL4A
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.33755323915816005,-1.02879186389275,0.42430703624733473,0.7153200806925126,1.0,10/28,23.39%,ESAM;WDR1;CXCL12;ARHGAP35;PLEKHG2;PFN1;LATS1;FCHSD1;RASA1;HCLS1
prerank,positive regulation of protein catabolic process (GO:0045732),-0.2613275625891088,-1.028710727688392,0.4023529411764706,0.7149683845560926,1.0,25/84,24.87%,DAB2IP;NEDD4L;WWP1;FOXO1;SMURF1;HECW2;TNFRSF1B;WNT5A;PLK2;APC;APOE;AMER1;CSNK2A1;FZR1;BARD1;HACE1;NEDD4;MSN;FAF1;CDKN1B;STX5;OAZ1;PLK3;AREL1;DTL
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.3547792652777252,1.0285824330467646,0.4260700389105058,0.9201595357211962,1.0,5/27,7.33%,BRD8;ATAT1;SGF29;RUVBL2;KAT5
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4285298485878934,1.0285494531767887,0.42322834645669294,0.9189365266915175,1.0,4/13,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,mRNA transport (GO:0051028),0.2787359731942374,1.0284292689962902,0.40695652173913044,0.9179702122107021,1.0,38/101,27.34%,MCM3AP;CPSF3;SRSF5;KIF5C;POM121;NUP155;HNRNPA2B1;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP;DDX39A;RAE1;RBM15B;SRSF2;ZFP36;U2AF2;NUP160;ZC3H11A;ZFP36L1;NUP133;THOC2;FIP1L1;POLDIP3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2367336920267974,-1.0281344994425115,0.3684210526315789,0.7158560099896036,1.0,27/158,13.32%,ROR1;RHOA;TRAF5;TNFSF10;ALPK1;MIER1;REL;NOD1;MID2;FLNA;BRD4;CARD16;TFRC;PRKD1;S100A13;SLC44A2;TRIM14;PLK2;TRIM25;MALT1;TERF2IP;EDA2R;CD74;BIRC3;TNFRSF19;ECM1;CD40
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.3992063044191847,-1.0280480803028835,0.4407114624505929,0.7154865495647972,1.0,6/14,30.54%,RHOA;RAP2A;CDC42;MSN;FOXJ1;CAMSAP3
prerank,inorganic ion transmembrane transport (GO:0098660),-0.42991404786690574,-1.0278167124987225,0.4458874458874459,0.7155498124299438,1.0,7/12,42.32%,ABCC9;KCNJ8;CACNA1H;ABCC8;P2RX3;KCNJ11;RHAG
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.35980866897212327,1.027716813259004,0.398876404494382,0.9175146338619231,1.0,8/22,17.45%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;ZDHHC23
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.35980866897212327,1.027716813259004,0.398876404494382,0.9175146338619231,1.0,8/22,17.45%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;ZDHHC23
prerank,mitochondrial translation (GO:0032543),-0.25592927710869856,-1.0276172138672626,0.385,0.7155008061927152,1.0,29/104,20.20%,GATB;DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MTIF3;GFM1;LARS2;MRPL23;MRPS31;NDUFA7;EARS2;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.2763927318997946,-1.026935953042116,0.4123456790123457,0.7167393314836835,1.0,30/68,30.12%,PAPOLA;GTF2H5;CPSF4;WDR33;GTF2H1;NCBP2;ERCC2;CLP1;POLR1F;POLR1G;SNRPE;CAVIN1;NCBP1;CSTF1;SMN1;POLR1A;UBTF;MED18;CCNH;POLR1H;POLR2F;SSU72;POLR1E;POLR2H;PCF11;SCAF8;SETX;POLR1C;CSTF3;POLR2E
prerank,negative regulation of macrophage activation (GO:0043031),0.3916487690630965,1.0266658903743224,0.4247619047619048,0.919558047584195,1.0,3/16,9.10%,SYT11;TAFA3;NR1H3
prerank,negative regulation of cell death (GO:0060548),-0.25962772684113533,-1.0266631499593875,0.37965260545905705,0.7168817437136684,1.0,14/88,9.34%,MECOM;PDE8A;CD200;CD34;BMP4;TNFRSF1B;CCN3;PRKD1;NCK1;CHMP4B;CHMP4A;CCN1;CDK5;FGF2
prerank,modulation by symbiont of entry into host (GO:0052372),-0.37356363927669584,-1.0264179801670832,0.4111111111111111,0.7169229200779935,1.0,5/16,17.65%,CAV1;TRIM14;TRIM25;NECTIN2;EXOC7
prerank,positive regulation of gene expression (GO:0010628),-0.21281733181407128,-1.026341317969773,0.36823104693140796,0.716576128760576,1.0,77/442,12.95%,LEF1;ACTB;LIMS1;MEF2C;NTRK3;PID1;CLDN5;NOS3;NIBAN1;GSN;ETS1;RAMP2;THBS1;NOTCH1;ACTG1;GAS6;PIK3R1;F3;EGFR;CD34;CTCF;NGF;RBM3;STAT3;BMP4;SFRP4;AGO1;PLSCR1;RPL5;APP;FN1;NOS1AP;PLA2R1;EIF3E;PLCG2;TFRC;SMAD1;WNT5A;S100A13;ERN1;EEF2;PDE2A;AR;MAPK1;SEC16B;RPS7;OCLN;SPRY2;MYBBP1A;ADAM19;RPS3;ACTA2;HEY2;TMEM119;GATA2;SOD1;EIF2AK3;FGF2;TENT4B;AGO2;IL15;FGF7;KLF4;EPHB2;PIK3CD;HGS;RPL23;TWIST1;DYRK1A;CD74;KRAS;DNMT3B;SERPINB9;BMP2;SMO;RAB27A;AGPAT1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.2776629267561218,1.0262226000689858,0.40619621342512907,0.919627490749329,1.0,15/95,10.07%,TGFBR3;DAB2;SNX6;HSPA1A;SMAD3;PPARA;STRAP;DKK3;NREP;CITED1;PDPK1;MTMR4;SPRED3;VEPH1;TGFBR1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3163488223573209,1.02619032185182,0.41729323308270677,0.9184342117937745,1.0,12/46,15.41%,LGR4;NPR3;NOVA1;RBPJ;ARRDC3;MAP2K6;ALDH1A1;NR1H3;DOCK7;NRDC;LAMA4;TFE3
prerank,MAPK cascade (GO:0000165),-0.22121045602246506,-1.0261592575620084,0.3625,0.7164790508899704,1.0,73/295,20.32%,SPTBN1;KITLG;TEK;MEF2C;SHANK3;RAPGEF2;DAB2IP;RASAL2;MAP3K5;RASGRP3;YWHAE;PIK3R1;EGFR;BCL2L1;RASGRF2;KDR;IL17RD;UBC;YWHAB;TNIK;MAP3K20;RPS27A;UBB;MET;PSMA6;PSMB7;MAPK1;SPTAN1;SHOC2;GRIN2B;PIK3CA;PDE6D;MAP4K4;FGF2;MAPKAPK2;FGF7;PSMB6;JAK1;FGF13;PSMB5;KRAS;NRAS;RANBP9;PRKG2;RET;RASA3;PEBP1;ABHD17C;IRS1;PPP1CC;PSMB8;MT3;PAQR3;PSMC4;ICMT;KBTBD7;PSMD11;TAOK3;FGFR3;MRAS;MAP3K8;DUSP6;PSMB4;GRIN1;PSMD14;TAOK1;MAPK12;MAPK3;MARK3;JAK3;GOLGA7;PSMD10;ABHD17B
prerank,fibrinolysis (GO:0042730),0.4089080670907664,1.0258506659570215,0.40194174757281553,0.9181590269134986,1.0,3/13,10.36%,PLAT;PLG;HRG
prerank,purine nucleotide metabolic process (GO:0006163),-0.33808953483727466,-1.0252382466401273,0.39957716701902746,0.7182267285275891,1.0,13/24,37.85%,XDH;HPRT1;GPX1;NT5C1A;NT5E;NT5C;GDA;FHIT;PRPSAP1;GART;PRPS2;NUDT15;PPAT
prerank,mitotic spindle organization (GO:0007052),-0.23728283902660507,-1.0249901399338837,0.39095744680851063,0.7183062166295978,1.0,57/153,28.45%,RHOA;STMN1;EML1;DYNC1I2;FLNA;SMC1A;MAP4;TNKS;PLK2;STAG1;NUP107;MAP9;DYNC1I1;PIBF1;KIF23;RPS27;RMDN1;MZT1;INCENP;DYNLL1;PPP1CC;ZWILCH;CLIP1;ZW10;DCTN6;PAFAH1B1;SEC13;STIL;PMF1;STAG2;CENPQ;CENPL;TOGARAM1;DYNC1H1;TAOK1;ARHGEF10;RAB11A;PRC1;NUP85;B9D2;GPSM2;TPX2;AAAS;KIFC1;NSL1;CENPN;NDEL1;KIF4A;CENPK;SPC25;SPDL1;MIS12;CDCA8;SGO1;TUBG2;VCP;BIRC5
prerank,protein homooligomerization (GO:0051260),0.27079282469711874,1.0247605823748827,0.41243862520458263,0.920092975076767,1.0,26/114,19.12%,ALDH1A2;UPB1;APPL2;TRPV1;VSTM5;ATL1;GSDMD;CLYBL;ADCY8;GOLGA2;ELAVL1;RNF135;KCNC2;SSBP1;TRPM2;BEND3;MICU1;ACACA;RNF213;CTH;ALAD;TRMT61B;NLRC4;ALDH9A1;ACOT13;USP16
prerank,negative regulation of blood coagulation (GO:0030195),0.3275805011273142,1.0245348187562777,0.4076086956521739,0.9194428815454321,1.0,7/38,10.36%,PDGFRA;TFPI;F10;PLAT;PLG;THBD;HRG
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.2792754570984112,-1.0240854963529475,0.38215102974828374,0.7201128794735733,1.0,25/57,25.53%,RPS15;RPL38;RPL5;RPS24;RPL7;RPS17;RPS16;RPL35A;RPS7;RPS28;SURF6;RPS25;RPL14;GTF3A;URB2;MRPL36;LTV1;MRTO4;EBNA1BP2;SDAD1;RRS1;NOP16;RPS19;CUL4A;RIOK1
prerank,neural crest cell development (GO:0014032),-0.29725923286147776,-1.0239721064546872,0.4069264069264069,0.7198171960767299,1.0,19/44,27.06%,SEMA6A;SEMA3C;SEMA7A;CORO1C;TBX1;SEMA5B;SEMA3E;SEMA3G;CDH2;SEMA5A;SEMA6D;SOX8;SEMA3F;SEMA4C;SOX11;TAPT1;SNAI2;SEMA4D;SEMA4F
prerank,histone modification (GO:0016570),0.26862693260762294,1.0239630073191084,0.4297385620915033,0.9198728610626751,1.0,27/109,20.32%,EYA1;EYA4;EYA2;BRD8;SGF29;RUVBL2;PRMT2;RCOR3;KAT5;MIER3;TAF10;NSD1;KDM4A;RCOR2;MAP3K12;HDAC4;TBL1XR1;NTMT1;SIRT1;NSD3;USP21;USP16;SIN3A;KAT6B;BRMS1L;KAT8;PHC1
prerank,steroid catabolic process (GO:0006706),0.4427217374929383,1.0239155867087293,0.4492753623188406,0.9187093367260938,1.0,10/10,55.76%,HSD17B11;HSD11B1;SPP1;HSD17B14;HSD17B6;CYP19A1;FGF23;YWHAH;CYP24A1;CYP27B1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3057576165852825,-1.0235359079472008,0.4164904862579281,0.7203345391099762,1.0,6/39,6.32%,UTRN;NEDD4L;FXYD5;YWHAE;FHL1;TRPC6
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.3650609526738375,-1.023500952478516,0.42411642411642414,0.7198629780457062,1.0,7/18,23.96%,PIK3R1;ERN1;NCK1;BAK1;FCGR2B;ATXN3;BOK
prerank,positive regulation of protein acetylation (GO:1901985),0.4220133139908038,1.0233009233008032,0.42276422764227645,0.9194101097210114,1.0,4/12,12.39%,PRKAA2;CAMK1;KAT5;RAPGEF3
prerank,synaptic vesicle recycling (GO:0036465),0.34990849072194874,1.0230178224805726,0.4376163873370577,0.9189789290715477,1.0,7/31,11.76%,CEL;NLGN2;WNT7A;SYT1;NLGN3;SYNJ2;CANX
prerank,membrane lipid metabolic process (GO:0006643),-0.342366321381176,-1.0228305915331395,0.41386554621848737,0.7210118065801335,1.0,4/22,4.01%,ST3GAL6;CYP1B1;AGK;B4GALT4
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4469117762248288,1.0227530438667078,0.42829076620825146,0.9185024797464593,1.0,5/10,24.97%,PRKAA2;KLF15;SIRT1;DIP2A;SETD5
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4013268536368621,-1.0224869661513012,0.4415841584158416,0.7212705494814441,1.0,2/13,7.91%,CAV1;BCAP31
prerank,eye photoreceptor cell development (GO:0042462),0.4014557269680269,1.022315724520419,0.44308943089430897,0.918640426186428,1.0,3/15,10.23%,USH1C;CEP290;TOPORS
prerank,regulation of exit from mitosis (GO:0007096),-0.29502136786257654,-1.021820022644895,0.41814159292035397,0.7223556274321815,1.0,6/38,7.05%,CDC27;UBC;ANAPC5;RPS27A;UBB;CDC16
prerank,cellular response to osmotic stress (GO:0071470),0.37208313004992966,1.0215596247513261,0.4166666666666667,0.9196413282376034,1.0,4/21,4.13%,OXSR1;WNK3;CAPN3;STK39
prerank,RNA export from nucleus (GO:0006405),0.274722321314396,1.021542221256852,0.4276206322795341,0.9184135969563028,1.0,25/100,19.97%,MCM3AP;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;NUP62CL;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3349681822101025,-1.0210586806264155,0.40563991323210413,0.723803996458367,1.0,13/26,30.39%,INSR;NOS1AP;PTGS2;KLF4;EDN1;DDAH1;KLF2;ASS1;DDAH2;TLR4;TMEM106A;CD36;TLR6
prerank,camera-type eye development (GO:0043010),-0.33665191482301327,-1.0207704395315087,0.4359504132231405,0.7240687984475658,1.0,9/25,21.97%,LAMA1;CYP1B1;FBN1;STRA6;VEGFA;ALDH1A3;EFEMP1;FOXL2;SKI
prerank,response to interferon-alpha (GO:0035455),-0.38082371383417973,-1.0204731630777149,0.4353182751540041,0.7242802925340913,1.0,6/16,21.59%,GAS6;IFITM3;TPR;IFITM1;IFNAR1;IFITM2
prerank,response to reactive oxygen species (GO:0000302),-0.285830462841649,-1.0204145541548262,0.4095022624434389,0.7238620686807653,1.0,12/54,9.75%,EGFR;PTPRK;JUN;PXN;APOD;MAPK1;RPS3;STK24;SOD1;CAT;APOE;GPX1
prerank,embryonic hemopoiesis (GO:0035162),-0.40442174564261063,-1.0203732599327755,0.4189473684210526,0.7233936311553608,1.0,4/12,9.95%,KITLG;TGFBR2;KDR;TAL1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3706031677854441,1.020318406097877,0.42418426103646834,0.9207813559549372,1.0,3/20,6.12%,PPIL6;PPIF;NKTR
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.3225098556888648,-1.0200140536472748,0.4117647058823529,0.7237752108830083,1.0,10/31,23.25%,GPHN;GCH1;LIAS;NFS1;MOCS1;LSS;NOXRED1;SRD5A1;PYCR3;SCP2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.37718780428166665,-1.019780233170466,0.4415322580645161,0.7238378402526267,1.0,10/16,39.92%,SHLD1;SMCHD1;FANCB;MAD2L2;SHLD3;CGAS;HELB;RADX;POLQ;SHLD2
prerank,peptidyl-threonine modification (GO:0018210),0.29499203790634987,1.0197233861459882,0.4292929292929293,0.9212910315416083,1.0,22/66,18.36%,ROCK2;OXSR1;WNK3;GALNT11;STK39;PDPK1;LRRK2;MAP3K10;TGFBR1;CSNK2A2;TAF1;GALNT3;GALNT2;MAP3K12;GALNT1;PRKDC;DYRK4;PRKCA;CDK5R1;NLK;HIPK2;AKT1
prerank,response to cholesterol (GO:0070723),-0.37536533751975676,-1.0196644742287966,0.42105263157894735,0.7235890877185109,1.0,5/17,12.67%,LRP6;TGFBR2;GRAMD1A;PTCH1;SMO
prerank,acylglycerol catabolic process (GO:0046464),-0.31690511478144395,-1.0189546226756065,0.43451143451143454,0.7248335418995852,1.0,4/30,12.54%,ABHD2;MGLL;PNPLA2;ABHD6
prerank,hexose metabolic process (GO:0019318),0.3197219815394028,1.0188967740694452,0.4340659340659341,0.9225581547526841,1.0,11/39,17.05%,CHST15;SORD;PGM1;ALDOB;GALT;FUCA1;BRAT1;PMM2;HECTD4;HK1;ALDOC
prerank,adipose tissue development (GO:0060612),-0.4243778700763817,-1.0187816543435886,0.40836653386454186,0.7247052207366508,1.0,6/11,30.57%,LRP5;SH3PXD2B;PGRMC2;SOX8;RORC;NAMPT
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3704691233506703,-1.0185904301428292,0.41875,0.7246569292546303,1.0,6/17,17.01%,JAG1;STAT3;CD55;BACH2;CD46;GNL1
prerank,negative regulation of binding (GO:0051100),-0.26470841356229025,-1.0185832159305495,0.42403628117913833,0.7241116030994728,1.0,12/81,6.70%,LEF1;ACTB;CAV1;WAPL;DISC1;NFKBIA;JUN;RALB;CARD16;CSNK1E;RACK1;PRKCD
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.3651172044637566,-1.0180656966057624,0.46322067594433397,0.7248599659920881,1.0,8/17,28.06%,FAF2;HM13;RHBDD1;AUP1;OS9;UFD1;HERPUD1;VCP
prerank,regulation of trophoblast cell migration (GO:1901163),-0.3853884211016908,-1.0178585189612621,0.4240631163708087,0.7248631470365576,1.0,4/14,14.57%,ARHGDIB;AGO2;VEGFA;ACVR1C
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.21948633803007261,1.0178022238714024,0.39390088945362134,0.9246352323595285,1.0,122/807,12.63%,PRDM6;AEBP1;BMP7;WWOX;BMP6;WNT4;DAB2;SNX6;DDX5;CBX7;SMAD3;KCNIP3;KMT5A;OSR1;NR2E1;MAGEA2;DNMT3L;SCML4;MSX2;CXXC5;CTR9;FHL2;THRB;SUFU;ZBTB38;CDKN2A;SCRT1;ARID4A;NR6A1;ZNF431;PCGF2;PPARA;GLIS3;CAPN3;TFDP2;CCAR2;DKK3;ENO1;ZHX1;LOXL3;IFI27;DLG1;PEG3;PRMT2;PAX6;IKZF1;RBPJ;PLK1;MZF1;DNMT3A;HNRNPU;HOXA7;RCOR3;ZKSCAN3;E2F1;CEBPA;CITED1;DPF1;ATN1;PBXIP1;NRG1;MOSPD1;FGFR2;LBH;JARID2;BEND5;KAT5;NR2F2;ZC3H8;BCL7A;PRDX5;CHD3;MIER3;IMPACT;MED1;KDM2A;HINFP;MAP3K10;MAX;DMAP1;NR1H3;E2F8;ZIC2;MED25;NKAP;RXRA;CLOCK;CBX6;ZFP90;PRDM2;C1QBP;MPHOSPH8;COMMD7;NSD1;FOXP4;LDB2;LDB1;PLCB1;BRD7;RITA1;LCOR;STAT1;FST;MBD1;TAF1;MXI1;KDM5C;QARS1;GATAD2A;PCGF6;CDC73;KDM4A;SOX9;CIPC;RLIM;BEND3;PML;RCOR2;RING1;RBAK;BHLHE41;PIAS4
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.31918879301874903,-1.0177321562334587,0.42083333333333334,0.7246382374194235,1.0,5/31,10.52%,SHANK3;PDLIM5;CDK5;ABI3;CFL1
prerank,carbohydrate transport (GO:0008643),0.43011374839058525,1.0175857892411455,0.4410058027079304,0.924005517104319,1.0,2/11,2.74%,SLC23A2;SLC23A1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.3069219688534056,-1.0173915451344926,0.4288888888888889,0.724928654377723,1.0,15/38,30.68%,HJURP;H3-3A;RBBP4;NASP;UBN1;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5;ASF1B
prerank,T cell receptor signaling pathway (GO:0050852),-0.23865299191618375,-1.0172582919899849,0.39452054794520547,0.724685626289189,1.0,37/138,23.25%,PDE4D;RFTN1;PIK3R1;PLCG1;PTPRJ;PLCG2;PAK2;TEC;NCK1;PSMA6;INPP5D;PSMB7;TNFRSF21;SPPL3;EIF2B2;PIK3CA;BCAR1;PSMB6;MALT1;PIK3CD;PSMB5;PTPRC;PSMB8;PSMC4;PSMD11;DENND1B;EIF2B1;PSMB4;PSMD14;ZC3H12A;PSMD10;PSME1;RIPK2;FYN;CD276;BCL10;PSMB3
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.36517500341102277,-1.017045735771234,0.4073275862068966,0.7246676272874727,1.0,9/18,27.88%,FLNA;DHX33;EIF2AK3;MAF1;ATF4;UBTF;SIRT7;RASL11A;LYAR
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.383148626031737,1.0168439280808717,0.4472168905950096,0.9249562187472012,1.0,1/17,0.29%,FGF1
prerank,vacuolar acidification (GO:0007035),0.36570200046424023,1.016580588110968,0.425,0.924529258409235,1.0,7/21,14.53%,ATP6V0A2;ATP6V1H;CCDC115;TMEM199;ATP6V0E2;CLN5;ATP6V0D2
prerank,regulation of Golgi organization (GO:1903358),-0.36030822527769746,-1.0163540322142641,0.4411134903640257,0.7258417509217185,1.0,9/17,33.21%,USP6NL;ARMH3;MAPK1;MAPK3;STX5;AKAP9;CAMSAP2;CAMSAP3;RBSN
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.25860764023138194,1.016337603797757,0.4068627450980392,0.9240034176925597,1.0,17/140,9.59%,ADCY5;CCR9;ACKR2;PDGFRA;TAC1;CACNB3;C5AR2;BDKRB1;JPH1;LPAR2;BDKRB2;ADCY8;LPAR1;DRD3;PTGER1;DLG4;C3AR1
prerank,response to light stimulus (GO:0009416),0.30083110376918065,1.0158790296544138,0.4003623188405797,0.9241274450544146,1.0,9/55,10.96%,DDB2;CCAR2;UBE4B;SPRTN;MSH6;REV1;CLOCK;MAPK10;USF1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2782268264279906,-1.015156130097862,0.44730679156908665,0.7283154882884431,1.0,22/59,25.76%,DAB2IP;NFKBIA;UBC;REL;RPS27A;UBB;RELB;NKIRAS1;TBKBP1;BIRC3;IRAK2;TAB1;RIPK1;TICAM1;ROCK1;RIPK2;BCL3;IRAK1BP1;BCL10;AZI2;TLR4;MAP3K14
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3650268594517478,-1.0150631455124508,0.45494505494505494,0.7280068521623316,1.0,6/18,20.25%,ADAM10;ADAM19;APOE;LDLRAP1;PSEN2;PSENEN
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3498557326095867,-1.0150437254093907,0.43254817987152033,0.7275152617393777,1.0,6/19,13.71%,PRKCD;ABCD2;TWIST1;PNPLA2;AKT2;IRS1
prerank,regulation of extracellular matrix organization (GO:1903053),0.40105863265409025,1.0149355485157552,0.422680412371134,0.9257308909392097,1.0,1/15,0.06%,AEBP1
prerank,regulation of mitochondrial fission (GO:0090140),-0.3358732860875725,-1.014862110513532,0.44329896907216493,0.7274392243378788,1.0,4/24,9.05%,DCN;KDR;MFF;MYO19
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.3239927578630707,1.0145142006369035,0.43316412859560066,0.9257440782913656,1.0,10/41,10.67%,ACTN2;ANK2;KCNJ5;KCNJ10;KCNH2;GABBR1;KCNN4;PDZK1;KCNJ16;GABBR2
prerank,microtubule anchoring (GO:0034453),0.4193794832265412,1.0142771502972254,0.4522417153996101,0.9252215736432049,1.0,3/12,11.11%,CLASP1;BICD1;PCM1
prerank,neuronal action potential (GO:0019228),-0.3377361421661899,-1.0139138567586732,0.4517543859649123,0.7293682666392352,1.0,7/22,21.60%,CACNA1G;KCNMB2;CACNA1I;SCN3A;GPER1;CACNA1H;SCN7A
prerank,response to nitric oxide (GO:0071731),-0.39164139924387537,-1.0138038368703641,0.4453125,0.7291108179857109,1.0,2/13,2.33%,FOXO1;GUCY1B1
prerank,metanephros development (GO:0001656),0.3495617538811093,1.0137898427299958,0.4344569288389513,0.9254362826173259,1.0,3/26,6.63%,BMP7;OSR1;CITED1
prerank,protein destabilization (GO:0031648),0.3364258756755084,1.0134247544929451,0.41366223908918404,0.9252302307713419,1.0,10/32,19.07%,DERL1;CAPN3;PLK1;HTT;CTSH;CDC73;SIRT1;MDM2;RNF139;PRNP
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.3806055632360493,1.0133497514424457,0.46863468634686345,0.9242150627150717,1.0,4/20,4.37%,ACTN2;OSR1;STK39;ADRA2A
prerank,fatty acid oxidation (GO:0019395),0.2974003064301902,1.0130938599107053,0.41638225255972694,0.92372171048197,1.0,11/57,12.22%,ADH7;ADH4;ACAT2;ACAT1;ACAD10;ECHS1;PPARGC1A;ABCD1;ACAD11;ECHDC2;CROT
prerank,determination of bilateral symmetry (GO:0009855),-0.3366441808676701,-1.0130553488991625,0.42857142857142855,0.7305063028152053,1.0,14/25,35.59%,NOTCH1;TBX1;DNAH11;STIL;CFAP53;DLL1;ODAD2;ODAD3;ZIC3;FOXJ1;NPHP3;LEFTY1;DNAAF4;BBS7
prerank,actin filament network formation (GO:0051639),-0.4134324588509911,-1.0128350818002845,0.4362934362934363,0.7305080470891183,1.0,2/11,4.45%,PLS3;ACTN1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3817424670348801,1.0127809090604791,0.4146825396825397,0.9234378791613469,1.0,4/17,5.34%,NOTCH2;GALNT11;BMPR1A;RBPJ
prerank,coenzyme A metabolic process (GO:0015936),0.3998512138043282,1.0126792585004496,0.4330097087378641,0.9224859914204071,1.0,4/14,12.22%,PANK1;ACAT1;PANK2;CROT
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.37166731532832453,-1.0123325793318718,0.43870967741935485,0.7312218877165333,1.0,10/18,25.41%,IL6ST;STAT3;IL6R;SRC;JAK1;CBL;SOCS3;SPI1;PTPN11;YAP1
prerank,calcium ion import (GO:0070509),-0.3246772643069925,-1.0123014096415945,0.4444444444444444,0.7307448728619782,1.0,10/28,15.31%,MICU3;CACNB2;CACNA1G;TRPC4;MCUB;CACNA1B;TRPV4;MICU2;SMDT1;CACNA1I
prerank,purine-containing compound catabolic process (GO:0072523),-0.3974887052205891,-1.0121350422802065,0.46963562753036436,0.7306629523042166,1.0,6/13,21.88%,XDH;GPX1;NT5C1A;NT5E;NT5C;GDA
prerank,nitric oxide metabolic process (GO:0046209),0.3980678917538717,1.0120691270065947,0.42653061224489797,0.9230612675724834,1.0,3/14,4.43%,GCHFR;NQO1;ARG2
prerank,female gonad development (GO:0008585),0.37620286535508074,1.01125114967026,0.4361904761904762,0.9243564464440935,1.0,5/19,10.52%,KIT;NR2F2;INHA;EIF2B4;COL9A3
prerank,response to thyroid hormone (GO:0097066),0.42098451166740825,1.0111352957769992,0.45090180360721444,0.9234469200367967,1.0,4/13,11.38%,THRB;BRD8;MED1;CTSH
prerank,positive regulation of integrin activation (GO:0033625),-0.41862941388752173,-1.0106231186029886,0.4448818897637795,0.7340137071937839,1.0,4/11,15.34%,PIEZO1;RASIP1;SRC;FERMT2
prerank,regulation of axon regeneration (GO:0048679),-0.4107333108453467,-1.0105953633788989,0.45348837209302323,0.7335327879673421,1.0,3/12,8.17%,PTN;SCARF1;STK24
prerank,regulation of cholesterol esterification (GO:0010872),-0.42785701586481056,-1.010498130173815,0.45930232558139533,0.7332392820246472,1.0,5/10,27.83%,AGTR1;APOE;STARD4;APOC1;AGT
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4280829113771273,1.0103828090153213,0.45691382765531063,0.9245145951692986,1.0,2/11,6.77%,GCK;C1QTNF3
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.2892178963870766,1.0100307733306382,0.4377224199288256,0.9243227236055775,1.0,13/72,11.39%,FGF1;FGF4;FLRT3;FGF9;TIAL1;TRIM71;KIF16B;FGFR2;FLRT1;PTBP1;TIA1;FRS2;GALNT3
prerank,regulation of cation channel activity (GO:2001257),0.27216979847127426,1.0100243452502873,0.42905405405405406,0.9230836562374867,1.0,19/89,15.09%,CACNG7;ACTN2;CACNB1;ANK2;CACNB3;NLGN2;JPH1;DLG1;FGF12;SHISA7;SHANK1;GSG1L;DLG4;CNIH3;FGF14;OPRM1;SHISA8;LRRC7;GRIA2
prerank,retrograde axonal transport (GO:0008090),-0.36987984432285503,-1.0091582307062694,0.4309278350515464,0.7361758331775969,1.0,5/16,17.93%,DST;SOD1;KIF1C;PAFAH1B1;DYNC1H1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.28287147522326805,-1.0090397249470164,0.481651376146789,0.7359209228327539,1.0,15/52,15.19%,YWHAE;YWHAB;UBE2D3;SAE1;ABLIM3;ARIH2;YWHAQ;YWHAZ;SREBF2;MICALL2;UBE2L3;FBXW7;UBL5;BBC3;UBE2J2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3015992439887312,-1.009015379477041,0.43537414965986393,0.7354295088842909,1.0,7/36,10.78%,GHR;CAV1;NOTCH1;CYP1B1;HES1;VHL;HGS
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.28823197211510937,-1.0087358101114976,0.41379310344827586,0.7356270123905913,1.0,9/46,12.57%,YWHAE;GAS6;PIK3R1;CDH1;FLNA;PRKCD;IPO5;NCBP2;TPR
prerank,striated muscle cell differentiation (GO:0051146),-0.3696112432640131,-1.0084336563373766,0.45322245322245325,0.735840432069936,1.0,11/16,37.17%,MEF2C;SORT1;MYOCD;BMP2;PLD3;SKI;CBY1;SIK1;POPDC3;POPDC2;MYEF2
prerank,negative regulation of mRNA processing (GO:0050686),0.395939314508697,1.0081914802499177,0.43052837573385516,0.9273103305977078,1.0,6/15,18.54%,SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;SRSF6
prerank,cellular response to ATP (GO:0071318),0.41395843803398874,1.0080314928212208,0.46774193548387094,0.9265639417374918,1.0,2/14,11.18%,TRPV1;TAF1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.29407069236286065,1.0078999036586276,0.44483985765124556,0.9232516071092058,1.0,20/61,20.29%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC22B;TFG;F8;PEF1;PDCD6
prerank,vesicle coating (GO:0006901),0.29407069236286065,1.0078999036586276,0.44483985765124556,0.9232516071092058,1.0,20/61,20.29%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC22B;TFG;F8;PEF1;PDCD6
prerank,COPII vesicle coating (GO:0048208),0.29407069236286065,1.0078999036586276,0.44483985765124556,0.9232516071092058,1.0,20/61,20.29%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC22B;TFG;F8;PEF1;PDCD6
prerank,protein ubiquitination (GO:0016567),0.22404472914236684,1.007652856004449,0.4226110363391655,0.9227987507607447,1.0,113/471,21.25%,RNF220;RNF152;EPAS1;RNF43;UBE2E2;DDB2;SH3RF2;CTR9;ASB2;PDZRN3;DTX1;DERL1;FBXL19;TRIM62;PSMD3;SIAH2;RNF41;RNF126;TRIM5;FBXL12;LEO1;PLK1;DZIP3;TRIM71;KLHL13;SHPRH;RNF14;TNKS2;UBE4B;UBA1;FBXO11;TRIM35;ARRB1;DTX2;PELI3;DTX3;HIF3A;RNF135;TRAF7;BRAP;TOPORS;SASH1;BCL2;FBXO6;RNF10;RNF20;RNF6;CAND2;PRPF19;TAF1;HLTF;RNFT1;UBE2W;OBI1;FBXO9;CDC73;RLIM;RNF31;NEDD8;FBXO17;FBXO41;PSMD1;SPSB2;PSMC5;RNF138;RNF7;PRKDC;PSMA1;UBE2R2;RBCK1;UCHL3;EIPR1;SIRT1;PSMD12;RNF213;KLHL20;TRIM3;FBXL16;MDM2;RBBP6;UBE2S;ANKIB1;ANAPC7;USP9X;RNF139;RNF13;FBXL22;KCTD13;TRIM63;RNF26;FBXO22;PSMD7;TRIM2;TRIM13;BFAR;FBXL5;KLHL7;SPSB1;KLHL42;TRIM41;PHC1;NFX1;RNF146;MYCBP2;RMND5A;UBOX5;KLHL21;HECW1;FBXL15;ZSWIM8;PSME2;TRIM32;RNF103-CHMP3
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.41660604527748785,-1.0076092339976788,0.44377510040160645,0.7374335282519745,1.0,5/11,15.67%,NOS3;GCH1;QDPR;PRKG2;DHFR
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3248978873128894,-1.0075991228371723,0.43333333333333335,0.7369053147142282,1.0,8/27,13.83%,CAV1;NFKBIA;PLTP;ZDHHC8;ABCA3;APOE;PTCH1;LRP1
prerank,fatty acid catabolic process (GO:0009062),0.2900704328531131,1.0075535986846724,0.42907801418439717,0.9218591023802679,1.0,14/67,12.22%,CEL;ACAT2;LPIN1;ACAT1;PCCA;ACAD10;ECHS1;MMUT;ABCD1;ACAD11;ECHDC2;PLA2G15;ABHD3;CROT
prerank,brain development (GO:0007420),-0.23800009893369586,-1.0074282699190842,0.4640198511166253,0.7367823272239485,1.0,20/136,12.19%,ADGRL2;SHANK3;RAPGEF2;PBX1;ZFHX3;COL4A1;SHROOM4;PBX3;TGFBR2;EML1;BPTF;NIPBL;APOD;UFC1;GRIN2B;DSCAML1;ADGRG1;ATXN1;PTCH1;MFSD2A
prerank,regulation of immunoglobulin production (GO:0002637),-0.3403508150558596,-1.0068704215744433,0.4543524416135881,0.7375990030117512,1.0,5/23,13.79%,VAMP3;EPHB2;PHB2;PTPRC;CD86
prerank,cochlea morphogenesis (GO:0090103),-0.42736518805456,-1.0068630654117532,0.47478991596638653,0.7370680542127851,1.0,2/10,4.34%,TBX18;TBX1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2793231533788513,-1.0067221599226237,0.45734597156398105,0.736888253681245,1.0,26/57,25.72%,TNFSF10;MAP3K5;NOD1;AIM2;PERP;BCAP31;CTSD;GRIN2B;MALT1;SOX7;TBC1D10A;ACVR1C;BAK1;USP50;GPER1;GRIN1;FOXL2;HMGB1;SYK;RIPK2;FYN;CASP1;BCL10;DAPK1;CASP8;F2R
prerank,error-free translesion synthesis (GO:0070987),-0.3418260844932791,-1.0066373745635515,0.45129224652087474,0.7365607176046784,1.0,4/22,5.64%,RPA1;UBC;RPS27A;UBB
prerank,ether lipid biosynthetic process (GO:0008611),-0.43194161720085544,-1.0063499904730864,0.45934959349593496,0.7367475099189766,1.0,3/10,8.56%,PLA2G4A;DHRS7B;PEX7
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.38158871318206933,1.0063369917724336,0.42418426103646834,0.9242839660721152,1.0,3/18,7.03%,CACNG7;NLGN2;NLGN3
prerank,regulation of sodium ion transport (GO:0002028),0.3273741619614295,1.0062485854599499,0.4404332129963899,0.9233324955258709,1.0,5/34,6.71%,WNK3;SNTA1;DLG1;FGF12;WNK4
prerank,establishment of spindle orientation (GO:0051294),0.3453051340579559,1.0061577892459153,0.43359375,0.9224041107994908,1.0,7/28,9.52%,PLK1;CLASP1;LLGL2;HTT;NDC80;MAD2L1;LLGL1
prerank,actin filament bundle organization (GO:0061572),0.33225024562069083,1.0059484277847501,0.4227941176470588,0.9217922217735413,1.0,6/33,6.79%,USH1C;RFLNA;BAIAP2;PAWR;ADD2;CORO1B
prerank,positive regulation of cell communication (GO:0010647),0.3451086323408673,1.0053742727463928,0.43148148148148147,0.9222929146861801,1.0,5/28,9.52%,WLS;SYT1;GRIK2;RIMS1;DLG4
prerank,base conversion or substitution editing (GO:0016553),-0.4169953020265646,-1.0050089074986244,0.4560327198364008,0.7396509662667002,1.0,3/11,20.16%,ADARB1;NUDT16;METTL3
prerank,kidney development (GO:0001822),0.287001708758368,1.0045051589597764,0.4536256323777403,0.9236612382987921,1.0,13/65,14.87%,BMP7;WNT4;GREB1L;OSR1;CITED1;LRP4;VANGL2;CEP290;TGFBR1;CTSH;BAG6;FOXC1;ARL3
prerank,epithelium development (GO:0060429),0.2663853240823701,1.0039878102551412,0.44805194805194803,0.9240364931523283,1.0,10/107,6.95%,ALDH1A2;WNT4;ERRFI1;OSR1;HNRNPH3;LOXL3;TRIM71;PGK1;NDRG4;FGFR2
prerank,central nervous system neuron differentiation (GO:0021953),0.3367009296050688,1.0039745622971106,0.433852140077821,0.9228499506902811,1.0,11/33,20.12%,MAP2;GRID2;NTRK2;MDGA2;GBA2;CHD5;ATP7A;FAIM2;SIN3A;SPOCK1;KNDC1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.2819084056130025,-1.0037461813030462,0.44298245614035087,0.7423200502577044,1.0,19/48,27.53%,PDE4D;PLCG1;UBASH3B;CAMK2D;CALM3;TRPC1;JPH2;CEMIP;PTK2B;PRKACA;APLNR;GPER1;DMD;NPSR1;JPH3;F2R;SELENON;CASQ1;CALM1
prerank,protein localization to cilium (GO:0061512),0.3259456812874264,1.0035263097239124,0.4411764705882353,0.9229683838220464,1.0,7/32,14.87%,TTC21B;TULP3;WDR19;WDR35;IFT122;TCTN2;ARL3
prerank,regulation of programmed cell death (GO:0043067),-0.2308714259988867,-1.0031169835853913,0.4515235457063712,0.7433884411016174,1.0,58/161,30.16%,HIP1;MECOM;ACTN4;STEAP3;ACER2;APAF1;ACTN1;FAS;CRADD;PERP;TPT1;TGM2;RPS3;CDK5;BCAR1;IFT57;MALT1;CTSB;PHLPP1;BIRC3;RARG;NME2;MADD;ALK;RTN4;RBM25;TMEM219;OSGIN1;PTPN6;STK26;TIGAR;RIPK1;JAK3;AKT1S1;ACER3;LCMT1;BCL3;SLK;CHM;CASP1;NUP62;FANK1;TRIAP1;DAPK1;ZBTB7A;LRP8;WFS1;RTKN;DAPK2;DDX42;AGT;VCP;BIRC5;FBXO10;MARK4;FLT3;PMAIP1;IRF3
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.2878228010110489,-1.0029629407604956,0.4344978165938865,0.7431933835237038,1.0,20/46,31.73%,MTAP;PAK2;PPIA;RPLP0;CNN2;SOD1;JAK1;CFL1;PDCD4;BOLA2;CDC42;CAPZA1;MSN;HNRNPF;IL12RB2;STAT4;AIP;MIF;LMNB1;RAP1B
prerank,presynaptic endocytosis (GO:0140238),0.3584885587284451,1.0027664062065305,0.46257197696737046,0.9240587971231479,1.0,7/24,15.04%,CEL;NLGN2;SYT1;NLGN3;SYNJ2;CANX;AMPH
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3872861958961622,-1.0025390683566366,0.45121951219512196,0.7437041604994942,1.0,4/14,15.55%,TFRC;SHLD1;NECTIN2;MAD2L2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.3102734620929796,-1.0020843610326124,0.43991416309012876,0.744311386909551,1.0,7/34,13.79%,SLC7A5;VAMP3;WNT5A;EPHB2;PHB2;PTPRC;CD86
prerank,androgen receptor signaling pathway (GO:0030521),0.4149496035824222,1.001245241598886,0.4503171247357294,0.9273476357738729,1.0,3/11,7.14%,DDX5;RNF14;DDX17
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.30947087859914396,-1.0009622039249286,0.4590909090909091,0.7466011328834016,1.0,20/34,34.99%,PDE4D;KCNQ1;CALM3;PRKACA;PLN;ZC3H12A;GJA5;PIK3CG;SLC8A1;STC1;RGS2;CALM1;HCN4;SMAD7;RNF207;NOS1;ADRA1A;ATP1B1;TNNI3K;CALM2
prerank,neuron differentiation (GO:0030182),0.24960458737676544,1.0008195847628378,0.4453125,0.927396726847325,1.0,21/165,10.11%,WNT4;HS6ST1;IL1RAPL1;VXN;WNT5B;TENM1;PBX2;DTNB;WNT7A;PAX6;FZD8;PBX4;CASP3;FZD3;WNT6;NTRK2;PTPRD;FZD7;TDP2;TGFBR1;LDB1
prerank,translational elongation (GO:0006414),-0.24827506865697457,-1.0006287276886496,0.44634146341463415,0.7469744116982672,1.0,28/101,20.20%,EEF2K;EEF1A1;DAP3;MRPS10;MRPL20;RACK1;EEF2;MRPL52;MRPL21;GFM1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;EEF1G;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.33422512438127483,-0.9999701014728941,0.4715447154471545,0.7481240305713485,1.0,7/24,12.34%,BMPR2;ACVRL1;DACH1;XRCC5;RPS3;TERF2IP;BLM
prerank,regulation of interferon-alpha production (GO:0032647),0.35865966290630275,0.9999253171567305,0.4548736462093863,0.9289617593299273,1.0,8/23,23.59%,CHUK;NLRC3;STAT1;HAVCR2;TLR8;DDX3X;PTPRS;SETD2
prerank,mRNA catabolic process (GO:0006402),0.3134472424651267,0.9998748520812196,0.44181818181818183,0.9278976021636616,1.0,8/44,14.28%,HSPA1A;DDX5;DHX34;SUPV3L1;LSM5;TUT4;AGO3;HSPA1B
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.4147949651375442,-0.999030885209212,0.4693069306930693,0.7499795655160352,1.0,3/11,13.36%,P4HA1;CRTAP;P4HA2
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3433753176801003,-0.9989489234074875,0.4636752136752137,0.7496414622680613,1.0,6/22,19.47%,SLC7A5;TNFRSF1B;WNT5A;TRIL;NOD2;BTK
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.40534943259130596,-0.998856905955495,0.4732824427480916,0.7492831899559492,1.0,4/11,30.30%,AGTR1;PLA2G7;AGT;PLA2G5
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.35612358524227683,-0.9986221561844656,0.45751633986928103,0.7493197860365909,1.0,4/17,10.10%,PTPRJ;DGKZ;CEACAM1;DUSP3
prerank,glycolipid metabolic process (GO:0006664),-0.2879549452690241,-0.9985799995414154,0.43779904306220097,0.7488609576149943,1.0,10/47,13.30%,ST3GAL4;ST6GALNAC3;ESYT2;ST3GAL6;ST8SIA6;ESYT3;HEXA;PSAP;UGCG;ARSA
prerank,regulation of stem cell differentiation (GO:2000736),-0.2522057607975374,-0.9985574126572435,0.46568627450980393,0.7483615586638149,1.0,25/89,23.25%,PTN;JAG1;TCF12;NOTCH1;LMO2;RUNX1;HES1;PSMA6;PSMB7;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;SP7;PSMB4;PSMD14;METTL3;PSMD10;PSME1;RBM24;PSMB3
prerank,nitric oxide biosynthetic process (GO:0006809),0.40212015261212886,0.9983779674873213,0.4491869918699187,0.9312622772652918,1.0,3/13,4.43%,GCHFR;NQO1;ARG2
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.2634998292138213,-0.9983298554397151,0.45893719806763283,0.7483884507289902,1.0,25/66,30.42%,FOXP1;STAT3;APP;CARD16;GBP5;WNT5A;AIM2;TRIM16;MALT1;HSPB1;GIT1;USP50;NOD2;ZC3H12A;MYD88;RIPK2;CASP1;CASP8;TLR4;F2R;CPTP;TMEM106A;CD36;TLR6;LGALS9
prerank,lysine metabolic process (GO:0006553),0.41711905975018304,0.9982170493010449,0.46153846153846156,0.9292775256445328,1.0,2/12,11.66%,ALDH7A1;GCDH
prerank,lysine catabolic process (GO:0006554),0.41711905975018304,0.9982170493010449,0.46153846153846156,0.9292775256445328,1.0,2/12,11.66%,ALDH7A1;GCDH
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3864962927022009,0.9979673072872003,0.4426559356136821,0.928794788631846,1.0,3/15,3.59%,FGF1;FGF4;SMOC2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.20785698065079158,0.9972518704429018,0.47884187082405344,0.9297672130200353,1.0,271/1667,15.61%,PRDM6;AEBP1;ZKSCAN2;MAF;RORA;FGF1;WWOX;EPAS1;HLF;BMP6;DAB2;CREB5;PPARGC1B;IGF1;DDX5;CBX7;IL18;SMAD3;KCNIP3;TRAK1;KDM7A;KMT5A;VGLL3;NPAS3;OSR1;NR2E1;MAGEA2;HMX2;MSX2;CXXC5;SOX5;BEX1;OVOL2;CTR9;FHL2;THRB;SUFU;ZSCAN29;ZBTB38;CDKN2A;TTC21B;SCRT1;CHD4;MYBL2;FBXL19;ARID4A;CREBRF;NR6A1;ARNT2;DOT1L;PBX2;KIT;ZNF431;PCGF2;PPARA;ZNF23;SALL4;ZFP3;NFYB;ESRRA;GLIS3;POU1F1;SLTM;UBP1;HOXB9;BMPR1A;TFDP2;BRD8;SIM1;WNT7A;CSRP3;CHUK;CCNT2;ENO1;ZHX1;SMARCD3;TNRC6A;KMT2A;HOXB3;MAFG;LPIN1;TET1;MEIS1;IFI27;CAMK1;DLG1;TIAL1;PEG3;RUVBL2;TCEA1;MLXIP;PAX6;IKZF1;PHF8;RBPJ;PLK1;IKZF2;MZF1;DNMT3A;AUTS2;ARID3A;HNRNPU;ZFHX2;TNIP3;WWTR1;ZBTB26;HOXA7;ZNF462;PBX4;RFX8;RNF14;NFYC;DRGX;RCOR3;ZKSCAN3;IKBKG;PCGF5;E2F1;CEBPA;CITED1;DPF1;ATN1;MOSPD1;FGFR2;HOXB6;DDX17;BCL11B;KAT5;NR2F2;TEF;ARRB1;KLF15;CHD3;ZSCAN22;SNF8;HOXA3;ZNF569;KDM5B;KDM6B;NLRP3;ZNF467;MIER3;PHF2;IMPACT;NFATC2IP;HES6;MED1;MAFA;TNIP2;PPARGC1A;ZFX;KDM2A;HINFP;HIF3A;MAX;DMAP1;EAF2;NR1H3;RHOQ;PHIP;E2F8;ZBTB22;HDX;ZIC2;MED25;HOXB4;NKAP;SSBP2;RXRA;CLOCK;CBX6;ZFP90;PRDM2;PSIP1;C1QBP;NSD1;SALL3;FOXP4;LDB2;LDB1;PRKCB;CSRNP3;BRD7;ZNF260;PPM1D;RNF10;RITA1;LCOR;BCLAF3;E2F4;CSRNP1;MAPK14;STAT1;USF1;BATF;FST;TAF1;MXI1;STAT2;WASL;FZD5;GATAD2A;PCGF6;ZBTB49;CDC73;DMTF1;SOX9;SRA1;MED12L;BEND3;RCOR2;RBAK;FHOD1;BHLHE41;PURB;PIAS4;BRD2;ZNF367;HBP1;JAZF1;GABPA;ZIC5;AGO3;YEATS4;SMYD2;ABCA2;ABHD14B;EN2;HDAC4;NOC2L;CTBP2;FOXC1;MEN1;ZSCAN20;ARNT;DICER1;ZNF483;PLAGL2;PSMC5;ZKSCAN4;MYBL1;ZFP64;CREB3L4;PRKDC;ZNF507;GABPB1;MLLT10;WBP2;SAFB2;TBL1XR1;BCL11A;PER2;WAS;MED15;HEXIM2;PTOV1;ZBTB43;ERF;ABL1;TADA1;MUC1;PPP3R1;MSX1;HNF4G;GADD45A;TFE3;HIC2;SIRT1;DPF3;IL6;HGF
prerank,hyaluronan metabolic process (GO:0030212),-0.32658511109050303,-0.9971782113004675,0.4535637149028078,0.7508810415530133,1.0,6/23,15.20%,CD44;FGF2;HEXA;CEMIP;HAS1;CEMIP2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.278259856335615,-0.9970861533620003,0.44243792325056436,0.7505477629765079,1.0,19/57,23.95%,GHR;IL6ST;STAT3;HES1;LYN;IL6R;IL15;PIBF1;ARL2BP;CD40;VEGFA;CSF1R;SOCS3;FGFR3;CRLF1;PPP2CA;CTF1;HCLS1;SOCS1
prerank,cholesterol homeostasis (GO:0042632),-0.27106483828804323,-0.9969931203065334,0.4532710280373832,0.7502327366841196,1.0,13/64,11.15%,CYP7B1;CAV1;SCARB1;LRP5;ABCA1;CYP39A1;NPC2;TTC39B;MTTP;HDAC9;APOE;INSIG1;LIMA1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4133770759977603,0.9969243050285919,0.4819277108433735,0.9295332936903243,1.0,3/12,8.19%,PRKCZ;GKAP1;SORBS1
prerank,regulation of chromatin binding (GO:0035561),-0.4318146565841336,-0.9969082113533306,0.4911937377690802,0.7498976263450114,1.0,2/10,9.60%,WAPL;HMBOX1
prerank,regulation of dendritic spine development (GO:0060998),-0.34681849854629354,-0.9968082778147227,0.46804123711340206,0.7496003445889861,1.0,2/19,0.56%,MEF2C;SHANK3
prerank,miRNA metabolic process (GO:0010586),0.37052413904248493,0.9966768852721213,0.4649805447470817,0.9290410683326418,1.0,6/20,15.04%,TRIM71;DDX17;BCDIN3D;TUT4;DICER1;SND1
prerank,connective tissue development (GO:0061448),-0.3092188598021096,-0.9966528025275978,0.46206896551724136,0.7494154214014623,1.0,5/35,5.93%,ZBTB16;LRP5;PKD1;CD44;SH3PXD2B
prerank,atrial septum morphogenesis (GO:0060413),-0.4233750391272176,-0.9964518826653934,0.47443762781186094,0.7493593842687337,1.0,4/10,8.50%,BMPR2;ACVR1;TGFB2;HEY2
prerank,T cell differentiation in thymus (GO:0033077),-0.38831645107599955,-0.9964367789099303,0.4554865424430642,0.7488554754546484,1.0,6/14,33.14%,GLI3;PTPRC;LIG4;ZFP36L2;FADD;RABL3
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3267017882359422,-0.9964289374170001,0.4573304157549234,0.748320666846698,1.0,5/26,10.47%,FOXP1;CRY1;STRN3;HEYL;PER1
prerank,protein-containing complex assembly (GO:0065003),0.23457626251081917,0.9964000792435003,0.4481203007518797,0.9286433298846659,1.0,69/259,20.29%,AFDN;F5;USH1C;CD247;WDCP;BET1;WDR19;CAPN3;PLEKHA7;PICALM;RSPH4A;KMT2A;DNAJB14;AFG3L2;ADD2;LEO1;GSDMD;ADCY8;IKBKG;KAT5;SHANK1;NAPA;RIMS1;LRRK2;GOLGA2;WASF1;PPARGC1A;NSF;TUBGCP4;LLGL1;DLG4;SEC23IP;CAND2;WASL;EPRS1;CDC73;SOX9;PML;CNIH3;TRAPPC1;USO1;WASF3;TERT;RAB1A;MEN1;PPP6C;TRAPPC4;TRAPPC3;WAS;TAPBP;TMED2;MDM2;MCFD2;HFE;NOL3;SEC22B;SKAP2;TFG;TCF7L2;F8;CX3CL1;MITF;SNX9;TFAP4;HGSNAT;PYGO1;PEF1;DNM1L;PDCD6
prerank,cellular response to amino acid starvation (GO:0034198),0.2849564729807433,0.9962444976089673,0.4471830985915493,0.927893291024245,1.0,17/71,15.20%,RNF152;NPRL3;RRAGC;ATP6V0B;ATP6V1H;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1;LAMTOR2;ATP6V0E2;ATP6V1C1;ATP6V0D2;NPRL2;LAMTOR3
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.34241349267078464,-0.996075320431687,0.46956521739130436,0.748679376040934,1.0,15/21,45.71%,DUSP3;PIBF1;JAK3;FCGR2B;SOX11;FOXJ1;SAMSN1;IL4I1;LAPTM5;GPNMB;VTCN1;TNFAIP3;FGL1;TNFAIP8L2;BANK1
prerank,positive regulation of cell aging (GO:0090343),0.4231417628033183,0.9958572364197502,0.4701195219123506,0.9278249534656243,1.0,3/11,4.43%,CDKN2A;LMNA;ARG2
prerank,endomembrane system organization (GO:0010256),-0.22608899173232377,-0.9958221659218697,0.47126436781609193,0.7487011713386044,1.0,37/178,16.55%,SPTBN1;SYNE1;ATP8B1;ATL3;LMAN2L;TMED10;WASHC4;USP6NL;CHMP2B;PRKD1;FBXW8;CSNK1A1;COG3;SEC16B;ALS2CL;RAB22A;EIF2AK3;GOLPH3;CAV2;BAG5;DYSF;SUN1;SEC31A;SQSTM1;LEMD3;SNX10;UBXN2A;SEC61A1;REEP3;SURF4;REEP5;ZW10;VAPB;TLCD1;LYSMD3;SYNGR2;USP50
prerank,cytosolic transport (GO:0016482),-0.2431528961222208,-0.9955285565524731,0.45112781954887216,0.7489272188507311,1.0,42/108,27.31%,MYO1D;RAB14;VPS53;VPS13C;ANKFY1;RAB6A;TBC1D5;VAMP3;SNX1;EMP2;VPS26A;SORT1;TMEM87B;PIK3C3;GOSR1;VPS13A;SYS1;TBC1D10A;AP2A1;STX8;SNX2;ANKRD27;STX6;RHOBTB3;DCTN1;PREPL;EPS15;SNX5;RIC1;VPS26B;VPS52;STX5;GAK;EVI5;DOP1B;RAB9B;VPS50;BET1L;PHETA1;YKT6;PHETA2;VTI1B
prerank,cellular calcium ion homeostasis (GO:0006874),-0.2384195370856696,-0.9952086087132925,0.4639175257731959,0.7491965454516437,1.0,31/133,15.99%,CAV1;STIM2;ATP2B1;TRPC3;YWHAE;SLC10A7;MICU3;SLC30A1;CAMK2D;NPTN;TRPC6;CXCL12;SLC35G1;TPT1;TRPC4;CCL13;ATP2A3;MCUB;TRPC1;TMCO1;EDN1;CAV2;EDN3;HTR2A;TRPV4;CD40;MICU2;SMDT1;VAPB;BAK1;PRKACA
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.2609364460784889,-0.9951157227662301,0.45584725536992843,0.748881338919653,1.0,20/66,23.39%,KAT7;PIK3R1;LIMK2;CDH1;FLNA;TFRC;PRKCD;ORMDL3;EIF2AK3;IPO5;NMD3;TPR;CCT2;FERMT2;ZC3H12A;MEPCE;JUP;DTX3L;DKC1;HCLS1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3340337245983871,-0.9951122462958016,0.4662698412698413,0.7483460808884481,1.0,7/24,15.85%,NOTCH1;CREB3L1;VEGFA;KLF2;MT3;ATF6B;ATF4
prerank,negative regulation of DNA binding (GO:0043392),-0.32132920775093315,-0.9950949178501703,0.4613733905579399,0.747842158936173,1.0,9/28,17.19%,LEF1;NFKBIA;JUN;TNKS;HEY2;SMO;MAD2L2;SP100;HEY1
prerank,mammary gland development (GO:0030879),-0.33957969669085064,-0.9947805233954059,0.4602510460251046,0.7480772598907975,1.0,6/21,13.82%,CAV1;TBX3;ARHGAP35;TGFB3;NOTCH4;VEGFA
prerank,positive regulation of transmembrane transport (GO:0034764),0.4061256887048329,0.9946083945732406,0.47379454926624737,0.9304034217620941,1.0,3/13,11.54%,ACSL1;CLIP3;AZIN2
prerank,establishment of protein localization to organelle (GO:0072594),0.2831757837245195,0.9944212795065046,0.4642233856893543,0.9297886192901439,1.0,17/72,18.36%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3;LAMP2;NXT1;RYR2;IL10RA;IPO8;TNPO2;HK1;IPO4;NUP88;AKT1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.27069477800041036,0.9943425720069475,0.4683760683760684,0.9288388315178996,1.0,24/96,19.97%,MCM3AP;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP
prerank,axonemal dynein complex assembly (GO:0070286),0.33426610789757494,0.9940521519670291,0.44045368620037806,0.9285299552592181,1.0,9/28,26.85%,DNAH1;DNAL1;DRC1;DNAAF2;DNAAF5;DNAAF3;DNAH5;DNAH17;ODAD4
prerank,intracellular protein transport (GO:0006886),0.23130382062038585,0.994051368352665,0.4700460829493088,0.9273389088585308,1.0,68/304,18.93%,RANBP3L;SNX6;TRAK1;APPL2;CTSA;WLS;IPO13;FAM53A;POM121;RAB21;STAM;NAPB;NUP155;CLIP3;COX18;SGSM3;NUP62CL;VPS26C;ARFGAP3;STX16;GGA2;STRADB;TNPO3;RUNDC1;TBC1D9B;KIF13B;NAPA;SNF8;RAB6B;ARL5B;NSF;SEC23IP;LAMP2;NXT1;TMED9;TMED4;SGSM2;IPO8;USO1;SNX8;RAB1A;TBC1D14;AP4M1;TBC1D10B;DESI1;FUT10;GGA1;VPS45;TBC1D16;AKAP6;RAB23;TNPO2;STX4;RAB19;TMED2;RPGR;IPO4;SEC31B;NUP88;SYNDIG1;PICK1;OXA1L;AKT1;HPS4;VPS29;GRTP1;SNX9;RAB38
prerank,dicarboxylic acid metabolic process (GO:0043648),0.294303944215464,0.9926450525648799,0.4308231173380035,0.9302307531998707,1.0,13/52,17.34%,ADHFE1;ALDH1L1;ME2;HAAO;SLC19A1;MTHFS;GOT1;MTHFD1;IDH2;MTHFR;GOT2;FPGS;MTHFD2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3918930300418678,0.9924519526130573,0.45136186770428016,0.9296270531146867,1.0,4/14,10.51%,LPIN1;ETNK2;PCYT2;CHKB
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.3731209618049705,-0.9918199932571828,0.45759368836291914,0.7550820931676158,1.0,2/15,2.44%,YWHAE;GAS6
prerank,alanine transport (GO:0032328),-0.4198712883693634,-0.991694505565486,0.4840085287846482,0.7548450371673797,1.0,1/10,0.35%,SLC6A6
prerank,positive regulation of viral genome replication (GO:0045070),0.33144260110847285,0.9914796981889165,0.46065259117082535,0.9313747061297661,1.0,4/29,7.53%,HACD3;TOP2B;PPARA;IFIT1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3249204268724077,-0.9914755713514489,0.48214285714285715,0.7548760393818537,1.0,11/27,20.35%,TEK;TNFAIP8L3;PRKD1;FLT1;FGF2;PTK2B;IRS1;PIK3R4;FGFR3;NOD2;AGAP2
prerank,early endosome to late endosome transport (GO:0045022),0.3640816226630827,0.9908261601387505,0.47900763358778625,0.9321791651458131,1.0,6/20,17.36%,WDR91;SNX16;KIF16B;SNF8;HOOK1;PTPN23
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.38022225812788973,0.9906369791620767,0.47843137254901963,0.9315733157477738,1.0,1/17,0.50%,LPGAT1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2899021529663717,-0.9905048978716812,0.47139588100686497,0.7569161433810742,1.0,11/44,20.01%,GSN;CDC42EP5;CDC42EP3;NCK1;WHAMM;CDC42EP2;PTK2B;PFN1;NCKAP1L;FCHSD1;HCK
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.426667636941345,0.9903057139900172,0.46123260437375746,0.9313898654293026,1.0,2/10,7.90%,BMP6;PLG
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.31054531099139826,-0.9902407893200799,0.4853273137697517,0.7569741678288279,1.0,11/30,24.43%,EIF3H;UBXN1;USP7;BAG5;N4BP1;RYBP;UCHL5;FHIT;GIPC1;TAF9;SVIP
prerank,regulation of secretion by cell (GO:1903530),0.2958567626778494,0.9901516913582155,0.44501718213058417,0.93066844707815,1.0,19/54,20.07%,SNCAIP;RAB21;SYT1;RAB3C;LLGL2;STXBP5L;RIMS1;NSF;LLGL1;CPLANE2;RAB13;CPLX1;SYN1;STX4;HTR1A;CPLX2;RHBDF1;SCG5;RAB15
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.27870261332740265,0.9901049029577667,0.4676258992805755,0.9296568890693703,1.0,22/74,18.36%,EYA1;IGF1;HSPA1A;EYA4;EYA2;SIAH2;PELI3;HTT;PHIP;TGFBR1;CFLAR;BCL2;FAIM;TERT;SCG2;HSPA1B;NOL3;FAIM2;RELA;IL1A;TCF7L2;AKT1
prerank,ubiquinone metabolic process (GO:0006743),0.38890913575791924,0.9900615815179088,0.4619883040935672,0.9285929220136011,1.0,6/15,20.55%,COQ10A;COQ8B;AIFM2;COQ7;COQ3;FDXR
prerank,regulation of phagocytosis (GO:0050764),-0.2738759003681874,-0.9899130064858237,0.45154185022026433,0.7572688383811207,1.0,12/53,13.63%,SCARB1;MERTK;GAS6;PLSCR1;RACK1;TGM2;DOCK2;GATA2;IL15;DYSF;RAB27A;PTPRC
prerank,positive regulation of ruffle assembly (GO:1900029),-0.39546511331224177,-0.9897818894959847,0.4684873949579832,0.7570430200315258,1.0,3/13,13.07%,EPS8;EPS8L2;PFN1
prerank,JNK cascade (GO:0007254),-0.29427285658018043,-0.9896867124611807,0.48081264108352145,0.7567485455249422,1.0,13/40,22.59%,MAP3K5;UBC;NOD1;RPS27A;UBB;TNFRSF19;IRAK2;TAB1;GPS1;NOD2;MAP2K7;RIPK2;MAP4K3
prerank,regulation of mRNA processing (GO:0050684),0.3246088312593511,0.9896083470158147,0.4727954971857411,0.928763281690483,1.0,13/32,26.13%,PABPN1;SLTM;SRSF10;SON;TIA1;YTHDC1;SAFB2;SAFB;LARP7;SRPK1;AHCYL1;JMJD6;ZFP36L1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.3820020088871393,-0.9892367030455561,0.5071574642126789,0.757316636831491,1.0,4/14,14.71%,FOXO3;FASTKD1;EARS2;MRPL12
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.2997560753171555,-0.9891113422419948,0.47558386411889597,0.7570894385034485,1.0,6/36,10.47%,MECOM;FOXO1;PPIA;AIDA;DUSP3;PER1
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3019001952149003,-0.9890909688916654,0.4572025052192067,0.7565954925777552,1.0,14/35,23.61%,DAB2IP;MFHAS1;XDH;PER1;PHLPP1;BMP2;VEGFA;RELL1;ZC3H12A;SPI1;MAP3K4;DUSP1;CYLD;PRMT1
prerank,spinal cord development (GO:0021510),-0.38841765816929974,-0.9889988153812337,0.4536290322580645,0.7562884390304013,1.0,5/12,22.65%,VIT;PKD1;SOX12;DLL1;SOX11
prerank,blood vessel endothelial cell migration (GO:0043534),0.3571142490807745,0.9889697477005565,0.44597249508840864,0.9294933954992647,1.0,3/22,2.36%,ROBO1;EFNB2;PIK3R3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2697270208292659,-0.9886977378306988,0.48068669527896996,0.756470304191013,1.0,11/63,8.77%,CAV1;ITGA6;ACVR1;TNFSF10;THBS1;BMP4;FAS;PAK2;AR;FEM1B;SRC
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.340129942705737,0.9883557458551376,0.4605263157894737,0.9301140669372506,1.0,10/30,18.92%,DAB2;DDX5;PRMT2;RNF14;RNF6;SAFB2;SIRT1;NCOR2;KDM1A;NCOR1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3453565754572801,-0.9883518126965495,0.46028513238289204,0.7567956865160651,1.0,4/20,6.06%,CRY1;STMN1;YWHAB;MET
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.25839856062974814,-0.9883490651725586,0.49078341013824883,0.7562548793921539,1.0,20/70,23.25%,B2M;VAMP3;ITGB5;TAP2;PSMA6;PSMB7;PSMB6;NCF2;PSMB5;LNPEP;PSMB8;PSMC4;PSMD11;SNAP23;PSMB4;PSMD14;PSMD10;PSME1;FCGR1A;PSMB3
prerank,maturation of LSU-rRNA (GO:0000470),0.34333861094739704,0.9883047332070705,0.45864661654135336,0.9290910524551045,1.0,1/26,0.08%,NSA2
prerank,mitotic cytokinetic process (GO:1902410),-0.34872018990695136,-0.9877772212852476,0.4660831509846827,0.7571862441140229,1.0,4/20,6.92%,RHOA;CHMP2B;CHMP4B;CHMP4A
prerank,positive regulation of mRNA processing (GO:0050685),-0.33875577436250914,-0.9877046582485283,0.4661508704061896,0.7568286989009841,1.0,9/21,25.86%,RBM3;PRDX6;PAF1;NCBP2;NCBP1;NCL;SNW1;TRA2B;DAZAP1
prerank,regulation of centrosome duplication (GO:0010824),-0.3140160606465524,-0.9873599269049831,0.5053304904051172,0.7571273152371492,1.0,12/30,27.41%,CHMP2B;PLK2;CHMP4B;CEP76;STIL;CEP295;CCNF;CHMP1B;FBXW5;CEP131;XRCC3;CENPJ
prerank,regulation of cellular pH (GO:0030641),-0.3217292057564774,-0.9871546767626004,0.47717842323651455,0.7570970020314922,1.0,6/29,14.88%,SLC4A10;SLC9A2;ATP5F1B;SLC26A6;SLC9B1;CA2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.30211293325433575,0.9871241979908719,0.4828828828828829,0.9313214328308372,1.0,9/48,8.98%,ADCY5;ADCY1;SLC26A1;PANK1;ACAT1;ADCY8;PANK2;AK5;AMPD3
prerank,actin nucleation (GO:0045010),-0.3490380929338013,-0.9869235768258198,0.4803312629399586,0.7571269139224355,1.0,10/21,34.03%,WHAMM;JMY;ARPC2;ARPC3;ACTR3;ARPC1B;ARPC1A;SPIRE2;SCIN;ARPC5
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.3030717586724516,-0.9862653125067185,0.4747252747252747,0.7582720709670554,1.0,13/33,22.53%,SLC39A8;GLS;GCLC;DDAH1;GCLM;ALDH18A1;GLUD1;ALDH5A1;CAD;PRODH;PYCR3;DDAH2;GGT1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.31103877010877284,-0.9862156073406975,0.4820627802690583,0.7578549358918167,1.0,6/28,12.57%,PIK3R1;CDH1;FLNA;PRKCD;IPO5;TPR
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3512469437800337,-0.9861353471131394,0.4811715481171548,0.7575239286486466,1.0,3/18,5.64%,UBC;RPS27A;UBB
prerank,cellular response to acid chemical (GO:0071229),-0.3209041150496354,-0.9855374966257049,0.47468354430379744,0.758519038922659,1.0,10/27,14.92%,SH3BP4;CAPN2;SPAAR;RPTOR;NSMF;IPO5;RRAGA;VEGFA;KLF2;GLRA2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4421173630520675,0.9854530818839716,0.5050505050505051,0.9350798878868477,1.0,2/10,3.24%,CDH3;FURIN
prerank,regulation of muscle cell differentiation (GO:0051147),-0.30902731376831455,-0.9849700722392156,0.4935064935064935,0.7594318580282885,1.0,10/31,20.11%,MEF2C;BOC;CTNNA1;HDAC9;IGF2;MYOCD;CDH2;ID2;MAPK12;CDC42
prerank,cellular response to alkaloid (GO:0071312),0.3789689424295817,0.9847568904034556,0.4714548802946593,0.9359112938848722,1.0,4/17,11.04%,TRPV1;CASP3;GSTM2;RYR2
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.30822683324469347,-0.9844926685693951,0.4805194805194805,0.7595578934927182,1.0,11/31,26.40%,GTF2H5;GTF2F1;GTF2H1;NCBP2;ERCC2;NCBP1;POLR2I;CCNH;CMTR2;POLR2F;POLR2H
prerank,7-methylguanosine RNA capping (GO:0009452),-0.30822683324469347,-0.9844926685693951,0.4805194805194805,0.7595578934927182,1.0,11/31,26.40%,GTF2H5;GTF2F1;GTF2H1;NCBP2;ERCC2;NCBP1;POLR2I;CCNH;CMTR2;POLR2F;POLR2H
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3935796381598652,0.9842360346055783,0.48927875243664715,0.9363032297587512,1.0,2/14,4.92%,IL18;EBI3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.31155127646421643,-0.9840833998843632,0.4820295983086681,0.7600854155871776,1.0,17/30,32.90%,UBC;RPS27A;UBB;UBE2D3;BIRC3;CD40;RIPK1;TICAM1;CASP8;TLR4;CD300LF;FADD;IRF3;TLR6;CD14;IKBKB;TLR3
prerank,epithelial cell-cell adhesion (GO:0090136),-0.40075896770037883,-0.9840251259531649,0.47638603696098564,0.7596817561520249,1.0,7/11,24.28%,VCL;CCN3;ITGB5;SERPINB8;DSP;JUP;THBS4
prerank,negative regulation of kinase activity (GO:0033673),0.28212192330524827,0.9840246858493132,0.4691780821917808,0.9357603432618921,1.0,5/62,6.70%,PRKAG2;DEPTOR;HNRNPU;WWTR1;PDPK1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.29755269124403555,-0.9840024555569502,0.47045951859956237,0.7591981009671306,1.0,11/36,17.95%,ENG;RASSF2;RAP2A;CALM3;PPP2R5C;PDGFC;PDGFD;ENPP1;VEGFA;TNKS1BP1;NBN
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3821958855268897,-0.9838834319710011,0.4762886597938144,0.7589566841249078,1.0,3/13,4.88%,CAV1;NEDD4L;CAB39
prerank,ureteric bud morphogenesis (GO:0060675),-0.37036519320208144,-0.9837034488554062,0.48434237995824636,0.7589199215635998,1.0,4/16,12.38%,BMP4;SIX1;FGF2;BMP2
prerank,negative regulation of lyase activity (GO:0051350),0.3858663461998776,0.9826861175957028,0.4952015355086372,0.9384501788782151,1.0,4/16,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,response to amino acid starvation (GO:1990928),0.28106840705694536,0.9824459812833334,0.4725663716814159,0.9379582484665042,1.0,17/72,15.20%,RNF152;NPRL3;RRAGC;ATP6V0B;ATP6V1H;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1;LAMTOR2;ATP6V0E2;ATP6V1C1;ATP6V0D2;NPRL2;LAMTOR3
prerank,endodermal cell fate commitment (GO:0001711),0.4343948076142985,0.9822008452785006,0.47775628626692457,0.9375072010191491,1.0,3/10,11.83%,CTR9;LEO1;CDC73
prerank,apoptotic mitochondrial changes (GO:0008637),0.322873563985069,0.9821348218809681,0.46715328467153283,0.9365183303882417,1.0,10/32,20.76%,IFIT2;CCAR2;FZD9;NDUFS1;BCL2;CLU;AIFM2;ATP2A1;DNM1L;BAX
prerank,regulation of spindle assembly (GO:0090169),0.33993467057049337,0.9820291977910529,0.48554913294797686,0.9356766304616511,1.0,8/25,16.50%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;SPAG5;CHMP1A
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.34140168242619096,0.9818466853026335,0.4843462246777164,0.9350461013581446,1.0,9/25,17.41%,HSPA1A;ABCB10;MED1;MAPK14;STAT1;ARNT;HSPA1B;PRKDC;STAT5B
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.3687881140423817,-0.9812559409522177,0.4826254826254826,0.7645763035591319,1.0,5/15,14.72%,CDC27;HECW2;CDC16;TPR;PTTG1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.3954894426462354,-0.9812305011552522,0.49056603773584906,0.7640977590311054,1.0,5/13,18.85%,NOS3;GLS;DDAH1;GLUD1;PRODH
prerank,peripheral nervous system development (GO:0007422),-0.33073761162913223,-0.981165508894858,0.491701244813278,0.7637344622130917,1.0,6/23,19.58%,ADGRG6;NGF;GPC1;PMP22;NFASC;SOX8
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3839890076770751,-0.9810448271795017,0.46356275303643724,0.7635041958158179,1.0,4/13,17.10%,NFU1;GLRX3;BOLA2;ISCA2
prerank,regulation of vacuole organization (GO:0044088),0.36553685022748983,0.981005263113972,0.47701149425287354,0.9363734013838715,1.0,11/20,26.50%,NPRL3;ENO1;ENO4;TBC1D14;NPRL2;ANXA2;ADPRH;PIKFYVE;IFT20;MTM1;ENO3
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.393078339083564,0.9808897139083944,0.4933078393881453,0.9355677023229689,1.0,5/15,12.34%,SPHK1;SMPD3;ORMDL2;SMPD2;SPHK2
prerank,phospholipid biosynthetic process (GO:0008654),-0.2951711220678393,-0.9807800566747822,0.5069124423963134,0.7636327782767018,1.0,5/36,4.99%,SGMS1;SGMS2;MBOAT1;AGK;CPNE3
prerank,sensory perception of light stimulus (GO:0050953),0.2705651717309117,0.9807010176194839,0.48247078464106846,0.9349483001408315,1.0,23/87,22.60%,USH1C;GPR143;EYA4;WHRN;EML2;ARR3;PAX6;PCDH15;CHRNB2;ADGRV1;ZIC2;RABGGTB;CRYBB1;RPGR;GRM8;OPA3;CABP4;CNGB1;MYO9A;RDH12;BBS2;PITPNA;CLRN1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4210152125703366,0.9806747091983788,0.4891518737672584,0.9327030122838317,1.0,1/12,1.69%,FHL2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4210152125703366,0.9806747091983788,0.4891518737672584,0.9327030122838317,1.0,1/12,1.69%,FHL2
prerank,regulation of TOR signaling (GO:0032006),0.2773433047201921,0.9805125943114401,0.4940374787052811,0.9320043527643359,1.0,25/67,24.50%,PRKAA2;NPRL3;RRAGC;RICTOR;DEPTOR;SLC38A9;PIH1D1;FBXO9;LAMTOR2;TSC1;NPRL2;LAMTOR3;SIRT1;TELO2;RRAGB;FNIP1;PDCD6;MLST8;LAMTOR1;TMEM127;EPM2A;ARAF;TTI1;GPAT3;UBR2
prerank,dendritic spine organization (GO:0097061),-0.32187354384277483,-0.9804581492938215,0.4957805907172996,0.7638944024058723,1.0,3/26,2.11%,SHANK3;DOCK10;INSR
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.34482023971076764,0.9802811449783952,0.46983546617915906,0.9315614807412002,1.0,12/22,27.51%,ANK2;GSTM2;HTT;RYR2;GSTO1;AKAP6;ATP2A1;STAC3;VMP1;SLC9A1;HAP1;STAC2
prerank,protein O-linked glycosylation (GO:0006493),0.2634991179727304,0.9802632909697001,0.48509933774834435,0.9304586334220458,1.0,20/96,15.98%,GXYLT2;TRAK1;CHST4;MUC19;ST3GAL3;TMTC4;GALNT11;GALNT14;TET1;LARGE1;GALNT12;GALNT3;FKTN;GALNT2;B3GLCT;DPM1;GALNT1;CRPPA;MUC1;TET2
prerank,proteasome assembly (GO:0043248),-0.39936984557421507,-0.9801289294936516,0.46830265848670755,0.7641862385386146,1.0,4/11,21.90%,PSMD11;ADRM1;PSMD10;PSMG1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.27044639568159856,-0.9800920097014159,0.5,0.7637477635681659,1.0,21/56,26.98%,SPTBN1;RHOA;STMN1;SNX18;CIT;CHMP4B;APC;KIF23;DCTN3;INCENP;IST1;NUSAP1;RHOB;RAB35;ROCK1;RASA1;ALKBH4;KIF4A;JTB;CEP55;RTKN
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3610885869386704,-0.9800435128396489,0.4732334047109208,0.7633170969848976,1.0,10/17,38.15%,CXCL12;SERPINE1;HMGB1;PLA2G7;CCR2;ANO6;AIF1;CXCL17;CCL5;CCR1
prerank,negative regulation of dephosphorylation (GO:0035305),0.3636115032992797,0.9800420987563947,0.46494464944649444,0.9299568346175588,1.0,2/18,2.54%,SH3RF2;SH2D4A
prerank,regulation of cytoskeleton organization (GO:0051493),-0.2405294140440521,-0.9797144866116864,0.4739583333333333,0.7636500117954427,1.0,30/108,23.36%,RHOBTB1;TJP1;RHOA;CLIC4;PHLDB1;IQGAP1;F11R;PHLDB2;CAPN2;PAK2;PRKCD;ARHGAP35;MAPK1;EFNA5;FAM107A;HIP1R;RND3;LRP1;BICD2;TRAF3IP1;TAOK1;RHOBTB3;MAPK3;ARHGEF5;RHOB;RAC3;ROCK1;RND2;CYLD;MAP6D1
prerank,regulation of urine volume (GO:0035809),0.4200222020424226,0.9795836705010059,0.49203187250996017,0.9301318899306011,1.0,3/10,20.59%,NPR3;ADCY6;INPP5K
prerank,negative regulation of lipid storage (GO:0010888),0.3585438014694696,0.979460715193038,0.47358490566037736,0.929358964436427,1.0,4/19,9.10%,OSBPL8;PPARA;ABHD5;NR1H3
prerank,regulation of fibrinolysis (GO:0051917),-0.38335666517143663,-0.9793896256894224,0.4888888888888889,0.7639053147659581,1.0,3/13,9.35%,FAP;THBS1;SERPINE1
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.2630970461210676,-0.9792348930634877,0.46774193548387094,0.7637685551136757,1.0,27/68,33.08%,STAT3;APP;PLCG2;ARHGEF2;WNT5A;IL6R;TWIST1;CD74;IFIH1;NOD2;IL33;HMGB1;MYD88;SYK;BCL10;PTPN11;TLR4;F2R;AIF1;TMEM106A;TLR6;LGALS9;TLR1;NOS2;TSLP;TLR3;TYROBP
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3308701564175408,-0.9791784671079636,0.480083857442348,0.7633668598762839,1.0,8/23,16.95%,ELOVL7;FAR2;ELOVL5;ACSL5;ELOVL6;ACSL3;ELOVL1;ACSL4
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.379929486551361,-0.9788906300943494,0.4926315789473684,0.7635788579227751,1.0,3/14,9.96%,GAS6;CARD16;CCDC3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.35430209402525986,0.9786271467759589,0.4770992366412214,0.9306620119159061,1.0,2/23,1.77%,IGF1;PRKAA2
prerank,mitochondrial protein processing (GO:0034982),0.40908883908678517,0.9785831149696773,0.4762886597938144,0.9296665907404311,1.0,2/11,5.63%,AFG3L2;IMMP1L
prerank,cellular response to reactive oxygen species (GO:0034614),-0.2709125852467074,-0.9781872549519655,0.5067264573991032,0.764853151758639,1.0,11/59,7.89%,NET1;MAP3K5;EGFR;CYP1B1;PTPRK;JUN;ANXA1;PRKCD;PXN;MAPK1;RPS3
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.29932005239123954,0.978146727338008,0.5018382352941176,0.9297947447946298,1.0,16/46,18.53%,IGF1;IL18;OGN;IGFBP3;NOX1;NDRG4;VIP;STAT1;MFN2;PRKDC;IL6;RBPMS2;TCF7L2;AKT1;IL12A;CX3CL1
prerank,cellular response to fatty acid (GO:0071398),-0.394723923407465,-0.978069281224148,0.49897750511247446,0.7646267281633213,1.0,4/12,19.09%,PID1;IRS1;NR1H4;ZC3H12A
prerank,cognition (GO:0050890),-0.2881457947115951,-0.9779698868558744,0.4875283446712018,0.7643622174888652,1.0,8/42,12.19%,ST3GAL4;SHROOM4;APP;CHMP2B;NIPBL;STRA6;FAM107A;MFSD2A
prerank,dendrite morphogenesis (GO:0048813),-0.29972548129974075,-0.9772414734495275,0.5064935064935064,0.7657305506794021,1.0,7/35,10.33%,SHANK3;FARP1;DOCK10;PTN;KLF7;BTBD3;EPHB2
prerank,receptor clustering (GO:0043113),0.3399034276365774,0.9771111977319414,0.4820415879017013,0.931577633265652,1.0,8/27,17.82%,MAGI2;DLG1;LRP4;DLG4;ITGB7;LRRC7;DNAJA3;PICK1
prerank,endoplasmic reticulum organization (GO:0007029),-0.2554363208941995,-0.9763841761607367,0.5150812064965197,0.7674100189470411,1.0,26/72,25.26%,ATL3;APP;LMAN2L;STX1A;SEC16B;EIF2AK3;CAV2;SEC31A;SEC61A1;SHTN1;REEP3;REEP5;VAPB;UBE2J2;RTN4;TOR1AIP2;RTN3;WDR83OS;REEP1;STX5;GAK;LPCAT3;DOP1B;TLE6;REEP2;VAPA
prerank,regulation of mitotic nuclear division (GO:0007088),0.28887222934337886,0.9762003706496585,0.46880570409982175,0.9329783234876492,1.0,7/55,9.15%,BMP7;IGF1;OBSL1;CDC25C;TOM1L2;DRD3;PHIP
prerank,smooth muscle contraction (GO:0006939),-0.37666828391494306,-0.976142193079333,0.5030800821355236,0.7675255796512069,1.0,5/14,8.19%,EDNRA;SMTN;PIK3C2A;ACTA2;MYH11
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.23902834405509715,-0.9760623365955283,0.5248756218905473,0.7666401063268031,1.0,28/104,23.25%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMA6;PSMB7;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMB8;TAB1;PSMC4;PSMD11;PRKACA;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;BCL10;PSMB3
prerank,cellular response to lectin (GO:1990858),-0.23902834405509715,-0.9760623365955283,0.5248756218905473,0.7666401063268031,1.0,28/104,23.25%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMA6;PSMB7;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMB8;TAB1;PSMC4;PSMD11;PRKACA;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;BCL10;PSMB3
prerank,regulation of sensory perception of pain (GO:0051930),-0.4013726537344561,-0.9758111509683619,0.52046783625731,0.7667346185613404,1.0,6/11,25.72%,CCN3;MGLL;TMEM100;ATPSCKMT;ACP3;F2R
prerank,endosome organization (GO:0007032),-0.2895409909263677,-0.9756641332112178,0.4855072463768116,0.7665783599691646,1.0,8/41,12.78%,CORO1C;WASHC4;CHMP2B;ALS2CL;RAB22A;SQSTM1;SNX10;RAB27A
prerank,establishment of protein localization to membrane (GO:0090150),0.2827238726668712,0.9756550183458291,0.48484848484848486,0.9333821575822265,1.0,9/66,9.20%,AFDN;SYNE3;MICALL1;ZDHHC12;RAB3GAP1;COX18;PRKCI;ZDHHC24;ZDHHC1
prerank,axon extension (GO:0048675),-0.3302948625751731,-0.9756026662040195,0.4891304347826087,0.7661922862568153,1.0,11/23,21.38%,NRP1;NRP2;SLIT2;CDK5;SEMA5B;MAP1B;SEMA5A;ULK2;SLIT1;SLIT3;SEMA3F
prerank,double-strand break repair (GO:0006302),0.24377648669395074,0.9754586529033074,0.49128367670364503,0.9328521505355899,1.0,33/158,18.14%,EYA1;PAXX;POLM;ERCC1;RECQL4;XRCC1;ACTR8;AUNIP;TENT4A;ABRAXAS1;MEIOB;EME2;KAT5;KDM2A;ZFYVE26;TDP2;MDC1;MRE11;PRPF19;KDM4A;CHEK2;PIAS4;RAD51D;RNF138;PRKDC;RPA3;ATM;AP5Z1;RAD52;POLN;XRCC2;APBB1;NHEJ1
prerank,vesicle transport along microtubule (GO:0047496),0.3469205372371514,0.9753253289685428,0.47591522157996147,0.932103212088312,1.0,8/23,19.57%,TRAK1;FYCO1;HTT;KIF3A;RAB1A;KIF3B;KIF1A;NDE1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4081596910353257,-0.975322075584249,0.5088408644400786,0.7663623546810985,1.0,4/10,16.87%,CSGALNACT1;XYLT1;B3GAT1;B3GAT3
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3420697619754781,-0.974932135146922,0.4780701754385965,0.7668080165643577,1.0,2/19,1.66%,PARD3;CLIC4
prerank,regulation of presynapse organization (GO:0099174),0.3672255272229997,0.9743653341745446,0.5020661157024794,0.9326133450261765,1.0,4/18,8.56%,IL1RAPL1;WNT7A;IL1RAPL2;PTPRD
prerank,regulation of presynapse assembly (GO:1905606),0.3672255272229997,0.9743653341745446,0.5020661157024794,0.9326133450261765,1.0,4/18,8.56%,IL1RAPL1;WNT7A;IL1RAPL2;PTPRD
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.383438742979057,-0.974243025324896,0.49794238683127573,0.7679948856419445,1.0,6/13,21.54%,RPS15;ABCE1;NMD3;LTV1;SDAD1;RRS1
prerank,phospholipid catabolic process (GO:0009395),-0.32888380471620704,-0.9742196921267794,0.5042918454935622,0.7675167908592134,1.0,4/24,14.67%,PLA2G4A;GPCPD1;PRDX6;SMPDL3A
prerank,protein autophosphorylation (GO:0046777),-0.22684135352319512,-0.9741429635231286,0.5335120643431636,0.7671632729103993,1.0,40/157,20.01%,TEK;INSR;PEAK1;EGFR;EEF2K;KDR;BMX;TNIK;CAMK2D;PAK2;TEC;PRKD1;ERN1;LYN;FLT1;PRKX;STK24;SRC;FLT4;EIF2AK3;STK33;MAPKAPK2;GRK5;STK10;DYRK1A;PTK2B;STK16;ALK;CSF1R;MKNK2;TAOK3;CAD;FGFR3;TAOK1;STK26;MAPK3;MARK3;STK17B;RIPK1;HCK
prerank,histone H3 acetylation (GO:0043966),-0.2927080982494773,-0.9741255415286147,0.5128755364806867,0.7666784675065998,1.0,10/40,16.91%,LEF1;KAT7;KAT6A;TRIM16;PER1;JADE2;TAF5L;BRCA2;BRPF3;ING4
prerank,response to exogenous dsRNA (GO:0043330),-0.3413390432823664,-0.9741190088896651,0.5010438413361169,0.7661616377823917,1.0,4/18,4.57%,CAV1;RFTN1;IRAK3;RALB
prerank,iron-sulfur cluster assembly (GO:0016226),-0.327251652670475,-0.973724923310326,0.4742063492063492,0.76660027450508,1.0,8/24,17.40%,NUBPL;NFU1;HSCB;NFS1;GLRX3;BOLA2;ISCA2;NUBP1
prerank,ear morphogenesis (GO:0042471),0.3556790824016078,0.9730758722463793,0.4903100775193798,0.9352487658818625,1.0,3/20,6.95%,OSR1;USH1C;FGFR2
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.21919721846737653,-0.9729292197356117,0.5126050420168067,0.7680894636440573,1.0,40/198,15.95%,PTPRB;PLCB4;PLCE1;PLA2G4A;PIP4K2A;INPP4A;LIMD1;LIMK2;PLCG1;STAT3;ALPL;AGK;PLCG2;PANK3;TNFAIP8L3;PAK2;INPP5D;PPP3CA;ALDOA;PRKCG;PIK3CA;PLPP1;CDK5;PPP1CA;PFKL;DUSP3;BCKDK;EPHB2;PIK3CD;GFPT2;DUSP23;AGPAT1;PTPRC;ENPP1;ALK;PLPP3;THNSL2;IPMK;NT5C;ACYP1
prerank,icosanoid secretion (GO:0032309),-0.3913447856263554,-0.972820090295215,0.4930966469428008,0.767851435078797,1.0,2/12,6.64%,ABCC4;ANXA1
prerank,cell part morphogenesis (GO:0032990),-0.38219083293516115,-0.9727944465644883,0.49803149606299213,0.7673704825755541,1.0,3/13,8.00%,PID1;MFF;NUBPL
prerank,protein kinase B signaling (GO:0043491),0.351525795008,0.9724610273134165,0.49427480916030536,0.9359325548609398,1.0,2/23,2.36%,IGF1;PIK3R3
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.2181394908579288,-0.9722206858595468,0.5349462365591398,0.7682993946681866,1.0,62/185,27.86%,YWHAE;CDC27;PKD1;HECW2;UBC;DYNC1I2;ANAPC5;CSNK1E;RPS27A;XPC;UBB;PSMA6;PSMB7;CDC16;TUBA1A;PSMB6;CEP76;PSMB5;FBXO5;DCTN3;ERCC2;ODF2;DYNLL1;FZR1;PSMB8;CCP110;ZW10;PSMC4;PRKAR2B;PSMD11;PAFAH1B1;ID2;PRKACA;PSMB4;DYNC1H1;PSMD14;PTPN6;CDC26;PSMD10;CSNK1D;DCTN1;PSME1;CEP41;TPX2;TUBA4A;CEP131;PSMB3;CDC23;CDK5RAP2;CUL3;RGCC;CEP152;HMMR;KIF14;ZFP36L2;AKAP9;ACTR1A;CUL1;CDK2;CENPJ;ANAPC1;CNTRL
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.34680495485417123,0.9713245153362036,0.4805447470817121,0.9380702071986962,1.0,5/22,8.73%,CACNB1;CACNB3;CRHR1;GNB5;DRD3
prerank,negative regulation of cell communication (GO:0010648),-0.3388004151189978,-0.9712571242539296,0.49290060851926976,0.770133553373366,1.0,5/21,9.54%,ACVR1;UBASH3B;HHIP;PTPN1;SOCS5
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.3490955044716687,0.9712306114251342,0.4806201550387597,0.9371970651321593,1.0,2/22,6.93%,BMP7;FLOT2
prerank,cellular response to pH (GO:0071467),0.36897958084626054,0.9711372493016585,0.5009940357852882,0.9363251014920451,1.0,4/17,13.36%,TRPV1;IMPACT;KCNK4;HYAL1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2577094844459204,-0.9710330453912008,0.49878934624697335,0.7701718156775549,1.0,13/76,9.91%,DAB2IP;TMSB4X;CD200;CYP1B1;PTGIS;NFKBIA;IRAK3;TRIM37;AIM2;NLRC5;DAP;USP7;KLF4
prerank,regulation of protein modification process (GO:0031399),-0.2683668143279859,-0.9710233327648211,0.5010940919037199,0.769659825853951,1.0,10/50,11.50%,CORO1C;FN1;FNIP2;SPRED2;LYN;PPP1R16B;HPF1;IGF2;PARG;HSPB1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.23750853220887996,-0.9709642600263096,0.5314861460957179,0.769260091011429,1.0,28/105,23.25%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMA6;PSMB7;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMB8;TAB1;PSMC4;PSMD11;PRKACA;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;BCL10;PSMB3
prerank,cardiolipin metabolic process (GO:0032048),-0.3761531216248416,-0.9704630765494309,0.504149377593361,0.769972947743286,1.0,4/13,17.92%,PLA2G4A;PTPMT1;PLA2G6;TAMM41
prerank,sodium ion import across plasma membrane (GO:0098719),0.37253791520635465,0.9703524134670606,0.49902152641878667,0.9374591205959257,1.0,1/17,0.21%,SLC6A1
prerank,regulation of gluconeogenesis (GO:0006111),0.33071319175522806,0.969956995551313,0.4714828897338403,0.9374658629572353,1.0,6/27,16.17%,GCK;C1QTNF3;PDK2;PPARGC1A;SIRT1;CLK2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.36967789626461245,-0.9697911941716825,0.5094339622641509,0.7712093131995794,1.0,7/15,17.41%,DCN;CSGALNACT1;CSPG4;VCAN;BGN;B3GAT3;NCAN
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.4000460762301936,0.9696730887955594,0.4573170731707317,0.9371499520333328,1.0,4/12,12.04%,HNRNPU;PCGF5;YTHDC1;RLIM
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2816519573030443,-0.9693630969565799,0.4879120879120879,0.7717419077943802,1.0,10/49,15.24%,SGMS1;CAV1;BCL2L1;RACK1;BCAP31;SRC;EIF2AK3;PTPMT1;BBC3;PLAUR
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3181715226567837,-0.9687964975647664,0.48008849557522126,0.7726381275281565,1.0,6/26,20.34%,CAV1;MFHAS1;IFI35;RSAD2;RTN4;HMGB1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.38782811806373607,0.9686799094347461,0.4866412213740458,0.9388918073704149,1.0,4/13,11.47%,NUPR1;NR1H3;USP19;CLU
prerank,regulation of blood circulation (GO:1903522),-0.29653362560161844,-0.9686580568509622,0.5021551724137931,0.7724372756725184,1.0,10/34,18.76%,ECE1;CAMK2D;AGTR1;KCNMB2;KCNQ1;KCNJ12;ACE2;TBX2;PLN;CACNA1H
prerank,plasma membrane tubulation (GO:0097320),-0.3854955140566748,-0.9686577739314135,0.5049115913555993,0.771904330515488,1.0,5/13,12.00%,CAVIN2;CHMP4A;WHAMM;EHD2;FNBP1L
prerank,ncRNA metabolic process (GO:0034660),0.30786212052710993,0.9680489421877462,0.50187265917603,0.9396815146876172,1.0,7/37,13.90%,DTD1;TDRD9;TRIM71;DDX17;BCDIN3D;TUT4;DICER1
prerank,gastrulation (GO:0007369),-0.361848295175376,-0.9679384350865762,0.4699792960662526,0.773163062726154,1.0,3/15,14.11%,LRP5;LMBRD1;TASOR
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.35177371342799235,0.9678992979403631,0.49906191369606,0.9389842407789817,1.0,5/21,17.21%,OSBPL8;PLA1A;OSBPL5;PLAAT3;OSBPL10
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.26339226330173665,0.9675943374897052,0.49835526315789475,0.9387559307982388,1.0,7/87,3.11%,NOTCH2;ROCK2;PDGFRA;RICTOR;BAIAP2;RHOBTB2;CELSR1
prerank,negative regulation of histone methylation (GO:0031061),0.42279480397370833,0.9675232259884698,0.48902195608782434,0.9378470159555317,1.0,4/10,17.55%,JARID2;PHF1;MTF2;KDM1A
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.21413532568352078,0.9674861349848847,0.5674232309746329,0.9368285784411149,1.0,120/572,19.24%,PRDM6;AEBP1;WWOX;BMP6;DAB2;HSPA1A;DDX5;CBX7;SMAD3;KCNIP3;KMT5A;OSR1;NR2E1;MAGEA2;MSX2;CXXC5;CTR9;FHL2;THRB;SUFU;SCRT1;NR6A1;ZNF431;PCGF2;PPARA;GLIS3;ENO1;ZHX1;IFI27;DLG1;PEG3;PAX6;RBPJ;PLK1;MZF1;DNMT3A;HNRNPU;HOXA7;ZKSCAN3;E2F1;ATN1;MOSPD1;FGFR2;KAT5;NR2F2;CHD3;MIER3;IMPACT;MED1;MAX;DMAP1;NR1H3;E2F8;MED25;NKAP;RXRA;CBX6;ZFP90;PRDM2;C1QBP;NSD1;FOXP4;LDB2;LDB1;RITA1;LCOR;STAT1;FST;TAF1;MXI1;GATAD2A;CDC73;SOX9;BEND3;BHLHE41;JAZF1;SMYD2;HDAC4;NOC2L;CTBP2;FOXC1;MEN1;DICER1;TBL1XR1;BCL11A;PER2;HEXIM2;ERF;GADD45A;SIRT1;TENM2;RARA;NCOR2;MDM2;MDFI;DNAJA3;CITED2;IRF8;RELA;MTF2;KDM1A;USP9X;TCF7L2;TCF25;FNIP1;HDGF;APBB1;ARID5B;PCGF1;MLX;MITF;IRF2BP2;NFKB1;POU6F1;NCOR1;MEF2A;SOX2;LIN37;CPEB3;SIN3A
prerank,sterol homeostasis (GO:0055092),-0.26348905324553823,-0.9674803281575989,0.5035460992907801,0.7737343969228028,1.0,13/65,11.15%,CYP7B1;CAV1;SCARB1;LRP5;ABCA1;CYP39A1;NPC2;TTC39B;MTTP;HDAC9;APOE;INSIG1;LIMA1
prerank,smoothened signaling pathway (GO:0007224),-0.30067162772126055,-0.967063949484185,0.5045454545454545,0.7742359878705499,1.0,12/32,20.93%,HIPK1;GLI3;ARL13B;TCTN3;PTCH1;SMO;PTCH2;EVC2;STIL;IFT27;DISP3;DYRK2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.25900739124490824,-0.9668424208271755,0.5261845386533666,0.7742641284312902,1.0,18/70,21.47%,TCF12;LMO2;RUNX1;PSMA6;PSMB7;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;METTL3;PSMD10;PSME1
prerank,protein deacetylation (GO:0006476),-0.28970928082079783,-0.9668382079958701,0.5121359223300971,0.7737396051572296,1.0,14/41,23.64%,MIER1;FLNA;PRDM5;HDAC7;HDAC9;SIRT5;MTA1;HDAC6;HDAC2;MIER2;MTA3;SIRT7;MSL3;SIRT6
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.41857053892538176,0.9665224444468172,0.4968553459119497,0.9384928683449819,1.0,3/10,11.20%,RUVBL2;PIH1D2;PIH1D1
prerank,response to calcium ion (GO:0051592),0.2574359993462867,0.9664898769311198,0.5081699346405228,0.9374770116755781,1.0,18/102,12.06%,SYT11;SYT12;PRKAA2;CPNE1;CAPN3;SYT9;ADCY1;CPNE4;PPIF;SYT1;ADCY8;SYT13;ADGRV1;SLC25A12;SYT10;RYR2;TRPM2;CPNE6
prerank,regulation of interleukin-13 production (GO:0032656),0.39631522132320207,0.9664420352992144,0.51171875,0.9364874918069513,1.0,2/13,1.59%,IL18;PRKCZ
prerank,cellular response to ketone (GO:1901655),0.31278383269115595,0.9656836879988068,0.5103969754253308,0.9375839867374618,1.0,6/35,12.34%,ADCY5;ROCK2;ADCY1;ADCY8;NDOR1;SPHK2
prerank,odontogenesis (GO:0042476),-0.29852672548040976,-0.965429642756674,0.5174825174825175,0.7767278713636231,1.0,7/35,12.38%,LRP6;TGFB2;BMP4;TBX1;AXIN2;TGFB3;BMP2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3850572634118966,0.9654096142544858,0.5078740157480315,0.9372950080768345,1.0,2/14,4.13%,OXSR1;STK39
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.34133675083371096,-0.9653826405229332,0.5081967213114754,0.7763085699495762,1.0,7/20,15.60%,NRP1;SLIT2;SERPINE1;S100A11;CCN4;LRP1;VTN
prerank,protein import (GO:0017038),0.26356679629108193,0.9653476665439058,0.5103092783505154,0.9363477245899399,1.0,20/84,19.04%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3;ATAD1;TOMM22;ABCD1;LAMP2;NXT1;CLU;IPO8;TNPO2;IPO4;SNX33;NUP88;AKT1;HSP90AA1
prerank,maintenance of protein localization in organelle (GO:0072595),0.3532748581782831,0.9652677569542707,0.499001996007984,0.9354649392047064,1.0,6/19,18.36%,HNRNPU;ARL2;TOPORS;PML;HK1;AKT1
prerank,response to growth factor (GO:0070848),-0.2839113180632015,-0.96473354629679,0.510158013544018,0.7774364402716893,1.0,10/41,14.57%,BMPR2;ACVR1;ACVRL1;TGFBR2;CPNE3;RACK1;KLF4;HDAC6;TBC1D7;ACVR1C
prerank,neuromuscular synaptic transmission (GO:0007274),0.36266233615230226,0.9643928475435405,0.49142857142857144,0.936829015937136,1.0,2/18,8.71%,DTNA;CHRNB2
prerank,positive regulation of lyase activity (GO:0051349),0.3739896054513996,0.9642129671233952,0.4906054279749478,0.936241828048228,1.0,1/14,0.44%,CACNA1D
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3119257129867894,-0.9635912054130377,0.5229759299781181,0.779740600142899,1.0,4/27,5.95%,PRKCH;NFKBIA;ABCA1;AGTR1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.3660642027036521,0.9630872078866825,0.5100806451612904,0.938314193856981,1.0,4/16,9.07%,APPL2;PPARA;NLRC3;ABCD1
prerank,regulation of transferase activity (GO:0051338),0.3643902263288388,0.9624868911034556,0.4896421845574388,0.9389156611639705,1.0,9/17,21.55%,PPP1R3F;LDB2;LDB1;PARP4;FEM1A;SMG6;ATM;PINX1;JMJD8
prerank,macromolecule catabolic process (GO:0009057),0.3269184730449726,0.9624834392634279,0.512720156555773,0.9378175498357262,1.0,6/26,14.99%,CAPN3;KIF16B;CTRL;CLN8;CLN5;UCHL3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.35801344559356785,0.9621645316525168,0.5009671179883946,0.9375791951052459,1.0,5/19,10.07%,TGFBR3;BMPR1A;RBPJ;FGFR2;TGFBR1
prerank,cellular response to interleukin-2 (GO:0071352),-0.3990542245750689,-0.9621544215469835,0.5313725490196078,0.7822422015222733,1.0,6/11,28.42%,JAK1;PTK2B;JAK3;SYK;IL2RA;IL2RG
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.3990542245750689,-0.9621544215469835,0.5313725490196078,0.7822422015222733,1.0,6/11,28.42%,JAK1;PTK2B;JAK3;SYK;IL2RA;IL2RG
prerank,negative regulation of inflammatory response (GO:0050728),-0.2205969756661419,-0.9620052949101271,0.5419161676646707,0.7820721227794251,1.0,30/182,11.81%,TEK;CALCRL;CD200;PPARD;RAMP2;MYH9;PTGIS;PLCG1;TNFRSF1B;MFHAS1;CCN3;PLCG2;ADCY4;GNB1;PTGDR;LYN;PRKCD;ADCY7;GNG2;PLK2;IAPP;MDK;SRC;ADCY2;APOE;KLF4;YES1;ADM;CYSLTR2;CYSLTR1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3225737928341899,0.9616618845941712,0.47882136279926335,0.9379460708218148,1.0,8/28,17.57%,HSPA1A;CLASP1;ARL2;DRG1;HSPA1B;MAPRE1;NAV3;CDK5R1
prerank,cGMP biosynthetic process (GO:0006182),-0.41179037533731566,-0.9616557114214185,0.5456431535269709,0.7823868585953296,1.0,3/10,18.89%,GUCY1B1;GUCY1A1;NPPC
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.22313747522893324,0.9616479897201009,0.593245227606461,0.9368801753440582,1.0,50/327,12.40%,DENND4A;RORA;PPARGC1B;CTR9;SUFU;ZBTB38;SCRT1;MYBL2;CRABP2;ARNT2;ZNF431;NFYB;ESRRA;POU1F1;TULP3;CCAR2;ASCC2;CCAR1;PQBP1;ACTR8;MZF1;WWTR1;RNF14;NFYC;E2F1;CEBPA;SRSF10;CHD3;PHF1;HES6;MAFA;PPARGC1A;HINFP;FZD7;SSBP2;CLOCK;CREBL2;PRDM2;GON4L;NSD1;TGFBR1;LDB1;RNF20;RNF6;ZFPL1;MAGED1;DMTF1;PML;CHEK2;RBAK
prerank,inner dynein arm assembly (GO:0036159),0.40684646469120467,0.9614632070026452,0.498,0.936305903752271,1.0,1/11,2.77%,DNAH1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.3189768497307539,0.9614627741435636,0.5056603773584906,0.9352100509354014,1.0,8/30,12.73%,LEPROT;PDCD5;HTRA2;RHOU;CSNK2A2;FZD5;ATG13;RNF31
prerank,epithelial cell morphogenesis (GO:0003382),0.37552540131126116,0.9611800247732113,0.5096153846153846,0.9349399986092554,1.0,4/17,9.77%,COL22A1;RILPL2;RILPL1;DACT2
prerank,negative regulation of nervous system development (GO:0051961),0.36904468205403357,0.961153788852945,0.5098425196850394,0.9339241253844376,1.0,5/17,15.60%,APPL2;WNT7A;PAX6;PCM1;IL6
prerank,negative regulation of protein kinase activity (GO:0006469),-0.2456265397585639,-0.9611360206084523,0.5340050377833753,0.783162890206562,1.0,18/88,13.63%,PTPRB;CAV1;DAB2IP;LRP6;LRP5;CORO1C;ADARB1;UBASH3B;PAK2;PPIA;CEACAM1;CDKN1C;PTPN1;DUSP3;HSPB1;GSKIP;DBNDD2;PTPRC
prerank,phospholipid metabolic process (GO:0006644),0.2718849124559168,0.96054563024538,0.5026642984014209,0.9345577547305826,1.0,16/71,17.39%,FITM2;AGPAT4;PLA2G4C;SMPD3;PCYT2;PLCD1;CLN8;PLPPR3;SMPD2;ACP6;PLA2G15;GDE1;ABCA2;PLBD2;PLAAT3;AGPAT2
prerank,mesenchymal cell development (GO:0014031),-0.3432309308316694,-0.9605140131635408,0.5126582278481012,0.7841837151395777,1.0,11/18,34.67%,NOTCH1;HEYL;HEY2;CDH2;SOX8;SOX11;TAPT1;SNAI2;TBX20;KBTBD8;NOLC1
prerank,glial cell differentiation (GO:0010001),-0.3118009441645657,-0.9604187332986673,0.5051975051975052,0.7838847403275715,1.0,10/28,22.65%,ADGRG6;STAT3;CDK5;PTPRZ1;CDH2;GPC1;SOX8;MYRF;METRN;SOX11
prerank,negative regulation of cellular component movement (GO:0051271),0.3799994029867835,0.9603130994908632,0.5059523809523809,0.9341300210077002,1.0,2/15,2.23%,TGFBR3;FBLN1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.27578314384920977,-0.9602176174026374,0.5033259423503326,0.7838031643854143,1.0,6/47,4.37%,SPTBN1;STXBP6;MACF1;EXOC6;RAB31;EXOC4
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.36470951405716684,0.9599259791816421,0.5075471698113208,0.9341647006173835,1.0,3/16,11.96%,APPL2;WDTC1;SOX9
prerank,regulation of DNA binding (GO:0051101),-0.2798553261194605,-0.9596932853784359,0.5424107142857143,0.7845925247361049,1.0,6/44,6.07%,LEF1;HJURP;NGF;NFKBIA;JUN;HES1
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.40165644537002804,-0.9596062029739693,0.5270541082164328,0.7842869762864745,1.0,9/11,45.87%,IL34;ID2;RIPK1;CASP8;FADD;LIF;PF4;HSF1;CSF1
prerank,nuclear body organization (GO:0030575),-0.3891608953750832,-0.9592865019919541,0.524896265560166,0.7845486618336049,1.0,4/12,16.55%,ETS1;SERBP1;USPL1;USP50
prerank,response to ionizing radiation (GO:0010212),0.26695491726402004,0.9591341370017895,0.5,0.9353222993101613,1.0,17/70,19.36%,EYA1;FANCD2;ABRAXAS1;KAT5;CLOCK;INIP;MAPK14;BRAT1;AEN;MEN1;GADD45A;SIRT1;ATM;CLK2;NHEJ1;FIGNL1;TRIM13
prerank,regulation of superoxide anion generation (GO:0032928),-0.36589107647324787,-0.9589727824124007,0.5020080321285141,0.7847806778246191,1.0,7/14,36.33%,PRKCD;SOD1;SYK;AATF;MAPT;TYROBP;CRP
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.25899263158013247,0.9589403831218888,0.5284974093264249,0.9347883834062523,1.0,26/95,17.06%,HS3ST3A1;UST;HS3ST3B1;OGN;CHST15;ST3GAL3;HS6ST1;OMD;NDST1;PXYLP1;B4GALT2;B4GALT1;B3GALT6;B4GALT3;HS3ST6;HS3ST5;HS6ST2;HYAL1;FMOD;CSPG5;ABCC5;DSE;NDST2;HS2ST1;CHST9;CHST3
prerank,icosanoid metabolic process (GO:0006690),0.2986281759158469,0.9585127565682136,0.5144927536231884,0.9349234608999738,1.0,6/40,7.80%,PTGS1;PON1;DAGLA;PLA2G4C;PNPLA8;PTGR1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.30127104297267576,-0.9581723031750807,0.5258620689655172,0.7862693957699552,1.0,6/32,6.49%,RAPGEF2;NEDD4L;HECW2;TNIK;RAP2A;FBXW8
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.25320176110141907,-0.9579387117518553,0.5492957746478874,0.7862924305179367,1.0,19/67,23.25%,B2M;VAMP3;ITGB5;TAP2;PSMA6;PSMB7;PSMB6;NCF2;PSMB5;PSMB8;PSMC4;PSMD11;SNAP23;PSMB4;PSMD14;PSMD10;PSME1;FCGR1A;PSMB3
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.2442853046400838,-0.9574233972917227,0.5246305418719212,0.7870510672576668,1.0,28/87,27.02%,FBXL7;DCUN1D3;FHL1;PSMA6;PSMB7;APC;KLF4;PSMB6;FAM107A;PSMB5;FBXO5;USP47;PSMB8;PSMC4;PSMD11;PTEN;PSMB4;PSMD14;CDK6;PSMD10;PSME1;PSMB3;E2F7;RGCC;JADE1;ZFP36L2;CDKN2B;CUL1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3489084497306065,0.9573936372922032,0.5070140280561122,0.9358195360466445,1.0,7/20,18.30%,GSTM2;GSTO2;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,glutathione derivative metabolic process (GO:1901685),0.3489084497306065,0.9573936372922032,0.5070140280561122,0.9358195360466445,1.0,7/20,18.30%,GSTM2;GSTO2;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,polyol biosynthetic process (GO:0046173),0.3678973913182447,0.9570690243482518,0.5110663983903421,0.9356644472028955,1.0,4/16,17.52%,ISYNA1;CYP27A1;IPPK;IP6K2
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.38623018881745724,-0.9570459278015926,0.534,0.7874372373372873,1.0,3/12,10.53%,SERINC5;SRR;SERINC3
prerank,cellular response to purine-containing compound (GO:0071415),0.4312323049128375,0.9566349576154155,0.5192697768762677,0.9357666613837661,1.0,3/10,11.47%,GSTM2;RYR2;TRPM2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.40621443279081026,-0.956512151740468,0.5086042065009561,0.7882542123398613,1.0,7/10,30.39%,MYD88;TICAM1;CD68;TLR4;TREM2;CD36;TLR6
prerank,negative regulation of gene expression (GO:0010629),0.22395518878773676,0.9558283545026366,0.5883211678832116,0.9368970127205635,1.0,46/302,14.43%,ROBO1;NOTCH2;WNT4;LGR4;SYT11;IGF1;HSPA1A;SLC24A3;ROCK2;OVOL2;PRKAA2;NDFIP1;TWSG1;CPNE1;OPRD1;BMPR1A;PICALM;TNRC6A;LRP3;TRIM71;DNMT3A;PTBP2;FLOT2;JARID2;PPHLN1;PTBP1;PHF1;LSM5;HINFP;EIF2AK2;PARP14;PAIP2B;MPHOSPH8;PPM1D;PAIP2;TAF1;EPRS1;KDM4A;EIF4E2;AGO3;TERT;TSC1;DICER1;HSPA1B;HAVCR2;FXR2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4020428836570322,0.9557574010268287,0.5181644359464627,0.9360113274468372,1.0,4/11,19.22%,DERL1;BAG6;RNF5;UGGT2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3429925217735064,0.9555569572529151,0.5325670498084292,0.9354984312240789,1.0,7/21,23.65%,GCK;HKDC1;G6PC3;HK1;GPI;PGLS;SHPK
prerank,regulation of translation (GO:0006417),-0.2199180502155153,-0.9554884836459131,0.5776566757493188,0.7903073772004977,1.0,60/173,29.77%,NIBAN1;THBS1;FOXO3;RBM3;RPL5;APP;RPS6KA3;RPL10;EIF3E;ALKBH1;EIF3H;RACK1;EEF2;RPS3;MTRF1;EIF2B2;EIF2AK3;EIF4E;HSPB1;NCBP2;SYNCRIP;EIF1B;NCBP1;EIF4G3;DHFR;FMR1;PRR16;DDX25;FXR1;GAPDH;RIDA;METTL3;NCL;PIWIL2;MTG1;EIF4H;BCL3;CAPRIN1;KLHL25;EIF4A3;NANOS3;EIF3B;RPL13A;DAPK1;BTG2;SHMT2;TYMS;HNRNPD;MTIF2;LTN1;METTL14;RPS6KA1;RPS4X;GEMIN5;SHMT1;NSUN5;IGF2BP2;PCIF1;IGF2BP1;CNOT1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3697264789566954,0.9553258345098566,0.491588785046729,0.935062200661107,1.0,4/17,11.04%,ANK2;SNTA1;KCNH2;RYR2
prerank,regulation of RNA splicing (GO:0043484),0.27380956066972334,0.9552806337609073,0.5232358003442341,0.9341151503951791,1.0,27/69,23.03%,HSPA1A;HNRNPH3;PQBP1;FASTK;PTBP2;SRSF10;SON;HNRNPL;PTBP1;TIA1;SRRM4;CLK3;YTHDC1;AFF2;GRSF1;MBNL3;CLK2;ZPR1;FAM50A;HNRNPH2;PTBP3;CLK1;POLR2A;LARP7;HNRNPH1;SRPK1;CELF1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.34358600030350867,-0.9552771622922446,0.5166666666666667,0.7902683903463176,1.0,7/18,16.95%,ELOVL7;ELOVL5;ACSL5;ELOVL6;ACSL3;ELOVL1;ACSL4
prerank,RNA splicing (GO:0008380),0.2579946714993673,0.9552191493785296,0.5300171526586621,0.9331977414500914,1.0,31/95,24.43%,RRAGC;NOVA1;CCAR2;HNRNPH3;SRSF10;PTBP1;PPARGC1A;ZMAT5;LSM4;MPHOSPH10;USP39;SRSF11;USB1;RNPS1;DHX8;PRPF6;NOL3;PRPF3;DDX39B;DDX47;SF3B2;SF3B1;SNRPB;CDK12;SCNM1;SF3B3;SRPK1;SNRPN;HNRNPC;WDR83;SRSF2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.2970755392084866,0.9544566134390056,0.5148861646234676,0.9342480356148753,1.0,13/45,19.72%,HSPA1A;DDX5;RIOK2;SUPV3L1;ZC3H18;WDR75;GRSF1;IL6;ZPR1;UTP15;RELA;NFKB1;POLR2A
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3434541193486752,0.9542423999955789,0.5214007782101168,0.9337224168987841,1.0,3/21,4.59%,CEL;CYP26B1;LPIN1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.29682966121839927,0.9539715706727595,0.5226039783001808,0.9334514165471766,1.0,3/39,2.86%,NNAT;GCK;NLGN2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2600678505103301,0.9533102227004057,0.5451505016722408,0.9342129428399104,1.0,26/88,22.19%,BMP7;SMAD3;STX18;ERCC1;STAM;SMPD3;NRG1;SNF8;GNL3L;PIH1D1;CHGA;CLU;HYAL1;PRKCA;TRABD2B;SLF1;FNIP1;CX3CL1;BRK1;TIRAP;BAX;EMILIN1;ATP13A2;SDCBP;SLX4;PLEK
prerank,body fluid secretion (GO:0007589),0.3781539561997051,0.9531446707491552,0.5265151515151515,0.9336239728262262,1.0,3/15,12.82%,PRLR;VIP;SLC22A2
prerank,protein autoprocessing (GO:0016540),0.36593635592722196,0.9531250233017581,0.5103578154425612,0.9326086850886267,1.0,3/17,7.31%,AFG3L2;HTRA2;SPRTN
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.40183793615778407,0.9530939421583821,0.5334608030592735,0.9316396579997049,1.0,3/11,8.02%,KCND3;KCNJ5;KCNH2
prerank,regulation of mRNA catabolic process (GO:0061013),-0.22751744514931946,-0.952887412794565,0.582010582010582,0.7955398004614589,1.0,34/121,23.25%,PRR5L;UBC;YWHAB;SERBP1;RPS27A;PABPC1;UBB;EXOSC1;PRKCD;PSMA6;PSMB7;PUM2;MAPKAPK2;PSMB6;YWHAZ;PSMB5;HSPB1;PUM1;PSMB8;PSMC4;PSMD11;FMR1;FXR1;CARHSP1;PSMB4;PSMD14;ZC3H12A;PSMD10;SET;PSME1;RBM24;EXOSC4;EXOSC5;PSMB3
prerank,ion transport (GO:0006811),0.2521111333452838,0.9528811918387657,0.539708265802269,0.9311802957371276,1.0,13/111,11.52%,TRPM3;SLC8A3;SLC5A5;SLC24A3;SLC26A1;GLRA1;WNK4;SLC15A2;CHRNB2;KCNN4;SLC12A5;SLC12A1;PLP2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3531684013842157,0.9527631311274913,0.5447619047619048,0.9304685358159545,1.0,6/20,13.17%,DAB2;PICALM;PKDCC;RHOQ;MRAP2;MRAP
prerank,negative regulation of viral process (GO:0048525),0.2831757265196566,0.9526052960116054,0.5332167832167832,0.9298608796418321,1.0,27/57,28.72%,OAS2;TRIM62;UBP1;TRIM5;TRIM35;IFIT1;EIF2AK2;OAS3;STAT1;PML;TRIM13;ILF3;LARP7;TRIM32;CHMP3;PARP10;BST2;SLPI;SRPK1;BTBD17;ZFP36;RNASEL;TRIM28;MAVS;TRIM8;MBL2;TRIM11
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2942372102399222,-0.952329707793712,0.5243128964059197,0.7963773546385085,1.0,9/32,23.86%,DEFA6;RPL39;RPL30;CCL13;ROMO1;GAPDH;HMGN2;RPS19;PGLYRP1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.31759305860901743,-0.9523268386617357,0.5524017467248908,0.7958453842142579,1.0,6/25,13.25%,RPL5;GABARAPL2;RPS7;PRKCG;RPL23;CSNK2A1
prerank,regulation of DNA replication (GO:0006275),-0.26979637058867484,-0.9520992231158891,0.5448577680525164,0.7959242728774798,1.0,15/49,24.66%,BCAR3;ACVRL1;KAT7;WAPL;EGFR;S100A11;FBXO5;BLM;BRPF3;ORC5;PPP2CA;FAF1;NUCKS1;EGF;CTC1
prerank,response to UV (GO:0009411),-0.24033565759048636,-0.9517143624995978,0.5547785547785548,0.7963228839277302,1.0,33/95,25.04%,DCUN1D3;EGFR;PTPRK;PRKCD;MFAP4;ZBTB1;CAT;GPX1;USP47;ERCC2;COPS9;SCARA3;RHBDD1;BAK1;FMR1;ATF4;UBE2A;N4BP1;RHNO1;PRIMPOL;CCND1;PCLAF;METTL3;NEDD4;XPA;MAP2K7;NSMCE3;BCL3;MAP3K4;MAP4K3;TRIAP1;DTL;USP1
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.3651721994963105,-0.9512020624431943,0.524390243902439,0.7970354422347872,1.0,8/14,23.54%,SEC24D;SEC23A;SEC31A;SEC24B;SAR1A;SEC13;SEC24A;TBC1D20
prerank,regulation of myotube differentiation (GO:0010830),-0.31736539195021096,-0.9511787740923929,0.5441767068273092,0.7965463097546178,1.0,5/24,8.65%,NOTCH1;PIEZO1;CCN3;HDAC9;TMEM119
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3271423930807931,0.951149096983327,0.5377855887521968,0.9328577368965655,1.0,10/27,18.21%,DDX5;KMT5A;SPRED3;SMYD2;MSX1;SIRT1;ATM;MDM2;KDM1A;SPRED1
prerank,diacylglycerol metabolic process (GO:0046339),-0.3168837826660623,-0.9510072400312075,0.5128205128205128,0.7964137163259788,1.0,3/23,3.37%,PLCE1;DGKH;DGKZ
prerank,positive regulation of histone acetylation (GO:0035066),0.3293101564032476,0.9508182982426728,0.5306513409961686,0.9326735061982855,1.0,8/23,15.28%,RUVBL2;ARRB1;PPARGC1A;BRD7;PIH1D1;SPHK2;WBP2;MUC1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3254089810700845,0.9507967426762098,0.518796992481203,0.9316716982210904,1.0,5/27,4.37%,CACNB1;ANK2;CACNB3;JPH1;ADRA2A
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.24039075171732333,-0.9507635258788488,0.557919621749409,0.7964936619241542,1.0,27/88,27.22%,FBXL7;PSMA6;PSMB7;FBXO31;FBXO4;PSMB6;PSMB5;FBXO44;FBXW7;FBXL18;PSMB8;PSMC4;PSMD11;PSMB4;AMN1;PSMD14;CCNF;FBXL4;FBXW5;PSMD10;PSME1;FBXL6;PSMB3;CUL4A;KIF14;CUL1;FBXW11
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.2758637350989306,-0.9505392078438278,0.4875283446712018,0.7965129880838693,1.0,14/46,17.73%,SEMA6A;DAB2IP;SPRED2;LYN;SPRY2;PTPN1;DUSP3;EPHB2;RANBP9;PTPRC;SPRY1;PTEN;GPER1;DUSP6
prerank,regulation of fibroblast proliferation (GO:0048145),0.28940226728782664,0.9505326585877532,0.51985559566787,0.9313435989857467,1.0,8/45,11.83%,IGF1;PDGFRA;SPHK1;E2F1;NLRC3;MED25;CD300A;CDC73
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3007963081058157,0.9504479515530546,0.5091240875912408,0.9305397913533507,1.0,9/38,12.73%,LEPROT;HTRA2;LRRK2;BAG4;RHOU;CSNK2A2;FZD5;ATG13;RNF31
prerank,lymphocyte proliferation (GO:0046651),-0.32572601814085755,-0.9502542176608559,0.5412262156448203,0.7966677093082934,1.0,5/22,13.63%,MEF2C;ELF4;CTPS1;CD40;PTPRC
prerank,positive regulation of interleukin-17 production (GO:0032740),0.34053539994983234,0.9500786801837068,0.5091277890466531,0.9305321426608325,1.0,2/22,1.35%,IL18;SPHK1
prerank,protein hydroxylation (GO:0018126),-0.36274211203355783,-0.9496955584419164,0.5399159663865546,0.7974835520847317,1.0,9/15,38.08%,PLOD2;PLOD3;JMJD4;EGLN3;JMJD7;P3H1;VIPAS39;PLOD1;P3H2
prerank,regulation of keratinocyte differentiation (GO:0045616),0.33688281345811,0.9491710651311512,0.5074906367041199,0.9319784489543086,1.0,4/24,8.34%,ERRFI1;ROCK2;HOXA7;MED1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.32182500612881665,0.9491510757779452,0.5141242937853108,0.9309839253670024,1.0,6/30,9.69%,ACSL1;HACD3;HACD4;HACD1;ABCD1;SLC27A6
prerank,positive regulation of telomere capping (GO:1904355),-0.3518216503233731,-0.949143727054709,0.5212121212121212,0.7983323207028558,1.0,7/17,25.93%,NEK7;TNKS;MAPK1;MAPK3;MAP2K7;MAP3K4;HNRNPD
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.29838568867148424,-0.9491311990023173,0.5138004246284501,0.7978301669199673,1.0,6/33,7.89%,NET1;MAP3K5;CYP1B1;ANXA1;PRKCD;RPS3
prerank,apical protein localization (GO:0045176),-0.4105683615271526,-0.9490896052530553,0.5337301587301587,0.7974144784296755,1.0,2/10,0.62%,ACTB;ATP8B1
prerank,fatty acid elongation (GO:0030497),0.3984705270527227,0.9489986601309363,0.5529411764705883,0.9303688283319776,1.0,4/13,9.07%,HACD3;HACD4;HACD1;ABCD1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3385068638809839,-0.9487960225762974,0.5417558886509636,0.7975714715771918,1.0,9/17,40.30%,NOS1AP;KCNE4;KCNAB1;KCNS2;RNF207;ANK3;VAMP2;KCNG1;KCNE5
prerank,cellular response to amyloid-beta (GO:1904646),0.30539127633557694,0.9478115632425976,0.5144404332129964,0.9326263465208658,1.0,3/35,1.71%,SNX6;IGF1;CACNB1
prerank,negative regulation of interferon-beta production (GO:0032688),0.4108674036134835,0.9474894453117103,0.5,0.9324632676468553,1.0,6/10,20.22%,NLRC3;CACTIN;PPM1B;SIRPA;PYCARD;PTPRS
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.27654759301954907,0.947451478804627,0.5372340425531915,0.9315150014215193,1.0,12/58,16.00%,PAXX;POLM;ERCC1;ABRAXAS1;KAT5;KDM2A;MDC1;MRE11;PRPF19;PIAS4;PRKDC;ATM
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.41535126665946076,-0.9469894282206177,0.5080645161290323,0.8016244033624084,1.0,5/10,31.10%,EIF2AK3;ATF4;QRICH1;HERPUD1;HSPA5
prerank,response to peptide hormone (GO:0043434),0.29345904607900375,0.9467722162347146,0.5344827586206896,0.9323315673720447,1.0,14/43,19.03%,TGFBR3;ROCK2;CYP11B1;CITED1;EIF2B4;STAT1;STAT2;TSC1;SIRT1;CREB1;STAT5B;AKT1;STAT6;KHK
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.28198982412518636,-0.9466445356521669,0.5682819383259912,0.8019182388461245,1.0,8/39,12.00%,MYO1D;ACTN4;MYO1B;SYT4;MYO19;MYO1F;DYNC1I1;FNBP1L
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.24798726777263153,-0.9464505834142224,0.5925925925925926,0.8018685875707833,1.0,28/78,26.95%,ACTB;PKD1;EGFR;CCNY;APC;CDKN1C;IPO7;SERTAD1;MYOCD;GTF2H1;IPO5;HHEX;BLM;PTEN;LATS1;CCNF;CCND1;PSMD10;CCND2;CCNH;CCNB2;CDKN1B;RGCC;LATS2;CDKN3;MAPRE3;CDKN2B;CCNT1
prerank,protein polyglutamylation (GO:0018095),0.40223913387667337,0.9463209559791517,0.5158102766798419,0.9325073716314776,1.0,4/11,21.52%,TTLL6;CFAP20;TTLL11;TTLL4
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.32182555101036603,-0.9461758648528928,0.5216450216450217,0.8019773127219403,1.0,5/23,15.44%,MYO10;DYNC1I2;TUBA1A;DYNC1I1;KIF1C
prerank,N-glycan processing (GO:0006491),-0.3346058211755374,-0.9459627704358974,0.5191489361702127,0.8019632208273181,1.0,6/18,14.69%,ST8SIA4;FUT8;ST8SIA6;MGAT4A;MGAT4B;ST8SIA2
prerank,regulation of mitochondrion organization (GO:0010821),-0.2736385091411708,-0.9458980271426969,0.5523385300668151,0.8015923693255368,1.0,21/47,31.01%,PID1;MFF;PDE2A;IAPP;MYO19;GOLPH3;SREBF2;SQSTM1;HDAC6;FBXW7;PRMT6;SIRT7;SREBF1;RHOT2;MUL1;TREM2;MAPT;STOX1;FLCN;VPS35;USP36
prerank,DNA catabolic process (GO:0006308),-0.383982653189854,-0.9458611500504943,0.5298804780876494,0.8011290759169156,1.0,5/11,36.15%,REXO4;DFFB;XRN2;ISG20;MUS81
prerank,protein polymerization (GO:0051258),-0.2610584794404566,-0.9455976185818129,0.582392776523702,0.8012608008774035,1.0,12/56,13.24%,GSN;MSRB2;CHMP4B;CHMP4A;MAP7D3;TPPP3;WASHC3;FAM107A;FGF13;MICALL2;PSTPIP2;TRPV4
prerank,renal water homeostasis (GO:0003091),0.3358298571437975,0.9453265098968271,0.5383177570093458,0.9342314022378061,1.0,3/23,6.20%,ADCY5;ADCY1;ADCY8
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3476086034656337,0.9449291135224802,0.51183970856102,0.9342980142976144,1.0,5/20,11.83%,CTR9;MEIS1;LEO1;LDB1;CDC73
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.3040918182159733,-0.9448716077102584,0.5491071428571429,0.8025761393577486,1.0,9/29,16.95%,ELOVL7;ELOVL5;ACSL5;FASN;ELOVL6;ACSL3;SCD;ELOVL1;ACSL4
prerank,regulation of mRNA stability (GO:0043488),-0.2223681343453196,-0.9445014430679085,0.6086956521739131,0.8029967833011016,1.0,42/145,23.25%,FTO;UBC;YWHAB;SERBP1;RPS27A;FASTKD1;PABPC1;UBB;EXOSC1;AXIN2;PRKCD;PSMA6;PSMB7;PUM2;MAPKAPK2;PSMB6;YWHAZ;PSMB5;HSPB1;FUS;PUM1;PSMB8;PSMC4;PSMD11;FMR1;TENT5C;TBRG4;FXR1;CARHSP1;PSMB4;PSMD14;RIDA;TENT5A;METTL3;PSMD10;SET;ROCK1;PSME1;RBM24;EXOSC4;EXOSC5;PSMB3
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3421826566579015,-0.9442268962246358,0.5555555555555556,0.8031539659101377,1.0,4/17,13.63%,PPP1R12A;ITGA1;CALM3;PTPRC
prerank,myelin maintenance (GO:0043217),-0.395223778105784,-0.9442050593806863,0.5588822355289421,0.8026675967422825,1.0,6/10,24.61%,ABCD2;SOD1;PRX;PTEN;MYRF;CXCR4
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3199246033306679,-0.9441240091699284,0.5528455284552846,0.8023442860811412,1.0,9/23,30.62%,PLA2G4A;MBOAT1;ABHD4;PLA2G6;LPCAT3;PLA2G4F;PLA2G4B;PLA2G5;LPCAT4
prerank,fatty acid beta-oxidation (GO:0006635),0.2808332131790326,0.9441211584426726,0.5263157894736842,0.9355237849878508,1.0,11/51,12.22%,ACAT2;IVD;ACAT1;ACAD10;ECHS1;ABCD1;AMACR;ACAD11;ECHDC2;GCDH;CROT
prerank,peroxisome organization (GO:0007031),-0.31699741004942683,-0.9440017189790366,0.565677966101695,0.8021248422210732,1.0,5/25,8.56%,TMEM135;MFF;SEC16B;ABCD2;PEX7
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.34448703857177165,-0.9439153911563768,0.5284552845528455,0.8017829922548214,1.0,4/17,9.91%,TMSB4X;ANXA1;OTUD7B;KLF4
prerank,somite development (GO:0061053),-0.3926120248384235,-0.94377575292504,0.5247933884297521,0.8016062039050543,1.0,4/11,13.20%,MEOX2;PTCH1;SMO;PPP2R3A
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.266079437168282,-0.9436353022627998,0.5750577367205543,0.8014313285815465,1.0,26/54,26.01%,RPL5;RPL10;RPL7;MRPL20;RPLP0;RPL35A;RPF1;RPL7A;SURF6;RPL6;RPL24;RPL10A;RPL14;RRP15;GTF3A;MRPL1;MRTO4;EBNA1BP2;RPL3;SDAD1;NHP2;RRS1;NOP16;RPL23A;PPAN;MDN1
prerank,regulation of cell cycle phase transition (GO:1901987),-0.2407213697946976,-0.9434853398822306,0.5763546798029556,0.8012835241798626,1.0,24/91,23.32%,CDC27;ANAPC5;XPC;PSMA6;PSMB7;CDC16;PSMB6;PSMB5;FBXO5;ERCC2;TCIM;FBXW7;FZR1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;CDC26;PSMD10;PSME1;CDKN1B;PSMB3;CDC23
prerank,regulation of protein metabolic process (GO:0051246),-0.273234838996944,-0.9434746116878086,0.5553047404063205,0.8007863995532412,1.0,11/44,16.11%,LTBP4;NEDD4L;APP;SPOPL;APOE;KLF4;HGS;GSAP;KLF2;PLAUR;ZDHHC2
prerank,primary miRNA processing (GO:0031053),0.4233249539034519,0.9433195610401826,0.5376984126984127,0.9367356691679234,1.0,2/10,4.91%,SMAD3;HNRNPA2B1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3684413955417378,0.9431291864455249,0.5383141762452107,0.9362273423398184,1.0,2/15,3.93%,TMEM33;ATL1
prerank,protein dephosphorylation (GO:0006470),0.2398431432410509,0.9429380789870795,0.5707395498392283,0.9356927351990113,1.0,24/135,13.75%,PPP2R2B;EYA1;DUSP29;EYA4;PTPN9;EYA2;PPM1M;PTPN4;PTPN13;DUSP11;PPEF2;PPM1G;TNS2;MTMR4;PTPRD;PTPN21;PPM1D;PPP1CB;MTMR2;CDC14B;PTPN14;PTPRO;PTPRU;PPP6C
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.24233132668518947,0.9428908180306723,0.592823712948518,0.9347589059839734,1.0,15/138,9.58%,NOTCH2;RORA;NR2E1;THRB;NR6A1;CCN2;PPARA;ESRRA;RBPJ;WWTR1;MED1;PPARGC1A;TAF10;NR1H3;RXRA
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.3909425252659269,0.9428483807285513,0.5399239543726235,0.9328052482434016,1.0,4/12,15.54%,IGF1;PTBP1;CHERP;AKAP6
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.3909425252659269,0.9428483807285513,0.5399239543726235,0.9328052482434016,1.0,4/12,15.54%,IGF1;PTBP1;CHERP;AKAP6
prerank,regulation of intracellular protein transport (GO:0033157),-0.2907831414339922,-0.9428254124492425,0.5565031982942431,0.8018596199522283,1.0,14/32,24.55%,PRR5L;BMP4;ICE1;PTPN1;RIPOR1;TPR;ZFAND1;B3GAT3;KIF20B;SIRT7;CEP131;OAZ1;PLK3;NDEL1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3899036431336269,-0.9428222291063811,0.5225048923679061,0.8013359859890299,1.0,6/11,30.95%,SCARB1;MFSD2A;CTDNEP1;SREBF1;LDLR;NR1H2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3719964087864948,0.9423625587240407,0.532520325203252,0.9331312261356335,1.0,6/15,18.36%,IGF1;PPIF;CLU;HGF;NOL3;AKT1
prerank,triglyceride metabolic process (GO:0006641),0.28598977135816206,0.9423182760436493,0.5505415162454874,0.9322145685891371,1.0,7/48,16.09%,LPGAT1;GK;LPIN1;MOGAT1;DGAT2;SIRT1;PLAAT3
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.24117963204969645,-0.9421061159497768,0.5985748218527316,0.8025236988019311,1.0,15/78,11.06%,CAV1;CBFA2T3;RNF144A;NKD2;COP1;RNF144B;CSNK1E;RACK1;ZYG11B;CSNK1A1;BCAP31;ARIH2;SOCS5;ARIH1;PABIR1
prerank,regulation of cell motility (GO:2000145),-0.22965037552705658,-0.9420302933604772,0.5968992248062015,0.8021808838705542,1.0,34/121,20.50%,FRMD5;SPOCK2;DOCK10;RHOA;TMSB4X;NTN1;EGFR;MACF1;SPATA13;FLNA;ROBO4;PRKX;CEACAM1;FGF2;ABI3;FGF7;TMSB10;PLXNC1;TWIST1;CCDC25;SST;AKT2;AMOT;CAVIN1;CSF1R;MEMO1;PLXNA4;OSGIN1;PRAG1;CDK6;AMOTL1;HACE1;RHOB;PLXND1
prerank,nucleotide biosynthetic process (GO:0009165),-0.3445566505048331,-0.9417876255244236,0.5277207392197125,0.8022670825295917,1.0,10/18,38.99%,ME1;HPRT1;RRM2B;NMNAT1;PRPSAP1;RRM1;GART;PRPS2;PPAT;RRM2
prerank,regulation of neuron apoptotic process (GO:0043523),-0.2369460292599353,-0.9415794400207587,0.6084788029925187,0.8022246004837822,1.0,35/96,26.03%,MEF2C;TGFB2;NDNF;FOXO3;NGF;SIX1;MDK;PRKCG;FOXQ1;CDK5;SOD1;TGFB3;APOE;NSMF;UNC5B;PTPRZ1;PTK2B;LANCL1;MT3;KCNB1;ATF4;SIX4;CRLF1;LIG4;AKT1S1;AGAP2;SET;RASA1;KDM2B;NFATC4;EGLN3;EPHA7;F2R;KIF14;WFS1
prerank,regulation of synapse assembly (GO:0051963),-0.2743085908048001,-0.9415424967628941,0.5489749430523918,0.8018034021413347,1.0,9/46,14.47%,GPC6;MEF2C;PDLIM5;APP;CLSTN2;IL1RAP;EPHB2;LHFPL4;SRPX2
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.3097318457575475,-0.9413771178418544,0.5615550755939525,0.8016837427132281,1.0,6/26,6.44%,ST3GAL4;ST3GAL6;B3GNT2;B4GALT4;ST3GAL1;LUM
prerank,dendritic spine morphogenesis (GO:0060997),-0.3603785677219923,-0.9413740336063771,0.5462012320328542,0.8011618043929079,1.0,2/15,0.82%,SHANK3;DOCK10
prerank,cellular response to insulin stimulus (GO:0032869),0.24442790805190964,0.9409697959026784,0.5491419656786272,0.9349569071105848,1.0,27/124,14.89%,CPEB2;GCK;BAIAP2;PIK3R3;ATP6V0A2;INSIG2;LPIN1;ATP6V0B;ATP6V1H;SOS1;PDPK1;PDK2;PRKCI;SORBS1;ATP6V1B2;RHOQ;PHIP;ATP6V1E1;USF1;EPRS1;RAB13;ATP6V0E2;ATP6V1C1;SLC27A4;PRKDC;ATP6V0D2;GOT1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3950754892881003,0.9408064281782462,0.536723163841808,0.9343751256364912,1.0,3/12,9.89%,TET1;PPHLN1;MPHOSPH8
prerank,negative regulation of telomere maintenance (GO:0032205),0.3664173930388971,0.9407734888489974,0.5407554671968191,0.9334287125678069,1.0,7/15,22.08%,ERCC1;TNKS2;RTEL1;SMG6;ATM;PINX1;SLX4
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.21222123473904692,-0.9404079990633336,0.6320224719101124,0.8029786441008461,1.0,54/190,20.85%,PDE3A;PDE4D;CAV1;DAB2IP;SLIT2;TMSB4X;THBS1;SH3BP4;LIMD1;BCL2L1;PTPRJ;CCN3;ESR1;PDE10A;PIK3IP1;XDH;CIT;RACK1;PDE2A;LYN;OTUD7B;PPP2R5C;IFI35;HDAC7;SRC;DUSP3;CD2AP;PER1;PHLPP1;TWIST1;TNFAIP8L1;PEBP1;TBC1D7;PLAUR;NR1H4;DDIT4;RNF157;APLNR;PHLPP2;PTEN;GPER1;UBR1;CARD19;USP10;ZC3H12A;MCL1;MARK3;RIPK1;SPI1;ARRB2;AKT1S1;PSMD10;PPP2R5B;AJUBA
prerank,positive regulation of proteolysis (GO:0045862),0.2775352502273585,0.9398810570820016,0.5580110497237569,0.9348555272703211,1.0,18/55,23.50%,SH3D19;FURIN;CAPN3;ADRA2A;CYFIP2;PLK1;CTSH;NRDC;NDUFA13;SNX33;ASPH;NLRC4;SNX9;ATP5IF1;TRIM32;RCN3;BTRC;PACSIN3
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.362654509504191,-0.939522851674562,0.5359342915811088,0.8046208488295137,1.0,3/13,7.09%,GJC1;CACNB2;KCNQ1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3632927643025414,-0.9393598679582924,0.5337423312883436,0.8044921686983706,1.0,3/13,13.74%,BPNT2;TPST2;ENPP1
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2191365206816651,-0.9392430523199574,0.6213333333333333,0.804224047293911,1.0,29/160,16.90%,HIP1;STXBP6;RPL38;PIK3C2A;TBCD;FCHO2;SGIP1;SMAD1;VAMP3;CLTB;NCK1;PXN;CHMP4B;CHMP4A;PTGES3;SRP19;SRC;NUP107;TIAM1;BBS12;IMMP2L;HIP1R;TPR;HIGD2A;CCT2;PSMD11;RTN4;DNAI4;ADRM1
prerank,membrane repolarization during action potential (GO:0086011),-0.36695262831694164,-0.9391854724637316,0.5458515283842795,0.803835029405971,1.0,5/13,15.86%,YWHAE;KCNJ2;KCNQ1;ATP1A1;KCNE4
prerank,regulation of transposition (GO:0010528),0.38909597857712536,0.9380159051287874,0.5384615384615384,0.9388993488709553,1.0,3/13,14.13%,TDRD9;SPOCD1;MYBL1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3828571175913645,0.9376252201419535,0.5288640595903166,0.9389445155511659,1.0,5/13,18.21%,DDX5;SPRED3;MSX1;ATM;SPRED1
prerank,cellular response to interleukin-12 (GO:0071349),-0.2682921010077605,-0.9370496377080548,0.5771812080536913,0.808509055503591,1.0,21/48,33.01%,MTAP;PAK2;PPIA;RPLP0;CNN2;SOD1;JAK1;CFL1;PDCD4;BOLA2;CDC42;CAPZA1;MSN;HNRNPF;IL12RB2;STAT4;AIP;MIF;LMNB1;RAP1B;CD47
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.344800019934391,0.9359734989048893,0.5415821501014199,0.9423418979218335,1.0,4/19,11.54%,RENBP;GNPNAT1;GNPDA1;PMM2
prerank,chromatin remodeling at centromere (GO:0031055),-0.29203570249662925,-0.935285746971968,0.5517970401691332,0.8121228141263994,1.0,12/31,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5
prerank,negative regulation of metabolic process (GO:0009892),0.2799164938405025,0.9351235614744459,0.544954128440367,0.9435889148261726,1.0,12/54,15.41%,LGR4;NPR3;NOVA1;RBPJ;ARRDC3;MAP2K6;ALDH1A1;NR1H3;DOCK7;NRDC;LAMA4;TFE3
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3149032976461338,0.9349040294394887,0.5359848484848485,0.9431699900005788,1.0,4/31,4.40%,HSPA1A;DNAJC18;OPTN;DNAJB14
prerank,positive regulation of cell cycle process (GO:0090068),-0.23476029783259483,-0.9348890004133549,0.6038647342995169,0.8126278466288553,1.0,31/91,25.85%,RHOA;SVIL;INSR;LRP5;PLSCR1;MAP3K20;CIT;IGF2;EDN1;EDN3;KIF23;TPR;RAD21;NUSAP1;CEP295;RHNO1;DYNC1H1;RANBP1;NUDT16;KIF20B;CDC42;GPSM2;EGF;GIPC1;E2F7;NUP62;CUL3;RGCC;XRCC3;PRKCE;KIF14
prerank,regulation of lymphocyte activation (GO:0051249),-0.37609636338222957,-0.9346510841921838,0.5519348268839104,0.8126675450801346,1.0,7/12,38.09%,DCAF15;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,ceramide transport (GO:0035627),-0.37838943501246425,-0.9346231470465874,0.5635245901639344,0.8122080568950659,1.0,8/12,28.25%,CERT1;PLTP;PLEKHA8;PSAP;SGPP1;GLTP;PLEKHA3;CPTP
prerank,C-terminal protein amino acid modification (GO:0018410),-0.39631477147396127,-0.9345101981012458,0.5422680412371134,0.8119493545081404,1.0,5/11,20.30%,ICMT;ATG12;ATG5;AGTPBP1;LCMT1
prerank,defense response to virus (GO:0051607),0.24786197177474267,0.9344007609002684,0.5768595041322314,0.9434672581698058,1.0,17/100,11.49%,IFIT2;OAS2;TRIM5;IFI27;PQBP1;NT5C3A;IFIT3;NCBP3;AGBL4;IFIT1;EIF2AK2;OAS3;ZDHHC1;RNF135;BCL2;STAT1;STAT2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3633052318480715,0.9342712104572192,0.5243664717348928,0.9428019562611277,1.0,5/15,12.49%,SOS1;CASP3;NTRK2;FRS2;BDNF
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2705876081391771,0.9339671243016848,0.5597826086956522,0.9426483841683028,1.0,16/68,19.11%,GTPBP1;ACSM2A;ACSM2B;ACAT1;GLYAT;LRRK2;AMPD3;RHOQ;CROT;ABHD14B;RAB23;ACOT1;ACOT6;TPST1;AK3;ACOT13
prerank,neurotrophin signaling pathway (GO:0038179),-0.3253430434221364,-0.9337504491880648,0.5666666666666667,0.8132773719085723,1.0,5/21,9.86%,RAPGEF2;RAP1A;NGF;BCAR1;SORT1
prerank,regulation of fat cell differentiation (GO:0045598),0.26092122338710316,0.9337503571348957,0.5627240143369175,0.9422465818270852,1.0,11/74,12.33%,RORA;TMEM64;SMAD3;LMO3;LRP3;WWTR1;E2F1;CREBL2;AAMDC;ADIG;CDS1
prerank,positive regulation of double-strand break repair (GO:2000781),-0.27616133793250797,-0.9334378321919498,0.5821205821205822,0.8135189449525753,1.0,15/39,31.32%,SHLD1;FUS;SMCHD1;FANCB;TIMELESS;MAD2L2;SLF2;SPIDR;DTX3L;PARP3;SHLD3;RAD51AP1;PARP1;SPIRE2;MRNIP
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.22579638856697548,-0.9332538130598552,0.6025,0.8134258378314434,1.0,34/116,23.06%,CALCRL;RAMP2;MYH9;PLCG1;PLCG2;ADCY4;GNB1;PTGDR;LYN;ADCY7;GNG2;PLK2;IAPP;SRC;ADCY2;YES1;ADM;CYSLTR2;CYSLTR1;PRKAR2B;PRKACA;PTH1R;ADCYAP1R1;GPR176;GPR27;HCK;NPSR1;PTHLH;SYK;FCGR1A;FYN;FCGR2B;GGT1;PRKAR1B
prerank,negative regulation of cell projection organization (GO:0031345),-0.2602980551948526,-0.93256924961755,0.583864118895966,0.814573733919146,1.0,17/48,22.98%,RAPGEF2;KANK1;SPRY2;GRIN2B;APOE;BAG5;TRPV4;MT3;PAQR3;RTN4RL1;PTEN;HDAC2;PRAG1;MYLIP;RTN4R;FYN;GAK
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.39591684109406666,-0.9319709247396953,0.5524193548387096,0.8155263729040357,1.0,3/10,2.27%,BMP5;LRP6;NOTCH1
prerank,tRNA methylation (GO:0030488),-0.2865916841997733,-0.9318082564214442,0.5833333333333334,0.8153901177278811,1.0,10/34,19.64%,METTL2B;METTL2A;THUMPD2;TRMT10A;FTSJ1;TRMT44;TYW3;METTL6;TRMT112;LCMT2
prerank,dendritic cell differentiation (GO:0097028),-0.3178095920563013,-0.9317745441179137,0.5550847457627118,0.8149452483466348,1.0,3/22,6.40%,GAS6;TGFBR2;LYN
prerank,peptide hormone secretion (GO:0030072),-0.30533545272817497,-0.9316327818601587,0.5520169851380042,0.8147577049569487,1.0,5/26,11.67%,LTBP4;SNX19;ANXA1;EDN1;EDN3
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.3023288359466907,-0.9316258209984728,0.559652928416486,0.8142463899673014,1.0,8/26,20.75%,ST3GAL4;ST8SIA6;GOLPH3;B4GALT5;GCNT1;ST3GAL2;ALG6;RRM2B
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.37378529935967747,0.9316038881682002,0.523719165085389,0.947022085518094,1.0,6/15,16.23%,KIT;WHRN;ADGRV1;KCNK4;PDZD7;LHFPL5
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.33274204516715067,0.9314946604675005,0.5489833641404805,0.9462728591334549,1.0,2/23,2.77%,PLK5;ZWINT
prerank,negative regulation of transmembrane transport (GO:0034763),-0.3947350150019363,-0.9309857397056577,0.5370741482965932,0.8152660049211774,1.0,3/10,16.03%,THBS1;AKT2;CTTNBP2NL
prerank,positive regulation of autophagy (GO:0010508),0.2637541181427553,0.9304337938777271,0.5798319327731093,0.9481015822977775,1.0,13/81,10.33%,RNF152;PRKAA2;PLEKHF1;OPTN;PIK3CB;TRIM5;IKBKG;KAT5;GPSM1;LRRK2;SESN1;HTT;PAFAH1B2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.3817580541149995,-0.9304227424431151,0.5442043222003929,0.8160789699125008,1.0,2/11,6.40%,MFHAS1;LYN
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.38813775508220294,0.9302201487522289,0.5470588235294118,0.9476813993260657,1.0,3/12,8.19%,IGF1;GCK;SORBS1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2434957580704037,-0.929971120629424,0.6194029850746269,0.816667629956835,1.0,14/75,13.41%,ACTB;MEF2C;FARP1;PARD3;APP;KLF7;TBCD;BTBD3;CDK5;S100A6;DSCAML1;RAB3A;MFSD2A;SHTN1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.3091522878397854,-0.9292682556742029,0.5868263473053892,0.8177911450384093,1.0,6/24,9.16%,IL6ST;CYP1B1;PTGS2;CCBE1;FLT4;EIF2AK3
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.3383489847298032,0.9289755309749699,0.5487804878048781,0.9500917859393244,1.0,7/20,17.57%,CHRM2;CHRNB2;LY6G6D;PLCB1;CHRM1;RGS8;CDK5R1
prerank,protein localization to cell junction (GO:1902414),-0.32358693150822293,-0.9289096422375334,0.5623762376237624,0.8181221838836037,1.0,6/22,11.47%,HEG1;TJP1;TJP2;PAK2;JAK1;JAM3
prerank,regulation of cytoplasmic transport (GO:1903649),-0.37427306158164636,-0.9287479254728831,0.5505154639175258,0.8180186286796413,1.0,3/11,8.77%,MAPK1;USP7;SRC
prerank,Golgi organization (GO:0007030),0.24532551002204367,0.9286154342955065,0.5748299319727891,0.9500099191115932,1.0,22/112,13.42%,PLK5;OBSL1;DYM;TANGO2;BET1;OPTN;CLASP1;FAM174B;STX16;LRRK2;GOLGA2;TRAPPC11;HTT;SEC23IP;MYO18A;VPS51;TMED9;GOLGA8B;GOLGA5;TMED4;STK25;RAB1A
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3321183153479096,0.928610886224311,0.5689981096408318,0.9490014918070523,1.0,3/23,8.03%,IGF1;NLRP2B;NLRP3
prerank,generation of neurons (GO:0048699),-0.2120331503837951,-0.9284324474741917,0.6323529411764706,0.8182328437789322,1.0,35/190,17.26%,NRP1;MEF2C;RAPGEF2;MARK1;TGFB2;NDNF;DISC1;RUNX2;RUNX1;SIX1;EML1;CEP85L;BHLHE40;LHX6;WNT5A;CIT;MET;HES1;HEYL;HEY2;CDK5;FGF13;ACSL3;FZD4;WNT9A;NGRN;FZD1;NR4A2;MAP1B;PAFAH1B1;SIX4;DDIT4;ACSL4;HEY1;IER2
prerank,pseudouridine synthesis (GO:0001522),-0.37404017837110126,-0.9284175541287553,0.564870259481038,0.8177497426990328,1.0,6/13,27.21%,PUS3;PUS7L;NHP2;DKC1;PUSL1;NOP10
prerank,response to interferon-beta (GO:0035456),-0.31732024271628106,-0.9282805205710226,0.5657894736842105,0.8175517880290817,1.0,4/22,7.87%,PLSCR1;IFITM3;AIM2;XAF1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.2878975579322615,-0.9281323509948485,0.5585585585585585,0.8173671619869759,1.0,7/31,15.38%,YWHAE;YWHAB;YWHAQ;YWHAZ;HIP1R;BBC3;BAK1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.26867182968051306,-0.9280875815210727,0.5887445887445888,0.8169492443871382,1.0,20/50,32.32%,ACTB;CDKN1C;SERTAD1;GTF2H1;BLM;CCNF;CCND1;CCND2;CCNH;CCNB2;CDKN1B;CDKN3;CDKN2B;CCNT1;CCNJ;STOX1;CDK5R2;CAMK2N1;CCNE1;CDC6
prerank,regulation of protein polymerization (GO:0032271),0.30177733016584823,0.927982771495585,0.5669144981412639,0.9496327633981778,1.0,11/35,23.15%,MAP2;ARHGAP28;PRUNE1;ARL2;ABL1;GBA2;HSP90AA1;ABITRAM;TTBK1;DBNL;PAK3
prerank,positive regulation of axonogenesis (GO:0050772),-0.2681569463004613,-0.9279467664223651,0.5803571428571429,0.8167505567032755,1.0,7/43,4.42%,SLIT2;RHOA;NTN1;SEMA7A;NGF;MACF1;TIAM2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.31208962115146777,0.9278475375985424,0.55765595463138,0.9489520717331869,1.0,7/33,11.83%,PLK5;APPL2;E2F1;CRNN;STXBP4;TAF1;CDC73
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3375431521876554,-0.9277571325768961,0.5523613963039015,0.8166744478807519,1.0,5/18,18.87%,RAD51B;BRD4;FBXO5;CCND1;RAB11A
prerank,cell proliferation in forebrain (GO:0021846),0.40865622534120327,0.9274783411882458,0.5653061224489796,0.9489432248978203,1.0,3/10,11.14%,WNT7A;PCM1;DOCK7
prerank,sensory organ development (GO:0007423),0.2830988604972551,0.9273675502938592,0.5782312925170068,0.9482273969695743,1.0,15/51,19.53%,SMOC1;PBX2;MEIS1;PAX6;MAB21L2;PBX4;ZDHHC16;CPAMD8;SHROOM2;FOXC1;ADAMTS18;RBP4;HIPK2;SOX2;MEIS3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.21290317332290926,0.9273359247694202,0.6916299559471366,0.9472951005711676,1.0,90/366,20.71%,DENND4A;RORA;PPARGC1B;CTR9;SUFU;ZBTB38;SCRT1;MYBL2;CRABP2;ARNT2;ZNF431;NFYB;ESRRA;POU1F1;TULP3;CCAR2;ASCC2;CCAR1;PQBP1;ACTR8;MZF1;WWTR1;RNF14;NFYC;E2F1;CEBPA;SRSF10;CHD3;PHF1;EIF2B4;HES6;MAFA;PPARGC1A;HINFP;FZD7;SSBP2;CLOCK;CREBL2;PRDM2;GON4L;NSD1;TGFBR1;LDB1;RNF20;RNF6;ZFPL1;MAGED1;OBI1;DMTF1;CYFIP1;PML;CHEK2;RBAK;TGFBRAP1;FOXC1;TSC1;MYBL1;SMC3;ABL1;ANKRD17;ELAVL2;METTL18;RBBP6;SOX6;RELA;MYCBP;MYT1;MTF2;SRRT;APBB1;NSD3;NLK;PCGF1;MLXIPL;MLX;MITF;SOX2;KAT6B;DDIT3;POLR2A;PUM3;REST;SUPT4H1;EIF2A;SPTY2D1;MLLT6;NFX1;GCFC2;HOXB7;TGIF2
prerank,protein localization to organelle (GO:0033365),0.23640310736013326,0.9269648425644239,0.6193548387096774,0.9472789517308375,1.0,28/133,17.01%,BMP7;ANK2;MICALL1;OBSL1;TTC21B;TULP3;CSRP3;LMNA;OPTN;WDR35;LRRK2;TIA1;TOR1B;BICD1;SCG3;TOPORS;IFT122;LAMP2;CCDC47;CYB5A;ARL3;FAM83H;MSX1;BANP;GET1;GBF1;MDM2;MTCH2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.19493555531149695,-0.9269601276724824,0.6810631229235881,0.8180800350201806,1.0,102/341,26.21%,FBXL7;NEDD4L;WWP1;ZNRF1;CDC27;PCNP;SMURF1;NTAN1;HECW2;RNF111;SPOPL;ANAPC5;RNF144A;RNF166;UBR4;COP1;RNF144B;RNF125;UBE2D3;KCTD10;PSMA6;ZNRF3;PSMB7;CDC16;TRIM25;OTUD7B;FEM1B;PPP2R5C;ARIH2;UBXN1;ARIH1;MVB12B;PSMB6;PSMB5;SQSTM1;MTA1;RAD23B;UBXN2A;UBE2L3;FBXW7;FZR1;PSMB8;PTTG1;VPS37A;RNF149;CBL;PSMC4;KLHL22;KBTBD7;PSMD11;KLHL3;KCTD5;OS9;UBE2A;RNF19A;UBA6;ADRM1;PCBP2;UBE2G1;PSMB4;RNF128;PSMD14;KCTD6;PPP1R11;ATE1;UCHL1;RMND5B;FBXL4;CDC26;HACE1;FBXW5;TGFB1I1;TRPC4AP;ARRB2;NEDD4;PSMD10;MYLIP;PSME1;FAF1;DTX3L;KLHL25;AGAP3;RNF150;RNF40;PSMB3;CDC23;FBXO45;ATXN3;TOM1L1;TSG101;KCTD17;CUL3;CDC34;AREL1;NHLRC3;DTL;UFD1;CUL4A;KIF14;UBQLN1;SPSB3;RNF168
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.30570210202310033,0.926920883989692,0.5601577909270217,0.9463769661351293,1.0,10/32,18.38%,MAP2;CLIP3;TTBK2;EML2;CLASP1;APC2;TUBB4A;MAPRE1;NAV3;MID1IP1
prerank,pyruvate metabolic process (GO:0006090),0.27454871777409096,0.9264079858521481,0.5839285714285715,0.9467741379021595,1.0,8/52,7.67%,GCK;ME2;ENO1;PGM1;ALDOB;ENO4;PGK1;HKDC1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.24203934302236912,0.9261175984172763,0.6190476190476191,0.9465151124759611,1.0,15/129,9.83%,RNF220;LGR4;LRRK1;WLS;CDH3;PTK7;PSMD3;CCAR2;GPRC5B;FZD9;TNKS2;FGFR2;LRRK2;RSPO1;LYPD6
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.38419874898979717,0.9257955735691021,0.5474308300395256,0.94635228171502,1.0,4/12,17.23%,DPYD;CRMP1;DPYSL2;UMPS
prerank,cilium organization (GO:0044782),0.2253386656012243,0.9255558341067744,0.6197183098591549,0.946002838336439,1.0,53/210,20.22%,CFAP44;DCDC2;INTU;CC2D2A;DYNLT2B;TEKT2;WDR19;GALNT11;ATAT1;RILPL2;IFT74;TTBK2;TEKT5;WDR35;CEP78;RILPL1;SNAP29;CFAP61;CEP290;DYNC2I2;TMEM138;BBS5;WDPCP;ARMC9;IFT122;B9D1;TTC8;TMEM67;PCM1;KIF3A;CPLANE2;IFT80;ASAP1;CDC14B;RAB1A;CFAP20;TCTN2;ARL3;RAB23;FUZ;RPGR;GBF1;PTPN23;OCRL;KIF3B;ARMC2;DYNC2H1;TTC36;RFX2;PTPDC1;CNGB1;CFAP54;TXNDC15
prerank,negative regulation of cartilage development (GO:0061037),-0.359349350208644,-0.9255530759800141,0.5612244897959183,0.820809714876195,1.0,7/13,26.12%,WNT9A;ADAMTS12;EFEMP1;GREM1;PTHLH;PTPN11;SNAI2
prerank,negative regulation of protein secretion (GO:0050709),-0.2730574515787443,-0.925181393792445,0.5864332603938731,0.8211877472327633,1.0,11/38,17.52%,CD200;CCN3;RAB11FIP5;MIDN;RAB11FIP1;APOE;RSAD2;IRS1;KCNB1;DPH3;RAB11FIP3
prerank,protein modification by small protein conjugation (GO:0032446),0.21124611503657476,0.9251806048251342,0.6686217008797654,0.9459676020955173,1.0,80/361,21.25%,RNF220;EYA1;RNF152;EPAS1;RNF43;CTR9;ASB2;PDZRN3;DTX1;DERL1;TRIM62;POM121;RNF41;NUP155;TRIM5;LEO1;PLK1;KLHL13;SHPRH;RNF14;UBA1;FBXO11;TRIM35;ARRB1;DCUN1D4;DTX2;DTX3;HIF3A;RNF135;TRAF7;BRAP;TOPORS;RNF20;RNF6;CAND2;HLTF;UBE2W;FBXO9;CDC73;NUP98;RLIM;PIAS4;NEDD8;SPSB2;RNF138;RNF7;PRKDC;UBE2R2;BCL11A;UCHL3;EIPR1;SIRT1;RNF213;KLHL20;NUP37;MDM2;RANGAP1;NUP88;UBE2S;ANAPC7;USP9X;RNF139;KCTD13;TRIM63;RNF26;TRIM13;NDC1;FBXL5;KLHL7;SPSB1;TRIM41;NFX1;MYCBP2;KLHL21;HECW1;FBXL15;ZSWIM8;TRIM32;URM1;RNF103-CHMP3
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3984608915166036,0.9249732592611164,0.5343035343035343,0.9455190458922941,1.0,2/10,8.15%,HSPA1A;IMPACT
prerank,negative regulation of T cell activation (GO:0050868),-0.28251820147535717,-0.9248841013076592,0.5509259259259259,0.8213855346940476,1.0,17/35,39.54%,TNFRSF21;CEACAM1;DUSP3;CD86;NCKAP1L;JAK3;GLMN;FCGR2B;CEBPB;IL4I1;LAPTM5;GPNMB;SDC4;VTCN1;ARG1;PDCD1LG2;CD80
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.19242000867449455,0.9247998054805892,0.8282828282828283,0.944953222288116,1.0,241/1645,14.25%,DENND4A;ZKSCAN2;MAF;BMP7;RORA;EPAS1;HLF;WNT4;CREB5;PPARGC1B;SNX6;IGF1;DDX5;SMAD3;TRAK1;KDM7A;KMT5A;VGLL3;NPAS3;OSR1;NR2E1;DNMT3L;HMX2;SCML4;MSX2;SOX5;OVOL2;CTR9;SUFU;ZSCAN29;ZBTB38;CDKN2A;TTC21B;SCRT1;CHD4;MYBL2;FBXL19;ARID4A;CREBRF;CRABP2;NR6A1;ARNT2;TENM1;PBX2;KIT;ZNF431;PPARA;ZNF23;SALL4;ZFP3;NFYB;ESRRA;GLIS3;POU1F1;SLTM;UBP1;TULP3;HOXB9;CAPN3;TFDP2;SIM1;WNT7A;PICALM;MSANTD1;CCAR2;CHUK;CCNT2;DKK3;ENO1;ZHX1;SMARCD3;LOXL3;KMT2A;HOXB3;MAFG;MEIS1;ASCC2;TIAL1;PEG3;CCAR1;RUVBL2;PCID2;PQBP1;PRMT2;MLXIP;PAX6;IKZF1;PHF8;RBPJ;ACTR8;IKZF2;MZF1;ARID3A;BICRAL;ZFHX2;WWTR1;ZBTB26;HOXA7;PBX4;RFX8;RNF14;NFYC;DRGX;RCOR3;ZKSCAN3;PCGF5;E2F1;CEBPA;CITED1;DPF1;PBXIP1;NRG1;LBH;HOXB6;DDX17;BCL11B;JARID2;SRSF10;BEND5;KAT5;NR2F2;ZC3H8;BCL7A;TEF;ARRB1;ARHGEF11;KLF15;CHD3;ZSCAN22;SNF8;HOXA3;ZNF569;KDM5B;KCNH2;ZNF467;PHF1;PHF2;HES6;MED1;MAFA;CEP290;PPARGC1A;ZFX;KDM2A;HINFP;MAP3K10;HIF3A;MAX;DMAP1;ZNF711;NR1H3;PHIP;E2F8;ZBTB22;HDX;ZIC2;FZD7;MLLT11;HOXB4;NKAP;SSBP2;RXRA;CLOCK;CREBL2;ZFP90;PRDM2;PSIP1;MPHOSPH8;COMMD7;GON4L;NSD1;SALL3;TGFBR1;FOXP4;LDB1;PLCB1;PRKCB;CSRNP3;BRD7;ZNF260;RNF10;RNF20;RNF6;LCOR;E2F4;CSRNP1;CAND2;MAPK14;STAT1;USF1;BATF;ZFPL1;MBD1;MAGED1;MXI1;STAT2;KDM5C;QARS1;GATAD2A;PCGF6;ZBTB49;DMTF1;KDM4A;SOX9;SRA1;CIPC;MED12L;RLIM;PML;RCOR2;RING1;CHEK2;RBAK;BHLHE41;PURB;PIAS4;BRD2;ZNF367;HBP1;CBFA2T2;GABPA;ZIC5;YEATS4;TGFBRAP1;ABCA2;MAP3K12;NIF3L1;EN2;HDAC4;CTBP2;FOXC1;MEN1;ZSCAN20;ARNT;ZNF483;PLAGL2;PSMC5;ZKSCAN4;MYBL1;POLR3C;CREB3L4
prerank,lipoxygenase pathway (GO:0019372),-0.356673170944214,-0.9245523641635218,0.562,0.8216692319631216,1.0,3/14,9.75%,PTGS2;PON2;GPX1
prerank,"transcription, DNA-templated (GO:0006351)",0.2219344299523129,0.9242992468781652,0.6476043276661515,0.9452907245889477,1.0,24/207,11.83%,MAF;DDX5;SOX5;CTR9;THRB;RRAGC;DTX1;GLIS3;CCNT2;POLRMT;TCEA1;LEO1;E2F1;TAF10;EAF2;CREBL2;DRG1;TOPORS;RNMT;MBD1;TSC22D1;TAF1;MLLT1;CDC73
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.38611881322162944,-0.9238141328158683,0.5744234800838575,0.8229135691399425,1.0,3/11,10.02%,IL6ST;STAT3;JAK1
prerank,positive regulation of vacuole organization (GO:0044090),-0.39302880579065325,-0.923743836929363,0.576171875,0.8225424040896676,1.0,2/10,4.57%,PIP4K2A;RALB
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3920867454825937,-0.9235614254948765,0.5831622176591376,0.8224637841496079,1.0,2/10,1.92%,ZBTB16;ACVRL1
prerank,protein sumoylation (GO:0016925),0.281267793781259,0.9230882921918545,0.552536231884058,0.9474552380831224,1.0,10/49,17.13%,EYA1;POM121;NUP155;TOPORS;NUP98;PIAS4;BCL11A;NUP37;RANGAP1;NUP88
prerank,protein heterooligomerization (GO:0051291),0.3498188178564131,0.9229501635439904,0.5572815533980583,0.9468155077825567,1.0,4/17,9.39%,TMEM120B;CPSF6;CPSF7;KCNC2
prerank,sterol transport (GO:0015918),-0.3298511262380336,-0.9225503300244808,0.5628865979381443,0.824348983206774,1.0,3/19,6.51%,CAV1;NPC2;OSBP
prerank,calcium-mediated signaling (GO:0019722),0.24950084635657024,0.9225196011487337,0.6089193825042881,0.9469668434518171,1.0,14/93,11.47%,CCR9;ACKR2;SPHK1;ANK2;GPR143;DMPK;PDPK1;NUDT4;LRRK2;NMUR1;ADGRL1;RYR2;KSR2;TRPM2
prerank,positive regulation of insulin secretion (GO:0032024),0.2907668715825342,0.9224558800994713,0.5817843866171004,0.9461256403580183,1.0,4/36,6.20%,NNAT;GCK;NLGN2;ADCY8
prerank,myeloid cell development (GO:0061515),-0.3273547789551178,-0.9216310966387293,0.5655737704918032,0.8260551307337773,1.0,5/18,16.13%,FOXP1;APP;SRC;NCKAP1L;NRROS
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.38856828899783463,0.921329525727306,0.547808764940239,0.9480606748625422,1.0,1/12,0.87%,IL18
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.39170060605357726,-0.9212508121143218,0.5859375,0.8264343501619298,1.0,3/10,15.60%,ITGA5;MT3;VTN
prerank,regulation of viral release from host cell (GO:1902186),0.3355340932337852,0.9212290968087695,0.54510556621881,0.9473358113602093,1.0,7/21,21.25%,TRIM62;TRIM5;TRIM35;PML;TRIM13;TRIM32;CHMP3
prerank,cellular response to cAMP (GO:0071320),-0.29064903786572444,-0.9210105122374367,0.5831485587583148,0.8264902024639802,1.0,7/30,16.14%,RAPGEF2;RAP1A;PDE2A;KCNQ1;AHR;SLC26A6;CFTR
prerank,positive regulation of secretion by cell (GO:1903532),-0.24396306763825215,-0.9209907947740964,0.631578947368421,0.8260130425309816,1.0,22/70,20.36%,SLC12A2;TGFB2;UNC13B;STX1A;TMED10;PPIA;TGFB3;GOLPH3;CD2AP;EDN1;EXOC1;EDN3;RAB3A;BMP2;RAB27A;APBB3;KCNB1;CFTR;GPER1;EXPH5;MYOM1;RAB27B
prerank,protein methylation (GO:0006479),0.28734403511188716,0.9209090203925009,0.5846153846153846,0.9472148788527606,1.0,13/40,21.97%,EEF2KMT;PRMT2;N6AMT1;FAM98B;NSD1;PCMT1;PRMT3;ETF1;NTMT1;NSD3;SNRPB;VCPKMT;PRMT5
prerank,regulation of tau-protein kinase activity (GO:1902947),0.40035151591237206,0.9208905045839888,0.5456389452332657,0.9462696178173869,1.0,10/10,59.99%,CLU;HSP90AA1;SORL1;RB1;HSP90AB1;IFNG;DKK1;NAB2;C5AR1;EGR1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.30573592298248436,0.9205198962423535,0.5537918871252204,0.9462540420680027,1.0,6/30,11.04%,CACNA1D;ANK2;SNTA1;FGF12;KCNH2;RYR2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.20618240330791732,-0.9202878495843309,0.727810650887574,0.8271819771210561,1.0,34/208,12.62%,ROR1;DAB2IP;RHOA;TRAF5;TNFSF10;ALPK1;MIER1;REL;NOD1;ESR1;MID2;PLCG2;FLNA;BRD4;CARD16;TFRC;PRKD1;WNT5A;S100A13;SLC44A2;TRIM14;PLK2;TRIM25;OTUD7B;PER1;MALT1;TERF2IP;EDA2R;HSPB1;SQSTM1;CD74;BIRC3;TNFRSF19;ECM1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3678219480181963,-0.920210240844789,0.6024340770791075,0.8268487516483174,1.0,6/13,19.30%,MDFIC;APOD;TPR;SP100;BARD1;CABP1
prerank,phasic smooth muscle contraction (GO:0014821),-0.3915247779195509,-0.920027643735814,0.5623721881390593,0.8267710150920331,1.0,6/10,38.90%,EDN1;EDN3;PTGER3;DRD2;TIFAB;HTR1D
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.3363797595229211,0.91991877136371,0.5716981132075472,0.946783819289089,1.0,7/20,19.30%,FITM2;ACSM2A;GCDH;DGAT2;ACACA;FAR1;HSD17B4
prerank,glutamate receptor signaling pathway (GO:0007215),0.29200544324987543,0.9198891432698902,0.5672514619883041,0.9458638769834046,1.0,9/37,17.57%,DAGLA;GRIN3A;GRID2;GRIK2;CPEB4;PLCB1;GRIA2;GRM8;CDK5R1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.22426451251118396,-0.9190844832056247,0.6518518518518519,0.8284793001612413,1.0,33/100,23.57%,EIF3H;CBFA2T3;RNF144A;NKD2;COP1;RNF144B;CSNK1E;RACK1;ZYG11B;CSNK1A1;ARIH2;UBXN1;USP7;SOCS5;ARIH1;BAG5;PABIR1;RAD23B;FOXF2;GABARAP;GNA12;RNF19A;N4BP1;RYBP;PSMD10;TRIB2;CSNK1D;UCHL5;GLMN;FHIT;TRIB3;GIPC1;TAF9
prerank,telomere maintenance (GO:0000723),-0.26113896017733523,-0.9187596529464799,0.6312056737588653,0.82872872140022,1.0,18/50,26.20%,RPA1;XRCC5;PTGES3;SMC5;TERF2IP;BLM;TEP1;SP100;ZBTB48;NBN;RPA2;POLD4;TEN1;PARP3;XRCC3;CTC1;TINF2;TERF2
prerank,endocrine system development (GO:0035270),0.334506781092509,0.9186162826095255,0.5612648221343873,0.9483194312565396,1.0,3/21,10.07%,WNT4;DKK3;TGFBR1
prerank,ion homeostasis (GO:0050801),-0.29558657348357653,-0.9185668532118553,0.5796178343949044,0.8286515478654609,1.0,4/30,5.60%,SLC4A10;NEDD4L;FHL1;CAMK2D
prerank,development of primary male sexual characteristics (GO:0046546),-0.282298438923254,-0.918446952408804,0.6047516198704104,0.8283965431314149,1.0,5/34,6.86%,KITLG;TGFB2;LHFPL2;WNT5A;AR
prerank,inner mitochondrial membrane organization (GO:0007007),-0.25875637940997576,-0.9183239985006407,0.6026785714285714,0.828174851163357,1.0,11/47,15.64%,AGK;TIMM22;ATP5MF;ATP5F1E;ATP5F1B;DNAJC11;ATP5MC3;GHITM;ROMO1;ATP5F1D;TIMM29
prerank,cellular response to chemical stress (GO:0062197),-0.23236235536598288,-0.9180940029467474,0.6408977556109726,0.8282002956965347,1.0,21/96,16.08%,CAV1;LRRC8D;FOXO1;FOXO3;PRR5L;FAS;PRKD1;PPIA;ETV5;PIK3CA;SOD1;CAT;GPX1;NCF2;PRDX6;TRPV4;MT3;VKORC1L1;ZFAND1;ATF4;SRXN1
prerank,activation of phospholipase C activity (GO:0007202),-0.29555287809396324,-0.9179538428912605,0.5833333333333334,0.8280087421849873,1.0,7/29,14.23%,EDNRA;EGFR;PLCG1;PHB2;HTR2A;CD86;P2RY6
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3348354032803854,0.9178279565297621,0.5653846153846154,0.9493517718218902,1.0,2/22,5.02%,ROCK2;PPP4R4
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.31990907295165333,-0.9177747695378494,0.5870020964360587,0.8279370887311841,1.0,5/20,9.55%,PID1;BCL2L1;NUMB;TMEM59;ABI3
prerank,axon development (GO:0061564),-0.23702079437973922,-0.9173908633866503,0.6308900523560209,0.8283261942545174,1.0,17/78,16.66%,ACTB;PARD3;APP;KLF7;GRM7;ARHGAP35;CDK5;S100A6;EPHB2;DSCAML1;RAB3A;SHTN1;MAP1B;DHFR;SEMA5A;RTN4;RTN4RL1
prerank,response to insulin (GO:0032868),0.2538367179194086,0.9169821010318416,0.6159052453468697,0.9505775080786949,1.0,26/80,22.04%,CPEB2;GCK;INSIG2;LPIN1;CITED1;PDPK1;PRKCI;SORBS1;RHOQ;USF1;EPRS1;RAB13;TSC1;PRKDC;GOT1;SIRT1;AKT1;KHK;INHBB;RAB15;EIF6;INPP5K;MYO5A;DENND4C;CAPN10;SLC27A1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.3501567604515505,0.9165804664202976,0.5602409638554217,0.9506713453597451,1.0,3/17,5.45%,NUPR1;PPARA;PPIF
prerank,protein K48-linked ubiquitination (GO:0070936),0.2738093586114132,0.9163369285723388,0.5486725663716814,0.9503045317271359,1.0,4/54,4.67%,RNF152;UBE2E2;RNF126;IFI27
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.22054565962090933,-0.9158357053056452,0.6584158415841584,0.8314906984836913,1.0,39/124,25.56%,PTPRM;FRY;RAPGEF2;APP;STMN1;FAM161A;STX3;MAP4;LYN;MYOC;CDK5;APOE;LIMA1;FRYL;MICALL2;SH3GL2;ODF2;CSF1R;ATCAY;MANF;STMN4;CDK16;RAB11A;FAM161B;MNS1;NEDD4;HMGB1;TTC17;RAB35;ROCK1;IQCG;RYK;NPY;PRMT1;BTG2;KIFAP3;ULK1;VAPA;CARMIL1
prerank,negative regulation of hemostasis (GO:1900047),-0.3630372130239681,-0.9152276904119185,0.5627450980392157,0.832410085465635,1.0,5/12,15.60%,CD34;SERPINE1;APOE;EDN1;VTN
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3347071070960242,0.9152075757266595,0.5791505791505791,0.9521706877562036,1.0,3/20,10.07%,NUPR1;FLOT2;CFLAR
prerank,carboxylic acid metabolic process (GO:0019752),-0.2809905558047212,-0.9148059212561707,0.5995423340961098,0.83287812765479,1.0,6/33,6.34%,SLC2A1;PLA2G4A;CSGALNACT1;PTGIS;ST3GAL1;SLC2A3
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.340833619835746,-0.91371321321846,0.596116504854369,0.8349578394726598,1.0,8/16,25.72%,RUNX1;BMP4;CREB3L1;TGFB3;HDAC2;RGCC;AMELX;F2R
prerank,negative regulation of neuron projection development (GO:0010977),0.2661855423608829,0.9136003864253172,0.6,0.9554041930115896,1.0,12/56,15.22%,EFNB2;PTPN9;CRMP1;RUFY3;NGEF;LRP4;LPAR1;EPHA4;CBFA2T2;PTPRO;BCL11A;TSKU
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3467044363374878,0.9134816523999697,0.564299424184261,0.9547506296121432,1.0,2/16,0.78%,IGF1;ROCK2
prerank,regulation of aerobic respiration (GO:1903715),0.35009391451297867,0.9133470061875805,0.5748502994011976,0.9541313511986816,1.0,4/15,16.57%,COX7A1;COX7A2L;ABCD1;ATP7A
prerank,peptidyl-lysine modification (GO:0018205),0.24519685974870062,0.9132589304002341,0.6360544217687075,0.9533617426821694,1.0,19/99,17.13%,EYA1;NNAT;SENP3;POM121;NUP155;LOXL3;LOXL1;KAT5;TOPORS;NUP98;PIAS4;HDAC4;BCL11A;SIRT1;NUP37;ATP7A;CTH;RANGAP1;NUP88
prerank,negative regulation of cilium assembly (GO:1902018),-0.3694904511632682,-0.9129819899987259,0.5903614457831325,0.8361268980738007,1.0,6/12,19.79%,LIMK2;MAP4;EVI5L;TBC1D7;CCP110;CEP97
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.381401550400506,-0.9128895242677962,0.566,0.8358193730794858,1.0,3/10,5.60%,NEDD4L;HECW2;CAMK2D
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.29565857099128384,-0.9128157895714021,0.594758064516129,0.8354579036252089,1.0,6/26,9.16%,IL6ST;CYP1B1;PTGS2;CCBE1;FLT4;EIF2AK3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.29699019995659104,-0.9127951260415079,0.5930735930735931,0.8349731217130324,1.0,12/26,27.92%,MET;OCLN;RPS3;TRPV4;CLIP1;KATNB1;TOGARAM1;DCTN1;CDK5RAP2;FES;AKAP9;MAPT
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.36095196216059444,0.9126074667259463,0.5525291828793775,0.9540073605062671,1.0,2/14,8.07%,HSPA1A;LRRK2
prerank,regulation of lipid storage (GO:0010883),-0.3087524154326916,-0.9125063815979205,0.6078431372549019,0.8351560819998731,1.0,6/22,19.90%,FTO;NFKBIA;FBXW7;C3;ZC3H12A;MEST
prerank,phospholipid homeostasis (GO:0055091),-0.3793914870087945,-0.9124355545188293,0.6018867924528302,0.8347749787899279,1.0,3/11,25.93%,ABCA1;TLCD1;FABP3
prerank,neuron remodeling (GO:0016322),-0.39668293806941096,-0.9121803779743953,0.5795677799607073,0.8348366896674607,1.0,3/10,3.64%,ANKS1A;SCARF1;APP
prerank,glutathione biosynthetic process (GO:0006750),-0.37043815935768154,-0.911687813249214,0.5870020964360587,0.8354773760617095,1.0,6/11,29.75%,GSS;GCLC;GCLM;GGT1;HAGH;CHAC2
prerank,respiratory chain complex IV assembly (GO:0008535),0.32264164706554177,0.9116378895808426,0.59251968503937,0.9555330390349691,1.0,9/21,25.76%,COX18;COX10;COX14;TIMM21;COX20;OXA1L;COA6;COX19;FASTKD3
prerank,neuron projection development (GO:0031175),-0.20961390640710417,-0.9107182065090892,0.717032967032967,0.8372236908346211,1.0,42/168,21.29%,PTPRM;FRY;SHANK3;DOCK10;RAPGEF2;DAB2IP;NGF;APP;STMN1;TNIK;STX3;UBB;MAP4;LYN;GRM7;DCLK1;MYOC;CDK5;MAP4K4;APOE;EPHB2;FRYL;MICALL2;SH3GL2;SHTN1;ANKRD27;NCKAP1L;TAOK3;PTEN;ATCAY;TAOK1;MANF;STMN4;KIF20B;CDK16;RAB11A;CDC42;TRIO;NEDD4;HMGB1;RAB35;ROCK1
prerank,calcium ion transport into cytosol (GO:0060402),0.32751395757379786,0.9105648478326469,0.5927342256214149,0.9572842741756796,1.0,5/21,11.47%,CACNB3;JPH1;GRIN2D;RYR2;TRPM2
prerank,TOR signaling (GO:0031929),0.3097873545532769,0.9103862355767511,0.5743879472693032,0.9567103160256292,1.0,2/26,2.19%,NPRL3;RICTOR
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.32390764158313484,0.9102970454266214,0.5751503006012024,0.9559627694949172,1.0,5/21,12.71%,HS3ST3B1;HS6ST1;HS6ST3;HS3ST5;HS6ST2
prerank,regulation of protein neddylation (GO:2000434),0.40016097504566706,0.9102444069622074,0.5763747454175153,0.9551083432406595,1.0,2/10,7.62%,EPAS1;DCUN1D4
prerank,regulation of NMDA receptor activity (GO:2000310),0.2956361576303453,0.9100899351462949,0.5863377609108159,0.9545479645654911,1.0,9/32,19.03%,ACTN2;SLC6A9;DLG1;DLG4;OPRM1;LRRC7;GRIA2;NEFL;MAPK8IP2
prerank,lipid phosphorylation (GO:0046834),-0.3861798755292236,-0.9100252930045358,0.577962577962578,0.8383703931938615,1.0,2/10,3.37%,DGKH;DGKZ
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2984784503512439,-0.9099550702143769,0.6008146639511202,0.8379988028229235,1.0,7/27,15.78%,CRY1;BHLHE40;PPP1CA;PER1;MTA1;PPP1CC;ID2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2608139164414893,0.9097668827043164,0.6354344122657581,0.9544175660880122,1.0,20/66,21.13%,UBE2E2;PLK5;APPL2;CDKN2A;DLG1;PRMT2;E2F1;PLCB1;BRD7;CDC73;LSM11;HYAL1;ANKRD17;AKT1;WEE1;FGF10;CDK2AP2;DDX3X;PSME2;KANK2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2681391098646528,0.9096992023659753,0.5875420875420876,0.9535904194641632,1.0,18/59,18.36%,ROCK2;OXSR1;WNK3;STK39;PDPK1;LRRK2;MAP3K10;TGFBR1;CSNK2A2;TAF1;MAP3K12;PRKDC;DYRK4;PRKCA;CDK5R1;NLK;HIPK2;AKT1
prerank,cellular response to nutrient levels (GO:0031669),-0.24618176419777055,-0.9094711423859697,0.6544622425629291,0.838606499075072,1.0,18/62,18.43%,BMPR2;FOXO1;WIPI1;RALB;TFEB;MAP1LC3B;STK24;RPTOR;RIPOR1;FAM107A;SREBF2;MFSD2A;RRAGA;GAS2L1;KCNB1;CLEC16A;WDR45B;STK26
prerank,calcium import into the mitochondrion (GO:0036444),-0.3765154229810745,-0.9086958658953782,0.5808383233532934,0.8398660995323768,1.0,4/10,14.31%,MICU3;MCUB;MICU2;SMDT1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.33179000427127586,0.908481329874198,0.5596868884540117,0.9557240497559213,1.0,3/21,3.86%,IGF1;BMPR1A;FGF9
prerank,positive regulation of nervous system development (GO:0051962),0.2798253923718456,0.9082847636464483,0.6036697247706422,0.9552605188360855,1.0,11/42,17.49%,IL1RAPL1;NLGN2;WNT7A;GRID2;NLGN3;PTPRD;FAIM;BDNF;OPRM1;EPHB1;SYNDIG1
prerank,calcium ion homeostasis (GO:0055074),0.2447605929138343,0.9080795868955093,0.6028119507908611,0.9547630773830501,1.0,8/95,4.15%,SLC8A3;SLC24A3;ATP13A5;ANK2;DMPK;FAM20A;CSRP3;ATP13A3
prerank,protein deubiquitination (GO:0016579),-0.2003697130452554,-0.9080683550000446,0.7741046831955923,0.8407916438039309,1.0,64/242,23.59%,ACTB;RHOA;USP24;NFKBIA;UBC;ESR1;SMAD1;RPS27A;UBB;ATXN7;PSMA6;AR;PSMB7;USP46;OTUD7B;APC;MINDY1;USP7;USP35;EIF3F;PSMB6;SPATA2;BABAM2;HGS;PSMB5;MINDY2;RAD23B;BIRC3;USP47;RNF123;PSMB8;CCP110;IFIH1;TAB1;PSMC4;FOXO4;PSMD11;ENY2;CFTR;USP50;ADRM1;JOSD1;PTEN;RUVBL1;PSMB4;RNF128;PSMD14;BARD1;IL33;UCHL1;USP10;ZC3H12A;RIPK1;ARRB2;PSMD10;RCE1;UCHL5;PSME1;TRRAP;USP15;PSMB3;CYLD;ATXN3;POLB
prerank,membrane lipid catabolic process (GO:0046466),0.39237923559305,0.9077516979002349,0.5315487571701721,0.9546283779072966,1.0,4/10,18.30%,NAGA;FUCA1;SMPD2;MGST2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.24946999441620513,-0.9077227500934683,0.6142857142857143,0.8411014505993333,1.0,19/60,24.19%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;FBXO4;FGF2;HMBOX1;KLF4;CCT2;PARM1;GREM1;MAPK3;MAP2K7;RFC4;MAP3K4;DKC1;POLG2;RGCC
prerank,signal peptide processing (GO:0006465),-0.370487793634635,-0.9075605847145367,0.6007905138339921,0.8409773681583612,1.0,3/11,14.21%,PCSK5;SPPL3;HM13
prerank,positive regulation of protein polymerization (GO:0032273),-0.24260315215020178,-0.9074232393300367,0.635678391959799,0.8408011682938675,1.0,21/65,26.29%,CDC42EP5;CDC42EP3;MET;NCK1;OCLN;RPS3;TPPP3;CDC42EP2;PTK2B;PFN1;CLIP1;NCKAP1L;TOGARAM1;FCHSD1;HCK;DCTN1;CDK5RAP2;FES;PRKCE;CARMIL1;AKAP9
prerank,negative regulation of protein binding (GO:0032091),0.25651717702730864,0.907215077748569,0.6127886323268206,0.9550490274958963,1.0,10/71,8.46%,IFIT2;DAB2;MAP2;TFIP11;CAMK1;TTBK2;IFIT1;LRRK2;GNL3L;GOLGA2
prerank,positive regulation of protein import (GO:1904591),-0.28515682629792644,-0.9068142048214337,0.6261467889908257,0.841710356708955,1.0,10/30,23.39%,PIK3R1;CDH1;FLNA;PRKCD;IPO5;TPR;ZC3H12A;ARHGEF5;JUP;HCLS1
prerank,negative regulation of immune effector process (GO:0002698),0.370673605088038,0.9067485490902261,0.5668662674650699,0.9552658134735791,1.0,3/13,14.32%,ENPP3;CD300A;HAVCR2
prerank,cellular response to ionizing radiation (GO:0071479),-0.26058891289579156,-0.9066623125509068,0.6048565121412803,0.8415165165165166,1.0,15/47,28.05%,NET1;MAP3K20;NIPBL;XRCC5;BLM;TNKS1BP1;RHNO1;LIG4;SPIDR;RHOB;TMEM109;NUCKS1;YAP1;GRB2;RAD51AP1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.3900100810989163,-0.9066616929519483,0.5957854406130269,0.8409908972057629,1.0,2/10,10.72%,PFKL;GFPT2
prerank,protein polyubiquitination (GO:0000209),-0.19650705540102373,-0.9060496676291588,0.7888198757763976,0.841886414087829,1.0,68/297,20.39%,FBXL7;NEDD4L;TRAF5;WWP1;ZNRF1;CDC27;SMURF1;HECW2;UBC;ANAPC5;LMO7;RNF144A;RNF166;UBE2V2;RNF144B;RPS27A;RNF125;UBB;UBE2D3;TNKS;FBXW8;TRIM14;TRIM56;UBE2J1;PSMA6;ZNRF2;PSMB7;CDC16;CBFB;FBXO31;FBXO30;ARIH2;FBXO4;ARIH1;PSMB6;FBXO32;PSMB5;UBE2L3;UBE2Q1;FBXW2;FBXO44;LNPEP;FBXW7;FBXL18;TPP2;FBXO28;FZR1;PPIL2;PSMB8;UBE2J2;PSMC4;KBTBD7;PSMD11;KLHL3;UBE2A;RNF19A;UBE2G1;PSMB4;PSMD14;BARD1;CCNF;FBXL4;CDC26;HACE1;FBXW5;NEDD4;PSMD10;MYLIP
prerank,positive regulation of organelle assembly (GO:1902117),-0.264324665047445,-0.9059290260128111,0.6645702306079665,0.8416430857830246,1.0,14/44,23.98%,PIP4K2A;RALB;CNOT6L;ARHGAP35;G3BP1;CAPG;CCP110;RAB3GAP2;DYNC1H1;GPSM2;ENTR1;TAPT1;NUP62;KCTD17
prerank,nuclear transport (GO:0051169),0.35363141199705617,0.9059275356570952,0.5723140495867769,0.9564314258132478,1.0,4/16,11.89%,CITED1;PSIP1;NXT1;NUP98
prerank,B cell differentiation (GO:0030183),-0.26196575729084604,-0.9056190617211131,0.6256038647342995,0.8418450841129775,1.0,9/46,13.63%,VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;HDAC9;HHEX;ITGA4;PTPRC
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.38999571669093563,0.9054951190010462,0.5526838966202783,0.9565580695803324,1.0,3/10,14.47%,GABRG1;GABRG3;GABRB2
prerank,positive regulation of cell cycle (GO:0045787),-0.24756605139638888,-0.9054650437528999,0.6380510440835266,0.8416872488917463,1.0,10/62,10.10%,LRP6;TGFB2;TBX3;PKD1;EGFR;APP;CCNY;EIF4E;TAL1;DUSP3
prerank,cAMP metabolic process (GO:0046058),0.3718710324866918,0.9052067547838774,0.5828343313373253,0.9563245788244799,1.0,3/13,6.20%,ADCY5;ADCY1;ADCY8
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3634303353953312,-0.9049552853450668,0.5833333333333334,0.8423539269075405,1.0,6/12,29.75%,GSS;GCLC;GCLM;GGT1;HAGH;CHAC2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.35463944772173595,-0.9049253128202333,0.611439842209073,0.8419014183306897,1.0,5/12,27.62%,IAPP;APOE;PFDN6;TREM2;LDLR
prerank,cell chemotaxis (GO:0060326),-0.24691682733405237,-0.9048693752873167,0.6330275229357798,0.8415124394137375,1.0,10/60,10.56%,NRP1;LEF1;ABCC1;CCN3;AGTR1;CXCL12;PRKCD;BCAR1;PARVA;ACKR3
prerank,glycerolipid metabolic process (GO:0046486),-0.36210959329423004,-0.9047183730060807,0.5745526838966203,0.8413371115985006,1.0,8/11,43.94%,DGKZ;DGKB;DGKG;DGKA;PIP5K1A;DGKQ;PDXP;PNPLA3
prerank,negative regulation of peptidase activity (GO:0010466),-0.2612480855311545,-0.904134489733023,0.613882863340564,0.8421540695403764,1.0,21/47,31.99%,SPOCK2;SERPINF1;CST3;UBXN1;SERPINE1;SERPINB8;SERPINB9;ECM1;LRP1;VTN;GAPDH;SERPINH1;SERPINI1;TIMP1;AGT;AHSG;PARK7;SERPINE2;SERPINC1;TIMP2;CRB2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.2665115254822805,-0.9040756716832778,0.6342592592592593,0.8417766568269219,1.0,9/38,15.93%,CAV1;GAS6;APP;IL34;PTPN1;NEDD9;PTPRC;CSF1R;RAP2B
prerank,negative regulation of response to external stimulus (GO:0032102),-0.22013087580449248,-0.9036937907818865,0.6906666666666667,0.8421730677941281,1.0,16/105,10.10%,TEK;PPARD;PTGIS;IRAK3;MFHAS1;CD109;CCN3;CASK;CARD16;AJAP1;PRKCD;FGF2;SERPINE1;APOE;KLF4;DUSP3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.28364335866779294,-0.9035055370237254,0.6261261261261262,0.8421382167738996,1.0,17/31,41.45%,LYN;TNFRSF21;CD86;GLMN;FCGR2B;SOX11;CEBPB;IL4I1;GPNMB;TYROBP;SDC4;VTCN1;ARG1;PDCD1LG2;CD80;CTLA4;BLK
prerank,ceramide catabolic process (GO:0046514),-0.34740286666619724,-0.9034284355578184,0.6027944111776448,0.8417889609759598,1.0,4/14,20.23%,ACER2;HEXA;ASAH2;ACER3
prerank,regulation of cellular response to heat (GO:1900034),-0.2364986825810637,-0.9034086973691885,0.6430317848410758,0.8413123988370421,1.0,25/77,24.75%,RPA1;YWHAE;CD34;CAMK2D;MAPK1;PTGES3;NUP107;MAPKAPK2;RPTOR;BAG5;TPR;HSBP1;HIKESHI;BAG1;SEC13;DNAJC2;RPA2;MAPK3;NUP50;AKT1S1;NUP85;AAAS;NUP62;NUP214;IER5
prerank,insulin secretion (GO:0030073),-0.3178640804794008,-0.9026180484247271,0.5862068965517241,0.8425907698981558,1.0,4/19,14.34%,RAB11FIP5;SNX19;ANXA1;RAB11B
prerank,regulation of protein transport (GO:0051223),-0.2960013005994918,-0.9023705101890018,0.6078431372549019,0.8426371480558673,1.0,5/27,8.95%,DISP1;DNAJC1;DNAJA1;GAPVD1;PTPN1
prerank,type I interferon signaling pathway (GO:0060337),0.2809062289749878,0.9020928623995087,0.6136363636363636,0.9624839178338624,1.0,12/41,18.86%,IFIT2;OAS2;IFI27;IFIT3;IFIT1;OAS3;STAT1;STAT2;TYK2;IRF8;IP6K2;ADAR
prerank,cellular response to type I interferon (GO:0071357),0.2809062289749878,0.9020928623995087,0.6136363636363636,0.9624839178338624,1.0,12/41,18.86%,IFIT2;OAS2;IFI27;IFIT3;IFIT1;OAS3;STAT1;STAT2;TYK2;IRF8;IP6K2;ADAR
prerank,granulocyte differentiation (GO:0030851),-0.3240291829900363,-0.9019861152233501,0.6077235772357723,0.8429830594984111,1.0,3/18,9.95%,LEF1;CBFA2T3;TAL1
prerank,membrane protein proteolysis (GO:0033619),-0.272392057218958,-0.9018063896176999,0.6401869158878505,0.8428798261460683,1.0,12/37,26.39%,MYH9;ADAM10;ADAM19;SPPL3;RET;HM13;RHBDD1;PSEN2;PSENEN;ERAP1;MBTPS2;PRTN3
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.3706989964430172,-0.9015739016641006,0.5686653771760155,0.8429118773946361,1.0,3/11,3.58%,ACVR1;TGFB2;TGFBR2
prerank,defense response to symbiont (GO:0140546),0.24289350263154297,0.9013701996940675,0.635593220338983,0.9633960264468475,1.0,15/92,11.49%,IFIT2;OAS2;TRIM5;IFI27;PQBP1;NT5C3A;IFIT3;NCBP3;AGBL4;IFIT1;EIF2AK2;OAS3;BCL2;STAT1;STAT2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2901334597189606,-0.9011001370157267,0.6329670329670329,0.8434529532617133,1.0,4/29,5.72%,CAV1;TNFSF10;THBS1;PAK2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.37060961497909095,0.9010683666988368,0.5914396887159533,0.9632208461540255,1.0,6/12,21.10%,CHRNB2;EPHA4;TSKU;EPHB1;MYCBP2;GLI2
prerank,tRNA wobble uridine modification (GO:0002098),0.3616437229072278,0.9009335725479389,0.5976331360946746,0.9625931714778602,1.0,5/14,23.53%,TRMT9B;GTPBP3;KTI12;URM1;ELP1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3169883610678913,0.9007952241417544,0.5884543761638734,0.9620012080294116,1.0,5/25,12.21%,LEPROT;CHMP6;VTA1;UBXN6;DENND10
prerank,regulation of neuron differentiation (GO:0045664),0.24854622749330402,0.9006016020585929,0.6395759717314488,0.9615113079183303,1.0,10/76,8.34%,BMP7;DTX1;CPNE1;GPRC5B;BEND6;ZFHX2;NREP;LRRK2;IMPACT;MED1
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3152589911150612,-0.9004191138355163,0.5890688259109311,0.8444591962173492,1.0,7/20,21.76%,SYNE1;SUN1;MORC3;ARL2BP;SP100;BARD1;BCL3
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.28094284158718574,-0.9003713956780199,0.6351648351648351,0.8440402640868644,1.0,4/31,5.07%,PARD3;RHOA;WDR1;RAP2A
prerank,negative regulation of protein catabolic process (GO:0042177),-0.26604768729162487,-0.9002045587580709,0.6082251082251082,0.8438992896979421,1.0,6/40,7.90%,DAB2IP;EGFR;IRAK3;FLNA;CST3;PRKCG
prerank,regulation of lipid catabolic process (GO:0050994),0.33963321719823625,0.9000339983167872,0.5711538461538461,0.9619401904395605,1.0,3/19,9.07%,ADRA2A;LONP2;ABCD1
prerank,mitotic cytokinesis (GO:0000281),-0.2586052608493641,-0.8995491875198858,0.6605080831408776,0.8449104099678812,1.0,17/47,26.98%,SPTBN1;STMN1;SNX18;CIT;CHMP4B;APC;KIF23;INCENP;NUSAP1;RHOB;RAB35;ROCK1;RASA1;KIF4A;JTB;CEP55;RTKN
prerank,modification-dependent protein catabolic process (GO:0019941),-0.2026046194622815,-0.8993768326217707,0.7586206896551724,0.8447651819723471,1.0,59/193,25.22%,FBXL7;NEDD4L;CDC27;SMURF1;NTAN1;RNF111;UBC;ANAPC5;RNF144A;RNF166;UBR4;RNF144B;RPS27A;RNF125;UBB;KCTD10;ZNRF3;CDC16;TRIM25;ARIH2;ARIH1;SQSTM1;ISG15;UBE2L3;FZR1;PTTG1;RNF149;CBL;PSMD11;KLHL3;OS9;UBE2A;RNF19A;UBA6;ADRM1;UBE2G1;RNF128;PSMD14;KCTD6;PPP1R11;PCYOX1L;FBXL4;CDC26;HACE1;TRPC4AP;NEDD4;MYLIP;DTX3L;KLHL25;RNF150;RNF40;CDC23;FBXO45;ATXN3;CUL3;CDC34;AREL1;DTL;UFD1
prerank,peptidyl-proline modification (GO:0018208),0.31429535942777465,0.8993021221001536,0.6018691588785047,0.9628941338397986,1.0,3/25,6.12%,PPIL6;PPIF;NKTR
prerank,regulation of neurogenesis (GO:0050767),-0.2519881080470108,-0.8989473489714129,0.672566371681416,0.845198885594791,1.0,10/55,8.50%,B2M;NOTCH1;SERPINF1;BHLHE40;NUMB;HES1;HEYL;TGM2;SPEN;HEY2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.21770255717868361,-0.8989073150167801,0.6811224489795918,0.8447652374337681,1.0,33/117,23.06%,CALCRL;RAMP2;MYH9;PLCG1;PLCG2;ADCY4;GNB1;PTGDR;LYN;ADCY7;GNG2;PLK2;IAPP;SRC;ADCY2;YES1;ADM;CYSLTR2;CYSLTR1;PRKAR2B;PRKACA;PTH1R;ADCYAP1R1;GPR176;GPR27;HCK;NPSR1;PTHLH;SYK;FCGR1A;FYN;GGT1;PRKAR1B
prerank,negative regulation of bone remodeling (GO:0046851),-0.3724504993751193,-0.8988215913414465,0.593939393939394,0.844433900677418,1.0,3/11,18.96%,UBASH3B;TMEM119;GREM1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2995870377606676,-0.8988071025425926,0.6030368763557483,0.8439461250969607,1.0,9/24,27.53%,PDE4D;CAMK2D;CALM3;JPH2;PRKACA;DMD;JPH3;SELENON;CALM1
prerank,cellular response to UV (GO:0034644),-0.23579806267503098,-0.8986955079123056,0.6681818181818182,0.8436684639141351,1.0,21/76,21.67%,PTPRK;CARD16;CRIP1;XPC;PRKCD;MFAP4;ZBTB1;USP47;COPS9;RHBDD1;BAK1;FMR1;ATF4;MMP2;N4BP1;RHNO1;METTL3;NEDD4;XPA;CHEK1;NSMCE3
prerank,ether lipid metabolic process (GO:0046485),-0.3457659726987714,-0.8986650608787999,0.6056338028169014,0.8432026939041813,1.0,4/14,15.75%,DHRS7B;PEX7;PLA2G6;PAFAH1B1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.26533447603967175,-0.8983376965978368,0.6231884057971014,0.8434443269842472,1.0,8/42,14.67%,DEFA6;RPL30;IL6R;SERPINE1;DROSHA;MPEG1;RARRES2;ROMO1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.36768419488841675,0.8980513314601802,0.5633802816901409,0.9651697762101472,1.0,3/13,9.32%,PCID2;NDC80;MAD2L1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.2664784896328133,-0.8980215146768645,0.6553191489361702,0.843639965180786,1.0,15/38,26.64%,DAB2IP;APAF1;RBBP4;SUZ12;YAF2;FOXO4;RHNO1;EPC1;RYBP;MGA;CHEK1;BMI1;PHC3;CDKN2B;TFDP1
prerank,protein-containing complex subunit organization (GO:0043933),0.23542315081552895,0.8979656357207466,0.6678200692041523,0.9644084354232438,1.0,30/109,19.51%,CD247;WDR19;CAPN3;PICALM;KMT2A;AFG3L2;ADD2;IKBKG;SHANK1;RIMS1;WASF1;PPARGC1A;TUBGCP4;LLGL1;DLG4;WASL;EPRS1;NUP98;SOX9;PML;WASF3;WAS;TAPBP;MDM2;HFE;SKAP2;MITF;SNX9;TFAP4;NDC1
prerank,positive regulation of chromosome organization (GO:2001252),-0.34700571602933467,-0.8976164818225275,0.5900990099009901,0.8440358527883574,1.0,7/15,23.83%,GNL3;RAD21;SHCBP1L;NBN;LIG4;SIRT6;PPP1R10
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3784937991286959,0.8975371387368208,0.5630081300813008,0.9645152648658942,1.0,1/11,0.43%,WNT4
prerank,synaptic membrane adhesion (GO:0099560),-0.3485022646399291,-0.8971269870868258,0.5703422053231939,0.8446501893513106,1.0,1/14,0.21%,GPC6
prerank,membrane raft organization (GO:0031579),-0.3394911484804115,-0.8970148742892694,0.5894736842105263,0.8443731157694885,1.0,5/15,19.29%,RFTN1;EMP2;S100A10;NAXE;YJEFN3
prerank,homocysteine metabolic process (GO:0050667),0.3749234542154687,0.8962095995361415,0.5731462925851704,0.9669215122745223,1.0,5/11,26.01%,MMUT;MTHFR;CTH;BLMH;DPEP1
prerank,response to retinoic acid (GO:0032526),0.2638448447005489,0.8951970083093111,0.6161790017211703,0.9685830243929341,1.0,15/59,18.15%,HSD17B2;WNT5B;PTK7;WNT6;HTRA2;FZD7;RXRA;CTSH;SOX9;NDUFA13;RBP4;ATM;RARA;CREB1;FZD10
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.3447801551621629,0.8947541946736001,0.5932835820895522,0.9687349747938802,1.0,4/18,13.46%,C5AR2;SPG21;C3AR1;BAG6
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.35523388685817137,-0.8947029172480839,0.6052631578947368,0.8490661938937801,1.0,5/13,18.15%,NOS3;GCH1;QDPR;PRKG2;MTHFD1L
prerank,sister chromatid segregation (GO:0000819),0.2916271345732926,0.8939852463142571,0.6203007518796992,0.9697265301354919,1.0,6/31,9.75%,TOP2B;ZWINT;PLK1;DSN1;NDC80;TUBG1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.3730167004925229,0.8937381349633003,0.5946502057613169,0.9694009894857555,1.0,5/11,24.24%,PARP14;PARP4;PARP16;PARP10;TIPARP
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.3517273868268605,0.8937005364492059,0.6211538461538462,0.9685286246281581,1.0,3/15,8.02%,KCND3;KCNJ5;KCNH2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.3810467313293501,0.8936609377797672,0.5543933054393305,0.96766032374069,1.0,3/10,11.66%,IVD;ACAD11;GCDH
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.30022744281465186,-0.893528386277965,0.604602510460251,0.8511589580786525,1.0,6/24,11.83%,BCL2L1;CD44;CXCL12;TPT1;ACKR3;CD74
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.3730206074223964,-0.8932065395311884,0.5988023952095808,0.8513792738631538,1.0,8/11,37.12%,FGF2;IPMK;PPIP5K1;ITPKC;ITPKB;PPIP5K2;ITPKA;IP6K3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3153974917619663,0.8931616694451203,0.595703125,0.9679135331283308,1.0,4/23,10.91%,IGF1;EFNB2;NRG1;MAPK14
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.28119819263124296,-0.8930698298779833,0.597872340425532,0.851172044515044,1.0,8/30,17.32%,MLLT3;BMP4;KDR;FLT1;FLT4;PTPRC;CSF1R;SP7
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.38857943418437035,0.893002562374875,0.5881147540983607,0.9673143318510493,1.0,2/10,11.77%,TFIP11;RTEL1
prerank,regulation of interleukin-4 production (GO:0032673),-0.3091374540076429,-0.8929151629695162,0.6319148936170212,0.850995899086957,1.0,2/21,3.21%,LEF1;SLC7A5
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.3065956157506813,-0.8929056991267533,0.6509240246406571,0.8505103000034475,1.0,11/23,29.60%,FAF2;SURF4;AUP1;OS9;SEC13;UFD1;HERPUD1;VCP;TECPR2;RANGRF;LMAN1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.2269554827479019,0.8928641816232976,0.7061688311688312,0.9666932210309698,1.0,14/152,6.95%,RNF220;LGR4;LRRK1;RSPO2;WLS;WNT5B;CDH3;PTK7;PSMD3;CCAR2;GPRC5B;FZD9;TNKS2;FGFR2
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.24166388239078718,-0.8927863635707479,0.6442953020134228,0.8502616356323321,1.0,11/64,11.24%,PLA2G4A;CYP1B1;PTGS2;ACOX1;MGLL;ELOVL5;ACSL5;GPX1;ELOVL6;ACSL3;HACL1
prerank,glycine metabolic process (GO:0006544),0.36965576946751943,0.8927164621853835,0.5841784989858012,0.9660771958031596,1.0,3/12,16.00%,GLDC;GLYAT;GCAT
prerank,centromere complex assembly (GO:0034508),-0.2716371827195866,-0.8926094622779613,0.6652360515021459,0.8501617643217058,1.0,13/36,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;MIS12;RSF1;SMARCA5
prerank,positive regulation of cyclase activity (GO:0031281),0.35584656748313354,0.8925804320245744,0.5970149253731343,0.965442412794416,1.0,1/14,0.44%,CACNA1D
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.26818631274125754,0.8925372357820255,0.6342342342342342,0.9645877418527462,1.0,11/51,13.90%,BMP7;GAS7;CNTNAP2;LRRK2;WASF1;KLK8;GPM6A;DTNBP1;BDNF;NYAP2;DICER1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.29577440064007504,0.892426480686174,0.6074950690335306,0.963906605552915,1.0,3/30,8.53%,ROBO1;ARRB1;LPAR1
prerank,regulation of catabolic process (GO:0009894),-0.32518606170724146,-0.8924254917169311,0.6242299794661191,0.8500435604107341,1.0,7/18,16.11%,NEDD4L;FAP;ITGB1;HGS;ZDHHC7;RARRES2;ZDHHC2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2483595637259093,0.8917687390412071,0.6602112676056338,0.9645403647322397,1.0,22/84,20.88%,IGF1;SPHK1;RTN1;TRIM71;NTRK2;ORMDL2;EIF2AK2;PAIP2B;PAIP2;CLU;EPRS1;EIF4E2;TSC1;FXR2;RNF139;GIGYF2;PRNP;CPEB3;ILF3;DDX3X;LARP1;CNOT8
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2859729604460532,-0.8911720797130726,0.6464646464646465,0.8523829959529838,1.0,11/29,25.19%,WNT5A;NLRC5;PTPN1;ISG15;ABCE1;PTPN6;METTL3;ZBP1;TTLL12;MUL1;PTPN11
prerank,iron ion transport (GO:0006826),-0.25838360106539116,-0.8908006822308011,0.6214953271028038,0.8526921213144848,1.0,10/47,14.34%,SCARA5;STEAP3;ATP6V0A4;SLC40A1;TFRC;ATP6V0D1;ATP6V0A1;ARHGAP1;ATP6V1D;RAB11B
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.3074426914742001,-0.8906797949534717,0.6114790286975718,0.8524236999174788,1.0,6/20,24.79%,ADAM10;HM13;RHBDD1;PSEN2;PSENEN;MBTPS2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.31137509211837255,0.8906469075254616,0.6102003642987249,0.9663626099031787,1.0,4/25,8.94%,GPR143;ITPR1;LRRK2;HTT
prerank,response to UV-A (GO:0070141),-0.3476218287392018,-0.890448540069864,0.6,0.8524294409351881,1.0,5/14,30.21%,EGFR;MMP2;CCND1;TIMP1;MMP3
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.3777218992653689,-0.8902765452352868,0.6204819277108434,0.852275725114896,1.0,4/10,23.33%,AGO2;DROSHA;MRPL44;TARBP2
prerank,regulation of mast cell degranulation (GO:0043304),0.35446362971197454,0.8898508034514755,0.5785123966942148,0.9673353279456387,1.0,3/14,12.34%,UNC13D;CD300A;SPHK2
prerank,ovarian follicle development (GO:0001541),0.36219567184114626,0.8897784666885513,0.6135458167330677,0.9665601864229453,1.0,3/13,8.19%,KIT;INHA;EIF2B4
prerank,axonal fasciculation (GO:0007413),-0.35381352792810766,-0.8896450762025369,0.6192560175054704,0.8531840404039898,1.0,4/12,16.45%,ARHGAP35;EPHB2;SEMA5A;RTN4
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.34265841126904173,-0.8895705000411152,0.6149068322981367,0.8528271545704149,1.0,6/14,14.99%,ABCD2;TWIST1;MFSD2A;AKT2;IRS1;TYSND1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.32878758839222477,-0.8892080532059374,0.5963488843813387,0.8531218816976784,1.0,6/16,25.89%,SHLD1;SMCHD1;MAD2L2;DTX3L;PARP3;SHLD3
prerank,protein secretion (GO:0009306),-0.24282225630637627,-0.8889711403536646,0.6578366445916115,0.8531401839732567,1.0,11/56,12.39%,STEAP3;PCSK5;ABCA1;MIA2;MON1A;SNX19;ANXA1;MTTP;GOLPH3;RAB3A;PDIA4
prerank,nucleotide-excision repair (GO:0006289),-0.2228262553046427,-0.8886750632176756,0.7154046997389034,0.8532952687264421,1.0,30/101,24.21%,RPA1;RNF111;UBC;RPS27A;XPC;UBB;SLC30A9;USP7;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2;AQR;BRCA2;PPIE;GPS1;RPA2;LIG4;POLA1;XPA;POLR2I;COPS6;RFC4;CCNH;POLD4;POLR2F;ATXN3;POLB;COPS4
prerank,neuron projection regeneration (GO:0031102),-0.3790720239420007,-0.8886679962291597,0.5973025048169557,0.8527963447878264,1.0,3/10,16.66%,PTN;DHFR;RTN4RL1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3234641782479513,-0.8883460109702275,0.6274509803921569,0.8530293114960974,1.0,8/17,25.72%,RUNX1;BMP4;CREB3L1;TGFB3;HDAC2;RGCC;AMELX;F2R
prerank,regulation of innate immune response (GO:0045088),-0.24427954698667256,-0.8880693697295541,0.6540284360189573,0.8531132339270464,1.0,22/57,27.88%,POLR3F;PLSCR1;IRAK3;GBP5;IFI35;XIAP;PTPN1;ABCE1;BIRC3;POLR3B;N4BP1;PTPN6;POLR3D;NMI;FCGR2B;ERAP1;MUL1;CASP8;PTPN11;LRP8;TREM2;LYAR
prerank,megakaryocyte differentiation (GO:0030219),0.38086894953220396,0.8880189964779964,0.6038461538461538,0.9699490106098997,1.0,2/11,8.34%,KIT;MED1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3114948400539659,0.8878128137152371,0.6102941176470589,0.9694999627945673,1.0,3/24,11.37%,LPGAT1;PNPLA8;PLA2G15
prerank,response to amyloid-beta (GO:1904645),0.27293727605234946,0.8876846630734905,0.6312949640287769,0.968849918773008,1.0,3/44,1.71%,SNX6;IGF1;CACNB1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3445622349788334,0.8870301171873316,0.6115384615384616,0.9694607285577189,1.0,7/16,21.97%,MRAP2;GRP;CHGA;MRAP;PRKCA;KLK6;PRMT5
prerank,innate immune response (GO:0045087),-0.19777606416681703,-0.8869904662526351,0.8391812865497076,0.8550253618803682,1.0,50/217,21.59%,B2M;ALPK1;APP;MFHAS1;REL;SERINC5;MID2;DEFA6;PLCG2;IFITM3;GCH1;RPL39;LYN;NLRC5;TRIM14;TRIM56;TRIM25;RELB;MFAP4;SRC;CAPZA2;NCF2;YES1;MALT1;SERINC3;PIK3CD;ISG15;CD74;PHB2;PTK2B;CD40;RARRES2;ADAM15;IFIH1;NRROS;SP100;IFITM1;NOD2;C3;IRF5;BTK;KYNU;HCK;POLR3A;CAPZA1;HMGB1;MYD88;SYK;RIPK2;IFITM2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.3280305313188069,-0.8868674583768751,0.6063157894736843,0.8547795721427448,1.0,4/17,11.50%,PPIA;SOD1;BAG5;HSPB1
prerank,RNA biosynthetic process (GO:0032774),-0.275515658383765,-0.8862859909254766,0.6610169491525424,0.8555598352547049,1.0,13/31,30.26%,NCOA6;SMN1;POLA1;TBPL1;POLA2;NAT14;PRIM2;BRF2;SETX;RSF1;HELB;TAF7;SMARCA5
prerank,urogenital system development (GO:0001655),0.3738904842188846,0.8860308535532138,0.5872093023255814,0.9710344213874456,1.0,2/11,11.96%,OSR1;SOX9
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.2737183359128997,-0.8858713047278339,0.6510638297872341,0.8559921191849365,1.0,10/35,21.79%,NEK7;TNKS;XRCC5;MAPK1;FBXO4;HMBOX1;CCT2;MAPK3;MAP2K7;MAP3K4
prerank,carbohydrate derivative catabolic process (GO:1901136),0.32838341931224957,0.8855087985049437,0.5936883629191322,0.9713684326530186,1.0,5/18,15.07%,NAGA;FUCA1;FBXO6;FBXO17;ADAMTS9
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.18999140448231355,-0.8854798174079173,0.8606271777003485,0.8563926990651128,1.0,106/336,26.92%,FOXP1;ACER2;RPA1;RAD51B;FOXO1;BCL2L1;TNFRSF1B;CRY1;HERC2;FNIP2;ALKBH1;SMC1A;CSNK1E;CRIP1;XPC;NIPBL;XRCC5;LYN;REXO4;FBXO31;APC;RPS3;ZBTB1;HPF1;CHD1L;SMC5;XIAP;RPAIN;STK33;MAPKAPK2;CDKN2AIP;WDR76;RNF169;BABAM2;OARD1;GTF2H1;NFATC2;SUSD6;DCUN1D5;BLM;KIN;USP47;NCOA6;SUV39H1;TIMELESS;BAK1;FMR1;UBE2A;TAOK3;UBA6;FANCG;GNL1;SLF2;TOP2A;NBN;BOD1L1;BARD1;MASTL;TAOK1;CCND1;MAPK12;USP10;MAPK3;ZC3H12A;MCL1;TIGAR;PCLAF;SIRT7;POLA1;METTL3;XPA;SPIDR;DYRK2;RFC4;CHEK1;NSMCE4A;MUTYH;NSMCE3;DTX3L;BCL3;WDHD1;TRRAP;RBM24;FBXO45;TAF9;POLB;PARP3;TRAIP;BOK;AATF;ZBTB40;ASH2L;PLK3;BTG2;XRCC3;DTL;POLE3;YAP1;CUL4A;NUDT1;VAV3;RNF168;OTUB1;FANCL;GRB2;RFC2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.34395838885260077,-0.8849948283476485,0.6336842105263157,0.8570504852994238,1.0,7/14,34.79%,PUM2;PUM1;ZCCHC3;USP15;OASL;TLR3;TLR2
prerank,quinone biosynthetic process (GO:1901663),0.35134483324548976,0.8849327530341455,0.6019607843137255,0.9718747992649049,1.0,5/14,20.55%,COQ10A;COQ8B;COQ7;COQ3;FDXR
prerank,positive regulation of protein metabolic process (GO:0051247),-0.21496205922759318,-0.8848970837937218,0.7463054187192119,0.8567616753649786,1.0,20/110,14.94%,DAB2IP;NEDD4L;WWP1;FOXO1;NFKBIA;SMURF1;HECW2;APP;WNT5A;AGTR1;PLK2;APC;APOE;KLF4;RANBP9;CSNK2A1;CD86;KLF2;FZR1;RAB1B
prerank,positive regulation of organelle organization (GO:0010638),0.2941676595593869,0.8847620362545612,0.6332703213610587,0.9713651018761476,1.0,6/32,11.52%,STX18;RAB3GAP1;FYCO1;HTRA2;PPARGC1A;TMED9
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.24503391757676218,0.8847454900661608,0.6690140845070423,0.9704565314164021,1.0,16/87,13.36%,FGF1;FGF4;FLRT3;FGF9;TIAL1;TRIM71;KIF16B;FGFR2;FLRT1;PTBP1;TIA1;FRS2;GALNT3;DSTYK;FGFBP1;HYAL1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.2685682701967251,0.8844887495656697,0.6458715596330276,0.9701391288888476,1.0,8/49,13.88%,PRKCZ;OPRD1;TFIP11;NLRP2B;NLRC3;IMPACT;CLU;PMEPA1
prerank,regulation of DNA repair (GO:0006282),0.2732145226891907,0.8844090844360079,0.6611418047882136,0.9693794184994188,1.0,3/44,2.60%,EYA1;EYA4;EYA2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.22130819508815522,-0.8843217408707896,0.7230046948356808,0.8575839628249836,1.0,15/104,12.38%,ACTB;DAB2IP;RHOA;LRP6;LRP5;RALB;CAB39;CALM3;SRC;RPTOR;HGS;SERTAD1;GTF2H1;BLM;INCENP
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.32019552734963747,-0.8842065657196574,0.6180698151950719,0.8573270478229269,1.0,4/18,12.38%,NOTCH1;CCN3;TMEM119;BMP2
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.21904806902262117,-0.883790748648319,0.7277227722772277,0.8577339693087991,1.0,15/91,14.91%,HIP1;NRP1;STON2;SCARB1;CDH13;MAPK1;USP7;SRC;PTPN1;ZFYVE16;RAB3A;HIP1R;PTPRC;RAB11B;RAB5C
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.32191101085762375,0.8837230498092367,0.6073500967117988,0.9682192992047606,1.0,4/20,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.32191101085762375,0.8837230498092367,0.6073500967117988,0.9682192992047606,1.0,4/20,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.32191101085762375,0.8837230498092367,0.6073500967117988,0.9682192992047606,1.0,4/20,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,response to glucose (GO:0009749),-0.252155326340065,-0.8832707088783849,0.6934782608695652,0.8583935301534585,1.0,12/46,18.95%,THBS1;GAS6;UNC13B;ERN1;RACK1;EIF2B2;PFKL;KCNB1;PRKACA;EIF2B1;GPER1;NKX6-1
prerank,positive regulation of viral transcription (GO:0050434),-0.29977658314750766,-0.8832363901227115,0.6614699331848553,0.8579510262720125,1.0,12/25,37.01%,MDFIC;GTF2F1;POLR2I;POLR2F;POLR2H;NELFCD;CCNT1;RSF1;POLR2E;POLR2J;NELFE;DHX9
prerank,regulation of gastrulation (GO:0010470),-0.3347946223200944,-0.883126083215128,0.604887983706721,0.8576861798277406,1.0,3/14,6.03%,PHLDB1;PHLDB2;RACK1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2399416679120515,0.8829765758342337,0.6677852348993288,0.9690244413699167,1.0,19/85,18.66%,DAB2;HSPA1A;NUPR1;SH3RF2;PLK1;RNF14;CEBPA;LRRK2;TAF1;RNFT1;CLU;BAG6;PSMC5;HSPA1B;DNAJB2;MDM2;ANKIB1;RNF180;FBXO22
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.3474030351466957,-0.8828160057382392,0.6072144288577155,0.8573283042858292,1.0,6/13,28.42%,STAT3;IL15;JAK1;JAK3;GRB2;IL2RG
prerank,cellular response to interleukin-15 (GO:0071350),-0.3474030351466957,-0.8828160057382392,0.6072144288577155,0.8573283042858292,1.0,6/13,28.42%,STAT3;IL15;JAK1;JAK3;GRB2;IL2RG
prerank,organelle assembly (GO:0070925),-0.18434269140572748,-0.8822692830873426,0.9015873015873016,0.8580284521955478,1.0,66/385,15.14%,ABCC4;PGM5;ABLIM1;NEK7;GSN;NOTCH1;PKD1;DISC1;CD34;LIMD1;STARD9;ATG3;WIPI1;EXOC6;RPS23;EXOC4;FAM161A;FLNA;CHMP2B;GABARAPL2;IFT140;TNKS;SH3PXD2B;ABLIM3;CHMP4B;CHMP4A;ARL13B;MAP1LC3B;RB1CC1;ABCA3;BBS9;RPS3;G3BP1;VPS36;ATP6V0D1;TMOD3;PDE6D;ATG16L1;RP2;PARVA;EHD2;EXOC1;HGS;WDR11;TCTN3;PIK3C3;PIBF1;SNX10;FNBP1L;EHD4;UBXN2A;ATP6V1D;STX7;HDAC6;GABARAP;IST1;DYNLL1;AVIL;CYS1;UBAP2L;DZIP1L;VPS37A;BBIP1;RAB1B;TMEM216;CFAP43
prerank,stress-activated MAPK cascade (GO:0051403),-0.23677489184225303,-0.882249365012059,0.6843373493975904,0.8575587905135542,1.0,18/61,22.62%,MAP3K5;UBC;NOD1;MAP3K20;RPS27A;UBB;MAPK1;TNFRSF19;IRAK2;TAB1;GPS1;MAP3K8;NOD2;MAPK3;MAP2K7;RIPK2;MAP4K3;MAPK11
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.36416411478173166,-0.882166558442361,0.6205450733752621,0.8572338368293103,1.0,2/11,9.75%,CAT;GPX1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.38521065266488536,0.8815565492609692,0.6098562628336756,0.971600876590669,1.0,1/10,0.97%,ACTN2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.2348121744209704,-0.8815156664041515,0.6940298507462687,0.8581070213007522,1.0,20/74,23.51%,NOTCH1;LIMD1;UBC;RPS27A;UBB;PSMA6;PSMB7;VHL;PSMB6;PSMB5;VEGFA;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;PSMB3;EGLN3
prerank,regulation of cholesterol transport (GO:0032374),0.3262518851693005,0.8814591886307894,0.6308851224105462,0.9709057991166244,1.0,8/20,22.03%,ABCA13;NR1H3;ABCA2;ABCB4;ABCA5;NUS1;NFKB1;LAMTOR1
prerank,positive regulation of neurogenesis (GO:0050769),0.2517271666744943,0.8814048793895589,0.6618705035971223,0.9701092272495963,1.0,10/68,9.03%,ROBO1;OBSL1;IL1RAPL1;PLXNA2;SMARCD3;FZD3;PLXNA1;NTRK2;PTPRD;PLXNA3
prerank,regulation of isotype switching (GO:0045191),-0.338034029611557,-0.8814016746166431,0.6088709677419355,0.8578755996143194,1.0,5/14,25.89%,TFRC;SHLD1;MAD2L2;PARP3;SHLD3
prerank,protein-DNA complex disassembly (GO:0032986),-0.3309528880112334,-0.881358432189154,0.6310483870967742,0.857447074880025,1.0,5/16,20.48%,SMARCC1;ARID1A;RPL23;SMARCA4;SET
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.26409306995556003,-0.8812848504366237,0.6689497716894978,0.8571071498858053,1.0,12/37,22.58%,RPA1;UBC;RPS27A;UBB;CHD1L;GTF2H5;GTF2H1;ERCC2;RPA2;XPA;RFC4;POLD4
prerank,mitochondrial translational termination (GO:0070126),-0.22621053102965516,-0.8811590277162621,0.744578313253012,0.8568872698193294,1.0,23/88,20.20%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.37579518459953853,-0.8811217931850223,0.6083499005964215,0.8564473120103802,1.0,4/10,16.59%,ABCA3;PHB2;MFSD2A;MTMR1
prerank,regulation of biosynthetic process (GO:0009889),0.36967984934086634,0.8801003831401851,0.6342494714587738,0.9723568569581544,1.0,11/11,63.06%,SPHK2;MID1IP1;ALOX5;PIKFYVE;SNCA;PCK1;UCP1;SLC25A33;CCN6;GSTP1;THRSP
prerank,cilium assembly (GO:0060271),0.20456274488763054,0.8800540102453118,0.7953216374269005,0.9715349486052323,1.0,70/297,20.22%,CFAP44;DCDC2;INTU;TTC21B;CC2D2A;DYNLT2B;TEKT2;WDR19;GALNT11;RSPH4A;ATAT1;RILPL2;IFT74;TTBK2;TEKT5;WDR35;DYNC2LI1;PLK1;CEP78;RILPL1;CLASP1;KIF3C;SNAP29;BBOF1;VANGL2;CEP290;DYNC2I2;TMEM138;BBS5;WDPCP;ARMC9;TUBG1;IFT122;B9D1;E2F4;TTC8;TMEM67;PCM1;KIF3A;CPLANE2;IFT80;ASAP1;SFI1;CDC14B;RAB1A;TUBB4A;CFAP20;TCTN2;ARL3;MAPRE1;RAB23;NINL;NEDD1;FUZ;CETN2;RPGR;GBF1;PTPN23;C2CD3;OCRL;KIF3B;DYNC2H1;HSP90AA1;TTC36;NDE1;RFX2;PTPDC1;CNGB1;CFAP54;TXNDC15
prerank,regulation of intracellular pH (GO:0051453),-0.27599945021708017,-0.8796294920481302,0.6555323590814196,0.8592426073382744,1.0,7/34,16.14%,SLC4A10;SLC9A2;ATP5F1B;SLC26A6;SLC9B1;CA2;CFTR
prerank,regulation of axon extension (GO:0030516),-0.2591520282612374,-0.8795990571795632,0.6645161290322581,0.8587942627302769,1.0,9/37,16.45%,NTN1;SEMA7A;MACF1;APOE;SEMA3G;SHTN1;MT3;LIMK1;RTN4
prerank,gene silencing by miRNA (GO:0035195),-0.27545016619578405,-0.8795109349124242,0.6289592760180995,0.858458300134852,1.0,11/32,23.33%,LIMD1;AGO1;ZC3H7A;PUM2;AGO2;NOTCH4;PUM1;AGO4;XPO5;AJUBA;TARBP2
prerank,regulation of ion transmembrane transport (GO:0034765),0.2867540267812002,0.8794426154426942,0.6273504273504273,0.9721038902134718,1.0,6/33,9.74%,KCNJ13;WNK3;KCNJ5;KCNJ10;KCNH2;KCNJ16
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.34087458514177826,-0.8792965413513919,0.6007905138339921,0.858401820389706,1.0,9/13,47.49%,PRKCD;SOD1;SYK;MAPT;TYROBP;CRP;GSTP1;F2RL1;CD177
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.2858814493791336,-0.8791856463568944,0.6431818181818182,0.8581549627199788,1.0,14/27,29.16%,PDE4D;CAV1;CAMK2D;CTNNA3;FGF13;DSG2;PLN;DSP;JUP;GJA5;STC1;AKAP9;HCN4;RANGRF
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.2736751515729766,-0.8791615609071372,0.6471774193548387,0.8576948357679661,1.0,10/28,24.80%,UBC;NOD1;RPS27A;UBB;IRAK2;TAB1;NOD2;RIPK2;CYLD;CASP8
prerank,regulation of endocytosis (GO:0030100),0.2598519781772385,0.8790982395450737,0.6593806921675774,0.9720024517936489,1.0,6/61,4.69%,DAB2;SYT11;SPHK1;PICALM;CLIP3;RUFY2
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3348036242078662,0.8788308803885801,0.6247619047619047,0.9717099593115148,1.0,4/17,16.37%,PRKCZ;NLRP3;HAVCR2;RARA
prerank,nuclear envelope organization (GO:0006998),0.32473080954809186,0.8787677264651546,0.6086142322097379,0.9709358907404627,1.0,3/20,8.40%,DMPK;NUP155;TOR1B
prerank,sphingosine biosynthetic process (GO:0046512),0.36797885532255603,0.8785849773970795,0.5944798301486199,0.9695382387390504,1.0,3/11,13.27%,SPHK1;SPHK2;ABCA2
prerank,sphingoid biosynthetic process (GO:0046520),0.36797885532255603,0.8785849773970795,0.5944798301486199,0.9695382387390504,1.0,3/11,13.27%,SPHK1;SPHK2;ABCA2
prerank,phosphatidylserine metabolic process (GO:0006658),0.2910749343326236,0.8784232698046817,0.6486988847583643,0.9690297145944344,1.0,5/32,11.37%,OSBPL8;PLA1A;PTDSS2;OSBPL5;PLA2G15
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3120938763974225,0.8783024946897794,0.6274900398406374,0.968423288291128,1.0,6/22,18.41%,PPARA;SORBS1;CREBL2;CREB1;AKT1;MLXIPL
prerank,regulation of interleukin-6 production (GO:0032675),-0.22095190615508928,-0.8781099359578585,0.748792270531401,0.8593973147465631,1.0,38/96,33.08%,CD200;GAS6;AFAP1L2;STAT3;IRAK3;APP;PLCG2;ARHGEF2;WNT5A;IL6R;MAPKAPK2;TWIST1;CD74;IFIH1;NCKAP1L;NOD2;IL33;PTPN6;ZC3H12A;HMGB1;MYD88;SYK;BCL10;PTPN11;TLR4;F2R;AIF1;TREM2;FOXJ1;TMEM106A;TLR6;LGALS9;TLR1;NOS2;TSLP;TLR3;CD47;TYROBP
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.31475982099017347,0.8779927347826069,0.6349809885931559,0.9682659123418321,1.0,9/25,21.98%,LEO1;HNRNPU;EAF2;LDB1;CDC73;SUPT4H1;LARP7;CDK12;WDR43
prerank,cellular response to UV-A (GO:0071492),-0.3663250704363351,-0.8775460953490527,0.6126482213438735,0.8600806329824731,1.0,9/11,49.01%,MMP2;TIMP1;MMP3;MME;OPN5;MMP9;CERS1;PPID;OPN1SW
prerank,oligodendrocyte development (GO:0014003),-0.33133132655841635,-0.8773333111845022,0.6673387096774194,0.8600532817266059,1.0,7/15,32.35%,EIF2B2;B4GALT5;EIF2B1;MYRF;NSUN5;B4GALT6;PRDM8
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.35351889599643954,-0.8771878657582567,0.621414913957935,0.859864487988406,1.0,6/12,24.01%,PROM1;STAT3;VEGFA;AGTPBP1;MYO7A;RORB
prerank,negative regulation of establishment of protein localization (GO:1904950),0.37356755407442427,0.8769485878233954,0.6201232032854209,0.9698971644327077,1.0,3/10,16.39%,NDFIP1;SNX3;NDFIP2
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3559666107830877,-0.8769100421540266,0.6331360946745562,0.8599396530431013,1.0,4/12,23.07%,DDC;MAOA;ODC1;HNMT
prerank,transferrin transport (GO:0033572),-0.2720896568114668,-0.8766051325324592,0.6750572082379863,0.8600767043787422,1.0,9/33,16.78%,STEAP3;ATP6V0A4;TFRC;ATP6V0D1;ATP6V0A1;ARHGAP1;ATP6V1D;RAB11B;TCIRG1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.26643610273131874,-0.8765392361689008,0.6651884700665188,0.8597039079851919,1.0,9/35,18.14%,PPP1R12A;ITGA1;NUAK1;CALM3;PPP1R2;PPP6R1;BOD1L1;PPP1R11;MASTL
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3651053604328928,0.8761966084991072,0.6198347107438017,0.9707505917088696,1.0,3/12,11.04%,DSC2;DLG1;RYR2
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.23374865913567094,-0.8760686359601658,0.7540983606557377,0.8602220437846525,1.0,25/69,26.03%,MEF2C;NDNF;NGF;SIX1;MDK;PRKCG;FOXQ1;SOD1;TGFB3;APOE;UNC5B;PTPRZ1;PTK2B;MT3;SIX4;CRLF1;LIG4;AGAP2;SET;RASA1;KDM2B;NFATC4;F2R;KIF14;WFS1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.28761880503234694,0.8757956612010953,0.6306620209059234,0.9708247304918508,1.0,11/35,17.41%,HSPA1A;ABCB10;MED1;LDB1;MAPK14;STAT1;ARNT;HSPA1B;PRKDC;HSPA9;STAT5B
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3543546171715282,0.875588934537485,0.574235807860262,0.9703682120862969,1.0,5/13,27.46%,SPHK2;ITGAM;STX4;LAMP1;AP1G1
prerank,protein acylation (GO:0043543),0.27939616835175585,0.8753805970015714,0.6537717601547389,0.9699495282697037,1.0,10/38,17.45%,SPHK1;ZDHHC12;ZDHHC1;CLOCK;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,muscle cell migration (GO:0014812),-0.36673670480510845,-0.8752965346107968,0.6317829457364341,0.8613164834818436,1.0,2/10,4.28%,SIX1;CCN3
prerank,regulation of endocytic recycling (GO:2001135),0.36977429716820365,0.8752097902944511,0.6090534979423868,0.9694378571148435,1.0,1/11,0.97%,ACTN2
prerank,positive regulation of viral life cycle (GO:1903902),-0.2964234430198456,-0.8751501527519173,0.6470588235294118,0.8611015404734496,1.0,4/22,15.68%,CHMP2B;CD74;KPNA2;FMR1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.2823743253653007,0.8750150336302369,0.6529080675422139,0.9689736448965321,1.0,9/35,16.96%,PPARGC1B;DDX5;RNF14;DDX17;MED1;PMEPA1;WBP2;SAFB;TADA3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.37263131777883673,0.8743059753009579,0.6024844720496895,0.969759674431041,1.0,4/10,18.88%,KAT5;MUC1;HIPK2;TFAP4
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.2865246849203873,-0.8737810197956405,0.670061099796334,0.8635476585442778,1.0,5/24,9.55%,PID1;BCL2L1;NUMB;TMEM59;ABI3
prerank,male gonad development (GO:0008584),0.2835100356576409,0.8732954092636754,0.6427255985267035,0.9712570190483818,1.0,3/34,3.86%,WNT4;KIT;FGF9
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.28876119955959234,-0.8730949015446521,0.6331877729257642,0.8644559200351263,1.0,12/27,29.83%,ERN1;TRIR;NUDT16;ZC3H12A;TOE1;NYNRIN;NHP2;RNASE4;PCF11;POP7;XRN1;CSTF3
prerank,regulation of protein ubiquitination (GO:0031396),-0.21281422587077486,-0.873012896475884,0.800498753117207,0.8641145839438584,1.0,23/108,14.30%,CAV1;CRY1;SPOPL;DNAJA1;UBB;SPRY2;RPS3;PRKCG;UBXN1;XIAP;FBXO4;FAM107A;AMER1;MALT1;BAG5;SQSTM1;ISG15;FOXF2;BIRC3;UBE2L3;TBC1D7;FBXW7;PHF23
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3362024848447712,-0.8728605552801898,0.6297029702970297,0.8639364048682291,1.0,6/14,26.20%,TNKS;XRCC5;TERF2IP;BRCA2;TINF2;TERF2
prerank,positive regulation of cell death (GO:0010942),-0.23856404944698972,-0.8728131982178834,0.7043879907621247,0.8635385831030967,1.0,20/59,22.51%,SLC6A6;ACER2;MAP3K5;BMP4;WNT5A;AXIN2;APC;GRIN2B;RARG;LRP1;MT3;DDIT4;PRODH;ZC3H12A;RIPK1;RIPK2;FAF1;FYN;CDKN1B;FCGR2B
prerank,regulation of phosphorylation (GO:0042325),0.22742616298853158,0.87244748380496,0.7459546925566343,0.9724072118883413,1.0,15/120,12.11%,PRKAG2;BMP7;GCK;CDKN2A;POM121;NUP155;INHA;PHIP;ROPN1L;FZD7;LDB2;LDB1;STAT2;NUP98;PML
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.36131614993278116,-0.8717362038992398,0.611328125,0.8653518182624597,1.0,4/11,13.71%,GHR;PIK3R1;EIF2AK3;IRS1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3766370086322058,0.8716280669826044,0.6323232323232323,0.973431737807792,1.0,3/10,10.98%,LMBR1L;HOXB4;BATF
prerank,cellular defense response (GO:0006968),0.27312647266167034,0.8708980125478922,0.650994575045208,0.9742244852995748,1.0,2/40,1.32%,CCR9;DCDC2
prerank,negative regulation of defense response (GO:0031348),0.24573561043735498,0.8708204401988837,0.7288135593220338,0.9734898806088087,1.0,10/77,9.85%,RORA;ENPP3;PPARA;METRNL;C1QTNF3;NLRC3;NLRP3;CACTIN;NR1H3;C1QBP
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3298911929187556,-0.8707951474356976,0.648068669527897,0.8668365040735713,1.0,4/14,11.83%,SEMA7A;PLCG2;WNT5A;CD74
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3204866026740234,0.8707845386004697,0.6326923076923077,0.9726533347181575,1.0,3/21,6.20%,ADCY5;ADCY1;ADCY8
prerank,female gamete generation (GO:0007292),-0.2824929409943287,-0.8705998966974587,0.6593625498007968,0.8667357403124258,1.0,17/29,46.82%,PTN;MDK;DMC1;METTL3;PIWIL2;NANOS3;TRIP13;NANOS1;BMP15;IHO1;FSHR;MARF1;NANOS2;M1AP;BCL2L10;FMN2;HORMAD1
prerank,RNA metabolic process (GO:0016070),0.22928911663449017,0.8705972784663525,0.7467741935483871,0.9721888630071158,1.0,29/127,18.86%,CELF2;RNASEH2A;PABPN1;NOVA1;TFIP11;HNRNPH3;ELAVL4;HNRNPA2B1;DUSP11;HNRNPU;HNRNPA3;SUPV3L1;DDX17;HNRNPL;PTBP1;BICD1;MPHOSPH10;AGO3;DICER1;RBM5;SND1;LSM8;POLR2D;DHX8;HNRNPH2;DDX39B;MTREX;THOC1;ADAR
prerank,phagosome-lysosome fusion (GO:0090385),-0.369800218691915,-0.870490513338415,0.6390977443609023,0.8664461387280306,1.0,8/10,44.10%,ARL8B;RAB20;RAB39A;PLA2G5;CLN3;RAB34;RAB7B;RAB7A
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.37779087281174945,-0.8701284855325255,0.6209016393442623,0.8667471100297987,1.0,4/10,18.16%,CRY1;FEM1B;WDR76;RPA2
prerank,response to amino acid (GO:0043200),-0.2759188283171731,-0.8697264226427461,0.648471615720524,0.8671106409225654,1.0,11/31,20.24%,SH3BP4;CAPN2;GLRB;SPAAR;RPTOR;NSMF;IPO5;RRAGA;GLRA2;GRIN1;RRAGD
prerank,zinc ion transmembrane transport (GO:0071577),-0.2964630995224772,-0.8696346942146166,0.6807610993657506,0.8667961780680699,1.0,5/22,13.08%,SLC39A10;SLC30A1;SLC39A8;SLC39A7;SLC30A5
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.2286993782151395,-0.8695909547803573,0.7482993197278912,0.8663800630580092,1.0,18/75,18.38%,PLCE1;RGS3;RGS12;RGS5;CRY1;YWHAB;MGLL;RGS6;EDN1;GRK5;ZDHHC7;RGS4;GIT1;GIT2;RNF157;GPER1;PDE6H;C3
prerank,response to organic cyclic compound (GO:0014070),0.2613028081071651,0.8692353508406938,0.6642728904847397,0.9744317971957422,1.0,11/52,15.34%,IL18;TRPV1;GLDC;LRRK2;CHRNB2;DRD3;PAQR7;TRPM2;ABCA2;ABCB4;GGT5
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.2720963734538513,-0.8691915860727787,0.6540084388185654,0.8667727251780234,1.0,20/29,41.81%,RPS16;RPS8;BMS1;DCAF13;PWP2;RRS1;RPS21;RPS19;WDR46;HELB;DHX37;TSR1;NOP14;RPP40;HEATR1;UTP4;NOL10;UTP20;UTP6;MRPS11
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.35681553432345964,0.8687532850944155,0.6322314049586777,0.9746790516449184,1.0,6/13,26.06%,SRSF10;PRPF19;PRPF6;PRPF3;SART3;PRPF8
prerank,regulation of cellular response to stress (GO:0080135),0.2279976054734759,0.8680538656725492,0.7189014539579968,0.9754478663686599,1.0,21/115,16.21%,HSPA1A;ROCK2;NUPR1;POM121;CCAR2;NUP155;ADCY8;ARMT1;ABCD1;USP19;BAG4;NUP98;OPRM1;HSPA1B;AIFM2;RPA3;VASH1;ABL1;SIRT1;ATM;NUP37
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.290430979316044,-0.8679188220865381,0.6405919661733616,0.8690367965572837,1.0,9/24,25.14%,MEF2C;BOC;CTNNA1;MYOCD;CDH2;MAPK12;CDC42;MAPK11;BNIP2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.29363906594218403,-0.8678478632404043,0.6666666666666666,0.8686665956194457,1.0,9/24,23.59%,RPA1;UBC;RPS27A;UBB;RPA2;LIG4;RFC4;POLD4;POLB
prerank,negative regulation of cell activation (GO:0050866),-0.33408916695195234,-0.8674329324472351,0.6489795918367347,0.8689967598013575,1.0,3/14,9.64%,NOS3;CD200;APOE
prerank,ncRNA 3'-end processing (GO:0043628),-0.33080010074904576,-0.8672796323186706,0.6659574468085107,0.8688496233599629,1.0,6/14,35.07%,ELAC2;TOE1;INTS6L;ERI1;PTCD1;INTS12
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.22216144075980945,-0.866932034990298,0.7377892030848329,0.869031958644312,1.0,35/88,31.21%,DAB2IP;DNAJC1;CST3;RACK1;RPS3;CDK5;EIF2AK3;APOE;EDN1;SYNCRIP;HDAC6;DHFR;FMR1;FXR1;GAPDH;RIDA;NCL;CAPRIN1;EIF4A3;RIC1;NANOS3;RPL13A;DAPK1;BTG2;TYMS;SHMT1;IGF2BP2;PCIF1;IGF2BP1;CNOT1;SERPINE2;PATL2;CLN3;CAMK2N1;CNOT10
prerank,determination of left/right symmetry (GO:0007368),-0.2641852548445821,-0.8665898564977844,0.6811279826464208,0.8692722464428816,1.0,17/37,35.59%,NOTCH1;TBX1;SMO;DNAH11;STIL;CFAP53;DLL1;ODAD2;ENKUR;ODAD3;ZIC3;FOXJ1;NPHP3;CCDC40;LEFTY1;DNAAF4;BBS7
prerank,positive regulation of intracellular transport (GO:0032388),0.27605598214385607,0.866220405025452,0.6723809523809524,0.9788703135332367,1.0,9/38,17.80%,ACTN2;STX18;TENM1;RUFY3;CEP290;PCM1;EIPR1;SPAG5;ATP2A1
prerank,regulation of cell development (GO:0060284),0.27490491920854027,0.8660659262526007,0.6888045540796964,0.9783074292321797,1.0,10/36,18.66%,NOTCH2;PRUNE1;HES6;CLOCK;DOCK7;BHLHE41;PER2;AKT1;CX3CL1;FBXO22
prerank,potassium ion export across plasma membrane (GO:0097623),-0.3394474429212624,-0.865995552164999,0.6502145922746781,0.8700207157170535,1.0,3/13,8.97%,KCNT2;KCNQ1;KCNK5
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.35043814179883387,-0.8659146074768904,0.6640159045725647,0.8697078599634586,1.0,3/12,16.14%,ANO1;PLA2G6;CFTR
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.21955777761840634,-0.8657214346595383,0.7481840193704601,0.8696055715025904,1.0,16/76,13.66%,SMURF1;CBFA2T3;RNF144A;NKD2;COP1;RNF144B;CSNK1E;RACK1;ZYG11B;CSNK1A1;ARIH2;SOCS5;ARIH1;PABIR1;GABARAP;FBXW7
prerank,protein targeting (GO:0006605),0.22565734145231853,0.8654298666315174,0.7219512195121951,0.978858056538665,1.0,22/118,15.85%,TRAK1;MICALL1;ZDHHC12;PITRM1;TOMM40;ZFAND6;TIMM17A;KIF13B;PRKCI;LONP2;TOMM22;ZDHHC24;ZDHHC1;PEX1;LAMP2;MFN2;ZDHHC6;ZDHHC3;AP4M1;FUT10;AKAP6;ZDHHC21
prerank,response to glucocorticoid (GO:0051384),-0.2791172217235387,-0.8652180901854335,0.6845360824742268,0.8701902080865529,1.0,4/26,12.71%,SLIT2;ANXA1;FAM107A;UBE2L3
prerank,regulation of feeding behavior (GO:0060259),0.36859219870746196,0.8649826559978712,0.6334661354581673,0.9789654130183545,1.0,1/11,0.68%,LEPR
prerank,positive regulation of hormone secretion (GO:0046887),0.32433937138027435,0.8648375763343608,0.623574144486692,0.9783858624427082,1.0,4/17,16.92%,VAMP7;C1QTNF3;GRP;HFE
prerank,protein localization to chromatin (GO:0071168),0.32372703607481346,0.8648297481178736,0.6549707602339181,0.9774821595486599,1.0,5/18,11.20%,SGF29;RUVBL2;PLK1;PPHLN1;PIH1D1
prerank,regulation of organelle assembly (GO:1902115),0.24025820488838256,0.8647882593116024,0.7292035398230089,0.9766555871582215,1.0,10/73,8.17%,DCDC2;NPRL3;STX18;DYNLT2B;STAM;SGSM3;DYNC2LI1;ATXN2L;TBC1D9B;RABEP2
prerank,renal absorption (GO:0070293),-0.37000903240438887,-0.8646220327919811,0.6469387755102041,0.870931269429816,1.0,4/10,22.49%,GSN;KCNQ1;KLHL3;HAS2
prerank,striated muscle cell development (GO:0055002),-0.33775133326427237,-0.8645003841953036,0.6587771203155819,0.8706714377212462,1.0,2/14,8.89%,PGM5;TMOD3
prerank,signal transduction by p53 class mediator (GO:0072331),0.2898245878270989,0.8642091902528701,0.6585820895522388,0.9770638785367183,1.0,5/30,10.98%,DDX5;MAGEA2;PDK2;NDRG1;BATF
prerank,histone H3 deacetylation (GO:0070932),-0.3298430114055164,-0.8637357339199231,0.6450939457202505,0.8717296030997234,1.0,6/15,24.90%,HDAC9;PER1;HDAC2;SIRT7;SIRT6;ELK4
prerank,negative regulation of DNA replication (GO:0008156),0.350277683164449,0.8631476973854589,0.6303030303030303,0.9786217526609875,1.0,2/13,4.97%,GMNC;TSPYL2
prerank,regulation of peptidase activity (GO:0052547),-0.30453352607315864,-0.8629154434190411,0.6525252525252525,0.8729294489599051,1.0,5/19,18.62%,CAV1;CST3;ECM1;PSMB8;MAPK12
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.32173907210037805,0.8629041866988989,0.6482213438735178,0.9782311194817086,1.0,5/19,22.28%,NQO1;CHRNB2;RAPSN;ACHE;RIC3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3234407979371655,-0.8627592491569097,0.6733067729083665,0.8727326331226927,1.0,2/16,6.84%,CLDN5;CLDN14
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.30117647378165696,-0.8624520720408252,0.6447638603696099,0.8728339702326393,1.0,11/21,38.66%,RAD51B;BRD4;FBXO5;CCND1;RAB11A;DTL;STOX1;CDK1;DYRK3;CCNB1;VPS4B
prerank,endoderm development (GO:0007492),-0.34385434492063754,-0.8621738303211199,0.6591375770020534,0.872900074348483,1.0,8/13,38.97%,SOX17;SOX7;DUSP1;LHX1;TBX20;DUSP5;DUSP2;GATA4
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.312540953636754,-0.8617110934588532,0.6747474747474748,0.8733748190709484,1.0,8/16,23.95%,CAV1;VHL;HGS;PIBF1;SOCS3;PPP2CA;BCL3;SOCS1
prerank,negative regulation of transport (GO:0051051),0.2595347169787626,0.8616536580465345,0.6820702402957486,0.9802770666991958,1.0,9/51,16.72%,SYT11;NDFIP1;NRG1;NR1H3;SCAMP5;MTMR2;SNX3;NDFIP2;SNX33
prerank,response to purine-containing compound (GO:0014074),-0.3117381744053781,-0.8613657238349582,0.6519916142557652,0.8735669517836172,1.0,2/17,2.31%,TRPC3;ABCC9
prerank,synaptic vesicle localization (GO:0097479),0.3532891427812058,0.8613353334115836,0.6278195488721805,0.9801209596744694,1.0,6/13,25.66%,KIF5C;SNAPIN;SPG11;SYNDIG1;SYNJ1;KIF5A
prerank,positive regulation of filopodium assembly (GO:0051491),0.29750608028614356,0.8613118816627797,0.6579439252336449,0.9792547242525383,1.0,8/24,17.73%,DOCK11;TENM1;RHOQ;GPM6A;WASL;MIEN1;TENM2;RIPOR2
prerank,mitochondrial translational elongation (GO:0070125),-0.2219066354967217,-0.8611967628712542,0.7929292929292929,0.8733988181627317,1.0,23/88,20.20%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;GFM1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3578659958922893,-0.8609437186158186,0.6483931947069943,0.873435248344103,1.0,1/10,0.88%,RAPGEF2
prerank,aminoglycan biosynthetic process (GO:0006023),0.25971475386542214,0.8603574607685534,0.7135036496350365,0.9805280238201454,1.0,9/49,12.71%,HS3ST3A1;HS3ST3B1;HS6ST1;NDST1;PXYLP1;B3GALT6;HS3ST6;HS3ST5;HS6ST2
prerank,regulation of microtubule depolymerization (GO:0031114),-0.2800995349164623,-0.8602933104752811,0.6581196581196581,0.8743163647930284,1.0,13/25,32.41%,ARHGEF2;ATXN7;APC;FGF13;TRPV4;KATNB1;MAP1B;TAOK1;TPX2;CAMSAP2;CIB1;CAMSAP3;CAMSAP1
prerank,regulation of primary metabolic process (GO:0080090),0.22340743955090192,0.8601483809428274,0.7562893081761006,0.9800971203682783,1.0,28/126,19.41%,ROCK2;NQO1;PPARA;NFYB;PSMD3;SMARCD3;NFYC;CHD9;MED1;SC5D;RXRA;PSMD1;PSMC5;SQLE;CYP51A1;PSMA1;TBL1XR1;RUBCNL;ACACA;PSMD12;TM6SF2;NCOR2;GGPS1;HMGCR;PSMD7;NCOR1;SIN3A;OPA3
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2815661796237314,0.8601343779492778,0.6779359430604982,0.9792131908476485,1.0,6/33,11.83%,PLK5;CDKN2A;DLG1;PRMT2;BRD7;CDC73
prerank,T cell differentiation (GO:0030217),0.2702985473446342,0.8600917078854151,0.6601769911504425,0.9784092296105387,1.0,3/40,3.31%,LEPR;KIT;LMBR1L
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.285085418949648,-0.860001121341518,0.6624737945492662,0.8743791993699299,1.0,5/24,8.25%,BCL2L1;CREB3L1;AQP11;RACK1;UBXN1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.327911262925224,0.85996048329254,0.6403162055335968,0.9778214114816859,1.0,5/16,12.34%,PPARA;ENO1;ANTKMT;PPARGC1A;SPHK2
prerank,positive regulation of receptor internalization (GO:0002092),-0.28936594190591713,-0.8597376585850893,0.6776180698151951,0.8744346752803664,1.0,8/22,23.12%,INSR;SFRP4;TBC1D5;VEGFA;FMR1;GREM1;ARRB2;EGF
prerank,muscle tissue morphogenesis (GO:0060415),-0.32154169510852637,-0.8597282000024012,0.6627218934911243,0.8739577639621289,1.0,5/16,12.38%,NOTCH1;BMP4;TBX1;HEY2;BMP2
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3184033231530143,0.8595164425674297,0.650375939849624,0.9779999564799529,1.0,5/20,19.37%,HSPA1A;PTGES3L;CLU;HSP90AA1;LONP1
prerank,neuromuscular process (GO:0050905),-0.32432184670079794,-0.8593875066943633,0.6465863453815262,0.8741728052601656,1.0,5/16,21.28%,GCH1;STRA6;PAFAH1B1;AGTPBP1;DCTN1
prerank,negative regulation of hippo signaling (GO:0035331),-0.3443149287201524,-0.8589483487552149,0.6659959758551308,0.8745701706462705,1.0,4/12,20.85%,LIMD1;CIT;MARK3;AJUBA
prerank,snRNA metabolic process (GO:0016073),-0.30980289037220954,-0.8585563197771237,0.6824457593688363,0.8748609437208273,1.0,5/17,20.01%,INTS11;RBM7;INTS10;INTS9;MEPCE
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.30177391246648083,-0.8585557294204882,0.6619144602851323,0.8743594538756659,1.0,6/20,20.85%,LIMD1;AGO1;AGO2;HELZ;AGO4;AJUBA
prerank,cellular response to estrogen stimulus (GO:0071391),-0.32673503972508283,-0.8585544777229761,0.6694386694386695,0.8738643484523557,1.0,4/14,14.83%,AR;PELP1;SERPINB9;ARID5A
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3298914039906731,0.858296633594996,0.6378600823045267,0.979904341398742,1.0,4/15,11.49%,USP18;CACTIN;OAS3;STAT2
prerank,chromatin remodeling (GO:0006338),-0.21337845647868978,-0.8582747395191028,0.7706855791962175,0.8739235254446686,1.0,12/100,8.61%,ACTB;ESR1;BPTF;ARID1B;SMARCC1;BAZ2B;EZH1;ZBTB1;GATAD2B;RBBP4;CHD1L;ARID1A
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.22427456425646505,-0.8581188653649285,0.7659574468085106,0.8737171779690635,1.0,17/72,21.47%,REL;CARD14;PSMA6;PSMB7;RELB;PSMB6;MALT1;PSMB5;BIRC3;PSMB8;PSMC4;PSMD11;NFKB2;PSMB4;PSMD14;PSMD10;PSME1
prerank,regulation of mitotic cell cycle (GO:0007346),-0.1964732328647276,-0.8576753534202943,0.8408488063660478,0.8741199626770587,1.0,43/171,23.32%,TTC28;NEK7;CDC27;IQGAP1;AFAP1L2;BTG1;APP;ANAPC5;XPC;PSMA6;PSMB7;CDC16;CDKN1C;EIF4E;TAL1;PSMB6;DUSP3;CAV2;BTG3;PSMB5;FBXO5;ERCC2;FZR1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;KIF20B;CDC26;ASAH2;PSMD10;L3MBTL1;THAP1;PSME1;TTLL12;CDKN1B;RNF40;CDK11B;MKI67;PSMB3;CYLD;CDC23
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.378462689696079,-0.8575385985836033,0.6476377952755905,0.873910841145312,1.0,2/10,2.04%,CAV1;ENG
prerank,zymogen activation (GO:0031638),0.2708132081206642,0.8575084704660945,0.6793103448275862,0.9808079634555109,1.0,11/39,23.29%,FURIN;CYFIP2;PGK1;PLAT;CTSH;KLK1;ASPH;NLRC4;OMA1;C1RL;LGMN
prerank,proteoglycan biosynthetic process (GO:0030166),0.28729725987859805,0.8573452012565627,0.6731517509727627,0.9802544320382166,1.0,5/31,7.91%,IGF1;HS3ST3B1;CHST10;PXYLP1;B3GALT6
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3021109067732324,0.8566408059965197,0.677007299270073,0.9809738436019495,1.0,7/26,20.75%,IGF1;FHL2;PTBP1;CHERP;AKAP6;PRNP;RCAN1
prerank,regulation of double-strand break repair (GO:2000779),-0.252783645613476,-0.8564633106488658,0.7076271186440678,0.8755323486773552,1.0,16/39,31.32%,RNF169;TERF2IP;TWIST1;PPP4R2;TIMELESS;SLF2;RPA2;SIRT7;SPIDR;CHEK1;SIRT6;OTUB2;OTUB1;RAD51AP1;SPIRE2;MRNIP
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.30114104783032164,-0.8559062578180252,0.6715176715176715,0.8762344358382816,1.0,6/20,13.66%,BMP5;ASXL3;CEACAM1;BMP2;ACADVL;FBXW7
prerank,positive regulation of biosynthetic process (GO:0009891),0.26853205210317455,0.8557774412803638,0.6862745098039216,0.9820610102542053,1.0,9/40,18.41%,WNT4;SLC5A3;PPARA;SORBS1;CREBL2;CYBA;CREB1;AKT1;MLXIPL
prerank,primary neural tube formation (GO:0014020),0.2869145320975921,0.8557077634686526,0.6712328767123288,0.981321699906079,1.0,8/30,16.18%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFD1;MTHFR;FUZ
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.3496361545384785,-0.8552892479319126,0.6724806201550387,0.8769552475299601,1.0,5/11,26.87%,TENT4B;EXOSC4;DKC1;EXOSC5;EXOSC3
prerank,mRNA 3'-end processing (GO:0031124),0.24202363479694455,0.8550112534252694,0.7162872154115587,0.9820060670107015,1.0,20/78,18.54%,PABPN1;CPSF3;SRSF5;CPSF6;LEO1;CPSF7;SLBP;CDC73;UPF3B;LSM11;RPRD2;SRSF11;PAPOLB;GRSF1;POLR2D;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.30398381610161623,0.8549740274613159,0.6666666666666666,0.9811834524482465,1.0,2/22,0.78%,IGF1;ROCK2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.24399111230586717,-0.8549134852046198,0.7391304347826086,0.8772148084330942,1.0,3/48,3.21%,PDE4D;IL1R1;SLC7A5
prerank,gonad development (GO:0008406),0.2684867089264198,0.8545075895157354,0.6728280961182994,0.9813090515675479,1.0,6/41,11.96%,WNT4;KIT;FGF9;NR2F2;COL9A3;SOX9
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.32180906318717545,-0.8544270431496348,0.6653465346534654,0.8776994598125128,1.0,4/15,5.55%,SIX1;TGFBR2;TBX1;NIPBL
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.3470684531433777,0.8543875409781542,0.6449704142011834,0.9806648257379889,1.0,1/12,0.98%,PLK5
prerank,regulation of pH (GO:0006885),0.36335171368596497,0.854001280141393,0.6549019607843137,0.9806642981717377,1.0,3/11,13.33%,LACC1;PDK2;CLCN3
prerank,regulation of interleukin-17 production (GO:0032660),0.2790121775754697,0.8537383368056486,0.6611111111111111,0.9803701186807471,1.0,2/31,1.35%,IL18;SPHK1
prerank,phosphate ion homeostasis (GO:0055062),-0.36019528816693364,-0.8535420695427544,0.6867704280155642,0.8789690740500845,1.0,2/10,13.74%,SFRP4;ENPP1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.24284460007213643,0.8534258078684254,0.7335640138408305,0.98017498253308,1.0,11/63,13.52%,LEPR;NUPR1;TIMP3;ZKSCAN3;GOLGA2;BCL2;ATRAID;IL10RA;KDM4A;MTMR2;TBC1D14
prerank,response to UV-B (GO:0010224),-0.33930105403201954,-0.8533199896537388,0.6589473684210526,0.8789268698310756,1.0,2/12,7.72%,CRIP1;MFAP4
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.27012081268223065,-0.8532500873782766,0.67590618336887,0.8785803847532243,1.0,14/29,38.76%,GAS6;CXCL12;SERPINE1;HMGB1;PLA2G7;JAM2;CCR2;ANO6;AIF1;LGALS9;CXCL17;CCL5;CCR1;IL4
prerank,neuron maturation (GO:0042551),-0.3087693264176197,-0.8526416062082884,0.6653386454183267,0.8793312727279685,1.0,5/18,10.32%,ANKS1A;SCARF1;APP;LGI4;B4GALT5
prerank,regulation of cellular catabolic process (GO:0031329),0.25168392199581474,0.8526103371881385,0.7155322862129145,0.98112009252959,1.0,9/62,9.07%,NUPR1;RRAGC;WDR91;ITPR1;MTMR4;RMC1;LRRK2;LONP2;ABCD1
prerank,regulation of neuroblast proliferation (GO:1902692),0.3329047459819338,0.8524959213549423,0.65,0.9804648452321668,1.0,4/15,8.07%,TAFA3;SMARCD3;FZD3;LRRK2
prerank,activin receptor signaling pathway (GO:0032924),0.3335532780873891,0.8522915313406044,0.6666666666666666,0.9800362379742329,1.0,2/15,10.07%,SMAD3;TGFBR1
prerank,regulation of cytokinesis (GO:0032465),-0.2192502835398583,-0.8518150494622222,0.7912621359223301,0.8805329577413656,1.0,37/78,33.15%,RHOA;SVIL;BCL2L1;CIT;PLK2;CALM3;MYO19;MAP9;PIK3C3;KIF23;PIK3R4;CCP110;GIT1;RAB11FIP3;KIF20B;RAB11A;KIF13A;PRC1;CDC42;ENTR1;FSD1;GIPC1;E2F7;CUL3;PLK3;PRKCE;KIF14;CALM1;DRD2;FLCN;CSPP1;SH3GLB1;KIF20A;AURKA;CDC6;OPN1MW;BIRC6
prerank,regulation of phospholipase activity (GO:0010517),0.3719078625398774,0.8518075157103847,0.6525252525252525,0.9802396341881915,1.0,2/10,6.95%,PDPK1;FGFR2
prerank,chromosome organization (GO:0051276),0.22851833143135342,0.8515277782802143,0.7381756756756757,0.9799552158683376,1.0,26/99,20.72%,DDB2;TOP2B;DOT1L;HMGN3;NUP155;PHF1;MSH6;NDC80;LDB1;SETD7;MSH3;ABL1;MTHFR;BAHD1;SIRT1;CETN2;FAM50A;SAFB;MTF2;TCF7L2;CENPV;SOX2;ACTL6B;COPS7A;SUPT4H1;NUF2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2532865622156155,-0.8514919164749768,0.7169373549883991,0.8806836206049,1.0,12/39,22.58%,RPA1;UBC;RPS27A;UBB;CHD1L;GTF2H5;GTF2H1;ERCC2;RPA2;XPA;RFC4;POLD4
prerank,regulation of autophagosome maturation (GO:1901096),-0.33250517660284307,-0.8512456221870518,0.670061099796334,0.8806592691114331,1.0,4/13,16.38%,PHF23;TBC1D25;CLEC16A;TMEM39A
prerank,necroptotic process (GO:0070266),-0.32202138327530494,-0.8511564024856083,0.6434426229508197,0.8803408293350821,1.0,8/16,32.90%,IPMK;MLKL;RIPK1;TICAM1;CYLD;TLR4;CD14;TLR3
prerank,protein targeting to membrane (GO:0006612),-0.21861991536977943,-0.8508826565887864,0.7830423940149626,0.8804043817457042,1.0,24/83,23.69%,PARD3;ATG3;ZDHHC20;AQP11;CHMP4B;CHMP4A;ABCD2;SRP19;SEC61A1;ZDHHC7;VPS37A;SRP14;ICMT;ZDHHC2;ACBD5;PEX14;SRPRA;PEX2;GDAP1;GOLGA7;CHM;MYO1C;SEC62;PEX12
prerank,multivesicular body organization (GO:0036257),-0.26264137584784936,-0.8507733694089222,0.7065217391304348,0.8801403201053546,1.0,10/31,18.87%,CHMP2B;CHMP4B;CHMP4A;VPS36;HGS;RAB27A;IST1;VPS37A;CHMP1B;RAB11A
prerank,diol biosynthetic process (GO:0034312),-0.324565780314271,-0.8507687032911124,0.6884615384615385,0.879648270198599,1.0,6/15,20.23%,ACER2;GCH1;QDPR;DHFR;ASAH2;ACER3
prerank,embryonic digit morphogenesis (GO:0042733),-0.30982403247146745,-0.8507165898071899,0.6843267108167771,0.879242158205851,1.0,6/18,12.91%,ECE1;TBX3;GLI3;MAP3K20;TWIST1;TBX2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.24458289206912073,0.8504585770518464,0.7214532871972318,0.9814903338990021,1.0,18/62,21.20%,HSPA1A;CCAR2;ENO1;PPIF;DDIAS;HTRA2;LRRK2;BCL2;CLU;NOC2L;NDUFA13;SIRT1;MDM2;NOL3;AKT1;DDX3X;HYOU1;TRIM32
prerank,glycosaminoglycan metabolic process (GO:0030203),0.2514477942907313,0.8493393820365233,0.7332123411978222,0.9831177080463741,1.0,16/54,19.43%,HS3ST3A1;HS3ST3B1;HS6ST1;NDST1;PXYLP1;B3GALT6;FUCA1;HS3ST6;HS3ST5;HS6ST2;NDST2;HS2ST1;CHST9;B3GAT2;IDUA;HGSNAT
prerank,regulation of necroptotic process (GO:0060544),-0.2912661150905778,-0.8485831538617317,0.6894409937888198,0.8830966357585485,1.0,10/23,27.08%,ARHGEF2;YBX3;SPATA2;BIRC3;MLKL;RIPK1;ZBP1;CYLD;CASP8;PELI1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.27795083557347294,-0.8484769607748068,0.6739606126914661,0.882817314392014,1.0,2/27,1.61%,PLA2G4A;GPCPD1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.21140377446397962,0.8480717898542917,0.7984732824427481,0.9850572775149107,1.0,16/166,9.58%,NOTCH2;RORA;NR2E1;THRB;NR6A1;CCN2;PPARA;ESRRA;POLRMT;RBPJ;WWTR1;MED1;PPARGC1A;TAF10;NR1H3;RXRA
prerank,actin filament bundle assembly (GO:0051017),0.2812500356147239,0.84802602659489,0.6791044776119403,0.9842641610246685,1.0,5/33,6.79%,USH1C;BAIAP2;PAWR;ADD2;CORO1B
prerank,positive regulation of cell killing (GO:0031343),0.3468764842333627,0.8468907547493568,0.6506986027944112,0.985897910817697,1.0,3/13,13.78%,NOX1;FZD7;CYBA
prerank,protein stabilization (GO:0050821),-0.19588333158272853,-0.8468423321958363,0.8683473389355743,0.8854398830915948,1.0,35/168,18.41%,HIP1;RASSF2;STK3;PIK3R1;RPL5;NAA16;FLNA;SOX17;PRKCD;COG3;RPS7;PTGES3;USP7;VHL;CRTAP;PARVA;MFSD1;RPL23;BAG5;MORC3;PHB2;HIP1R;PFN1;FBXW7;CCT2;MT3;PLPP3;BAG1;RTN4;NCLN;PTEN;SUGT1;GAPDH;ATF7IP;DNLZ
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3122789575613138,0.8466560685633341,0.659963436928702,0.9855516697872464,1.0,1/20,0.87%,IL18
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.35919666794377725,0.8463740910526375,0.6597938144329897,0.9853097955626902,1.0,1/11,0.82%,DDX5
prerank,myeloid dendritic cell activation (GO:0001773),-0.3432328167906913,-0.8462785582822085,0.6857749469214437,0.8860264539777725,1.0,2/12,7.73%,TGFBR2;DOCK2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.28317723315129956,0.845923229044755,0.6761565836298933,0.9854206088749143,1.0,10/29,18.86%,SMAD3;HNRNPA2B1;TRIM71;TUT4;ZC3H7B;AGO3;DICER1;SNIP1;SRRT;ADAR
prerank,histone methylation (GO:0016571),0.29518778212054286,0.8458481150661371,0.6778398510242085,0.984690229390112,1.0,7/26,18.09%,PRMT2;N6AMT1;NSD1;SMYD3;SMYD2;NTMT1;NSD3
prerank,negative regulation of reproductive process (GO:2000242),0.32365172589583446,0.8456967773419705,0.6590909090909091,0.9841589976137978,1.0,1/17,0.69%,IGF1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.30839215380830726,-0.8456467322072236,0.7006237006237006,0.8867654682875958,1.0,5/18,15.25%,CD200;RPS6KA5;PRKD1;VEGFA;CRTC3
prerank,negative regulation of viral transcription (GO:0032897),-0.3298481685178918,-0.8451204564092203,0.6857142857142857,0.8873120149177036,1.0,3/13,6.52%,MID2;IFITM3;TRIM14
prerank,regulation of complement activation (GO:0030449),0.26834149917078054,0.8450343355346669,0.7190388170055453,0.984742665933584,1.0,7/40,11.47%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,regulation of chemotaxis (GO:0050920),0.28071320898626884,0.8448933621302828,0.691683569979716,0.9841607129469576,1.0,2/30,1.53%,PDGFRA;EFNB2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.3030151497917313,-0.8447997815400661,0.6895238095238095,0.8874513122389184,1.0,5/19,10.11%,POLR3F;ICE1;AR;RPTOR;MAF1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2605137876221054,-0.844744218892894,0.7115384615384616,0.8870633431490701,1.0,5/33,7.25%,RUNX1;H3-3A;ESR1;AR;CBFB
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.23571982427400412,0.8446246241793653,0.7345575959933222,0.9838258990758366,1.0,12/76,10.95%,ACTN2;C5AR2;OPRD1;ADRA2A;CHRM2;LPAR1;NMUR1;DRD3;C3AR1;VIP;GRPR;CHRM1
prerank,positive regulation of protein transport (GO:0051222),0.24085263170436227,0.8445249295450707,0.7406779661016949,0.9831775666448651,1.0,9/67,11.11%,BMP6;IGF1;FRMD4A;TENM1;RUFY3;CEP290;MYO18A;IER3IP1;PCM1
prerank,excitatory postsynaptic potential (GO:0060079),0.3146619395065946,0.8444798792804078,0.6653061224489796,0.9823947077901001,1.0,4/19,8.07%,RAB3GAP1;GRID2;GRIN2D;LRRK2
prerank,regulation of receptor internalization (GO:0002090),-0.25725897512502727,-0.8443489540450154,0.7198275862068966,0.8873732306967748,1.0,12/35,24.06%,INSR;SFRP4;MKLN1;TBC1D5;ANKRD13A;VEGFA;FMR1;ANKRD13B;GREM1;ARRB2;EGF;ANKRD13D
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.1934628464092652,-0.8439344511978686,0.8875,0.8876706404858901,1.0,55/166,27.62%,NIBAN1;BCAR3;SCARB1;INSR;KAT7;THBS1;EGFR;RBM3;EPM2AIP1;RPL5;NOS1AP;PTGS2;EIF3E;ELOVL5;EEF2;NNMT;IGF2;FGF2;KLF4;EDN1;STARD4;DDAH1;NMD3;MFSD2A;AKT2;IRS1;KLF2;FMR1;BRPF3;PRR16;FXR1;PTH1R;ASS1;CTDNEP1;METTL3;PIWIL2;DYRK2;FAF1;BCL3;EIF4A3;DDAH2;SREBF1;EGF;GIPC1;PRMT1;RGCC;CTC1;PPP1R3E;TLR4;HNRNPD;FABP3;METTL14;RPS4X;SLC25A37;LDLR
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3377248172156292,-0.8435955250701762,0.6818181818181818,0.8878621862918448,1.0,2/12,3.16%,NFKBIA;ABCA1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.3093945131760155,-0.8435655845460783,0.6914660831509847,0.8874299638771007,1.0,3/18,4.28%,EGFR;BMP4;ESR1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.32885622543332593,0.8434614262743607,0.6583333333333333,0.9837643573648696,1.0,4/15,17.73%,CAMK1;MAPK14;RAPGEF3;RIPOR2
prerank,regulation of cellular senescence (GO:2000772),-0.2662102288527809,-0.8433511392266237,0.7101769911504425,0.8873593287464011,1.0,9/28,18.98%,B2M;AKT3;NUAK1;ABI3;FBXO5;TWIST1;EEF1E1;YPEL3;CDK6
prerank,negative regulation of macroautophagy (GO:0016242),0.29188896245388174,0.8433147906393446,0.7040618955512572,0.9832102157781951,1.0,10/26,26.28%,NUPR1;QSOX1;LRRK2;TSC1;SEC22B;AKT1;NRBP2;LZTS1;FEZ1;MTM1
prerank,histone H4 acetylation (GO:0043967),0.25782788154387204,0.8431915713392751,0.7085514834205934,0.9826015510302536,1.0,17/47,21.30%,BRD8;KANSL2;KMT2A;RUVBL2;MEAF6;DMAP1;EP400;BEND3;YEATS4;CHD5;MCRS1;TADA3;APBB1;MSL1;ACTL6B;KAT8;ACTL6A
prerank,heart process (GO:0003015),-0.32547016170693766,-0.8431500139252425,0.6966067864271457,0.8872460632800935,1.0,3/14,9.75%,SGCD;SOD1;GPX1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.30628294658128125,0.8430887748388471,0.6888045540796964,0.9819398968321382,1.0,4/20,13.20%,SLC8A3;AFG3L2;SLC25A23;MICU1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.28617304340489447,-0.8429355995273368,0.6969026548672567,0.8871805909402907,1.0,9/23,20.71%,GLI3;RACK1;HHIP;HERC4;PTCH1;ENPP1;PTCH2;KCTD6;MOSMO
prerank,inositol phosphate metabolic process (GO:0043647),-0.24219906490123574,-0.842900997848808,0.7601809954751131,0.8867383462501635,1.0,7/46,9.34%,PLCB4;PLCE1;INPP4A;PLCG1;PLCG2;INPP5D;FGF2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3542355166398237,0.8428984473392331,0.6719367588932806,0.9814637024961556,1.0,3/13,6.42%,HACD3;HACD4;HACD1
prerank,myelin assembly (GO:0032288),-0.3600279261043434,-0.8427895565003195,0.6625,0.8864536475913269,1.0,3/10,18.39%,CD9;GPC1;PMP22
prerank,RNA transport (GO:0050658),0.24132606184174973,0.8426927954171486,0.7457044673539519,0.981004281321376,1.0,25/71,26.52%,SIDT1;SRSF5;KIF5C;POM121;NUP155;HNRNPA2B1;NUP62CL;SLBP;UPF3B;SRSF11;RNPS1;ALYREF;DDX39B;THOC1;SRSF6;RBFOX1;SARNP;DDX39A;RAE1;SRSF2;ZFP36;U2AF2;ZC3H11A;ZFP36L1;THOC2
prerank,synaptic vesicle transport (GO:0048489),0.35886825730088995,0.8426177608472035,0.6590038314176245,0.9803091869635789,1.0,3/11,13.83%,KIF5C;SNAPIN;SPG11
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.3372436602358294,-0.842598674941947,0.6750972762645915,0.8863226785747006,1.0,5/12,21.03%,ARHGAP35;B4GALT5;EPHB2;PTEN;EPHB6
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.31297041174675216,-0.8422234476060265,0.6801705756929638,0.8865623896470785,1.0,4/16,9.64%,SCARB1;NOS1AP;GCH1;APOE
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.33894057250451987,-0.8422140090147631,0.6890243902439024,0.8860831735296969,1.0,6/12,24.64%,BMP4;TPR;SIRT7;NEDD4;AAAS;NUP214
prerank,spermatid development (GO:0007286),0.2766506907301599,0.842004165906714,0.7075471698113207,0.9807635983699713,1.0,2/32,4.95%,CCDC42;TDRD5
prerank,regulation of cell cycle process (GO:0010564),-0.20818839969201178,-0.8418670709994289,0.8341968911917098,0.8862660271269691,1.0,31/104,23.15%,DCUN1D3;BCL2L1;PLK2;CALM3;APC;TIPIN;MYO19;CAV2;MAP9;FBXO5;PIK3C3;CSNK2A1;PIK3R4;CCP110;GIT1;RAB11FIP3;GPER1;DYNC1H1;NUDT16;KIF20B;RAB11A;KIF13A;PRC1;CDC42;L3MBTL1;CHEK1;RPRD1B;KNSTRN;ENTR1;FSD1;MKI67
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3526513321064251,0.8417864851999989,0.6344294003868471,0.9803674705185229,1.0,2/12,8.17%,SOAT2;SOAT1
prerank,tube closure (GO:0060606),0.28160175233123674,0.8417732331892588,0.684931506849315,0.9795175671206409,1.0,8/31,16.18%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFD1;MTHFR;FUZ
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.34348075485179225,0.8417521545608401,0.659217877094972,0.9786939868692961,1.0,3/12,9.07%,PPARA;PPARGC1A;ABCD1
prerank,diterpenoid metabolic process (GO:0016101),0.25244838067452136,0.8417161112702402,0.7355072463768116,0.9778945940411314,1.0,4/55,2.46%,ADH7;ADH4;ABCA4;RBP1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.35883368069288485,0.8416013246119602,0.6425855513307985,0.9772589498753891,1.0,2/11,6.37%,NUPR1;FZD9
prerank,positive regulation of signaling (GO:0023056),0.2743103046372468,0.8415453963232759,0.6925925925925925,0.9765137985732675,1.0,6/37,9.52%,WLS;SYT1;GRIK2;RIMS1;NSF;DLG4
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.22855434539452218,-0.8413467717426133,0.7777777777777778,0.8868164608211718,1.0,13/59,18.58%,LEF1;RUNX2;AGO1;JUN;CBFB;MED27;TWIST1;MED31;CSF1R;MED14;PTEN;AGO4;CCND1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.32149332997666646,0.8412517406257118,0.6771929824561403,0.9762801084234531,1.0,3/17,8.02%,ANK2;SNTA1;KCNH2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.30930950457958517,0.8412249722205183,0.68359375,0.9754637522480507,1.0,4/20,11.57%,IL18;PRKCZ;NLRP3;FZD5
prerank,response to nutrient levels (GO:0031667),-0.3092260751089704,-0.8405936664417903,0.6817288801571709,0.8877515636419341,1.0,10/17,35.02%,RPTOR;FAM107A;KCNB1;ATF4;CD68;ULK1;MEAK7;EIF4G1;PRKAA1;RPS6KB1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3006942374619505,0.8404033683973998,0.6886446886446886,0.9763924247908736,1.0,6/24,10.43%,DNMT3A;JARID2;PPHLN1;PHF1;MPHOSPH8;PPM1D
prerank,nucleus organization (GO:0006997),-0.24082951753930965,-0.8403861632000861,0.7798165137614679,0.8876698576228006,1.0,12/47,18.79%,SYNE1;CHMP2B;ATXN7;CHMP4B;CHMP4A;SUN1;LEMD3;TPR;REEP3;PITPNB;CTDNEP1;CHMP1B
prerank,negative regulation of coagulation (GO:0050819),-0.3192052069458815,-0.8400912589500292,0.6534653465346535,0.8877014354292483,1.0,5/14,15.60%,CD34;SERPINE1;APOE;EDN1;VTN
prerank,lysosome localization (GO:0032418),-0.2525643735455322,-0.8398817059133904,0.7130620985010707,0.8875936875680022,1.0,17/37,32.71%,MYH9;TFEB;S100A13;PIK3CD;RAB3A;HDAC6;ARL8B;NDEL1;MILR1;BORCS6;PIK3CG;HPS6;TMEM106B;PLEKHM1;FLCN;SYTL4;RAB34
prerank,negative regulation of insulin secretion (GO:0046676),-0.3070385227198153,-0.8395955367821124,0.6801705756929638,0.8876726190626472,1.0,5/17,15.35%,CCN3;KLF7;MIDN;IRS1;KCNB1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.33556011943982966,0.8394354886385681,0.650887573964497,0.977646764977854,1.0,4/14,18.26%,ENPP3;AK5;AK1;AK3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3297050907352852,-0.839177152297312,0.6915520628683693,0.8879704057505781,1.0,4/13,20.46%,PIK3C3;PIK3R4;IRAK2;MYD88
prerank,response to axon injury (GO:0048678),0.3114364591215568,0.8389294354503144,0.6780684104627767,0.9778459684661989,1.0,5/18,14.34%,FLRT3;NREP;GAP43;SARM1;MORN4
prerank,DNA metabolic process (GO:0006259),-0.18250303366902115,-0.8387068295145621,0.9151515151515152,0.8883786826104011,1.0,85/270,28.22%,RPA1;RAD51B;UBC;ALKBH1;SMC1A;UBE2V2;CSNK1E;RPS27A;XPC;UBB;AXIN2;XRCC5;REXO4;ZBTB1;PTGES3;USP7;CHD1L;RPAIN;PARG;TERF2IP;GTF2H1;DMC1;BLM;ORC1;RAD21;TIMELESS;ZNF445;DDX23;KPNA2;NT5E;UBE2A;SP100;DFFB;FANCG;TOP2A;TDG;ORC2;NEIL3;NBN;BARD1;RPA2;PRIMPOL;CDC45;ORC5;LIG4;SIRT7;POLA1;XPA;HMGB1;RFC4;CHEK1;NSMCE4A;POLA2;DNMT1;MUTYH;TOP1;NSMCE3;MCM3;WDHD1;TRRAP;PURA;POLD4;SMUG1;POLB;PARP3;BTG2;XRCC3;CDC34;CTC1;TINF2;PRIM2;POLE3;TYMS;UHRF2;NUDT1;MCM5;TERF2;FANCL;MCM6;RFC2;CDK2;RECQL5;RAD51AP1;VCP;CBS
prerank,regulation of cellular metabolic process (GO:0031323),0.25750459046034846,0.8380743163180586,0.7029520295202952,0.9788124432641082,1.0,17/45,24.49%,PPARA;RNF41;KIF16B;PDK2;PANK2;MPV17;RSPO1;ABCA2;TBC1D16;ACACA;NCOR2;COQ7;EIF6;LAMTOR1;PDK4;ARF1;BCO2
prerank,protein modification by small protein removal (GO:0070646),-0.1845675875536706,-0.8380118707818589,0.9681159420289855,0.8892485945626042,1.0,64/252,23.59%,ACTB;RHOA;USP24;NFKBIA;UBC;ESR1;SMAD1;RPS27A;UBB;ATXN7;PSMA6;AR;PSMB7;USP46;OTUD7B;APC;USP7;USP35;USPL1;EIF3F;SENP6;PSMB6;BABAM2;HGS;PSMB5;RAD23B;BIRC3;USP47;RNF123;PSMB8;CCP110;IFIH1;TAB1;PSMC4;FOXO4;PSMD11;CFTR;GPS1;USP50;ADRM1;JOSD1;PTEN;RUVBL1;PSMB4;RNF128;PSMD14;BARD1;IL33;UCHL1;USP10;ZC3H12A;RIPK1;ARRB2;PSMD10;COPS6;RCE1;UCHL5;PSME1;TRRAP;USP15;PSMB3;CYLD;ATXN3;POLB
prerank,translational termination (GO:0006415),-0.2119769408618514,-0.8375443525757558,0.8615751789976134,0.8896803825244897,1.0,25/95,20.20%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MRPL23;MRPS31;ABCE1;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;TRMT112;MRPL33;MRPL35
prerank,glycosphingolipid metabolic process (GO:0006687),0.26247748855160974,0.83699585388056,0.697632058287796,0.980291463493705,1.0,10/42,16.04%,CTSA;ST3GAL5;SUMF1;LARGE1;SMPD3;SMPD2;ST6GALNAC6;ABCA2;CERK;GBA2
prerank,cardiocyte differentiation (GO:0035051),-0.35546275891939483,-0.8367506808611862,0.6933867735470942,0.89071138568105,1.0,3/10,12.38%,TGFB2;MYOCD;BMP2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.22917344110413915,0.8366217147133086,0.7837837837837838,0.9802366994435077,1.0,28/80,22.42%,STX18;ARFGAP3;ARFGAP2;KIF3C;NAPA;RAB6B;HTT;NSF;RINT1;KIF3A;COPG1;TMED9;COPG2;RAB1A;RER1;TAPBP;COPE;TMED2;GBF1;COPB1;SEC22B;PICK1;KIF3B;KLC1;KLC2;UVRAG;ATP9B;LMAN2
prerank,positive regulation of transport (GO:0051050),-0.2166977583138773,-0.836011857777841,0.8167420814479638,0.8916665851915534,1.0,18/85,17.98%,ACTB;NEDD4L;MERTK;GAS6;ANXA1;DOCK2;GATA2;IL15;APOE;ACSL3;HIP1R;RAB27A;AKT2;LRP1;BAK1;FMR1;DYNC1H1;CD151
prerank,regulation of synapse organization (GO:0050807),-0.2694307241658258,-0.835532207306041,0.7527114967462039,0.8920765983530485,1.0,5/26,13.56%,MEF2C;PDLIM5;WNT5A;YWHAZ;ABHD17C
prerank,lung epithelium development (GO:0060428),0.35972331078299224,0.8353729129264502,0.6520874751491054,0.9821031650172869,1.0,1/10,0.50%,ERRFI1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.3218812024694204,-0.8349653259697649,0.6755555555555556,0.8926542970999342,1.0,4/15,17.64%,LRP6;TBX1;BMP2;HDAC2
prerank,negative regulation of autophagosome assembly (GO:1902902),0.33612185749459866,0.8346355099192719,0.6590038314176245,0.9827498294960003,1.0,2/13,8.07%,NUPR1;LRRK2
prerank,peptidyl-methionine modification (GO:0018206),0.354501048937382,0.8344921693897959,0.6742268041237114,0.9821765171970009,1.0,1/12,0.84%,METAP2
prerank,response to ATP (GO:0033198),-0.30153651890368605,-0.8341618687146968,0.7064989517819706,0.8936919039090175,1.0,2/18,2.31%,TRPC3;ABCC9
prerank,vitamin transport (GO:0051180),-0.2706022360454353,-0.8341462325081654,0.7204301075268817,0.8932216854380148,1.0,3/29,8.59%,ABCG2;SLC5A6;CUBN
prerank,nucleocytoplasmic transport (GO:0006913),-0.2539190964343961,-0.8336410263869977,0.7510822510822511,0.8936931369222438,1.0,10/40,15.22%,SNRPD1;BACH2;MALT1;RSRC1;ATXN1;SNRPD2;NCBP2;GEMIN8;SNRPE;NCBP1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.34931066848597986,0.8333117992781283,0.6646586345381527,0.9838112820229584,1.0,4/12,19.30%,ACSL1;ABCD1;FADS2;HSD17B4
prerank,myotube cell development (GO:0014904),0.3702889586908158,0.8331800801815787,0.6804979253112033,0.9832074745878794,1.0,1/10,0.69%,IGF1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.34553507948883727,-0.8328782108980292,0.7107438016528925,0.8946821117469015,1.0,6/11,23.95%,CAV1;VHL;HGS;SOCS3;BCL3;SOCS1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.2167724755183049,-0.8325835412570828,0.7950617283950617,0.8947242729132273,1.0,31/72,36.96%,RPA1;UBC;DCP1B;RPS27A;UBB;REXO4;CHD1L;GTF2H5;GTF2H1;ERCC2;ENPP1;RPA2;ZC3H12A;XPA;RFC4;POLD4;RNASE4;PNRC2;CUL4A;RFC2;XRN2;PARP1;ISG20;OGG1;FEN1;EDC3;GTF2H2;DDX1;MUS81;ANKLE1;IHO1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.21275221716831405,-0.8322832929093888,0.7905405405405406,0.8947965381881388,1.0,32/80,29.60%,VPS53;ANKFY1;RAB6A;TBC1D5;VAMP3;SNX1;VPS26A;TMEM87B;GOSR1;TBC1D10A;SURF4;SNX2;STX6;RHOBTB3;DCTN1;PREPL;SNX5;RIC1;VPS26B;VPS52;STX5;EVI5;RAB9B;VPS50;BET1L;PHETA1;YKT6;PHETA2;VTI1B;GOSR2;HEATR5A;LMAN1
prerank,cellular response to leucine starvation (GO:1990253),0.3643397462776168,0.8321038889231169,0.6611570247933884,0.9846375505576355,1.0,3/10,16.73%,IMPACT;SESN1;RRAGB
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.2746515952976265,-0.8316367269460114,0.7040169133192389,0.8950409868296249,1.0,5/23,14.59%,YWHAE;YWHAB;YWHAQ;YWHAZ;BBC3
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.2746515952976265,-0.8316367269460114,0.7040169133192389,0.8950409868296249,1.0,5/23,14.59%,YWHAE;YWHAB;YWHAQ;YWHAZ;BBC3
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.33788207409576454,-0.8313468314831958,0.7014314928425358,0.8950877563556844,1.0,6/11,24.11%,TPR;TASOR;ATF7IP;DNMT1;SIRT6;SETDB2
prerank,negative regulation of cell cycle process (GO:0010948),0.23992639610311375,0.8312696023489393,0.7648114901256733,0.9855829543225337,1.0,9/61,12.26%,BMP7;PCGF2;TFDP2;E2F1;TOM1L2;MAX;E2F8;PCGF6;RING1
prerank,receptor recycling (GO:0001881),-0.3494167620105152,-0.8306250673170881,0.6720321931589537,0.8959173618634934,1.0,5/10,30.32%,RAB11B;PHETA1;PHETA2;NSG1;LMTK2
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3523050041620913,-0.8306091551837909,0.6700404858299596,0.8954573421456001,1.0,2/10,6.04%,GNL3;SAE1
prerank,RNA 3'-end processing (GO:0031123),0.23705884578103978,0.830232361911812,0.7700170357751278,0.9869000261582436,1.0,15/69,18.54%,PABPN1;CPSF3;SRSF5;TENT4A;SUPV3L1;CPSF7;TUT4;UPF3B;RPRD2;SRSF11;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.30556190296370894,0.8300227779740565,0.6693069306930693,0.986496682717502,1.0,5/18,18.04%,COX18;COX14;TIMM21;COX20;OXA1L
prerank,photoperiodism (GO:0009648),-0.2710334245749876,-0.8298936460478638,0.7086776859504132,0.896281634236787,1.0,7/28,15.78%,CRY1;BHLHE40;PPP1CA;PER1;MTA1;PPP1CC;ID2
prerank,response to acidic pH (GO:0010447),0.34013585822562253,0.8298851861722569,0.6903846153846154,0.9859121057381256,1.0,2/13,8.15%,TRPV1;IMPACT
prerank,DNA repair (GO:0006281),0.19452820487478434,0.8293598067640768,0.9220389805097451,0.9861300117489018,1.0,53/284,18.00%,EYA1;DDB2;RNASEH2A;DOT1L;ERCC1;RECQL4;PMS2;FANCD2;XRCC1;ASCC2;ACTR8;TENT4A;POLD2;ABRAXAS1;EME2;SPRTN;KAT5;MBD4;MSH6;EXO5;HINFP;RFC5;TDP2;MDC1;FANCI;KMT5C;PARP4;MRE11;INIP;MLH3;FBXO6;KDM4A;CHEK2;PIAS4;MSH3;MEN1;RAD51D;POLI;POLE;PRKDC;RPA3;NEIL1;ABL1;GADD45A;FAAP100;SIRT1;ATM;CETN2;RAD52;POLN;XRCC2;RAD17;APBB1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.3109906704608565,-0.8284098691294658,0.7005988023952096,0.8984824056758289,1.0,4/15,13.42%,ERN1;TSEN2;CPSF4;CLP1
prerank,regulation of humoral immune response (GO:0002920),0.2562981355669708,0.8282782133471372,0.7423423423423423,0.9874892580718561,1.0,7/44,11.47%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,protein deneddylation (GO:0000338),-0.3517399348454924,-0.828029182477141,0.6525252525252525,0.898667463705408,1.0,3/10,24.21%,GPS1;COPS6;COPS4
prerank,ubiquinone biosynthetic process (GO:0006744),0.32256667579465637,0.8278226646864975,0.6848249027237354,0.987564416189326,1.0,5/15,20.55%,COQ10A;COQ8B;COQ7;COQ3;FDXR
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.28937310537905503,-0.827565691038564,0.6957403651115619,0.8990393021365407,1.0,7/21,17.39%,RPL5;RPS7;RPL23;FBXO5;FZR1;MAD2L2;PTEN
prerank,NAD biosynthetic process (GO:0009435),-0.2888255078451139,-0.8270777642634372,0.6993987975951904,0.8994386235765546,1.0,7/20,23.73%,PTGIS;PTGS2;NNMT;NUDT12;NAXE;KYNU;NMNAT1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.25462985578563446,0.8266190687846486,0.710431654676259,0.9891977219019746,1.0,3/47,1.73%,WNT4;ROCK2;GCK
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.31511115379840776,-0.8264824102408568,0.688659793814433,0.9000403132384498,1.0,9/15,30.95%,SCARB1;MFSD2A;FBXW7;C3;CTDNEP1;SREBF1;LDLR;SIK1;NR1H2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.23185622749914447,0.8263774680981559,0.756578947368421,0.9888598058055477,1.0,11/80,10.23%,MAGEA2;SPHK1;NDFIP1;DERL1;PLK1;ARRDC3;SPRTN;DCUN1D4;LRRK2;FANCI;TOPORS
prerank,cortical cytoskeleton organization (GO:0030865),-0.24247758348073245,-0.8262645177002861,0.7591743119266054,0.8999315549837757,1.0,3/41,1.39%,FMNL2;RHOBTB1;RHOA
prerank,cell differentiation in hindbrain (GO:0021533),0.3503052241453126,0.8262537554544443,0.6863157894736842,0.9882688254769945,1.0,4/11,20.12%,GRID2;ATP7A;FAIM2;KNDC1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3186767925726499,-0.826012676843391,0.700836820083682,0.8998946216805934,1.0,5/14,27.01%,RAPGEF2;PRKAR2B;PRKAR1B;PKIA;PRKAR2A
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.3631200998727623,0.8258897319678761,0.6679920477137177,0.9881776729078185,1.0,2/10,10.26%,APPL2;PRKCB
prerank,water-soluble vitamin metabolic process (GO:0006767),0.23301720435579576,0.8257567477768338,0.7658862876254181,0.9876138376287373,1.0,18/68,17.34%,ALDH1L1;SLC23A2;SLC23A1;PCCA;PANK2;GSTO2;SLC19A1;MMUT;AMN;MTHFS;GSTO1;CYB5A;THTPA;MTHFD1;MTHFR;FPGS;AASDHPPT;MTHFD2
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.34050620549819544,-0.8252188703237122,0.6984126984126984,0.9008589640236434,1.0,5/11,18.13%,PAPOLA;PAF1;NCBP2;NCBP1;BARD1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3134175798238362,-0.8248453816882646,0.7203219315895373,0.9010426998932746,1.0,2/15,5.95%,PRKCH;AGTR1
prerank,nuclear pore complex assembly (GO:0051292),-0.3478300674109899,-0.8246302057025259,0.7033195020746889,0.9009572607949147,1.0,3/10,16.45%,NUP107;TPR;RTN4
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.2023663176615568,-0.8241839601721156,0.8446866485013624,0.901264386887108,1.0,11/112,5.85%,FOXP1;THBS1;GAS6;CD34;STAT3;PTPRJ;IRAK3;APP;PLCG2;ARHGEF2;WNT5A
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.33220198044297383,0.8238730473251965,0.7032755298651252,0.9906780926947564,1.0,1/13,1.86%,GTPBP1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.2338965643687015,-0.823183485167851,0.8035320088300221,0.9025660486243963,1.0,8/51,9.60%,NEK7;TNKS;XRCC5;MAPK1;SRC;FBXO4;TENT4B;HMBOX1
prerank,endocytic recycling (GO:0032456),-0.23636876108315244,-0.8226188138866766,0.7855579868708972,0.903096078534675,1.0,18/50,22.82%,RAB14;VPS53;CMTM6;VPS26A;EHD2;MICALL2;EHD4;RAB11B;ANKRD27;STX6;DENND1B;RAB11FIP3;RAB35;EPS15;CCDC22;DENND1A;ENTR1;VPS52
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2157085759739698,-0.8225717112747051,0.821882951653944,0.9026740486353145,1.0,23/72,26.92%,RPA1;UBC;RPS27A;UBB;USP7;GTF2H5;GTF2H1;ERCC2;AQR;PPIE;GPS1;RPA2;XPA;POLR2I;COPS6;RFC4;CCNH;POLD4;POLR2F;COPS4;CUL4A;POLR2H;RFC2
prerank,regulation of immune effector process (GO:0002697),0.25875881506783893,0.822457207620461,0.7416974169741697,0.9927393451315193,1.0,7/41,11.47%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,positive regulation of cellular protein localization (GO:1903829),0.23626164246858514,0.8224400505091164,0.7773851590106007,0.9919164464620597,1.0,9/69,9.94%,SYT11;PRKAA2;SLC5A3;PLK1;WWTR1;GNL3L;NDC80;PDZK1;BICD1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.2948942362503174,0.8224347653567902,0.7045454545454546,0.9910668637744954,1.0,4/21,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3144247138669776,-0.8219847179232161,0.6970954356846473,0.9032491846506526,1.0,6/14,31.32%,FUS;FANCB;TIMELESS;RAD51AP1;PARP1;MRNIP
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.311176071643674,0.8219209827177582,0.7001972386587771,0.9912479437221666,1.0,7/19,21.64%,HTRA2;HTT;CSNK2A2;FZD5;VDAC1;DNM1L;ATP13A2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.31376182254582863,0.8214001788931754,0.6936758893280632,0.9914667952651085,1.0,5/18,16.77%,GINS1;POLD2;POLE;MCM7;MCMDC2
prerank,RNA catabolic process (GO:0006401),0.25600467721954284,0.8213256490529193,0.773851590106007,0.990759998693745,1.0,9/46,18.14%,HSPA1A;RNASEH2A;SUPV3L1;LSM5;AGO3;HSPA1B;SND1;ZPR1;MTREX
prerank,regulation of actin filament-based movement (GO:1903115),0.3583334671563255,0.8209711170211385,0.6666666666666666,0.990646724871316,1.0,2/10,6.78%,ANK2;PDPN
prerank,positive regulation of catalytic activity (GO:0043085),0.2638282092839732,0.8206525879979601,0.7179023508137432,0.9904483436965911,1.0,13/37,18.38%,SLC5A3;PHACTR4;MSH6;SSBP1;MAPK14;AZIN2;APH1A;MSH3;ABL1;STX4;ATP7A;NHEJ1;MID1IP1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.35473655272299964,0.8205856606787126,0.7034220532319392,0.9897469187759675,1.0,3/10,11.82%,FURIN;ATRAID;EPHA4
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.32777010030026654,-0.8205363996289878,0.6911487758945386,0.9053594925792927,1.0,7/12,37.85%,HPRT1;AMPD2;ADA;PRPSAP1;GART;PRPS2;PPAT
prerank,homologous chromosome segregation (GO:0045143),0.30560870009084234,0.8205118240160723,0.701171875,0.9890486990504176,1.0,3/20,14.10%,FANCD2;MEIOB;CENPC
prerank,DNA conformation change (GO:0071103),-0.2997590266333642,-0.8204756536104869,0.7214137214137214,0.9049812281156128,1.0,6/17,21.40%,KAT6A;HHEX;NAA10;TOP2A;HMGB1;TOP1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.24513883335282535,0.8204015288477428,0.7717996289424861,0.9884347705605355,1.0,9/46,15.83%,PITRM1;AIFM1;TOMM40;TIMM17A;TOMM22;MFN2;PAM16;TIMM21;HK1
prerank,RNA methylation (GO:0001510),-0.21867117008959508,-0.8203908951416412,0.815668202764977,0.9046628876571751,1.0,15/60,20.16%,METTL2B;METTL2A;THUMPD2;TRMT10A;FTSJ1;TRMT44;TYW3;WTAP;METTL6;DIMT1;TRMT112;LCMT2;NSUN4;MEPCE;METTL3
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.30454617575056225,-0.8200287652097904,0.7177914110429447,0.9048193347546404,1.0,2/16,1.96%,PTN;TGFB2
prerank,regulation of establishment of cell polarity (GO:2000114),-0.3086702766670828,-0.819945887569781,0.7325349301397206,0.90447723755319,1.0,7/16,21.29%,GSN;KANK1;RACK1;PTK2B;SHTN1;KIF20B;ROCK1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.3410817947983512,-0.8197909046768408,0.6792079207920793,0.904261248147711,1.0,4/10,22.36%,ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.23679303363277288,0.8188005351465483,0.7671957671957672,0.9908583263713266,1.0,3/59,2.70%,ALDH1A2;ACSM2A;ACSM2B
prerank,histone exchange (GO:0043486),-0.24542050543131766,-0.8186199422386481,0.7521551724137931,0.9058213859713818,1.0,14/37,31.30%,HJURP;RBBP4;NASP;ACTR6;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5;ANP32E
prerank,tRNA modification (GO:0006400),-0.21867192894199414,-0.8185514600658449,0.8215962441314554,0.9054385864072624,1.0,15/62,19.64%,ALKBH1;METTL2B;METTL2A;THUMPD2;PUS3;THUMPD1;TRMT10A;FTSJ1;TRIT1;TRMT44;CDKAL1;TYW3;METTL6;TRMT112;LCMT2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.2908958165514566,0.8183644738861443,0.7177570093457943,0.9909041442989257,1.0,6/24,19.24%,PQBP1;ZDHHC1;STAT1;IL12RB1;HSP90AA1;SIN3A
prerank,zinc ion transport (GO:0006829),0.2928985373559399,0.81829084018804,0.6996197718631179,0.9901887659306808,1.0,4/21,11.47%,SLC30A6;SLC30A10;SLC39A13;TRPM2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.1740712828308032,-0.818128843511935,0.9903846153846154,0.9056935039584042,1.0,98/314,28.93%,FBXL7;NEDD4L;WWP1;ZNRF1;CDC27;PCNP;SMURF1;HECW2;UBC;FAF2;SPOPL;ANAPC5;COP1;RPS27A;UBB;UBE2D3;KCTD10;UBE2J1;PSMA6;PSMB7;CDC16;TRIM25;FBXO31;FEM1B;PPP2R5C;UBXN1;STT3B;FBXO4;PSMB6;PSMB5;FBXO5;MTA1;RAD23B;UBXN2A;FBXO44;FBXW7;FBXL18;FZR1;PSMB8;PTTG1;UBE2J2;PSMC4;KLHL22;KBTBD7;AUP1;PSMD11;KCTD5;OS9;UBE2A;PCBP2;UBE2G1;ECRG4;PSMB4;AMN1;PSMD14;UCHL1;CCNF;RMND5B;UBR1;FBXL4;CDC26;HACE1;FBXW5;ARRB2;NEDD4;PSMD10;PSME1;FAF1;AGAP3;FBXL6;PSMB3;CDC23;FBXO45;ATXN3;KCTD17;CUL3;CDC34;AREL1;NHLRC3;UFD1;CUL4A;KIF14;UBQLN1;WFS1;SPSB3;LTN1;CUL1;PELI1;FBXW11;CDK2;ANAPC1;ZFAND2B;HERPUD1;VCP;EDEM1;ZFAND2A;ARMC8;FBXO2
prerank,protein import into nucleus (GO:0006606),0.23372988013235133,0.817944623228775,0.7754749568221071,0.9900416517415866,1.0,7/66,6.98%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3
prerank,triglyceride catabolic process (GO:0019433),-0.28571344345500904,-0.8177950884350624,0.722567287784679,0.9057909736546453,1.0,10/19,52.93%,PNPLA2;FABP5;FABP3;FABP4;LPL;FABP12;PNPLA3;FABP7;LIPG;CPS1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.30561745191008477,-0.8173183172731397,0.7006109979633401,0.9061515228491621,1.0,9/16,43.28%,NAA16;NAA10;NAA15;NAA50;AANAT;NAA60;NAA40;NAA35;NAA11
prerank,snRNA processing (GO:0016180),-0.29960840186985427,-0.8171059651389315,0.742914979757085,0.9060427480624347,1.0,5/16,22.48%,INTS11;INTS10;INTS9;TOE1;INTS6L
prerank,neural tube closure (GO:0001843),0.26573861743650196,0.8170884757625396,0.7209302325581395,0.9908981653895382,1.0,8/34,16.18%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFD1;MTHFR;FUZ
prerank,non-motile cilium assembly (GO:1905515),-0.2536223289201237,-0.8168905825157177,0.762114537444934,0.9059196389892108,1.0,10/30,21.28%,DISC1;ARL13B;IFT57;PIBF1;GORAB;TMEM216;TOGARAM1;TMEM107;CSNK1D;DCTN1
prerank,mitochondrion localization (GO:0051646),0.30421171708404604,0.8168823276296183,0.7181818181818181,0.9904789052331038,1.0,6/19,18.95%,TRAK1;LRRK2;BRAT1;MFN2;ATP2A1;MEF2A
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.33259800073003554,-0.8166657508115335,0.6926147704590818,0.9057939123531329,1.0,2/11,7.25%,RUNX1;CBFB
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.2564363522744407,-0.8163104860170554,0.7579185520361991,0.9058876254365963,1.0,8/33,11.93%,KMT2E;EGFR;PLCG2;ANXA1;ADAMTS1;RPTOR;PAF1;PHB2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.2759390232150264,0.8159084732843597,0.7366412213740458,0.9915304736007755,1.0,2/29,6.95%,TGFBR3;FGFR2
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.2995962578102578,-0.8158172699776414,0.7161904761904762,0.9062911177054974,1.0,11/17,41.10%,TERF2IP;TDG;NEIL3;MUTYH;SMUG1;TINF2;TERF2;OGG1;UNG;NTHL1;TERF1
prerank,autophagosome maturation (GO:0097352),0.26596687722872225,0.8156249175171418,0.7001862197392924,0.9912137144380962,1.0,6/32,11.53%,SNX14;VAMP7;SNAP29;VPS16;LAMP2;LIX1L
prerank,negative regulation of organelle assembly (GO:1902116),0.26404687765656437,0.8155267727233754,0.7541589648798521,0.9905868277682748,1.0,4/35,8.07%,NUPR1;ODF2L;TCHP;LRRK2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.22438359966652827,-0.8155242018058967,0.8252427184466019,0.9063137266778256,1.0,13/60,18.58%,LEF1;RUNX2;AGO1;CBFB;HEY2;MED27;MED31;CSF1R;MED14;PTEN;AGO4;ATF7IP;CCND1
prerank,cellular response to oxidative stress (GO:0034599),0.21401500784987174,0.8154087750767317,0.837248322147651,0.9899900091552557,1.0,28/118,20.59%,CPEB2;HSPA1A;PDGFRA;PRKAA2;RBM11;CHUK;PDK2;HTRA2;PRDX5;LRRK2;PPARGC1A;MPV17;CYCS;ALDH3B1;MAPK9;CYBA;ARNT;HSPA1B;ABL1;STX4;RAD52;ERO1A;AKT1;NCF1;LONP1;EIF2S1;PYROXD1;ERCC6L2
prerank,isotype switching (GO:0045190),0.3498476148978482,0.815150809202745,0.7131147540983607,0.9896826183562518,1.0,2/10,10.98%,MSH6;BATF
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.24670636952579664,-0.8150665728376424,0.796875,0.9066321289249956,1.0,14/37,28.37%,ENTPD1;ENTPD6;SIDT2;ENTPD2;ADPRM;NCBP1;DFFB;NUDT16;PPP1R8;NUDT1;HNRNPD;RNASEH2B;XRN2;PABPC4
prerank,mitotic cell cycle phase transition (GO:0044772),-0.1821137040076977,-0.8149929907843366,0.9395604395604396,0.9062751815142558,1.0,64/204,27.44%,FBXL7;ACVR1;YWHAE;CDC27;PPP1R12A;CDK14;DYNC1I2;CACUL1;PPP2R2D;CSNK1E;EPS8;CCNY;PLK2;CHMP4B;CDC16;TUBA1A;EIF4E;CEP76;DCTN3;NASP;ODF2;DYNLL1;CCP110;PRKAR2B;PAFAH1B1;PRKACA;LATS1;DYNC1H1;MASTL;CCNF;CCND1;CDK6;LCMT1;AJUBA;CSNK1D;CCND2;DCTN1;CEP41;CCNH;FBXL6;TUBA4A;CCNB2;CDKN1B;CEP131;CDC23;CDK5RAP2;CUL3;LATS2;CEP152;PLK3;CDC34;PIM2;KDM8;CDKN3;CUL4A;PPP2R2A;AKAP9;CDKN2B;ACTR1A;CUL1;FBXW11;CDK2;CENPJ;ANAPC1
prerank,diol metabolic process (GO:0034311),-0.29411492526234245,-0.8148934361397462,0.7085953878406709,0.9059460451722067,1.0,8/19,19.49%,NOS3;DEGS2;GCH1;PLPP1;PRKG2;PLPP3;SGPP1;ASAH2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2854337353582277,0.8146236995180106,0.7137404580152672,0.9898895774144314,1.0,8/22,21.81%,CCNT2;LEO1;CDC73;ALYREF;DDX39B;THOC1;SUPT4H1;CDK12
prerank,motile cilium assembly (GO:0044458),0.3366184653483887,0.8141684424021142,0.6970873786407767,0.9899653718313071,1.0,3/12,10.81%,BBOF1;BBS5;E2F4
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.3500963083896313,0.8139510428511968,0.7047244094488189,0.9895556711677588,1.0,2/10,11.35%,APPL2;CD300A
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.31952788647721964,-0.8133235639808307,0.734,0.9081656630648782,1.0,3/14,15.38%,DAB2IP;PTPN1;BAK1
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.20352511989390648,-0.8130732580184722,0.8771498771498771,0.9081146006433364,1.0,29/95,28.72%,RPA1;RAD51B;HELQ;NIPBL;REV3L;MMS22L;SMC5;RAD54B;BLM;RAD21;FANCB;PALB2;BRCA2;NBN;PSMD14;RPA2;RMI1;CDC45;RAD51AP2;SPIDR;MCM3;NUCKS1;XRCC3;REC8;MCM5;MCM6;RECQL5;RAD51AP1;PARP1
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.21841945972173224,-0.8129148324237009,0.8337236533957846,0.9079143732855276,1.0,20/62,24.64%,LIMD1;STAT3;H3-3A;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;FMR1;SEC13;FXR1;NUP50;NUP85;POLR2I;AJUBA;AAAS;POLR2F;NUP62;NUP214
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.2424220084214681,-0.812856436476732,0.8083333333333333,0.9075392260853584,1.0,13/36,26.64%,DAB2IP;APAF1;RBBP4;SUZ12;YAF2;FOXO4;EPC1;RYBP;MGA;CHEK1;BMI1;PHC3;TFDP1
prerank,brain morphogenesis (GO:0048854),-0.3314498410085057,-0.8128402348938947,0.7107942973523421,0.9070810659265487,1.0,5/12,27.22%,SHANK3;PAFAH1B1;PTEN;SPEF2;FBXW11
prerank,regulation of viral life cycle (GO:1903900),0.29420440934791353,0.812268452875193,0.7381370826010545,0.99208591764024,1.0,5/21,16.29%,TRIM62;TRIM5;HS3ST5;TYRO3;AXL
prerank,polyol metabolic process (GO:0019751),-0.2307263398975659,-0.8122573405608534,0.7969094922737306,0.9075726256282847,1.0,6/46,6.96%,PLCB4;PLCE1;INPP4A;PLCG1;PLCG2;INPP5D
prerank,organophosphate biosynthetic process (GO:0090407),0.2543285984799619,0.8117398483022177,0.7815275310834814,0.9922619375894886,1.0,4/37,6.93%,GK;FITM2;AGPAT4;PCYT2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.25631160992350827,-0.8115384203957138,0.756198347107438,0.9083348131552037,1.0,7/28,15.85%,DAB2IP;MAP3K5;ERN1;ATP2A3;BBC3;BAK1;ATF4
prerank,histone mRNA catabolic process (GO:0071044),-0.30368567815775344,-0.8113626277278195,0.7283464566929134,0.9081493426618599,1.0,6/15,28.74%,TENT2;TENT4B;MTPAP;EXOSC4;ERI1;XRN1
prerank,I-kappaB phosphorylation (GO:0007252),-0.35342080413264354,-0.8113371952107765,0.705244122965642,0.9077075340358793,1.0,1/10,0.94%,DAB2IP
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.29680893339249736,-0.8112396786113778,0.7303822937625755,0.9073950833512864,1.0,6/17,23.96%,BCL2L1;MFF;BBC3;BAK1;TIMM50;BOK
prerank,snRNA transcription (GO:0009301),-0.21317437765788014,-0.8104917576406213,0.8625592417061612,0.9081693556715066,1.0,20/70,26.95%,ICE1;INTS11;USPL1;GTF2F1;NCBP2;POU2F1;ELL2;NCBP1;INTS10;ELL;INTS9;POLR2I;RPRD1B;POLR2F;TAF9;GTF2E2;GTF2E1;RPRD1A;POLR2H;CCNT1
prerank,regulation of calcium ion transport (GO:0051924),0.2428864889829083,0.810455714600536,0.7675675675675676,0.9939719380457441,1.0,4/54,4.37%,CACNA1D;ANK2;WNK3;ADRA2A
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2559700220685693,0.8103278138617498,0.7554744525547445,0.9933952801431439,1.0,15/39,21.69%,TANGO2;ARFGAP3;RAB3C;COPG1;CANX;TVP23B;RAB13;COPG2;SCG2;MIA3;NECAB3;TANGO6;LTBP2;RAB15;RCN3
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.321172648053082,-0.809339446948499,0.7463917525773196,0.9096825566147416,1.0,2/13,3.22%,PPARD;BMP4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.23838298804214353,0.8091275105447224,0.7595628415300546,0.9949366126631722,1.0,14/54,17.43%,TFDP2;ARID3A;CDC25C;E2F1;E2F8;E2F4;PML;CHEK2;MUC1;PCBP4;GADD45A;ATM;MDM2;CNOT3
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.22705410284974348,0.8090862485995612,0.7939609236234458,0.9941679999338929,1.0,23/80,20.34%,ROCK2;PICALM;PASK;CASP3;SMPD3;ELAVL1;SMPD2;CLU;EPHA4;SPHK2;UPF3B;ABCA2;FXR2;PRKDC;METTL5;IL6;PYM1;UPF3A;RELA;CPEB3;LARP4B;DDX3X;EIF6
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.28361701402823436,-0.8090041592695487,0.7344961240310077,0.9097964181960646,1.0,4/19,9.46%,RUNX1;BMP4;CREB3L1;TGFB3
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.26337405624551097,-0.8089275159762733,0.7392241379310345,0.9094610616054195,1.0,10/27,25.59%,DTYMK;CTPS1;NME2;AK4;CTPS2;DUT;RRM2B;AK2;TYMS;DCTD
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2133671732031862,-0.8089178762463937,0.8615751789976134,0.9089893688459532,1.0,14/75,15.76%,PLA2G4A;GPCPD1;DGKH;PLCG1;AGK;SERINC5;CPNE3;ABCA3;PIGC;PRDX6;ABHD6;PLA2G6;PAFAH1B1;CSF1R
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2252471343891187,-0.8086723675869089,0.8260869565217391,0.9089083404181495,1.0,16/53,23.30%,PSMA6;PSMB7;PSMB6;BCKDK;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;AZIN1;ODC1;PSMB3;OAZ1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3418232786404391,-0.8085146508076642,0.7480314960629921,0.9086956046192477,1.0,1/10,0.90%,PLA2G4A
prerank,cellular response to radiation (GO:0071478),-0.24144693797505545,-0.8081001422235075,0.7957894736842105,0.9089006746374414,1.0,16/40,34.03%,NET1;BLM;TNKS1BP1;RHNO1;LIG4;GPR88;SPIDR;RHOB;NSMCE3;GRB2;RAD51AP1;GPR52;RRH;OPN1MW3;OPN1MW;TP53
prerank,cellular response to amino acid stimulus (GO:0071230),-0.2529469627287101,-0.8079581135246515,0.7770961145194274,0.9086678123687769,1.0,13/33,22.09%,SH3BP4;CAPN2;SPAAR;RPTOR;NSMF;IPO5;RRAGA;SESN3;GLRA2;KLHL22;UBR1;RRAGD;FYN
prerank,regulation of actin filament depolymerization (GO:0030834),-0.3231416592421633,-0.807875829702282,0.7071713147410359,0.908331425880797,1.0,4/12,16.30%,WDR1;PIK3CA;LIMA1;SEMA5A
prerank,DNA replication checkpoint signaling (GO:0000076),-0.2966115666667218,-0.8078484866709351,0.7352941176470589,0.9078903257282734,1.0,7/16,33.23%,TIPIN;ORC1;TIMELESS;CDC45;HUS1B;CDC6;TICRR
prerank,regulation of protein localization to centrosome (GO:1904779),-0.34058255052447,-0.807314469211901,0.7054108216432866,0.9083352347400194,1.0,5/10,33.39%,APC;NUP62;MARK4;PARD6A;CEP250
prerank,mitotic sister chromatid segregation (GO:0000070),0.21621823966173795,0.8072094704196588,0.8480801335559266,0.9969407008974625,1.0,12/98,10.44%,KMT5A;NCAPD2;EML4;CHMP6;ZWINT;PHF8;PLK1;TENT4A;DSN1;NDC80;TUBG1;CSNK2A2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.32512403945207047,-0.8069824210637936,0.6991701244813278,0.9083862310432547,1.0,2/12,4.28%,STAT3;ESR1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.29395655940565735,-0.8068058923538848,0.7251585623678647,0.9082253314842903,1.0,4/16,22.65%,TNFRSF1B;AHR;TNFSF8;SOX11
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.24093514882372946,-0.8061613346020746,0.7875,0.9088303425955552,1.0,14/37,20.96%,STAT3;GBP5;ADCY7;APOD;ABCD2;CHID1;PER1;PDCD4;NOD2;ZC3H12A;PLD3;CUEDC2;MYD88;TICAM1
prerank,aerobic electron transport chain (GO:0019646),-0.21521611120750903,-0.8059628239075152,0.8341013824884793,0.9086754624749517,1.0,18/68,19.55%,SDHAF2;COX6C;NDUFA10;NDUFA8;NDUFS6;COX7C;NDUFA7;NDUFA5;NDUFA4;UQCR11;COX8A;UQCRFS1;UQCRB;COX4I1;NDUFA1;NDUFS7;NDUFS8;COX15
prerank,mRNA stabilization (GO:0048255),0.26099348584715004,0.8054962520503182,0.7875457875457875,0.9994366859458841,1.0,8/40,11.92%,ANGEL2;ELAVL4;HNRNPU;E2F1;ELAVL1;VIP;MAPK14;BOLL
prerank,axonal transport (GO:0098930),0.2596415893987127,0.8053229044987169,0.7536496350364964,0.9989367149730537,1.0,11/36,20.75%,RAB21;AP3S2;SNAPIN;KIF3A;DTNBP1;AP3B2;NEFL;KIF1B;KIF3B;KIF1A;AP3S1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.31261571073104716,-0.8051054512921874,0.749498997995992,0.9097201601083137,1.0,4/14,15.22%,ERN1;CPSF4;NCBP2;NCBP1
prerank,regulation of cilium assembly (GO:1902017),0.23418734837961563,0.8048160914506454,0.8171846435100548,0.9990380358446821,1.0,9/62,8.94%,DCDC2;ODF2L;DYNLT2B;SGSM3;DYNC2LI1;TCHP;TBC1D9B;RABEP2;HTT
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.25936140240316663,-0.8045816871763157,0.7610619469026548,0.910145784101549,1.0,8/28,22.21%,DAB2IP;SMURF1;ECSCR;FBXW7;FMR1;PTEN;TMTC3;CCDC22
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.2968336932583143,-0.8045462154124313,0.744,0.9097163983907278,1.0,9/15,30.39%,DHX33;GBP5;USP50;MYD88;TLR4;TREM2;CPTP;CD36;TLR6
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2948764322939842,0.8044610468071927,0.731610337972167,0.998852228909408,1.0,8/20,20.24%,CDKN2A;PLK1;CEBPA;NR2F2;MEN1;HEXIM2;TFAP4;CDK5RAP1
prerank,protein deacylation (GO:0035601),-0.27102377972595976,-0.8043976931129482,0.7330508474576272,0.9094837920537011,1.0,7/23,23.64%,HDAC7;SIRT5;HDAC6;ABHD17C;SIRT7;ABHD17B;SIRT6
prerank,cholesterol transport (GO:0030301),0.24997030923325295,0.8043377862769662,0.772972972972973,0.9982376374722189,1.0,13/45,21.58%,CEL;ABCG5;SOAT2;STARD5;SOAT1;OSBPL5;CLU;TSKU;STAR;ABCA5;RELCH;NPC1;SERAC1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3009839691192707,-0.8038704063248183,0.7368421052631579,0.9098953759974343,1.0,4/14,13.82%,WNT5A;FLT4;CD40;VEGFA
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.24991507078763098,-0.8033831227327088,0.778969957081545,0.9102249765464484,1.0,12/33,27.24%,RPA1;PTGES3;TERF2IP;TNKS1BP1;ZBTB48;NHP2;DKC1;CTC1;TINF2;TERF2;NOP10;CDK2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.32641245982978134,-0.8027211569749696,0.7292110874200426,0.9108344303758837,1.0,6/12,32.70%,CEACAM1;PIBF1;ACADVL;TRIB3;APOC1;ERLIN1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3576649008396718,0.8016740984502817,0.7043650793650794,1.0,1.0,3/10,18.78%,ADRA2A;HBEGF;NCF1
prerank,protein insertion into ER membrane (GO:0045048),0.25467623840465764,0.8015562398921409,0.768141592920354,1.0,1.0,12/37,19.13%,EMC2;EMC4;CCDC47;CYB5A;BAG6;MMGT1;GET1;UBL4A;EMC10;TRAM1;PRNP;EMC1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.20002017258922733,-0.8014029671764074,0.9024390243902439,0.9126004826053739,1.0,36/101,30.95%,NIBAN1;THBS1;NFKBIA;RBM3;RPL5;EIF3E;AGTR1;PERP;EEF2;KLF4;AMER1;IST1;TBC1D10A;BAK1;FMR1;PRR16;FXR1;HDAC2;METTL3;PIWIL2;MSN;FAF1;BCL3;EIF4A3;CASP8;HNRNPD;METTL14;FBXW11;RPS4X;AGT;NSUN5;PTTG1IP;PCIF1;FADD;VPS35;NR1H2
prerank,cell-cell junction maintenance (GO:0045217),-0.3264933380978374,-0.800640304948686,0.7161172161172161,0.913335867291638,1.0,5/11,26.39%,TJP1;FERMT2;CSF1R;F2R;PRTN3
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.22650636428472498,-0.8006183434613982,0.8246013667425968,0.912888898768435,1.0,15/50,23.30%,PSMA6;PSMB7;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;AZIN1;ODC1;PSMB3;OAZ1
prerank,sulfur compound catabolic process (GO:0044273),0.258952192347959,0.8004777636639578,0.7792207792207793,1.0,1.0,10/38,16.79%,OGN;OMD;FITM2;ACAT1;GALNS;HYAL1;FMOD;CSPG5;GGT5;CTH
prerank,positive regulation of sodium ion transport (GO:0010765),0.33830064173225316,0.8001681982692646,0.7292929292929293,1.0,1.0,1/12,2.29%,WNK3
prerank,negative regulation of histone modification (GO:0031057),0.31507054378124294,0.80010087368501,0.721881390593047,1.0,1.0,3/14,13.56%,JARID2;SPHK2;NOC2L
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2727750952269832,-0.7995335033980964,0.7681159420289855,0.9141335009813409,1.0,4/21,9.16%,BCL2L1;CREB3L1;NCK1;EIF2AK3
prerank,protein neddylation (GO:0045116),-0.32385887777189176,-0.7993172175191756,0.7532467532467533,0.9140043354968801,1.0,3/13,11.76%,DCUN1D3;UBE2F;DCUN1D5
prerank,peptidyl-arginine modification (GO:0018195),-0.2983585849488945,-0.7987795515834403,0.7415506958250497,0.9143923032151332,1.0,10/15,47.03%,ART3;PRMT7;KRTCAP2;PRMT1;PARK7;ART1;PADI1;PADI4;PRMT8;ART5
prerank,defense response to tumor cell (GO:0002357),0.35084196703068254,0.7985860315001224,0.7080152671755725,1.0,1.0,1/10,0.98%,PLK5
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.26941511983749167,-0.7982316147477118,0.7477272727272727,0.9147718067038894,1.0,4/22,10.10%,PTPRJ;DGKZ;CEACAM1;DUSP3
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2220927238667918,-0.7976943901091005,0.8358862144420132,0.914690991400518,1.0,13/56,19.94%,TIMMDC1;NUBPL;NDUFA10;NDUFA8;TMEM126A;NDUFS6;NDUFA7;NDUFA5;NDUFAF6;NDUFA1;NDUFS7;NDUFS8;NDUFAF8
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2220927238667918,-0.7976943901091005,0.8358862144420132,0.914690991400518,1.0,13/56,19.94%,TIMMDC1;NUBPL;NDUFA10;NDUFA8;TMEM126A;NDUFS6;NDUFA7;NDUFA5;NDUFAF6;NDUFA1;NDUFS7;NDUFS8;NDUFAF8
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.26069943457207884,0.7976136901347487,0.7536764705882353,1.0,1.0,8/33,14.47%,HSPA1A;ABCB10;MED1;MAPK14;STAT1;ARNT;HSPA1B;PRKDC
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2554665699588935,-0.7974998475664393,0.7928870292887029,0.9145263625831707,1.0,11/29,27.24%,RPA1;PPIA;PTGES3;TERF2IP;TNKS1BP1;NHP2;DKC1;TINF2;TERF2;NOP10;CDK2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2666309222974828,0.7970874684420381,0.7787769784172662,1.0,1.0,5/30,11.35%,SH3BP5L;PRKCZ;SH3BP5;PARP14;CD300A
prerank,positive regulation of nuclear division (GO:0051785),-0.26279076412101027,-0.7968859437886242,0.7938775510204081,0.9150154837681445,1.0,9/25,24.19%,INSR;LRP5;IGF2;EDN1;EDN3;NUSAP1;EGF;NUP62;RGCC
prerank,central nervous system neuron development (GO:0021954),-0.3033361829290256,-0.7962742319548879,0.7317073170731707,0.9155281821936332,1.0,4/15,10.32%,RAPGEF2;LHX6;ARHGAP35;B4GALT5
prerank,androgen metabolic process (GO:0008209),0.30228874670742756,0.7961996294276324,0.7217898832684825,1.0,1.0,4/18,23.76%,MED1;HSD17B11;HSD17B4;SHH
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2565255806794821,0.7958315860080091,0.7682242990654206,1.0,1.0,7/34,14.18%,LGR4;NLRP2B;OTUD4;CACTIN;CD300A;SARM1;TYRO3
prerank,regulation of hormone secretion (GO:0046883),0.31104100598233475,0.7951687364785638,0.7343096234309623,1.0,1.0,1/15,0.66%,SNX6
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.22302774414674198,0.7950775653941563,0.8388214904679376,1.0,1.0,24/72,22.83%,TFDP2;ARID3A;CDC25C;E2F1;KAT5;E2F8;NDRG1;E2F4;BATF;PML;CHEK2;MUC1;PCBP4;GADD45A;ATM;MDM2;CNOT3;HIPK2;TFAP4;BAX;CNOT8;MYO6;ATRX;MDM4
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.24738094525371004,-0.7949572344675382,0.7918454935622318,0.9171373993614037,1.0,13/31,34.79%,PLCG2;MDK;CD40;IRF5;HMGB1;SYK;RIPK2;MAPK11;TLR4;LGALS9;LAPTM5;TLR3;TLR2
prerank,histone deubiquitination (GO:0016578),-0.28023729596910196,-0.7949476339937567,0.7494908350305499,0.9166669508157507,1.0,8/18,34.85%,ATXN7;USP7;ENY2;TRRAP;USP15;USP36;BRCC3;ATXN7L3
prerank,negative regulation of signaling (GO:0023057),0.27628754426961016,0.7945172503142102,0.7655954631379962,1.0,1.0,5/25,13.54%,IGFBP3;GLRA1;OPTN;BRAP;OPRM1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.32473666633204534,-0.7944922474774059,0.7347740667976425,0.9169333918997101,1.0,6/10,30.76%,PIBF1;SOCS3;PPP2CA;SOCS1;INPP5F;PPP2R1A
prerank,negative regulation of locomotion (GO:0040013),-0.31521474221545936,-0.7941753834574783,0.7495145631067961,0.9169484287307961,1.0,2/12,10.10%,FRMD5;DUSP3
prerank,regulation of macrophage activation (GO:0043030),-0.2504874030677924,-0.7939761037562594,0.7974947807933194,0.916788557314286,1.0,4/30,5.85%,CD200;THBS1;MFHAS1;WNT5A
prerank,replicative senescence (GO:0090399),0.32632443936179334,0.793885720655893,0.7321428571428571,1.0,1.0,4/12,16.00%,CDKN2A;CHEK2;TERT;ATM
prerank,tRNA metabolic process (GO:0006399),0.29778938403630884,0.7937930518389117,0.75,1.0,1.0,3/17,11.67%,DTD1;TRPT1;DARS2
prerank,chromatin assembly (GO:0031497),-0.23629846251671574,-0.7937461530968639,0.7955555555555556,0.9166922361985347,1.0,6/38,12.68%,CTCF;H3-3A;EZH1;RBBP4;PAF1;LIN54
prerank,DNA packaging (GO:0006323),-0.2910374976859068,-0.7936541528971816,0.768595041322314,0.9163572933058054,1.0,9/16,39.19%,KAT6A;RBBP4;NAA10;CHAF1A;BANF2;BANF1;TP53;H1-0;CHAF1B
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.31008475388456913,0.7933068166967866,0.7316602316602316,1.0,1.0,5/16,16.60%,ANK2;LRRK2;RYR2;MIA3;GBF1
prerank,cellular response to nitrogen compound (GO:1901699),0.2919012690825684,0.7929868430469668,0.7538759689922481,1.0,1.0,1/20,0.78%,ROCK2
prerank,recombinational repair (GO:0000725),-0.20418884143671215,-0.7927222659296332,0.8932714617169374,0.9173249926701532,1.0,17/77,20.43%,RPA1;RAD51B;HELQ;REV3L;MMS22L;SMC5;RAD54B;BLM;PALB2;BRCA2;RHNO1;NBN;PSMD14;RPA2;RMI1;RAD51AP2;SPIDR
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.2834810257666963,0.7924233999535186,0.7751004016064257,1.0,1.0,4/21,13.14%,PPARA;SLC30A10;ABCD1;TRAP1
prerank,histone acetylation (GO:0016573),0.22662130908057668,0.7923359333146126,0.827054794520548,1.0,1.0,20/69,19.95%,BRD8;SGF29;RUVBL2;MEAF6;KAT5;TAF10;DMAP1;EP400;KAT14;BEND3;YEATS4;TADA1;CHD5;TADA3;APBB1;KAT6B;DR1;MAP3K7;ACTL6B;KAT8
prerank,positive regulation of isotype switching (GO:0045830),-0.296420764879383,-0.7923025068569073,0.7357723577235772,0.9174896614703026,1.0,4/15,15.55%,TFRC;SHLD1;CD40;MAD2L2
prerank,positive regulation of RNA splicing (GO:0033120),-0.2540261434869139,-0.7921898528498825,0.8087318087318087,0.917187450530458,1.0,12/29,30.49%,PIK3R1;RBM3;ERN1;PRDX6;DYRK1A;NCBP1;NCL;SNW1;TRA2B;DAZAP1;SETX;HABP4
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.30363053424361713,-0.791324555967014,0.768,0.9180979570285444,1.0,9/14,37.85%,RFK;ADSS1;IMPDH1;ADSS2;ADK;PAICS;IMPDH2;GART;PPAT
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.2919566501394737,-0.7910382222792955,0.7782426778242678,0.9180451463356254,1.0,6/17,19.55%,COX6C;COX7C;NDUFA4;COX8A;COX4I1;COX15
prerank,cholesterol efflux (GO:0033344),0.29080869504668716,0.7906848263503429,0.7432950191570882,1.0,1.0,3/20,8.17%,ABCG5;SOAT2;SOAT1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.2106622043781044,-0.7906443565209617,0.8604118993135011,0.9182183970892558,1.0,18/69,19.55%,SDHAF2;COX6C;NDUFA10;NDUFA8;NDUFS6;COX7C;NDUFA7;NDUFA5;NDUFA4;UQCR11;COX8A;UQCRFS1;UQCRB;COX4I1;NDUFA1;NDUFS7;NDUFS8;COX15
prerank,mesenchymal to epithelial transition (GO:0060231),0.34941407731626484,0.79046361977597,0.7111111111111111,1.0,1.0,2/10,9.38%,CITED1;FZD7
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2443964524466782,0.790373664691593,0.7801418439716312,1.0,1.0,17/48,20.76%,E2F1;HTRA2;MSH6;IKBKE;TOPORS;BCL2;PML;CHEK2;BAG6;AEN;PRKDC;ABL1;SIRT1;ATM;HIPK2;PYCARD;BAX
prerank,glutamate metabolic process (GO:0006536),-0.2781403938221857,-0.7903638796828866,0.7707006369426752,0.9181808592313313,1.0,8/19,22.53%,GLS;GCLC;GCLM;ALDH18A1;GLUD1;ALDH5A1;PRODH;GGT1
prerank,transcription by RNA polymerase III (GO:0006383),-0.2608560400729829,-0.7902169100628741,0.7870967741935484,0.917933528564205,1.0,11/27,35.74%,ICE1;GTF3C5;POLR3H;GTF3A;ELL;GTF3C3;SNAPC5;GTF3C6;SNAPC4;GTF3C2;SNAPC3
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.2786585807336534,0.7901135853873719,0.7781818181818182,1.0,1.0,3/26,6.20%,ADCY5;ADRA2A;ADCY8
prerank,cellular response to unfolded protein (GO:0034620),0.2717610730188159,0.7895919563200359,0.7752380952380953,1.0,1.0,3/26,5.52%,HSPA1A;OPTN;ABCB10
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.2669579168146578,-0.7890816175213068,0.7910750507099391,0.9192381358448299,1.0,9/22,23.61%,MFHAS1;XDH;BMP2;VEGFA;RELL1;ZC3H12A;SPI1;MAP3K4;PRMT1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.2212491740918074,0.788587378088944,0.8571428571428571,1.0,1.0,11/70,11.81%,PON1;STARD7;PLA2G4C;LPIN1;PNPLA8;NR1H3;CHPT1;CSNK2A2;CHKB;PLA2G15;ABHD3
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.33506616416421536,-0.7882868644990403,0.7475728155339806,0.9200531648060504,1.0,2/10,5.61%,SEC14L1;RNF125
prerank,erythrocyte development (GO:0048821),0.34221424466997197,0.7881595671753105,0.7524950099800399,1.0,1.0,2/10,8.34%,ABCB10;MED1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.23871519677849667,-0.787998640932284,0.8236607142857143,0.9200313190486779,1.0,6/33,12.21%,PTPRJ;DGKZ;RPS3;CEACAM1;DUSP3;NECTIN2
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.23573256854004726,0.7872193502210751,0.8125,1.0,1.0,20/51,26.44%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LBR;LEMD2;CHMP3;CHMP7;CHMP4C;SPAST;VRK1;NUP160;SUMO1;RCC1;NUP133
prerank,mitotic nuclear membrane organization (GO:0101024),0.23573256854004726,0.7872193502210751,0.8125,1.0,1.0,20/51,26.44%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LBR;LEMD2;CHMP3;CHMP7;CHMP4C;SPAST;VRK1;NUP160;SUMO1;RCC1;NUP133
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.19000560838687502,-0.7868679481751839,0.926509186351706,0.9212651900862769,1.0,24/132,15.22%,RPS15;RPL38;RPL5;RPL10;MRPL20;COIL;SNRNP200;XRCC5;RPLP0;RPS5;SNRPD1;RPS28;PTGES3;RPL6;PRMT7;RPL24;RPS27;SNRPD2;RRP7A;CLP1;GEMIN8;SNRPE;DDX23;NCBP1
prerank,peptide catabolic process (GO:0043171),0.28135820381507987,0.7861518568716482,0.7640232108317214,1.0,1.0,5/23,15.34%,ADAMTS13;CPQ;CTSH;TRHDE;GGT5
prerank,intracellular protein transmembrane transport (GO:0065002),-0.23168831386645192,-0.7860787824235452,0.8241758241758241,0.9219931059011519,1.0,15/42,27.66%,PEX7;SEC61A1;AKT2;ROMO1;GRPEL1;TIMM23;PEX14;DNLZ;PEX2;TOMM40L;TIMM50;SEC62;PEX12;RTN2;ZFAND2B
prerank,embryonic axis specification (GO:0000578),0.30668494203830904,0.7854545086659288,0.7221135029354208,1.0,1.0,2/15,3.68%,CXXC4;WNT7A
prerank,cellular response to estradiol stimulus (GO:0071392),-0.2799143395991983,-0.7854136967883074,0.7752577319587629,0.9225335926028466,1.0,12/18,39.24%,EGFR;ESR1;NRIP1;GPER1;NCOA3;CCDC62;SSTR2;POU4F1;RAMP3;CRHBP;FAM210B;SSTR1
prerank,tRNA processing (GO:0008033),-0.21456513423057158,-0.7842767665260537,0.863961813842482,0.9238277338571155,1.0,29/61,36.23%,TSEN2;PUS3;THUMPD1;TRMT10A;FTSJ1;TRMT10B;CPSF4;TRIT1;ELAC2;CLP1;CDKAL1;RPP21;ADAT1;LCMT2;RTCB;WDR4;AARS2;RTRAF;ADAT2;POP7;CTU2;TRMT61A;CTU1;PTCD1;RPP40;THG1L;DDX1;KARS1;DTWD1
prerank,response to cAMP (GO:0051591),-0.23536506882063835,-0.7842119630111998,0.8344370860927153,0.9234435915635546,1.0,6/37,12.77%,RAPGEF2;RAP1A;PDE2A;KCNQ1;AHR;SLC26A6
prerank,response to muscle stretch (GO:0035994),-0.3001268181658161,-0.7841514787849041,0.7607758620689655,0.9230578677474028,1.0,8/15,34.61%,GSN;PIK3CA;CDH2;DMD;SLC8A1;TTN;CTNNB1;TCAP
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.2925966908904364,-0.7838947319966093,0.7762645914396887,0.9229955605306552,1.0,6/15,28.06%,FAF2;AUP1;OS9;UFD1;HERPUD1;VCP
prerank,regulation of RNA export from nucleus (GO:0046831),0.34104582266717254,0.7836107510879953,0.7112403100775194,1.0,1.0,3/11,16.67%,CPSF6;NSUN2;AKAP8L
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.3421149513399601,-0.7833933591167237,0.7616387337057728,0.9232680476662034,1.0,1/10,6.03%,GNB1
prerank,cellular response to retinoic acid (GO:0071300),0.2503342342281162,0.7832997380137077,0.813953488372093,1.0,1.0,10/42,18.15%,WNT5B;PTK7;WNT6;HTRA2;FZD7;SOX9;NDUFA13;ATM;CREB1;FZD10
prerank,second-messenger-mediated signaling (GO:0019932),0.2176582225414573,0.7830893262905739,0.8671328671328671,1.0,1.0,11/82,11.28%,CCR9;ACKR2;SPHK1;GPR62;PDPK1;NUDT4;LRRK2;MAFA;NMUR1;RYR2;KSR2
prerank,protein import into peroxisome matrix (GO:0016558),-0.3124583999827505,-0.7830630103562667,0.77079107505071,0.9232987377126987,1.0,4/12,23.69%,PEX7;PEX14;PEX2;PEX12
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.32432295894703633,0.782979553684302,0.7281746031746031,1.0,1.0,2/13,7.76%,CPSF6;CPSF7
prerank,GPI anchor metabolic process (GO:0006505),0.26724480842388953,0.7828358366267602,0.7605893186003683,1.0,1.0,11/26,28.71%,PIGH;PIGG;DPM1;PGAP4;PGAP2;PIGO;DPM2;PIGB;MPPE1;PGAP3;PIGW
prerank,defense response to bacterium (GO:0042742),0.20858108154539504,0.7825468091163541,0.8817733990147784,1.0,1.0,19/105,20.02%,COLEC12;OAS2;PGLYRP3;CFP;OPTN;GSDMD;OAS3;CHGA;GBP6;RAB1A;TNFRSF14;IL6;ANKRD17;STAB2;IL12A;NLRC4;TIRAP;SHC1;PYCARD
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.21528605588787397,0.782325804578705,0.8543046357615894,1.0,1.0,29/94,20.76%,DDX5;ITPR1;AIFM1;E2F1;PDK2;HTRA2;TMEM117;MSH6;DNAJC10;IKBKE;MLLT11;C1QBP;TOPORS;BCL2;PML;CHEK2;PDK1;BAG6;PRKDC;ABL1;ATM;ERO1A;ATP2A1;HIPK2;RRP8;DDIT3;PYCARD;DDX3X;BAX
prerank,tRNA aminoacylation (GO:0043039),-0.2344951293939139,-0.7822857539845826,0.8155555555555556,0.9240265164387522,1.0,7/37,13.40%,GATB;WARS2;DARS1;LARS2;YARS2;EEF1E1;GARS1
prerank,regulation of interferon-beta production (GO:0032648),0.23995678820162442,0.7819376251655126,0.8007312614259597,1.0,1.0,14/46,20.22%,OAS2;NLRC3;CACTIN;OAS3;RNF135;POLR3C;TLR8;PPM1B;SIRPA;TIRAP;HSP90AA1;PYCARD;DDX3X;PTPRS
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.28094396874126454,0.7817599973522421,0.7509505703422054,1.0,1.0,12/23,27.60%,MTMR4;INPP5J;SYNJ2;MTMR2;MTMR10;OCRL;INPP5K;PIP4P2;SYNJ1;MTM1;TPTE;PIP4P1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.19368950025314458,0.7812323574541725,0.9236760124610592,1.0,1.0,40/173,17.94%,F5;ANK1;ANK2;BET1;PROZ;F10;VAMP7;ARFGAP3;ARFGAP2;NAPA;GOLGA2;TRAPPC11;NSF;IER3IP1;COPG1;TMED9;CNIH3;TMED4;TRAPPC1;SPTBN2;COPG2;USO1;RAB1A;MIA3;ACTR10;SPTA1;TRAPPC4;CAPZB;TRAPPC3;GOLT1A;CNIH4;DYNC1LI2;COPE;TMED2;GBF1;COPB1;MCFD2;SEC22B;TFG;F8
prerank,cristae formation (GO:0042407),-0.2535608136518761,-0.7812167567713361,0.8082788671023965,0.9251932128488642,1.0,9/27,25.63%,ATP5MF;ATP5F1E;ATP5F1B;DNAJC11;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD;LETM1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.2758301390957084,-0.7805862105064194,0.7524557956777996,0.9256682292756655,1.0,8/20,27.85%,CAMK2D;TGM2;BCAP31;TMCO1;BAK1;KCTD17;WFS1;HERPUD1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.3064075165857219,-0.7803053953310681,0.7827868852459017,0.9256416343143531,1.0,5/13,23.12%,MGAT5;HES1;PTPRC;JAK3;EGF
prerank,inner ear morphogenesis (GO:0042472),0.2804471622016334,0.7800420509534794,0.7732558139534884,1.0,1.0,4/22,11.96%,USH1C;FGFR2;MYO3A;SOX9
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.278233410405491,0.7799027577892487,0.7782101167315175,1.0,1.0,8/22,20.24%,CDKN2A;PLK1;CEBPA;NR2F2;MEN1;HEXIM2;TFAP4;CDK5RAP1
prerank,regulation of centrosome cycle (GO:0046605),-0.27479316328308623,-0.7794262099764822,0.791578947368421,0.926487781497614,1.0,12/21,40.95%,CHMP2B;CHMP4B;CHMP1B;FBXW5;CEP131;XRCC3;MARK4;AURKA;PKHD1;ATF5;VPS4B;PDCD6IP
prerank,protein targeting to peroxisome (GO:0006625),0.2573722253667972,0.7793957475125501,0.802536231884058,1.0,1.0,5/29,10.43%,ZFAND6;ATAD1;LONP2;ABCD1;PEX1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.3320571500420198,0.7788200936816494,0.7274549098196392,1.0,1.0,4/10,18.53%,SMARCD3;FZD3;KDM1A;CX3CL1
prerank,negative regulation of biosynthetic process (GO:0009890),0.3008153090566906,0.7787532869233053,0.75,1.0,1.0,7/16,21.84%,PPARA;SLC30A10;ABCD1;TRAP1;IL6;EMILIN1;CIITA
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.2669055641454634,0.7786930191202076,0.7763636363636364,1.0,1.0,7/29,15.25%,MAGEA2;PLK1;ARRDC3;DCUN1D4;TOPORS;FEM1A;ABL1
prerank,positive regulation of cellular senescence (GO:2000774),0.33772604748561397,0.7783763452528745,0.722567287784679,1.0,1.0,2/10,4.43%,CDKN2A;ARG2
prerank,regulation of osteoblast proliferation (GO:0033688),-0.27882494890400855,-0.7783169280597594,0.774390243902439,0.927606699585575,1.0,7/17,22.25%,RHOA;CCN1;TMEM119;BMP2;GREM1;SOX8;HPSE
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2664536607243564,0.7771658862348142,0.7910714285714285,1.0,1.0,10/26,22.21%,NLRC3;CACTIN;C1QBP;MAPKBP1;TYRO3;PPM1B;RNF26;NFKBIL1;ILRUN;DHX58
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2275684134991522,0.7768046100391961,0.8391224862888482,1.0,1.0,13/57,17.82%,FANCD2;PLK1;ABRAXAS1;EME2;RINT1;MDC1;MRE11;CHEK2;CDC14B;PRKDC;ATM;CLSPN;RAD17
prerank,negative regulation of type I interferon production (GO:0032480),-0.22967366098896358,-0.7767892900572481,0.8571428571428571,0.9294180880387778,1.0,9/40,17.21%,REL;RNF125;NLRC5;TRIM25;RELB;ISG15;IFIH1;TRAF3IP1;PCBP2
prerank,establishment of mitotic spindle localization (GO:0040001),0.26542389457844406,0.7765058392125265,0.7948207171314741,1.0,1.0,5/28,9.32%,PLK1;CLASP1;HTT;NDC80;MAD2L1
prerank,defense response to fungus (GO:0050832),-0.2828389268371617,-0.7764701463667014,0.784394250513347,0.9294421717882884,1.0,4/17,23.22%,PLCG2;RARRES2;GAPDH;BCL10
prerank,DNA recombination (GO:0006310),-0.23518027975446038,-0.776426206135049,0.8165938864628821,0.9290307790746207,1.0,10/37,20.34%,RPA1;RAD51B;RPAIN;RAD54B;DMC1;BLM;RAD21;RHNO1;LIG4;HMGB1
prerank,regulation of autophagosome assembly (GO:2000785),0.25522250062904384,0.7762474232800367,0.8070500927643784,1.0,1.0,4/33,8.07%,NUPR1;NPRL3;RAB3GAP1;LRRK2
prerank,lipoprotein localization (GO:0044872),0.33744837546687056,0.7760052521386075,0.7346938775510204,1.0,1.0,5/11,26.10%,PRKCB;ZDHHC3;MIA3;VMP1;PPARG
prerank,regulation of neuron death (GO:1901214),0.21854373936832294,0.7759790991694289,0.846551724137931,1.0,1.0,23/82,20.10%,EFNB2;PM20D1;PICALM;GRID2;DHCR24;RILPL1;IKBKG;HTRA2;LRRK2;PPARGC1A;CHGA;CLU;TSC1;SARM1;ITGAM;EPHB1;FAIM2;AKT1;C1QA;TRIM2;PRNP;REST;EIF2S1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.27500740594802237,0.7755979537642275,0.7566037735849057,1.0,1.0,3/22,7.85%,STAM;RNF126;SNF8
prerank,negative regulation of B cell proliferation (GO:0030889),-0.32938082011842584,-0.7752312656288789,0.7570498915401301,0.9303502123767303,1.0,2/11,7.08%,LYN;TNFRSF21
prerank,regulation of actin filament-based process (GO:0032970),0.21612561356098403,0.774899988353428,0.8669950738916257,1.0,1.0,5/70,3.11%,ROCK2;RICTOR;BAIAP2;RHOBTB2;CELSR1
prerank,protein targeting to mitochondrion (GO:0006626),0.2302362070609729,0.7748382276898489,0.8301886792452831,1.0,1.0,10/52,15.15%,PITRM1;AIFM1;IMMP1L;TOMM40;TIMM17A;TOMM22;MFN2;PAM16;NDUFA13;TIMM21
prerank,DNA double-strand break processing (GO:0000729),0.2884902748715869,0.7747374061078556,0.7605363984674329,1.0,1.0,6/18,22.08%,KAT5;MRE11;RNF138;ATM;RAD52;SLX4
prerank,positive regulation of histone modification (GO:0031058),-0.23739792742826657,-0.7747272284423042,0.7941787941787942,0.9306388433206569,1.0,8/33,19.05%,RPS6KA5;GLYR1;NIPBL;SAP30BP;PAF1;FMR1;APLNR;MAPK3
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2518742611700513,-0.7746258411662816,0.8095238095238095,0.9303094411188032,1.0,8/27,18.81%,CDC27;ANAPC5;UBE2D3;CDC16;UBE2L3;FZR1;UBE2A;CDC26
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.292634415138912,-0.7743720540859981,0.7474949899799599,0.9301947053811671,1.0,3/15,13.83%,FAP;CST3;LRP1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.2213120028010641,-0.7742205121264171,0.8461538461538461,0.9299195914221735,1.0,12/48,21.87%,EGFR;IRAK3;FLNA;IAPP;PRKCG;APOE;EDN1;MAD2L2;PFDN6;AGAP2;ROCK1;AZIN1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.33309786682065723,-0.7741093429595212,0.7582846003898636,0.9296205363303732,1.0,3/10,22.21%,APC;CDC42;KNSTRN
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.29080704228975657,-0.7740414503618805,0.7759674134419552,0.9292426066071301,1.0,4/15,17.68%,ANXA1;FAM107A;UBE2L3;GPER1
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.2639314086702904,-0.7739183957132597,0.7895833333333333,0.9289415941826171,1.0,11/21,32.41%,ARHGEF2;ATXN7;APC;FGF13;KATNB1;TAOK1;TPX2;CAMSAP2;CIB1;CAMSAP3;CAMSAP1
prerank,cellular respiration (GO:0045333),0.24307890500764162,0.7738657446150832,0.8089053803339518,1.0,1.0,13/41,21.46%,COQ10A;NDUFS1;PPARGC1A;UQCRH;CYCS;SDHC;COX10;LYRM7;OXA1L;SDHB;ETFDH;NR4A3;SLC25A13
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.26005741150526585,-0.7737403945303586,0.8047210300429185,0.9287239172296643,1.0,6/23,16.03%,SLIT2;MPP1;MDK;JAM3;CD74;NCKAP1L
prerank,regulation of B cell activation (GO:0050864),-0.25468874783984974,-0.7737213793972832,0.8127659574468085,0.928276468660639,1.0,10/25,34.02%,AHR;NOD2;FCGR2B;ZFP36L2;FOXJ1;SAMSN1;IL4I1;LAPTM5;IKZF3;THEMIS2
prerank,microtubule bundle formation (GO:0001578),-0.2246469145664913,-0.7733027082028078,0.8403547671840355,0.9284120128336824,1.0,17/42,34.92%,NCKAP5;TPPP3;GAS2L1;NCKAP5L;CLIP1;TOGARAM1;RP1;AAAS;CDK5RAP2;CFAP46;FOXJ1;MARK4;KIF20A;PSRC1;CFAP206;NAV1;CCDC40
prerank,nucleosome disassembly (GO:0006337),-0.301038879957024,-0.7732934245210391,0.7489878542510121,0.9274653252612727,1.0,4/14,20.48%,SMARCC1;ARID1A;SMARCA4;SET
prerank,chromatin disassembly (GO:0031498),-0.301038879957024,-0.7732934245210391,0.7489878542510121,0.9274653252612727,1.0,4/14,20.48%,SMARCC1;ARID1A;SMARCA4;SET
prerank,positive regulation of natural killer cell activation (GO:0032816),0.3116032690157948,0.7732018589255636,0.7452107279693486,1.0,1.0,1/13,0.87%,IL18
prerank,long-chain fatty acid import into cell (GO:0044539),0.3339602361159899,0.7729689920080997,0.7509505703422054,1.0,1.0,1/10,0.68%,ACSL1
prerank,peptidyl-lysine acetylation (GO:0018394),0.33642298271816923,0.7727365103750463,0.7614314115308151,1.0,1.0,3/10,15.49%,KAT5;BAG6;SIRT1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3199073183359229,0.7726145425531153,0.7455268389662028,1.0,1.0,1/11,1.96%,LRRC38
prerank,inflammatory response (GO:0006954),0.18977169003568714,0.7723432613050849,0.9474497681607419,1.0,1.0,36/195,18.84%,IL18;TAC1;C5AR2;KIT;IL17D;ADCY1;CHUK;LOXL3;PLA2G4C;BDKRB2;NOX1;ADCY8;IKBKG;PRDX5;NLRP3;KLRG1;LTB4R2;PTGER1;C3AR1;PARP4;HYAL1;HDAC4;CDO1;SCG2;CYBA;TLR5;GGT5;IL6;TAC4;HRH1;RELA;IL1A;TPST1;CX3CL1;NLRC4;NFKB1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.1998866204104972,-0.7723071262120992,0.9151376146788991,0.928455918359215,1.0,28/83,27.86%,YWHAE;DYNC1I2;CSNK1E;TUBA1A;CEP76;DCTN3;ODF2;DYNLL1;CCP110;PRKAR2B;PAFAH1B1;PRKACA;DYNC1H1;CSNK1D;DCTN1;CEP41;TPX2;TUBA4A;CEP131;CDK5RAP2;CEP152;HMMR;KIF14;AKAP9;ACTR1A;CDK2;CENPJ;CNTRL
prerank,regulation of cell death (GO:0010941),0.20799406472351148,0.7719730515401756,0.9011725293132329,1.0,1.0,14/94,14.28%,BMP7;HSPA1A;CCN2;OLFM4;DHCR24;RILPL1;LRRK2;IMPACT;PRR7;CLU;PARP16;TSC1;SARM1;HSPA1B
prerank,histone deacetylation (GO:0016575),-0.2254096865490658,-0.7716003247427714,0.8418604651162791,0.9289886380100285,1.0,14/43,26.26%,MIER1;PRDM5;HDAC9;PER1;MTA1;HDAC6;HDAC2;MIER2;MTA3;SIRT7;MSL3;SIRT6;ELK4;RCOR1
prerank,regulation of telomere maintenance (GO:0032204),-0.2594599827367061,-0.7712137380522552,0.7827004219409283,0.9290908977967147,1.0,11/26,26.20%,GNL3;XRCC5;USP7;TERF2IP;YLPM1;NBN;SIRT6;PPP1R10;TINF2;HNRNPD;TERF2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.2834602297601971,-0.7711766949694182,0.7852882703777336,0.9286650540612037,1.0,4/16,16.51%,MEF2C;MCTP2;FMR1;MCTP1
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.2730877811785679,-0.7708334861363483,0.810752688172043,0.9286736726384512,1.0,9/18,38.05%,NCKAP1L;PRDM1;METTL3;CCR2;ZFP36L2;IL4I1;IKZF3;PRELID1;CRTAM
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2626789014758034,0.7700962739418099,0.7958015267175572,1.0,1.0,3/26,4.38%,NPR3;CDH3;PIK3CB
prerank,multivesicular body assembly (GO:0036258),-0.23929719353143575,-0.7700521986203442,0.8438818565400844,0.9293053434292167,1.0,9/30,18.87%,CHMP2B;CHMP4B;CHMP4A;VPS36;HGS;IST1;VPS37A;CHMP1B;RAB11A
prerank,establishment of spindle localization (GO:0051293),0.3028290908041946,0.7698092297491055,0.7440476190476191,1.0,1.0,3/14,9.52%,CLASP1;LLGL2;LLGL1
prerank,regulation of interferon-gamma production (GO:0032649),-0.20348445427355716,-0.7696491446520582,0.8816425120772947,0.929392929522808,1.0,4/71,3.21%,PDE4D;IL1R1;GAS6;SLC7A5
prerank,positive regulation of bone resorption (GO:0045780),-0.3194284216035759,-0.769471650646995,0.7679671457905544,0.9291770115131535,1.0,5/11,34.43%,TNFRSF11A;SYK;PLEKHM1;MC4R;ATP6AP1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.2195337307118688,-0.7694669960410763,0.8635346756152126,0.928706110378999,1.0,22/49,32.90%,F3;AFAP1L2;STAT3;NOD1;SERPINE1;CD74;NOD2;RIPK1;HMGB1;MYD88;SYK;BCL10;TLR4;F2R;PARK7;FADD;LAMTOR5;LGALS9;TLR1;NOS2;CD14;TLR3
prerank,proteasomal protein catabolic process (GO:0010498),0.18637798076865467,0.769147723582456,0.963963963963964,1.0,1.0,51/201,21.17%,DERL1;FBXL19;HECTD3;PSMD3;SIAH2;RNF41;RNF126;IFI27;MAEA;TRIM71;SOCS6;UBE4B;KAT5;ARRB1;CLOCK;TOPORS;PRPF19;UBE2W;CCDC47;UBXN6;PML;PSMD1;BAG6;SPSB2;PSMC5;RNF5;PSMA1;FEM1C;TBL1XR1;RBCK1;SIRT1;PSMD12;KLHL20;TRIM3;MDM2;KCTD2;RNF139;FBXL22;KCTD13;PSMD7;TRIM2;TRIM13;BFAR;DDIT3;SPSB1;KLHL42;RMND5A;HECW1;ZSWIM8;PSME2;TRIM9
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.2603755057157109,0.7687476125475744,0.8040293040293041,1.0,1.0,5/29,10.46%,DHX34;HNRNPU;E2F1;ELAVL1;VIP
prerank,positive regulation of lymphocyte activation (GO:0051251),0.25819560859418555,0.7680691228929278,0.8136531365313653,1.0,1.0,7/28,20.02%,TNIP2;PRKDC;IL6;IL12A;SIRPA;FGF10;PYCARD
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2415441551110938,-0.7680103766956649,0.8070175438596491,0.9302762827667042,1.0,12/30,29.47%,SHLD1;RNF169;TWIST1;SMCHD1;FANCB;MAD2L2;NUDT16L1;OTUB2;SHLD3;OTUB1;CGAS;HELB
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.29123746360838904,-0.7679273843895765,0.8102766798418972,0.9299233661629603,1.0,6/15,25.71%,STAT3;GBP5;NOD2;MYD88;TICAM1;TLR4
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.29498927925222185,-0.76780487868198,0.7744510978043913,0.9296401875778171,1.0,2/13,8.86%,BMP4;SOD1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.25148547857410936,0.7676830647887957,0.7961904761904762,1.0,1.0,6/31,15.15%,AIFM1;TOMM40;TIMM17A;PEX1;PAM16;TIMM21
prerank,positive regulation of macrophage activation (GO:0043032),0.2896279784552111,0.7676116558002782,0.782435129740519,1.0,1.0,3/17,8.49%,TAFA3;CEBPA;TNIP2
prerank,negative regulation of immune response (GO:0050777),0.19246203905080445,0.7673908477771806,0.9484375,1.0,1.0,29/154,18.50%,ADCY5;PTH2R;CD247;ENPP3;FURIN;ADCY1;CRHR1;GPR45;ADCY8;HTR7;HRH2;NLRC3;CACTIN;C1QBP;VIP;MAPK14;CD300A;MAPKBP1;TYRO3;HAVCR2;GGT5;IL6;GIPR;PPM1B;CREB1;COL3A1;VIPR2;ADCY6;RNF26
prerank,snRNA 3'-end processing (GO:0034472),0.2816991585378043,0.7672187191267311,0.7794392523364486,1.0,1.0,4/19,15.58%,EXOSC8;EXOSC2;USB1;INTS8
prerank,neurogenesis (GO:0022008),0.23851929275561307,0.7671576279521238,0.8083182640144665,1.0,1.0,6/43,10.61%,TRAK1;VXN;DAGLA;WDR62;LPAR1;RITA1
prerank,establishment of melanosome localization (GO:0032401),0.2827782780482386,0.7670111233689969,0.7728119180633147,1.0,1.0,3/19,13.11%,GPR143;BBS5;SHROOM2
prerank,telomere organization (GO:0032200),0.2390507572804152,0.7667340745923996,0.8474264705882353,1.0,1.0,10/43,16.00%,DOT1L;RECQL4;POLD2;MRE11;RTEL1;TERT;RAD51D;PRKDC;RPA3;ATM
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3021891782529068,-0.7665438061132273,0.790356394129979,0.9309689888934317,1.0,2/14,10.53%,CARD14;MALT1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.33099736398602464,0.7664462198737036,0.7495291902071564,1.0,1.0,2/10,11.40%,ALDH7A1;COMT
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.31931658174993244,0.7658169522062022,0.748046875,1.0,1.0,1/12,0.36%,UST
prerank,fatty acid biosynthetic process (GO:0006633),-0.20515059256953622,-0.7650840928303991,0.9044444444444445,0.9324564155209222,1.0,14/63,19.49%,ABHD2;ELOVL7;PTGS2;ELOVL5;FADS3;ELOVL6;LIAS;SCD;ELOVL1;TECRL;ELOVL4;MCAT;MLYCD;ASAH2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.31389148484319945,0.7647517978699624,0.7537878787878788,1.0,1.0,5/13,16.06%,OAS2;EBI3;STAT1;CANX;TYK2
prerank,regulation of endopeptidase activity (GO:0052548),0.2251317710049957,0.7636913046176748,0.8512110726643599,1.0,1.0,10/59,14.45%,TIMP3;SERPINA10;FURIN;PICALM;SERPIND1;HRG;APH1A;NRDC;SERPINA9;SERPINE3
prerank,positive regulation of leukocyte activation (GO:0002696),-0.2727213773923015,-0.7634581028344233,0.8104838709677419,0.934254359012568,1.0,4/18,18.27%,THBS1;WNT5A;NECTIN2;IL33
prerank,phosphatidic acid metabolic process (GO:0046473),-0.21681775466744713,-0.7632196129588263,0.9068181818181819,0.9341144849336562,1.0,8/48,14.60%,PLA2G4A;DGKH;DGKZ;AGPAT1;ABHD4;ABHD8;PLA2G6;AGPAT5
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.2858553447756871,-0.7630059449645997,0.808,0.9339365972495499,1.0,7/16,30.95%,SCARB1;PNPLA2;MFSD2A;CTDNEP1;SREBF1;LDLR;NR1H2
prerank,positive regulation of TOR signaling (GO:0032008),0.23736023848756352,0.763000684063632,0.8545454545454545,1.0,1.0,10/40,17.90%,RRAGC;RICTOR;GPR137C;SLC38A9;PIH1D1;LAMTOR2;LAMTOR3;TELO2;RRAGB;FNIP1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.277306086912376,-0.7625499884771657,0.8256302521008403,0.9340866114726376,1.0,3/17,9.86%,PCSK5;HDAC9;SORT1
prerank,N-terminal protein amino acid modification (GO:0031365),0.3022958970795429,0.7624831195370074,0.7545271629778671,1.0,1.0,1/14,0.84%,METAP2
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.24836513887274056,-0.7623514569865626,0.8225469728601252,0.9338720941520868,1.0,5/26,10.10%,APP;HES1;EIF4E;TAL1;DUSP3
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3284948231624153,0.7622167891088033,0.7425742574257426,1.0,1.0,4/10,22.82%,JARID2;SIRT1;KDM1A;ATRX
prerank,T cell proliferation (GO:0042098),-0.2981575500235894,-0.761702254037212,0.784394250513347,0.9343190246310115,1.0,8/13,38.05%,DOCK8;CTPS1;CADM1;MSN;PIK3CG;RASGRP1;TNFRSF4;CRTAM
prerank,negative regulation of leukocyte activation (GO:0002695),-0.2893485259143598,-0.7613891973152932,0.7814432989690722,0.9342827385463386,1.0,8/15,33.12%,CD200;GPER1;ZC3H12A;FCGR2B;MILR1;CD300LF;GRN;CD84
prerank,actin filament polymerization (GO:0030041),-0.24191570839463505,-0.7613038742016768,0.84,0.9339342740633939,1.0,9/29,20.58%,GSN;MSRB2;WASHC3;FAM107A;MICALL2;PSTPIP2;PREX1;DIAPH3;TTC17
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.33394011675349966,0.7605733686830247,0.7393939393939394,1.0,1.0,10/10,66.63%,CNGB1;CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;TULP1;CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.33394011675349966,0.7605733686830247,0.7393939393939394,1.0,1.0,10/10,66.63%,CNGB1;CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;TULP1;CEP250
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.25180336553879407,0.7601145384857487,0.8211678832116789,1.0,1.0,7/30,14.60%,VAMP5;OPTN;GGA2;NSF;AMN;GGA1;GOLGA4
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2643902579606796,-0.7596656759847671,0.826530612244898,0.9357331637913202,1.0,7/22,22.29%,NUBPL;NFU1;HSCB;NFS1;ISCA2;NUBP1;FXN
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.2860610533229087,0.7596026184388581,0.7572254335260116,1.0,1.0,3/18,10.41%,SLC25A5;PPIF;BCL2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.27171123758976123,0.7594368906855211,0.7948717948717948,1.0,1.0,7/23,22.01%,DAB2;CITED1;MEN1;CITED2;HIPK2;SMAD4;SDCBP
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.27171123758976123,0.7594368906855211,0.7948717948717948,1.0,1.0,7/23,22.01%,DAB2;CITED1;MEN1;CITED2;HIPK2;SMAD4;SDCBP
prerank,receptor catabolic process (GO:0032801),-0.25898811901008323,-0.7593804251672205,0.8361344537815126,0.9356214608222005,1.0,9/24,23.19%,SMURF1;AP2B1;ZNRF3;VLDLR;AP2A1;PIK3R4;NEDD4;MYLIP;AP2M1
prerank,melanosome localization (GO:0032400),0.27161449463829257,0.759378985792083,0.7956204379562044,1.0,1.0,3/21,13.11%,GPR143;BBS5;SHROOM2
prerank,pyroptosis (GO:0070269),0.29985459672139425,0.7587293697943281,0.7764705882352941,1.0,1.0,2/15,5.72%,GSDME;GSDMD
prerank,oligodendrocyte differentiation (GO:0048709),0.2814021207298818,0.7579242625809637,0.7963709677419355,1.0,1.0,3/19,11.96%,SLC8A3;EIF2B4;SOX9
prerank,positive regulation of type I interferon production (GO:0032481),-0.20012823486495163,-0.7578161203372925,0.9142857142857143,0.937237316284434,1.0,29/73,32.90%,LRRFIP1;POLR3F;DHX33;XRCC5;TRIM56;G3BP1;ISG15;POLR3H;IFIH1;NFKB2;POLR3B;GAPDH;IRF5;POLR3A;MYD88;ZBP1;POLR3D;RIPK2;POLR2F;PTPN11;TLR4;POLR2H;CGAS;POLR1C;POLR2E;IRF3;CD14;CTNNB1;TLR3
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.23368471329917218,0.7575489215720234,0.8480565371024735,1.0,1.0,3/44,4.31%,ROCK2;GTPBP1;TNRC6A
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.25459218927064103,0.7573528057293177,0.8422053231939164,1.0,1.0,9/29,16.82%,NAPA;RAB6B;NSF;COPG1;GOLGA5;COPG2;TRAPPC3;COPE;COPB1
prerank,nucleotide metabolic process (GO:0009117),0.27251500576133103,0.7572520555574748,0.8082191780821918,1.0,1.0,5/23,15.11%,ENPP3;AK5;DCK;AK1;GUK1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.33053401293444384,0.7571747510711039,0.7638095238095238,1.0,1.0,1/10,3.27%,ERCC1
prerank,t-circle formation (GO:0090656),0.33053401293444384,0.7571747510711039,0.7638095238095238,1.0,1.0,1/10,3.27%,ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.33053401293444384,0.7571747510711039,0.7638095238095238,1.0,1.0,1/10,3.27%,ERCC1
prerank,regulation of neutrophil migration (GO:1902622),-0.3190743519303781,-0.756989464411366,0.7838383838383839,0.9378755867922272,1.0,3/10,16.03%,MPP1;JAM3;NCKAP1L
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.29205127208527215,0.7567286557869755,0.7703252032520326,1.0,1.0,4/18,9.52%,ROCK2;RUFY3;LLGL2;LLGL1
prerank,phagosome maturation (GO:0090382),0.24759337273060592,0.7566249567358476,0.8201438848920863,0.9997382807210071,1.0,8/35,14.53%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,covalent chromatin modification (GO:0016569),-0.2886334679086708,-0.756617975290571,0.7806324110671937,0.9379206061825607,1.0,10/14,44.75%,CHD1;MT3;SIRT7;PARK7;HDAC1;PARP2;MBD2;AURKB;HLCS;AURKC
prerank,sensory perception of chemical stimulus (GO:0007606),0.29109632048223005,0.7562764127278121,0.7676767676767676,0.9994929472549288,1.0,15/15,70.92%,SYT10;SLC24A4;UBR3;GNAL;MKKS;GFY;OBP2B;OMP;BEST2;C5AR1;BBS4;ADCY3;GNAS;CD36;DRD2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2639375779187736,0.7562207356982655,0.8160919540229885,0.9988055544686549,1.0,9/25,24.34%,DERL1;UBE2W;BAG6;RNF5;UGGT2;LONP1;OMA1;NGLY1;KLHL15
prerank,dermatan sulfate metabolic process (GO:0030205),0.3074087501513204,0.7560788567226049,0.7903846153846154,0.9982502412684061,1.0,1/13,0.36%,UST
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.18831160418212986,-0.7560559744117104,0.948905109489051,0.9382028860932702,1.0,21/95,23.22%,MEF2C;DAB2IP;RHOA;TNFRSF1B;DEFA6;CARD16;WNT5A;SERPINE1;PAF1;PDCD4;CD86;GIT1;NOD2;ZC3H12A;HMGB1;MYD88;TICAM1;SBNO2;CASP1;FCGR2B;BCL10
prerank,negative regulation of DNA recombination (GO:0045910),-0.2192376170194472,-0.7553079408614917,0.8647450110864745,0.93871885113136,1.0,16/43,30.12%,SHLD1;TERF2IP;BLM;SMCHD1;FANCB;MAD2L2;POLR2I;POLR2F;PARP3;TINF2;SHLD3;TERF2;POLR2H;CGAS;HELB;POLR2E
prerank,fluid transport (GO:0042044),-0.3047266162848818,-0.7550293601181337,0.7933070866141733,0.9386085426111098,1.0,2/12,12.77%,AQP11;SLC26A6
prerank,regulation of mRNA metabolic process (GO:1903311),0.3206272903599921,0.7545369835130007,0.7520661157024794,0.9998459793327251,1.0,4/11,22.91%,SLTM;SAFB2;SAFB;SRPK1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.27811189794537733,0.7542290389709118,0.8188539741219963,0.9987786967362833,1.0,2/21,3.27%,DDB2;ERCC1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.27811189794537733,0.7542290389709118,0.8188539741219963,0.9987786967362833,1.0,2/21,3.27%,DDB2;ERCC1
prerank,inositol phosphate catabolic process (GO:0071545),0.3158338221828,0.7538319003486598,0.7729941291585127,0.998615754711282,1.0,7/12,27.75%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A;NUDT3
prerank,integrated stress response signaling (GO:0140467),0.3072496690338594,0.7536024493861951,0.7813163481953291,0.9981771501273762,1.0,5/14,20.83%,IMPACT;EIF2AK1;DDIT3;EIF2S1;OMA1
prerank,regulation of cell division (GO:0051302),-0.199030223502061,-0.7530875651678858,0.9206730769230769,0.9406892853069309,1.0,34/72,33.44%,MLLT3;BCL2L1;RACK1;PLK2;CALM3;MYO19;TXNIP;TAL1;PIK3C3;BLM;PIK3R4;CCP110;GIT1;RAB11FIP3;RAB11A;KIF13A;PRC1;NCOA3;ENTR1;DLL1;FSD1;TLE6;PLK3;SUSD2;CALM1;CIB1;FLCN;CSPP1;SH3GLB1;MYC;KIF20A;AURKA;BIRC6;ESRRB
prerank,regulation of secretion (GO:0051046),0.30043749506082384,0.7519904454594529,0.778672032193159,0.9998394351897933,1.0,2/13,6.83%,OAS2;NRG1
prerank,regulation of macrophage differentiation (GO:0045649),-0.2764427209447241,-0.7519816913142681,0.7987804878048781,0.9416928994462743,1.0,11/15,46.04%,IL34;C1QC;ID2;RIPK1;CASP8;FADD;LIF;PF4;HSF1;CSF1;PTPN2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.28083370779509503,-0.7517902632898361,0.7768421052631579,0.9409926993688305,1.0,6/15,32.23%,PABPC1;AGO2;NANOS3;ZFP36L2;CNOT1;NANOS1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.28083370779509503,-0.7517902632898361,0.7768421052631579,0.9409926993688305,1.0,6/15,32.23%,PABPC1;AGO2;NANOS3;ZFP36L2;CNOT1;NANOS1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.3273740729793724,0.7512204419885329,0.7539370078740157,1.0,1.0,2/10,10.92%,NPTX1;NPTXR
prerank,rRNA 3'-end processing (GO:0031125),0.32423844360399884,0.7510695501536969,0.7440476190476191,0.9996984204845147,1.0,2/10,11.29%,EXOSC8;EXOSC2
prerank,cytoplasmic microtubule organization (GO:0031122),-0.2108518768373796,-0.7510274188890042,0.8894009216589862,0.9415332399182246,1.0,19/54,27.92%,RHOA;DST;LIMK2;CLIP4;CLIP2;TRPV4;CLIP1;KATNAL1;DYNC1H1;CRIPT;RAB11A;DCTN1;SLK;FSD1;PLK3;KATNA1;CAMSAP2;CIB1;MAPT
prerank,estrogen metabolic process (GO:0008210),0.2999961440302799,0.7509774230088966,0.7933070866141733,0.9990785408854368,1.0,3/15,19.30%,HSD17B2;HSD17B11;HSD17B4
prerank,regulation of T cell activation (GO:0050863),-0.22063587286537226,-0.7504653709879934,0.8937644341801386,0.9418099867283171,1.0,25/42,49.65%,TNFRSF1B;DUSP3;JAK3;METTL3;TNFSF8;CCR2;IL4I1;LAPTM5;LAT;GPNMB;CD47;CCL5;PRELID1;VTCN1;CRTAM;LCK;CCDC88B;TNFSF11;TNFSF9;FGL1;TNFAIP8L2;TBX21;LGALS3;TNFSF18;CD2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.22749421446147194,-0.750276886542654,0.8863636363636364,0.9415813525139742,1.0,12/32,27.53%,PLCG1;CALM3;TRPC1;JPH2;CEMIP;P2RY6;APLNR;GPER1;NPSR1;F2R;CASQ1;CALM1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.24548661452098453,0.7494822069284919,0.8292220113851992,1.0,1.0,5/33,12.97%,PABPN1;CPSF3;CPSF7;SLBP;LSM11
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.3239216332194842,-0.7491819098576116,0.7996070726915521,0.9425040488578487,1.0,5/10,29.94%,PDE8A;STK26;RIPK1;PARK7;PYCR1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.2600094880942008,-0.7478046213457434,0.8378947368421052,0.9437705203591842,1.0,8/21,33.69%,JUN;TWIST1;MED14;MED13;MED24;SETX;MED30;PAXIP1
prerank,regulation of viral genome replication (GO:0045069),-0.2079166527660914,-0.7475726364873214,0.9134396355353075,0.9435693675795847,1.0,13/56,17.37%,PLSCR1;ADARB1;IFITM3;PABPC1;PPIA;ISG15;RSAD2;IFIH1;VAPB;PPIE;TMEM39A;IFITM1;N4BP1
prerank,regulation of mitotic spindle organization (GO:0060236),0.2394119241710692,0.7472907645201362,0.8415300546448088,1.0,1.0,7/35,16.50%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;CHMP1A
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.1965918898016347,-0.7471169780256912,0.9294117647058824,0.9436878609536097,1.0,26/69,35.74%,ICE1;INTS11;GTF2F1;NCBP2;POU2F1;ELL2;NCBP1;INTS10;ELL;INTS9;POLR2I;RPRD1B;POLR2F;TAF9;GTF2E2;GTF2E1;RPRD1A;POLR2H;CCNT1;SNAPC5;POLR2E;SNAPC4;POLR2J;TAF5;INTS12;SNAPC3
prerank,cellular lipid catabolic process (GO:0044242),-0.2448491162735534,-0.7465241965720852,0.8298319327731093,0.9439556586870922,1.0,7/27,20.40%,PPARD;CYP1B1;ACOX1;LPIN3;MT3;ACBD5;SMPDL3B
prerank,negative regulation of proteolysis (GO:0045861),0.24752659181520428,0.7464003096082364,0.8387096774193549,1.0,1.0,7/34,13.46%,TIMP3;PLAT;LRRK2;CLN8;EPHA4;GAS1;BAG6
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.2399813486296088,0.7456026741014226,0.8074766355140187,1.0,1.0,5/35,11.88%,PCDHB11;CDH17;CDH10;CDH18;PCDHB3
prerank,regulation of cellular protein localization (GO:1903827),-0.21759959054353942,-0.7455688363719066,0.8744588744588745,0.9446859116174736,1.0,16/45,28.72%,GPC6;RAB11FIP5;RALB;CSNK1E;PTPN1;RAB11B;GPC1;GPC4;SPIDR;EGF;NDEL1;SUMO3;TRIM67;MAPT;VCP;PARP1
prerank,negative regulation of translation (GO:0017148),0.2022031519472382,0.7445379039612965,0.9037800687285223,1.0,1.0,20/87,20.88%,CPEB2;ROCK2;TRIM71;UNK;CPEB4;EIF2AK2;PAIP2B;PAIP2;EPRS1;EIF4E2;TSC1;FXR2;EIF4EBP3;RNF139;GIGYF2;CPEB3;ILF3;DDX3X;LARP1;CNOT8
prerank,mitochondrial gene expression (GO:0140053),-0.2203601882793455,-0.7443210017957423,0.8802660753880266,0.9457694740532152,1.0,9/42,17.19%,GATB;FOXO3;LARS2;MRPL23;NDUFA7;MRPL12;GFM2;PTCD3;MRPS12
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.177737207580152,-0.7442200897518023,0.966321243523316,0.9454326499985032,1.0,40/125,27.78%,STMN1;EML1;DYNC1I2;MAP4;TNKS;PLK2;NUP107;DYNC1I1;RPS27;RMDN1;INCENP;DYNLL1;PPP1CC;ZWILCH;CLIP1;ZW10;DCTN6;PAFAH1B1;SEC13;STIL;PMF1;CENPQ;CENPL;NUSAP1;DYNC1H1;TAOK1;NUP85;B9D2;GPSM2;NSL1;CENPN;NDEL1;KIF4A;CENPK;SPC25;SPDL1;MIS12;CDCA8;SGO1;TUBG2
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.22814595082649378,-0.7442166126390906,0.8731182795698925,0.9449616995541918,1.0,9/35,22.53%,FAR2;GGTA1;HMGCLL1;FASN;AACS;SCD;GGT7;AWAT2;GGT1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.2785674948425394,0.743656754408278,0.8011928429423459,1.0,1.0,6/18,17.57%,CHRM2;PLCB1;CHRM1;OPRM1;RGS8;CDK5R1
prerank,sphingosine metabolic process (GO:0006670),-0.27511913910816127,-0.7436188884315597,0.8280632411067194,0.9452593932170952,1.0,7/17,22.64%,ACER2;PLPP1;PLPP3;SGPP1;ASAH2;ACER3;PLPP2
prerank,nuclear membrane reassembly (GO:0031468),0.2199926150549892,0.7433322343387481,0.892226148409894,1.0,1.0,20/54,26.44%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LBR;LEMD2;CHMP3;CHMP7;CHMP4C;SPAST;VRK1;NUP160;SUMO1;RCC1;NUP133
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3064569205195997,0.7428525058613846,0.7954971857410882,1.0,1.0,2/11,11.59%,GSTM2;GSTO1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3064569205195997,0.7428525058613846,0.7954971857410882,1.0,1.0,2/11,11.59%,GSTM2;GSTO1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.2573793765166467,0.7427676414603865,0.7969924812030075,1.0,1.0,3/25,6.70%,ANK2;CAPN3;PDPK1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.30236858073700157,0.7425405085067873,0.8063872255489022,1.0,1.0,4/14,17.46%,RFLNA;TGFBR1;SOX9;ADAMTS7
prerank,aerobic respiration (GO:0009060),-0.25737249595649525,-0.7424816943766159,0.854122621564482,0.946190240750707,1.0,8/20,23.65%,ATP5F1D;UQCRB;NDUFS7;MTFR2;NDUFS8;SLC25A14;UQCR10;UQCRC1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.28589539876209236,-0.7423505060947516,0.8103092783505155,0.9458907888777922,1.0,1/14,0.48%,ACTN4
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.2710603257369948,0.7423243039034121,0.8047808764940239,1.0,1.0,6/21,18.53%,SMARCD3;FZD3;FZD9;NES;KDM1A;CX3CL1
prerank,dendritic cell migration (GO:0036336),-0.27792489583956465,-0.7405326011773035,0.8333333333333334,0.9475912116124674,1.0,11/16,44.94%,EPS8;HMGB1;CCR2;CXCR4;PIK3CG;CCL5;GPR183;CCR1;CCL19;CCR6;CXCR2
prerank,heterochromatin assembly (GO:0031507),0.2719715766485852,0.740396987884835,0.8101503759398496,1.0,1.0,8/20,21.64%,CDKN2A;BEND3;BAHD1;SIRT1;CENPV;RRP8;BAZ2A;HELLS
prerank,natural killer cell mediated immunity (GO:0002228),0.29467250382349264,0.7394284994999734,0.8011363636363636,1.0,1.0,1/15,2.98%,KLRD1
prerank,positive regulation of translation (GO:0045727),-0.18803118532629834,-0.739177616655389,0.9414634146341463,0.948815075315361,1.0,19/94,22.20%,NIBAN1;THBS1;RBM3;RPL5;EIF3E;EEF2;YBX3;CDC123;AGO2;RPS9;NGRN;FMR1;PRR16;FXR1;METTL3;PIWIL2;BCL3;EIF4A3;JMJD4
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.2989464908124276,-0.7391574585264278,0.7832310838445807,0.9483648122110017,1.0,8/12,51.07%,ZBTB1;CCR2;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,negative regulation of protein depolymerization (GO:1901880),-0.24553676690577697,-0.7390583930082784,0.8312236286919831,0.9479937458321573,1.0,8/24,18.24%,ARHGEF2;ATXN7;APC;PIK3CA;FGF13;LIMA1;KATNB1;TAOK1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2412901778263038,0.7390337296724216,0.8424908424908425,1.0,1.0,8/35,16.02%,XRCC1;POLD2;MBD4;RFC5;POLE;RPA3;NEIL1;POLG
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.24276954513856724,-0.738666018615198,0.8650963597430407,0.9480127702611245,1.0,7/26,21.29%,SHANK3;ACTG1;SYNPO2;PFN1;LIMK1;CDC42;ROCK1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3085087591853214,-0.7386655750995649,0.8125,0.9475382102927978,1.0,5/10,31.37%,NHP2;DKC1;NOP10;RPUSD3;TSR3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.1894416845851584,-0.7385009264479243,0.9618138424821002,0.9472518149642514,1.0,23/86,23.51%,LIMD1;UBC;RPS27A;UBB;PSMA6;PSMB7;VHL;PSMB6;PSMB5;VEGFA;KLF2;PSMB8;PSMC4;PSMD11;ATF4;PSMB4;PSMD14;PSMD10;ATF3;CHEK1;PSME1;PSMB3;EGLN3
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.2768709618009647,-0.7384359134662742,0.8305785123966942,0.946849727031494,1.0,4/16,14.94%,SNRNP200;SFSWAP;NCBP2;DDX23
prerank,positive regulation of translational initiation (GO:0045948),0.2816749554727477,0.7383500991719493,0.8193916349809885,1.0,1.0,7/18,24.44%,BOLL;POLR2D;UHMK1;DDX3X;LARP1;YTHDF3;YTHDF2
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.1817359845804522,-0.738231785065324,0.9664948453608248,0.9466152724353454,1.0,25/101,25.71%,MEF2C;DAB2IP;RHOA;TNFRSF1B;DEFA6;CARD16;WNT5A;LYN;SERPINE1;PAF1;PDCD4;CD86;GIT1;NOD2;ZC3H12A;HCK;HMGB1;MYD88;TICAM1;SBNO2;CASP1;BCL10;CD68;PRKCE;TLR4
prerank,regulation of response to stress (GO:0080134),0.3182807049570856,0.7381851324337695,0.771484375,1.0,1.0,2/10,13.54%,ADCY8;OPRM1
prerank,melanosome transport (GO:0032402),0.27471567457641244,0.7380910495387866,0.7954971857410882,1.0,1.0,2/18,9.00%,GPR143;BBS5
prerank,pigment granule transport (GO:0051904),0.27471567457641244,0.7380910495387866,0.7954971857410882,1.0,1.0,2/18,9.00%,GPR143;BBS5
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.2416402735848101,-0.7377476809718484,0.8697478991596639,0.9467210449885696,1.0,5/26,9.78%,KMT2E;EGFR;ANXA1;ADAMTS1;RPTOR
prerank,regulation of nuclear division (GO:0051783),0.2705591698617644,0.7376452814944072,0.7922330097087379,1.0,1.0,2/20,5.79%,OBSL1;CDC25C
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.30981275285426574,0.7375692724078597,0.7697095435684648,1.0,1.0,3/11,10.75%,EFNB2;FZD7;FRS2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.25523021966912113,-0.7370785734190465,0.8453389830508474,0.9471026198612407,1.0,8/20,24.62%,ENTPD1;APP;TXNIP;NT5E;SUGT1;C3;CASP1;ANO6
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2833913172853097,0.737011070853779,0.8174757281553398,1.0,1.0,6/16,24.20%,ACAT1;GCDH;ACACA;CBR4;ACSS1;DIP2A
prerank,heme biosynthetic process (GO:0006783),-0.25210728428325735,-0.7369723633456046,0.83125,0.9467596003063901,1.0,7/22,24.86%,ABCG2;NFE2L1;UROS;HMBS;COX15;FXN;FECH
prerank,synaptonemal complex organization (GO:0070193),-0.2747547659753303,-0.7366425627757144,0.8556701030927835,0.9462154954835474,1.0,7/15,35.26%,RAD21;TEX11;SYCP2;REC8;TRIP13;TEX12;STAG3
prerank,synaptonemal complex assembly (GO:0007130),-0.2747547659753303,-0.7366425627757144,0.8556701030927835,0.9462154954835474,1.0,7/15,35.26%,RAD21;TEX11;SYCP2;REC8;TRIP13;TEX12;STAG3
prerank,import into nucleus (GO:0051170),0.21063298372581818,0.7365651378078413,0.9253996447602132,1.0,1.0,7/73,6.98%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.2200273862862386,0.735292124034758,0.9129662522202486,1.0,1.0,9/53,16.76%,OPRD1;CHRM2;HTR7;HRH2;HTR1F;CHRM1;OPRM1;HTR1A;HRH1
prerank,negative regulation of T cell proliferation (GO:0042130),-0.23069921518075615,-0.7352617837485451,0.8706896551724138,0.9473847399146227,1.0,13/28,39.54%,TNFRSF21;CD86;GLMN;CEBPB;IL4I1;LGALS9;GPNMB;SDC4;VTCN1;ARG1;CRTAM;PDCD1LG2;CD80
prerank,proteoglycan metabolic process (GO:0006029),-0.243538256581764,-0.7347129211294581,0.8418803418803419,0.9475712419502369,1.0,3/26,4.81%,BMPR2;CSGALNACT1;CHST8
prerank,negative regulation of axonogenesis (GO:0050771),0.24759985461074507,0.7346544192493438,0.8303393213572854,1.0,1.0,4/27,10.62%,MAP2;RUFY3;LRP4;RNF6
prerank,placenta development (GO:0001890),0.3000270694417815,0.7345131060156807,0.8038461538461539,1.0,1.0,6/12,26.10%,CITED1;E2F8;PLAC1;CUL7;PTK2;PPARG
prerank,glycogen catabolic process (GO:0005980),-0.27535127539731247,-0.734491060177774,0.8092243186582809,0.9473676470387487,1.0,5/15,15.48%,RB1CC1;PYGB;GAA;PGM2;PHKA2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.31789228046312135,0.734469996838174,0.7802874743326489,1.0,1.0,4/11,11.20%,HTRA2;PRR7;CAAP1;PIH1D1
prerank,nucleosome organization (GO:0034728),-0.20566816152404202,-0.7335009909149611,0.9315068493150684,0.9480288207616124,1.0,9/55,13.28%,CTCF;H3-3A;BPTF;SMARCC1;ARID1A;PAF1;NASP;LIN54;ACTR6
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.30725518404462737,-0.7333196547544258,0.80083857442348,0.9477823406591094,1.0,4/10,21.33%,LYN;CD40;CD24;BTLA
prerank,sphingolipid catabolic process (GO:0030149),0.28922222183260354,0.7329507590294941,0.7888446215139442,1.0,1.0,2/15,10.24%,SPHK1;SMPD2
prerank,response to tumor necrosis factor (GO:0034612),-0.18562521979582963,-0.7329374255360083,0.9559902200488998,0.947750929728582,1.0,10/91,8.06%,PID1;DAB2IP;TNFRSF11A;GCH1;ARHGEF2;ADAM10;YBX3;TNFRSF21;RPS3;CCL13
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.2425581485866997,0.7317202884236894,0.84,1.0,1.0,9/32,20.02%,DDX5;PDK2;PML;BAG6;AEN;SIRT1;HIPK2;RRP8;PYCARD
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2090614568187102,0.731147602131028,0.8940754039497307,1.0,1.0,15/63,17.43%,TFDP2;ARID3A;CDC25C;E2F1;E2F8;E2F4;PML;CHEK2;PRKDC;MUC1;PCBP4;GADD45A;ATM;MDM2;CNOT3
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.2985721226944994,0.731051621733453,0.8194444444444444,1.0,1.0,3/12,18.36%,PPARA;MIA3;AKT1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.2466263845375402,0.7301546999545918,0.8446969696969697,1.0,1.0,5/28,15.08%,TFIP11;AUNIP;KMT5C;PRKDC;WAS
prerank,DNA biosynthetic process (GO:0071897),0.2740367424352139,0.7300727717382158,0.8163672654690619,1.0,1.0,4/16,15.49%,POLD2;TERT;POLE;SIRT1
prerank,regulation of calcium ion import (GO:0090279),-0.2528584900529142,-0.7290712461637652,0.8530701754385965,0.9517777627802217,1.0,7/21,25.77%,SLC30A1;CXCL12;PLN;PSEN2;FYN;EGF;STC1
prerank,regulation of cell aging (GO:0090342),0.31046441316748113,0.7286608937974007,0.7869481765834933,1.0,1.0,3/11,20.21%,LMNA;VASH1;NEK4
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.2875064262335748,-0.7279110894984022,0.8263598326359832,0.9526387101448403,1.0,3/13,17.16%,NECTIN2;STX7;PVR
prerank,regulation of interleukin-8 production (GO:0032677),-0.191354552033134,-0.7276782503978574,0.9477272727272728,0.9524231390733527,1.0,29/69,32.90%,TMSB4X;F3;AFAP1L2;STAT3;NOD1;ANXA1;OTUD7B;SERPINE1;KLF4;CD74;PTPRC;NOD2;RIPK1;HMGB1;MYD88;SYK;BCL3;BCL10;TLR4;F2R;PARK7;FADD;LAMTOR5;TLR6;LGALS9;TLR1;NOS2;CD14;TLR3
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.23988091374957193,-0.7275192212670201,0.8828633405639913,0.9521398793429444,1.0,5/26,15.85%,PDE8A;PPIA;BAG5;HSPB1;ATF4
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.30320665321596046,0.7266949064015203,0.790650406504065,1.0,1.0,4/11,18.88%,KAT5;MUC1;HIPK2;TFAP4
prerank,histone H2A ubiquitination (GO:0033522),0.2772292032971506,0.7261206992224548,0.808,1.0,1.0,7/17,26.89%,DDB2;RING1;PCGF1;UBR2;RNF8;BCOR;UBE2B
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.2925877128702842,0.7258627215374431,0.7900207900207901,1.0,1.0,4/13,14.17%,RAB3GAP1;GRIK2;SHISA7;SHISA8
prerank,response to gamma radiation (GO:0010332),-0.24140095094162373,-0.7255785646606759,0.8650963597430407,0.9539155976165873,1.0,3/24,6.25%,DCUN1D3;MAP3K20;XRCC5
prerank,positive regulation of neuron death (GO:1901216),0.22394954330617184,0.7253951396613543,0.891500904159132,1.0,1.0,13/46,20.76%,NUPR1;EFNB2;PICALM;CLU;SARM1;ITGAM;CDK5R1;C1QA;PRNP;DDIT3;REST;EIF2S1;BAX
prerank,response to unfolded protein (GO:0006986),0.22501814727398434,0.7250549077028555,0.8835877862595419,1.0,1.0,4/48,4.35%,HSPA1A;DERL1;OPTN;DNAJB4
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.24723316455178332,-0.724791025987183,0.8596112311015118,0.9543196543567326,1.0,4/21,16.39%,CNOT6L;CNOT11;PAN3;TNKS1BP1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.3093628191725881,0.72406028224473,0.8049792531120332,1.0,1.0,4/10,17.34%,MTHFS;MTHFD1;MTHFR;MTHFD2
prerank,protein acetylation (GO:0006473),-0.2282213642154382,-0.7238473478985663,0.8947368421052632,0.9548821422224998,1.0,3/30,4.55%,FOXO1;NAA16;KAT6A
prerank,regulation of viral transcription (GO:0046782),-0.21572440128759324,-0.7235876979767332,0.9204545454545454,0.9546917200824505,1.0,5/39,10.09%,MDFIC;MID2;IFITM3;TRIM14;GTF2F1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.26256554132334786,-0.7232478409315412,0.8421052631578947,0.954611868968863,1.0,10/18,39.99%,APOE;AMER1;RNF128;MSN;FAF1;PTTG1IP;VPS35;DACT1;EZR;RDX
prerank,negative regulation of catabolic process (GO:0009895),0.21948580656781685,0.7231382798614376,0.8869257950530035,1.0,1.0,11/47,18.92%,NUPR1;PPARA;ADRA2A;MAD2L1;AZIN2;HDAC4;CYP51A1;SNX3;BANP;HMGCR;NCOR1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2268081011977857,-0.7230847599008408,0.9144736842105263,0.954312068554353,1.0,19/33,47.19%,FBN1;UBASH3B;TLR4;GPR137B;CEBPB;LRRC17;TLR3;POU4F1;BGLAP;CCR1;IL4;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;CSF1;CCL3;IL12B
prerank,protein import into mitochondrial matrix (GO:0030150),0.2711176945390532,0.7222624516936923,0.8224489795918367,1.0,1.0,4/18,15.15%,TOMM40;TIMM17A;PAM16;TIMM21
prerank,cell junction maintenance (GO:0034331),0.2869145851328351,0.7216916506306209,0.8130081300813008,1.0,1.0,1/14,2.86%,NLGN2
prerank,mRNA destabilization (GO:0061157),0.22788165880921263,0.7204338451930946,0.8843283582089553,1.0,1.0,12/38,26.13%,ROCK2;TRIM71;TUT4;POLR2D;GIGYF2;CPEB3;DCPS;YTHDF3;CELF1;YTHDF2;ZFP36;ZFP36L1
prerank,regulation of response to biotic stimulus (GO:0002831),0.24723953434828436,0.7203649577956218,0.8405253283302064,1.0,1.0,4/28,9.37%,APPL2;TKFC;TRIM5;RNF135
prerank,membrane depolarization (GO:0051899),-0.22359524162548175,-0.7196053804054061,0.8979118329466357,0.9576340309810208,1.0,8/32,21.60%,CAV1;CACNA1G;CACNA1B;CACNB4;CACNA1I;SCN3A;CACNA1H;SCN7A
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.31151440817209697,-0.7194749908088166,0.8387096774193549,0.9573029722949816,1.0,5/10,29.99%,AKT2;IRS1;PTH1R;PRKCE;PMAIP1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3039228254792914,-0.7192899370518421,0.8388998035363457,0.957030452693106,1.0,4/10,22.51%,CEACAM1;PTPRC;ARRB2;FCGR2B
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.21819915081293778,-0.7190757656169383,0.9130434782608695,0.9567969910808872,1.0,11/38,23.17%,POLR3F;PLSCR1;GBP5;PUM2;IFI35;PUM1;POLR3B;ZCCHC3;POLR3D;NMI;USP15
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.2939793731950546,0.7188959095422488,0.8073022312373225,1.0,1.0,5/13,19.69%,MSX2;TAF1;PER2;SIN3A;DDIT3
prerank,RNA modification (GO:0009451),-0.2004782157926626,-0.7186779022572725,0.9383886255924171,0.9567701134417775,1.0,21/54,31.83%,ADARB1;ALKBH1;PUS3;THUMPD1;FTSJ1;TRIT1;CDKAL1;PUS7L;LCMT2;NSUN4;MEPCE;METTL3;WDR4;AARS2;NOP10;ADAT2;NSUN5;CTU2;TRMT61A;TSR3;CTU1
prerank,protein N-linked glycosylation (GO:0006487),0.20574727728696543,0.7185305895524351,0.9245614035087719,1.0,1.0,19/66,22.77%,MAN1C1;ASGR1;B4GALT1;TUSC3;MGAT4C;MAGT1;PMM2;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPAGT1;DPM2;ALG2;ALG12;PGM3;DOLPP1;ST6GAL1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.2554707999393917,0.7183430789832218,0.8283018867924529,1.0,1.0,7/23,19.69%,INHA;C1QBP;HAVCR2;AXL;RARA;PRNP;DDIT3
prerank,protein K63-linked deubiquitination (GO:0070536),-0.22446817434946298,-0.7181320148857991,0.8726114649681529,0.9568826382789771,1.0,10/31,24.93%,OTUD7B;USP7;SPATA2;BABAM2;USP50;PSMD14;CYLD;ATXN3;OTUB2;SHMT2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.1741581968670093,-0.7177673700678885,0.9822784810126582,0.9568057692440713,1.0,42/129,27.86%,FBXL7;YWHAE;PPP1R12A;CDK14;DYNC1I2;CSNK1E;CCNY;TUBA1A;CEP76;DCTN3;ODF2;DYNLL1;CCP110;PRKAR2B;PAFAH1B1;PRKACA;LATS1;DYNC1H1;MASTL;LCMT1;AJUBA;CSNK1D;DCTN1;CEP41;CCNH;FBXL6;TUBA4A;CCNB2;CEP131;CDK5RAP2;CEP152;PLK3;KDM8;PPP2R2A;AKAP9;CDKN2B;ACTR1A;CUL1;FBXW11;CDK2;CENPJ;CNTRL
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3090178161718735,0.7174003104406357,0.8167006109979633,1.0,1.0,6/11,26.82%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3090178161718735,0.7174003104406357,0.8167006109979633,1.0,1.0,6/11,26.82%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A
prerank,RNA destabilization (GO:0050779),0.2640616516955895,0.7170544086058018,0.8385826771653543,1.0,1.0,1/18,0.78%,ROCK2
prerank,regulation of gene silencing by RNA (GO:0060966),-0.20320277719778934,-0.7169868251711168,0.9488888888888889,0.9566903274536637,1.0,25/50,34.42%,H3-3A;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;FMR1;SEC13;NUP50;NUP85;POLR2I;AAAS;POLR2F;NUP62;NUP214;POLR2H;NUP205;POLR2E;NUP210;NUP43;POLR2J;EIF4G1;NUP35;NUP42
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.20320277719778934,-0.7169868251711168,0.9488888888888889,0.9566903274536637,1.0,25/50,34.42%,H3-3A;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;FMR1;SEC13;NUP50;NUP85;POLR2I;AAAS;POLR2F;NUP62;NUP214;POLR2H;NUP205;POLR2E;NUP210;NUP43;POLR2J;EIF4G1;NUP35;NUP42
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.24435349733685235,0.716905201477662,0.8679611650485437,1.0,1.0,9/30,19.92%,ASGR1;TUSC3;MAGT1;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPM2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.23256984012992526,-0.7166241315294778,0.8666666666666667,0.9565962012385425,1.0,9/26,22.09%,STAT3;AIM2;LYN;GRIN2B;USP50;GRIN1;PSENEN;PSME1;FYN
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.23503642208640319,0.7165465801251122,0.8870056497175142,1.0,1.0,6/32,11.81%,STARD7;LPIN1;CHPT1;CSNK2A2;CHKB;ABHD3
prerank,protein insertion into membrane (GO:0051205),-0.22344492150176384,-0.7158707472385488,0.8910675381263616,0.9569043025245959,1.0,3/32,4.03%,EGFR;APP;STX1A
prerank,cellular response to interferon-beta (GO:0035458),0.2821667198703726,0.7144095278222279,0.8450184501845018,1.0,1.0,3/14,14.97%,HTRA2;STAT1;NDUFA13
prerank,apoptotic DNA fragmentation (GO:0006309),0.279784080343655,0.7142300900385989,0.8036072144288577,1.0,1.0,4/16,16.96%,CASP3;DFFA;DICER1;EXOG
prerank,chromatin organization (GO:0006325),-0.1717120318684539,-0.7127256043645529,0.9878640776699029,0.9598013209845895,1.0,14/132,11.05%,MECOM;PRDM16;ESR1;BPTF;SMARCC1;BAZ2B;EZH1;ZBTB1;RBBP4;CHD1L;ARID1A;BRWD1;CHD1;PBRM1
prerank,sphingoid metabolic process (GO:0046519),-0.28694950092115423,-0.7125104784202096,0.8363273453093812,0.9595382557867852,1.0,6/12,22.64%,DEGS2;PLPP1;PLPP3;SGPP1;ASAH2;PLPP2
prerank,peptidyl-asparagine modification (GO:0018196),0.24113164506094267,0.7123803879753215,0.8856589147286822,1.0,1.0,9/31,19.92%,ASGR1;TUSC3;MAGT1;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPM2
prerank,fatty acid transport (GO:0015908),0.27235233585275986,0.7120364299231251,0.8487229862475442,1.0,1.0,4/17,15.79%,ACSL1;SLC27A6;SLC27A4;GOT2
prerank,digestive tract morphogenesis (GO:0048546),0.28731425114401576,0.712007479984997,0.832,1.0,1.0,2/14,6.95%,PDGFRA;FGFR2
prerank,response to hexose (GO:0009746),-0.23711836048054075,-0.7112200023184527,0.8661087866108786,0.9604159513415412,1.0,3/25,9.44%,THBS1;EIF2B2;PFKL
prerank,respiratory electron transport chain (GO:0022904),0.28774438769906174,0.7105267989794228,0.8385826771653543,1.0,1.0,6/14,23.32%,PPARGC1A;SLC25A12;SDHB;ETFDH;SLC25A13;SLC25A18
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.3043123469964222,0.7104606938730843,0.8107074569789675,1.0,1.0,10/10,69.59%,PRNP;PRKAR1A;SCRIB;CD274;RC3H1;BTN2A2;FOXP3;PDCD1LG2;CRTAM;LGALS9
prerank,outer dynein arm assembly (GO:0036158),0.28027344658512277,0.7102952854791318,0.8303747534516766,1.0,1.0,5/15,26.85%,DNAL1;DNAAF5;DNAH5;DNAH17;ODAD4
prerank,positive regulation of interferon-alpha production (GO:0032727),0.2660208930081654,0.7102566000623223,0.8286778398510242,1.0,1.0,7/19,28.31%,CHUK;STAT1;TLR8;DDX3X;SETD2;TLR7;MAVS
prerank,epithelial structure maintenance (GO:0010669),0.3007534555820738,0.7100948639650784,0.8163265306122449,1.0,1.0,1/11,3.11%,STRAP
prerank,establishment of mitotic spindle orientation (GO:0000132),0.2497547767607703,0.7098268660883014,0.8487229862475442,1.0,1.0,8/23,23.39%,PLK1;HTT;NDC80;MAD2L1;INSC;NDE1;CENPA;MISP
prerank,"phototransduction, visible light (GO:0007603)",-0.27986772993479786,-0.7088642939366263,0.8574338085539714,0.962434591826877,1.0,2/14,6.03%,GNA11;GNB1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.21320209992781197,-0.7088037156512247,0.9133333333333333,0.9620350390775989,1.0,9/40,20.46%,DEFA6;GBP4;RPL39;DROSHA;MPEG1;RARRES2;ROMO1;PPP1R11;MYD88
prerank,regulation of protein targeting to membrane (GO:0090313),-0.22743614863937767,-0.7082484991093513,0.9106382978723404,0.9621325591336657,1.0,11/28,31.06%,MFF;CEMIP;AKT2;KCNB1;MIEF1;FYN;MYO1C;DMTN;CIB1;GDI1;ITGB1BP1
prerank,negative regulation by host of viral process (GO:0044793),-0.2995174852554649,-0.7074989725908015,0.8529411764705882,0.9624020897078527,1.0,7/10,50.37%,ZC3H12A;VAPA;CRP;CCL8;PTX3;PSMC3;LTF
prerank,mitotic metaphase plate congression (GO:0007080),-0.19993352427227767,-0.7066087798694469,0.9203539823008849,0.9627856229776075,1.0,19/51,26.72%,CHMP2B;CHMP4B;CHMP4A;PIBF1;RMDN1;ZW10;CHMP1B;RAB11A;RRS1;KIFC1;CDC23;NUP62;CUL3;KIF22;KIF14;SPDL1;MIS12;CDCA8;CEP55
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.2723967468080142,0.7062069918671336,0.831758034026465,1.0,1.0,6/17,20.23%,MOSPD2;C1QBP;CAMK1D;RIPOR2;TIRAP;DNM1L
prerank,visual perception (GO:0007601),0.19697943177413224,0.7059849314903158,0.9651162790697675,1.0,1.0,19/84,22.27%,GPR143;EYA4;EML2;ARR3;PAX6;CHRNB2;ADGRV1;ZIC2;RABGGTB;CRYBB1;RPGR;GRM8;OPA3;CABP4;CNGB1;MYO9A;RDH12;BBS2;PITPNA
prerank,peptidyl-glutamic acid modification (GO:0018200),0.25079249387824787,0.7059425797689386,0.8759541984732825,1.0,1.0,6/24,21.52%,TTLL6;AGBL4;GGCX;CFAP20;TTLL11;TTLL4
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.2140551406357739,-0.7052250548435397,0.9170212765957447,0.9636858338329084,1.0,9/38,19.45%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;NDUFA1;NDUFS7;NDUFS8
prerank,negative regulation of developmental growth (GO:0048640),-0.22610438643137493,-0.7051386664440893,0.9002169197396963,0.9633065000993782,1.0,12/30,27.89%,FGF13;PTCH1;SEMA3G;MT3;RTN4;FGFR3;PTEN;ULK2;RTN4R;CDKN1B;ULK1;DCC
prerank,midbody abscission (GO:0061952),-0.2558319992528595,-0.7049514840376255,0.8568464730290456,0.9630217939757437,1.0,3/17,6.92%,CHMP2B;CHMP4B;CHMP4A
prerank,negative regulation of cellular senescence (GO:2000773),0.28443732695742463,0.7045709018120468,0.823076923076923,1.0,1.0,4/13,15.49%,SLC30A10;ZKSCAN3;TERT;SIRT1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2751634096859615,0.7043644637221887,0.857976653696498,1.0,1.0,3/15,8.55%,PPARA;PPM1K;SLC45A3
prerank,histone H4-K16 acetylation (GO:0043984),0.25599684759359365,0.704230086292787,0.8472998137802608,1.0,1.0,3/19,6.62%,KANSL2;KMT2A;MEAF6
prerank,telomere capping (GO:0016233),0.27234650964695317,0.7040142654670055,0.8609406952965235,1.0,1.0,3/16,14.47%,TFIP11;MRE11;PRKDC
prerank,synaptic vesicle membrane organization (GO:0048499),-0.26459390832718566,-0.7039629484665573,0.84,0.9635691395178938,1.0,5/17,17.48%,STX1A;STX3;SYNGR2;SNAP23;SYNGR1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2366287865743378,-0.7039176292012769,0.8875,0.9631371431406315,1.0,8/24,24.86%,ABCG2;NFE2L1;RSAD1;UROS;HMBS;COX15;FXN;FECH
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.22796334226040676,0.7034609522461795,0.8841911764705882,1.0,1.0,7/32,16.86%,PLK1;ABRAXAS1;RINT1;MRE11;CDC14B;ATM;CLSPN
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.20140399215010418,-0.7030539763829574,0.9457013574660633,0.9634925656024697,1.0,7/46,14.60%,PLA2G4A;DGKH;DGKZ;AGPAT1;ABHD4;ABHD8;AGPAT5
prerank,water transport (GO:0006833),-0.2773756566392823,-0.7029701826660755,0.8205645161290323,0.9631130160596479,1.0,2/12,16.14%,AQP11;CFTR
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2349745009022012,0.7026454979440562,0.8862815884476535,1.0,1.0,9/29,23.18%,EXOSC8;PATL1;LSM5;LSM4;EXOSC2;EDC4;CNOT8;DCPS;DCP2
prerank,interstrand cross-link repair (GO:0036297),-0.19618896242383657,-0.7019569308033524,0.9633620689655172,0.9636276988891004,1.0,18/53,28.06%,RPA1;UBC;RPS27A;UBB;FANCB;FANCG;NEIL3;RPA2;RAD51AP2;XPA;CENPX;NUCKS1;XRCC3;USP1;RNF168;FANCL;RAD51AP1;VCP
prerank,regulation of myoblast fusion (GO:1901739),0.2919296329506008,0.701426907733253,0.8588957055214724,1.0,1.0,3/11,17.73%,CFLAR;MAPK14;RIPOR2
prerank,positive regulation of neutrophil migration (GO:1902624),0.2682285776040162,0.7012400426954004,0.8418079096045198,1.0,1.0,6/18,20.23%,MOSPD2;C1QBP;CAMK1D;RIPOR2;TIRAP;DNM1L
prerank,tRNA wobble base modification (GO:0002097),0.28371253305003175,0.7008516924072231,0.8662790697674418,1.0,1.0,2/14,5.85%,TRMT9B;GTPBP3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.28666455764088017,0.7007804489875802,0.8458574181117534,1.0,1.0,2/13,9.11%,KRI1;NOP9
prerank,dendritic cell chemotaxis (GO:0002407),-0.2735365371570928,-0.7002750652145037,0.854251012145749,0.9648275591146852,1.0,10/14,44.94%,HMGB1;CCR2;CXCR4;PIK3CG;CCL5;GPR183;CCR1;CCL19;CCR6;CXCR2
prerank,sensory perception of smell (GO:0007608),0.29102322661644703,0.6986636975459584,0.8326359832635983,1.0,1.0,11/11,70.92%,SYT10;SLC24A4;UBR3;MKKS;GFY;OBP2B;OMP;BEST2;BBS4;ADCY3;DRD2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.2923876141663246,0.6979038559469882,0.816793893129771,1.0,1.0,1/12,0.53%,DAB2
prerank,negative regulation of B cell activation (GO:0050869),-0.24147169347338404,-0.6972293848782463,0.8777777777777778,0.9672480041104322,1.0,9/21,33.08%,LYN;TNFRSF21;ID2;FCGR2B;PARP3;FOXJ1;SAMSN1;LAPTM5;TYROBP
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.25058296302519484,-0.697132866862175,0.8924050632911392,0.9668716864825984,1.0,10/18,40.86%,ANXA1;FAM107A;UBE2L3;ZFP36L2;SSTR2;AQP1;KLF9;PCK2;ISL1;BCL2L11
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.2028636592904297,-0.6963338539202228,0.9290465631929047,0.9671600392093804,1.0,9/40,23.85%,MMS22L;TIPIN;BLM;TIMELESS;BOD1L1;PRIMPOL;CENPX;NUCKS1;TRAIP
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.2521310394042368,-0.6962025692135496,0.8909465020576132,0.9663364267227054,1.0,8/19,32.69%,TERF2IP;POLR2I;POLR2F;TINF2;TERF2;POLR2H;POLR2E;POLR2J
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.2521310394042368,-0.6962025692135496,0.8909465020576132,0.9663364267227054,1.0,8/19,32.69%,TERF2IP;POLR2I;POLR2F;TINF2;TERF2;POLR2H;POLR2E;POLR2J
prerank,mRNA methylation (GO:0080009),0.27294663942024106,0.6950018898755607,0.8568548387096774,1.0,1.0,6/15,23.41%,NSUN2;TRMT6;TRMT61B;TRMT10C;ZC3H13;METTL8
prerank,macrophage chemotaxis (GO:0048246),-0.2944999321147859,-0.6948783694961893,0.8524904214559387,0.9671313653711154,1.0,6/10,50.19%,TAFA4;CXCL17;CCL5;CCL3;LGALS3;CKLF
prerank,negative regulation of phagocytosis (GO:0050765),0.26156635697198277,0.694397914186448,0.8546511627906976,1.0,1.0,1/17,0.56%,SYT11
prerank,regulation of receptor recycling (GO:0001919),-0.2614184766578488,-0.6939464499564334,0.8612244897959184,0.9675003658708009,1.0,2/16,5.49%,ECE1;VAMP3
prerank,regulation of cilium movement (GO:0003352),-0.29483887941323406,-0.6927194842994283,0.8571428571428571,0.9681707884577253,1.0,5/10,34.92%,DNAH11;CFAP43;ODAD2;CFAP206;CCDC40
prerank,actin crosslink formation (GO:0051764),-0.27378112903234686,-0.691147144897007,0.865424430641822,0.969110798709618,1.0,3/12,13.49%,FLNA;EPS8;GAS2L1
prerank,cell cycle G2/M phase transition (GO:0044839),-0.16720804809132708,-0.6910355006764745,0.9974937343358395,0.9687424224273447,1.0,42/130,27.86%,FBXL7;YWHAE;PPP1R12A;CDK14;DYNC1I2;CSNK1E;CCNY;TUBA1A;CEP76;DCTN3;ODF2;DYNLL1;CCP110;PRKAR2B;PAFAH1B1;PRKACA;LATS1;DYNC1H1;MASTL;LCMT1;AJUBA;CSNK1D;DCTN1;CEP41;CCNH;FBXL6;TUBA4A;CCNB2;CEP131;CDK5RAP2;CEP152;PLK3;KDM8;PPP2R2A;AKAP9;CDKN2B;ACTR1A;CUL1;FBXW11;CDK2;CENPJ;CNTRL
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.28073383821946857,-0.6906728001122582,0.8641732283464567,0.9686007176037671,1.0,3/11,13.63%,CEACAM1;AHR;PTPRC
prerank,protein prenylation (GO:0018342),-0.293013590693072,-0.690026215742497,0.8588235294117647,0.9687339139757176,1.0,4/10,24.70%,PTAR1;RCE1;CHM;CHML
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.21440126082996805,0.689787818794623,0.92,1.0,1.0,12/42,19.42%,HARS2;TARS2;RARS2;EPRS1;QARS1;DARS2;TARS1;PPA1;IARS2;FARSA;IARS1;YARS1
prerank,organelle disassembly (GO:1903008),0.22376982351320424,0.6896120926194865,0.8983364140480592,1.0,1.0,9/33,22.86%,PLK5;RETREG1;GOLGA2;ATG2B;MRRF;GBF1;KLC1;EIF2D;DENR
prerank,microtubule polymerization (GO:0046785),0.23601141292879046,0.6895819836302404,0.8974358974358975,1.0,1.0,5/29,9.75%,CLASP1;TUBGCP5;GOLGA2;TUBGCP4;TUBG1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.2975656639770982,0.6895185036879129,0.8464566929133859,1.0,1.0,3/12,8.74%,SNAP29;SNAP47;SNAP25
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3036534062955606,0.6893748258228296,0.8279352226720648,1.0,1.0,3/10,12.34%,SMPD3;SMPD2;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3036534062955606,0.6893748258228296,0.8279352226720648,1.0,1.0,3/10,12.34%,SMPD3;SMPD2;SPHK2
prerank,cellular senescence (GO:0090398),0.23608901523292009,0.6890639840347644,0.8740601503759399,1.0,1.0,2/27,1.98%,MAGEA2;CDKN2A
prerank,negative regulation of translational initiation (GO:0045947),-0.27323153936230093,-0.6886316218691539,0.8726591760299626,0.9695409615619413,1.0,4/13,15.68%,EIF3E;AGO2;TPR;FMR1
prerank,detection of calcium ion (GO:0005513),-0.2714384382471345,-0.6884949392994275,0.8930957683741648,0.969194584558179,1.0,8/13,36.66%,KCNMB2;CALM3;STIM1;CALM1;KCNMB4;KCNIP2;CALM2;KCNMB1
prerank,transport along microtubule (GO:0010970),0.2757349778036979,0.6881557500761236,0.8483606557377049,1.0,1.0,5/13,17.65%,CLIP3;COPG1;COPG2;SPG11;BORCS5
prerank,Rac protein signal transduction (GO:0016601),0.2580677070724279,0.6880006163162062,0.8679611650485437,1.0,1.0,3/18,11.97%,HACD3;WASF1;CYFIP1
prerank,tRNA 5'-end processing (GO:0099116),0.26801101082628587,0.6879556382244791,0.8594059405940594,1.0,1.0,4/15,21.60%,POP4;RPP25L;TRMT10C;RPP30
prerank,miRNA mediated inhibition of translation (GO:0035278),0.2932597933170365,0.6879363738692096,0.8333333333333334,1.0,1.0,7/11,26.60%,TNRC6A;TRIM71;AGO3;EIF6;TNRC6C;ZFP36;RBM4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.2932597933170365,0.6879363738692096,0.8333333333333334,1.0,1.0,7/11,26.60%,TNRC6A;TRIM71;AGO3;EIF6;TNRC6C;ZFP36;RBM4
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.2295029382135153,-0.6876256879271316,0.8915929203539823,0.9694924084480034,1.0,6/24,19.31%,TGFB2;FOXO3;CDK5;FBXW7;ATF4;MCL1
prerank,protein O-linked mannosylation (GO:0035269),0.2540487390296097,0.6867742350312624,0.8823529411764706,1.0,1.0,8/18,22.13%,TMTC4;LARGE1;FKTN;DPM1;CRPPA;POMT1;DPM2;FKRP
prerank,cell cycle G1/S phase transition (GO:0044843),0.19892272942792405,0.6865490782874423,0.9525483304042179,1.0,1.0,7/61,8.86%,CDKN2A;PHF8;TRIM71;E2F1;USP26;HINFP;MAX
prerank,regulation of actin nucleation (GO:0051125),-0.2712615184708068,-0.6861810574252781,0.8689516129032258,0.970280123505256,1.0,2/12,10.16%,GSN;WHAMM
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.2816858935132972,-0.6859857634200943,0.8762677484787018,0.9699700703108882,1.0,5/11,23.65%,UQCR11;UQCRFS1;UQCRB;UQCR10;UQCRC1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.24533586568031407,0.6857819064088744,0.8876611418047882,1.0,1.0,3/21,11.96%,IGF1;CTSH;SOX9
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.2475488666424643,-0.685676997710883,0.8958333333333334,0.9697945419745537,1.0,7/18,30.64%,DAB2IP;AMER1;MSN;FAF1;RIC1;PTTG1IP;VPS35
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.2578134775509947,0.6849836156569681,0.8634615384615385,1.0,1.0,6/19,20.23%,MOSPD2;C1QBP;CAMK1D;RIPOR2;TIRAP;DNM1L
prerank,tyrosine metabolic process (GO:0006570),-0.28557528297329027,-0.6843664784111749,0.8647058823529412,0.9704792752160646,1.0,3/11,29.98%,FAH;HGD;IL4I1
prerank,detection of visible light (GO:0009584),0.267211846524514,0.6842620192250971,0.8582375478927203,1.0,1.0,1/16,2.38%,ABCA4
prerank,transition metal ion homeostasis (GO:0055076),0.22788925156290457,0.6842329296586844,0.9127906976744186,1.0,1.0,4/28,10.12%,HEPHL1;PICALM;CP;CUTC
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.27880622607053956,0.6840074697618964,0.8403846153846154,1.0,1.0,2/12,13.62%,CYP26B1;CTBP2
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.2459134132123366,-0.6839408835484448,0.8985200845665962,0.9703624516029634,1.0,3/18,13.63%,CD34;HDAC7;PTPRC
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.2319569124806505,0.6839209812037061,0.8969465648854962,1.0,1.0,5/26,11.95%,ITPR1;ITPR2;RYR2;TRPM2;CHERP
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.17474790181046312,-0.6827486596818448,0.9856459330143541,0.9709281303803192,1.0,32/95,28.39%,YWHAE;DYNC1I2;CSNK1E;TUBA1A;CEP76;TCTN3;DCTN3;ODF2;DYNLL1;CCP110;TMEM216;PRKAR2B;PAFAH1B1;KIF24;NPHP1;PRKACA;DYNC1H1;RAB11A;CEP97;CSNK1D;DCTN1;B9D2;CEP41;TUBA4A;CEP131;CDK5RAP2;CEP152;AKAP9;ACTR1A;CENPJ;CNTRL;TCTN1
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.26305427276417814,-0.6820035951268332,0.8588957055214724,0.9710919788529606,1.0,7/12,33.05%,IDH3B;GLUD1;ASS1;IDH3G;SIRT4;ACLY;IDH1
prerank,organelle transport along microtubule (GO:0072384),0.2268635225067221,0.6819576298278475,0.9287054409005628,1.0,1.0,6/31,13.42%,TRAK1;HTT;BICD1;COPG1;COPG2;RAB1A
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.28556812187712033,-0.6817118556744737,0.8733905579399142,0.970886373074168,1.0,7/11,29.66%,NOVA2;ZNF445;PCBP2;PCBP1;RASA1;IGF2BP2;IGF2BP1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.2721088819574214,-0.6816713798489203,0.8865979381443299,0.9704481284094664,1.0,1/12,2.11%,INSR
prerank,negative regulation of cell division (GO:0051782),-0.277609550100802,-0.6815395478798941,0.8804780876494024,0.9700897142649241,1.0,5/11,31.46%,TXNIP;BLM;E2F7;SUSD2;MYC
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2260502381874087,-0.6814735688624302,0.939203354297694,0.9696766980064551,1.0,7/24,22.73%,MFF;CEMIP;AKT2;KCNB1;MIEF1;FYN;MYO1C
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.25721534090193376,-0.6811321443978993,0.8822314049586777,0.9694691199695689,1.0,7/15,28.88%,SEC61A1;SRP14;RAB3GAP2;SRPRA;ZFAND2B;EDEM1;ZFAND2A
prerank,telomere maintenance via telomerase (GO:0007004),-0.21981512441098167,-0.6809895966720162,0.9168399168399168,0.9691306040842116,1.0,10/28,27.24%,RPA1;PTGES3;TERF2IP;TNKS1BP1;NHP2;DKC1;TINF2;TERF2;NOP10;CDK2
prerank,cellular response to gamma radiation (GO:0071480),-0.2481978795969264,-0.6807048044942793,0.8846960167714885,0.9689070285265444,1.0,2/17,6.25%,MAP3K20;XRCC5
prerank,nuclear membrane organization (GO:0071763),0.2491498726356509,0.6805497719537832,0.8803738317757009,1.0,1.0,7/19,24.38%,PLK1;TOR1B;TMEM43;AKAP8L;CHMP7;SPAST;TOR1AIP1
prerank,glucan catabolic process (GO:0009251),0.2751072830360446,0.6803191448407516,0.865234375,1.0,1.0,4/15,13.55%,PHKG2;PHKB;PYGL;PYGM
prerank,lytic vacuole organization (GO:0080171),0.2272040373823967,0.6796158895057811,0.9052044609665427,1.0,1.0,10/32,22.72%,ZKSCAN3;SNAPIN;LRRK2;CLN5;HPS1;HOOK1;HPS4;GNPTAB;LAMTOR1;HOOK2
prerank,negative regulation of histone acetylation (GO:0035067),0.2854698405487617,0.6786343091352934,0.8588235294117647,1.0,1.0,3/11,19.24%,NOC2L;SIRT1;SIN3A
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.21284224557860484,-0.6778670843947261,0.9229122055674518,0.9707786359012984,1.0,12/33,25.29%,PIK3R1;PIK3C2A;PIK3CA;EDN1;PIK3CD;HTR2A;IRS1;PTEN;NYAP1;IGF1R;PIK3C2B;PIK3CG
prerank,positive regulation of glucose metabolic process (GO:0010907),0.27487709904494384,0.6776347753783645,0.8635437881873728,1.0,1.0,4/14,18.36%,SLC45A3;PPARGC1A;SIRT1;AKT1
prerank,positive regulation of rRNA processing (GO:2000234),0.2934175440265844,0.6776174998513651,0.8562992125984252,1.0,1.0,4/10,21.98%,RIOK2;WDR75;UTP15;WDR43
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.24293098312908484,-0.677597862660794,0.8903225806451613,0.9705532643149494,1.0,6/19,22.07%,HIPK1;DDIT4;DYRK2;TMEM109;BCL3;SNW1
prerank,neuropeptide signaling pathway (GO:0007218),0.20200223890830582,0.6770125210619956,0.9594594594594594,1.0,1.0,10/58,17.18%,OPRD1;GLRA1;NTS;NMUR1;LTB4R2;GPR37;GRP;OPRM1;PENK;GPR149
prerank,negative regulation of defense response to virus (GO:0050687),-0.28172528595609436,-0.6769407723060495,0.9012345679012346,0.9706203192793232,1.0,5/10,24.48%,TRAF3IP1;PCBP2;TSPAN6;TARBP2;MUL1
prerank,protein mannosylation (GO:0035268),0.24295361353222872,0.6768579464722775,0.8936170212765957,1.0,1.0,9/22,22.13%,TMTC4;LARGE1;FKTN;DPM1;DPY19L1;CRPPA;POMT1;DPM2;FKRP
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.1887692038130534,-0.6765908714093655,0.9737470167064439,0.9704597391379001,1.0,21/57,32.04%,DCN;TNFSF10;KDR;MFF;HIP1R;BBC3;PLAUR;BAK1;GPER1;MIEF1;BIK;CAMKK2;BOK;MUL1;TREM2;HRK;PARK7;PMAIP1;VPS35;BMF;AURKA
prerank,positive regulation of interferon-beta production (GO:0032728),-0.21010227263754472,-0.676512608682304,0.9313131313131313,0.9700590801630863,1.0,11/33,25.71%,POLR3F;TRIM56;ISG15;IFIH1;POLR3B;IRF5;POLR3A;POLR3D;RIPK2;PTPN11;TLR4
prerank,glycogen biosynthetic process (GO:0005978),0.2826285590179707,0.6752401223959408,0.8649706457925636,1.0,1.0,3/12,15.02%,PGM1;GYG1;PER2
prerank,glucan biosynthetic process (GO:0009250),0.2826285590179707,0.6752401223959408,0.8649706457925636,1.0,1.0,3/12,15.02%,PGM1;GYG1;PER2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2510540677910295,0.6740807612501963,0.8800773694390716,1.0,1.0,5/17,19.55%,HNRNPU;CITED1;TERT;KDM1A;LTBP3
prerank,skeletal muscle contraction (GO:0003009),0.2492587489593251,0.6738430815864271,0.8834244080145719,1.0,1.0,5/19,22.87%,TNNI1;MYH14;STAC3;TNNC1;TNNI3
prerank,C4-dicarboxylate transport (GO:0015740),-0.2618442451682983,-0.6734236316560782,0.8729166666666667,0.9721700124937507,1.0,1/14,0.97%,LRRC8D
prerank,negative regulation of bone mineralization (GO:0030502),0.2749406258234647,0.672806653866748,0.889795918367347,1.0,1.0,1/13,1.65%,RFLNA
prerank,negative regulation of catalytic activity (GO:0043086),0.2376806423187668,0.6719920990308,0.89738430583501,1.0,1.0,4/24,10.28%,APBA3;CCAR2;IFIT1;NES
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.22552832649572319,0.6717206920533558,0.9201451905626135,1.0,1.0,4/29,15.41%,FANCD2;MEIOB;BAG6;SYCE2
prerank,protein localization to kinetochore (GO:0034501),-0.2528235185678434,-0.6710159031282066,0.891566265060241,0.9736628103152954,1.0,9/14,43.44%,ZWILCH;ZW10;SPDL1;MIS12;CDK1;KNL1;AURKB;RCC2;MTBP
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.22904428063171284,-0.670456685845784,0.9066937119675457,0.9736267915719458,1.0,8/22,34.03%,ESR1;PSMC4;MED14;MED13;MED24;MED30;PAXIP1;TP53
prerank,oxoacid metabolic process (GO:0043436),0.2300186476498324,0.6701830308122061,0.9042357274401474,1.0,1.0,6/27,18.85%,DDO;ABHD14B;PPA1;MINPP1;TPST1;LIPT1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.17310595803067919,-0.6697840744106778,0.9810874704491725,0.9737073549196265,1.0,18/87,19.94%,SDHAF2;TIMMDC1;NUBPL;NDUFA10;NDUFA8;TMEM126A;NDUFS6;IMMP2L;NDUFA7;SDHAF4;NDUFA5;NDUFAF6;SCO1;UQCRFS1;NDUFA1;NDUFS7;NDUFS8;NDUFAF8
prerank,positive regulation of telomere maintenance (GO:0032206),0.22103546077088365,0.6697633647688893,0.9330783938814532,1.0,1.0,6/31,12.11%,ERCC1;HNRNPA2B1;TNKS2;MRE11;RTEL1;PML
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.27708289443154277,0.6695236171377646,0.8511066398390342,1.0,1.0,4/12,20.72%,NDC80;CENPC;BOD1;NUF2
prerank,regulation of phosphate metabolic process (GO:0019220),-0.25225041232159184,-0.6692661754762208,0.8846153846153846,0.9736082497017465,1.0,5/16,19.46%,CD24;PGAM1;SRPX2;BARD1;TIGAR
prerank,defense response to protozoan (GO:0042832),-0.26921019468107943,-0.6690294903363447,0.8704761904761905,0.9733273084395798,1.0,7/12,39.65%,GBP4;CD40;MYD88;BATF2;LYST;PF4;GBP7
prerank,cellular polysaccharide catabolic process (GO:0044247),0.2650586240455622,0.6684359140985664,0.8869395711500975,1.0,1.0,4/16,13.55%,PHKG2;PHKB;PYGL;PYGM
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.22141716946202578,0.6683568831993218,0.9169675090252708,1.0,1.0,9/31,23.18%,EXOSC8;PATL1;LSM5;LSM4;EXOSC2;EDC4;CNOT8;DCPS;DCP2
prerank,regulation of stem cell population maintenance (GO:2000036),-0.2415272921144479,-0.6674053725495197,0.9118236472945892,0.9741461856448425,1.0,1/18,1.04%,PTN
prerank,regulation of protein export from nucleus (GO:0046825),0.23578512191172493,0.6670848417307814,0.9115913555992141,1.0,1.0,7/23,19.17%,IFI27;CAMK1;RAPGEF3;PTPN14;RANGAP1;TCF7L2;UHMK1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.2527926764830303,0.6669981118386633,0.8752327746741154,1.0,1.0,6/18,18.92%,PTBP2;PTBP1;TERT;NCOR2;PTBP3;NCOR1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.19608980443412888,-0.6649054466933799,0.9466666666666667,0.9756113332041978,1.0,7/40,15.83%,PID1;BCL2L1;UBB;SOD1;AKT2;BAK1;SLC25A36
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.290796431911009,0.6648775676250052,0.8754940711462451,1.0,1.0,5/10,26.13%,CCT3;CCT5;CCT8;WRAP53;CCT6A
prerank,neuron fate commitment (GO:0048663),0.26517471764504674,0.6642860757584025,0.8796844181459567,1.0,1.0,2/14,10.07%,PAX6;TGFBR1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.2187438112464633,0.6641429846474101,0.9285714285714286,1.0,1.0,5/31,11.83%,CDKN2A;DLG1;PRMT2;BRD7;CDC73
prerank,positive regulation of dendritic spine development (GO:0060999),0.23986695395102195,0.6634848535267478,0.9031007751937985,1.0,1.0,7/20,22.39%,CAMK1;LLPH;SHANK1;CAPRIN2;CPEB3;DLG5;DBNL
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.19472881029599654,0.6630960360292962,0.9536878216123499,1.0,1.0,8/62,11.83%,CTR9;CCNT2;TCEA1;PCID2;LEO1;EAF2;MLLT1;CDC73
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.2302745863721461,-0.6622914806855945,0.9183673469387755,0.9771574357176294,1.0,2/20,4.59%,BCL2L1;FAS
prerank,protein localization to condensed chromosome (GO:1903083),-0.25876031379199177,-0.6621528580774619,0.8829365079365079,0.9767954380057702,1.0,8/12,43.44%,ZWILCH;ZW10;SPDL1;MIS12;CDK1;KNL1;AURKB;MTBP
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.21134792437781086,0.6619722057968458,0.9403254972875226,1.0,1.0,2/36,2.63%,HSPA1A;CPNE1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2826451462777122,-0.6617239286515344,0.8680688336520076,0.9766546067396598,1.0,6/10,43.07%,EFHB;STIM1;CASQ1;CD84;GRAMD2A;HOMER2
prerank,superoxide anion generation (GO:0042554),0.27719798288162156,0.6609764238496755,0.8963414634146342,1.0,1.0,3/13,18.78%,NOX1;CYBA;NCF1
prerank,positive regulation of cytokinesis (GO:0032467),-0.20646700518706826,-0.6606482319034936,0.9507829977628636,0.9769746901181183,1.0,14/32,32.98%,RHOA;SVIL;CIT;KIF23;KIF20B;CDC42;GIPC1;CUL3;PRKCE;KIF14;DRD2;CSPP1;CDC6;OPN1MW
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2683191914032851,-0.6604764070622284,0.9065606361829026,0.9766296173546226,1.0,6/12,34.82%,SLC37A3;SLC25A14;SLC20A1;SLC37A4;XPR1;SLC20A2
prerank,protein K48-linked deubiquitination (GO:0071108),-0.21919885686510332,-0.6601514265039137,0.9445628997867804,0.9764056982118596,1.0,7/23,26.65%,OTUD7B;MINDY1;MINDY2;USP50;ATXN3;OTUB2;OTUB1
prerank,phosphate ion transport (GO:0006817),0.2580758182932479,0.6598584299879117,0.8913480885311871,1.0,1.0,2/16,9.13%,SLC25A11;SLC34A3
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2622166675618231,-0.6586367366329996,0.8862144420131292,0.9770454735686814,1.0,6/13,29.82%,PERP;TBC1D10A;BAK1;RIPK2;CASP8;FADD
prerank,modulation by host of viral genome replication (GO:0044827),-0.2600902950871561,-0.6583373337659455,0.8970873786407767,0.9767919959819719,1.0,6/13,25.26%,FMR1;ZC3H12A;PPIB;NUCKS1;TBC1D20;VAPA
prerank,protein lipidation (GO:0006497),0.19478870138346022,0.6579731885544416,0.9600760456273765,1.0,1.0,16/59,19.92%,ZDHHC12;ZDHHC1;ZDHHC16;PIGH;PIGG;ZDHHC6;ZDHHC3;DPM1;PGAP4;ZDHHC21;GLUL;PGAP2;ZDHHC23;WDR45;PIGO;DPM2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.2615541497736214,-0.6576580584583079,0.8852459016393442,0.9768114322533967,1.0,7/11,49.03%,MALT1;NFKBID;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,secretory granule organization (GO:0033363),-0.2778849458141886,-0.6569309376084457,0.8918367346938776,0.9768814994620386,1.0,1/10,3.16%,ABCA1
prerank,chromatin assembly or disassembly (GO:0006333),-0.2727308242448591,-0.6567450259784472,0.9025341130604289,0.9765434838231773,1.0,2/11,19.37%,RBBP4;CHAF1A
prerank,serine family amino acid catabolic process (GO:0009071),-0.2767460318266568,-0.6539976842590677,0.8844621513944223,0.978035265812843,1.0,7/10,39.67%,THNSL2;SHMT2;CBS;DLD;SHMT1;DAO;AMT
prerank,L-glutamate transmembrane transport (GO:0015813),-0.27780773855239066,-0.6537657020185125,0.8877551020408163,0.977728934682903,1.0,2/10,12.49%,SLC1A3;SLC1A1
prerank,maturation of SSU-rRNA (GO:0030490),-0.2043203833613371,-0.6536363795348656,0.9688888888888889,0.9773506761389424,1.0,15/34,33.66%,RPS16;RPS8;RPS28;BMS1;DCAF13;PWP2;RPS19;WDR46;RIOK1;HELB;DHX37;TSR3;TSR1;NOP14;HEATR1
prerank,T cell activation (GO:0042110),0.18694016600650268,0.6532640909779385,0.967128027681661,1.0,1.0,5/69,7.71%,LEPR;KIT;LMBR1L;NLRC3;KIF13B
prerank,negative regulation of secretion (GO:0051048),-0.27668341439998134,-0.6526981859873164,0.9,0.9775015280128693,1.0,4/10,23.12%,VAMP3;CD74;PTGER3;EGF
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.2264968743011343,0.6507294921377839,0.9343339587242027,1.0,1.0,4/25,13.27%,PICALM;DLG4;MTMR2;ABCA2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.2648754098170566,-0.6506328671513912,0.8902195608782435,0.9784795579974,1.0,2/11,15.85%,RACK1;ATF4
prerank,positive regulation of DNA binding (GO:0043388),0.2154634985087962,0.6502174831068186,0.9307282415630551,1.0,1.0,1/31,0.69%,IGF1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.2395539567163258,-0.6499208329987025,0.8925619834710744,0.9785113403674494,1.0,3/14,23.95%,JAK1;SOCS3;SOCS1
prerank,purine-containing compound salvage (GO:0043101),-0.2616396780971998,-0.6495179332745179,0.9198396793587175,0.9783028204382311,1.0,6/12,29.26%,GMPR;HPRT1;DGUOK;AMPD2;ADA;ADK
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.25694638320187585,0.6493287897340406,0.9024856596558317,1.0,1.0,9/15,29.58%,TNRC6A;TENT4A;CPEB3;TNRC6C;ZFP36;EIF4ENIF1;CNOT7;TNRC6B;TOB1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.2525329641218851,0.6488265081011886,0.8958742632612967,1.0,1.0,6/16,27.46%,KLRD1;SLAMF6;IL12A;LAMP1;CD226;AP1G1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.24568994116954662,0.6488176793808964,0.9049429657794676,1.0,1.0,5/18,18.36%,HTRA2;TRAP1;SIRT1;NOL3;AKT1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.2055208242278126,0.6485163359035901,0.9492481203007519,1.0,1.0,11/40,20.76%,IGF1;PPIF;PDCD5;MLLT11;CLU;HGF;NOL3;AKT1;PYCARD;DNM1L;BAX
prerank,rRNA modification (GO:0000154),-0.22263549346360467,-0.6484196100776609,0.9190371991247265,0.978579017413016,1.0,8/21,31.37%,THUMPD1;DIMT1;TRMT112;NSUN4;NHP2;DKC1;NOP10;TSR3
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.23055131503537798,-0.6481120390821343,0.9322033898305084,0.9783070514037416,1.0,11/22,31.06%,MDFIC;APOD;INSIG1;SP100;BARD1;CABP1;DMTN;LMAN1;PARK7;GDI1;ITGB1BP1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.2705153896775348,0.6476990495201546,0.8643410852713178,1.0,1.0,1/12,2.11%,SLC5A3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.2461316227522926,0.6470174858868715,0.9035250463821892,1.0,1.0,4/16,16.77%,RECQL4;SSBP1;MCM7;MCMDC2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.2557741100090137,0.6463382139011746,0.893491124260355,1.0,1.0,4/15,18.52%,RUVBL2;CCT3;CCT5;CCT8
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.22161988409191832,-0.6452409629955973,0.9517819706498952,0.9796992612812191,1.0,8/22,27.88%,DHX33;EIF2AK3;ATF4;UBTF;SMARCA4;NCL;RASL11A;LYAR
prerank,glycolipid biosynthetic process (GO:0009247),0.20497264682944316,0.6441852584957021,0.9519572953736655,1.0,1.0,10/38,19.92%,ST3GAL5;LARGE1;PIGH;PIGG;DPM1;SCCPDH;PGAP4;PGAP2;PIGO;DPM2
prerank,reticulophagy (GO:0061709),0.26821288791785775,0.6439557169633324,0.901840490797546,1.0,1.0,2/12,11.80%,RETREG1;ATG2B
prerank,anterior/posterior axis specification (GO:0009948),0.25417058640851675,0.6438373774011273,0.8921001926782274,1.0,1.0,1/15,1.66%,WLS
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.23950220591391416,0.6437842866249289,0.9137254901960784,1.0,1.0,4/19,13.37%,POLD2;DCK;AMPD3;TERT
prerank,telomere maintenance via recombination (GO:0000722),0.2772396357113834,0.6434902686766877,0.8939096267190569,1.0,1.0,2/11,14.01%,ERCC1;RAD51D
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2483463977369857,-0.6426722423754746,0.9136546184738956,0.9809018959228317,1.0,4/14,23.73%,ME1;NME2;AK4;NMNAT1
prerank,mitochondrial transcription (GO:0006390),-0.27095219941031085,-0.6422103514403318,0.9111111111111111,0.9807448732257161,1.0,2/10,14.71%,FOXO3;MRPL12
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.2336230879387255,-0.6421042419248394,0.9420289855072463,0.980353800063207,1.0,3/17,14.65%,CTCF;ZWILCH;ZW10
prerank,negative regulation of cell aging (GO:0090344),0.24546144500703904,0.6419339896112175,0.8851224105461394,1.0,1.0,4/16,15.49%,SLC30A10;ZKSCAN3;TERT;SIRT1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.25597762994042284,0.6417658792328345,0.9038854805725971,1.0,1.0,5/14,25.76%,C1QBP;TRMT10C;MPV17L2;RCC1L;FASTKD3
prerank,aminoglycan metabolic process (GO:0006022),-0.27159523113539286,-0.6410306074102982,0.892578125,0.9805528078345312,1.0,3/10,16.87%,XYLT1;B3GAT1;B3GAT3
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.1874742728240252,0.6407503526709818,0.9772727272727273,1.0,1.0,8/64,11.83%,CTR9;CCNT2;TCEA1;PCID2;LEO1;EAF2;MLLT1;CDC73
prerank,Golgi to lysosome transport (GO:0090160),0.26405273758119263,0.6403686574496371,0.8980392156862745,1.0,1.0,1/11,2.01%,CCDC91
prerank,nuclear pore organization (GO:0006999),-0.24860277034746922,-0.639574332870224,0.9163090128755365,0.9810125334160008,1.0,3/14,16.45%,NUP107;TPR;RTN4
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.20132628810384012,0.6377467157177225,0.9644128113879004,1.0,1.0,4/38,8.73%,MAGI2;PPARA;PIK3CB;DRD3
prerank,regulation of DNA recombination (GO:0000018),0.20858780039003125,0.6375764561088517,0.9512670565302144,1.0,1.0,8/32,18.36%,MSH6;MRE11;RTEL1;MSH3;ALYREF;KDM1A;FIGNL1;THOC1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.26217980914113515,0.637129302216774,0.8967611336032388,1.0,1.0,13/13,73.80%,HNRNPU;SUPT4H1;LARP7;RNF8;NELFA;EAPP;TCERG1;NELFB;HEXIM1;NELFE;RECQL5;NELFCD;RNF168
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.2593380167169993,-0.6363423425092106,0.8931451612903226,0.9824976096188316,1.0,5/11,28.79%,CD44;CD74;TAF9;TRIAP1;MIF
prerank,cellular component maintenance (GO:0043954),0.26258985756222814,0.6357846078685876,0.9026717557251909,1.0,1.0,4/12,19.07%,SUPV3L1;MTMR2;PICK1;PRNP
prerank,GPI anchor biosynthetic process (GO:0006506),0.21004697965078994,0.6355103849589686,0.9436363636363636,1.0,1.0,12/30,28.71%,PIGH;PIGG;DPM1;PGAP4;PGAP2;PIGO;DPM2;PIGS;PIGB;MPPE1;PGAP3;PIGW
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.20018174071546305,0.6355069581964748,0.9590443686006825,1.0,1.0,7/41,13.10%,GPRC5B;ADRA2A;NTRK2;DLG4;EPHA4;BDNF;HBEGF
prerank,regulation of ERAD pathway (GO:1904292),0.2651576332173162,0.6349245990060814,0.9117082533589251,1.0,1.0,3/11,13.46%,USP19;RNFT1;BAG6
prerank,negative regulation of viral genome replication (GO:0045071),0.2006867076760371,0.6342218882451751,0.9609929078014184,1.0,1.0,13/40,24.70%,OAS2;IFIT1;EIF2AK2;OAS3;MPHOSPH8;ILF3;INPP5K;PARP10;BST2;SLPI;SRPK1;SETDB1;BTBD17
prerank,mitotic recombination (GO:0006312),0.25409092393372457,0.6336367335034583,0.903921568627451,1.0,1.0,4/15,17.54%,ERCC1;MSH3;RAD51D;RAD52
prerank,protein O-linked glycosylation via serine (GO:0018242),0.2792110106506158,0.6325409687602842,0.8697478991596639,1.0,1.0,3/10,14.32%,GALNT3;GALNT2;GALNT1
prerank,amyloid-beta metabolic process (GO:0050435),-0.23078106547759708,-0.6324794440102017,0.9356846473029046,0.9843190640675695,1.0,4/16,23.99%,DYRK1A;PSEN2;PSENEN;MGAT3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.2682594226226533,0.6323942299157421,0.9083820662768031,1.0,1.0,4/12,18.92%,ELAVL1;TERT;NCOR2;NCOR1
prerank,negative regulation of immune system process (GO:0002683),0.24473518674051914,0.6323813008577117,0.9098039215686274,1.0,1.0,4/16,17.41%,IL17D;HOXA7;SOX9;COL3A1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.23829510400358178,0.6321189914150367,0.9180952380952381,1.0,1.0,5/18,19.84%,ADRA2A;BMP8A;CHGA;INHBB;REST
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.24061650643756086,0.630680266493283,0.9281437125748503,1.0,1.0,6/17,27.46%,KLRD1;SLAMF6;IL12A;LAMP1;CD226;AP1G1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.19552567967235765,0.6301817647302901,0.9777365491651205,1.0,1.0,7/47,14.45%,TIMP3;SERPINA10;PCID2;SERPIND1;HRG;SERPINA9;SERPINE3
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.23982902776121348,-0.6297628542404969,0.936046511627907,0.9854342745380701,1.0,3/15,11.93%,PLCG2;PAF1;PHB2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.24831385359446762,0.6285217324700227,0.9,1.0,1.0,1/15,3.39%,DAGLA
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.2621633498650262,0.6284625809287027,0.908183632734531,1.0,1.0,12/12,73.80%,HNRNPU;LARP7;RNF8;NELFA;EAPP;TCERG1;NELFB;HEXIM1;NELFE;RECQL5;NELFCD;RNF168
prerank,histone H4-K5 acetylation (GO:0043981),-0.24056692149083203,-0.6282568283710225,0.937246963562753,0.9853726530694651,1.0,6/15,26.32%,KAT7;JADE2;PHF20;ING4;JADE1;KANSL3
prerank,histone H4-K8 acetylation (GO:0043982),-0.24056692149083203,-0.6282568283710225,0.937246963562753,0.9853726530694651,1.0,6/15,26.32%,KAT7;JADE2;PHF20;ING4;JADE1;KANSL3
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.24140244234185187,-0.6275575071321622,0.937625754527163,0.9853001158338589,1.0,9/14,36.69%,ACOX1;ECI2;ACOX3;SCP2;DECR2;ACOX2;CRAT;ACOXL;ACOT8
prerank,regulation of rRNA processing (GO:2000232),0.2443517270549996,0.6259613138578911,0.9046692607003891,1.0,1.0,6/16,24.44%,RIOK2;WDR75;METTL18;UTP15;WDR43;YTHDF2
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.1840025105400977,-0.6249939253650797,0.9792626728110599,0.9862922820770004,1.0,17/43,33.64%,FOXN3;BABAM2;PABIR1;BLM;ORC1;FZR1;TAOK3;NBN;TAOK1;CHEK1;DTL;HUS1B;MRNIP;CDK1;CDC6;TICRR;BRCC3
prerank,ncRNA catabolic process (GO:0034661),-0.19896951622062992,-0.6248289964649398,0.9603340292275574,0.9859266687329341,1.0,10/28,30.05%,TENT4B;RBM7;TRIR;NUDT16;NUDT16L1;EXOSC4;EXOSC5;EXOSC3;XRN1;DIS3L2
prerank,membrane fusion (GO:0061025),0.20590722016993335,0.6247750371742573,0.9621212121212122,1.0,1.0,5/33,9.01%,SNAP29;MYOF;NAPA;RIMS1;NSF
prerank,ESCRT complex disassembly (GO:1904896),-0.2639065150146404,-0.6239274530875166,0.9056224899598394,0.9854984396160866,1.0,3/10,18.79%,CHMP2B;IST1;CHMP1B
prerank,ESCRT III complex disassembly (GO:1904903),-0.2639065150146404,-0.6239274530875166,0.9056224899598394,0.9854984396160866,1.0,3/10,18.79%,CHMP2B;IST1;CHMP1B
prerank,Golgi localization (GO:0051645),0.26892041288956836,0.6238676034107081,0.9065606361829026,1.0,1.0,3/11,12.65%,TBCCD1;COPG1;STK25
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.24101782055279547,0.623203347406985,0.9211538461538461,1.0,1.0,2/15,11.01%,MAGI2;FST
prerank,photoreceptor cell development (GO:0042461),-0.23614576151813418,-0.6231050551439452,0.9292929292929293,0.9855135246837327,1.0,6/14,26.42%,MFSD2A;VEGFA;RP1;MYO7A;RORB;CDHR1
prerank,stem cell development (GO:0048864),0.2404381787921645,0.62270161292055,0.9297912713472486,1.0,1.0,2/16,6.83%,WNT7A;NRG1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2630508385706804,0.6225167154884451,0.9110671936758893,1.0,1.0,5/11,26.13%,CCT3;CCT5;CCT8;WRAP53;CCT6A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.22076322596827586,0.6215520014161419,0.9452054794520548,1.0,1.0,3/26,7.55%,TCTA;HOXA7;INHA
prerank,glutathione metabolic process (GO:0006749),0.20039786739756726,0.6214421664749153,0.9662288930581614,1.0,1.0,9/38,18.30%,ETHE1;GSTM2;CNDP2;GGT5;GSTM1;OPLAH;GSTA3;GSTZ1;MGST2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.23450318503639783,-0.6202883173635244,0.9134020618556701,0.9865925131071119,1.0,5/15,29.75%,HOGA1;PRODH;GGT7;GGT1;CHAC2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.25790338218705183,0.6198668686088875,0.9183266932270916,1.0,1.0,6/12,26.13%,GNL3L;CCT3;CCT5;CCT8;WRAP53;CCT6A
prerank,negative regulation of innate immune response (GO:0045824),0.19643437835409194,0.6197879443104976,0.9653916211293261,1.0,1.0,6/34,14.18%,USP18;NLRC3;CACTIN;OAS3;STAT2;TYRO3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.2241032712318495,0.6191055170783619,0.941398865784499,1.0,1.0,6/22,19.36%,MAN1C1;RNF5;MAN1A2;RNF139;UGGT2;TRIM13
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2190468220561601,-0.6190621468658062,0.9394572025052192,0.9867587317678062,1.0,9/19,35.93%,PTP4A3;CCT2;CEP295;DKC1;TREM2;CENPJ;CCT7;CORO2B;CEP135
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.20538175499195604,-0.6190541358651982,0.9749478079331941,0.9862994084716009,1.0,14/25,37.85%,GMPR;HPRT1;DGUOK;AMPD2;ADA;SHMT2;SHMT1;ADK;PRPSAP1;PAICS;GART;PRPS2;AMPD1;PPAT
prerank,base-excision repair (GO:0006284),-0.17878173258190394,-0.6185744293510528,0.988479262672811,0.9860770057197665,1.0,13/48,23.59%,RPA1;PARG;USP47;PRMT6;TDG;NEIL3;RPA2;XPA;RFC4;MUTYH;POLD4;SMUG1;POLB
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.22788821253840247,-0.6179922041578464,0.9334677419354839,0.9859189545484361,1.0,7/16,31.28%,PIGC;PIGL;PIGX;PIGQ;PIGN;PIGF;PIGV
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.20847974096405977,0.6156936132768958,0.9666048237476809,1.0,1.0,5/29,16.64%,PLA2G4C;PNPLA8;NR1H3;PLAAT3;TMEM86B
prerank,mitotic DNA replication (GO:1902969),-0.2650520514050923,-0.6153923820081049,0.9187620889748549,0.9868106013326086,1.0,5/10,26.82%,CDC45;POLA1;MCM3;GINS3;MCM6
prerank,lysosome organization (GO:0007040),0.20234721486578874,0.6150809710762581,0.9658444022770398,1.0,1.0,10/36,22.72%,ZKSCAN3;SNAPIN;LRRK2;CLN5;HPS1;HOOK1;HPS4;GNPTAB;LAMTOR1;HOOK2
prerank,actin-myosin filament sliding (GO:0033275),-0.18471582890132313,-0.6138555518088059,0.9825870646766169,0.9866437120851151,1.0,15/38,36.05%,MYL6;TPM4;TPM2;TPM3;MYL4;DMD;TMOD1;NEB;TTN;MYBPC1;MYBPC2;TCAP;MYL3;ACTA1;TNNT3
prerank,muscle filament sliding (GO:0030049),-0.18471582890132313,-0.6138555518088059,0.9825870646766169,0.9866437120851151,1.0,15/38,36.05%,MYL6;TPM4;TPM2;TPM3;MYL4;DMD;TMOD1;NEB;TTN;MYBPC1;MYBPC2;TCAP;MYL3;ACTA1;TNNT3
prerank,peroxisomal membrane transport (GO:0015919),-0.19933881781949836,-0.6138166618806963,0.9632034632034632,0.9862047031822799,1.0,7/27,23.69%,ABCD2;PEX7;ACBD5;PEX14;PEX2;GDAP1;PEX12
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.23115494712651868,0.6135606896251392,0.9343629343629344,1.0,1.0,7/18,27.53%,PPARA;MIA3;AKT1;PAG1;WNK1;PTPN22;LAX1
prerank,negative regulation of chemokine production (GO:0032682),0.24254076831433308,0.6117996835716022,0.9163424124513618,1.0,1.0,4/14,18.76%,C1QTNF3;OAS3;IL6;SIRPA
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.253074740476197,0.6115116200967977,0.9192913385826772,1.0,1.0,8/13,29.58%,TNRC6A;CPEB3;TNRC6C;ZFP36;EIF4ENIF1;CNOT7;TNRC6B;TOB1
prerank,regulation of lymphocyte migration (GO:2000401),0.26122473064758245,0.6105765375646761,0.8982683982683982,1.0,1.0,4/10,23.93%,WASL;MIA3;AKT1;SLC8B1
prerank,protein import into peroxisome membrane (GO:0045046),-0.21098464040340603,-0.6095259175178946,0.9621052631578947,0.9878547560432273,1.0,11/22,38.94%,ABCD2;ACBD5;PEX14;PEX2;GDAP1;PEX12;RAB8B;SLC25A17;FIS1;PXMP4;PEX3
prerank,methylguanosine-cap decapping (GO:0110156),0.2621794583204895,0.6091428267955484,0.9097888675623801,1.0,1.0,4/10,23.18%,PATL1;EDC4;DCPS;DCP2
prerank,polyamine metabolic process (GO:0006595),0.24976837040045502,0.6088741073971973,0.924901185770751,1.0,1.0,3/13,22.30%,SAT1;DHPS;OAZ2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.22691126422025998,0.6088245349905131,0.9343629343629344,1.0,1.0,6/18,26.13%,RUVBL2;CCT3;CCT5;CCT8;DCP2;CCT6A
prerank,positive regulation of immune effector process (GO:0002699),0.2080663062948028,0.6084725193712409,0.9458041958041958,1.0,1.0,1/27,1.08%,APPL2
prerank,ruffle organization (GO:0031529),0.23333383297507104,0.6076813339382239,0.9233954451345756,1.0,1.0,4/16,22.19%,CORO1B;CYFIP1;INPP5K;PLEK
prerank,negative regulation of transferase activity (GO:0051348),-0.19326129821849933,-0.6070632966184091,0.9717391304347827,0.9886148930033632,1.0,12/28,34.03%,CDKN1C;SRC;BAG5;FBXO5;LIMK1;DTX3L;CDKN1B;MAPT;SMAD7;PARK7;PIF1;TP53
prerank,protein heterotetramerization (GO:0051290),0.24673701507435164,0.606871391472288,0.9204081632653062,1.0,1.0,2/13,7.76%,CPSF6;CPSF7
prerank,positive regulation of peptidase activity (GO:0010952),0.22068223960042063,0.6065760818095041,0.9551401869158879,0.9995158777938803,1.0,5/20,21.69%,CTSH;APH1A;NDUFA13;PSME2;RCN3
prerank,cell cycle checkpoint signaling (GO:0000075),0.2503789834524019,0.6061356825605032,0.9265873015873016,0.9990821141915152,1.0,3/12,19.49%,ZWINT;PRCC;WEE1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.24045422046090223,-0.6056704364788372,0.9268774703557312,0.9888172744209647,1.0,5/12,28.79%,CD44;CD74;TAF9;TRIAP1;MIF
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.2482581131127989,-0.604534886106346,0.9122448979591836,0.9884106364394258,1.0,10/10,75.20%,KLF4;MYADM;APOA1;IL10;IL1RN;ADIPOQ;MAPK7;MBP;MAP2K5;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.2482581131127989,-0.604534886106346,0.9122448979591836,0.9884106364394258,1.0,10/10,75.20%,KLF4;MYADM;APOA1;IL10;IL1RN;ADIPOQ;MAPK7;MBP;MAP2K5;WNK1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.21090099700999185,0.6044929302384405,0.9509433962264151,0.9992667248882217,1.0,10/25,28.01%,SRSF10;MPHOSPH10;PRPF6;PRPF3;SF3B1;SF3B3;WDR83;PRPF8;BCAS2;SNRNP40
prerank,regulation of lamellipodium organization (GO:1902743),-0.23176195585133108,-0.6034358433380517,0.9547325102880658,0.9884549949617836,1.0,5/14,26.41%,CD44;CDC42;CARMIL1;DMTN;TWF2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.2491661493367195,-0.6014030014276686,0.933852140077821,0.9888934192142065,1.0,3/11,20.63%,SIRT7;SMARCA4;NCL
prerank,regulation of defense response to virus by host (GO:0050691),0.20464199774468414,0.6010618174346243,0.9597806215722121,1.0,1.0,6/30,19.24%,PQBP1;ZDHHC1;STAT1;IL12RB1;HSP90AA1;SIN3A
prerank,T cell homeostasis (GO:0043029),-0.2564186904554936,-0.6000603109175617,0.9298597194388778,0.9890597630955169,1.0,5/10,29.99%,FAS;NCKAP1L;JAK3;FADD;PMAIP1
prerank,positive regulation of lipid storage (GO:0010884),-0.2114067526122615,-0.5996169365129174,0.9621848739495799,0.988779674338947,1.0,5/21,19.09%,SCARB1;SREBF2;C3;PLIN2;ZC3H12A
prerank,chemokine-mediated signaling pathway (GO:0070098),0.1913016572896537,0.5990238082243781,0.9706959706959707,1.0,1.0,2/42,4.13%,OXSR1;STK39
prerank,B cell activation involved in immune response (GO:0002312),0.24717539728530918,0.5967742091578281,0.9181636726546906,1.0,1.0,2/13,10.98%,MSH6;BATF
prerank,vitamin D metabolic process (GO:0042359),-0.23127461260874538,-0.595448175169342,0.946983546617916,0.9901802775365993,1.0,8/13,46.28%,CUBN;CYP2R1;LRP2;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.22613274002798672,-0.5950143211130575,0.9288537549407114,0.9899193898829682,1.0,3/14,13.42%,TSEN2;CPSF4;CLP1
prerank,histone H4 deacetylation (GO:0070933),-0.2532197386093221,-0.5947814778620472,0.9338842975206612,0.9895703218650501,1.0,3/10,26.26%,HDAC9;HDAC2;RCOR1
prerank,stress granule assembly (GO:0034063),0.21383365287277423,0.5934056268656438,0.9459459459459459,1.0,1.0,8/20,24.80%,ATXN2L;BICD1;OGFOD1;EIF2S1;DDX3X;YTHDF3;YTHDF2;CSDE1
prerank,regulation of B cell differentiation (GO:0045577),-0.21539515369103765,-0.5928487564203706,0.9519038076152304,0.9898891592635037,1.0,7/17,33.52%,ID2;NCKAP1L;BTK;SYK;ZFP36L2;IL4I1;IKZF3
prerank,lipoprotein transport (GO:0042953),0.26679300005442513,0.5920742420843432,0.906832298136646,1.0,1.0,4/10,26.10%,PRKCB;MIA3;VMP1;PPARG
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.23349042636186834,-0.5911797672263,0.951171875,0.9900881449797545,1.0,3/13,16.47%,SAE1;SENP6;UBA6
prerank,replication fork processing (GO:0031297),-0.17554814628809717,-0.5906907813312648,0.9772727272727273,0.9898295515510164,1.0,8/38,23.85%,MMS22L;BLM;BRCA2;BOD1L1;PRIMPOL;CENPX;NUCKS1;TRAIP
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.23381798500010473,0.5905168871439899,0.9508840864440079,1.0,1.0,5/14,25.10%,IKBKG;KCNN4;RELA;CD81;CD226
prerank,ncRNA export from nucleus (GO:0097064),0.1899664532801566,0.5886087128021248,0.9813432835820896,1.0,1.0,12/36,26.44%,POM121;NUP155;NUP98;TSC1;NUP37;NUP88;NDC1;RAE1;PHAX;NUP160;NPM1;NUP133
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.20626528940027195,0.5885463936388207,0.9582577132486388,1.0,1.0,3/23,10.95%,NR1H3;PARP14;STAT1
prerank,positive regulation of viral process (GO:0048524),-0.16131108880122919,-0.5883232095256504,0.9952941176470588,0.9903396398851599,1.0,16/60,26.95%,MDFIC;ADARB1;PABPC1;PPIA;GTF2F1;VAPB;KPNA2;PPIE;TMEM39A;POLR2I;POLR2F;TARBP2;TBC1D20;POLR2H;NELFCD;CCNT1
prerank,protein kinase A signaling (GO:0010737),0.2450552688668674,0.5879572296268389,0.9154639175257732,1.0,1.0,2/12,12.77%,TCP11;RAB13
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.264303768838717,0.5878967240418922,0.9375,1.0,1.0,3/10,19.23%,LEO1;CDC73;CPEB3
prerank,phospholipid dephosphorylation (GO:0046839),0.19096335184679444,0.5871798579290558,0.9759704251386322,1.0,1.0,10/37,20.98%,MTMR4;INPP5J;PLPPR3;SYNJ2;MTMR2;MTMR10;EPHX2;OCRL;INPP5K;PIP4P2
prerank,positive regulation of chemokine production (GO:0032722),-0.17143408284661482,-0.5871700808096031,0.989010989010989,0.9903087722170746,1.0,12/44,27.01%,APP;WNT5A;IL6R;TWIST1;CD74;CSF1R;IL33;HMGB1;SYK;TLR4;AIF1;HMOX1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.247247569210075,0.5864887601577706,0.9296875,0.9999123051909089,1.0,3/12,15.19%,INSIG2;ANKRD13C;RER1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.22749919036498956,-0.5864887198952817,0.9650924024640657,0.9900904101992132,1.0,8/16,30.55%,RRAGA;KLHL22;CLEC16A;RRAGD;SIK3;GPR137B;LAMTOR5;FLCN
prerank,RNA stabilization (GO:0043489),0.19105996185169907,0.586176649495576,0.9685314685314685,0.999393203850849,1.0,6/33,15.24%,HNRNPU;E2F1;ELAVL1;VIP;NSUN2;PAIP1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.22716699378702765,-0.5859265635831573,0.9664570230607966,0.9898364089444036,1.0,3/14,17.60%,RPL7;RPL35;ZNHIT6
prerank,spliceosomal snRNP assembly (GO:0000387),0.1848266688379318,0.5857927658851917,0.9822064056939501,0.9989024257061927,1.0,13/38,26.33%,STRAP;SRSF10;PRPF19;LSM4;SNUPN;PRPF6;PRPF3;SNRPB;PRMT5;SART3;SNRPC;PRPF8;GEMIN7
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.19790370025644277,-0.5845844152517448,0.9744680851063829,0.9898786430775657,1.0,5/25,17.68%,TNFSF10;MFF;BBC3;PLAUR;GPER1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.23149536454611377,0.5844180662454933,0.9428007889546351,0.998862343373209,1.0,5/15,17.55%,BCL2;MUC1;SIRT1;MDM2;KDM1A
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.21621191486442656,-0.5832701552777728,0.9495798319327731,0.9899272953460145,1.0,8/16,38.76%,APOE;MYOCD;LRP1;ROCK1;TREM2;ABCA7;HDAC1;IL4
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2341952209842567,-0.5827761105638264,0.9531568228105907,0.9896449719213348,1.0,1/12,4.20%,JUN
prerank,positive regulation of lipid localization (GO:1905954),-0.24578329578464697,-0.5827293194330477,0.9438669438669439,0.9892033863782929,1.0,4/11,26.12%,LRP1;C3;ZC3H12A;HILPDA
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.23590279447541965,0.5808822634240612,0.936127744510978,0.9997182311947593,1.0,3/13,14.64%,MBD4;UPP2;NEIL1
prerank,macrophage migration (GO:1905517),0.24039427423405307,0.5806468234201908,0.9464285714285714,0.9991592626908162,1.0,13/13,75.98%,P2RX4;P2RY12;EDNRB;CCL2;SAA1;EDN2;CKLF;LGALS3;CCL3;CCL5;CXCL17;CCR2;TAFA4
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.21799479237979882,-0.578912881826905,0.9536290322580645,0.9901509480390721,1.0,10/15,48.62%,NUDT16;ZC3H12A;NYNRIN;POP7;RPP40;ZC3H12D;RNASEH1;LACTB2;ZC3H12C;SLFN14
prerank,regulation of leukocyte migration (GO:0002685),-0.21494587410760643,-0.5785022665556055,0.9501039501039501,0.9898618818904047,1.0,3/16,16.03%,ANXA1;VEGFA;NCKAP1L
prerank,protein localization to centrosome (GO:0071539),-0.21386720250924734,-0.577567812011632,0.9642105263157895,0.9897511270332494,1.0,11/17,40.98%,PIBF1;SNX10;STIL;CSNK1D;CEP131;CEP83;GOLGB1;CCDC14;HOOK3;BBS4;DCTN2
prerank,sulfur amino acid catabolic process (GO:0000098),0.25133387734605495,0.5764365833357242,0.9298969072164949,1.0,1.0,10/10,74.88%,CTH;BLMH;MTRR;MAT1A;GADL1;TST;TXN2;ADO;CBS;MPST
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.20348676059625437,0.5762143028063331,0.9628180039138943,0.9996900260560885,1.0,3/24,8.29%,HNRNPU;TNKS2;GNL3L
prerank,inhibitory synapse assembly (GO:1904862),0.24117282008982527,0.573676432973771,0.9559748427672956,1.0,1.0,3/11,18.56%,CBLN4;GABRB2;GABRB3
prerank,nucleic acid metabolic process (GO:0090304),0.16507383724110505,0.5731968401535409,0.9948275862068966,0.9995729724647915,1.0,17/69,23.82%,HNRNPA2B1;DUSP11;HNRNPU;HNRNPA3;HNRNPL;PTBP1;LSM8;POLR2D;POLG;HNRNPH2;POLR2A;HNRNPH1;DNASE1L2;MMS19;DDX24;POLR2B;HNRNPC
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.2462141510220458,0.5726161396056557,0.9493927125506073,0.9984794886100216,1.0,4/11,20.57%,CCT3;CCT5;CCT8;LARP7
prerank,regulation of protein localization to Cajal body (GO:1904869),0.2462141510220458,0.5726161396056557,0.9493927125506073,0.9984794886100216,1.0,4/11,20.57%,CCT3;CCT5;CCT8;LARP7
prerank,transcription preinitiation complex assembly (GO:0070897),0.2416347542218594,0.5717659221060725,0.9515151515151515,0.9981537028726463,1.0,12/12,75.85%,TAF1;DR1;GTF2A2;TAF12;GTF2B;TBP;TAF11;TAF7L;TAF1B;BDP1;TAF7;POLR1E
prerank,axoneme assembly (GO:0035082),0.1881785811199682,0.5714927037369758,0.9830827067669173,0.9975997243142702,1.0,3/31,13.59%,RSPH4A;DRC1;DNAAF2
prerank,P-body assembly (GO:0033962),-0.22862723862419776,-0.570012656682775,0.9525773195876288,0.9918919206296795,1.0,5/12,32.62%,LIMD1;DYNC1H1;LSM3;PATL2;EDC3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2295328980411852,0.5694613507521619,0.9576107899807321,0.9977136110450494,1.0,13/13,77.07%,VDAC2;BAX;RHOT1;BLOC1S2;BAD;RTL10;MOAP1;BNIP3L;BNIP3;BCL2L11;BMF;PMAIP1;RHOT2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.21619808042346467,0.5688747546584723,0.9662698412698413,0.9972890174937132,1.0,4/18,11.83%,NLRC3;MED25;CD300A;CDC73
prerank,negative regulation of interleukin-17 production (GO:0032700),0.24324251528277818,0.5686035936295367,0.9284332688588007,0.9967346708138711,1.0,3/10,19.69%,IL12A;PRNP;DDIT3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.20201673542734377,-0.5678244648529828,0.985200845665962,0.9921407689513928,1.0,8/19,32.53%,TRIL;NR1H4;NMI;RAB11FIP2;PRKCE;TLR4;LGALS9;CD14
prerank,cell differentiation in spinal cord (GO:0021515),0.2539367322502616,0.5677559407835205,0.9227642276422764,0.9963695497232579,1.0,2/10,17.37%,MDGA2;SOX6
prerank,microtubule-based transport (GO:0099111),-0.2265067361456652,-0.5673436838103231,0.9651639344262295,0.9918460538852746,1.0,5/13,26.04%,DYNC1I2;DYNC1I1;CABYR;ADCY10;SPEF2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.21116178778674083,-0.5669971177453081,0.9524793388429752,0.9914826296658474,1.0,3/16,13.63%,CEACAM1;STX7;PTPRC
prerank,regulation of defense response to virus (GO:0050688),0.22662080467670592,0.5667350747237583,0.9417293233082706,0.9960955500915224,1.0,4/14,21.27%,C1QBP;PPM1B;RNF26;ILRUN
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.20294100631003084,-0.5664272883804482,0.9683168316831683,0.9912077730823022,1.0,8/19,32.42%,SRC;TENT4B;TEN1;CTC1;TINF2;TERF2;XRN1;PIF1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.23307660702608837,-0.5657338496656954,0.9653061224489796,0.9909939112342987,1.0,8/12,40.02%,SREBF2;SREBF1;LPCAT3;MBTPS2;H6PD;RAN;DGKQ;KPNB1
prerank,B cell mediated immunity (GO:0019724),-0.23688105344281388,-0.563694306014797,0.9567099567099567,0.9911871408244993,1.0,5/10,44.08%,CD74;FCGR2B;FCER1G;CARD9;SLA2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.21699401922971018,-0.5635827187034416,0.973305954825462,0.9907669231050417,1.0,10/15,40.98%,PIBF1;SNX10;STIL;CSNK1D;CEP131;CEP83;CCDC14;HOOK3;BBS4;DCTN2
prerank,toxin transport (GO:1901998),-0.24581607038811104,-0.5634969373289933,0.9401197604790419,0.9903418435120326,1.0,1/10,6.18%,ADAM10
prerank,mitochondrion transport along microtubule (GO:0047497),-0.22298085918959687,-0.5632597277949506,0.9454545454545454,0.9899661252128731,1.0,4/13,27.92%,UBB;RHOT2;SYBU;MAPT
prerank,programmed necrotic cell death (GO:0097300),-0.2062180532788845,-0.5625625167335901,0.9796334012219959,0.9897072937122894,1.0,8/18,32.90%,IPMK;MLKL;RIPK1;TICAM1;CYLD;TLR4;CD14;TLR3
prerank,protein ADP-ribosylation (GO:0006471),-0.18177856419978505,-0.5621650168413972,0.9836065573770492,0.9893852149116602,1.0,8/28,25.11%,TNKS;ART3;HPF1;SIRT5;PARP8;SIRT6;PARP3;PARP12
prerank,piRNA metabolic process (GO:0034587),0.20801406858434862,0.5606133540464006,0.97,0.9975272966048163,1.0,19/19,79.22%,TDRD9;MYBL1;DDX4;TDRD12;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;TEX15;FKBP6;TDRKH;PIWIL4;EXD1;PIWIL2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.21775235823520736,0.5595058621851481,0.9516441005802708,0.997251380246959,1.0,5/15,23.97%,EBI3;NKAP;IL12A;SHH;PNP
prerank,negative regulation of receptor internalization (GO:0002091),-0.2268241954126352,-0.5576089697036476,0.9517374517374517,0.9902871497580124,1.0,5/12,30.07%,ANKRD13A;ANKRD13B;ANKRD13D;NECAB2;WDR54
prerank,extracellular transport (GO:0006858),0.2236401611783829,0.5543939219164227,0.9535353535353536,0.9982524320609574,1.0,3/13,18.94%,ROPN1L;DNAAF2;SPA17
prerank,protein targeting to lysosome (GO:0006622),0.20298313165834983,0.5511751453819234,0.9724950884086444,0.9986779249902431,1.0,4/20,13.79%,SNX16;LAMP2;CLU;AP4M1
prerank,eosinophil migration (GO:0072677),-0.2137359848015335,-0.5510324747240346,0.9740518962075848,0.991286460564689,1.0,9/14,48.21%,CCL13;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.2137359848015335,-0.5510324747240346,0.9740518962075848,0.991286460564689,1.0,9/14,48.21%,CCL13;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.22107275089084943,-0.5505225223571926,0.9744094488188977,0.9909875027959073,1.0,7/12,37.85%,ADSS1;IMPDH1;ADSS2;PAICS;IMPDH2;GART;PPAT
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.1669144695511356,-0.550266702420703,0.9862385321100917,0.9905987492194389,1.0,7/37,17.90%,ANKRD13A;APOE;EDN1;SIRT5;AP1AR;MT3;ANKRD13B
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.19387271367335715,0.5501178372538386,0.974,0.9983392114845832,1.0,6/23,20.76%,COX18;TOMM22;NDUFA13;HSP90AA1;MAIP1;BAX
prerank,apoptotic nuclear changes (GO:0030262),0.19443674052806684,0.54922131369615,0.9757009345794393,0.9979827824950575,1.0,5/24,16.96%,CASP3;DFFA;ACIN1;DICER1;EXOG
prerank,positive regulation of cilium assembly (GO:0045724),0.20383959966697057,0.547665509015623,0.950920245398773,0.9977765268078951,1.0,2/18,8.94%,SEPTIN9;HTT
prerank,tRNA 5'-leader removal (GO:0001682),0.22062778078698003,0.5455880521202179,0.963531669865643,0.9977790876093904,1.0,3/13,21.60%,POP4;RPP25L;RPP30
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.16121156530387812,0.5438565809716338,0.9982698961937716,0.9976245815669446,1.0,14/52,23.21%,EXOSC8;PATL1;LSM5;LSM4;EXOSC2;TUT4;POLR2D;EDC4;CNOT3;CNOT8;DCPS;PNLDC1;DCP2;PAN2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.19029970972246715,-0.5398879957452528,0.9849462365591398,0.9928949590715771,1.0,11/20,37.85%,HPRT1;ADSS1;IMPDH1;AK4;AMPD2;ADSS2;PAICS;IMPDH2;GART;AMPD1;PPAT
prerank,glycoprotein catabolic process (GO:0006516),-0.19155355524531684,-0.5379265028879391,0.9807321772639692,0.992921372284443,1.0,6/17,28.93%,STT3B;FBXO44;ADAMTS12;EDEM2;EDEM1;FBXO2
prerank,V(D)J recombination (GO:0033151),-0.22430803277781314,-0.5365470001277216,0.9574036511156186,0.9927858576849075,1.0,3/11,23.02%,LIG4;HMGB1;DCAF1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.19846752920487382,0.5321639771354886,0.9783464566929134,1.0,1.0,19/19,80.18%,ROPN1L;DNAAF2;SPA17;ODAD4;OFD1;CCDC39;CCDC103;SPAG17;AQP4;NEK10;DNAAF1;RFX3;DNAAF4;CCDC40;NPHP3;SPEF2;ADCY10;CFAP53;CABYR
prerank,histone mRNA metabolic process (GO:0008334),0.180264259543097,0.5302229072894695,0.994263862332696,1.0,1.0,5/27,16.00%,CPSF3;TUT4;SLBP;LSM11;ATM
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.1774008517606897,-0.5273471350297189,0.9936440677966102,0.9944288505031048,1.0,8/23,30.42%,PIK3R6;NECTIN2;PVR;ARRB2;CADM1;RAET1E;RASGRP1;LGALS9
prerank,mitochondrial genome maintenance (GO:0000002),-0.22217661326628937,-0.5260334537099198,0.9849785407725322,0.9942498666757701,1.0,1/11,3.36%,AKT3
prerank,negative regulation of centrosome duplication (GO:0010826),0.2235823861082134,0.5259873204069242,0.9708333333333333,1.0,1.0,2/11,11.10%,CENATAC;TMEM67
prerank,mRNA modification (GO:0016556),0.1877647070538323,0.5250060705798265,0.974308300395257,0.9999835018326984,1.0,8/22,25.21%,NSUN2;TRMT6;TRMT61B;TRMT10C;RPUSD2;ZC3H13;METTL8;TRUB1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.2194086837512309,-0.5239444469738775,0.9568788501026694,0.9942477950140786,1.0,6/11,42.00%,HDAC2;TMEM106A;TAF7;PF4;IL4;XBP1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.1770773096925986,-0.5226608449033262,0.9898785425101214,0.9940667409301513,1.0,8/22,28.05%,PPP1CA;DUSP6;PPP2CA;DUSP1;PDP1;DUSP7;DUSP18;PPP5C
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.172004554296308,0.5198311510556363,0.996268656716418,0.9998337939216553,1.0,6/32,19.51%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1
prerank,tRNA export from nucleus (GO:0006409),0.172004554296308,0.5198311510556363,0.996268656716418,0.9998337939216553,1.0,6/32,19.51%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1
prerank,protein localization to phagophore assembly site (GO:0034497),0.21876091601010322,0.5167178577353554,0.961864406779661,0.999873090686171,1.0,5/11,24.30%,MFN2;ATG13;WDR45;TRAPPC8;PACS2
prerank,regulation of mitochondrial translation (GO:0070129),-0.1761696711326534,-0.514480701748972,0.989010989010989,0.9951671181966373,1.0,9/21,36.22%,ALKBH1;NGRN;MTG1;SHMT2;RPUSD3;MTG2;MRPS27;MALSU1;TRUB2
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.18500549715227016,-0.5133281650555015,0.9797160243407708,0.99492504503305,1.0,6/18,32.90%,FBN1;FBXW7;TLR4;GPR137B;LRRC17;TLR3
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.2187365713422431,-0.5124336448582406,0.9723320158102767,0.9946218781769014,1.0,4/10,34.45%,QDPR;KYNU;IL4I1;PCBD1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.1979415531030927,0.512166460458783,0.9847036328871893,1.0,1.0,7/16,32.58%,TRIM71;CPEB3;ZFP36;ZFP36L1;UPF1;PLEKHN1;TARDBP
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.20580984608705474,-0.5114732748554718,0.9766990291262136,0.9943380682131909,1.0,6/12,36.15%,CDC45;MCM3;MCM5;MCM6;GINS2;MUS81
prerank,regulation of oxidoreductase activity (GO:0051341),0.20957524608138317,0.5098303768472391,0.9824175824175824,0.9999935708298846,1.0,4/13,19.96%,ABL1;ATP7A;OXA1L;ECSIT
prerank,serine family amino acid metabolic process (GO:0009069),0.19202782590072454,0.5027312861146449,0.9865384615384616,1.0,1.0,4/16,16.79%,GLYAT;CDO1;MTHFD1;CTH
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.19738824711200403,-0.502624328202602,0.9815950920245399,0.9953548257752319,1.0,13/13,80.28%,ALG6;ALG3;ALG11;ALG13;ALG1;SRD5A3;ALG8;ALG14;ALG9;MPDU1;ALG12;ALG2;DPAGT1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.17109237624728113,0.5001372231061021,0.9840319361277445,1.0,1.0,6/23,23.04%,GSTM2;EPHX2;GSTM1;ALOX5;ACSBG1;GPX4
prerank,tRNA transport (GO:0051031),0.16133873706871116,0.4984309830159631,0.9963503649635036,1.0,1.0,6/35,19.51%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.21778843072466986,0.49803206316415105,0.9728155339805825,0.9995587105400726,1.0,1/10,6.92%,PDK2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.1931131902905774,0.4970152516390227,0.988929889298893,0.9990836899386106,1.0,1/16,5.33%,VAMP7
prerank,negative regulation of lipid catabolic process (GO:0050995),0.1889863154444598,0.4924534579825766,0.9884169884169884,0.9992080183967207,1.0,1/17,4.37%,ADRA2A
prerank,intermediate filament organization (GO:0045109),-0.18122085150859898,-0.4893503236252406,0.993801652892562,0.9968610809564136,1.0,3/17,21.30%,GFAP;DSP;BFSP2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.20334731844099477,0.48804838882683793,0.982421875,0.9992534693319399,1.0,4/12,23.09%,CHEK2;CLSPN;RAD17;NAE1
prerank,cranial nerve development (GO:0021545),-0.20241548177455798,-0.4861248405465233,0.9799599198396793,0.9968485874077786,1.0,6/11,40.22%,TMEM126A;SALL1;POU4F1;TIFAB;ISL1;ERBB3
prerank,central nervous system myelination (GO:0022010),-0.20091979014301067,-0.4853162524038637,0.9874213836477987,0.9965065673144146,1.0,5/11,34.50%,B4GALT5;PTEN;MYRF;B4GALT6;TENM4
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.20055521114401342,0.48440850436884225,0.9806201550387597,0.9991260946904662,1.0,5/13,23.25%,STX4;SNX33;GPD1L;RIC3;MAP1A
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.17251008413063254,0.4833452744645533,0.9942748091603053,0.9986286948982589,1.0,4/23,16.96%,CASP3;DFFA;DICER1;EXOG
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.19316072155401703,-0.4787669609822042,0.988,0.9968207501710576,1.0,5/12,28.72%,TNKS;PARP8;PARP3;PARP12;PARP1
prerank,rRNA catabolic process (GO:0016075),0.18456511838736994,0.47559114611584263,0.9924098671726755,0.9990811783169691,1.0,2/16,11.29%,EXOSC8;EXOSC2
prerank,positive regulation of calcium ion import (GO:0090280),-0.19226117733539844,-0.4745996754524682,0.9919191919191919,0.9968180942443242,1.0,1/12,6.52%,CXCL12
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.1836411496811112,0.47357355562942494,0.988394584139265,0.9987056978637121,1.0,7/17,29.24%,NUS1;DPAGT1;ALG2;ALG12;DOLPP1;MPDU1;ALG9
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.15918337454880405,0.4731446224809581,0.9963768115942029,0.998117160141444,1.0,9/29,27.46%,KLRD1;SLAMF6;ITGAM;IL12A;IL12RB1;LAMP1;CD226;CYRIB;AP1G1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.19855618330194602,0.46919169064873234,0.9943396226415094,0.9979636300536214,1.0,11/11,80.16%,ITGAM;STX4;MAVS;CAMK4;ITGB2;CD177;F2RL1;STAP1;TYROBP;TICAM1;SPI1
prerank,nucleosome assembly (GO:0006334),0.15679481924101524,0.46513576011255675,1.0,0.9977974021493866,1.0,11/31,26.20%,SOX9;BRD2;NAP1L2;CABIN1;IPO4;KAT6B;SPTY2D1;SART3;ATRX;NPM1;ANP32B
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.17313764527971048,-0.46353319265815685,0.9917864476386037,0.9974897536399118,1.0,9/16,37.85%,ADSS1;IMPDH1;AMPD2;ADSS2;PAICS;IMPDH2;GART;AMPD1;PPAT
prerank,immunoglobulin mediated immune response (GO:0016064),-0.19372856748057388,-0.45981121177263284,0.9937369519832986,0.9973704287789849,1.0,2/10,22.51%,CD74;FCGR2B
prerank,cytoplasmic translational initiation (GO:0002183),0.17651899898900678,0.4530862001338902,0.9957894736842106,0.9983629656813591,1.0,8/17,29.83%,EIF4A2;EIF3A;EIF2D;DENR;EIF3D;RBM4;EIF2S2;DHX29
prerank,regulation of protein kinase A signaling (GO:0010738),-0.15680568044484233,-0.45233412786228655,0.9978813559322034,0.9975437246833395,1.0,11/20,42.17%,IAPP;TCIM;PRKAR2B;PRKAR1B;PRKAR2A;MIF;RAMP3;AKAP12;FSHR;PJA2;MC1R
prerank,regulation of response to oxidative stress (GO:1902882),0.18878758231757017,0.4454356601578151,0.9917525773195877,0.9984027524885442,1.0,2/11,14.30%,ABCD1;AIFM2
prerank,microglial cell activation (GO:0001774),-0.1502659246536524,-0.4414634133840274,0.9960474308300395,0.9978279440365133,1.0,1/21,3.64%,APP
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.19031801500335918,0.43524289660979865,0.9963963963963964,0.9985117900935255,1.0,2/10,18.83%,NR1H3;TIRAP
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.14841566022892924,0.43283955666574286,0.9962825278810409,0.9980552505829235,1.0,3/27,9.59%,LPAR1;DRD3;C3AR1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.15946418612042434,-0.41568455158884016,0.997872340425532,0.9987240113676895,1.0,6/15,32.58%,ACACB;MLYCD;PMVK;HMGCS2;NUDT7;ACLY
prerank,long-term memory (GO:0007616),0.15119680868005145,0.40836748130333494,1.0,0.9986612219069183,1.0,7/19,30.10%,SHANK1;PRNP;CPEB3;SGK1;RASGRF1;CAMK4;EIF2AK4
